Citrus Sinensis ID: 016401

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390
Protein Sequence
MASASLGNGGVGSSRSVNGFKNIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccEEEEEEEcccccccccEEEEEEEEEEEccccEEEEEEEEcccccEEEEEEccccccHHHHHHHHHHHcccccEEEEcEEEEcccccccEEEEEEEEcccccHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccccccccccEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccccccHHHHHHccHHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
ccccEcccccccccccccccccEcccccccccEEEEEEEccccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHHcHHHHHHHcccccccc
Coil and Loop (DISEMBL)
masaslgnggvgssrsvngfkniidgvgaetGHVIRttiggrngnskqKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLdhpnivalkhcffsttDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCigichrdikpqnllvnphthqlklcdfgsakvlvkgepnvsyicsryyrapelifgateyttaIDIWSTGCVMAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikphpwhkvfqkrlppeaVDLVCRffqyspnlrctaleacvhpffdelrdpntrlpngrplpplfnfkppelsgippetinrlipEHARKQNLFMALHS
Flexible Loop (DISEMBL)
masaslgnggvgssrsvNGFKNIIDGVGAETGHVIrttiggrngnskQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVaikkvlqdkrYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNysrihqrmpLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Low Complexity Region (SEG)
MASAslgnggvgssrsvngFKNIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKeelylnlvleyvpeTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Disordered region (IsUnstruct)
*****************NGFKNIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR**************************************************
Disordered Region (DISOPRED)
*********************************VIRTTIG****NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQN*******
Disordered Region (DISEMBL)
************SSRSVNGFKNIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Disordered Region (DISPRO)
**********************IID***AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLF*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASASLGNGGVGSSRSVNGFKNIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	390	2.2.26 [Sep-21-2011]
Q39019	421	Shaggy-related protein ki	yes	no	0.997	0.923	0.827	0.0
Q9FVS6	420	Shaggy-related protein ki	no	no	0.989	0.919	0.816	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	0.938	0.892	0.819	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.923	0.875	0.825	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.938	0.890	0.809	0.0
P43288	405	Shaggy-related protein ki	no	no	0.941	0.906	0.809	0.0
P43289	409	Shaggy-related protein ki	no	no	0.941	0.897	0.803	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	0.941	0.892	0.809	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	0.923	0.880	0.816	0.0
Q96287	472	Shaggy-related protein ki	no	no	0.917	0.758	0.773	1e-174

>sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2

 Score =  726 bits (1873), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/422 (82%), Positives = 369/422 (87%), Gaps = 33/422 (7%)

Query: 1   MASASLGNGGVGSSRSVNGFK--------------------------------NIIDGVG 28
           MAS+ LGNG VG+SRS  G K                                +IIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 29  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 88
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 89  YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 148
           YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 149 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 209 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 328
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 329 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 388
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEHARKQNLFMAL
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

Query: 389 HS 390
           HS
Sbjct: 420 HS 421

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1

 Score =  710 bits (1832), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/419 (81%), Positives = 365/419 (87%), Gaps = 33/419 (7%)

Query: 4   ASLGNGGVGSSRSVNGFKN--------------------------------IIDGVGAET 31
           + LGNG VGSSRS    KN                                IIDGVGAE 
Sbjct: 3   SHLGNG-VGSSRSAKNTKNTSSSVDWLSRDMLEMKIRDKTEADEERDSEPDIIDGVGAEP 61

Query: 32  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 91
           GHVI TT+ GRNG S+Q VSYIAEHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKRYKN
Sbjct: 62  GHVITTTLPGRNGQSRQTVSYIAEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKN 121

Query: 92  RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 151
           RELQIMQMLDHPN+V LKH F+S T+ EE+YLNLVLE+VPETVNR AR+YSR++Q MPLI
Sbjct: 122 RELQIMQMLDHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNRTARSYSRMNQLMPLI 181

Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
           YVKLYTYQICR LAY+HNC G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+S
Sbjct: 182 YVKLYTYQICRGLAYLHNCCGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNIS 241

Query: 212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
           YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT
Sbjct: 242 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 301

Query: 272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
           PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTA+EAC
Sbjct: 302 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAVEAC 361

Query: 332 VHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS 390
           +HPFFDELRDPN RLPNGRPLPPLFNFKP ELSGIPPET++RL+PEHARKQN FMALHS
Sbjct: 362 IHPFFDELRDPNARLPNGRPLPPLFNFKPQELSGIPPETVDRLVPEHARKQNHFMALHS 420

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  650 bits (1678), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 300/366 (81%), Positives = 332/366 (90%)

Query: 23  IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
           ++DG G ETGH+I TTIGG+NG  KQ +SY+AE +VG GSFG+VFQAKC ETGE VAIKK
Sbjct: 45  VVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKK 104

Query: 83  VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 142
           VLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV R++++YS
Sbjct: 105 VLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYS 164

Query: 143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
           R +QRMP+IYVKLYTYQICRALAYIH  +G+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKV
Sbjct: 165 RANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 224

Query: 203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
           LVKGEPN+SYICSRYYRAPELIFGATEYTT IDIWS GCV+AELLLGQPLFPGESGVDQL
Sbjct: 225 LVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQL 284

Query: 263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
           VEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR PPEAVDLV R  QYSPN
Sbjct: 285 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPN 344

Query: 323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
           LR TA+EA VHPFFDELRDPNTRLPNGR LPPLFNFKP EL G   E +++LIP+HARKQ
Sbjct: 345 LRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQ 404

Query: 383 NLFMAL 388
             F+AL
Sbjct: 405 CSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 297/360 (82%), Positives = 330/360 (91%)

Query: 23  IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
           I+DG G ETGH+I TTIGG+NG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKK
Sbjct: 45  IVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKK 104

Query: 83  VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 142
           VLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ R+Y+
Sbjct: 105 VLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYN 164

Query: 143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
           +++QRMP+IYVKLY+YQICRALAYIHN IG+CHRDIKPQNLLVNPHTHQLK+CDFGSAKV
Sbjct: 165 KMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKV 224

Query: 203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
           LVKGEPN+SYICSRYYRAPELIFGATEYTTAIDIWS GCV+ ELLLGQPLFPGESGVDQL
Sbjct: 225 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQL 284

Query: 263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
           VEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPN
Sbjct: 285 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 344

Query: 323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
           LR TALEA VHPF+D++RDPNTRLPNGR LPPLFNFK  EL G+P E + +L+P HARKQ
Sbjct: 345 LRSTALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQ 404

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  642 bits (1657), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 297/367 (80%), Positives = 331/367 (90%), Gaps = 1/367 (0%)

Query: 22  NIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK 81
           +++DG   E GHVI TTIGG+NG  KQ +SY+AE  VG GSFGVVFQAKC ETGE VAIK
Sbjct: 44  HVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIK 103

Query: 82  KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY 141
           KVLQDKRYKNRELQ M++LDHPN+V LKHCFFSTT+K+ELYLNLVLE+VPETV+R+ R+Y
Sbjct: 104 KVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHY 163

Query: 142 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
           S+++QRMPLIYVKLY+YQICR+LAYIHNC+G+ HRDIKPQNLLVNPHTHQLKLCDFGSAK
Sbjct: 164 SKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAK 223

Query: 202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
           VLVKGEPN+SYICSRYYRAPELIFGATEYT+AIDIWS GCV+ ELLLGQPLFPG SGVDQ
Sbjct: 224 VLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQ 283

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F+KR+PPEAVDLV R  QYSP
Sbjct: 284 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSP 343

Query: 322 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
           NLR TALEA VHPFFDELRDPNTRLPNGR LPPLFNFK  EL G+P E + +L+P HARK
Sbjct: 344 NLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHARK 403

Query: 382 Q-NLFMA 387
           Q +LF +
Sbjct: 404 QCSLFAS 410

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  641 bits (1654), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 297/367 (80%), Positives = 332/367 (90%)

Query: 22  NIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK 81
            ++DG G ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIK
Sbjct: 39  TVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIK 98

Query: 82  KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY 141
           KVLQD+RYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y
Sbjct: 99  KVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHY 158

Query: 142 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
           ++++QRMPLIYVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAK
Sbjct: 159 NKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 218

Query: 202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
           VLVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGESGVDQ
Sbjct: 219 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQ 278

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSP
Sbjct: 279 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP 338

Query: 322 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
           NLR  AL+  VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+PEHARK
Sbjct: 339 NLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARK 398

Query: 382 QNLFMAL 388
           Q  ++ L
Sbjct: 399 QCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  640 bits (1652), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 295/367 (80%), Positives = 334/367 (91%)

Query: 22  NIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK 81
            I++G   ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIK
Sbjct: 43  TIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIK 102

Query: 82  KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY 141
           KVLQD+RYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y
Sbjct: 103 KVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHY 162

Query: 142 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
           ++++QRMPL+YVKLYTYQI R+L+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAK
Sbjct: 163 NKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 222

Query: 202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
           VLVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGESGVDQ
Sbjct: 223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQ 282

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSP
Sbjct: 283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP 342

Query: 322 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
           NLRC AL++ VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+PEHARK
Sbjct: 343 NLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARK 402

Query: 382 QNLFMAL 388
           Q  +++L
Sbjct: 403 QCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  640 bits (1652), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 297/367 (80%), Positives = 330/367 (89%)

Query: 22  NIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK 81
            ++DG G ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIK
Sbjct: 45  TVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIK 104

Query: 82  KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY 141
           KVLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y
Sbjct: 105 KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHY 164

Query: 142 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
           S+++QRMP+IYVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAK
Sbjct: 165 SKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 224

Query: 202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
           VLVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE GVDQ
Sbjct: 225 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQ 284

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+P EAVDLV R  QYSP
Sbjct: 285 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSP 344

Query: 322 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
           NLRC AL+   HPFFDELRDPN RLP GR LPPLFNFKP EL G+P ET+ +L+PEHARK
Sbjct: 345 NLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHARK 404

Query: 382 QNLFMAL 388
           Q  F+ L
Sbjct: 405 QCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  633 bits (1632), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 294/360 (81%), Positives = 326/360 (90%)

Query: 23  IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
           I+DG G ETGH+I TTIGGR+G  KQ +SY+AE +VG GSFGVVFQAKC ETGE VAIKK
Sbjct: 44  IVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKK 103

Query: 83  VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 142
           VLQDKRYKNRELQ M++LDHPN+V LKHCFFSTT+K+E+YLNLVLEYVPETV+R+ ++Y+
Sbjct: 104 VLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYN 163

Query: 143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
           +++QRMPLI VKLYTYQI RAL+YIH+ IG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKV
Sbjct: 164 KLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 223

Query: 203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
           LVKGEPN+SYICSRYYRAPELIFGATEYTTAIDIWS GCV+AELLLGQPLFPGESGVDQL
Sbjct: 224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQL 283

Query: 263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
           VEIIKVLGTPTREEIKCMNPNY EFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPN
Sbjct: 284 VEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 343

Query: 323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
           LRCTALEA  H FFDELRDPNTRLPNGR LPPLFNFK  EL G+  E + +L+PEHARKQ
Sbjct: 344 LRCTALEAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPEHARKQ 403

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  611 bits (1576), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 277/358 (77%), Positives = 315/358 (87%)

Query: 23  IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
           +++G G ETG VI TT+GGR+G  KQ +SY+A+ VVGTGSFGVVFQAKC ETGE VAIKK
Sbjct: 109 VVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKK 168

Query: 83  VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 142
           VLQDKRYKNRELQIM++ DHPN+V L+H FFSTTDK+ELYLNLVLEYVPETV R +++Y+
Sbjct: 169 VLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYT 228

Query: 143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
           +++Q MP+I+V+LYTYQICRAL Y+H  +G+CHRDIKPQNLLVNP THQLK+CDFGSAK+
Sbjct: 229 KMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKM 288

Query: 203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
           LV GEPN+SYICSRYYRAPELIFGATEYT AID+WS GCVMAELLLGQPLFPGESG+DQL
Sbjct: 289 LVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQL 348

Query: 263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
           VEIIK+LGTPTREEI+CMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPN
Sbjct: 349 VEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 408

Query: 323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHAR 380
           LRCTALEAC HPFFD+LRDPN  LPNGR LPPLFNF   EL+G   E   RLIP H +
Sbjct: 409 LRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	390
449460309	428	PREDICTED: shaggy-related protein kinase	1.0	0.911	0.886	0.0
225465185	422	PREDICTED: shaggy-related protein kinase	1.0	0.924	0.879	0.0
224119932	422	predicted protein [Populus trichocarpa]	1.0	0.924	0.874	0.0
224129720	422	predicted protein [Populus trichocarpa]	1.0	0.924	0.872	0.0
357445263	428	Glycogen synthase kinase-3-like protein	1.0	0.911	0.859	0.0
359806970	420	uncharacterized protein LOC100799387 [Gl	0.946	0.878	0.959	0.0
24637171	432	GSK-3-like protein MsK4 [Medicago sativa	0.946	0.854	0.962	0.0
359806021	420	uncharacterized protein LOC100820098 [Gl	0.946	0.878	0.951	0.0
116787454	424	unknown [Picea sitchensis]	1.0	0.919	0.834	0.0
15218288	421	Shaggy-related protein kinase kappa [Ara	0.997	0.923	0.827	0.0

>gi|449460309|ref|XP_004147888.1| PREDICTED: shaggy-related protein kinase kappa-like [Cucumis sativus]

 Score =  775 bits (2001), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/422 (88%), Positives = 385/422 (91%), Gaps = 32/422 (7%)

Query: 1   MASASLGNGGVGSSRSVNGFK--------------------------------NIIDGVG 28
           MASASLGNGGVGSSRS+NGFK                                +IIDGVG
Sbjct: 7   MASASLGNGGVGSSRSINGFKGSSSSVDWLGREMLEMRLRDKTDTDEDRDSEPDIIDGVG 66

Query: 29  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 88
           AE GHVIRTTIGGRNG SKQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 67  AEAGHVIRTTIGGRNGQSKQNISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 126

Query: 89  YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 148
           YKNRELQIMQMLDHPNIV+LKHCFFSTTDKEE+YLNLVLE+VPETVNRIARNYSRI QRM
Sbjct: 127 YKNRELQIMQMLDHPNIVSLKHCFFSTTDKEEVYLNLVLEFVPETVNRIARNYSRISQRM 186

Query: 149 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP
Sbjct: 187 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 246

Query: 209 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG+PLFPGESGVDQLVEIIKV
Sbjct: 247 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGKPLFPGESGVDQLVEIIKV 306

Query: 269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 328
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 307 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 366

Query: 329 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 388
           EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP EL+GIPP+T+NRLIPEHARKQNLFMAL
Sbjct: 367 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPQELAGIPPDTVNRLIPEHARKQNLFMAL 426

Query: 389 HS 390
           H+
Sbjct: 427 HT 428

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225465185|ref|XP_002263398.1| PREDICTED: shaggy-related protein kinase kappa [Vitis vinifera] gi|297739515|emb|CBI29697.3| unnamed protein product [Vitis vinifera]

 Score =  762 bits (1967), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/422 (87%), Positives = 380/422 (90%), Gaps = 32/422 (7%)

Query: 1   MASASLGNGGVGSSRSVNGFK--------------------------------NIIDGVG 28
           MASASLG+GGVGSSR+ NGFK                                +IIDGVG
Sbjct: 1   MASASLGHGGVGSSRTANGFKGSSSSVDWLGREMLEMRLRDRVDQDDDRDSEPDIIDGVG 60

Query: 29  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 88
           AE GHVIRTT GGRNG SKQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTFGGRNGQSKQTVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120

Query: 89  YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 148
           YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE+VPETVNRIARNYSRI+QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEFVPETVNRIARNYSRINQRM 180

Query: 149 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240

Query: 209 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 328
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 329 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 388
           EAC+HPFFDELRDP+TRLPNGRPLPPLFNFKP ELSGIP +   RLIPEHARKQNLFMAL
Sbjct: 361 EACIHPFFDELRDPSTRLPNGRPLPPLFNFKPQELSGIPSDIRTRLIPEHARKQNLFMAL 420

Query: 389 HS 390
           H+
Sbjct: 421 HT 422

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119932|ref|XP_002331098.1| predicted protein [Populus trichocarpa] gi|222872826|gb|EEF09957.1| predicted protein [Populus trichocarpa]

 Score =  757 bits (1955), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/422 (87%), Positives = 379/422 (89%), Gaps = 32/422 (7%)

Query: 1   MASASLGNGGVGSSRSVNGFK--------------------------------NIIDGVG 28
           M+SASLGNGGVGSSRSVNGFK                                +IIDGVG
Sbjct: 1   MSSASLGNGGVGSSRSVNGFKSSSSSMDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60

Query: 29  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 88
           AE GHVIRTTIGGRNG S+Q VSYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTIGGRNGQSRQTVSYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120

Query: 89  YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 148
           YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR + RM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRNNPRM 180

Query: 149 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240

Query: 209 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 328
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 329 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 388
           EAC+HPFFDELRDP TRLPNGRPLPPLFNFKP ELSGIP + +NRLIP++ARKQNLFMAL
Sbjct: 361 EACIHPFFDELRDPATRLPNGRPLPPLFNFKPQELSGIPTDIVNRLIPDYARKQNLFMAL 420

Query: 389 HS 390
           H+
Sbjct: 421 HT 422

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224129720|ref|XP_002328786.1| predicted protein [Populus trichocarpa] gi|222839084|gb|EEE77435.1| predicted protein [Populus trichocarpa]

 Score =  756 bits (1952), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/422 (87%), Positives = 377/422 (89%), Gaps = 32/422 (7%)

Query: 1   MASASLGNGGVGSSRSVNGFK--------------------------------NIIDGVG 28
           M+SASLGNGGVGSSRSVNGFK                                +IIDGVG
Sbjct: 1   MSSASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60

Query: 29  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 88
           AE GHVIRTTIGGRNG S+Q +SYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTIGGRNGQSRQTISYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120

Query: 89  YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 148
           YKNRELQIMQMLDHPNIVALKH FFSTTDKEELYLNLVLEYVP+TVNRIARNYSR  QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHSFFSTTDKEELYLNLVLEYVPDTVNRIARNYSRNSQRM 180

Query: 149 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCDFGSAKVLVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240

Query: 209 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 328
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 329 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 388
           EACVHPFFDELRDP TRLPNGRPLPPLFNFK  ELSGIP + +NRLIPE+ARKQNLFMAL
Sbjct: 361 EACVHPFFDELRDPTTRLPNGRPLPPLFNFKSQELSGIPTDIVNRLIPEYARKQNLFMAL 420

Query: 389 HS 390
           H+
Sbjct: 421 HT 422

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357445263|ref|XP_003592909.1| Glycogen synthase kinase-3-like protein [Medicago truncatula] gi|92893880|gb|ABE91930.1| Protein kinase [Medicago truncatula] gi|355481957|gb|AES63160.1| Glycogen synthase kinase-3-like protein [Medicago truncatula]

 Score =  749 bits (1933), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/428 (85%), Positives = 377/428 (88%), Gaps = 38/428 (8%)

Query: 1   MASASLGNGGVGSSR--------------------------------------SVNGFKN 22
           MASASLGNGG+GSS                                       +     +
Sbjct: 1   MASASLGNGGIGSSSRSAAALRAASSSVDWLGREMLHMNLNRDHDHDDDDEDDARESEPD 60

Query: 23  IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
           IIDGVGAETGHVIRT+I  RNG SKQ VSYIAEHVVGTGSFG VFQAKCRETGEIVAIKK
Sbjct: 61  IIDGVGAETGHVIRTSIAARNGQSKQNVSYIAEHVVGTGSFGTVFQAKCRETGEIVAIKK 120

Query: 83  VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 142
           VLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS
Sbjct: 121 VLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 180

Query: 143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
           RI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV
Sbjct: 181 RINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 240

Query: 203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
           LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL
Sbjct: 241 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 300

Query: 263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
           VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN
Sbjct: 301 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 360

Query: 323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
           LRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP ELSGIPP+ INRLIPEHARKQ
Sbjct: 361 LRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPDVINRLIPEHARKQ 420

Query: 383 NLFMALHS 390
           NLFMALH+
Sbjct: 421 NLFMALHT 428

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806970|ref|NP_001241073.1| uncharacterized protein LOC100799387 [Glycine max] gi|255641011|gb|ACU20785.1| unknown [Glycine max]

 Score =  748 bits (1931), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/369 (95%), Positives = 364/369 (98%)

Query: 22  NIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK 81
           +IIDGVGAETGHVIRT+IGGRNG SKQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK
Sbjct: 52  DIIDGVGAETGHVIRTSIGGRNGQSKQNVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK 111

Query: 82  KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY 141
           KVLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEE+YLNLVLEYVPETVNRIAR+Y
Sbjct: 112 KVLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEEVYLNLVLEYVPETVNRIARSY 171

Query: 142 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
           SRI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK
Sbjct: 172 SRINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 231

Query: 202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
           VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ
Sbjct: 232 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 291

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP
Sbjct: 292 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 351

Query: 322 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
           NLRCTALEAC+HPFFDELRDPNTRLPN RPLPPLFNFKP ELSG+PP+ INRLIPEHARK
Sbjct: 352 NLRCTALEACIHPFFDELRDPNTRLPNARPLPPLFNFKPQELSGVPPDVINRLIPEHARK 411

Query: 382 QNLFMALHS 390
           QNLFMALH+
Sbjct: 412 QNLFMALHT 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|24637171|gb|AAN63591.1|AF432225_1 GSK-3-like protein MsK4 [Medicago sativa]

 Score =  748 bits (1930), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/369 (96%), Positives = 362/369 (98%)

Query: 22  NIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK 81
           +IIDGVGAETGHVIRT+I  RNG SKQ VSYIAEHVVGTGSFG VFQAKCRETGEIVAIK
Sbjct: 64  DIIDGVGAETGHVIRTSIAARNGQSKQNVSYIAEHVVGTGSFGTVFQAKCRETGEIVAIK 123

Query: 82  KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY 141
           KVLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEELYLNLVLEYVPETVNRIARNY
Sbjct: 124 KVLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEELYLNLVLEYVPETVNRIARNY 183

Query: 142 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
           SRI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK
Sbjct: 184 SRINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 243

Query: 202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
           VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ
Sbjct: 244 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 303

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP
Sbjct: 304 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 363

Query: 322 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
           NLRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP ELSGIPP+ INRLIPEHARK
Sbjct: 364 NLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPDVINRLIPEHARK 423

Query: 382 QNLFMALHS 390
           QNLFMALH+
Sbjct: 424 QNLFMALHT 432

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806021|ref|NP_001240918.1| uncharacterized protein LOC100820098 [Glycine max] gi|255639602|gb|ACU20095.1| unknown [Glycine max]

 Score =  746 bits (1925), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/369 (95%), Positives = 365/369 (98%)

Query: 22  NIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK 81
           +IIDG+GAETGHVIRT++GGRNG SKQ VSYI+EHVVGTGSFGVVFQAKCRETGEIVAIK
Sbjct: 52  DIIDGLGAETGHVIRTSVGGRNGQSKQNVSYISEHVVGTGSFGVVFQAKCRETGEIVAIK 111

Query: 82  KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY 141
           KVLQDKRYKNRELQIMQMLDHPNIVAL+HCF+STTDKEE+YLNLVLEYVPETVNRIAR+Y
Sbjct: 112 KVLQDKRYKNRELQIMQMLDHPNIVALRHCFYSTTDKEEVYLNLVLEYVPETVNRIARSY 171

Query: 142 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
           SRI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK
Sbjct: 172 SRINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 231

Query: 202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
           VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ
Sbjct: 232 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 291

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP
Sbjct: 292 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 351

Query: 322 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
           NLRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP ELSG+PP+ INRLIPEHARK
Sbjct: 352 NLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELSGVPPDVINRLIPEHARK 411

Query: 382 QNLFMALHS 390
           QNLFMALH+
Sbjct: 412 QNLFMALHT 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116787454|gb|ABK24513.1| unknown [Picea sitchensis]

 Score =  734 bits (1895), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/424 (83%), Positives = 376/424 (88%), Gaps = 34/424 (8%)

Query: 1   MASASLG-NGGVGSSRSVNGFKN---------------------------------IIDG 26
           MASASLG +GGVGSSR++N  K                                  I+DG
Sbjct: 1   MASASLGHSGGVGSSRTINRLKGPVNSVDWLGREMLEMRIRDNKLDVDDEKDIEPAIVDG 60

Query: 27  VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 86
           +GAE+GH+I TTIGGRNG  KQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD
Sbjct: 61  MGAESGHIIATTIGGRNGQPKQTISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 120

Query: 87  KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ 146
           KRYKNRELQIM MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR+Y+R++Q
Sbjct: 121 KRYKNRELQIMHMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARHYNRMNQ 180

Query: 147 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 206
           RMPLIYVKLY+YQICR+LAYIHNC+GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG
Sbjct: 181 RMPLIYVKLYSYQICRSLAYIHNCVGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 240

Query: 207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
           EPN+SYICSRYYRAPELIFGATEYTTAID+WSTGCVMAELLLGQPLFPGESGVDQLVEII
Sbjct: 241 EPNISYICSRYYRAPELIFGATEYTTAIDMWSTGCVMAELLLGQPLFPGESGVDQLVEII 300

Query: 267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 326
           KVLGTPTREEIKCMNPNYTEFKFPQIK HPWHKVFQKRLPPEAVDLV R  QYSPNLRCT
Sbjct: 301 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKVFQKRLPPEAVDLVSRLLQYSPNLRCT 360

Query: 327 ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFM 386
           ALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP EL+GIPP+T+ RLIPEHARKQNLFM
Sbjct: 361 ALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELAGIPPDTLERLIPEHARKQNLFM 420

Query: 387 ALHS 390
           ALH+
Sbjct: 421 ALHT 424

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15218288|ref|NP_172455.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|30681397|ref|NP_849627.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|42571421|ref|NP_973801.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|79317477|ref|NP_001031013.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323818|ref|NP_001077498.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323820|ref|NP_001077499.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|38503402|sp|Q39019.2|KSG10_ARATH RecName: Full=Shaggy-related protein kinase kappa; AltName: Full=ASK-kappa; Short=AtK-1 gi|20260176|gb|AAM12986.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|23197848|gb|AAN15451.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|332190380|gb|AEE28501.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190381|gb|AEE28502.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190382|gb|AEE28503.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190383|gb|AEE28504.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190384|gb|AEE28505.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190385|gb|AEE28506.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana]

 Score =  726 bits (1873), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/422 (82%), Positives = 369/422 (87%), Gaps = 33/422 (7%)

Query: 1   MASASLGNGGVGSSRSVNGFK--------------------------------NIIDGVG 28
           MAS+ LGNG VG+SRS  G K                                +IIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 29  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 88
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 89  YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 148
           YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 149 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 209 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 328
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 329 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 388
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEHARKQNLFMAL
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

Query: 389 HS 390
           HS
Sbjct: 420 HS 421

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	390
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.946	0.876	0.875	2.7e-180
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.938	0.892	0.784	2.5e-161
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.938	0.903	0.775	3.6e-160
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.938	0.894	0.770	9.6e-160
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.920	0.871	0.741	7.6e-151
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.920	0.882	0.738	3.3e-150
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.917	0.758	0.737	1.4e-149
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.920	0.944	0.713	5.5e-148
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.920	0.819	0.685	2.8e-137
UNIPROTKB|E2R4Y4	420	GSK3B "Uncharacterized protein	0.905	0.840	0.65	2.5e-120

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1750 (621.1 bits), Expect = 2.7e-180, P = 2.7e-180
 Identities = 323/369 (87%), Positives = 339/369 (91%)

Query:    22 NIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK 81
             +IIDG GAE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIK
Sbjct:    53 DIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIK 112

Query:    82 KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNY 141
             KVLQDKRYKNRELQIMQMLDHPN VALKH FFS TD               TVNR+AR+Y
Sbjct:   113 KVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSY 172

Query:   142 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
             SR +Q MPLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAK
Sbjct:   173 SRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAK 232

Query:   202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
             VLVKGEPNVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ
Sbjct:   233 VLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 292

Query:   262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
             LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSP
Sbjct:   293 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSP 352

Query:   322 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
             NLRCTALEAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEHARK
Sbjct:   353 NLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARK 412

Query:   382 QNLFMALHS 390
             QNLFMALHS
Sbjct:   413 QNLFMALHS 421

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1571 (558.1 bits), Expect = 2.5e-161, P = 2.5e-161
 Identities = 287/366 (78%), Positives = 318/366 (86%)

Query:    23 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
             ++DG G ETGH+I TTIGG+NG  KQ +SY+AE +VG GSFG+VFQAKC ETGE VAIKK
Sbjct:    45 VVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKK 104

Query:    83 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 142
             VLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K              TV R++++YS
Sbjct:   105 VLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYS 164

Query:   143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
             R +QRMP+IYVKLYTYQICRALAYIH  +G+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKV
Sbjct:   165 RANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 224

Query:   203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
             LVKGEPN+SYICSRYYRAPELIFGATEYTT IDIWS GCV+AELLLGQPLFPGESGVDQL
Sbjct:   225 LVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQL 284

Query:   263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             VEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR PPEAVDLV R  QYSPN
Sbjct:   285 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPN 344

Query:   323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
             LR TA+EA VHPFFDELRDPNTRLPNGR LPPLFNFKP EL G   E +++LIP+HARKQ
Sbjct:   345 LRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQ 404

Query:   383 NLFMAL 388
               F+AL
Sbjct:   405 CSFLAL 410

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1560 (554.2 bits), Expect = 3.6e-160, P = 3.6e-160
 Identities = 284/366 (77%), Positives = 318/366 (86%)

Query:    23 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
             ++DG G ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKK
Sbjct:    40 VVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKK 99

Query:    83 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 142
             VLQD+RYKNRELQ M++LDHPN+V+LKHCFFSTT+K              TV+R+ ++Y+
Sbjct:   100 VLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYN 159

Query:   143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
             +++QRMPLIYVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKV
Sbjct:   160 KLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 219

Query:   203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
             LVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGESGVDQL
Sbjct:   220 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQL 279

Query:   263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             VEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPN
Sbjct:   280 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 339

Query:   323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
             LR  AL+  VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+PEHARKQ
Sbjct:   340 LRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQ 399

Query:   383 NLFMAL 388
               ++ L
Sbjct:   400 CPWLGL 405

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1556 (552.8 bits), Expect = 9.6e-160, P = 9.6e-160
 Identities = 282/366 (77%), Positives = 320/366 (87%)

Query:    23 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
             I++G   ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKK
Sbjct:    44 IVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKK 103

Query:    83 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 142
             VLQD+RYKNRELQ M++LDHPN+V+LKHCFFSTT+K              TV+R+ ++Y+
Sbjct:   104 VLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYN 163

Query:   143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
             +++QRMPL+YVKLYTYQI R+L+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGSAKV
Sbjct:   164 KLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 223

Query:   203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
             LVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGESGVDQL
Sbjct:   224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQL 283

Query:   263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             VEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPN
Sbjct:   284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 343

Query:   323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
             LRC AL++ VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+PEHARKQ
Sbjct:   344 LRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQ 403

Query:   383 NLFMAL 388
               +++L
Sbjct:   404 CPWLSL 409

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1472 (523.2 bits), Expect = 7.6e-151, P = 7.6e-151
 Identities = 267/360 (74%), Positives = 306/360 (85%)

Query:    23 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
             +I+G  A TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+VFQAKC ETGE VAIKK
Sbjct:    43 VIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKK 102

Query:    83 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 142
             VLQD+RYKNRELQ+M+++DHPN+V+LKHCFFSTT +              T+ R+ ++Y+
Sbjct:   103 VLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYT 162

Query:   143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
               +QRMP+ YVKLYTYQI R LAYIH   G+CHRD+KPQNLLV+P THQ KLCDFGSAKV
Sbjct:   163 SSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKV 222

Query:   203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
             LVKGE N+SYICSRYYRAPELIFGATEYT++IDIWS GCV+AELLLGQPLFPGE+ VDQL
Sbjct:   223 LVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQL 282

Query:   263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             VEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL  R  QYSP+
Sbjct:   283 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 342

Query:   323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
             LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK  ELSG  PE INRLIPEH R+Q
Sbjct:   343 LRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELSGASPELINRLIPEHVRRQ 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1466 (521.1 bits), Expect = 3.3e-150, P = 3.3e-150
 Identities = 266/360 (73%), Positives = 304/360 (84%)

Query:    23 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
             +I+G  A TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+VFQAKC ETGE VAIKK
Sbjct:    41 VIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKK 100

Query:    83 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 142
             VLQD+RYKNRELQ+M+ +DHPN+++LKHCFFSTT +              T+ R+ R+Y+
Sbjct:   101 VLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYT 160

Query:   143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
               +QRMP+ YVKLYTYQI R LAYIH   G+CHRD+KPQNLLV+P THQ+KLCDFGSAKV
Sbjct:   161 SSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 220

Query:   203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
             LVKGEPN+SYICSRYYRAPELIFGATEYT +IDIWS GCV+AELLLGQPLFPGE+ VDQL
Sbjct:   221 LVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQL 280

Query:   263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             VEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL  R  QYSP+
Sbjct:   281 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 340

Query:   323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
             LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK  EL G   E INRLIPEH R+Q
Sbjct:   341 LRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELGGASMELINRLIPEHVRRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1460 (519.0 bits), Expect = 1.4e-149, P = 1.4e-149
 Identities = 264/358 (73%), Positives = 301/358 (84%)

Query:    23 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
             +++G G ETG VI TT+GGR+G  KQ +SY+A+ VVGTGSFGVVFQAKC ETGE VAIKK
Sbjct:   109 VVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKK 168

Query:    83 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 142
             VLQDKRYKNRELQIM++ DHPN+V L+H FFSTTDK              TV R +++Y+
Sbjct:   169 VLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYT 228

Query:   143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
             +++Q MP+I+V+LYTYQICRAL Y+H  +G+CHRDIKPQNLLVNP THQLK+CDFGSAK+
Sbjct:   229 KMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKM 288

Query:   203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
             LV GEPN+SYICSRYYRAPELIFGATEYT AID+WS GCVMAELLLGQPLFPGESG+DQL
Sbjct:   289 LVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQL 348

Query:   263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             VEIIK+LGTPTREEI+CMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPN
Sbjct:   349 VEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 408

Query:   323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHAR 380
             LRCTALEAC HPFFD+LRDPN  LPNGR LPPLFNF   EL+G   E   RLIP H +
Sbjct:   409 LRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1445 (513.7 bits), Expect = 5.5e-148, P = 5.5e-148
 Identities = 257/360 (71%), Positives = 303/360 (84%)

Query:    23 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
             ++DG    TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+VFQAKC ETGE VAIKK
Sbjct:    11 VVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKK 70

Query:    83 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 142
             VLQD+RYKNRELQ+M+++DHPN+V LKHCFFSTT K              ++ R+ ++YS
Sbjct:    71 VLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYS 130

Query:   143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
               +QRMPL+YVKLY YQI R LAYIHN  G+CHRD+KPQNLLV+P THQ+K+CDFGSAK 
Sbjct:   131 SANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190

Query:   203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
             LVKGE N+SYICSR+YRAPELIFGATEYTT+IDIWS GCV+AELLLGQPLFPGE+ VDQL
Sbjct:   191 LVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 250

Query:   263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             VEIIKVLGTPTREEI+CMNP+YT+F+FPQIK HPWHK+F KR+PPEA+D   R  QYSP+
Sbjct:   251 VEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPS 310

Query:   323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 382
             LRCTALEAC HPFFDELR+PN RLPNGRP PPLFNFK  E++G  PE +N+LIP+H ++Q
Sbjct:   311 LRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQ-EVAGSSPELVNKLIPDHIKRQ 369

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1344 (478.2 bits), Expect = 2.8e-137, P = 2.8e-137
 Identities = 246/359 (68%), Positives = 288/359 (80%)

Query:    23 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 82
             II G G E+G +I T   G N    + +SY AEHV+GTGSFGVVFQAKC ET E VAIKK
Sbjct:    80 IIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEKVAIKK 139

Query:    83 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 142
             VLQDKRYKNRELQIM+MLDHPN+V LKH FFSTT+K              T+ R +R+Y+
Sbjct:   140 VLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYT 199

Query:   143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
             +++Q MPLIY++LYTYQICRA+ Y+H  +G+CHRDIKPQNLLVN  TH++K+CDFGSAK+
Sbjct:   200 KMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKM 259

Query:   203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
             L+ GEPN+SYICSRYYRAPELIFGATEYT+AID+WS GCVMAEL LG PLFPGE+ VDQL
Sbjct:   260 LIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGETSVDQL 319

Query:   263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             VEIIK+LGTP REEIK MNP Y +FKFPQIK  PWHK+F++++ PEA+DL  R  QYSPN
Sbjct:   320 VEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLLQYSPN 379

Query:   323 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
             LRCTALEAC HPFFD+LRDP   LPNGR LPPLF+F   EL+G   E  +RLIPEHARK
Sbjct:   380 LRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|E2R4Y4 GSK3B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1184 (421.8 bits), Expect = 2.5e-120, P = 2.5e-120
 Identities = 234/360 (65%), Positives = 276/360 (76%)

Query:    25 DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
             D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct:    31 DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88

Query:    85 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
             QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct:    89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query:   144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
               Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct:   149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query:   204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
             V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct:   208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query:   264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
             EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct:   268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327

Query:   324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
             R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct:   328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.8038	0.9410	0.8973	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.8092	0.9410	0.9061	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6306	0.8743	0.8811	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7694	0.9205	0.8820	no	no
A8X5H5	GSK3_CAEBR	2, ., 7, ., 1, 1, ., 2, 6	0.6576	0.8487	0.9220	N/A	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7722	0.9205	0.8713	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.7444	0.9205	0.9447	no	no
Q388M1	GSK3B_TRYB2	2, ., 7, ., 1, 1, ., 2, 6	0.5192	0.8410	0.9318	N/A	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.8270	0.9974	0.9239	yes	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5833	0.7564	0.7972	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6687	0.8230	0.8867	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.8162	0.9897	0.9190	no	no
O23145	KSG2_ARATH	2, ., 7, ., 1, 1, ., 1	0.7214	0.9205	0.8329	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.8166	0.9230	0.8801	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6805	0.9051	0.8404	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6556	0.8487	0.7087	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8092	0.9410	0.8929	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8092	0.9384	0.8905	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.825	0.9230	0.8759	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7709	0.9179	0.7649	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6805	0.9051	0.8404	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8196	0.9384	0.8926	no	no
Q91757	GSK3B_XENLA	2, ., 7, ., 1, 1, ., 2, 6	0.6603	0.9307	0.8642	N/A	no
Q5YJC2	GSK3B_SPECI	2, ., 7, ., 1, 1, ., 1	0.6777	0.9051	0.8404	N/A	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6805	0.9051	0.8404	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	390
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-136
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-91
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-87
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-86
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-84
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-82
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-81
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-79
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-78
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-76
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-74
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-73
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-68
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-66
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-66
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-65
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-65
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-64
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-64
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-63
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-62
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-62
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-60
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-59
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-59
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-58
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-58
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-58
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-57
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-57
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-57
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-55
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-54
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-54
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-53
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-53
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-52
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-51
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-51
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-51
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-50
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-50
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-50
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-49
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-49
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-49
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-49
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-49
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-48
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-48
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-48
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-46
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-43
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-41
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-40
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-39
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-39
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-39
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-37
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-36
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-35
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-35
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-35
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-35
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-34
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-34
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-32
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-30
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-29
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-28
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-28
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-28
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-28
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-27
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-25
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-24
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-23
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-21
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-20
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-19
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-19
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-18
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-18
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-17
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-17
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-17
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-17
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-16
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-16
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-16
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-15
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-13
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-06
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.001
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.002
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.004

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  397 bits (1020), Expect = e-136
 Identities = 176/337 (52%), Positives = 245/337 (72%), Gaps = 5/337 (1%)

Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 104
           N     SY   +++G GSFGVV++A C +T E VAIKKVLQD +YKNREL IM+ L+H N
Sbjct: 61  NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHIN 120

Query: 105 IVALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           I+ LK  +++     +++ ++LN+V+E++P+TV++  ++Y+R +  +PL  VKLY+YQ+C
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
           RALAYIH+   ICHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ +VSYICSR+YRAP
Sbjct: 181 RALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           EL+ GAT YTT ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MN
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
           PNY + KFP +KP    KVF K  P +A++ + +F +Y P  R   +EA   PFFD+LRD
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359

Query: 342 PNTRLPNG-RPLPPLFNFKPPELSGIPPETINRLIPE 377
           P  +LP     LP LFNF   E+  +      ++IP+
Sbjct: 360 PCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  278 bits (714), Expect = 1e-91
 Identities = 118/330 (35%), Positives = 178/330 (53%), Gaps = 29/330 (8%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 105
           Y     +G+G++GVV  A  + TG  VAIKK+      L D +   RE+++++ L H NI
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 106 VALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQIC 161
           + L       S  D  ++Y+  V E +   ++++      I    PL   +++ + YQI 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKV------IKSPQPLTDDHIQYFLYQIL 113

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRY 217
           R L Y+H+   + HRD+KP N+LVN     LK+CDFG A+ +   E        Y+ +R+
Sbjct: 114 RGLKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
           YRAPEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231

Query: 278 KCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
           K + +     +    P+    P  K+F     PEA+DL+ +   + P  R TA EA  HP
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHP 290

Query: 335 FFDELRDPNTRLPNGRPLPPLFNFKPPELS 364
           +  +L DP    P  +P      F   EL+
Sbjct: 291 YLAQLHDPE-DEPVAKPPFDFDFFDDDELT 319

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  264 bits (678), Expect = 5e-87
 Identities = 117/302 (38%), Positives = 171/302 (56%), Gaps = 37/302 (12%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 103
           Y     +G G++GVV++A+ ++TGEIVA+KK+  D   +         RE+ +++ L HP
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICR 162
           NIV L     +   + +LYL  V EY    +    + Y  +    +    +K   YQ+ R
Sbjct: 59  NIVKLLDVIHT---ERKLYL--VFEYCDMDL----KKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYR 219
            LAY H    I HRD+KPQN+L+N     LKL DFG A+    G P  +Y   + + +YR
Sbjct: 110 GLAYCH-SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYR 165

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE++ G+  Y+TA+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E    
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW-- 223

Query: 280 MNPNYTEFK-----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
             P  T+       FP+  P    KV   RL PE +DL+ +  QY+P  R +A EA  HP
Sbjct: 224 --PGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280

Query: 335 FF 336
           +F
Sbjct: 281 YF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  263 bits (673), Expect = 2e-86
 Identities = 116/298 (38%), Positives = 171/298 (57%), Gaps = 25/298 (8%)

Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKN---RELQIMQMLD 101
           QK+  I     G G++GVV++A+ + TGEIVAIKK+              RE+++++ L+
Sbjct: 2   QKLGKI-----GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN 56

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           HPNI+ L   F     K +LYL  V E++   + ++ ++  R    +P   +K Y YQ+ 
Sbjct: 57  HPNIIKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLL 108

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRA 220
           + LA+ H+  GI HRD+KP+NLL+N     LKL DFG A+       P   Y+ +R+YRA
Sbjct: 109 QGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PEL+ G   Y+T +DIWS GC+ AELL  +PLFPG+S +DQL +I + LGTP  E     
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226

Query: 281 NPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                  +F FP+    P  K+F     P+A+DL+ +   Y P+ R TA +A  HP+F
Sbjct: 227 TSLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  258 bits (661), Expect = 2e-84
 Identities = 111/290 (38%), Positives = 167/290 (57%), Gaps = 23/290 (7%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G+ G+VF+AK RETGE VA+KKV   +          RE++ +Q   HP +V L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           F          L  V+EY+P  ++ + R+  R    +P   VK Y   + + +AY+H   
Sbjct: 68  F---PHGSGFVL--VMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA-N 118

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELIFGATE 229
           GI HRD+KP NLL++     LK+ DFG A++  + EP +    + +R+YRAPEL++GA +
Sbjct: 119 GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTE 286
           Y   +D+W+ GC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDYNK 236

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
             FP+ KP P  ++F     PEA+DL+     Y P+ R +A EA  HP+F
Sbjct: 237 ITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  251 bits (643), Expect = 4e-82
 Identities = 105/292 (35%), Positives = 155/292 (53%), Gaps = 45/292 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 106
           Y     +G GSFG V+ A+ ++TG++VAIK +      +D+    RE++I++ L HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
            L   F    D+++LYL  V+EY    +  + + +       R+     + Y  QI  AL
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSAL 110

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            Y+H+  GI HRD+KP+N+L++   H +KL DFG A+ L  GE   +++ +  Y APE++
Sbjct: 111 EYLHSK-GIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
            G   Y  A+DIWS G ++ ELL G+P FPG+   DQL+E+ K +G P            
Sbjct: 169 LG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK----------- 213

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                P   P  W       + PEA DL+ +     P  R TA EA  HPFF
Sbjct: 214 -----PPFPPPEW------DISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  251 bits (644), Expect = 1e-81
 Identities = 112/299 (37%), Positives = 162/299 (54%), Gaps = 29/299 (9%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 102
           Y     +G G++ VV++A+ +ETG IVAIKK+   +R +          RE++++Q L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 103 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           PNI+ L   F          +NLV E++   + ++ ++ S +        +K Y     R
Sbjct: 62  PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIKDKSIVLT---PADIKSYMLMTLR 113

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC---SRYYR 219
            L Y+H+   I HRD+KP NLL+      LKL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APEL+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 280 MN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           +   P+Y EFK     P P  ++F      +A+DL+ R    +PN R TA +A  HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  244 bits (626), Expect = 4e-79
 Identities = 115/292 (39%), Positives = 164/292 (56%), Gaps = 21/292 (7%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALK 109
            VVG G++GVV + + + TGEIVAIKK  +   D+  K    RE+++++ L H NIV LK
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F     K  LYL  V EYV  T+  +          +P   V+ Y +Q+ +A+AY H+
Sbjct: 67  EAFRR---KGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHS 118

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNVSYICSRYYRAPELIFGA 227
              I HRDIKP+N+LV+     LKLCDFG A+ L      P   Y+ +R+YRAPEL+ G 
Sbjct: 119 -HNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 285
           T Y   +D+W+ GC+MAELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP + 
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236

Query: 286 EFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
              FP+   P    + +  ++   A+D +    +  P  R T  E   HP+F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  242 bits (620), Expect = 1e-78
 Identities = 98/292 (33%), Positives = 147/292 (50%), Gaps = 39/292 (13%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y     +G+GSFG V++AK + TG+IVA+K + +            RE++I++ L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L   F    DK+ LYL  V+EY          +Y      +     K    QI R L 
Sbjct: 61  VRLIDAF---EDKDHLYL--VMEYCEGGDLF---DYLSRGGPLSEDEAKKIALQILRGLE 112

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELI 224
           Y+H+  GI HRD+KP+N+L++     +K+ DFG AK L+K      +++ + +Y APE++
Sbjct: 113 YLHSN-GIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL 170

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
            G   Y   +D+WS G ++ ELL G+P F GE+ +DQL  I ++LG P            
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------- 219

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
              +F + K              EA DL+ +     P+ R TA E   HP+F
Sbjct: 220 ---EFDEPKWSS--------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  238 bits (609), Expect = 1e-76
 Identities = 109/291 (37%), Positives = 172/291 (59%), Gaps = 26/291 (8%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQ-IMQMLDHPNIVALK 109
           +G G+FG V+ A+ +ETGE+VAIKK+ +  ++ +       RE++ + ++ +HPNIV LK
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F    + +ELY   V EY+   + ++ +   R  +      ++   YQI + LA+IH 
Sbjct: 65  EVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             G  HRD+KP+NLLV+     +K+ DFG A+ +    P   Y+ +R+YRAPE++  +T 
Sbjct: 118 H-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYT 285
           Y++ +DIW+ GC+MAEL   +PLFPG S +DQL +I  VLGTPT+++     K  +    
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--L 233

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            F+FPQ  P   H++      PEA+DL+    ++ P  R TA +A  HP+F
Sbjct: 234 GFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  231 bits (591), Expect = 7e-74
 Identities = 97/292 (33%), Positives = 158/292 (54%), Gaps = 24/292 (8%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 110
           +G G++G V++A+ ++TGE+VA+KK+  +   K        RE++++Q L HPNIV LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
              S   K  +Y+  V EY+   +  +  +      +     +K Y  Q+   L Y+H+ 
Sbjct: 66  IVTSK-GKGSIYM--VFEYMDHDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 227
            GI HRDIK  N+L+N     LKL DFG A+   K   +  Y   + + +YR PEL+ GA
Sbjct: 120 -GILHRDIKGSNILINNDGV-LKLADFGLARPYTK-RNSADYTNRVITLWYRPPELLLGA 176

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 284
           T Y   +D+WS GC++AEL LG+P+F G + ++QL +I ++ G+PT E    +  + P +
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWF 235

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
              K  +       + F+  + P A+DL+ +     P  R +A +A  H +F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  230 bits (590), Expect = 4e-73
 Identities = 109/305 (35%), Positives = 176/305 (57%), Gaps = 35/305 (11%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM---QMLDHPNIVAL 108
           +G G++G+V++A  R T E+VA+KK+        D +   RE  IM   ++ DHPNIV L
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDHPNIVKL 72

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQICRALAY 166
            +   +  DK+ +YL  V EY+   ++ + R      +H+R    Y+    YQ+ +AL Y
Sbjct: 73  LNVIKAENDKD-IYL--VFEYMETDLHAVIRANILEDVHKR----YI---MYQLLKALKY 122

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS------YICSRYYRA 220
           IH+   + HRD+KP N+L+N     +KL DFG A+ L + E N        Y+ +R+YRA
Sbjct: 123 IHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE++ G+T YT  +D+WS GC++ E+LLG+PLFPG S ++QL +II+V+G P+ E+I+ +
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 281 NPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
              +        P     P  ++   +   +A+DL+ +   ++PN R TA EA  HP+  
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299

Query: 338 ELRDP 342
           +  +P
Sbjct: 300 QFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  218 bits (558), Expect = 2e-68
 Identities = 109/309 (35%), Positives = 166/309 (53%), Gaps = 28/309 (9%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPN 104
            Y     +G+G++GVV  A    +G+ VAIKK      V    +   REL+I++   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI--YVKLYTYQICR 162
           I+A++         +   + +V++ +   ++ I      IH   PL   +++ + YQ+ R
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHI------IHSDQPLTEEHIRYFLYQLLR 118

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRY 217
            L YIH+   + HRD+KP NLLVN     L++ DFG A+ L             Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
           YRAPEL+    EYTTAID+WS GC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 278 KCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
             +       Y +   P+ +P PW K+F K   PEA+DL+ +  Q+ P  R T  +A  H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294

Query: 334 PFFDELRDP 342
           PF  +  DP
Sbjct: 295 PFLAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  212 bits (543), Expect = 1e-66
 Identities = 104/293 (35%), Positives = 164/293 (55%), Gaps = 30/293 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGEIVA+KK+  +   +       RE+ +++ L+HPNIV L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQRMPLIYVKLYTYQICRALAYIHN 169
             S     +LYL  V E++    +   + Y  S     +    +K Y YQ+ + +AY H+
Sbjct: 67  VHSEN---KLYL--VFEFL----DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 226
              + HRD+KPQNLL++     LKL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 118 H-RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 173

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 283
           + +Y+T +DIWS GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PD 232

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           Y    FP+       KV    L  + +DL+ +   Y P  R +A  A  HP+F
Sbjct: 233 YKP-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  213 bits (544), Expect = 4e-66
 Identities = 108/305 (35%), Positives = 164/305 (53%), Gaps = 26/305 (8%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 103
           Y     VG+G++G V  A   +TG  VAIKK+ +        KR Y  REL++++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 104 NIVALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           N++ L   F   +  E+   + LV   +   +N I +      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
            L YIH+  GI HRD+KP N+ VN    +LK+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++     Y   +DIWS GC+MAELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 283 ----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
               NY +   PQ+    + +VF     P A+DL+ +     P+ R TA EA  HP+  E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 339 LRDPN 343
             DP 
Sbjct: 304 YHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  210 bits (537), Expect = 1e-65
 Identities = 115/306 (37%), Positives = 170/306 (55%), Gaps = 37/306 (12%)

Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 101
           +K++ I E     G++GVV++A+ ++TGEIVA+KK+  +K  +       RE+ I+  L 
Sbjct: 8   EKLNRIEE-----GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62

Query: 102 HPNIVALKHCFF-STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 160
           HPNIV +K     S  DK  +Y+  V+EYV   +  +      + Q      VK    Q+
Sbjct: 63  HPNIVTVKEVVVGSNLDK--IYM--VMEYVEHDLKSL---METMKQPFLQSEVKCLMLQL 115

Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 217
              +A++H+   I HRD+K  NLL+N +   LK+CDFG A+    G P   Y   + + +
Sbjct: 116 LSGVAHLHD-NWILHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLW 171

Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
           YRAPEL+ GA EY+TAID+WS GC+ AELL  +PLFPG+S +DQL +I K+LGTPT +  
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 278 KCMNPNYTEFKFPQIKPHPWHKVFQ--KRLPP-----EAVDLVCRFFQYSPNLRCTALEA 330
               P ++E    + K    +   Q  K+ P         DL+ R   Y P  R +A +A
Sbjct: 232 ----PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287

Query: 331 CVHPFF 336
             HP+F
Sbjct: 288 LKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  211 bits (538), Expect = 2e-65
 Identities = 106/325 (32%), Positives = 175/325 (53%), Gaps = 28/325 (8%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 105
           Y     +G G++G+V  A  + TG  VAIKK+         +R   RE++I++   H NI
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65

Query: 106 VALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           + +       + +   ++Y+  V E +   + ++ +      Q +   +++ + YQI R 
Sbjct: 66  IGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRG 118

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYYR 219
           L YIH+   + HRD+KP NLL+N     LK+CDFG A++      +      Y+ +R+YR
Sbjct: 119 LKYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE++  +  YT AIDIWS GC++AE+L  +PLFPG+  + QL  I+ VLGTP++E++ C
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236

Query: 280 M-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
           + +    NY +   P     PW+K+F     P+A+DL+ +   ++P+ R T  EA  HP+
Sbjct: 237 IISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Query: 336 FDELRDPNTRLPNGRPLPPLFNFKP 360
            ++  DP+       P P  F    
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFD 319

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  207 bits (528), Expect = 8e-64
 Identities = 115/330 (34%), Positives = 181/330 (54%), Gaps = 26/330 (7%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           +G G++G+V  AK  ET E VAIKK+        D +   RE+++++ LDH N++A+K  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 112 FFSTTDK--EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                 +   ++Y+  V E +   +++I R+     Q +   + + + YQ+ R L YIH+
Sbjct: 73  MPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGAT 228
              + HRD+KP NLL+N +   LK+CDFG A+    KG+    Y+ +R+YRAPEL+   +
Sbjct: 127 A-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF 287
           EYTTAID+WS GC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + N     +
Sbjct: 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244

Query: 288 --KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 345
               P      + ++F     P A+DL+ +   + P+ R T  EA  HP+   L DP+  
Sbjct: 245 IRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303

Query: 346 LPNGRPLPPLFNFKPPELSGIPPETINRLI 375
                P    F+F+   L+    E I  LI
Sbjct: 304 PVCQTPFS--FDFEEDALT---EEDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  205 bits (523), Expect = 8e-64
 Identities = 109/292 (37%), Positives = 164/292 (56%), Gaps = 27/292 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 111
           +G GS+GVVF+ + RETG+IVAIKK ++       K+   RE+++++ L HPN+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 112 FFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 168
           F     + +  L+LV EY   TV N + +N     + +P   +K   +Q  +A+ + H  
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 227
           NCI   HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G 
Sbjct: 120 NCI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 285
           T+Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  + 
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235

Query: 286 EFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
               P+ +   P    F   +   A+  +    Q  P  R +  E   HP+F
Sbjct: 236 GLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  204 bits (521), Expect = 2e-63
 Identities = 116/291 (39%), Positives = 173/291 (59%), Gaps = 23/291 (7%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALKH 110
           +VG GS+G+V + K +ETG+IVAIKK L+   DK  K    RE+++++ L H N+V L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 111 CFFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F     K+ LYL  V E+V  TV + + +  + + +      V+ Y +QI R + + H+
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGAT 228
              I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE    Y+ +R+YRAPEL+ G T
Sbjct: 119 H-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 286
           +Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP +  
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236

Query: 287 FKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            + P++K   P  K F K L    +DL  +  +  P+ R ++ +   H FF
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  202 bits (516), Expect = 1e-62
 Identities = 103/295 (34%), Positives = 160/295 (54%), Gaps = 23/295 (7%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNIVALKH 110
           +G G++G V++A+ + TG++VA+KK   +   +       RE+ ++QML     IV L  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                    +  L LV EY+   + + +  N     + +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 226
             G+ HRD+KPQNLLV+     LK+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
           +T Y+T +DIWS GC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241

Query: 287 FK----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
            +    FPQ KP    +     L PE +DL+ +  +Y P  R +A  A  HP+FD
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  200 bits (510), Expect = 7e-62
 Identities = 102/287 (35%), Positives = 152/287 (52%), Gaps = 21/287 (7%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQML-DHPNIVALKH 110
           G G+F  V +A+ R+TG+  AIK +   K +K+       RE+Q ++ L  HPNI+ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
             F   D++   L LV E +   +  + +      + +P   VK Y YQ+ ++L ++H  
Sbjct: 66  VLF---DRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            GI HRDIKP+N+L+      LKL DFGS + +    P   YI +R+YRAPE +     Y
Sbjct: 120 -GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEFKF 289
              +DIW+ GCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  + F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236

Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           P  K     K+       E +DL+ +   Y P+ R TA +A  HP+F
Sbjct: 237 PSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  196 bits (499), Expect = 3e-60
 Identities = 107/292 (36%), Positives = 168/292 (57%), Gaps = 28/292 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 112
           +G G++  V++ + R TGEIVA+K++  D          RE+ +M+ L H NIV L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHN 169
             T +K    L LV EY+ + + +    Y   H     +    VK +TYQ+ + +A+ H 
Sbjct: 67  IHTENK----LMLVFEYMDKDLKK----YMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 226
              + HRD+KPQNLL+N    +LKL DFG A+    G P  ++   + + +YRAP+++ G
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 284
           +  Y+T+IDIWS GC+MAE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            +  FP+  P    ++F     P  +DL+ R  Q +P LR +A +A  HP+F
Sbjct: 235 -KPTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  194 bits (495), Expect = 1e-59
 Identities = 103/298 (34%), Positives = 162/298 (54%), Gaps = 24/298 (8%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 105
           +Y     +G GS+  V++ + + TG++VA+K++ L+ +        RE  +++ L H NI
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L H    T       L LV EY+   + +   +       + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLA 117

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 222
           Y H    + HRD+KPQNLL++    +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YCHQ-RRVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 279
           ++ G+TEY+T++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E      
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            NP +  + FP   P P      +    P   +L  +F QY P  R +A EA  HP+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  194 bits (495), Expect = 4e-59
 Identities = 104/295 (35%), Positives = 171/295 (57%), Gaps = 25/295 (8%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 111
           VG G+FG+V  A+ + TG+ VAIKK+++        +   REL++++ L H NI++L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           F S    E++Y   V E +   ++R+  +     + +   +++ + YQI R L Y+H+  
Sbjct: 78  FISP--LEDIYF--VTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA- 127

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEY 230
           G+ HRD+KP N+L+N +   LK+CDFG A++    +P ++ Y+ +RYYRAPE++    +Y
Sbjct: 128 GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 287
              +DIWS GC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + + N   F  
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243

Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
             P+ +P P+ + F+    P A+DL+ +   + P  R +A EA  HP+     DP
Sbjct: 244 SLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  192 bits (491), Expect = 1e-58
 Identities = 110/326 (33%), Positives = 157/326 (48%), Gaps = 52/326 (15%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 109
           + +G G++G+V++A+   +GEIVA+KKV  D           RE+ ++  L HPNIV LK
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 168
                   K    + LV+EY  + +  +  N            VK    Q+ R L Y+H 
Sbjct: 73  EV---VVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 225
           N I   HRD+K  NLL+      LK+ DFG A+    G P       + + +YRAPEL+ 
Sbjct: 127 NFI--IHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLL 181

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 283
           G T YTTAID+W+ GC++AELL  +PL PG+S ++QL  II++LGTP        +  P 
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 284 YTEFKFPQ-----IKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
             +F  P+     +K   PW       L    + L+     Y P  R TA EA    +F 
Sbjct: 242 VGKFTLPKQPYNNLKHKFPW-------LSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Query: 338 ELRDPNTRLPNGRPLPPLFNFKPPEL 363
           E           +PLP       PE+
Sbjct: 295 E-----------KPLP-----CEPEM 304

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  191 bits (486), Expect = 2e-58
 Identities = 110/306 (35%), Positives = 166/306 (54%), Gaps = 41/306 (13%)

Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 101
           QKV  I E     G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+
Sbjct: 3   QKVEKIGE-----GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           HPNIV L     +   + +LYL  V E++ + + +           +PLI  K Y +Q+ 
Sbjct: 58  HPNIVKLLDVIHT---ENKLYL--VFEFLHQDLKKFMDASPLSGIPLPLI--KSYLFQLL 110

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 218
           + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +Y
Sbjct: 111 QGLAFCHSH-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWY 166

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
           RAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP      
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV--- 223

Query: 279 CMNPNYTEFK-----FPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 330
            + P  T        FP+         F K +PP   +  DL+ +   Y PN R +A  A
Sbjct: 224 -VWPGVTSLPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278

Query: 331 CVHPFF 336
             HPFF
Sbjct: 279 LAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  191 bits (487), Expect = 9e-58
 Identities = 119/333 (35%), Positives = 180/333 (54%), Gaps = 33/333 (9%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 105
           Y  + V+G GS+GVV  A    TGE VAIKK+      + D     RE++++++L HP+I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR---NYSRIHQRMPLIYVKLYTYQICR 162
           V +KH     + +E   + +V E +   ++++ +   + +  H        + + YQ+ R
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-------QFFLYQLLR 114

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYY 218
           AL YIH    + HRD+KP+N+L N    +LK+CDFG A+V     P       Y+ +R+Y
Sbjct: 115 ALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 219 RAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           RAPEL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E 
Sbjct: 173 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231

Query: 277 I-KCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACV 332
           I +  N     +     K  P    F ++ P   P A+ L+ R   + P  R TA EA  
Sbjct: 232 ISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289

Query: 333 HPFFDELRDPNTRLPNGRPLPPL-FNFKPPELS 364
            P+F  L     R P+ +P+  L F F+   L+
Sbjct: 290 DPYFKGLAKVE-REPSAQPITKLEFEFERRRLT 321

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  189 bits (481), Expect = 2e-57
 Identities = 105/298 (35%), Positives = 171/298 (57%), Gaps = 29/298 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ R T E +A+KK+  ++  +       RE+ +++ + H NIV L+  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 112 FFSTTDKEELYLNLVLEYVPETVNR---IARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             S     E  L LV EY+   + +    + ++++ + R+    +K Y YQI R +AY H
Sbjct: 70  VHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILRGIAYCH 119

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 225
           +   + HRD+KPQNLL++  T+ LKL DFG A+    G P  ++   + + +YRAPE++ 
Sbjct: 120 SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILL 176

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 283
           G+  Y+T +DIWS GC+ AE++  +PLFPG+S +D+L +I ++LGTP  E    +   P+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
           Y    FP+  P     V    L P  VDL+ +  +  P+ R TA  A  H +F +L D
Sbjct: 237 YKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  188 bits (479), Expect = 2e-57
 Identities = 97/291 (33%), Positives = 142/291 (48%), Gaps = 46/291 (15%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 109
            ++G GSFG V+ A  ++TGE++A+K V L     +      RE++I+  L HPNIV   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 110 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             + S  D+E+  LN+ LEYV   +++ + + + ++ + +    ++ YT QI   LAY+H
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
           +  GI HRDIK  N+LV+     +KL DFG AK L     GE   S   + Y+ APE+I 
Sbjct: 119 SN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
           G  EY  A DIWS GC + E+  G+P +         +  I   G P             
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
               P+I  H         L  EA D + +  +  P  R TA E   HPF 
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  188 bits (478), Expect = 4e-57
 Identities = 110/296 (37%), Positives = 160/296 (54%), Gaps = 36/296 (12%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             S  DK+   L LV EY  + + +    +   +  +    VK + +Q+ + LA+ H+  
Sbjct: 68  LHS--DKK---LTLVFEYCDQDLKKY---FDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KPQNLL+N +  +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 229 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E      P  +  
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW----PGVS-- 229

Query: 288 KFPQIKPHP-------WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           K P  KP+P          V   +L     DL+      +P  R +A EA  HP+F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  183 bits (466), Expect = 9e-55
 Identities = 107/313 (34%), Positives = 159/313 (50%), Gaps = 45/313 (14%)

Query: 58  VGTGSFGVVFQAKCRET--GEIVAIKKV-------LQDKRYKNRELQIMQML-DHPNIVA 107
           +G G++G+V  A+  ET   E VAIKK+       +  KR   REL++++    H NI  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66

Query: 108 LKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           L            ELYL    E +   +++I R+     Q +   + + + YQI   L Y
Sbjct: 67  LYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKY 120

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVS-YICSRYYRAP 221
           IH+   + HRD+KP NLLVN    +LK+CDFG A+       +    ++ Y+ +R+YRAP
Sbjct: 121 IHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------ 275
           E++     YT AID+WS GC++AELL  +P+F G+  VDQL +I++VLGTP  E      
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238

Query: 276 EIKCMN-----PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 330
             K  N     PN  +  F  I P+           P A+DL+ +   + P  R +  EA
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNA---------NPLALDLLEKLLAFDPTKRISVEEA 289

Query: 331 CVHPFFDELRDPN 343
             HP+     DP+
Sbjct: 290 LEHPYLAIWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  183 bits (466), Expect = 1e-54
 Identities = 108/301 (35%), Positives = 165/301 (54%), Gaps = 30/301 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A  R TG  VAIKK+       L  KR   REL++++ + H N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81

Query: 111 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F      +  +   LV+ ++   + ++ +     H+++    ++   YQ+ + L YIH 
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA 136

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I     
Sbjct: 137 A-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMH 192

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           YT  +DIWS GC+MAE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY 
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252

Query: 286 EFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
           + K P+ +     K F+  LP   P AV+++ +        R TA EA  HP+F+E  DP
Sbjct: 253 K-KLPRFR----KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Query: 343 N 343
            
Sbjct: 308 E 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  182 bits (464), Expect = 1e-54
 Identities = 99/304 (32%), Positives = 146/304 (48%), Gaps = 35/304 (11%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 111
           G G+FG V++A+  +TG +VA+KK+L     K+       RE++I++ L HPN+V L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 112 FFSTTDKE-----ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
                DK       +Y+  V  Y+   ++ +  N   +      I  K Y  Q+   + Y
Sbjct: 76  AVERPDKSKRKRGSVYM--VTPYMDHDLSGLLEN-PSVKLTESQI--KCYMLQLLEGINY 130

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------------IC 214
           +H    I HRDIK  N+L++ +   LK+ DFG A+      PN               + 
Sbjct: 131 LH-ENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188

Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           +R+YR PEL+ G   YTTA+DIW  GCV AE+   +P+  G+S +DQL  I K+ GTPT 
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248

Query: 275 EEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 332
           E        P           P    + F K   PE +DL+ +     P  R TA +A  
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLG-PEGLDLLSKLLSLDPYKRLTASDALE 307

Query: 333 HPFF 336
           HP+F
Sbjct: 308 HPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  180 bits (458), Expect = 4e-54
 Identities = 99/294 (33%), Positives = 162/294 (55%), Gaps = 31/294 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLDHPNIVA 107
           +G G++GVV++ + ++TG+IVA+KK+    R ++          RE+ +++ L HPNIV 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L+         +E  L L+ E++   + +   +     Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM-----QESRLYLIFEFLSMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 224
           H+   + HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HS-RRVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 282
            G+  Y+T +DIWS G + AE+   +PLF G+S +DQL  I ++LGTPT +    +   P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           +Y    FP+ K     +   K L  + +DL+ +   Y P  R +A +A  HP+F
Sbjct: 234 DYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  176 bits (448), Expect = 1e-53
 Identities = 69/247 (27%), Positives = 121/247 (48%), Gaps = 40/247 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 112
           +G G FG V+ A+ ++TG+ VAIK + ++          RE++I++ L+HPNIV L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 113 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
                ++E +L LV+EY    ++  + +       ++    +     QI   L Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN- 111

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEY 230
           GI HRD+KP+N+L++    ++KL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 289
           +   DIWS G ++ EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 290 PQIKPHP 296
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  177 bits (450), Expect = 7e-53
 Identities = 97/295 (32%), Positives = 150/295 (50%), Gaps = 30/295 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD---HPN 104
           +G G++G V++A+   TG  VA+KKV    R             RE+ +++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV L           EL L LV E+V + +        +    +P   +K    Q+ R +
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK--PGLPPETIKDLMRQLLRGV 120

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            ++H    I HRD+KPQN+LV     Q+K+ DFG A++        S + + +YRAPE++
Sbjct: 121 DFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
             ++ Y T +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE    N + 
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP-RNVSL 236

Query: 285 TEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
               FP   P      F+  +P    E +DL+ +   ++P+ R +A EA  HP+F
Sbjct: 237 PRSSFPSYTPRS----FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  177 bits (450), Expect = 2e-52
 Identities = 104/303 (34%), Positives = 160/303 (52%), Gaps = 23/303 (7%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNI 105
           Y +   VG+G++G V  A  + TGE VAIKK+    Q + +  R   EL +++ + H N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 106 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           + L   F S    +E     LV+ Y+   + +I      +   +    V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            YIH+  GI HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVTRWYRAPEVI 186

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--- 281
                Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ +    
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246

Query: 282 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
             +Y +   P+     +  +F  +  P+AVDL+ +  +   + R TA EA  HP+FD  R
Sbjct: 247 AKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304

Query: 341 DPN 343
           D +
Sbjct: 305 DAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  175 bits (444), Expect = 3e-51
 Identities = 90/334 (26%), Positives = 136/334 (40%), Gaps = 48/334 (14%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHP 103
           SY     +G GSFG V+ A+ R+   +VA+K + +    K+       RE+QI+  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 104 -NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
            NIV L   F     ++E  L LV+EYV                 +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-------SYICS 215
           AL Y+H+  GI HRDIKP+N+L++     +KL DFG AK+L              + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 216 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG 270
             Y APE++ G +    +++ DIWS G  + ELL G P F GE       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 330
           TP                       P      + +   A DL+ +     P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 331 CVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 364
             H     L+   + L +          +     
Sbjct: 273 LSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPP 306

Length = 384

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  172 bits (438), Expect = 6e-51
 Identities = 106/299 (35%), Positives = 164/299 (54%), Gaps = 23/299 (7%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
           +YI    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L       TDK    L LV EY+ + + +   +   I   M +  VK++ YQI R LA
Sbjct: 67  VTLHDIVH--TDKS---LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 222
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++ G++EY+T ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 283 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           N  +  + FP+ KP P       RL  E ++L+ +F QY    R +A EA  H +F  L
Sbjct: 235 NDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  172 bits (436), Expect = 7e-51
 Identities = 114/295 (38%), Positives = 160/295 (54%), Gaps = 30/295 (10%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 110
           VVG G++GVV + + +ET EIVAIKK          K    REL++++ L   NIV LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL----IYVKLYTYQICRALAY 166
            F     + +LYL  V EYV        +N   + + MP       V+ Y YQ+ +A+ +
Sbjct: 68  AF---RRRGKLYL--VFEYV-------EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYICSRYYRAPELI 224
            H    I HRDIKP+NLL++ H   LKLCDFG A+ L +G       Y+ +R+YR+PEL+
Sbjct: 116 CHKN-DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NP 282
            GA  Y  A+D+WS GC++ EL  GQPLFPGES +DQL  I KVLG    E++K    NP
Sbjct: 174 LGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232

Query: 283 NYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            +   +FP +  P    + +   L    +DL+    + +P  R    +   HP F
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  173 bits (439), Expect = 2e-50
 Identities = 109/307 (35%), Positives = 158/307 (51%), Gaps = 43/307 (14%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK---VLQD----KRYKNRELQIMQMLDHPNIV---- 106
           +G G+FGVV+       G+ VA+KK   V Q+    KR   REL+++    H N++    
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66

Query: 107 ----ALKHCFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQIC 161
                    F      EE+Y+  V E +   +++ I        Q +   +VK++ YQI 
Sbjct: 67  ILQPPHIDPF------EEIYV--VTELMQSDLHKIIVSP-----QPLSSDHVKVFLYQIL 113

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-----ICSR 216
           R L Y+H+  GI HRDIKP NLLVN +   LK+CDFG A+V    EP+ S      + ++
Sbjct: 114 RGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVVTQ 168

Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           YYRAPE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + QL  I  +LGTP+ E 
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228

Query: 277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 333
           ++                 P   V          EAV L+CR   + P+ R +A +A  H
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288

Query: 334 PFFDELR 340
           P+ DE R
Sbjct: 289 PYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  170 bits (433), Expect = 6e-50
 Identities = 102/329 (31%), Positives = 154/329 (46%), Gaps = 54/329 (16%)

Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------- 91
           +  ++      H+ G G++G V +A    TG+IVAIKKV +     N             
Sbjct: 5   SISERYIQKGAHL-GEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCG 62

Query: 92  ------RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 145
                 REL+IM  + H NI+ L   +      E  ++NLV++ +   + ++     +I 
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYV-----EGDFINLVMDIMASDLKKVVD--RKI- 114

Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---- 201
            R+    VK    QI   L  +H      HRD+ P N+ +N      K+ DFG A+    
Sbjct: 115 -RLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKG-ICKIADFGLARRYGY 171

Query: 202 -VLVKGEPNVSYICSR----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
                       +  R          +YRAPEL+ GA +Y  A+D+WS GC+ AELL G+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Query: 251 PLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 307
           PLFPGE+ +DQL  I ++LGTP  +   + K + P YTEF     KP     +F      
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL-PLYTEFTP--RKPKDLKTIFPNA-SD 287

Query: 308 EAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           +A+DL+    + +P  R +A EA  H +F
Sbjct: 288 DAIDLLQSLLKLNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  170 bits (432), Expect = 9e-50
 Identities = 101/304 (33%), Positives = 158/304 (51%), Gaps = 21/304 (6%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           VG+G++G V  A      + VA+KK+      L   R   REL++++ + H N++ L   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 112 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           F   T  E    + LV   +   +N I +      Q++   +V+   YQ+ R L YIH+ 
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            GI HRD+KP N+ VN    +L++ DFG A+     +    Y+ +R+YRAPE++     Y
Sbjct: 138 -GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWMHY 193

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +K ++  +      
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253

Query: 291 QIKPHPWH---KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 347
            +   P     K+F +   P A+DL+ +      + R +A EA  HP+F +  DP    P
Sbjct: 254 SLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE-P 311

Query: 348 NGRP 351
              P
Sbjct: 312 EAEP 315

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  170 bits (432), Expect = 1e-49
 Identities = 92/307 (29%), Positives = 158/307 (51%), Gaps = 44/307 (14%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-VLQDKR---YKNRELQIMQMLDHPNIVALKHCFF 113
           +G GS G+VF A   +  + VA+KK VL D +   +  RE++I++ LDH NIV +     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 114 S-----TTDKEELY----LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
                 T D   L     + +V EY+   +  +          +   + +L+ YQ+ R L
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGL 127

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-------ICSRY 217
            YIH+   + HRD+KP N+ +N     LK+ DFG A+++   +P+ S+       + +++
Sbjct: 128 KYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKW 183

Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTR 274
           YR+P L+     YT AID+W+ GC+ AE+L G+PLF G   ++Q+   +E + V+    R
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 275 EEIKCMNPNYTEFKFPQIKPHPW--HKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALE 329
            E+  + P++       ++       +  +  LP   PEA+D + +   ++P  R TA E
Sbjct: 244 NELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 330 ACVHPFF 336
           A +HP+ 
Sbjct: 297 ALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  169 bits (430), Expect = 1e-49
 Identities = 106/322 (32%), Positives = 151/322 (46%), Gaps = 56/322 (17%)

Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 108
           +G G++G V++AK +    G+  AIKK   DK           RE+ +++ L H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRA 163
              F    DK    + L+ +Y    + +I + + +     I   M    VK   +QI   
Sbjct: 68  VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM----VKSLLWQILNG 120

Query: 164 LAYIH-NCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKGEPNVSY 212
           + Y+H N +   HRD+KP N+LV    P    +K+ D G A       K L   +P V  
Sbjct: 121 VHYLHSNWV--LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLV 263
           I   +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G             DQL 
Sbjct: 179 I---WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235

Query: 264 EIIKVLGTPTREE---IKCMNPNYTEFKFPQIKPHPW----HKVFQKRLP--PEAVDLVC 314
            I +VLGTPT ++   IK M P Y                  K  +K      +  DL+ 
Sbjct: 236 RIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294

Query: 315 RFFQYSPNLRCTALEACVHPFF 336
           +  +Y P  R TA EA  HP+F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  168 bits (426), Expect = 3e-49
 Identities = 98/308 (31%), Positives = 164/308 (53%), Gaps = 23/308 (7%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
           +YI    +G G++  V++ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L H    T    E  L LV EY+ + + +   +       + +  VKL+ +Q+ R L 
Sbjct: 67  VTL-HDIIHT----EKSLTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 222
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 280
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
           N  +  + +P+ +    H     RL  +  +L+ +  Q+    R +A EA  HP+F  L 
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 341 DPNTRLPN 348
           +   +LP+
Sbjct: 294 ERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  167 bits (423), Expect = 6e-49
 Identities = 110/301 (36%), Positives = 166/301 (55%), Gaps = 30/301 (9%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 104
           SY+    +G GS+  V++   R  G++VA+K V+  K  +       RE  +++ L H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           IV L H    T +     L  V EY+  +    + ++   +H       V+L+ +Q+ R 
Sbjct: 65  IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRG 115

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRA 220
           LAYIH    I HRD+KPQNLL++ +  +LKL DFG A+   K  P+ +Y   + + +YR 
Sbjct: 116 LAYIHG-QHILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRP 171

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC 279
           P+++ GAT+Y++A+DIW  GC+  E+L GQP FPG S V +QL +I  VLG PT +    
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231

Query: 280 MN--PNYTEFKFPQIKPHPWHKVFQKRL--PPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
           ++  PNY    F   KP     V+ KRL  PP+A DL  +     P  R +A +A +HP+
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVW-KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Query: 336 F 336
           F
Sbjct: 291 F 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  168 bits (427), Expect = 6e-49
 Identities = 104/298 (34%), Positives = 158/298 (53%), Gaps = 24/298 (8%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 111 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F      EE   + LV   +   +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 138

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  163 bits (415), Expect = 4e-48
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 42/285 (14%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHC 111
             +G G FG V++A+ + TG+ VAIK + L+ K  K     E+QI++   HPNIV     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 112 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           +     K+EL+  +V+E+    ++  + ++    +Q +    +     ++ + L Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            GI HRDIK  N+L+     ++KL DFG +  L   +   + + + Y+ APE+I G   Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
               DIWS G    EL  G+P +  E    + +  I   G P                  
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPP---------------GLR 218

Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
              P  W          E  D + +  Q +P  R TA +   HPF
Sbjct: 219 --NPEKW--------SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  163 bits (415), Expect = 5e-48
 Identities = 91/292 (31%), Positives = 137/292 (46%), Gaps = 55/292 (18%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALKH 110
           +G GSFG V   + ++TG++ A+K     K+++ K   +   E  I+  ++HP IV L H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59

Query: 111 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             F T +K    L LVLEY P  E  + +++       R      + Y  +I  AL Y+H
Sbjct: 60  YAFQTEEK----LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLH 110

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 227
           +  GI +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y  A+D WS G ++ E+L G+P F  E    ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CV--HPFF 336
           +FP            + L PEA DL+    Q  P  R  +  A  +  HPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  164 bits (415), Expect = 8e-48
 Identities = 97/296 (32%), Positives = 156/296 (52%), Gaps = 23/296 (7%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
           +Y+    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L H    T    E  L LV EY+   + +   N   +   M +  VK++ +Q+ R L+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 222
           Y H    I HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 118 YCHK-RKILHRDLKPQNLLIN-EKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM 280
           ++ G+TEY+T ID+W  GC++ E+  G+P+FPG +  ++L  I ++LGTPT E       
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           N  +  + FPQ +  P       RL  + +DL+     Y    R +A  A  H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  159 bits (404), Expect = 6e-46
 Identities = 97/310 (31%), Positives = 150/310 (48%), Gaps = 53/310 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 110
            +G G++G V++A+ ++TGE+VA+KKV  D   +       RE++I++ L+H NIV LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 111 CFFSTTD-----KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY------- 158
                 D     K++    LV EY+              H  M L+   L  +       
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMD-------------HDLMGLLESGLVHFSEDHIKS 120

Query: 159 ---QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYI 213
              Q+   L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E  P  + +
Sbjct: 121 FMKQLLEGLNYCHK-KNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
            + +YR PEL+ G   Y  AID+WS GC++ EL   +P+F     + QL  I ++ G+P 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 274 REEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRL-------PPEAVDLVCRFFQYSPNLRC 325
                 + P+  +   F  +KP    K +++RL       P  A+DL+       P+ RC
Sbjct: 239 ----PAVWPDVIKLPYFNTMKP---KKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291

Query: 326 TALEACVHPF 335
           TA EA   P+
Sbjct: 292 TAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  154 bits (392), Expect = 1e-43
 Identities = 103/319 (32%), Positives = 161/319 (50%), Gaps = 44/319 (13%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKR-YKNRELQIMQMLDHP 103
           Y     +G+G+ G+V  A    TG+ VAIKK       V   KR Y  REL +M++++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 104 NIVALKHCFFSTTDK-----EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 158
           NI+ L + F  T  K     +++YL  V+E +   + ++       H+RM  +      Y
Sbjct: 76  NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYL-----LY 125

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 218
           Q+   + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
           RAPE+I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  +II+ LGTP+ E + 
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 279 CMNP---NYTEFKFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNL 323
            + P   NY E + P+   + + ++F             K    +A DL+ +     P  
Sbjct: 243 RLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 324 RCTALEACVHPFFDELRDP 342
           R +  +A  HP+ +   DP
Sbjct: 302 RISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  147 bits (373), Expect = 2e-41
 Identities = 93/302 (30%), Positives = 141/302 (46%), Gaps = 34/302 (11%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH- 110
           +G G+FG VF+A+ ++T +IVA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 111 CFFSTT----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           C    T     K   YL  V E+     + +A   S  + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAP 221
           IH    I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 280
           EL+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E      
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252

Query: 281 N-PNYTEFKFPQ-----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
               + + + PQ     +K      V      P A+DL+ +     P  R  A  A  H 
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYVKD----PHALDLIDKLLVLDPAKRIDADTALNHD 308

Query: 335 FF 336
           FF
Sbjct: 309 FF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  143 bits (362), Expect = 5e-40
 Identities = 94/296 (31%), Positives = 147/296 (49%), Gaps = 32/296 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 104
           +G G++G V++A+   +G  VA+K V    R +  E             L+ ++  DHPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 105 IVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQR-MPLIYVKLYTYQIC 161
           IV L   C  S TD+E   + LV E+V + +    R Y  ++    +P   +K    Q  
Sbjct: 64  IVRLMDVCATSRTDRE-TKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 162 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
           R L ++H NCI   HRD+KP+N+LV     Q+KL DFG A++          + + +YRA
Sbjct: 119 RGLDFLHANCI--VHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 176 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 233

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           +       F    P P   V  + +      L+     ++P+ R +A  A  HPFF
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  141 bits (357), Expect = 2e-39
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 105
           Y     +G GSFG V+  + +  G++  +K++       +++     E++I++ L+HPNI
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +     F     +E+  L +V+EY     +++  +   +  +  P   +  +  Q+C AL
Sbjct: 62  IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRA 220
            Y+H+   I HRDIKPQN+ +      +KL DFG +KVL      V    +     YY +
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLT-SNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLS 171

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
           PEL      Y    DIWS GCV+ EL   +  F GE+
Sbjct: 172 PELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  140 bits (355), Expect = 2e-39
 Identities = 90/287 (31%), Positives = 134/287 (46%), Gaps = 46/287 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVL---QDKRYK------NRELQIMQMLDHPNIVAL 108
           +G+GSFG V++    + G+  A+K+V      +  +       +E+ ++  L HPNIV  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
               +  T++EE  L + LE VP     +A+   + +   P   ++LYT QI   L Y+H
Sbjct: 67  ----YLGTEREEDNLYIFLELVPG--GSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLH 119

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
           +     HRDIK  N+LV+     +KL DFG AK +V+     S+  S Y+ APE+I    
Sbjct: 120 D-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y  A DIWS GC + E+  G+P +    GV  + +I +    P                
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------------- 221

Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                P P H      L  EA D + +  Q  P+LR TA E   HPF
Sbjct: 222 -----PIPDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  140 bits (354), Expect = 8e-39
 Identities = 101/302 (33%), Positives = 158/302 (52%), Gaps = 26/302 (8%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 105
           SY     +G GS+  V++ K +  G++VA+K + LQ++        RE  +++ L H NI
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 106 VALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           V L H    T +     L LV EYV  +    + ++   +H       VKL+ +Q+ R L
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 221
           +YIH    I HRD+KPQNLL++  T +LKL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 SYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPP 172

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM 280
           +++ G+TEY+T +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232

Query: 281 N--PNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
           +  P++   +F    P    + + K      A DL  +  Q  P  R +A  A  H +F 
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292

Query: 338 EL 339
           +L
Sbjct: 293 DL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  135 bits (343), Expect = 2e-37
 Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 50/294 (17%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 109
           + +G G+FG V+ A   +TGE++A+K++ +QD   K       E++++++L HPN+V   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 110 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             +     +E++Y+   +EY    T+  +   + RI   +    +++YT Q+   LAY+H
Sbjct: 64  -YYGVEVHREKVYI--FMEYCSGGTLEELLE-HGRI---LDEHVIRVYTLQLLEGLAYLH 116

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRAPEL 223
           +  GI HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+
Sbjct: 117 SH-GIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 224 IFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           I G     +  A DIWS GCV+ E+  G+  +       Q++  +     P         
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP-------- 226

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                   P             +L PE  D + R  +  P  R TA E   HPF
Sbjct: 227 -------IPDS----------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  135 bits (341), Expect = 6e-37
 Identities = 88/320 (27%), Positives = 138/320 (43%), Gaps = 77/320 (24%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLD-HP 103
           +    ++G GSF  V  AK +ET +  AIK     +++++K+  Y   E +++  L+ HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
            I+ L + F    D+E LY   VLEY P   N     Y R +  +     + Y  +I  A
Sbjct: 63  GIIKLYYTF---QDEENLY--FVLEYAP---NGELLQYIRKYGSLDEKCTRFYAAEILLA 114

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRY-- 217
           L Y+H+  GI HRD+KP+N+L++   H +K+ DFG+AKVL                    
Sbjct: 115 LEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 218 ---------------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
                          Y +PEL+        + D+W+ GC++ ++L G+P F G +  + L
Sbjct: 173 EKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYL 229

Query: 263 V--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
              +I+K                  E+ FP               PP+A DL+ +     
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260

Query: 321 PNLRCTALEACV----HPFF 336
           P  R    E       HPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 1e-36
 Identities = 87/288 (30%), Positives = 139/288 (48%), Gaps = 48/288 (16%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALKH 110
           ++G G+FGVV++    ETG+ VAIK++ L+  + +      +E+ +++ L HPNIV    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                  +    L ++LEY    ++ +I + +    + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELIFGAT 228
             G+ HRDIK  N+L       +KL DFG A K+    + + S + + Y+ APE+I   +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
             +TA DIWS GC + ELL G P +                          +NP    F+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYD------------------------LNPMAALFR 210

Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
             Q   HP      + + PE  D + + FQ  PNLR TA +   HP+ 
Sbjct: 211 IVQ-DDHP---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  134 bits (337), Expect = 1e-35
 Identities = 95/305 (31%), Positives = 154/305 (50%), Gaps = 29/305 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 112 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           F      EE   + LV+E +   + ++  +    H+RM  +      YQ+   + ++H+ 
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGIKHLHSA 142

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 143 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGY 199

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 287
              +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E 
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259

Query: 288 K-------FPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
           +       F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+  
Sbjct: 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319

Query: 338 ELRDP 342
              DP
Sbjct: 320 VWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  133 bits (336), Expect = 1e-35
 Identities = 98/305 (32%), Positives = 154/305 (50%), Gaps = 29/305 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 112 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           F      EE   + LV+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 138

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 139 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 286
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255

Query: 287 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
                   FP++ P    P      K    +A DL+ +     P  R +  EA  HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315

Query: 338 ELRDP 342
              DP
Sbjct: 316 VWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  130 bits (330), Expect = 1e-35
 Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 45/271 (16%)

Query: 61  GSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALKHCFF 113
           G++G VF AK + TG+I AIK +   D   KN+      E  I+     P +V L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 114 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           S   K+ LYL  V+EY+P   +  +  N   + + +     ++Y  +I  AL Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113

Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------PNVSYICSRYYRAPEL 223
           I HRD+KP N+L++ + H LKL DFG +KV +             +   + +  Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII--KVLGTPTREEI---- 277
           I G   ++  +D WS GC++ E L+G P F GE+  +++ + I    +  P   E+    
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVEVSDEA 230

Query: 278 -----KCMNPNYTE---FK-FPQIKPHPWHK 299
                K + P+  +    K   +IK HP+ K
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  128 bits (325), Expect = 7e-35
 Identities = 74/241 (30%), Positives = 127/241 (52%), Gaps = 21/241 (8%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYK-NRELQIMQMLDHPNIVALKH 110
            V+G GS GVV++ + + TG+I A+KK+     ++ R +  REL+ ++  + P +V    
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F+      E  +++VLEY+   ++  + +       ++P   +     QI + L Y+H 
Sbjct: 67  AFYK-----EGEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFGAT 228
              I HRDIKP NLL+N    ++K+ DFG +KVL    +   +++ +  Y +PE I G +
Sbjct: 118 KRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 229 EYTTAIDIWSTGCVMAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
            Y+ A DIWS G  + E  LG+ P L PG+    +L++ I   G P     +  +P + +
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPEFRD 234

Query: 287 F 287
           F
Sbjct: 235 F 235

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  130 bits (329), Expect = 1e-34
 Identities = 96/306 (31%), Positives = 155/306 (50%), Gaps = 31/306 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 112 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           F      EE   + +V+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 145

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 287
              +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262

Query: 288 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

Query: 337 DELRDP 342
           +   DP
Sbjct: 322 NVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  127 bits (322), Expect = 2e-34
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 47/290 (16%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKN---RELQIMQMLDHPNIVALKHC 111
            +G G+ GVV +   R TG+I+A+K +    ++  +    REL I+   + P IV     
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           F++  D     +++ +EY+      + +    +  R+P   +      + + L Y+H   
Sbjct: 68  FYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 231
            I HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y+
Sbjct: 121 KIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDYS 177

Query: 232 TAIDIWSTGCVMAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYTE 286
              DIWS G  + EL  G+  +P E+       + L  I+               P    
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP---- 221

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
              P++    +         P+  D V       P  R +  E   HPF 
Sbjct: 222 ---PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  127 bits (320), Expect = 5e-34
 Identities = 93/304 (30%), Positives = 154/304 (50%), Gaps = 29/304 (9%)

Query: 48  QKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQML 100
           Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L
Sbjct: 1   QQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 101 D---HPNIVAL-KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 156
           +   HPN+V L   C  S TD+E   L LV E+V + +             +P   +K  
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 115

Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
            +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + + 
Sbjct: 116 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTL 173

Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+
Sbjct: 174 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232

Query: 277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE----AVDLVCRFFQYSPNLRCTALEACV 332
                P                 +  ++   +      DL+ +   ++P  R +A  A  
Sbjct: 233 W----PRDVALPRQAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286

Query: 333 HPFF 336
           HP+F
Sbjct: 287 HPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  125 bits (317), Expect = 2e-33
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 26/207 (12%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 109
            +GTGSFG V   + + +G+  A+K     K+++ K+ +    E +I+Q + HP +V L 
Sbjct: 8   TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
             F     +++  L LV+EYVP  E  + + ++      R P    + Y  Q+  AL Y+
Sbjct: 68  GSF-----QDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYL 117

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 226
           H+   I +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I  
Sbjct: 118 HSL-DIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIILS 172

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLF 253
              Y  A+D W+ G ++ E+L G P F
Sbjct: 173 -KGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  122 bits (308), Expect = 2e-32
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 48/238 (20%)

Query: 55  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
              +G G+FG V++   +         VA+K + +D   +      RE +IM+ LDHPNI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 163
           V L       T++E L   +V+EY+P        +Y R ++   L    L  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 164 LAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 219
           + Y+   N I   HRD+  +N LV      +K+ DFG ++ L   +         YY+  
Sbjct: 116 MEYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVK 162

Query: 220 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 267
                    APE +    ++T+  D+WS G ++ E+  LG+  +PG S   +++E +K
Sbjct: 163 GGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 3e-32
 Identities = 98/349 (28%), Positives = 146/349 (41%), Gaps = 87/349 (24%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
           V+G G+FG V+  + ++TG++ A+K + +    K  ++        I+   D P IV L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
             ++S  D+E LY  LV+EY+P  + +N + R         P    + Y  ++  AL  +
Sbjct: 67  --YYSFQDEEHLY--LVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSV 117

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------------------VLV 204
           H  +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 205 KGEPNVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
           +   +               Y APE++ G T Y    D WS G ++ E+L G P F  ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 258 GVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 316
               L E        T  +I     N+ E  +FP   P          + PEA+DL+CR 
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPPDPP----------VSPEAIDLICRL 268

Query: 317 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSG 365
                +   +  E   HPFF           N R   P F    PELS 
Sbjct: 269 LCDPEDRLGSFEEIKSHPFF-----KGIDWENLRETKPPF---VPELSS 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  121 bits (306), Expect = 4e-32
 Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 47/237 (19%)

Query: 55  EHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
              +G G+FG V++ K +         VA+K + +D   +      RE +IM+ LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 164
           V L       T++E LY  +V+EY+         +Y R ++ ++ L  +  +  QI R +
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 165 AYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+   N I   HRD+  +N LV      +K+ DFG ++ L   +         YYR   
Sbjct: 116 EYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRG 162

Query: 220 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 267
                   APE +    ++T+  D+WS G ++ E+  LG+  +PG S  ++++E +K
Sbjct: 163 GKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  117 bits (295), Expect = 1e-30
 Identities = 83/287 (28%), Positives = 128/287 (44%), Gaps = 47/287 (16%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFS 114
            +G GS+G V++A  +ETG++VAIK V  ++  +   +E+ I++  D P IV     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 115 TTDKEELYLNLVLEY-VPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
            TD     L +V+EY    +V+ I    N +   + +  I      YQ  + L Y+H+  
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-----LYQTLKGLEYLHS-N 118

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIFGATE 229
              HRDIK  N+L+N    Q KL DFG +  L     + N + I + ++ APE+I     
Sbjct: 119 KKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRN-TVIGTPFWMAPEVIQE-IG 175

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           Y    DIWS G    E+  G+P                    P  +    ++P    F  
Sbjct: 176 YNNKADIWSLGITAIEMAEGKP--------------------PYSD----IHPMRAIFMI 211

Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           P  KP P      ++  PE  D V +     P  R +A++   HPF 
Sbjct: 212 PN-KPPPTLSD-PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  117 bits (295), Expect = 1e-30
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 22/225 (9%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 110
            +G GSFG V + + +  G+I+  K++       ++K+    E+ I++ L HPNIV    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                 D+    L +V+EY     + ++ +   +  + +   ++     Q+  AL   HN
Sbjct: 67  RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 170 CIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 222
                  + HRD+KP N+ ++   + +KL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
            +   + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  117 bits (294), Expect = 2e-30
 Identities = 91/305 (29%), Positives = 142/305 (46%), Gaps = 53/305 (17%)

Query: 50  VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYK------NRELQ 95
             ++   ++G G++G V+ A    TGE++A+K+V          D R K        E++
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 96  IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVK 154
            ++ LDH NIV          +  E YL++ LEYVP  ++    R Y R  +++    V+
Sbjct: 61  TLKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VR 111

Query: 155 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNVS 211
            +T Q+   LAY+H+  GI HRD+K  NLLV+      K+ DFG +K    +   + N+S
Sbjct: 112 FFTEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMS 169

Query: 212 YICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
              S ++ APE+I   ++ Y+  +DIWS GCV+ E+  G+  +  E              
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-------------- 215

Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 330
               E I  M     +   P I P          L P A+D +   F  +P+ R TA E 
Sbjct: 216 ----EAIAAMFKLGNKRSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTAREL 266

Query: 331 CVHPF 335
             HPF
Sbjct: 267 LQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  116 bits (293), Expect = 3e-30
 Identities = 93/308 (30%), Positives = 141/308 (45%), Gaps = 67/308 (21%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKN------RELQIMQ 98
           +I   ++G+GSFG V+      +GE++A+K+V           R ++      RE+ +++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 99  MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT 157
            L H NIV               +LN+ LEYVP  +V  +  NY    + +    V+ + 
Sbjct: 62  ELQHENIVQYLGSSLDAD-----HLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV------- 210
            QI + L Y+HN  GI HRDIK  N+LV+ +   +K+ DFG +K   K E N        
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNG 167

Query: 211 ---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
              S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223

Query: 268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 327
           +                 E   P+I  +         +  EA+D + + F+   N R TA
Sbjct: 224 I----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258

Query: 328 LEACVHPF 335
            E   HPF
Sbjct: 259 AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  116 bits (293), Expect = 6e-30
 Identities = 85/294 (28%), Positives = 129/294 (43%), Gaps = 58/294 (19%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN--RELQIMQMLDHPNIVALKHCF 112
             +G G+ G V++A  R TG+ VAIKK+ L+ +  +    E+ IM+   HPNIV     +
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 113 FSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
                 +EL++  V+EY+         T N +  N  +I       YV     ++ + L 
Sbjct: 85  L---VGDELWV--VMEYMDGGSLTDIITQNFVRMNEPQI------AYVCR---EVLQGLE 130

Query: 166 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPE 222
           Y+H  N I   HRDIK  N+L++     +KL DFG A  L K +    S + + Y+ APE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           +I    +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P    +K    
Sbjct: 187 VIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK---- 237

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                      P  W   F+        D + +     P  R +A E   HPF 
Sbjct: 238 ----------NPEKWSPEFK--------DFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  113 bits (286), Expect = 3e-29
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 107
            +G G+FG V++   +  GE     VA+K + +    +       E  IM+ L HPNIV 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
           L       T  E LY  +V EY+P        ++ R H +++ L  +     QI + + Y
Sbjct: 66  LLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 167 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 219
           +   N +   HRD+  +N LV      +K+ DFG ++ + + +         YYR     
Sbjct: 118 LESKNFV---HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGG 164

Query: 220 -------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
                  APE +    ++T+  D+WS G ++ E+  LG+  +PG S  +
Sbjct: 165 KLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 4e-29
 Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 56/290 (19%)

Query: 61  GSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQ---IMQMLDHPNIVALKHCF 112
           G+FG V+ AK R TG+  AIK      ++   +  N + +   +M   + P +  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYIHN 169
           +S   K+  YL LV+EY+         + + + + +   P  + K Y  ++   +  +H 
Sbjct: 64  YSFQSKD--YLYLVMEYLN------GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRDIKP+NLL++   H LKL DFG ++    G  N  ++ +  Y APE I G  +
Sbjct: 116 -RGIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
                D WS GCV+ E L G P F  E+  D + + I          I            
Sbjct: 171 -DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRIN----------- 211

Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF 336
                  W +  ++   PEAVDL+ R     P  R  A    E   HPFF
Sbjct: 212 -------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  112 bits (282), Expect = 1e-28
 Identities = 76/295 (25%), Positives = 126/295 (42%), Gaps = 48/295 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPN 104
           +    V+G G+FG V   + R+T ++ A+K     K ++    +N   E +I+Q L+HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 163
           +V L   ++S  D+E +YL  V++ +     R    Y    + +     VK +  +I  A
Sbjct: 62  LVNL---WYSFQDEENMYL--VVDLLLGGDLR----YHLSQKVKFSEEQVKFWICEIVLA 112

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
           L Y+H+  GI HRDIKP N+L++   H + + DF  A  +       S   +  Y APE+
Sbjct: 113 LEYLHS-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEV 170

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           +     Y+ A+D WS G    E L G+  + G S                R++I      
Sbjct: 171 LCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQI------ 210

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEACVHPFF 336
               K            +      EA+D + +  +  P  R      +   HP+F
Sbjct: 211 --RAKQETADVL-----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 4e-28
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 48/228 (21%)

Query: 57  VVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 108
            +G G+FG V++ K +        VA+K + +D   + R     E ++M+ L HPN+V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKL--YTYQICR 162
                  T++E LY  LVLEY+         R +R      ++  L    L  +  QI +
Sbjct: 62  LGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 163 ALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 219
            + Y+     +   HRD+  +N LV      +K+ DFG ++ +   +         YYR 
Sbjct: 117 GMEYLASKKFV---HRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 220 -----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
                      APE +     +T+  D+WS G ++ E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  110 bits (278), Expect = 4e-28
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 56/296 (18%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G G FG V   K +      A+K V          + +   E +I++  +HP IV L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 111 CFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             F    K++ Y+ +++EY       T+ R    +     R        Y   +  A  Y
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           +HN  GI +RD+KP+NLL++     +KL DFG AK L  G+   ++  +  Y APE+I  
Sbjct: 109 LHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
              Y  ++D WS G ++ ELL G+P F GE   D +             +I   N     
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL-- 213

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFD 337
            +FP              +   A DL+ +  + +P  R   L+  +     H +F+
Sbjct: 214 -EFPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  111 bits (278), Expect = 9e-28
 Identities = 95/318 (29%), Positives = 156/318 (49%), Gaps = 48/318 (15%)

Query: 58  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 112
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN++AL+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 113 FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
            S +D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+
Sbjct: 68  LSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 168 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 217
           H    + HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 268
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240

Query: 269 LGTPTR---EEIKCMNPNY----TEFKFPQIKPHPWHKVFQK-RLPPEA--VDLVCRFFQ 318
           +G P     E+I+ M P Y     +F+          K  +K ++ P++    L+ +   
Sbjct: 241 MGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299

Query: 319 YSPNLRCTALEACVHPFF 336
             P  R T+ +A   P+F
Sbjct: 300 MDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  111 bits (278), Expect = 9e-28
 Identities = 98/320 (30%), Positives = 158/320 (49%), Gaps = 52/320 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 112
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN+++L+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQR---MPLIYVKLYTYQICRALAYI 167
            S  D++   + L+ +Y    +  I + +  S+ +++   +P   VK   YQI   + Y+
Sbjct: 68  LSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 168 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 217
           H    + HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 268
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240

Query: 269 LGTPTR---EEIKCMNPNYTEFK-FPQ--------IKPHPWHKVFQKRLPPEAVDLVCRF 316
           +G P     E+IK M  + T  K F +        IK    HKV   +   +A  L+ + 
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKL 297

Query: 317 FQYSPNLRCTALEACVHPFF 336
               P  R T+ +A   P+F
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  109 bits (275), Expect = 9e-28
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNR---ELQIMQMLDHPN 104
           +  E  +G G F VV++A C   G +VA+KKV    + D + +     E+ +++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           ++     F      E   LN+VLE      ++R+ +++ +  + +P   +  Y  Q+C A
Sbjct: 64  VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRAPE 222
           L ++H+   I HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
            I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  108 bits (271), Expect = 3e-27
 Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 51/296 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYKN--RELQIMQMLDHPNIV 106
            +GTG+F   +QA+  +TG ++A+K+V         Q++  +   +E+++M  L+HP+I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
                  +T   E+ + NL +E++   +V+ +   Y    +    + +  YT Q+ R L+
Sbjct: 67  ---RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGLS 117

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRA 220
           Y+H    I HRD+K  NLL++    +L++ DFG+A  L       GE     + +  + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K         I   
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IASA 226

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    P I  H         L P   D+  R  +  P  R  + E   HP F
Sbjct: 227 TTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 4e-27
 Identities = 86/298 (28%), Positives = 126/298 (42%), Gaps = 59/298 (19%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYKNRELQ---IMQMLDHPNIVALKH 110
           VG G +G VF AK ++TGEIVA+    K +L         L    I+       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHN 169
            F    D E LY  L +EYVP    R   N   +  +     + + Y  ++  A+  +H 
Sbjct: 69  AF---QDDEYLY--LAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
            +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE++ G   
Sbjct: 120 -LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KG 174

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           Y   +D WS GC++ E L G P F G                          PN T   +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGS------------------------TPNET---W 207

Query: 290 PQIKPHPWHKVFQK--------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
             +K   W +  Q+         L  EA DL+ +          +  +   HPFF E+
Sbjct: 208 ENLK--YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 5e-26
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDH---PNIVAL 108
           ++G G++G V++ K   TG +VA+K +  D    +     RE+ ++  L     PNI   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +          L +++EY      R       I ++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 227
             +G+ HRDIK  N+LV  +T  +KLCDFG A +L +     S ++ + Y+ APE+I   
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
             Y T  DIWS G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  102 bits (256), Expect = 8e-25
 Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 27/210 (12%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 108
             +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 166
           K C+       E    LV+EY   +    A +   +H++ PL  V++    +   + LAY
Sbjct: 81  KGCYL-----REHTAWLVMEYCLGS----ASDILEVHKK-PLQEVEIAAICHGALQGLAY 130

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           +H+   I HRDIK  N+L+      +KL DFGSA ++    P  S++ + Y+ APE+I  
Sbjct: 131 LHSHERI-HRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILA 185

Query: 227 ATE--YTTAIDIWSTGCVMAELLLGQ-PLF 253
             E  Y   +D+WS G    EL   + PLF
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  101 bits (253), Expect = 4e-24
 Identities = 102/346 (29%), Positives = 153/346 (44%), Gaps = 63/346 (18%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKH 110
           +GTGSFG V  AK + TGE  AIK     ++L+ K+ +   +E  I+  L HP IV +  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F    D+  +Y   +LE+V   V      + R   R P    K Y  ++  A  Y+H+ 
Sbjct: 86  SF---QDENRVY--FLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRAPELIFGAT 228
             I +RD+KP+NLL++   H +K+ DFG AK +    P+ ++ +C +  Y APE+I  + 
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVI-QSK 190

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            +  A+D W+ G ++ E + G P F  +              TP R   K +       K
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLK 233

Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDELRDPN 343
           FP      W   F  R    A DLV    Q     R   L+  V     HP+F    + +
Sbjct: 234 FPN-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA-NWD 280

Query: 344 TRLPNGRPLP-PLFNFKPPELSGI---PPETINRLIPEHARKQNLF 385
                  P P P+    P + S     P   ++RL P  A +Q  F
Sbjct: 281 KLYARYYPAPIPVRVKSPGDTSNFEKYPDSPVDRLPPLTAAQQAEF 326

Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  100 bits (250), Expect = 8e-24
 Identities = 71/209 (33%), Positives = 102/209 (48%), Gaps = 26/209 (12%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIM-------QMLDHPNIVA 107
           V+G GSFG V  AK +  G+  A+ KVLQ K    K  +  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           L H  F T DK    L  VL+YV   E    + R      +  P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTADK----LYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALG 110

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 224
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLF 253
                Y   +D W  G V+ E+L G P F
Sbjct: 169 R-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 37/285 (12%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 104
           ++  H +G GSFG V+ A    T E+VA+KK+    +  N       +E++ +Q L HPN
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICR 162
            +  K C+      +E    LV+EY   +    A +   +H++ PL  V++   T+   +
Sbjct: 83  TIEYKGCYL-----KEHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQ 132

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
            LAY+H+   I HRDIK  N+L+     Q+KL DFGSA       P  S++ + Y+ APE
Sbjct: 133 GLAYLHSHNMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPE 187

Query: 223 LIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           +I    E  Y   +D+WS G    EL   +P     + +  L  I +   +PT +  +  
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWT 246

Query: 281 NP-----NYTEFKFPQIKPHPW----HKVFQKRLPPEA-VDLVCR 315
           +      +Y   K PQ +P       H   ++  P    +DL+ R
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQR 291

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.4 bits (245), Expect = 1e-23
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 42/287 (14%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK---NRELQIMQMLDHPNIVALKHCF 112
           V+G G++G+V+ A+   T   +AIK++  +D RY    + E+ +   L H NIV      
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----- 69

Query: 113 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           +  +D E  +  + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYLHD- 126

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELI-FGAT 228
             I HRDIK  N+LVN ++  +K+ DFG++K L    P   ++  +  Y APE+I  G  
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y    DIWS GC + E+  G+P F                       I+   P    FK
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAAMFK 223

Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
               K HP      + L  EA + + R F+  P+ R +A +    PF
Sbjct: 224 VGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 99.1 bits (247), Expect = 1e-23
 Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 36/215 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           VGTG+FG V   + R +    A+K +       L+ +++ + E ++++ + HP I+ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 111 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            F++  D+  LY+  ++EYVP  E  + + RN  R      L     Y  +I  AL Y+H
Sbjct: 67  -FWTEHDQRFLYM--LMEYVPGGELFSYL-RNSGRFSNSTGL----FYASEIVCALEYLH 118

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAPE 222
           +   I +RD+KP+N+L++   H +KL DFG AK L        G P         Y APE
Sbjct: 119 S-KEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPE 168

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
           +I  +  +  A+D W+ G ++ E+L+G P F  ++
Sbjct: 169 VI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 80/293 (27%), Positives = 123/293 (41%), Gaps = 52/293 (17%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK---RYKNRELQIMQMLDHPNIVALKHC 111
             +G+G++G V++A+   TGE+VAIK + L+         +E+ +++   HPNIVA    
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAYIHNC 170
           +          L +V+EY      +     +R       I YV   T +    LAY+H  
Sbjct: 69  YLRRD-----KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK---GLAYLHE- 119

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIFGAT 228
            G  HRDIK  N+L+      +KL DFG +  L     +   S+I + Y+ APE+   A 
Sbjct: 120 TGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEVA--AV 175

Query: 229 E----YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           E    Y    DIW+ G    EL   Q P+F         +  ++ L   ++         
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS-------- 219

Query: 284 YTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
              F  P++K    W  VF         D + +     P  R TA +   HPF
Sbjct: 220 --NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 71/213 (33%), Positives = 100/213 (46%), Gaps = 36/213 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNI 105
           YI   V+G G+FG     +  E   +V  K+V L     K R     E+ I+ +L HPNI
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           +A  + F      ++  L + +EY       ++I R   +  Q      V  Y +QI  A
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR---QKGQLFEEEMVLWYLFQIVSA 113

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNVSYIC 214
           ++YIH   GI HRDIK  N+ +      +KL DFG +K+L         V G P      
Sbjct: 114 VSYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------ 165

Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
             YY +PEL  G  +Y    DIW+ GCV+ ELL
Sbjct: 166 --YYMSPELCQGV-KYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.3 bits (237), Expect = 2e-22
 Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 51/292 (17%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR------ELQIMQMLDHPNIVAL 108
           +G G+FG V+     +TG  +A+K+V         K        E+Q+++ L H  IV  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             C     D E L +   +EY+P       ++  + +  +     + YT QI   + Y+H
Sbjct: 70  YGCL---RDDETLSI--FMEYMP---GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPELI 224
           + + I HRDIK  N+L +     +KL DFG++K L      G    S   + Y+ +PE+I
Sbjct: 122 SNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
            G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT           
Sbjct: 180 SGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN---------- 225

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                PQ+  H         + P+A + + R F  +   R +A E   H F 
Sbjct: 226 -----PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 95.3 bits (237), Expect = 2e-22
 Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 16/208 (7%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKH 110
           VVG G+FG+V   + +   ++V IK++  ++  K+       E Q++++L HPNI+    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F      E+  L +V+EY P  T+    +   R +  +    +  +  QI  AL ++H 
Sbjct: 67  NFL-----EDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
            + I HRD+K QN+L++ H   +K+ DFG +K+L       + + +  Y +PEL  G   
Sbjct: 120 KL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KP 177

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGES 257
           Y    DIW+ GCV+ EL   +  F   +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 49/298 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 111
           +G GS G+V  A  + TG  VA+KK+  D R + R      E+ IM+   HPNIV +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 112 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           + S    +EL++  V+E++    +  I       H RM    +      + +AL+++H  
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA- 133

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATE 229
            G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     
Sbjct: 134 QGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLP 191

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           Y T +DIWS G ++ E++ G+P +  E  +  +            + I+   P       
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP------- 232

Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 347
           P++K    HKV      P     + R     P  R TA E   HPF  +   P++ +P
Sbjct: 233 PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 29/214 (13%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQML-DHPNIVALKH 110
           V+G G++G V++A+ ++TG++VAIK  + D           E  I++   +HPNI     
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 111 CFF---STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            F       + ++L+  LV+E     +V  + +   +  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 167 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPEL 223
           +H    I   HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+
Sbjct: 129 LHENKVI---HRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 224 IFGATE------YTTAIDIWSTGCVMAELLLGQP 251
           I  A +      Y    D+WS G    EL  G+P
Sbjct: 185 I--ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (236), Expect = 5e-22
 Identities = 92/320 (28%), Positives = 139/320 (43%), Gaps = 56/320 (17%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 110
           +G GSFG V Q + R+T  I A+K + +       E+        ++  ++ P IV LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
             FS    E+LYL L      E  + + R       R  L   + YT ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHK- 111

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATE 229
             + +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           YT A+D W+ G ++ E+L G P F  E+ V+++    K+L  P R               
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR--------------- 211

Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDPNTRL 346
                      F      +A DL+       P  R     A E   HPFF +L     +L
Sbjct: 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WKKL 258

Query: 347 PNGRPLPPLFNFKPPELSGI 366
                 PP   FKP   S I
Sbjct: 259 LMKGIQPP---FKPAVSSAI 275

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.8 bits (234), Expect = 8e-22
 Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 57/296 (19%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 106
           +     +G GSFG V++A  + T ++VAIK +       +     +E+Q +     P I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
                F   +      L +++EY          +  +   ++   Y+     ++   L Y
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCG---GGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 219
           +H   G  HRDIK  N+L++     +KL DFG     V G+   S +  R       ++ 
Sbjct: 114 LHE-EGKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFWM 165

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE+I   + Y    DIWS G    EL  G+P  P  S +  +    +VL        K 
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPKN 213

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            NP       P ++ + + K F+        D V       P  R +A E   H F
Sbjct: 214 -NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 86/321 (26%), Positives = 134/321 (41%), Gaps = 61/321 (19%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 109
           +G G FG V   + + TG++ A KK L  KR K R        E +I++ +    IV+L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 110 HCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           + F  T D   L + L+    L+Y    V       +R            Y  QI   L 
Sbjct: 60  YAF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR---------AIFYAAQIICGLE 109

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           ++H    I +RD+KP+N+L++ H + +++ D G A  L  G+       +  Y APE++ 
Sbjct: 110 HLHQ-RRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
           G   Y  ++D ++ GC + E++ G+  F       Q  E ++      +EE+K       
Sbjct: 168 GE-VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-M 213

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 340
             ++P             +  PEA DL     Q  P  R      +A E   HP F +L 
Sbjct: 214 AVEYPD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261

Query: 341 DPNTRLPNGRPLPPLFNFKPP 361
               RL  G   PP   F P 
Sbjct: 262 WR--RLEAGMLEPP---FIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 58/299 (19%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 108
           V+G GSFG V  A+ + T E+ A+K      +LQD   +    E +++ +   HP +  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAY 166
            H  F T D+    L  V+EYV    N     +  I +  R      + Y  +I   L +
Sbjct: 62  -HSCFQTKDR----LFFVMEYV----NGGDLMF-HIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 225
           +H   GI +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               Y  A+D W+ G ++ E+L GQ  F G+   D+L + I             +     
Sbjct: 170 Y-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSI-------------LEDEV- 213

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDEL 339
                          + + L  EA  ++  F   +P  R   L         HPFF E+
Sbjct: 214 --------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 51/303 (16%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKHCF 112
           G G++GVV + +   TG I+A+K++   +  +  K    +L I M+ +D P  V      
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           F   D     + + +E +  ++++  +        +P   +      I +AL Y+H+ + 
Sbjct: 70  FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 229
           + HRD+KP N+L+N    Q+KLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           Y    D+WS G  M EL  G+  FP +S             TP                F
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTP----------------F 214

Query: 290 PQIK-----PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
            Q+K     P P  ++  ++  PE  D V +  + +   R    E   HPFF+     NT
Sbjct: 215 QQLKQVVEEPSP--QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272

Query: 345 RLP 347
            + 
Sbjct: 273 DVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 93.2 bits (231), Expect = 2e-21
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 110
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           C+       E    LV+EY   + + +   + +  Q + +  V   T+   + LAY+H+ 
Sbjct: 83  CYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLHSH 134

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 229
             + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    E 
Sbjct: 135 -NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEG 189

Query: 230 -YTTAIDIWSTGCVMAELLLGQP 251
            Y   +D+WS G    EL   +P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 93.2 bits (231), Expect = 3e-21
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 26/205 (12%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 110
           +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q + HPN +  K 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 168
           C+       E    LV+EY   +    A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 93  CYL-----REHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH 142

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
           +   I HRDIK  N+L+     Q+KL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 SHNMI-HRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 229 E--YTTAIDIWSTGCVMAELLLGQP 251
           E  Y   +D+WS G    EL   +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 86/311 (27%), Positives = 136/311 (43%), Gaps = 67/311 (21%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 109
           V+G G+FG V   + + + ++ A+K + + +  K         E  IM   +   IV L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL- 108

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           H  F    +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 109 HYAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----IPEKWARFYTAEVVLALDAI 158

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPE 222
           H+ +G  HRD+KP N+L++   H LKL DFG+    +K + N    C        Y +PE
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213

Query: 223 LIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           ++    G   Y    D WS G  + E+L+G   F  +S V          GT +    K 
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------GTYS----KI 259

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF- 336
           M+ +     FP              +  +A DL+C F         R    E   HPFF 
Sbjct: 260 MD-HKNSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308

Query: 337 ------DELRD 341
                 D +R+
Sbjct: 309 NDQWTFDNIRE 319

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 92.2 bits (229), Expect = 5e-21
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 65/310 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALK 109
           ++  G++G V+  + +ET +  A+KK+  Q+   +N+      E  I+   ++P +V++ 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM- 66

Query: 110 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            C F T    + +L +V+EYV       + +N       +P+   ++Y  +   AL Y+H
Sbjct: 67  FCSFET----KRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYLH 118

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNV--------------SYI 213
           N  GI HRD+KP NLL+    H +KL DFG +K+ L+    N+                +
Sbjct: 119 N-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 214 C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 272
           C +  Y APE+I     Y   +D W+ G ++ E L+G   F G++  +   ++I      
Sbjct: 177 CGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----- 230

Query: 273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALE 329
             ++I    P   E                  LP +A DL+ R  + +P  R     A E
Sbjct: 231 --DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAFE 269

Query: 330 ACVHPFFDEL 339
              H FF  L
Sbjct: 270 VKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.0 bits (226), Expect = 5e-21
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 112
           G GS+G V++ K     +  A+K+V L     K R     E++I+  ++HPNI++ K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 113 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIH 168
               D  +L +  V+EY P  +    I++   R  +R  +   +++    Q+ R L  +H
Sbjct: 69  L---DGNKLCI--VMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 169 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 227
               I HRD+K  N LLV      +K+ D G +KVL K     + I + +Y APE ++  
Sbjct: 121 E-QKILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKG 175

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
             Y+   DIWS GC++ E+    P F   S  D   ++ +
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 36/286 (12%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 112
           +G G+ G V + K   TG ++A K V    +        RELQIM     P IV+    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 113 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
            +  +     + + +E++   +++RI +    I    P+  +      +   L Y++N  
Sbjct: 73  LNENN-----ICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTYLYNVH 123

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 231
            I HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 232 TAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              D+WS G  + EL LG+ P        D   + + +L                     
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223

Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           QI   P  ++     P +  D V       P  R T  + C  P F
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 90.7 bits (225), Expect = 8e-21
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 31/213 (14%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYK--NRELQIMQMLDHPNIV 106
           V+G G++G V+       G+++A+K+V  D        K Y+    E+ +++ L H NIV
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
                 +  T  ++  +++ +E+VP     I+   +R       ++ K YT QI   +AY
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPG--GSISSILNRFGPLPEPVFCK-YTKQILDGVAY 117

Query: 167 IH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI-------CSRYY 218
           +H NC+   HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 118 LHNNCV--VHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 251
            APE+I   + Y    DIWS GC + E+  G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 39/301 (12%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK-RYKN---RELQIMQMLDHPNIVALKHC 111
            +G G+ GVV +   R +G I+A K + L+ K   +N   REL+++   + P IV     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 112 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           F+S  D E   +++ +E++   +++++ +   RI    P   +   +  + R L Y+   
Sbjct: 68  FYS--DGE---ISICMEHMDGGSLDQVLKKAGRI----PENILGKISIAVLRGLTYLREK 118

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
           T   DIWS G  + E+ +G+   P         E+  + G P   E +    +      P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPV-SEGEAKESHRPVSGHP 230

Query: 291 QIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPF 335
              P P   +F+           +LP      E  D V +  + +P  R    E   HPF
Sbjct: 231 PDSPRPM-AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289

Query: 336 F 336
            
Sbjct: 290 I 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.5 bits (225), Expect = 8e-21
 Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 52/296 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHC 111
           V+G G+  VV+ A C    E VAIK++  +K   +     +E+Q M   +HPN+V   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 112 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F     +EL+  LV+ Y+     ++ +  +Y R      +I   L   ++ + L Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRYYRAPELI 224
             G  HRDIK  N+L+      +K+ DFG +  L  G          ++ +  + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCM 280
                Y    DIWS G    EL  G        P +     L+  ++             
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQ------------- 221

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           N        P ++    +K + K        ++    Q  P+ R TA E   H FF
Sbjct: 222 ND------PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)

Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALA 165
            K   +S   +    L LV+EY+P    R  + ++  R+  R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 166 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSR 216
           Y+     +   HRD+  +N+LV      +K+ DFG  KVL          EP  S I   
Sbjct: 123 YLGSKRYV---HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI--- 175

Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAEL 246
           ++ APE +   ++++ A D+WS G V+ EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 33/209 (15%)

Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 106
           +G G FG V    CR       TGE VA+K        Q +    RE++I++ LDH NIV
Sbjct: 12  LGEGHFGKVE--LCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 165
             K             L L++EY+P    R    Y + H+ ++ L  + L++ QIC+ + 
Sbjct: 70  KYKGV---CEKPGGRSLRLIMEYLPSGSLRD---YLQRHRDQINLKRLLLFSSQICKGMD 123

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYY 218
           Y+ +     HRD+  +N+LV      +K+ DFG AKVL +        EP  S I   +Y
Sbjct: 124 YLGS-QRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY 179

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELL 247
            APE +  +  +++A D+WS G  + EL 
Sbjct: 180 -APECLRTSK-FSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.1 bits (223), Expect = 1e-20
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 17/211 (8%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 107
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 7   EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
               F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C AL +
Sbjct: 67  YYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIF 225
           +H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE I 
Sbjct: 122 MHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
               Y    DIWS GC++ E+   Q  F G+
Sbjct: 180 -ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 85/310 (27%), Positives = 137/310 (44%), Gaps = 47/310 (15%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF---- 112
           V+G GSFG V  A+ + T E  AIK + +D   ++ +++   +      +A +H F    
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           F T   +E +L  V+EY+      +  +      R      + Y  +I   L ++H   G
Sbjct: 62  FCTFQTKE-HLFFVMEYL--NGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK-G 116

Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYT 231
           I +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++ G  +Y 
Sbjct: 117 IIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYN 174

Query: 232 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 291
            ++D WS G ++ E+L+GQ  F GE   D+L + I         +               
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR-------------- 212

Query: 292 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACVHPFFDELRDPNTRLPNGR 350
               P    F + +  EA D + + F+  P  R     +   HPFF   R  +      R
Sbjct: 213 ----PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWERLEKR 262

Query: 351 PLPPLFNFKP 360
            +PP   FKP
Sbjct: 263 EIPP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 49/285 (17%)

Query: 57  VVGTGSFGVVF---QAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPNIV 106
           V+G GSFG VF   +    + G++ A+K       KV    R K  E  I+  ++HP IV
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICRAL 164
            L H  F T  K    L L+L+++     R    ++R+ + +      VK Y  ++  AL
Sbjct: 62  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPEL 223
            ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 112 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPT--------- 273
           +     +T + D WS G +M E+L G   F G+   + +  I+K  LG P          
Sbjct: 170 V-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 228

Query: 274 -REEIKCMNPNYTEFKFPQ----IKPHP------WHKVFQKRLPP 307
            R   K  NP       P     IK HP      W+K++++ + P
Sbjct: 229 LRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 78/304 (25%), Positives = 120/304 (39%), Gaps = 68/304 (22%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           G G+FG V++A+ +ETG   A K +       L+D      E+ I+    HPNIV L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 112 FFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIH 168
           +F         L +++E+     ++ I     R      L    ++    Q+  AL ++H
Sbjct: 71  YFYENK-----LWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH 120

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI--- 224
           +   + HRD+K  N+L+      +KL DFG SAK     +   ++I + Y+ APE++   
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 225 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
            F    Y    DIWS G  + EL   +P                    P  E    +NP 
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPM 214

Query: 284 YTEFKFPQ------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
               K  +       +P  W   F         D +       P+ R TA E   HPF  
Sbjct: 215 RVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVS 266

Query: 338 ELRD 341
           +  D
Sbjct: 267 DQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 50/281 (17%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFF 113
           G G+ G V + + + TG I A+K +  D     ++   REL+I +    P IV     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 114 STTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              D+    + + +EY     +     ++ +   RI ++  L  +      + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPELI 224
           +   I HRDIKP N+L+     Q+KLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 S-RKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 273
            G   Y+   D+WS G  + E+   +  FP E     G  +L+  I  +  P        
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 274 ----REEIK-----CMNPNYTEFKFP-QIKPHPWHKVFQKR 304
                EE K     C+  + T    P  +  HPW K   K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 89.5 bits (222), Expect = 5e-20
 Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 59/296 (19%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG+  A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F  T D     L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALGYL 111

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 226
           H+C  + +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
             +Y  A+D W  G VM E++ G+ P +  +   ++L E+I +      EEI+       
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR------- 213

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
                          F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 87.7 bits (217), Expect = 7e-20
 Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 22/217 (10%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 110
            +G GSFG ++ AK +   E   IK++      +++K    +E+ ++  + HPNIV    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT--- 63

Query: 111 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            FF++  +E   L +V+EY    + + RI R    +     ++    +  QI   L +IH
Sbjct: 64  -FFASF-QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHIH 118

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 226
           +   I HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE I  
Sbjct: 119 D-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-ICQ 175

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
              Y    DIWS GCV+ EL   +  F G + + QLV
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 50/300 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIVALKHCF 112
           +G G++G V++   R TG  +A+K++   L + ++     EL I+     P IV     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 113 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           F      E  + + +EY+   +++++        + +P   ++  TY + + L ++    
Sbjct: 69  F-----IEGAVYMCMEYMDAGSLDKLYAGGVAT-EGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI-----FG 226
            I HRD+KP N+LVN +  Q+KLCDFG +  LV      +  C  Y  APE I       
Sbjct: 123 NIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQ 180

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPN 283
              YT   D+WS G  + E+ LG+  +P E+  +   QL  I+   G P       +   
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSG 233

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           Y+                      +A D V +     PN R T  +   HP+  + ++ +
Sbjct: 234 YS---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 87/282 (30%), Positives = 128/282 (45%), Gaps = 45/282 (15%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 107
           V+G GSFG V  AK +  G+  A+ KVLQ K   NR+ Q         +++ + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAV-KVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           L H  F TT+K    L  VL++V   E    + R  S      P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASALG 110

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 224
           Y+H+ I I +RD+KP+N+L++   H + L DFG  K  +      +  C +  Y APE+I
Sbjct: 111 YLHS-INIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII-KVL----GTPT------ 273
                Y   +D W  G V+ E+L G P F      +    I+ K L    G         
Sbjct: 169 -RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSIL 227

Query: 274 REEIKCMNPNYTEFK--FPQIKPHP------WHKVFQKRLPP 307
            E ++         K  F +I+ HP      W  + QK++PP
Sbjct: 228 EELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 24/227 (10%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQ--DKRYKN---RELQIMQMLDHPNI 105
           +   + +G GSFGVVF+   +    + A+K++ L   ++R +     E +++  LD   I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +     F      ++  LN+V+EY     ++++ +      + +P   V  +  QI   L
Sbjct: 62  IRYYESFL-----DKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGL 114

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 220
           A++H+   I HRDIK  NL ++ +   +K+ D G AK+L     N ++    + + YY +
Sbjct: 115 AHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLS 169

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
           PEL      Y    D+W+ G V+ E   G+  F   +    +++II+
Sbjct: 170 PELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 57/303 (18%)

Query: 57  VVGTGSFGVVFQAKCR---ETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 104
           V+GTG++G VF  +     + G++ A+K      ++Q  +         Q+L+     P 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           +V L H  F T  K    L+L+L+YV   E    +   Y R  +      V++Y  +I  
Sbjct: 67  LVTL-HYAFQTDTK----LHLILDYVNGGELFTHL---YQR--EHFTESEVRVYIAEIVL 116

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 220
           AL ++H  +GI +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    Y A
Sbjct: 117 ALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 221 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           PE+I G +  +  A+D WS G +  ELL G   F  +   +   EI       +R  +K 
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRRILKS 227

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 336
             P                  F K +  EA D + +  +  P  R     A E   HPFF
Sbjct: 228 KPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Query: 337 DEL 339
             +
Sbjct: 270 QGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 87.2 bits (216), Expect = 4e-19
 Identities = 88/300 (29%), Positives = 129/300 (43%), Gaps = 63/300 (21%)

Query: 57  VVGTGSFGVVFQAK---CRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPN 104
           V+G G +G VFQ +     +TG+I A+K VL+         D  +   E  I++ + HP 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           IV L    F T  K    L L+LEY+   E    + R    +           Y  +I  
Sbjct: 62  IVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEISL 111

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAP 221
           AL ++H   GI +RD+KP+N+L++   H +KL DFG  K  +         C    Y AP
Sbjct: 112 ALEHLHQ-QGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E I   + +  A+D WS G +M ++L G P F  E+    + +I+K          K   
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNL 219

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
           P Y                    L PEA DL+ +  + +P+ R       A E   HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 86.6 bits (214), Expect = 5e-19
 Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 55/314 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 108
           ++G GSFG VF A+ + T +  AIK + +D    + +++   +         +HP +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            +C F T  KE L+   V+EY+      +  +    H +  L     Y  +I   L ++H
Sbjct: 62  -YCTFQT--KENLFF--VMEYL--NGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH 113

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 227
           +  GI +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G 
Sbjct: 114 S-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG- 170

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
            +Y T++D WS G ++ E+L+GQ  F G    +              + I+  NP Y  +
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCYPRW 218

Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNTRL 346
                            L  EA D++ + F   P  R     +   HPFF E+    + L
Sbjct: 219 -----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID--WSAL 259

Query: 347 PNGRPLPPLFNFKP 360
                 PP   FKP
Sbjct: 260 EEREIEPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 80/308 (25%), Positives = 125/308 (40%), Gaps = 86/308 (27%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALK 109
           V+G G+FG V   + ++TG I A+KK+ + +   K +      E  I+   D+P +V L 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F     ++E YL L++EY+P  + +  + +      +     Y+     +   A+  I
Sbjct: 68  YSF-----QDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIA----ETILAIDSI 117

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPN--VSYI 213
           H  +G  HRDIKP NLL++   H +KL DFG              ++L    P+  + +I
Sbjct: 118 HK-LGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 214 CSRY-------------------------YRAPELIFGATEYTTAIDIWSTGCVMAELLL 248
                                        Y APE +F  T Y    D WS G +M E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEMLV 234

Query: 249 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE 308
           G P F  +               P     K +N   T  +FP           +  L PE
Sbjct: 235 GYPPFCSD--------------NPQETYRKIINWKET-LQFPD----------EVPLSPE 269

Query: 309 AVDLVCRF 316
           A DL+ R 
Sbjct: 270 AKDLIKRL 277

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 90/301 (29%), Positives = 137/301 (45%), Gaps = 60/301 (19%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQM-LDHPNIVAL 108
           V+G GSFG V  A+ + T E+ AIK      +LQD        E +I+ +   HP + AL
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            HC F T D+    L  V+EYV   + + +I R+      R      + Y  ++  AL +
Sbjct: 62  -HCCFQTKDR----LFFVMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMF 111

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 225
           +H   G+ +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I 
Sbjct: 112 LHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-IL 168

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
              EY  ++D W+ G +M E++ GQP F  ++  D L E I                 + 
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL----------------HD 211

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC-----VHPFFDE 338
           +  +P      W       L  EAV ++  F   +PN R  C A +        HPFF E
Sbjct: 212 DVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Query: 339 L 339
           +
Sbjct: 260 I 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 30/233 (12%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQ----IMQMLDHPNIVALKHC 111
           +G G+FG V +   + +G I+A+K++    D++ + R L     +M+  D P IV     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK---- 67

Query: 112 FFSTTDKE-------ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           F+    +E       EL +++ L+   + V      Y  +   +P   +        +AL
Sbjct: 68  FYGALFREGDCWICMEL-MDISLDKFYKYV------YEVLKSVIPEEILGKIAVATVKAL 120

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            Y+   + I HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179

Query: 225 --FGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 274
                  Y    D+WS G  + E+  G+  +P   S  DQL +++K  G P  
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 86/316 (27%), Positives = 144/316 (45%), Gaps = 59/316 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 108
           V+G GSFG V  A+ +  GE  A+K + +D    + +++   +         ++P +  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            +C F T +    +L  V+E++   + +  I         R  L     Y  +I   L +
Sbjct: 62  -YCTFQTKE----HLFFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQF 111

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 225
           +H+  GI +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ 
Sbjct: 112 LHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
           G  +YT ++D WS G ++ E+L+GQ  F G+   D+L E I+V  TP             
Sbjct: 170 G-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------- 213

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNT 344
              +P+     W       +  E+ D++ + F+  P  R   +     HPFF  +   N 
Sbjct: 214 --HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---NW 256

Query: 345 RLPNGRPLPPLFNFKP 360
                R L P   FKP
Sbjct: 257 TALEKRELDP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 92/305 (30%), Positives = 140/305 (45%), Gaps = 60/305 (19%)

Query: 57  VVGTGSFGVVF---QAKCRETGEIVAIKKVLQD----KRYKNRELQIM--QMLDH----P 103
           V+GTG++G VF   +    +TG++ A+K VLQ     ++ K  E       +L+H    P
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLIYVKLYTYQIC 161
            +V L H  F T  K    L+L+L+YV          ++ ++QR       V+ Y+ +I 
Sbjct: 66  FLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGEII 115

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YR 219
            AL ++H  +GI +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    Y 
Sbjct: 116 LALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE+I G   +  A+D WS G ++ ELL G   F  E   +   E+       +R  +KC
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILKC 226

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 334
             P                  F   + PEA DL+ +  +  P  R       A E   HP
Sbjct: 227 DPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268

Query: 335 FFDEL 339
           FF  L
Sbjct: 269 FFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 67/224 (29%), Positives = 120/224 (53%), Gaps = 28/224 (12%)

Query: 58  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G G+ GVV + + + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F+S  D E   +++ +E++   +++++ +   RI + +    +   +  + R LAY+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 230 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 272
           Y+   DIWS G  + EL +G+ P+ P ++      E+  + G P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 90/339 (26%), Positives = 142/339 (41%), Gaps = 81/339 (23%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKK----VLQDKR---YKNRELQIMQMLDHPNIVALK 109
           +VG G FG V   + + TG+I A+K     VL  +    +   E  I+ + + P I  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F    DK+ LYL  V+EY P  + ++ + R   +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELI- 224
           H  +G  HRDIKP+N+L++   H +KL DFGSA  L   +   S   + +  Y APE++ 
Sbjct: 119 HQ-MGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 225 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
                G   Y    D WS G +  E++ G+  F   +       I+              
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222

Query: 281 NPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA------CVH 333
             N+  F KFP+            ++  + +DL+        +L C   E       C H
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLI-------QSLLCGQKERLGYEGLCCH 263

Query: 334 PFFDELRDPNTRLPNGRPLPPLF----------NFKPPE 362
           PFF ++   N R      LPP            NF  PE
Sbjct: 264 PFFSKIDWNNIR----NSLPPFVPTLKSDDDTSNFDEPE 298

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 67/229 (29%), Positives = 122/229 (53%), Gaps = 23/229 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G G+ GVVF+   + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F+S  D E   +++ +E++   +++++ +   RI +++    +   +  + + L Y+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 230 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 277
           Y+   DIWS G  + E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 82.4 bits (203), Expect = 7e-18
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHP 103
           ++  E  +G G F  V++A C    + VA+KKV    + D + +    +E+ +++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           N++     F    +     LN+VLE      ++++ + + +  + +P   V  Y  Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAP 221
           A+ ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
           E I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 82.2 bits (203), Expect = 8e-18
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNI 105
           Y+    +G GSFG     K +E G+   IK++    +  K  +   +E+ ++  + HPNI
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQIC 161
           V  +  F     +E   L +V++Y           Y +I+ +  +++    +  +  QIC
Sbjct: 62  VQYQESF-----EENGNLYIVMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 220
            AL ++H+   I HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELL 247
           PE I     Y    DIW+ GCV+ E+ 
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 82.0 bits (202), Expect = 9e-18
 Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 61/297 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 107
           ++G G+FG V+     +TG  +A+K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
              C     D  E  L++ +E++P  ++    ++Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVSY 121

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 222
           +H+ + I HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           +I G   Y    DIWS GC + E+L  +P +   +  + +  I K+   PT       NP
Sbjct: 180 VISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT-------NP 228

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
                                 LPP   D  CR F     L+   +EA + P  DEL
Sbjct: 229 ---------------------VLPPHVSDH-CRDF-----LKRIFVEAKLRPSADEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 70/237 (29%), Positives = 116/237 (48%), Gaps = 43/237 (18%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 104
           Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           +V L  C F    +++ YL +V+EY+P  + VN ++ NY      +P  + K YT ++  
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVL 153

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSY 212
           AL  IH+ +G+ HRD+KP N+L++ H H LKL DFG+   + +          G P+   
Sbjct: 154 ALDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD--- 208

Query: 213 ICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
                Y +PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 209 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE----------LQIMQMLDHPNIVA 107
           +G G+FG V+Q + ++T  I A+K + + +    +E          L    + + P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           LK  F + +D     L LV +Y+   E    + +       R      K Y  ++  AL 
Sbjct: 61  LKFSFQTDSD-----LYLVTDYMSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALE 110

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELI 224
           ++H    I +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++
Sbjct: 111 HLHK-YDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII---------KVLGTPTRE 275
                YT  +D WS G ++ E+  G   F  E    Q+   I          VL    R+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNVLSDEGRQ 227

Query: 276 EIKCM---NPNY---TEFKFPQIKPHP------WHKVFQKRLPP 307
            +K +   NP +         ++K HP      W  + +K++ P
Sbjct: 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITP 271

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 107
           V+G GSFG V  AK +  G   A+ KVLQ K    ++ Q         +++ L HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAV-KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           L + F +    E+LY   VL+YV   E    + R    +  R      + Y  ++  A+ 
Sbjct: 61  LHYSFQTA---EKLY--FVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAIG 110

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 224
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  V+ E   S  C +  Y APE +
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-V 167

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLF 253
                Y   +D W  G V+ E+L G P F
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 65/235 (27%), Positives = 117/235 (49%), Gaps = 27/235 (11%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 107
           ++G G+FG V+     +TG  +A+K+V  D   +           E+Q+++ L H  IV 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
              C     D EE  L++ +EY+P  ++    + Y  + + +     + YT QI + ++Y
Sbjct: 69  YYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVSY 121

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVSYICSRYYRAPE 222
           +H+ + I HRDIK  N+L +     +KL DFG++K    + + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
           +I G   Y    D+WS  C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 180 VISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 57/302 (18%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 111
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 112 FFSTTDKEELYLNLVLEYV-----PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           + S    EEL++  ++E++      + V++   N  +I               + +AL Y
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQI---------ATVCESVLQALCY 132

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 225
           +H+  G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I 
Sbjct: 133 LHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI- 189

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
             T Y T +DIWS G ++ E++ G+P +  +S V  +  +        R+          
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS--------- 232

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 345
                   P P  K   K + P   D + R     P  R TA E   HPF  +   P   
Sbjct: 233 --------PPPKLKNAHK-ISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECL 283

Query: 346 LP 347
           +P
Sbjct: 284 VP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 22/209 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKN----RELQIMQM-LDHPNIVALKHC 111
           +G+G+ G V++ + ++TG ++A+K++ +   + +N     +L ++    D P IV     
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIHNC 170
           F + +D     + + +E +   ++++ +   RI   +P  I  K+ T  I +AL Y+   
Sbjct: 83  FITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKM-TVAIVKALHYLKEK 133

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGAT- 228
            G+ HRD+KP N+L++  +  +KLCDFG +  LV  +    S  C+ Y  APE I     
Sbjct: 134 HGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDP 191

Query: 229 --EYTTAIDIWSTGCVMAELLLGQPLFPG 255
             +Y    D+WS G  + EL  GQ  +  
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 107
           V+G GSFG V  A+ +   +  A+K VLQ K    K  E  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           L H  F T DK    L  VL+Y+   E    + R    +  R      + Y  +I  AL 
Sbjct: 61  L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 224
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++
Sbjct: 111 YLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLF 253
                Y   +D W  G V+ E+L G P F
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 75/293 (25%), Positives = 137/293 (46%), Gaps = 55/293 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 108
           V+G GS+  V   + ++T  I A+K + ++    + ++  +Q          +HP +V L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             CF     + E  L  V+E+V   + +  + R      +++P  + + Y+ +I  AL +
Sbjct: 62  HSCF-----QTESRLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNF 111

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 225
           +H   GI +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII--KVLGTPTRE 275
           G  +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I  K +  P   
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 276 EIKC-------MNPNYTE-------FKFPQIKPHP------WHKVFQKR-LPP 307
            +K        +N +  E         F  IK HP      W  + QK+ LPP
Sbjct: 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 79.6 bits (196), Expect = 5e-17
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
           Y    VVG GSFG     +   + +  A+K++   K         +E  ++  + HPNIV
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           A K  F     + + +L +V+EY    + + +I     ++    P   +  +  Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPEL 223
            +IH    + HRDIK +N+ +     ++KL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHE-KRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 224 IFGATEYTTAIDIWSTGCVMAEL 246
           I+    Y    DIWS GC++ EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 79.7 bits (196), Expect = 5e-17
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 52/293 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 107
           ++G G+FG V+     +TG  +A K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
              C     D+ E  L + +EY+P  +V    + Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSY 121

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 222
           +H+ + I HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           +I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT       NP
Sbjct: 180 VISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-------NP 228

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                        P H     R      D +   F  + + R +A E   HPF
Sbjct: 229 -----------QLPSHISEHAR------DFLGCIFVEARH-RPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 47/297 (15%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 111
           +G GS G+V  A  + +G++VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           +      +EL+  +V+E++       A      H RM    +      + +AL+ +H   
Sbjct: 86  YLV---GDELW--VVMEFLEGG----ALTDIVTHTRMNEEQIAAVCLAVLKALSVLH-AQ 135

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEY 230
           G+ HRDIK  ++L+  H  ++KL DFG    + K  P   S + + Y+ APELI     Y
Sbjct: 136 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPY 193

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 234

Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 347
           ++K    HKV      P     + R     P  R TA E   HPF  +   P+  +P
Sbjct: 235 KLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 6e-17
 Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 47/242 (19%)

Query: 58  VGTGSFGVVFQAKCRETG--EI-VAIK-----KVLQDKRYKNRELQIMQMLDHPNIVALK 109
           +G G+FG V +         E+ VA+K      +   K+   RE  +M  LDHP IV L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 110 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
                    E L   LV+E  P   + +    Y +  + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLK----YLKKRREIPVSDLKELAHQVAMGMAYLE 112

Query: 169 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 219
           +     HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 220 ----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 272
               APE I     +++  D+WS G  + E    G   +    G +   ++E  + L  P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Query: 273 TR 274
             
Sbjct: 221 EE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 81/305 (26%), Positives = 138/305 (45%), Gaps = 59/305 (19%)

Query: 57  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 104
           V+GTG++G VF   +    ++G++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICR 162
           +V L + F + T      L+L+L+Y+          ++ + QR       V++Y+ +I  
Sbjct: 67  LVTLHYAFQTDTK-----LHLILDYING-----GELFTHLSQRERFKEQEVQIYSGEIVL 116

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 220
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K   + E   +Y  C    Y A
Sbjct: 117 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 221 PELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           P+++ G    +  A+D WS G +M ELL G   F  +   +   EI       +R  +K 
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKS 227

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 334
             P      +PQ             +   A D++ R     P  R       A E   HP
Sbjct: 228 EPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP 269

Query: 335 FFDEL 339
           FF ++
Sbjct: 270 FFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 80.8 bits (199), Expect = 7e-17
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 43/232 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALK 109
           V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P +V L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F     +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 110 YAF-----QDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLALDAI 158

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSYICSRY 217
           H+ +G  HRD+KP N+L++   H LKL DFG+   + K          G P+        
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-------- 208

Query: 218 YRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
           Y +PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 9e-17
 Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 48/239 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR----ELQIMQMLDHPNIVALK 109
           ++G G  G VF  + + TG++ A+K   K    KR K +    E +I+  LDHP +  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 110 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             F + T     YL LV++Y P   + R+ +   +  + +     + Y  ++  AL Y+H
Sbjct: 68  ASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDF-------------------GSAKVLVKGEPN 209
             +GI +RD+KP+N+L++   H + L DF                   GS +  V   P+
Sbjct: 121 -LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 210 VSYICS-----------RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
            ++                Y APE+I G   + +A+D W+ G ++ E+L G   F G +
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 112
           +G G+FG V++AK +ETG  +A  KV++ K  +       E++I+   +HP IV L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 113 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           +      +  L +++E+ P   V+ I     R     P I  ++   Q+  AL Y+H+ +
Sbjct: 79  Y-----WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQI--QVICRQMLEALQYLHS-M 129

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT-- 228
            I HRD+K  N+L+      +KL DFG SAK +   +   S+I + Y+ APE++   T  
Sbjct: 130 KIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 229 --EYTTAIDIWSTGCVMAELLLGQP 251
              Y    DIWS G  + E+   +P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 91/315 (28%), Positives = 138/315 (43%), Gaps = 58/315 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 108
           V+G GSFG V  A+ +E+G + A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            +C F T D+    L  V+E+V           SR   R      + Y  +I  AL ++H
Sbjct: 62  -YCCFQTPDR----LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH 113

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 227
           +  GI +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I   
Sbjct: 114 D-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQE 170

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y  ++D W+ G ++ E+L G   F  E+  D L E I        +E+          
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV---------- 213

Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTAL--EACV--HPFFDELRD 341
                       V+   L  +AVD++  F   +P +R     L  E  +  HPFF EL  
Sbjct: 214 ------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL-- 259

Query: 342 PNTRLPNGRPLPPLF 356
            +    N R + P F
Sbjct: 260 -DWEKLNRRQIEPPF 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 23/220 (10%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 109
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ + D P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           H  F T D+    L  V+EYV   + +  I +   +  +   + Y      +I   L ++
Sbjct: 67  HSCFQTVDR----LYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAA----EISVGLFFL 117

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 226
           H   GI +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I  
Sbjct: 118 HR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-A 174

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
              Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 62/296 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKNRELQIM-QMLDHPNIVAL 108
           V+G GS+  V   + ++T  I A+K V        +D  +   E  +  Q  +HP +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             CF     + E  L  V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 62  HSCF-----QTESRLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 111

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 225
           +H   GI +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII----------- 266
           G  +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I           
Sbjct: 170 GE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 267 ---------KVLGTPTREEIKCMNPNYTEFKFPQIKPHP------WHKVFQKRLPP 307
                      L    +E + C      +  F  I+ HP      W  + QK++ P
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQVVP 280

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 67/235 (28%), Positives = 119/235 (50%), Gaps = 32/235 (13%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH--------PNIVAL 108
           V+G GS+  V   + ++  +I A+K V ++  + + ++  +Q   H        P +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             CF +T+      L LV+EYV   + +  + R      +++P  + + Y  +IC AL +
Sbjct: 62  HSCFQTTSR-----LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNF 111

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 225
           +H   GI +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 274
           G  EY  ++D W+ G +M E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 170 GE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 37/245 (15%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 109
           +G G FG V   + + TG++ A KK L  KR K +        E +I++ ++ P IV L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 110 HCFFSTTDKEELYLNLV--------LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + F S T     +L LV        L+Y    V        R+      I+   Y+ QI 
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMERV------IH---YSAQIT 105

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
             + ++H+ + I +RD+KP+N+L++      +L D G A  L  G+       +  Y AP
Sbjct: 106 CGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAP 163

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E I     Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  +
Sbjct: 164 E-ILKEEPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEH 219

Query: 282 PNYTE 286
            N+TE
Sbjct: 220 QNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 37/211 (17%)

Query: 57  VVGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 107
           V+G G FG V    +      TGE+VA+K + ++   +N      E+ I++ L H NIV 
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
            K C    +++    L L++EYVP       R+Y   H ++ L  + L+  QIC  +AY+
Sbjct: 71  YKGC---CSEQGGKGLQLIMEYVPLGS---LRDYLPKH-KLNLAQLLLFAQQICEGMAYL 123

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE----- 222
           H+   I HRD+  +N+L++ +   +K+ DFG AK + +G          YYR  E     
Sbjct: 124 HSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGDSP 173

Query: 223 LIFGATE------YTTAIDIWSTGCVMAELL 247
           + + A E      ++ A D+WS G  + ELL
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 41/293 (13%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHC 111
           ++G G+ G V++A    T  I+A+K +  D     ++    EL+I+   D P I+     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           FF      E  +++  E++             +++++P   +      + + L Y+ + +
Sbjct: 68  FFV-----ENRISICTEFMDG-------GSLDVYRKIPEHVLGRIAVAVVKGLTYLWS-L 114

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 231
            I HRD+KP N+LVN    Q+KLCDFG +  LV      +Y+ +  Y APE I G  +Y 
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171

Query: 232 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 291
              D+WS G    EL LG+  +P        +  +++L     E+             P 
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PV 219

Query: 292 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
           +    + + F        V  + +  +  P  R        HPF  +  D N 
Sbjct: 220 LPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 94/335 (28%), Positives = 142/335 (42%), Gaps = 65/335 (19%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKN----RELQIMQMLDHPNIVALK 109
           V+G G+FG V   K + TG++ A+K   K    KR +      E  ++   D   I  L 
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F     ++E  L LV++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKG--EPNVS-----YICSRYYRAP 221
            +G  HRDIKP N+L++ + H ++L DFGS  ++L  G  + NV+     YI     +A 
Sbjct: 121 -LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E   G   Y    D WS G  M E+L G+  F  ES V+   +I+               
Sbjct: 179 E--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--------------- 221

Query: 282 PNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFD 337
            N+ E F+FP              +  EA DL+ R    SP  R       +   HPFF+
Sbjct: 222 -NHKEHFQFPPDVTD---------VSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFFE 270

Query: 338 ELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETIN 372
            +   N R        P      PE+S  P +T N
Sbjct: 271 GIDWDNIRNST----APYV----PEVSS-PTDTSN 296

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
           V+G GSFG V  A+ + T E+ AIK + +D   ++ +++       ++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 167
           H  F T D+        L +V E VN     Y  I Q  +    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-HIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 226
           H+  GI +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
              Y  ++D W+ G ++ E+L GQP F GE
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 7e-16
 Identities = 84/326 (25%), Positives = 134/326 (41%), Gaps = 71/326 (21%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 108
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 109 KHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQI 160
            + +  T D   L L L+    L++              I+      +       Y  +I
Sbjct: 66  AYAY-ETKDALCLVLTLMNGGDLKF-------------HIYNMGNPGFDEERAVFYAAEI 111

Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
              L  +H    I +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y A
Sbjct: 112 TCGLEDLHR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMA 169

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE++     YT + D W  GC++ E++ G+  F          E +K      REE++  
Sbjct: 170 PEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERR 216

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--C---TALEACVHPF 335
                E              + ++    A  +  +     P  R  C    A E   HPF
Sbjct: 217 VKEDQE-------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263

Query: 336 FDELRDPN-TRLPNGRPLPPLFNFKP 360
           F   R  N  RL  G   PP   F P
Sbjct: 264 F---RTANFKRLEAGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 76.5 bits (188), Expect = 8e-16
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 54/289 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 105
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 106 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           V + + F  T DK    L+L+    L Y       ++++       M     + Y  +I 
Sbjct: 60  VCMSYAF-HTPDKLSFILDLMNGGDLHY------HLSQHGVFSEAEM-----RFYAAEII 107

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQ----------------------PLFPGESGV 259
           E++     Y ++ D +S GC++ +LL G                          P     
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224

Query: 260 DQLVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 307
           +    +  +L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 77.7 bits (191), Expect = 9e-16
 Identities = 91/348 (26%), Positives = 145/348 (41%), Gaps = 99/348 (28%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHP 103
           ++    +G G+FG V  A   +T  + A+K  L+ K   NR        E  I+   D+ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNE 61

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
            +V L   ++S  DK+ LY   V++Y+P  + ++ + R      +  P +  + Y  ++ 
Sbjct: 62  WVVKL---YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELT 111

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG------ 206
            A+  +H  +G  HRDIKP N+L++   H +KL DFG         ++K   KG      
Sbjct: 112 LAIESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 207 --EPN-------------------------------VSYICSRYYRAPELIFGATEYTTA 233
             EP+                                S + +  Y APE++     YT  
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQL 228

Query: 234 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 293
            D WS G ++ E+L+GQP F              +  TPT  ++K +N   T    PQ+K
Sbjct: 229 CDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK 274

Query: 294 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDEL 339
                      L PEAVDL+ +    +     R  A +   HPFF E+
Sbjct: 275 -----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 21/206 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 111
           +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           +      +EL++  V+E++       A      H RM    +      + RAL+Y+HN  
Sbjct: 88  YLV---GDELWV--VMEFLEGG----ALTDIVTHTRMNEEQIATVCLSVLRALSYLHN-Q 137

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATEY 230
           G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     Y
Sbjct: 138 GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPY 195

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGE 256
            T +DIWS G ++ E++ G+P +  E
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 104
           +Y    VVG GS+G V   + R  G+   IKK+       ++++   +E Q++  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IVA +  +    + E+  L +V+ +  E  +   +   +  + +P   V  +  QI  AL
Sbjct: 61  IVAYRESW----EGEDGLLYIVMGFC-EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPEL 223
            Y+H    I HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHE-KHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 224 IFGATEYTTAIDIWSTGCVMAEL 246
            F    Y    D+W+ GC + E+
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 49/285 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNI 105
           V+G G FG V  A+ ++TGE+ AIK  L+               + R  +      HP +
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIK-ALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           V L  CF     + E ++  V+EY    + +  I  +               Y   +   
Sbjct: 65  VNLFACF-----QTEDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLG 113

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 222
           L Y+H    I +RD+K  NLL++     +K+ DFG  K  +      S  C +  + APE
Sbjct: 114 LQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG---ESGVDQLV-EIIKVLGTPTREEIK 278
           ++   T YT A+D W  G ++ E+L+G+  FPG   E   D +V + ++     +RE I 
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAIS 230

Query: 279 CM------NPN----YTEFKFPQIKPHP------WHKVFQKRLPP 307
            M      NP       E     +K  P      W  +  +++ P
Sbjct: 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKP 275

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 56/295 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F  T D+    L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALDYL 111

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 226
           H+   + +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE +  
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLE 169

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------- 214

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
                         F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 215 --------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.2 bits (182), Expect = 7e-15
 Identities = 70/258 (27%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 99
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 100 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 154
             HPNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 155 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 209
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172

Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 270 GTPTREEIKCMNPNYTEF 287
           GTP  +  + ++  + +F
Sbjct: 231 GTPELQNPEKLSAIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 86/339 (25%), Positives = 136/339 (40%), Gaps = 97/339 (28%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           V+G G+FG V   + ++TG+I A+K +L+ + +K  +L        ++   D P +V+L 
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67

Query: 110 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           + F     ++  YL L++E++P   +  +   Y    + +     + Y  +   A+  +H
Sbjct: 68  YSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAVH 118

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNVSYICSR 216
             +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I +R
Sbjct: 119 K-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 217 Y------------------------------------YRAPELIFGATEYTTAIDIWSTG 240
                                                Y APE IF    Y    D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLG 235

Query: 241 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHK 299
            +M E L+G P F  E+  +   +II                N+ E   FP         
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-------- 271

Query: 300 VFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF 336
                L  EA DL+ R    + N   R  A E   HPFF
Sbjct: 272 --DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 73.7 bits (181), Expect = 8e-15
 Identities = 63/245 (25%), Positives = 117/245 (47%), Gaps = 31/245 (12%)

Query: 53  IAEHVVGTGSFGVVFQAKCRETGE-IVAIKKVL-------QDKRYKNRELQ--------I 96
           + EH+ G+G+FG V++ + +  G+ ++A+K++        +DKR +++ +         I
Sbjct: 4   VLEHL-GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 97  MQMLDHPNIVALKHCFFSTTDKEELYLNLVL-EYVP--ETVNRIARNYSRI-HQRMPLIY 152
            + L HPNIV     F    + + LY+ + L E  P  E  N +     R   +R+  I+
Sbjct: 63  KEQLRHPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           V     Q+  AL Y+H    I HRD+ P N+++     ++ + DFG AK         S 
Sbjct: 120 V-----QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSV 173

Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 272
           + +  Y  PE++     Y    D+W+ GC++ ++   QP F   + +    +I++ +  P
Sbjct: 174 VGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232

Query: 273 TREEI 277
             E +
Sbjct: 233 LPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 23/205 (11%)

Query: 58  VGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALK 109
           +GTGSFG V  A  + E    VAIK+  + K  K +       E +I+  ++HP  V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F     K+E YL LVLE+V   +      + R ++R P      Y  QI     Y+ +
Sbjct: 98  GSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGAT 228
            + I +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++    
Sbjct: 150 -LNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVG 204

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            +  A D W+ G  + E+L+G P F
Sbjct: 205 -HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 84/319 (26%), Positives = 138/319 (43%), Gaps = 62/319 (19%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F  T D+    L  V+EY    E    ++R      +R      + Y  +I  AL Y+
Sbjct: 62  YAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYL 111

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 226
           H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR-------- 213

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 341
                         F + L PEA  L+    +  P  R       A E   H FF  +  
Sbjct: 214 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259

Query: 342 PNTRLPNGRPLPPLFNFKP 360
            +  +   + LPP   FKP
Sbjct: 260 QD--VVQKKLLPP---FKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 86/317 (27%), Positives = 136/317 (42%), Gaps = 53/317 (16%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 108
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            + + +   K+ L L L L    +    I   Y              Y  +IC  L  +H
Sbjct: 66  AYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
               I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++    
Sbjct: 120 Q-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNE 176

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ +     E  
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE-- 222

Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPN 343
                       + ++  P+A  L        P  R       A E   HP F ++    
Sbjct: 223 -----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN--F 269

Query: 344 TRLPNGRPLPPLFNFKP 360
            RL  G   PP   FKP
Sbjct: 270 KRLEAGMLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 22/206 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 113
           +G+G++G V++A+   TGE+ AIK +     +D     +E+ +M+   H NIVA    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 114 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 173
           S   +++L++   +E+      +   + +       + YV   T Q    L Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127

Query: 174 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 229
            HRDIK  N+L+  + H +KL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 230 -YTTAIDIWSTGCVMAELL-LGQPLF 253
            Y    DIW+ G    EL  L  P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 27/243 (11%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 112
           +G G+FG V++A+ +ETG ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 113 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 169
           +   +     L +++E+     V+ +     R     PL    +++   Q   AL Y+H 
Sbjct: 72  YYENN-----LWILIEFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHE 121

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
              I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T
Sbjct: 122 N-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 229 E----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                Y    D+WS G  + E+   +P     + +  L++I K    PT  +    +  +
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEF 238

Query: 285 TEF 287
            +F
Sbjct: 239 KDF 241

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 28/208 (13%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCF 112
           +G+G+ G V++   R TG + A+K +  +     +R   RE++I++ ++HPN+V   H  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKC-HDM 140

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           F    +    + ++LE++    +  +   + I     L  V     QI   +AY+H    
Sbjct: 141 FDHNGE----IQVLLEFM----DGGSLEGTHIADEQFLADV---ARQILSGIAYLHR-RH 188

Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELI-----FG 226
           I HRDIKP NLL+N     +K+ DFG +++L +  +P  S + +  Y +PE I      G
Sbjct: 189 IVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFP 254
           A +   A DIWS G  + E  LG+  FP
Sbjct: 248 AYD-GYAGDIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 31/212 (14%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 105
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 106 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           V + + F  T DK    L+L+    L Y           +   H       ++ Y  +I 
Sbjct: 60  VCMTYAF-HTPDKLCFILDLMNGGDLHY-----------HLSQHGVFSEKEMRFYATEII 107

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
           E++   T Y ++ D +S GC++ +LL G   F
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.1 bits (176), Expect = 4e-14
 Identities = 72/258 (27%), Positives = 124/258 (48%), Gaps = 38/258 (14%)

Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQM 99
           G+ K+K  Y     +G G+ G VF A    TG+ VAIK++   K+ K      E+ +M+ 
Sbjct: 15  GDPKKK--YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 100 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 154
           L +PNIV     F      +EL++  V+EY+      + V     + ++I          
Sbjct: 73  LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAA-------- 119

Query: 155 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 209
                +CR    AL ++H    + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKR 172

Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 270 GTPTREEIKCMNPNYTEF 287
           GTP  +  + ++P + +F
Sbjct: 231 GTPELQNPEKLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 35/208 (16%)

Query: 57  VVGTGSFGVVFQA--KCRETGEI-VAIKKVLQDKRYKNREL-----QIMQMLDHPNIVAL 108
            +G G FG V+Q      E  +I VA+K          RE       IM+  DHP+IV L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYI 167
                      E  + +V+E  P       R+Y ++++  + L  + LY+YQ+  ALAY+
Sbjct: 73  IGVI------TENPVWIVMELAPLGE---LRSYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 168 H--NCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 219
                +   HRDI  +N+LV +P    +KL DFG ++ L   E    Y  S+      + 
Sbjct: 124 ESKRFV---HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWM 175

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE I     +T+A D+W  G  M E+L
Sbjct: 176 APESI-NFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 108
           V+G G FG V   + R TG++ A K+ L+ KR K R        E QI++ ++   +V L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            + + +   K+ L L L +    +    I   Y+  +          Y  +I   L  +H
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
                 +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++    
Sbjct: 120 R-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NNQ 176

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPG 255
            YT + D W  GC++ E++ GQ  F G
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 30/295 (10%)

Query: 61  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 120
           GS G VF A  +       + K+ Q K     E  ++Q ++HP+++ +K    S      
Sbjct: 77  GSEGRVFVAT-KPGQPDPVVLKIGQ-KGTTLIEAMLLQNVNHPSVIRMKDTLVS----GA 130

Query: 121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 180
           +   ++  Y  +    + +    +     LI  K    QI   L Y+H    I HRD+K 
Sbjct: 131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK----QILEGLRYLHA-QRIIHRDVKT 185

Query: 181 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG 240
           +N+ +N    Q+ + D G+A+  V     +    +    APE +    +Y +  DIWS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243

Query: 241 CVMAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEIKCMNPNYT 285
            V+ E+L             P    +S    L++II  L       P     + +   + 
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302

Query: 286 EFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           E+   + +P+  +  FQ+  LP +   LV +   +   +R +A E   +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 71.7 bits (175), Expect = 2e-13
 Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 41/244 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G G FG VF  K + T E    K +      +R K++   E+ +M+ L H NIV     
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI---YVKLYTYQICRALAYIH 168
           F +  +++   L +++E+       ++RN  + ++    I    +   T Q+  ALAY H
Sbjct: 81  FLNKANQK---LYILMEFC--DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135

Query: 169 NCIG------ICHRDIKPQNLLVNPHTHQL----------------KLCDFGSAKVLVKG 206
           N         + HRD+KPQN+ ++     +                K+ DFG +K +  G
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI--G 193

Query: 207 EPNVSYIC--SRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
             ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   +   QL+
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253

Query: 264 EIIK 267
             +K
Sbjct: 254 SELK 257

Length = 1021

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 81/344 (23%), Positives = 122/344 (35%), Gaps = 113/344 (32%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 109
           +G G+FG V   +  +T  + A+K  L+      R        E  I+   D+  +V L 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVKL- 66

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAY 166
             ++S  DK+ LY   V++Y+P        +   +  R+        + Y  ++  A+  
Sbjct: 67  --YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116

Query: 167 IHNCIGICHRDIKPQNLLVNPH----------------THQLKL---------------- 194
           +H  +G  HRDIKP N+L++                  TH  K                 
Sbjct: 117 VHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 195 -------CDFGSAKVLVK------------GEPNVSYICSRYYRAPELIFGATEYTTAID 235
                  C     +   K            G PN        Y APE++   T YT   D
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLCD 226

Query: 236 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 295
            WS G ++ E+L+GQP F  +              TP   ++K +N   T    P     
Sbjct: 227 WWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE-TTLHIP----- 266

Query: 296 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 336
                 Q +L  EA DL+ R        R     A E   HPFF
Sbjct: 267 -----SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 86/327 (26%), Positives = 131/327 (40%), Gaps = 83/327 (25%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA------LKH 110
           V+G G+FG V   + ++TG I A+K +L+      +E Q+  +    +I+       +  
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKE-QVAHIRAERDILVEADGAWVVK 65

Query: 111 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  IH
Sbjct: 66  MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIH 118

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------------------------ 198
             +G  HRDIKP NLL++   H +KL DFG                              
Sbjct: 119 Q-LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 199 ----SAKVLVKGEPNVSY--ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 252
                A+   K    ++Y  + +  Y APE +F  T Y    D WS G +M E+L+G P 
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 253 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL 312
           F  E              TP     K MN   T   FP   P          +  +A DL
Sbjct: 236 FCSE--------------TPQETYRKVMNWKET-LVFPPEVP----------ISEKAKDL 270

Query: 313 VCRFFQYSPNL--RCTALEACVHPFFD 337
           + RF   S N        E   HPFF+
Sbjct: 271 ILRFCTDSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 65/206 (31%), Positives = 90/206 (43%), Gaps = 34/206 (16%)

Query: 73  ETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 124
            TG  VAIK +  D         R++ RE  +   L HPNIVAL      + +     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 184
            V EYVP    R  R        +P         Q+  ALA  HN  GI HRD+KPQN++
Sbjct: 56  AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 185 VN-----PHTHQLKLCDFGSAKVLVK-GEPNVS-------YICSRYYRAPELIFGATEYT 231
           V+     PH    K+ DFG   +L    + +V+        + +  Y APE + G    T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167

Query: 232 TAIDIWSTGCVMAELLLGQPLFPGES 257
              D+++ G +  E L GQ +  G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 113
           VG+G++G V++A+   TGE+ A+K +      D     +E+ +++   H NIVA    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 114 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 173
           S   +E+L+  + +EY      +   + +     + + YV   T Q    LAY+H+  G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127

Query: 174 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 229
            HRDIK  N+L+  +   +KL DFG +AK+        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184

Query: 230 -YTTAIDIWSTGCVMAELLLGQP 251
            Y    DIW+ G    EL   QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 54/264 (20%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIVALKHCF 112
           +G G+FG V++   +   E VA+K          KR   +E +I++  DHPNIV L    
Sbjct: 3   IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL---I 58

Query: 113 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 168
                K+ +Y  +V+E VP    +  + +  +    R+ +  +   +      + Y+   
Sbjct: 59  GVCVQKQPIY--IVMELVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK 112

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------AP 221
           NCI   HRD+  +N LV    + LK+ DFG    + + E    Y  S   +       AP
Sbjct: 113 NCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 222 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           E L +G   YT+  D+WS G ++ E   LG   +PG S               TRE I+ 
Sbjct: 165 EALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------------TRERIE- 209

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQK 303
               Y     PQ+ P   +++  +
Sbjct: 210 --SGY-RMPAPQLCPEEIYRLMLQ 230

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 16/220 (7%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 116
           V+G G+FG V   K + T  I A+K + + +  K  E    +  +  N++    C + TT
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWITT 65

Query: 117 ----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
                ++E YL LV++Y       +    S+   R+P    + Y  ++  A+  IH  + 
Sbjct: 66  LHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LH 122

Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF----G 226
             HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     G
Sbjct: 123 YVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
             +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 23/220 (10%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 109
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 167
           H  F T D+        L +V E VN     Y +I Q  R    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-QIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 226
           H+  GI +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.0 bits (167), Expect = 6e-13
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)

Query: 61  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKE 119
           G FG V   K + T + + ++K+++ K +   E  + Q M D+PN + L +    TT K 
Sbjct: 27  GKFGKVSVLKHKPTQK-LFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSV--TTLKG 83

Query: 120 ELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            +   L+++Y+      + +        +   ++    VK    Q+  AL  +H    I 
Sbjct: 84  HV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHK-HNII 131

Query: 175 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 234
           H DIK +N+L +    ++ LCD+G  K  + G P+  Y  +  Y +PE I G   Y  + 
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSC-YDGTLDYFSPEKIKGHN-YDVSF 187

Query: 235 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 294
           D W+ G +  ELL G+   P +   D   E +         +++ +              
Sbjct: 188 DWWAVGVLTYELLTGK--HPFKEDED---EEL---------DLESLLKRQQ--------- 224

Query: 295 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFF 336
                 F K +   A D V    +Y+ N R T     + HPF 
Sbjct: 225 --KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 48/234 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 107
           V+G+G+FG V++      GE     VAIK + ++   K       E  +M  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 108 L-------KHCFFSTTDKEELYLNLVLEYVPETVNRIAR----NYSRIHQRMPLIYVKLY 156
           L       +    +    + + L  +L+YV    + I      N+               
Sbjct: 74  LLGICLSSQVQLIT----QLMPLGCLLDYVRNHKDNIGSQYLLNWCV------------- 116

Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
             QI + ++Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +
Sbjct: 117 --QIAKGMSYLEE-KRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 217 Y---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
               + A E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 173 VPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + +G+  A+K + ++      E+       ++++   HP + +LK
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F  T D+    L  V+EYV   E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTKDR----LCFVMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDYL 111

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 226
           H+   I +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLE 168

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 39/229 (17%)

Query: 58  VGTGSFGVVFQAKCRE-TGEI--VAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALK 109
           +G GSFGVV + +     G++  VA+K +  DK         +E  IM  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR----MPLIYVKLYTYQICRALA 165
               +        L +V E  P     +     R+ +       +  +  Y  QI   + 
Sbjct: 63  GVVLTHP------LMMVTELAP-----LGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 166 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 219
           Y+     I   HRD+  +N+L+     ++K+ DFG  + L + E +  Y+   + +    
Sbjct: 112 YLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFA 165

Query: 220 --APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 265
             APE +   T ++ A D+W  G  + E+   G+  + G SG   L +I
Sbjct: 166 WCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 59/251 (23%)

Query: 56  HVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 104
             +G G+FG V +A+            VA+K +  D   K+      E+++M+M+  H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNR-IARNYSRIHQRMPLIYVKLY 156
           I+ L       T +  LY  +V+EY             R      S    R P   +   
Sbjct: 78  IINLLGV---CTQEGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 157 -----TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
                 YQ+ R + ++    CI   HRD+  +N+LV    H +K+ DFG A+       +
Sbjct: 133 DLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVT-EDHVMKIADFGLAR-------D 181

Query: 210 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 256
           + +I   YYR            APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 182 IHHI--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI 238

Query: 257 SGVDQLVEIIK 267
             V++L +++K
Sbjct: 239 P-VEELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)

Query: 58  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 108
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           K      T+     + L++E++P    +  + RN ++I+ +  L     Y  QIC+ + Y
Sbjct: 72  KGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL----KYAVQICKGMDY 124

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 219
           + +   + HRD+  +N+LV    HQ+K+ DFG  K +   E +  Y   +       ++ 
Sbjct: 125 LGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +  +  Y  A D+WS G  + ELL
Sbjct: 180 APECLIQSKFYI-ASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 85/343 (24%), Positives = 152/343 (44%), Gaps = 60/343 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQML------DHPNIVA 107
           ++G G+FG V +A  R+  E  A+K V    +Y      E+Q M+ +      D   ++ 
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 108 LKHCFFSTTDKEELYLNLVL-EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           ++  F      E  ++ +V+ +Y P  ++ I ++    H+ +  I      +Q   AL Y
Sbjct: 196 IQRYF----QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDY 246

Query: 167 IHNCIGICHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKVLVKGEPNVS 211
            H  + + H D+KP+N+L       V+P T++        +++CD G      +     +
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTA 304

Query: 212 YICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
            + +R+YR+PE++ G    Y+T  D+WS GC++ EL  G+ L+     ++ L  + K LG
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362

Query: 271 T-PTREEIKCMNPNYTEF--KFPQIKP--HPWH--KVFQKRLPPEAV------DLVCRFF 317
             P+    +C             Q++P   P H  ++ + R   E +      DL+    
Sbjct: 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422

Query: 318 QYSPNLRCTALEACVHP----FFDELRD-PNTRLPNGRP-LPP 354
            Y    R  A +   HP    ++ E R  PN   P+ R  L P
Sbjct: 423 HYDRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463

Length = 467

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 30/221 (13%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +G+G FGVV   K R   + VAIK + +    +     E ++M  L HP +V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQL---YGV 67

Query: 115 TTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            T ++ LY+  V E++     +N + +   ++ + M L   +     +C  + Y+     
Sbjct: 68  CTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGMEYLERN-S 120

Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELIFG 226
             HRD+  +N LV+  T  +K+ DFG  + ++  E    Y  S        +  PE +F 
Sbjct: 121 FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWSPPE-VFN 174

Query: 227 ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII 266
            ++Y++  D+WS G +M E+   G+  F  +S   ++VE+I
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 66.2 bits (161), Expect = 8e-12
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 23/225 (10%)

Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEIVAIKKV-LQDKR---YKNRELQIMQM 99
           N+ ++  Y+   +VG       F A +  +  E V  K V L D+R   Y   EL  +  
Sbjct: 62  NNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAA 121

Query: 100 LDHPNIVALKHCF-FSTTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPL--IYVKL 155
            DH  IV  KH   F + DK    L L++EY     +N+  +   R+ + +P     V L
Sbjct: 122 CDHFGIV--KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGL 173

Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSY 212
             YQI  AL  +H+   + HRD+K  N+ + P T  +KL DFG +K     V  +   S+
Sbjct: 174 LFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
             + YY APEL +    Y+   D+WS G ++ ELL     F G S
Sbjct: 232 CGTPYYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 77/307 (25%), Positives = 122/307 (39%), Gaps = 49/307 (15%)

Query: 61  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 120
           G+ G  F     +T E V IK     +     E  I++ ++HP+I+ LK  F        
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF-------- 152

Query: 121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 180
            Y       +P     +   Y    + + +  +      + RA+ Y+H    I HRDIK 
Sbjct: 153 TYNKFTCLILPRYKTDL-YCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKA 210

Query: 181 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY--------RAPELIFGATEYTT 232
           +N+ +N H   + L DFG+A   V    N      +YY         APEL+     Y  
Sbjct: 211 ENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGP 262

Query: 233 AIDIWSTGCVMAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTRE---------- 275
           A+DIWS G V+ E+         + G+D       Q+  II+  GT   E          
Sbjct: 263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322

Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
           EI       +  K P  +P  W  +++  LP +   L+C+   +  + R +A        
Sbjct: 323 EIYIGLAKKSSRK-PGSRP-LWTNLYE--LPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378

Query: 336 FDELRDP 342
           F ++ DP
Sbjct: 379 FQDIPDP 385

Length = 391

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 112
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 170
              T      L +++EY+         +   + +  PL   ++ T   +I + L Y+H+ 
Sbjct: 72  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATE 229
             I HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 230 YTTAIDIWSTGCVMAELLLGQP 251
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 22/223 (9%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 109
           V+G G+FG V   K +   ++ A+K + + +  K         E  ++   D+  I  L 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F    D+  LYL  V++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF---QDENNLYL--VMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF-- 225
            +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++   
Sbjct: 121 -LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 226 --GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 108
           V+G G FG V   + R TG++ A KK L+ KR K R        E +I++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAY 166
            + + +   K+ L L L +    +    I    N     QR        Y  ++C  L  
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR-----AIFYAAELCCGLED 117

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           +     I +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y APE+I  
Sbjct: 118 LQR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-N 174

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLF 253
             +YT + D W  GC++ E++ GQ  F
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 22/202 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 112
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 170
              T      L +++EY+         +   + +  P    ++ T   +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 229
             I HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177

Query: 230 YTTAIDIWSTGCVMAELLLGQP 251
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 79/305 (25%), Positives = 121/305 (39%), Gaps = 83/305 (27%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           V+G G+FG V   + ++TG + A+K      +L+ ++  +   E  I+   D   +V + 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM- 66

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
             F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  I
Sbjct: 67  --FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSI 117

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--------------- 212
           H  +G  HRDIKP NLL++   H +KL DFG    L K      Y               
Sbjct: 118 HQ-LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 213 ---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 251
                                + +  Y APE +F  T Y    D WS G +M E+L+G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 252 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD 311
            F  E              TP     K MN   T   FP   P          +  +A D
Sbjct: 235 PFCSE--------------TPQETYKKVMNWKET-LIFPPEVP----------ISEKAKD 269

Query: 312 LVCRF 316
           L+ RF
Sbjct: 270 LILRF 274

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 80/307 (26%), Positives = 134/307 (43%), Gaps = 63/307 (20%)

Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 99
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 100 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 154
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 155 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 209
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172

Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 329
           GTP     +  NP                    +RL     D + R  +   + R +A E
Sbjct: 231 GTP-----ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKE 265

Query: 330 ACVHPFF 336
              HPF 
Sbjct: 266 LLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 26/207 (12%)

Query: 55  EHVVGTGSFGVVFQAKCRETG--EI-VAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 106
           E V+G G FG V   + +  G  EI VAIK +     +K+ ++   E  IM   DHPNI+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 165
            L+     T  K  +   +V EY+    N     + R H  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYME---NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRA 220
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 177

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELL 247
           PE I    ++T+A D+WS G VM E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 57  VVGTGSFGVVFQAKC----RETGEI-VAIKKVLQDKRYKNR-----ELQIMQML-DHPNI 105
            +G G+FG V +A      +    + VA+K +        R     EL+IM  L +H NI
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 106 VALKHCFFSTTDKEELYLNLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           V L     + T    + +  + EY    + +N + R          L+    ++YQ+ + 
Sbjct: 102 VNL---LGACTIGGPILV--ITEYCCYGDLLNFLRRKRESFLTLEDLLS---FSYQVAKG 153

Query: 164 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 218
           +A++   NCI   HRD+  +N+L+  H   +K+CDFG A+ ++     V    +R    +
Sbjct: 154 MAFLASKNCI---HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 58/242 (23%)

Query: 58  VGTGSFGVVFQAKCRE-----TGEI-VAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 106
           +G+G+FG V++    +     +G I VA+K        Q+K+   +E  +M   +HPNIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 107 A-LKHCFFSTTDKEELYLNL-------VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 158
             L  C       E  Y+ +       +L Y+ +   R+ R    +     L+ + L   
Sbjct: 63  KLLGVCL----LNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLDVA 116

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYIC 214
           + C  L  +H      HRD+  +N LV+   +     +K+ DFG A+ + K         
Sbjct: 117 KGCVYLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--------- 163

Query: 215 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
           S YYR            APE L+ G   +TT  D+WS G +M E+L LGQ  +P  +  +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Query: 261 QL 262
            L
Sbjct: 222 VL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 68/258 (26%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 99
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 100 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 154
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 74  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 120

Query: 155 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 209
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 121 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 173

Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 174 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATN 231

Query: 270 GTPTREEIKCMNPNYTEF 287
           GTP  +  + ++  + +F
Sbjct: 232 GTPELQNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 62/322 (19%)

Query: 64  GVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHCFFSTTD 117
            +V  AK + T  +VA+KK+  D   K        E+   + L HPNI+     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 118 KEELYL-----------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             ELY+           +L+  + PE               +P + +      +  AL Y
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEG--------------LPELAIAFILKDVLNALDY 116

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------EPNVSYICSRYY 218
           IH+  G  HR +K  ++L++     + L     +  ++K         +   S + +  +
Sbjct: 117 IHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 219 RAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--- 274
            +PE++    + Y    DI+S G    EL  G   F        L+E  KV GT      
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLD 232

Query: 275 -----EEIKCMNPNYTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 326
                     M+ + +  + P  +    HP+ + F           V    Q  P  R +
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFS----EHFHQFVELCLQRDPESRPS 288

Query: 327 ALEACVHPFFDELRDPNTRLPN 348
           A +   H FF + +  NT L +
Sbjct: 289 ASQLLNHSFFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 26/199 (13%)

Query: 58  VGTGSFGVVFQAKCRETGEI-VAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 113
           +G+G FGVV   K R  G+I VAIK + +    ++    E ++M  L HPN+V L   + 
Sbjct: 12  LGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YG 66

Query: 114 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIG 172
             T +  +++  V EY+    N    NY R  +        L     +C A+ Y+ +  G
Sbjct: 67  VCTKQRPIFI--VTEYM---ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-G 120

Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-----APELIFGA 227
             HRD+  +N LV    + +K+ DFG A+ ++  +    Y  S+  +     AP  +F  
Sbjct: 121 FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDY 175

Query: 228 TEYTTAIDIWSTGCVMAEL 246
           + +++  D+WS G +M E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 112
           +G G++G V++   ++ G + A+ K+L      + E++    I+Q L +HPN+V     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAV-KILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 113 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           +         L LVLE     +V  + +      QR+    +    Y     L ++HN  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            I HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 231 TTA----IDIWSTGCVMAELLLGQP 251
             +     D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 20/227 (8%)

Query: 52  YIAEHVVGTGSFGVVF---QAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDH 102
           YI +  +G GSFG V+     K      +  +K++        +    N+E Q++  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 103 PNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           P IV     F      E     ++ EY     ++          + +    V  +  Q+ 
Sbjct: 62  PAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 220
             + Y+H    I HRD+K +N+ +    + LK+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQ-RRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
           PE +     Y +  DIWS GC++ E+      F G++ +  ++ I++
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 31/209 (14%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE---IVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 106
           E V+G G FG V + + +  G+    VAIK +     DK+  +   E  IM   DHPNI+
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 164
            L+     +       + ++ EY+    N     + R +  +      V +    I   +
Sbjct: 69  RLEGVVTKSRP-----VMIITEYM---ENGSLDKFLRENDGKFTVGQLVGM-LRGIASGM 119

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYY 218
            Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+ 
Sbjct: 120 KYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELL 247
            APE I    ++T+A D+WS G VM E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 113
           VVG G++G V++ +  +TG++ AIK   V +D+  +   E+ +++   H   +A  +  F
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 114 --STTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
              +    +  L LV+E+    +V  + +N       +   ++     +I R LA++H  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLH-A 139

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 225
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 140 HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197

Query: 226 -GATEYTTAIDIWSTGCVMAELLLGQP 251
                Y    DIWS G    E+  G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 112
           +G GSFG V++     T E+VAIK + L++   +     +E+ ++   D P I      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHNC 170
              T      L +++EY+         +   + +  PL   Y+     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 229
             I HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 230 YTTAIDIWSTGCVMAELLLGQP 251
           Y    DIWS G    EL  G+P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 20/196 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 115 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIGI 173
            T +  +Y  +V EY+    N    NY R H +       L     +C  +AY+ +   I
Sbjct: 68  CTKQRPIY--IVTEYMS---NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 174 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEY 230
            HRD+  +N LV+     +K+ DFG ++ ++  E   S + S++   +  PE +   +++
Sbjct: 123 -HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLYSKF 178

Query: 231 TTAIDIWSTGCVMAEL 246
           ++  D+W+ G +M E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 112
           +G G++G VF+   ++ G   A+K +L      + E++    I++ L DHPN+V     +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 113 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           +    K    L LVLE     +V  + + + +  +RM    +    ++    L ++H   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGA--- 227
            I HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I      
Sbjct: 145 TI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 228 -TEYTTAIDIWSTGCVMAELLLGQP 251
            + Y    D+WS G    EL  G P
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFST 115
           G G FG V+      T + VA+K +           +E QIM+ L H  +V L   +   
Sbjct: 15  GAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL---YAVC 70

Query: 116 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIH--NCI 171
           +++E +Y  +V EY+ + ++    ++      R+P L+ +     QI   +AY+   N I
Sbjct: 71  SEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQIAEGMAYLESRNYI 125

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI-FGA 227
              HRD+  +N+LV  +    K+ DFG A+++   E   +   +++   + APE   +G 
Sbjct: 126 ---HRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYG- 179

Query: 228 TEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
             +T   D+WS G ++ E++  G+  +PG
Sbjct: 180 -RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 26/228 (11%)

Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLD 101
           Q   Y    V+G+G+ G V  AK    GE  A+K V        DK     E+  +   D
Sbjct: 30  QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD 89

Query: 102 HPNIVALKHCFFSTTDKEE---LYLNLVLEYV------PETVNRIARNYSRIHQRMPLIY 152
             +IV     F     +     L + LVL+Y        E  +R   N +       L++
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPN 209
           +     Q+  A+ ++H+   I HRDIK  N+L+  +   +KL DFG +K+    V  +  
Sbjct: 150 I-----QVLLAVHHVHSKHMI-HRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVG 202

Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
            ++  + YY APE I+    Y+   D++S G ++ ELL  +  F GE+
Sbjct: 203 RTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 17/160 (10%)

Query: 61  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALK------HCFFS 114
           G+FG V+  + +   ++ A+K V++     N+ + + Q+    + +AL       H ++S
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNM-VHQVQAERDALALSKSPFIVHLYYS 72

Query: 115 TTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 173
                 +YL  V+EY +   V  +   Y    + M + Y+     ++  AL Y+H   GI
Sbjct: 73  LQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-GI 125

Query: 174 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
            HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 126 IHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 109
           +G G FG V   + R TG++ A KK L  KR K R        E +I+  +    IV+L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           + F + TD     L LV+  +     R    N    +   P      YT QI   L ++H
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGA 227
               I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL+ G 
Sbjct: 115 Q-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG- 171

Query: 228 TEYTTAIDIWSTGCVMAELL 247
            EY  ++D ++ G  + E++
Sbjct: 172 EEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 50  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 100
           VS +  E V+G G FG V + + +  G+    VAIK +      K R     E  IM   
Sbjct: 3   VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62

Query: 101 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQ 159
           DHPNI+ L+     T  +  + +   +E      N    ++ R +  +  +I +      
Sbjct: 63  DHPNIIHLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 216
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S    
Sbjct: 115 IAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 217 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
               + APE I    ++T+A D+WS G VM E++
Sbjct: 173 IPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 58.6 bits (141), Expect = 1e-09
 Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 113
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 114 STTDKEEL--YLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
              +   +   L LV+E+    +V  + +N       +   ++     +I R L+++H  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 130

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 225
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 131 -KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 187

Query: 226 -GATEYTTAIDIWSTGCVMAELLLGQP 251
                Y    D+WS G    E+  G P
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 60/236 (25%)

Query: 57  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNI 105
            +G G+FG VF  +C         E+VA+ K L++      ++   RE +++    H NI
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRM--------PLIYVKLY 156
           V         T+ +     +V EY+    +N+  R++      +         L   +L 
Sbjct: 71  VKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 157 --TYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
               QI   + Y+   H      HRD+  +N LV  +   +K+ DFG ++ +        
Sbjct: 126 QIAVQIASGMVYLASQH----FVHRDLATRNCLVG-YDLVVKIGDFGMSRDV-------- 172

Query: 212 YICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 253
           Y    YYR             PE I     +TT  D+WS G V+ E+     QP +
Sbjct: 173 YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + V+G G FG VF+   +  G     VAIK +      K R     E  IM    H NI+
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 164
            L+               ++ EY+    N     Y R H  +      V +    I   +
Sbjct: 70  RLEGVVTKFKP-----AMIITEYME---NGALDKYLRDHDGEFSSYQLVGMLR-GIAAGM 120

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 219
            Y+ + +   HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 121 KYLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWT 177

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE I    ++T+A D+WS G VM E++
Sbjct: 178 APEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 18/149 (12%)

Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 184 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 239

Query: 214 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 269
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +  
Sbjct: 240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEF 291

Query: 270 GTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
               +E  +   P+YT  +  Q     WH
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 29/216 (13%)

Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL- 108
             +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L 
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 109 -----KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
                +  F+  T+    Y NL L+Y+ E  NR         Q +  + +     QI  A
Sbjct: 69  GVCTREPPFYIITEFMT-YGNL-LDYLREC-NR---------QEVNAVVLLYMATQISSA 116

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRA 220
           + Y+     I HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + A
Sbjct: 117 MEYLEKKNFI-HRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTA 173

Query: 221 PELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 255
           PE +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 174 PESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 57  VVGTGSFGVVFQAK----CRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIV 106
            +G G FG VF AK      E GE + + K LQ  + +N      REL + + L H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYT--YQI 160
            L        + E  Y+  +LEY      +   R  ++     +  PL   +      QI
Sbjct: 72  RL---LGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 219
              + ++ N     HRD+  +N LV   + Q +       KV +       Y  S YY+ 
Sbjct: 127 ALGMDHLSN-ARFVHRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYYKL 175

Query: 220 ----------APELIFGATEYTTAIDIWSTGCVMAEL 246
                     APE +    +++T  D+WS G +M E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 26/197 (13%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPNIVALKHCFFS 114
           +G G FG V     R  G+ VA+K +  D         E  +M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 115 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
                 LY  +V EY+    + +    SR    + L     +   +C  + Y+       
Sbjct: 71  --QGNPLY--IVTEYM-AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFV 124

Query: 175 HRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATE 229
           HRD+  +N+LV   +  L  K+ DFG AK     E +      +    + APE +    +
Sbjct: 125 HRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175

Query: 230 YTTAIDIWSTGCVMAEL 246
           ++T  D+WS G ++ E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 38/225 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +G G FG V++     T   VA+K +            E QIM+ L HP ++ L   +  
Sbjct: 14  LGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---YAV 69

Query: 115 TTDKEELYL-------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
            T +E +Y+         +LEY    +   A    ++ Q + +        Q+   +AY+
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEY----LQGGAGRALKLPQLIDM------AAQVASGMAYL 119

Query: 168 --HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 222
              N I   HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + APE
Sbjct: 120 EAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPE 174

Query: 223 LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 264
                  ++   D+WS G ++ E++  G+  +PG +   V Q V+
Sbjct: 175 AAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 11/106 (10%)

Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-- 211
           +TYQ+ R + ++   NC+   HRD+  +N+L+      +K+CDFG A+ ++     VS  
Sbjct: 242 FTYQVARGMEFLASKNCV---HRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 212 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
                  + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)

Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           Y++Q+ R + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 179 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 234

Query: 214 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            +R    + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 235 SARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 54/237 (22%), Positives = 104/237 (43%), Gaps = 49/237 (20%)

Query: 57  VVGTGSFGVV-----FQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 106
            +G G FG V     F+ K R     VA+K + ++      R    E  +++ ++HP+++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL----------- 155
            L   + + +    L L  ++EY         R++ R  +++   Y+             
Sbjct: 67  KL---YGACSQDGPLLL--IVEYAKYGS---LRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 156 -------------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
                        + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++ 
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVLV-AEGRKMKISDFGLSRD 176

Query: 203 LVKGEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
           + + +  V     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 58/283 (20%)

Query: 58  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 104
           +G G FG V  A+         +    VA+K +  D   K+      E+++M+M+  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR--------IARNYSRIHQRMP---LIYV 153
           I+ L     + T    LY+  ++EY  +   R            YS    R+P   + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 154 KLY--TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
            L   TYQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG    L +   N
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVT-ENNVMKIADFG----LARDVNN 189

Query: 210 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
           + Y            + APE +F    YT   D+WS G +M E+  LG   +PG   V++
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEE 247

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 304
           L +++K  G    +   C N  Y   +        WH +   R
Sbjct: 248 LFKLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 16/95 (16%)

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 218
           Q+  A+ YIH   GI HRDIK +N+LVN     + L DFG+A    +G    S+    +Y
Sbjct: 268 QLLSAIDYIH-GEGIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320

Query: 219 --------RAPELIFGATEYTTAIDIWSTGCVMAE 245
                    APE++ G   YT ++DIWS G V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 70/320 (21%), Positives = 124/320 (38%), Gaps = 95/320 (29%)

Query: 49  KVSYIAEHVVGTGSFGVVFQ--AKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQ 98
           K++ I E  +G GSFG+V++  AK    GE    VAIK V ++   + R     E  +M+
Sbjct: 7   KITLIRE--LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64

Query: 99  MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETV--NRIA----RNYSRIHQ------ 146
             +  ++V L              L +V    P  V    +A    ++Y R  +      
Sbjct: 65  EFNCHHVVRL--------------LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENN 110

Query: 147 --RMPLIYVKLYTY--QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
               P    K      +I   +AY+       HRD+  +N +V      +K+ DFG  + 
Sbjct: 111 PGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVA-EDLTVKIGDFGMTRD 168

Query: 203 LVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LG 249
           + + +         YYR            APE +     +TT  D+WS G V+ E+  L 
Sbjct: 169 IYETD---------YYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLA 218

Query: 250 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 309
           +  + G S  +++++ +         +   ++        P+  P    ++ +       
Sbjct: 219 EQPYQGLSN-EEVLKFVI--------DGGHLDL-------PENCPDKLLELMR------- 255

Query: 310 VDLVCRFFQYSPNLRCTALE 329
                  +QY+P +R T LE
Sbjct: 256 -----MCWQYNPKMRPTFLE 270

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 19/110 (17%)

Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 206
           ++ Q+ + + ++   NCI   HRD+  +N+L+       K+CDFG A+        +VKG
Sbjct: 217 FSSQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
              +       + APE IF    YT   D+WS G ++ E+  LG+  +PG
Sbjct: 273 NARLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 61/243 (25%), Positives = 94/243 (38%), Gaps = 68/243 (27%)

Query: 46  SKQKVSYIAEHVVGTGSFGVV-----FQAKCRETGEIVAIK--------KVLQDKRYKNR 92
               V ++ E  +G G+FG V          R +   VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 93  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIA 138
           E ++M  L HPNIV    C      KE+    L  EY+                 V   +
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 139 RNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCD 196
            + +         ++ +   QI   + Y+  H+     HRD+  +N LV      +K+ D
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISD 167

Query: 197 FGSAKVLVKGEPNVSYICSRYYR------------APELI-FGATEYTTAIDIWSTGCVM 243
           FG ++ +   +         YYR             PE I +G  ++TT  DIWS G V+
Sbjct: 168 FGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVL 216

Query: 244 AEL 246
            E+
Sbjct: 217 WEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 26/199 (13%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCFF 113
           +G+G FG+V+     E  + VAIK +    + ++ +   E Q+M  L HP +V L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 114 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIH-NC 170
             +      + LV E++    +    +Y R  QR       L      +C  +AY+  + 
Sbjct: 70  ERSP-----ICLVFEFME---HGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGA 227
           +   HRD+  +N LV      +K+ DFG  + ++  +   S   +++   + +PE +F  
Sbjct: 121 V--IHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSF 175

Query: 228 TEYTTAIDIWSTGCVMAEL 246
           ++Y++  D+WS G +M E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 19/110 (17%)

Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 206
           ++YQ+ + ++++   NCI   HRD+  +N+L+  H    K+CDFG A+        +VKG
Sbjct: 219 FSYQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKG 274

Query: 207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
              +       + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 275 NARLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)

Query: 57  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYK-NREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE     VAIK++ +    K N+E+     +M  +D+P++  
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 108 LKH-CFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           L   C  ST     + +    +L+YV E  + I              Y+  +  QI + +
Sbjct: 74  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-----------YLLNWCVQIAKGM 122

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I     YT   D+WS G  + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 18/149 (12%)

Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           Y++Q+ R + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 178 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 233

Query: 214 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 269
            +R    + APE IF    YTT  D+WS G ++ E+  LG   +PG       V+I +  
Sbjct: 234 DARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEEF 285

Query: 270 GTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
               +E  +   P Y   +   I    WH
Sbjct: 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWH 314

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 27/270 (10%)

Query: 80  IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR 139
           I K +   +   RE+ I++ + H  I+ L H +         + + V   +P+    +  
Sbjct: 123 IVKAVTGGKTPGREIDILKTISHRAIINLIHAY--------RWKSTVCMVMPKYKCDLF- 173

Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
            Y      +PL        ++  ALAY+H   GI HRD+K +N+ ++   + + L DFG+
Sbjct: 174 TYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAV-LGDFGA 231

Query: 200 AKVLVKGEPNVSYICSRY-----YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLF 253
           A  L       +  C  +       +PEL+     Y    DIWS G V+ E+ +    LF
Sbjct: 232 ACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 254 PGE--SGVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPP 307
             +  S   QL  II+ +     E  +  + N    + ++      P+    V +K    
Sbjct: 289 GKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMH 348

Query: 308 EAVD-LVCRFFQYSPNLRCTALEACVHPFF 336
             V+ L+ +   +    R +A +    P F
Sbjct: 349 MDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378

Length = 392

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 41/218 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNR---ELQIMQMLDHPNIVALKHC 111
           ++G G+FG VF+   ++    VA+K   +D  +  K +   E +I++  DHPNIV L   
Sbjct: 2   LLGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 112 FFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
               T ++ +Y  +V+E VP     +  R  ++  +  Q +       +       +AY+
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109

Query: 168 H--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 219
              NCI   HRD+  +N LV    + LK+ DFG    + + E +  Y  S        + 
Sbjct: 110 ESKNCI---HRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWT 161

Query: 220 APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
           APE L +G   Y++  D+WS G ++ E   LG   +PG
Sbjct: 162 APEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 23/151 (15%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALKH 110
           +G G+FG V  A+  +T  + A+K + + D   +N+      E  I+   D+  +V L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL-- 66

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYI 167
            ++S  DK+ LY   V++Y+P        +   +  RM   P    + Y  ++  A+  +
Sbjct: 67  -YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 198
           H  +G  HRDIKP N+L++   H +KL DFG
Sbjct: 118 HK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 35/213 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +G G FG V+        + VAIK + Q          E  +M+ L HP +V L    ++
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL----YA 68

Query: 115 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIH--NC 170
              +E +Y+  + EY+    N    ++ +  + + L   KL     QI   +A+I   N 
Sbjct: 69  VVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELI 224
           I   HRD++  N+LV+  T   K+ DFG A+++   E    Y           + APE I
Sbjct: 124 I---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPEAI 175

Query: 225 -FGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            +G   +T   D+WS G ++ E++  G+  +PG
Sbjct: 176 NYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 58  VGTGSFGVVFQA--KCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 109
           +G+G+FG V +   K R+    VAIK VL+++  K+      RE +IM  LD+P IV + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                  + E L   LV+E        + +  S     + +  V    +Q+   + Y+  
Sbjct: 61  ---IGVCEAEALM--LVMEMASG--GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 170 CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-------YRAP 221
                HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + AP
Sbjct: 114 -KNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++++  D+WS G  M E  
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 79/317 (24%), Positives = 124/317 (39%), Gaps = 81/317 (25%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 108 LKHCFFSTTDKEELYL---NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           L     S T +    L     +L+YV E  + I               +  +  QI + +
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQ-----------LLLNWCVQIAKGM 122

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A 
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           E I    ++T   D+WS G  + EL+   G+P                  G PTRE    
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTREI--- 220

Query: 280 MNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
             P+  E   + PQ              PP     +C    Y   ++C  ++A   P F 
Sbjct: 221 --PDLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFK 259

Query: 338 EL--------RDPNTRL 346
           EL        RDP   L
Sbjct: 260 ELAAEFSRMARDPQRYL 276

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 50/236 (21%)

Query: 47  KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKV-----LQDKRYKNRELQI 96
           +  + Y+ +  +G G+FG VFQA+       E   +VA+K +        +    RE  +
Sbjct: 4   RNNIEYVRD--IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 97  MQMLDHPNIVAL--------KHC----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRI 144
           M   DHPNIV L          C    + +  D  E   +          +  +      
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 145 HQRMPLIYVKLY--TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
              +PL   +      Q+   +AY+     + HRD+  +N LV  +   +K+ DFG ++ 
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSRN 179

Query: 203 LVKGEPNVSYICSRYYRA------------PELIFGATEYTTAIDIWSTGCVMAEL 246
           +   +         YY+A            PE IF    YTT  D+W+ G V+ E+
Sbjct: 180 IYSAD---------YYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 48/191 (25%), Positives = 75/191 (39%), Gaps = 44/191 (23%)

Query: 79  AIKKVLQDKRYKNRELQIMQMLDHPNIVAL-------KHCFFSTTDKEELYLNLVL-EYV 130
           A     +D     +E++I+  L  PNI  L                 E   LN  L ++V
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114

Query: 131 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPH 188
            ET        S+      L+Y+     QI   + Y+   N +   HRD+  +N LV   
Sbjct: 115 AETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK- 165

Query: 189 THQLKLCDFGSAKVLVKGEPNVSYICSRYY----RAP--------ELIFGATEYTTAIDI 236
            + +K+ DFG ++ L        Y    YY    RAP        E +    ++TT  D+
Sbjct: 166 NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDV 215

Query: 237 WSTGCVMAELL 247
           W+ G  + E+L
Sbjct: 216 WAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 40/226 (17%)

Query: 57  VVGTGSFGVVFQAKCR-ETGEI--VAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 107
           ++G G FG V + +   + G    VA+K +  D    +       E   M+  DHPN++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 108 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRA 163
           L    F  +  +++   +V L ++          YSR+    +++PL  +  +   I   
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAP 221
           + Y+ N   I HRD+  +N ++      + +C  DFG +K +  G+         YYR  
Sbjct: 126 MEYLSNRNFI-HRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 222 ELI-----FGATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 255
            +      + A E      YT+  D+W+ G  M E+   GQ  +PG
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 49/243 (20%)

Query: 58  VGTGSFGVVFQA--KCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALK 109
           +G+G+FG V +   K +++ + VA+K +  D      K    RE  +MQ LD+P IV + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYI- 167
                  + E   L + L  +      + +N +        L+      +Q+   + Y+ 
Sbjct: 62  ---IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELV------HQVSMGMKYLE 112

Query: 168 -HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------- 219
             N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+       
Sbjct: 113 ETNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALGADE--------NYYKAKTHGKW 160

Query: 220 -----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVEIIKVLGT 271
                APE +    ++++  D+WS G +M E    GQ  + G  G  V Q++E  + +  
Sbjct: 161 PVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC 219

Query: 272 PTR 274
           P R
Sbjct: 220 PQR 222

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 21/187 (11%)

Query: 128 EYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNL 183
           +Y+P    R  R+ + I++   L Y+ L  ++YQ+   + ++   NC+   HRD+  +N+
Sbjct: 215 QYLPSAPERTRRD-TLINESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNV 270

Query: 184 LVNPHTHQLKLCDFGSAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTG 240
           L+      +K+CDFG A+ +++    +S         + APE IF    YTT  D+WS G
Sbjct: 271 LIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFG 328

Query: 241 CVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK 299
            ++ E+  LG   +P     +Q    IK          +   P +   +  +I    W +
Sbjct: 329 ILLWEIFTLGGTPYPELPMNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEE 381

Query: 300 VFQKRLP 306
            F+ R  
Sbjct: 382 KFEIRPD 388

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 26/69 (37%), Positives = 38/69 (55%), Gaps = 9/69 (13%)

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY- 217
           QI  AL  +H+  GI HRD+KPQN++ +  +   K+ D G+A  L  G   ++YI   + 
Sbjct: 263 QILFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 218 ----YRAPE 222
               Y APE
Sbjct: 319 LDPRYAAPE 327

Length = 566

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 44/218 (20%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVALKHCFF 113
           +G+G FG V++   +     VAIK +  D   K +    E+Q ++ L H ++++L   F 
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL---FA 69

Query: 114 STTDKEELYL--------NLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
             +  E +Y+        +L L ++  PE          ++     LI +     Q+   
Sbjct: 70  VCSVGEPVYIITELMEKGSL-LAFLRSPE---------GQVLPVASLIDM---ACQVAEG 116

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----Y 218
           +AY+       HRD+  +N+LV       K+ DFG A+++   E    Y+ S       +
Sbjct: 117 MAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLI--KED--VYLSSDKKIPYKW 170

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG 255
            APE       ++T  D+WS G ++ E+   GQ  +PG
Sbjct: 171 TAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)

Query: 103 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQI 160
           PN+V L     S     E  + LVL++         + +S I +   +P   VK +  ++
Sbjct: 45  PNMVCLHKYIVS-----EDSVFLVLQHAEG-----GKLWSHISKFLNIPEECVKRWAAEM 94

Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 219
             AL  +H   GI  RD+ P N+L++   H ++L  F       + E +         Y 
Sbjct: 95  VVALDALHR-EGIVCRDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYC 149

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK 278
           APE + G +E T A D WS G ++ ELL G+ L     SG++                  
Sbjct: 150 APE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----------------- 191

Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----H 333
                +T    P+             +  EA  L+ +  Q++P  R  A  A V     H
Sbjct: 192 -----HTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234

Query: 334 PFF 336
           PFF
Sbjct: 235 PFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 84/317 (26%), Positives = 132/317 (41%), Gaps = 75/317 (23%)

Query: 58  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 104
           +G G FG V  A+              VA+K +  D   K+      E+++M+M+  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR---IAR-----NYSRIHQRMP---LIYV 153
           I+ L     + T    LY+  ++EY  +   R    AR     +YS    ++P   L + 
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 154 KLYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
            L +  YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG    L +   N
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVT-EDNVMKIADFG----LARDVHN 186

Query: 210 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
           + Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEE 244

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR----------------- 304
           L +++K  G    +   C +  Y       I    WH V  +R                 
Sbjct: 245 LFKLLKE-GHRMDKPANCTHELY------MIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297

Query: 305 LPPEAVDLVCRFFQYSP 321
              E +DL   F QYSP
Sbjct: 298 STDEYLDLSVPFEQYSP 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 50/223 (22%)

Query: 58  VGTGSFGVVFQAKC--------RETGEIVAIKKVLQDKRYK-NRELQIMQMLDHPNIVAL 108
           +G G+FG VF A+C        +    + A+K+  +  R    RE +++ +L H +IV  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 109 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNY---------SRIHQRMPLIYVKLY-- 156
              F+    +    L +V EY+    +NR  R++                 L   ++   
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
             QI   + Y+ + +   HRD+  +N LV      +K+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYLAS-LHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 217 YYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 247
           YYR             PE I    ++TT  DIWS G V+ E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 29/206 (14%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------- 107
           V+G+G+FG V++      GE V I   ++  R         ++LD   ++A         
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 108 -LKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
            L  C  ST     + +    +L+YV E  +RI               +  +  QI + +
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQ-----------DLLNWCVQIAKGM 122

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
           +Y+   + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A 
Sbjct: 123 SYLEE-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I     +T   D+WS G  + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 77/318 (24%), Positives = 134/318 (42%), Gaps = 76/318 (23%)

Query: 58  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQMLD-HPN 104
           +G G FG V +A+         +    VA+K +  +   K+      E+++M+++  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR------------IARNYSRIHQRMPLIY 152
           I+ L       T +  LY+  ++EY  +   R               + +++ +   L +
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-QLSF 133

Query: 153 VKLYT--YQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
             L +  YQ+ R + Y+ +  CI   HRD+  +N+LV    + +K+ DFG    L +G  
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVT-EDNVMKIADFG----LARGVH 185

Query: 209 NVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
           ++ Y            + APE +F    YT   D+WS G +M E+  LG   +PG     
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP--- 241

Query: 261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR---------------- 304
            + E+ K+L    RE  +   P+    +   +    WH V  +R                
Sbjct: 242 -VEELFKLL----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296

Query: 305 LPPEAVDLVCRFFQYSPN 322
           +  E +DL   F QYSP+
Sbjct: 297 VSEEYLDLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 58  VGTGSFGVVFQAKCRETGEI--VAIK--KVLQDKRYKN----RELQIMQMLDHPNIVALK 109
           +G G FG V + +  +   I  VA+K  K+    R +      E   M+  DHPN++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 110 HCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRALA 165
                T + E     +V L ++          YSR+    Q +P   +  +   I   + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           Y+ +   I HRD+  +N ++N + + + + DFG +K +  G+    Y   R  + P + +
Sbjct: 127 YLSSKSFI-HRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP-VKW 180

Query: 226 GATE------YTTAIDIWSTGCVMAELLL-GQPLFPG 255
            A E      YTT  D+WS G  M E+   GQ  +PG
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 56/231 (24%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNR---ELQIMQMLDHPNIVALKH 110
           +G G  G V+ A        VA+KK+ +D       K R   E +I   L HP IV +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67

Query: 111 CFFSTTDKEELYLNLVLEYVP-ETVNRIARNY-------SRIHQRMPL-----IYVKLYT 157
            +   +D + +Y  +   Y+   T+  + ++          + ++  +     I+ K   
Sbjct: 68  -YSICSDGDPVYYTM--PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK--- 121

Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV 210
             IC  + Y+H+  G+ HRD+KP N+L+      + L D+G+A         L+  + + 
Sbjct: 122 --ICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDE 177

Query: 211 SYICSRY------------YRAPELIFG--ATEYTTAIDIWSTGCVMAELL 247
             IC               Y APE + G  A+E T   DI++ G ++ ++L
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 53/226 (23%)

Query: 57  VVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKRYKNRELQIMQML---------DHP 103
           ++  G+FG +F     +      E V +K V         E+Q+  +L          H 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCLLYGLSHQ 68

Query: 104 NIVALKH-CFFSTTDKEELY-------LNLVLE---YVPETVNRIARNYSRIHQRMPLIY 152
           NI+ + H C         LY       L L L+          +       +H  M +  
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH--MAI-- 124

Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
                 QI   ++Y+H   G+ H+DI  +N +++    Q+K+ D   ++ L   +    Y
Sbjct: 125 ------QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----Y 172

Query: 213 IC-----SRYYR--APELIFGATEYTTAIDIWSTGCVMAELL-LGQ 250
            C     +R  +  A E +    EY++A D+WS G ++ EL+ LGQ
Sbjct: 173 HCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 40/226 (17%)

Query: 57  VVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 107
           ++G G FG V +A+ +    + + VA+K +  D    +      RE   M+  DHPN++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 108 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRA 163
           L      +  K  L + +V L ++           SRI +    +PL  +  +   I   
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYR-- 219
           + Y+ +     HRD+  +N ++N     + +C  DFG +K +  G+         YYR  
Sbjct: 126 MEYLSS-KNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 220 -APELIFG--ATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 255
            A +L     A E      YTT  D+W+ G  M E++  GQ  + G
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 37/218 (16%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQ-----DKRYKNRELQIMQML-DHPNIV 106
           + V+G G+FG V +A+ ++ G  +  AIK++ +     D R    EL+++  L  HPNI+
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 107 -ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK----------- 154
             L  C      +   YL L +EY P          SR+ +  P   +            
Sbjct: 72  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 155 --LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPN 209
              +   + R + Y+     I HRD+  +N+LV    +  K+ DFG ++   V VK    
Sbjct: 126 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 181

Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 182 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 68/288 (23%)

Query: 58  VGTGSFGVVFQAKC-----RETGEI--VAIKKVLQDKRYKN-----RELQIMQML-DHPN 104
           +G G FG V  A+       +   +  VA+K +  D   K+      E+++M+M+  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR----------IARNYSRIHQRMPLIYVK 154
           I+ L     + T    LY+  ++EY  +   R          +   Y+        +  K
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 155 LY---TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
                 YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG A+       +
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVT-EDNVMKIADFGLAR-------D 189

Query: 210 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 256
           + +I   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 190 IHHI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV 246

Query: 257 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 304
             V++L +++K  G    +   C N  Y   +        WH V  +R
Sbjct: 247 P-VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 61/249 (24%), Positives = 107/249 (42%), Gaps = 39/249 (15%)

Query: 57  VVGTGSFGVVFQAKCRETGEI---VAIKKV-----LQDKRYKNRELQIMQMLDHPNIVAL 108
           V+G G FG V+     ++       A+K +     L++     +E  IM+   HPN+++L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICRAL 164
                     E   L +VL Y+    +   RN+ R     P    LI   L   Q+ + +
Sbjct: 62  LGICL---PSEGSPL-VVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGL---QVAKGM 111

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL- 223
            Y+ +     HRD+  +N +++  +  +K+ DFG A+ +   E    Y     +   +L 
Sbjct: 112 EYLAS-KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLP 165

Query: 224 -IFGATE------YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 275
             + A E      +TT  D+WS G ++ EL+  G P +P     D  V +++  G    +
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQ 223

Query: 276 EIKCMNPNY 284
              C +P Y
Sbjct: 224 PEYCPDPLY 232

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 34/204 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G G+FG VF  + R     VA+K         L+ K  +  E +I++   HPNIV L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ--EARILKQYSHPNIVRL-- 58

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA---YI 167
                T K+ +Y  +V+E V     +     + +    P + VK     +  A A   Y+
Sbjct: 59  -IGVCTQKQPIY--IVMELV-----QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110

Query: 168 HN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 222
            +  CI   HRD+  +N LV    + LK+ DFG ++    G    +    +    + APE
Sbjct: 111 ESKHCI---HRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166

Query: 223 -LIFGATEYTTAIDIWSTGCVMAE 245
            L +G   Y++  D+WS G ++ E
Sbjct: 167 ALNYG--RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 44.3 bits (104), Expect = 4e-05
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +G G FG V+      T + VAIK +           +E QIM+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 115 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 173
              +E +Y+  V E++ + ++    +     + ++P + V +   QI   +AYI   +  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIER-MNY 123

Query: 174 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 229
            HRD++  N+LV  +    K+ DFG A+ L++     +   +++   + APE  ++G   
Sbjct: 124 IHRDLRAANILVGDNL-VCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179

Query: 230 YTTAIDIWSTGCVMAELLL-GQPLFPG 255
           +T   D+WS G ++ EL+  G+  +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 27/189 (14%)

Query: 77  IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP 131
           +VA+K +  D  K  +N   +E++IM  L +PNI+ L      + D     L ++ EY+ 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL-GVCVSDDP----LCMITEYME 100

Query: 132 E------TVNRIARNYSRIHQRMPLIYVKLYTY---QICRALAYIHNCIGICHRDIKPQN 182
                     R   +       +P + +    Y   QI   + Y+ + +   HRD+  +N
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRN 159

Query: 183 LLVNPHTHQLKLCDFGSAKVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWS 238
            LV  H + +K+ DFG ++ L  G+       + +  R+     ++ G  ++TTA D+W+
Sbjct: 160 CLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWA 216

Query: 239 TGCVMAELL 247
            G  + E+ 
Sbjct: 217 FGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 77/347 (22%), Positives = 131/347 (37%), Gaps = 85/347 (24%)

Query: 57  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 108
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           +  F    D E   +   + Y     + I  ++      + + Y+      + +AL YIH
Sbjct: 65  RATFI--ADNELWVVTSFMAY-GSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIH 118

Query: 169 NCIGICHRDIKPQNLLVN-----------------PHTHQLKLC-DFG--SAKVLVKGEP 208
           + +G  HR +K  ++L++                  H  +L++  DF   S KVL    P
Sbjct: 119 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL----P 173

Query: 209 NVSYICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
            +S         PE++    + Y    DI+S G    EL  G   F        L+E  K
Sbjct: 174 WLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--K 222

Query: 268 VLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKPHPWHKVF 301
           + GT                  P+R        E      P  +     +   HP+++ F
Sbjct: 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRTF 279

Query: 302 QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL-RDPNTRLP 347
                P     V +  Q +P+ R +A     H FF ++ R  +  LP
Sbjct: 280 S----PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 51/225 (22%)

Query: 55  EHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIMQML-DHPNIV 106
           E V+G G+FG V +A  ++ G ++ A  K+L++   +N       EL+++  L  HPNI+
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 107 AL-KHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRM 148
            L   C      +   YL + +EY P              ET    A+ +   S +  + 
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 149 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
            L     +   +   + Y+     I HRD+  +N+LV  +    K+ DFG    L +GE 
Sbjct: 121 LL----QFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLAS-KIADFG----LSRGEE 170

Query: 209 NVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 247
              Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 171 --VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 143 RIHQRMP-----LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 197
           +I   MP     +  +K    Q+   L  +H  IGI HRDIKP+NLLV     Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDF 353

Query: 198 GSAKVLVKG---EPNVSYICSRYYRAPELI 224
           G+A  +  G    P    +  RY    EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +G G FG V+        + VA+K +            E QIM+ L H  +V L    ++
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL----YA 68

Query: 115 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 173
              +E +Y+  V EY+ + ++    ++      ++P + V +   Q+   +AYI   +  
Sbjct: 69  VVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMAYIER-MNY 123

Query: 174 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 229
            HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE  ++G   
Sbjct: 124 IHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179

Query: 230 YTTAIDIWSTGCVMAELLL-GQPLFPG 255
           +T   D+WS G ++ EL+  G+  +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 29/121 (23%)

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 218
           QI   + Y+ + +   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYLSS-LNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 219 R------------APELIFGATEYTTAIDIWSTGCVMAELLL---GQPLFPGESGVDQLV 263
           R            A E I    ++TTA D+W+ G  + E+L+    QP   GE   +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251

Query: 264 E 264
           E
Sbjct: 252 E 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 8/116 (6%)

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSR 216
           Q+  A+ YIH+   + HRDIK +N+ +N    ++ L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVL 269
              +PE++ G   Y    DIWS G ++ ++L       G+ G     QL++II  L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 49/232 (21%)

Query: 57  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
            +G G+FG V++   R          VA+K + +    ++      E  IM   +H NIV
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 107 ALKHCFFSTTDKEELYLNLVL-------EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 159
                   + ++   ++ L L        ++ E   R  R  S   +   L++      +
Sbjct: 73  ---RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD--LLFCARDVAK 127

Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRY 217
            C+ L   H      HRDI  +N L+         K+ DFG A+ + +         + Y
Sbjct: 128 GCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASY 174

Query: 218 YR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 257
           YR            P   F    +T+  D+WS G ++ E+  LG   +PG +
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 52/201 (25%)

Query: 77  IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVAL--------KHC----FFSTTDKE 119
           +VA+K + +D  K  +N   +E++IM  L  PNI+ L          C    +    D  
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK 179
           +       +   E  + +  +YS       LI++     QI   + Y+ + +   HRD+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYST------LIFMAT---QIASGMKYLSS-LNFVHRDLA 157

Query: 180 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA-------------PELIFG 226
            +N LV    + +K+ DFG ++ L  G+         YYR                ++ G
Sbjct: 158 TRNCLVG-KNYTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMSWESILLG 207

Query: 227 ATEYTTAIDIWSTGCVMAELL 247
             ++TTA D+W+ G  + E+L
Sbjct: 208 --KFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 40.1 bits (93), Expect = 0.001
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 51/223 (22%)

Query: 57  VVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIM-QMLDHPNIV-A 107
           V+G G+FG V +A+ ++ G  + A  K +++   K+       EL+++ ++  HPNI+  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRMPL 150
           L  C      +   YL L +EY P              ET    A      S +  +  L
Sbjct: 62  LGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 151 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
            +       + R + Y+     I HRD+  +N+LV  +    K+ DFG    L +G+   
Sbjct: 116 HFAA----DVARGMDYLSQKQFI-HRDLAARNILVGENYVA-KIADFG----LSRGQE-- 163

Query: 211 SYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 247
            Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 164 VYVKKTMGRLP-VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 48/218 (22%), Positives = 82/218 (37%), Gaps = 48/218 (22%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRE----TGEIVA----------------------IKKVLQ 85
           +  + ++G G FG V++ +C        + VA                      I K+  
Sbjct: 14  WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 86  DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 145
            K   N        +DH  I     C      +   Y  ++LE + E    I   + RI 
Sbjct: 74  WKNIHN--------IDHLGIPKYYGCGSFKRCRM-YYRFILLEKLVENTKEI---FKRIK 121

Query: 146 QR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 204
            +   LI  K     +   L YIH   GI H DIKP+N++V+ + ++  + D+G A   +
Sbjct: 122 CKNKKLI--KNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGN-NRGYIIDYGIASHFI 177

Query: 205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCV 242
               ++      Y +  + +   T Y   +D  +  CV
Sbjct: 178 IHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210

Length = 294

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 78/331 (23%), Positives = 138/331 (41%), Gaps = 85/331 (25%)

Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 95
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 96  IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLI 151
           +M+     ++V L         K +  L +V+E +     ++  R  R  +  +   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 152 YVK---LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
            ++       +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 209 NVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFP 254
                   YYR            APE +     +TT+ D+WS G V+ E+  L  QP + 
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223

Query: 255 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 314
           G S  +Q+++ +             M+  Y +         P         P    DL+ 
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255

Query: 315 RFFQYSPNLRCTALEAC------VHPFFDEL 339
             +Q++P +R T LE        +HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 31/207 (14%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQI------MQMLDHPNIVA 107
           ++G+G FG V +      G+ + I    K +QD+  +    +I      M  LDH  IV 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 108 LKH-CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           L   C  ++       L LV +  P    ++ + ++   +  +  L +      QI + +
Sbjct: 74  LLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKGM 122

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 220
            Y+     + HR++  +N+L+   +  +++ DFG A +L   +    Y       ++   
Sbjct: 123 YYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELL 247
             ++FG   YT   D+WS G  + E++
Sbjct: 181 ESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 54/224 (24%)

Query: 58  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 108
           +G G+FG VF A+C     E  +I+   K L+D     ++  +RE +++  L H +IV  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK- 71

Query: 109 KHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVKL 155
               F     E   L +V EY+             P+ V     N      +  ++++  
Sbjct: 72  ----FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI-- 125

Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
              QI   + Y+ +     HRD+  +N LV  +   +K+ DFG ++ +   +        
Sbjct: 126 -AQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTD-------- 174

Query: 216 RYYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 247
            YYR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	390
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
PRK10345	210	hypothetical protein; Provisional	99.83
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
smart00090	237	RIO RIO-like kinase.	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
KOG1243	690	consensus Protein kinase [General function predict	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.34
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.29
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.25
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.12
COG4248	637	Uncharacterized protein with protein kinase and he	99.08
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.03
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.02
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.9
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
PRK09902	216	hypothetical protein; Provisional	98.75
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.69
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.69
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.62
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.56
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.34
PF01636	239	APH: Phosphotransferase enzyme family This family	98.3
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.26
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.09
PLN02876	822	acyl-CoA dehydrogenase	97.97
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.97
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.92
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.84
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.83
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.82
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.78
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.75
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.54
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.54
KOG2270	520	consensus Serine/threonine protein kinase involved	97.53
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.51
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.51
PRK05231	319	homoserine kinase; Provisional	97.49
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.47
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.27
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.2
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.05
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.0
PLN02236	344	choline kinase	97.0
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.91
PRK12396	409	5-methylribose kinase; Reviewed	96.8
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.72
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.7
PLN02756	418	S-methyl-5-thioribose kinase	96.65
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.52
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.35
PTZ00384	383	choline kinase; Provisional	96.29
PRK10593	297	hypothetical protein; Provisional	95.84
PRK11768	325	serine/threonine protein kinase; Provisional	95.73
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.35
PRK06148	1013	hypothetical protein; Provisional	94.44
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.39
PRK10271	188	thiK thiamine kinase; Provisional	94.18
PTZ00296	442	choline kinase; Provisional	93.94
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.63
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.48

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-73  Score=498.43  Aligned_cols=353  Identities=74%  Similarity=1.202  Sum_probs=331.6

Q ss_pred             ccceEEeeecccCCCCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecc
Q 016401           31 TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH  110 (390)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  110 (390)
                      ...+....+.+.........+|.-.+++|+|+||.||.|....+++.||||++.++.+...+|+.+|++++|||||++..
T Consensus         5 ~~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~   84 (364)
T KOG0658|consen    5 SGHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLY   84 (364)
T ss_pred             ceeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEE
Confidence            34556677777777777888999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC
Q 016401          111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  190 (390)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  190 (390)
                      +|....+.+..|+.+||||++.+|.+.++.+...+..++...++.+++||++||+|||+ .|||||||||+|+|+|.+.+
T Consensus        85 ~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg  163 (364)
T KOG0658|consen   85 FFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTG  163 (364)
T ss_pred             EEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCC
Confidence            99877666677889999999999999999988888999999999999999999999998 99999999999999999977


Q ss_pred             cEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016401          191 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  270 (390)
Q Consensus       191 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  270 (390)
                      .+||||||.|+....+++..++.+|+.|+|||.+++...|+.+.||||.||++.||+-|++.|+|.+..+++..|++.+|
T Consensus       164 ~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG  243 (364)
T KOG0658|consen  164 VLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG  243 (364)
T ss_pred             eEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCC
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR  350 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~  350 (390)
                      .|+.+++.+|++++.++.+|+++..+|.+.+....++++.+|+.++|+++|.+|.++.++|.||||+.+++++..++++.
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~  323 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGR  323 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCC
Confidence            99999999999999999999999999999888999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCCChHHHhhhCcHHHHhhhhh
Q 016401          351 PLPPLFNFKPPELSGIPPETINRLIPEHARKQNLF  385 (390)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (390)
                      .+|++++|+.. .....++..+.++|++.......
T Consensus       324 ~lp~lf~f~~~-e~~~~~~~~~~l~p~~~~~~~~~  357 (364)
T KOG0658|consen  324 PLPPLFNFKRA-ELGISPELVNVLIPEHLREQEKD  357 (364)
T ss_pred             cCCCccCchHH-HhccchHHHHhhccHhhhhhccc
Confidence            99999999976 45678889999999998766543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-62  Score=441.97  Aligned_cols=282  Identities=36%  Similarity=0.663  Sum_probs=254.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .++|.+.+.||.|+||.||+|+.+.+++.||||++++.     .....||++.|++|+ |||||++.+++.+.    +..
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~----~~~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN----DRI   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc----Cce
Confidence            35899999999999999999999999999999988654     333448999999998 99999999998532    226


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+|||||+.+|+++++.+   ...|++..++.|++||+.||+|+|+ +|+.|||+||+|||+.... .|||+|||+|+.
T Consensus        85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~-~iKiaDFGLARe  159 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGND-VIKIADFGLARE  159 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccc-eeEecccccccc
Confidence            9999999999999998874   5789999999999999999999998 9999999999999999765 799999999999


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  280 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  280 (390)
                      +....+.+.++.|+||+|||+++....|+.+.|+|++|||++|+.+-++.|+|.++.|++.+|++.+|.|..+.+...  
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            988888999999999999999999999999999999999999999999999999999999999999999998776542  


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      -...-.+.+|.....++..+++. .+.++.+||.+||.|||.+||||.++|+||||+...
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            12234578899999999888865 999999999999999999999999999999998643

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-60  Score=418.69  Aligned_cols=315  Identities=38%  Similarity=0.672  Sum_probs=268.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .|...+.||.|+||.|+.|.++.+|+.||||++..      ......||+++|+.++|+||+.+.+++.......-.-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            57778999999999999999999999999998852      234445899999999999999999998663434455589


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|+|+|+.+|.++++.    ++.+++..++.+++||+.||+|+|+ .+|+||||||.|+|++.+. .+||||||+|+...
T Consensus       103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD  176 (359)
T ss_pred             EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCC-CEEeccccceeecc
Confidence            9999999898888875    3459999999999999999999998 9999999999999999987 79999999998775


Q ss_pred             c---CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 K---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .   ....+.++.|.+|+|||++.....|+.+.||||+|||+.||++|++.|+|.+..+++..|+..+|.|..+.+..+.
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            3   3344778889999999999988899999999999999999999999999999999999999999999999888765


Q ss_pred             cCc---ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCC
Q 016401          282 PNY---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  358 (390)
Q Consensus       282 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  358 (390)
                      ...   --.+.|..++.+|...|+ +.++.+.||+.+||.+||.+|+|++|+|+||||..+.++......    .+.+..
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~----~~~~~~  331 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC----QPIFDS  331 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC----CCCCcc
Confidence            221   123678888999999995 899999999999999999999999999999999999988765322    221111


Q ss_pred             CCCCCCCCChHHHhhhCcHHH
Q 016401          359 KPPELSGIPPETINRLIPEHA  379 (390)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~  379 (390)
                        .+.. .+-+.++.+++++.
T Consensus       332 --~~~~-~~~~~~r~~i~~e~  349 (359)
T KOG0660|consen  332 --FEHE-LTEEELRELIYKEI  349 (359)
T ss_pred             --cccc-ccHHHHHHHHHHHH
Confidence              2222 66778888777764

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.5e-61  Score=411.56  Aligned_cols=279  Identities=37%  Similarity=0.683  Sum_probs=246.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +.|+...++|+|+||.||+|+++.||+.||||++....      ....||+++|++++|+|+|.++++|     .....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            46899999999999999999999999999999995432      2334899999999999999999999     556668


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++|+|||+.++...+..   ...+++...++.+++|++.|+.|+|+ +++|||||||+||||+.++ .+||||||+|+..
T Consensus        77 hLVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L  151 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNG-VVKLCDFGFARTL  151 (396)
T ss_pred             EEEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCC-cEEeccchhhHhh
Confidence            99999999877555554   45789999999999999999999998 8999999999999999998 8999999999987


Q ss_pred             c-cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh--hc
Q 016401          204 V-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM  280 (390)
Q Consensus       204 ~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--~~  280 (390)
                      . .+...+.++.|+||+|||.+.++..|+..+||||+||++.||++|.+.|+|..+.+++..|.+.+|........  ..
T Consensus       152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            7 56667888999999999999998999999999999999999999999999999999999999999987766554  44


Q ss_pred             CcCcccccCCCCCCC-CcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      ++-|...++|..... +....+ ++++.-+.||+++||+.||.+|++.+++|.||||+++
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             CCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            677788888877543 344444 5678899999999999999999999999999999765

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4e-58  Score=386.96  Aligned_cols=279  Identities=38%  Similarity=0.671  Sum_probs=242.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|...+.||+|.||.||+|++..||+.||||+++...      ....||++.|+.++|+||+.++++|..     ...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-----~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-----KSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-----CCce
Confidence            47999999999999999999999999999999985432      234589999999999999999999943     3337


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      .+|+||++.+|..++++.   ...++...++.++.+++.||+|||+ +.|+||||||.|+|+++++ .+||+|||+|+.+
T Consensus        77 ~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDG-QLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCC-cEEeecccchhcc
Confidence            799999999998888763   4568999999999999999999998 9999999999999999998 8999999999987


Q ss_pred             ccCCCC-cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...... ...+.|.+|+|||.+.+...|+..+|+||+|||+.||+.|.+.|+|.++.+++..|++.+|.|..+.|..+..
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            654433 3337799999999999999999999999999999999999999999999999999999999999998877653


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      --+...+...+..+....| ...+.++.||+.+||.+||.+|+|+.|+|+|+||...
T Consensus       232 lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             cccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence            3333333344555555555 4678888999999999999999999999999999874

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.6e-57  Score=436.68  Aligned_cols=330  Identities=53%  Similarity=0.991  Sum_probs=282.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCC---CCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT---DKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~l  125 (390)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++||||+++++++....   .....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            35799999999999999999999999999999998777666778999999999999999988775432   233456889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      ||||+++++...+..+......+++..++.++.||+.||+|||+ .||+||||||+|||++.++..+||+|||+|+....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            99999998888777666666789999999999999999999998 99999999999999997765799999999987665


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++.+.++.|..+.+..+++.+.
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence            55556678899999999987766799999999999999999999999999999999999999999999999988888888


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCC-CCCCCCCCCCCCCCCC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN-GRPLPPLFNFKPPELS  364 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  364 (390)
                      .+.++......+...++...++++++||.+||++||.+|+|+.++|+||||+.++++...++. ....|+++++...+..
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK  383 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence            888888877788888888899999999999999999999999999999999998876554433 2455666666655555


Q ss_pred             CCChHHHhhhCcHHH
Q 016401          365 GIPPETINRLIPEHA  379 (390)
Q Consensus       365 ~~~~~~~~~~~~~~~  379 (390)
                      .+.++..+.+++...
T Consensus       384 ~~~~~~~~~~~~~~~  398 (440)
T PTZ00036        384 EMSDACRRKIIPKCT  398 (440)
T ss_pred             hCCHHHHHHHhhHHH
Confidence            566666666665543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-59  Score=412.54  Aligned_cols=259  Identities=34%  Similarity=0.490  Sum_probs=212.7

Q ss_pred             CcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----------hhHHHHHHHHHhCCCCceeeecceecc
Q 016401           46 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFS  114 (390)
Q Consensus        46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~  114 (390)
                      +.-.+.|.+.+.||+|+||.|-+|..+.||+.||||++.+..           ...++|+++|++|+|||||+++++|  
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f--  245 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF--  245 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee--
Confidence            345568999999999999999999999999999999985432           2235899999999999999999999  


Q ss_pred             CCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC--CCc
Q 016401          115 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQ  191 (390)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~  191 (390)
                         ....+.|+||||++| .|.+.+-.    ++.+.+..-+.+++||+.|+.|||+ .||+||||||+|||+..+  ...
T Consensus       246 ---~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~l  317 (475)
T KOG0615|consen  246 ---EVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCL  317 (475)
T ss_pred             ---ecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceE
Confidence               444557899999995 55444433    4667788889999999999999998 999999999999999655  336


Q ss_pred             EEEeecCCccccccCCCCcceeeccccccchhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Q 016401          192 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEIIKV  268 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~  268 (390)
                      +||+|||+|+.........+.+|||.|.|||++.+.  ..+..++|+||+||+||-+++|.+||.+..... ...+|.+.
T Consensus       318 lKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G  397 (475)
T KOG0615|consen  318 LKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG  397 (475)
T ss_pred             EEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC
Confidence            999999999988877777889999999999999543  234568999999999999999999998865444 33444331


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                       .+.        +....+..+++++++||++||..||++|||++++|+||||+..
T Consensus       398 -----------------~y~--------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  398 -----------------RYA--------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             -----------------ccc--------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence                             010        1111225689999999999999999999999999999999864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-57  Score=422.80  Aligned_cols=250  Identities=31%  Similarity=0.518  Sum_probs=222.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+|...++||+|+|+.||.+++..+|+.||+|++.+.       .....+|++|.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            4899999999999999999999999999999998642       23345899999999999999999999     66677


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+|.|+|. ++|..+++    ....++|.+++.+++||+.||.|||+ ++|+|||||..|++++++. +|||+|||+|.
T Consensus        93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcC-cEEecccceee
Confidence            999999999 57666555    35789999999999999999999998 9999999999999999998 79999999999


Q ss_pred             ccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ..... +...+.+|||.|+|||++.. ...+..+||||+||+||.||+|+|||...+..+.+.+|..             
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-------------  232 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-------------  232 (592)
T ss_pred             eecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence            88644 77788999999999999965 4589999999999999999999999999988888888876             


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                          .++.+|            ..++.++++||.+||+.||.+|||++++|.|+||...-
T Consensus       233 ----~~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  233 ----NEYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             ----cCcccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence                234443            46899999999999999999999999999999995543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-57  Score=402.46  Aligned_cols=265  Identities=33%  Similarity=0.519  Sum_probs=224.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ....|++.++||+|+||+|+.++.+.+++.||+|++++.       ......|..+|..++||+||+++..|     ++.
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence            345899999999999999999999999999999988653       33445799999999999999999998     445


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+|+|+||+.| .|...++.    ++.+++..+++++.+|+.||.|||+ +|||||||||+|||+|.+|+ ++|+|||+
T Consensus        98 ~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GH-i~LtDFgL  171 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGH-IKLTDFGL  171 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCc-EEEecccc
Confidence            559999999996 66555543    6789999999999999999999998 99999999999999999995 99999999


Q ss_pred             cccccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          200 AKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       200 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      |+.... +....+.+||+.|||||++.+. .|+.++|+||||+++|+|++|.+||.+.+..+...+|.+.-         
T Consensus       172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---------  241 (357)
T KOG0598|consen  172 CKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---------  241 (357)
T ss_pred             chhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------
Confidence            985443 4455667999999999999776 59999999999999999999999999999888888887631         


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC----CHHHHhcCCcccccCCCCCCCCCCCCCCC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELRDPNTRLPNGRPLPP  354 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----s~~~~l~hp~f~~~~~~~~~~~~~~~~~~  354 (390)
                                         ....+..++.++++||+++|..||++|.    ++.++.+||||.++++.  .+......||
T Consensus       242 -------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~--~l~~k~l~Pp  300 (357)
T KOG0598|consen  242 -------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE--KLLAKKLSPP  300 (357)
T ss_pred             -------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH--HHHhcCCCCC
Confidence                               0111234899999999999999999996    68899999999998753  3444444443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-57  Score=394.39  Aligned_cols=289  Identities=34%  Similarity=0.560  Sum_probs=247.3

Q ss_pred             CCCCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh------hHHHHHHHHHhCCCCceeeecceeccCC
Q 016401           43 NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        43 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      .+..+....|+.+..|++|+||.||+|+++.|++.||+|+++.+..      ...||+.+|.+++|||||.+.++.....
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            3455666799999999999999999999999999999999975432      2248999999999999999999875432


Q ss_pred             CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          117 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                         -..+|+|||||+.+|..++....   +++...+++.++.|++.|++|||. +.|+||||||+|+|++..| .+||+|
T Consensus       149 ---~d~iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G-~lKiaD  220 (419)
T KOG0663|consen  149 ---MDKIYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKG-ILKIAD  220 (419)
T ss_pred             ---cceeeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCC-cEEecc
Confidence               22378999999999988888753   789999999999999999999998 9999999999999999888 799999


Q ss_pred             cCCccccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          197 FGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       197 fg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ||+|+.+..... .+..+-|.||+|||.+++...|+++.|+||+|||+.||+++.+.|+|..+.+++.+|++.+|.|...
T Consensus       221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~  300 (419)
T KOG0663|consen  221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA  300 (419)
T ss_pred             cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence            999998765533 4566789999999999999999999999999999999999999999999999999999999999987


Q ss_pred             HHhhcC--cCcccccCCCCCCCCcccccccC-CChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          276 EIKCMN--PNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       276 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      .|....  +......++..+...+...|+.. ++....+|++.+|.+||.+|.||.+.|+|.||.+.
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence            664321  11123445555555566666544 67999999999999999999999999999999984

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-57  Score=412.67  Aligned_cols=285  Identities=35%  Similarity=0.602  Sum_probs=241.0

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ..+..+.|+.+++||+|.||.||+|++..+|+.||+|++.-+.      ....||+.||++|+||||+++.+...+.   
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---  188 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---  188 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---
Confidence            3456678999999999999999999999999999999986433      3345899999999999999999988543   


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          119 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       119 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ....+|||+|||+.+|..++..   ..-.|++.+++.+|.||+.||+|||+ +||+|||||.+|||||.+| .+||+|||
T Consensus       189 ~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G-~LKiaDFG  263 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNG-VLKIADFG  263 (560)
T ss_pred             CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCC-CEEecccc
Confidence            3455899999999988777764   23479999999999999999999998 9999999999999999998 89999999


Q ss_pred             CccccccCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          199 SAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       199 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      +|+.+....  ..+..+.|.||+|||++++...|+.++|+||+||||.||++|++.|+|.++.+++..|++.+|.|....
T Consensus       264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            999654433  456778899999999999999999999999999999999999999999999999999999999999987


Q ss_pred             HhhcC-cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          277 IKCMN-PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       277 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      |.... +.+..++...--.+.+...+ ..++..+.+|+..||..||.+|.||.++|.|+||..
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            76221 22222222222122333333 578999999999999999999999999999999943

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-56  Score=409.43  Aligned_cols=256  Identities=31%  Similarity=0.577  Sum_probs=225.1

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      +....|..++.||+|+|++|++|+++.+++.||||++.+.       ..+..+|..+|.+| .||.|++++..|     .
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence            3456899999999999999999999999999999988543       23445799999999 899999999988     4


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      ++..+|+|+||++ |+|..++..+    +.+++..+++++.||+.||+|||+ +|||||||||+|||+|+|+ .+||+||
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dm-hikITDF  218 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDG-HIKITDF  218 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCC-cEEEeec
Confidence            4555889999998 6888888775    679999999999999999999998 9999999999999999999 6999999


Q ss_pred             CCccccccCCC--------------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 016401          198 GSAKVLVKGEP--------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  263 (390)
Q Consensus       198 g~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  263 (390)
                      |.|+.+.....              ..+++||..|.+||++. ....++.+|+|+||||+|+|+.|.+||.+.++.-.++
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence            99987643211              14589999999999994 5568999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      +|++.                 ++.            |++++++.++|||+++|..||.+|+|+.+|.+||||.++.+.+
T Consensus       298 kI~~l-----------------~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  298 KIQAL-----------------DYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHHh-----------------ccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            99884                 233            3468999999999999999999999999999999999997654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-56  Score=394.09  Aligned_cols=256  Identities=30%  Similarity=0.551  Sum_probs=215.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+.++.||+|..|+||+|+|+.|++.+|+|.+...     .+.+.+|+++++.++|||||++|++|+....    -+++
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI  155 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI  155 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence            678889999999999999999999999999998322     3445689999999999999999999965332    3789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||++ +|..++..    .+++++..+..++.+++.||.|||..++||||||||+|||++..| .|||||||.++...
T Consensus       156 ~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lv  230 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILV  230 (364)
T ss_pred             ehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhh
Confidence            9999995 87776665    377999999999999999999999548999999999999999998 89999999998776


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHHhh
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-----SGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +. ...+++||..|||||.+.+. .|+.++||||||++++|+++|+.||...     +..+.+..|+.   .|+.     
T Consensus       231 nS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP-----  300 (364)
T KOG0581|consen  231 NS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP-----  300 (364)
T ss_pred             hh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC-----
Confidence            55 55788999999999999665 5999999999999999999999999874     33344444432   1110     


Q ss_pred             cCcCcccccCCCCCCCCccccccc-CCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  345 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~  345 (390)
                                          .++. .+++++++||..||++||.+|+|+.|+++|||+++..+++..
T Consensus       301 --------------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd  347 (364)
T KOG0581|consen  301 --------------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD  347 (364)
T ss_pred             --------------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence                                1223 389999999999999999999999999999999987665543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-55  Score=376.03  Aligned_cols=250  Identities=29%  Similarity=0.487  Sum_probs=220.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      -.+|+..+.||.|+||.|.+++++.+|..||+|++.+..       ....+|..+|+.+.||++++++..+     .+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence            358999999999999999999999999999999986543       2234799999999999999999888     5566


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ++|+||||++| .|.++++.    .+++++..+++++.||+.||+|||+ .+|++|||||+|||+|.+| .+||+|||+|
T Consensus       118 ~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G-~iKitDFGFA  191 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNG-HIKITDFGFA  191 (355)
T ss_pred             eEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCC-cEEEEeccce
Confidence            69999999996 56555554    6789999999999999999999998 9999999999999999999 5999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      +....  ...+.+|||.|+|||++.. ..|+.++|+||||+++|||+.|.+||.+.+....+.+|++.            
T Consensus       192 K~v~~--rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------------  256 (355)
T KOG0616|consen  192 KRVSG--RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------------  256 (355)
T ss_pred             EEecC--cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC------------
Confidence            97743  3678899999999999954 56999999999999999999999999999999999999873            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                           .+.            ||+.++++++|||+++|+.|-.+|.     ...++.+||||+++.+
T Consensus       257 -----~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W  305 (355)
T KOG0616|consen  257 -----KVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW  305 (355)
T ss_pred             -----ccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence                 233            3467899999999999999999995     4679999999998874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.3e-54  Score=396.63  Aligned_cols=262  Identities=33%  Similarity=0.525  Sum_probs=220.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+.|.+++.||+|+||.||+|+.+.||..||+|++++...       ....|..+|...++|+||+++..|     .+.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            34689999999999999999999999999999999976432       234699999999999999999999     667


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .++||||||++| ++..++..    .+.+++.++++++.+++.|++.||+ .|+|||||||+|+|||..|| +||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GH-iKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGH-IKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCC-Eeeccccc
Confidence            779999999996 66666654    5789999999999999999999998 99999999999999999995 99999999


Q ss_pred             cccccc------------------------CC-----C-------------------CcceeeccccccchhhcCCCCCC
Q 016401          200 AKVLVK------------------------GE-----P-------------------NVSYICSRYYRAPELIFGATEYT  231 (390)
Q Consensus       200 a~~~~~------------------------~~-----~-------------------~~~~~~t~~y~aPE~~~~~~~~~  231 (390)
                      ++....                        ..     .                   ..+.+|||.|+|||++.+.. |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            853311                        00     0                   02468999999999998765 99


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHH
Q 016401          232 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD  311 (390)
Q Consensus       232 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (390)
                      ..+|+||||||+||||.|.+||.+.++.+...+|..--               ..+.+|..          ..++++++|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------------~~l~fP~~----------~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------------ETLKFPEE----------VDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------------hhccCCCc----------CcccHHHHH
Confidence            99999999999999999999999999999999887621               11222221          346899999


Q ss_pred             HHHHhcccCCCcCCC---HHHHhcCCcccccCCCCCCCC
Q 016401          312 LVCRFFQYSPNLRCT---ALEACVHPFFDELRDPNTRLP  347 (390)
Q Consensus       312 li~~~L~~dP~~R~s---~~~~l~hp~f~~~~~~~~~~~  347 (390)
                      ||.+||+ ||++|..   +.||.+||||+++.+....-.
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~  459 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREM  459 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcC
Confidence            9999999 9999995   889999999999987654433

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.6e-54  Score=379.97  Aligned_cols=289  Identities=35%  Similarity=0.699  Sum_probs=240.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh------hHHHHHHHHHhCCCCc-eeeecceeccCCC-CCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPN-IVALKHCFFSTTD-KEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~-~~~~  121 (390)
                      ..|..+++||+|+||+||+|+++.+|+.||+|++.-+..      ...+|+.+|+.++|+| |+.+++++.+... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            468888999999999999999999999999999864432      2358999999999999 9999999855431 2334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+++||||++.+|..++.........++...++.+++||+.||+|||+ ++|+||||||+||||++++ .+||+|||+|+
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr  168 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSG-VLKLADFGLAR  168 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCC-cEeeeccchHH
Confidence            688999999999988887754433567778999999999999999998 9999999999999999988 79999999998


Q ss_pred             ccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...-. ...+..++|.+|+|||++++...|++..||||+|||++||+++++.|++..+.+++..|.+.+|.|..+.|...
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            66533 33566788999999999999988999999999999999999999999999999999999999999998776543


Q ss_pred             C--cCcccccCCCCC-CCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          281 N--PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       281 ~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      .  +.+.. .++... ..++.... ++.+++..+++.+||+.||.+|.|++.+|.||||+.+..+
T Consensus       249 ~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  249 SSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             cccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            2  11111 233332 33333333 3455799999999999999999999999999999987543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-54  Score=402.81  Aligned_cols=283  Identities=30%  Similarity=0.486  Sum_probs=236.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      -|++++.||.|+.|.|-+|+|..||+..|||++.+.       ...+++|+-+|+.+.|||++++++++     .+..++
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~l   87 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHL   87 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceE
Confidence            599999999999999999999999999999999765       45677999999999999999999999     556669


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+|.||++| .|.+++..    .+++++..+.++++||+.|+.|+|. .+||||||||+|+|+|.+. ++||+|||+|..
T Consensus        88 ylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~-nIKIADFGMAsL  161 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKN-NIKIADFGMASL  161 (786)
T ss_pred             EEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhccc-CEeeeccceeec
Confidence            999999995 55444433    6889999999999999999999998 8999999999999999988 699999999998


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...+.-..+.||+|.|.|||++.+..+.+.++||||+|||||.||+|+.||.+.+-...+.++.+               
T Consensus       162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~---------------  226 (786)
T KOG0588|consen  162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR---------------  226 (786)
T ss_pred             ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc---------------
Confidence            77777778899999999999999888789999999999999999999999987665555555444               


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPE  362 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (390)
                        ..|.+|            .++++++++||++||..||++|+|..||++|||+.+..+.........+.. .....-+.
T Consensus       227 --G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~-~~i~s~ps  291 (786)
T KOG0588|consen  227 --GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVS-VPILSIPS  291 (786)
T ss_pred             --CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcc-cceeecCC
Confidence              234444            579999999999999999999999999999999998765443322111100 01111244


Q ss_pred             CCCCChHHHhhh
Q 016401          363 LSGIPPETINRL  374 (390)
Q Consensus       363 ~~~~~~~~~~~~  374 (390)
                      ...|++..++.+
T Consensus       292 ~~~IDp~Il~~l  303 (786)
T KOG0588|consen  292 IQEIDPLILQHL  303 (786)
T ss_pred             cccCCHHHHhhh
Confidence            567788777644

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-53  Score=401.42  Aligned_cols=279  Identities=37%  Similarity=0.632  Sum_probs=231.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHH---HHHHHHHhCC-C-----CceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD-H-----PNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~  121 (390)
                      +|.+.+.||+|+||.|.+|.+..|++.||||+++......+   .|+++|..|+ |     -|+|+++++|..     ..
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----r~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----RN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----cc
Confidence            79999999999999999999999999999999988776654   4899999986 3     489999999954     44


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc-CCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~~vkl~Dfg~a  200 (390)
                      ++|||+|+++.+|.++++....  .+++...++.++.||+.||.+||+ .||||+||||+||||. .+...|||+|||.|
T Consensus       262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence            5999999999999999987543  469999999999999999999998 9999999999999994 33447999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...  .....+++.++.|+|||++++.. |+.+.||||||||++||++|.++|+|.++.+++..|++.+|.|+...+...
T Consensus       339 c~~--~q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFE--SQRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             ccc--CCcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            754  44455889999999999998865 999999999999999999999999999999999999999999998877544


Q ss_pred             CcCcccccC----C--------------------------CC----CCCCcccccccCCChhHHHHHHHhcccCCCcCCC
Q 016401          281 NPNYTEFKF----P--------------------------QI----KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  326 (390)
Q Consensus       281 ~~~~~~~~~----~--------------------------~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s  326 (390)
                      ......++-    +                          ..    ....+...+...-...+.|||++||+|||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            322211111    0                          00    1111222222223356899999999999999999


Q ss_pred             HHHHhcCCcccccC
Q 016401          327 ALEACVHPFFDELR  340 (390)
Q Consensus       327 ~~~~l~hp~f~~~~  340 (390)
                      +.++|+||||....
T Consensus       496 p~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  496 PAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHhcCccccccc
Confidence            99999999998643

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-53  Score=376.16  Aligned_cols=252  Identities=31%  Similarity=0.541  Sum_probs=216.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..|.+.+.||+|+||+||+|+++.++..||||.+.+..      .....|+++|+.++|||||.+++++     ....++
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~i   84 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDFI   84 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCeE
Confidence            47999999999999999999999999999999986542      2335799999999999999999998     444579


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC-C----CcEEEeec
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-T----HQLKLCDF  197 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~----~~vkl~Df  197 (390)
                      |+|||||+ |+|..+++.    .+.+++..++.++.||+.||++||+ ++||||||||+||||+.. .    ..+||+||
T Consensus        85 ~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             EEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            99999999 688877775    4689999999999999999999998 999999999999999764 1    25899999


Q ss_pred             CCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          198 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       198 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      |+|+....+....+.+|++.|||||++. ...|+.|+|+||+|+++|+|++|++||...+..+.+..+.+.-        
T Consensus       160 GfAR~L~~~~~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~--------  230 (429)
T KOG0595|consen  160 GFARFLQPGSMAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN--------  230 (429)
T ss_pred             chhhhCCchhHHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc--------
Confidence            9999988887778899999999999995 4569999999999999999999999999988877776443311        


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                        .....++..++....+|+..+|+.+|..|.+..+-+.|+++..
T Consensus       231 ------------------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  231 ------------------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             ------------------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                              0111122446778889999999999999999999999999865

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-53  Score=397.71  Aligned_cols=264  Identities=29%  Similarity=0.491  Sum_probs=224.2

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  119 (390)
                      .-.+|++.++||+|+||+|+++..+.+++.||||.++++.       .....|.+|+... +||.++.++.+|     ..
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence            3468999999999999999999999999999999987653       2234688888887 499999999999     44


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..++|+||||+.|+.   +.. ....+.+++..+++++..++.||+|||+ +||||||||.+|||+|.+|+ +||+|||+
T Consensus       441 ~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh-~kiADFGl  514 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGH-VKIADFGL  514 (694)
T ss_pred             CCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCc-EEeccccc
Confidence            455999999999754   111 1224789999999999999999999998 99999999999999999995 99999999


Q ss_pred             ccccc-cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          200 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       200 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ++... .+....+++|||.|+|||++.+. .|+.++|+|||||+|||||.|..||+++++.+.+..|+..          
T Consensus       515 cKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------  583 (694)
T KOG0694|consen  515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------  583 (694)
T ss_pred             ccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Confidence            98654 55666788999999999999655 5999999999999999999999999999999999988762          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCCCCCCCCCCCCCC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLP  353 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~~~~~~~~~~~~~  353 (390)
                             +..            +|..++.++.++++++|.+||++|+.     +.+|.+||||+.+.  |..+.+.+.-|
T Consensus       584 -------~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~--w~~L~~r~i~P  642 (694)
T KOG0694|consen  584 -------EVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID--WDDLLNRRIKP  642 (694)
T ss_pred             -------CCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC--HHHHhhccCCC
Confidence                   222            33568999999999999999999996     57899999999997  45555555555


Q ss_pred             C
Q 016401          354 P  354 (390)
Q Consensus       354 ~  354 (390)
                      |
T Consensus       643 P  643 (694)
T KOG0694|consen  643 P  643 (694)
T ss_pred             C
Confidence            4

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-52  Score=385.83  Aligned_cols=250  Identities=35%  Similarity=0.509  Sum_probs=216.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHhCC-CCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  118 (390)
                      ...|.+.+.||+|+||+|++|.+..+++.||+|++.+.         .....+|+.++++++ ||||+++++++...   
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~---   92 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP---   92 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC---
Confidence            34799999999999999999999999999999977543         123347999999999 99999999999433   


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC-CCcEEEee
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCD  196 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~D  196 (390)
                        ..+|+||||+.| +|.+.+..    .+++.+..++.++.||+.|++|||+ +||+||||||+|||++.+ + ++||+|
T Consensus        93 --~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~-~~Kl~D  164 (370)
T KOG0583|consen   93 --TKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEG-NLKLSD  164 (370)
T ss_pred             --CeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCC-CEEEec
Confidence              338899999996 77666654    5789999999999999999999998 999999999999999998 6 899999


Q ss_pred             cCCcccc-ccCCCCcceeeccccccchhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          197 FGSAKVL-VKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       197 fg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      ||++... .......+.+||+.|+|||++.+.. +.+.++||||+|++||.|++|+.||...+....+..|.+.      
T Consensus       165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~------  238 (370)
T KOG0583|consen  165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG------  238 (370)
T ss_pred             cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC------
Confidence            9999877 4556677889999999999997766 4568999999999999999999999998877777775542      


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCC-ChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL-PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                 .+.+|            ..+ ++++++||++||..||.+|+|+.++++||||+.
T Consensus       239 -----------~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 -----------EFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -----------CccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                       23333            346 999999999999999999999999999999996

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-54  Score=356.96  Aligned_cols=254  Identities=31%  Similarity=0.451  Sum_probs=216.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .++|.+.+.||+|.|+.|+++.+..+|+.+|+|++..      +....++|++|.+.|+||||+++.+.+     .+..+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence            3589999999999999999999999999999998742      334567899999999999999999887     66778


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC--CCCcEEEeecCC
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGS  199 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~Dfg~  199 (390)
                      .|+|+|++.| ++-.-+-.    ..-+++..+-.++.||++||+|+|. +||||||+||+|+++-+  ++..+||+|||+
T Consensus        85 ~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             eEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccce
Confidence            9999999997 33222222    1347888899999999999999998 99999999999999943  344799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      |.....+.......|||.|||||++.. .+|+..+|||+.|++||-|+.|.+||.+.+....+.+|.+.           
T Consensus       160 Ai~l~~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-----------  227 (355)
T KOG0033|consen  160 AIEVNDGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-----------  227 (355)
T ss_pred             EEEeCCccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-----------
Confidence            998887766778899999999999955 55999999999999999999999999999888888888762           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                            .+.++   .     ..++++++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus       228 ------~yd~~---~-----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  228 ------AYDYP---S-----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             ------ccCCC---C-----cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                  22221   1     122679999999999999999999999999999999975

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-51  Score=367.00  Aligned_cols=275  Identities=27%  Similarity=0.465  Sum_probs=228.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      .-..|++++.||+|.-|+||+|+.+.++..+|+|++.++.       ...+.|.+||+.++||.++.+|..|     +.+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~  149 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD  149 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence            3458999999999999999999999999999999996543       2234699999999999999999999     667


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .+.|++||||+| +|..+.+.  +....+++..+++++.+++.||+|||- .|||+|||||+||||.++|| |.|+||.+
T Consensus       150 ~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGH-IMLsDFDL  225 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGH-IMLSDFDL  225 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCc-EEeeeccc
Confidence            789999999996 66555443  346779999999999999999999997 99999999999999999995 99999998


Q ss_pred             cccccc---------------------------------C-C-----------------------CCcceeeccccccch
Q 016401          200 AKVLVK---------------------------------G-E-----------------------PNVSYICSRYYRAPE  222 (390)
Q Consensus       200 a~~~~~---------------------------------~-~-----------------------~~~~~~~t~~y~aPE  222 (390)
                      +.....                                 . .                       ...+++||-.|+|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            643210                                 0 0                       013467899999999


Q ss_pred             hhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccc
Q 016401          223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ  302 (390)
Q Consensus       223 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (390)
                      ++.+.. .+.++|+|+||+++|||+.|..||.|.+..+.+.+|+..                 ..++|..          
T Consensus       306 vI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~----------  357 (459)
T KOG0610|consen  306 VIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE----------  357 (459)
T ss_pred             eeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------
Confidence            997655 799999999999999999999999999999999988762                 3334432          


Q ss_pred             cCCChhHHHHHHHhcccCCCcCCC----HHHHhcCCcccccCCCCCCCCCCCCCCCCCCCC
Q 016401          303 KRLPPEAVDLVCRFFQYSPNLRCT----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  359 (390)
Q Consensus       303 ~~~~~~~~~li~~~L~~dP~~R~s----~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  359 (390)
                      +.++..++|||+++|.+||.+|+.    |+||.+||||++++|.-.+...++.+|...+..
T Consensus       358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~  418 (459)
T KOG0610|consen  358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG  418 (459)
T ss_pred             CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence            357899999999999999999998    999999999999998755555545555554443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-52  Score=385.78  Aligned_cols=249  Identities=32%  Similarity=0.513  Sum_probs=216.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..      ....+|++|++.++|||||.+++.|     +....+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            47999999999999999999999999999999985433      3356899999999999999999999     444559


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++|+||+.|+|..++..    .+.++++.++.++++++.||.|||+ .+|+|||+||.|||++..+ .+|+||||+|+.+
T Consensus        77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGG-TLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence            99999999998888875    5789999999999999999999998 9999999999999999988 7999999999987


Q ss_pred             ccCCCC-cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..+... ....|||.|||||++. ...|+..+|+|||||++||+++|++||....-.+....|.+.              
T Consensus       151 ~~~t~vltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d--------------  215 (808)
T KOG0597|consen  151 STNTSVLTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD--------------  215 (808)
T ss_pred             ccCceeeeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC--------------
Confidence            665433 4567899999999996 556999999999999999999999999887655555555541              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                         ...            .+.+++..+++|+..+|.+||.+|+|..+++.|||.++-
T Consensus       216 ---~v~------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  216 ---PVK------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ---CCC------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence               111            124689999999999999999999999999999999763

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-53  Score=361.28  Aligned_cols=255  Identities=28%  Similarity=0.512  Sum_probs=211.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEec------cchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..|++.++||+|+||.||++.+..+|+.+|.|.+.      +.....-.|+.+|++|+|||||++++.-+.   .+...+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence            37999999999999999999999999999999874      223334579999999999999999884322   444557


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc-CC--cccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IG--ICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~-~~--ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ++|||||+ |+|.+.++.+....+.+++..++.++.|+|.||.++|+. .+  |+||||||.||+++.+| .|||+|||+
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL  174 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGL  174 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchh
Confidence            89999999 699999999999899999999999999999999999961 23  99999999999999998 799999999


Q ss_pred             ccccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          200 AKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       200 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ++....... ..+++|||+||+||.+.+. .|+.+|||||+||++|||+.-++||.+.+-.+.-.+|... ..|+     
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~-----  247 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPP-----  247 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCC-----
Confidence            987754432 3578999999999999654 5999999999999999999999999999655555555432 1111     


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                                .|           ....|.++..||..|+..||+.||+.     +|+++++..
T Consensus       248 ----------~p-----------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  248 ----------LP-----------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             ----------Cc-----------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence                      11           03478999999999999999999986     666666543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-51  Score=372.44  Aligned_cols=257  Identities=29%  Similarity=0.451  Sum_probs=213.6

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------------------hhHHHHHHHHHhCCCCceeee
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------RYKNRELQIMQMLDHPNIVAL  108 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------~~~~~E~~~l~~l~h~~iv~~  108 (390)
                      ..-++|++.+.||+|.||+|-+|++..+++.||||++.+..                  ....+|+.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            35579999999999999999999999999999999985422                  133579999999999999999


Q ss_pred             cceeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCC-CcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC
Q 016401          109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  187 (390)
Q Consensus       109 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~  187 (390)
                      +++.   ++.....+|||+|||..+-.  ..  ...... +++.+++.++++++.||+|||. +|||||||||+|+||++
T Consensus       174 iEvL---DDP~s~~~YlVley~s~G~v--~w--~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  174 IEVL---DDPESDKLYLVLEYCSKGEV--KW--CPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEee---cCcccCceEEEEEeccCCcc--cc--CCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcC
Confidence            9997   44566679999999984221  11  111233 8999999999999999999998 99999999999999999


Q ss_pred             CCCcEEEeecCCccccccCCC------CcceeeccccccchhhcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016401          188 HTHQLKLCDFGSAKVLVKGEP------NVSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG  258 (390)
Q Consensus       188 ~~~~vkl~Dfg~a~~~~~~~~------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  258 (390)
                      ++ .|||+|||.+.....+..      ....+|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||.+...
T Consensus       246 ~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  246 DG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            98 799999999875533211      234789999999999976   23457899999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          259 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      .+.+.+|+..                 .+.+|..          +.+..+++|||.+||++||++|+++.++..|||...
T Consensus       325 ~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  325 LELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            9999888762                 2333332          246889999999999999999999999999999976


Q ss_pred             c
Q 016401          339 L  339 (390)
Q Consensus       339 ~  339 (390)
                      -
T Consensus       378 ~  378 (576)
T KOG0585|consen  378 D  378 (576)
T ss_pred             C
Confidence            4

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.6e-50  Score=368.17  Aligned_cols=276  Identities=33%  Similarity=0.639  Sum_probs=227.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+|.+.+.||.|+||.||+|+++.+++.||+|++...     .....+|+.+++.++||||+++++++.     ...+.|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence            4799999999999999999999999999999988532     123457999999999999999999883     334588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+++++...+...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++...
T Consensus        80 lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~  154 (288)
T cd07871          80 LVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARAKS  154 (288)
T ss_pred             EEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEECcCcceeecc
Confidence            99999999887666532   3457889999999999999999998 9999999999999999888 79999999987543


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  282 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  282 (390)
                      ... ......+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+..+.+..... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            222 223456789999999997666689999999999999999999999999998899999999999888877655322 


Q ss_pred             -CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                       .+....++.....++... .+.+++++++||++||++||.+|+|++|+|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence             222233333333333322 24678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=363.47  Aligned_cols=256  Identities=34%  Similarity=0.566  Sum_probs=208.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|...+.||+|+||.||++.++.+|+.+|||.+...    .....+|+.+|.+++|||||++++......+   ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence            34799999999999999999999999999999988655    3446899999999999999999886422221   4678


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC-CCCcEEEeecCCccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKV  202 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~Dfg~a~~  202 (390)
                      ++|||+++ +|.+++..+.   +.+++..++.+..|++.||+|||+ +||+||||||+|||++. ++ .+||+|||+++.
T Consensus        93 i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~  167 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNG-DVKLADFGLAKK  167 (313)
T ss_pred             eeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCC-eEEeccCccccc
Confidence            99999995 8777776532   269999999999999999999998 99999999999999998 56 799999999986


Q ss_pred             ccc----CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHH
Q 016401          203 LVK----GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       203 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ...    ........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+...         
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---------  238 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---------  238 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---------
Confidence            653    222345789999999999965332345999999999999999999999873 333333322221         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                               -..|         .++..+++++++||.+||.+||++||||+++|+|||.+..
T Consensus       239 ---------~~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  239 ---------DSLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             ---------CCCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence                     0111         2446789999999999999999999999999999999764

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-49  Score=370.55  Aligned_cols=285  Identities=38%  Similarity=0.671  Sum_probs=226.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|+||.||+|.+..+++.||||++...      .....+|+++++.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            599999999999999999999999999999988532      12345799999999999999999988654444445678


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||++++|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            9999999888776653    3568999999999999999999998 9999999999999999888 79999999987543


Q ss_pred             cCCC----CcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          205 KGEP----NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       205 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ....    .....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2211    1345689999999998542 4589999999999999999999999999888888888888888887665543


Q ss_pred             cCcCcc-c-c-cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          280 MNPNYT-E-F-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       280 ~~~~~~-~-~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ...... . + ........++...+ +.+++++.+||.+||..||++|||+.++|+||||+.+...
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence            321100 0 0 00111111122222 3578899999999999999999999999999999887653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-50  Score=321.35  Aligned_cols=278  Identities=35%  Similarity=0.629  Sum_probs=235.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .|...++||+|.||+||+|++..+++.||+|.+.-+.      ....+|+-+|+.++|.|||+++++.     ..+..+-
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence            5788899999999999999999999999999985432      3446899999999999999999987     3344478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|+|||..+|..+..   ..++.++.+.++.++.|++.||.++|+ +++.||||||+|.||+.+| .+||+|||+++.+.
T Consensus        78 lvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ng-elkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNG-ELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence            999999987755544   456889999999999999999999998 8999999999999999999 89999999998764


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..- -....+.|.+|++|.++.+..-|++..|+||.||++.|+.. |++.|++.+..+++.+|+..+|.|..+.+..+..
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            322 12334569999999999999999999999999999999985 9999999999999999999999999988876643


Q ss_pred             CcccccCCCCCCC-CcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          283 NYTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       283 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      -.....+|..+.. .|.+.. ++++...+||++++|..+|.+|++++++++||||.+.
T Consensus       233 lpdyk~yp~ypattswsqiv-p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIV-PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCCCcccCCccccchHHHHh-hhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            3333344444333 344444 5788899999999999999999999999999999864

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.1e-49  Score=363.79  Aligned_cols=282  Identities=32%  Similarity=0.554  Sum_probs=217.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..+|++.+.||+|+||.||+|+++.+++.||||++....     ....+|+.+++.++||||+++++++.     .....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence            457999999999999999999999999999999985322     23457999999999999999999883     33458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||+++++...+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTG-ELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECCCCcceec
Confidence            89999999888766653   23568899999999999999999998 9999999999999999887 7999999998644


Q ss_pred             ccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcC
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+..+ .+.+..+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            222 2223456789999999987666689999999999999999999999987544 45566666666666554433211


Q ss_pred             c--CcccccCCCCCCCCccccc-ccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          282 P--NYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       282 ~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      .  .+..-.+....+..+...+ ....++++++||++||++||++|+|+.++|+||||+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            0  0000001111111111111 113567899999999999999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-49  Score=356.06  Aligned_cols=266  Identities=26%  Similarity=0.434  Sum_probs=218.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ....|++...||.|..++||+|+...+++.||||++.-++     ..+.+|+..|+.++||||++++.+|...     ..
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-----SE   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----ce
Confidence            3458999999999999999999999999999999996443     3456899999999999999999999543     34


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||+||. |++.+++..+..  ..++|..+..++++++.||.|||. +|.||||||+.||||+.+| .|||+|||.+.
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG-~VkLadFgvsa  174 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDG-TVKLADFGVSA  174 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCC-cEEEcCceeee
Confidence            899999998 688888887654  559999999999999999999998 9999999999999999999 79999999875


Q ss_pred             ccccCCCC-----cceeeccccccchhh-cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          202 VLVKGEPN-----VSYICSRYYRAPELI-FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       202 ~~~~~~~~-----~~~~~t~~y~aPE~~-~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      .+......     .+.+||++|||||++ .....|+.|+||||||++..||.+|..||....+.+.+...++  +.|+..
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~  252 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTL  252 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCc
Confidence            44333221     455789999999995 3445699999999999999999999999998887777655444  333211


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      ....                 ...--...++..++.+|..||++||.+|||+.++|+|+||+..+.
T Consensus       253 ~t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  253 LTSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             cccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            1000                 000011356789999999999999999999999999999997654

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-50  Score=372.24  Aligned_cols=250  Identities=29%  Similarity=0.475  Sum_probs=216.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..|.....||+|+.|.||.|+...+++.||||.+...    +....+|+.+|+..+|+|||.+++.|....+     +++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEE
Confidence            4799999999999999999999999999999998533    3445589999999999999999999865533     889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||++| +|.+++..     ..++|.++..++++++.||+|||. +||+|||||.+|||++.++ .+||+|||+|..+.
T Consensus       348 VMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQIS  420 (550)
T ss_pred             EEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCC-cEEEeeeeeeeccc
Confidence            9999996 66666654     459999999999999999999998 9999999999999999998 69999999998776


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ... ...+.+|||+|||||++. ...|+++.||||||++++||+-|.+||-..++...++.|... |.|..         
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~l---------  489 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKL---------  489 (550)
T ss_pred             cccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCc---------
Confidence            554 567789999999999994 456999999999999999999999999998888888777653 22211         


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                      ..+..+++.++|||.+||+.|+++|+++.++|+||||+.
T Consensus       490 ----------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  490 ----------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             ----------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                            123578999999999999999999999999999999954

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.4e-48  Score=355.80  Aligned_cols=275  Identities=39%  Similarity=0.710  Sum_probs=218.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|+||.||+|+++.+++.||+|++....      ....+|+.+++.++||||+++++++     .....+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            6999999999999999999999999999999885431      2345799999999999999999988     3345688


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+++++...+..   ....+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            9999999876554432   23568999999999999999999998 9999999999999999887 79999999997654


Q ss_pred             cCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 016401          205 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  281 (390)
Q Consensus       205 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  281 (390)
                      ...  ......+|+.|+|||++.+. .++.++|+||+||++|+|++|++||.+.+..+.+..+....+..+...+.... 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            322  22345689999999999654 48999999999999999999999999988888777777776666655443221 


Q ss_pred             -cCcccccCCCCC-CCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          282 -PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       282 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                       +.+.....+... ...+.......++.++.+||++||++||++|||++++|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             111111111110 1111222234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9e-51  Score=343.63  Aligned_cols=254  Identities=28%  Similarity=0.486  Sum_probs=218.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------h-----hhHHHHHHHHHhC-CCCceeeecceeccCCC
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------K-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  117 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  117 (390)
                      .|.-.+.||.|..+.|-+|.++.+|..+|+|++...       .     ....+|+.||+++ .||+|+++.++|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            688889999999999999999999999999988321       1     1123699999998 699999999999     


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      +.+.++++|+|.|+ |.|.+++..    .-.+++...+.+|+|++.|+.|||. ++||||||||+|||+|++. ++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~-~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNM-NIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecccc-ceEEec
Confidence            66677899999998 677776654    4568999999999999999999998 9999999999999999887 899999


Q ss_pred             cCCccccccCCCCcceeeccccccchhhc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016401          197 FGSAKVLVKGEPNVSYICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       197 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      ||+|+....++.....+|||.|+|||.+.     +...|+..+|+|++|+|+|.|+.|.+||......-++..|.+.-  
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk--  244 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK--  244 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc--
Confidence            99999999999999999999999999983     34558999999999999999999999999887777777776621  


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                     +.+   ....|     .+++.+.+|||.+||+.||.+|+|++|+|+||||..+-
T Consensus       245 ---------------yqF---~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~  290 (411)
T KOG0599|consen  245 ---------------YQF---RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA  290 (411)
T ss_pred             ---------------ccc---CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence                           111   11122     56899999999999999999999999999999997653

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-48  Score=366.73  Aligned_cols=284  Identities=31%  Similarity=0.553  Sum_probs=223.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            5899999999999999999999999999999998532      2234579999999999999999998754322 12235


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+||||+++++...+.      ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus       101 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~  172 (359)
T cd07876         101 VYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  172 (359)
T ss_pred             eEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEecCCCccc
Confidence            78999999988765543      357888999999999999999998 9999999999999999888 799999999976


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.......
T Consensus       173 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         173 ACTNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             cccCccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            544444455678999999999965 4589999999999999999999999999988888888888888877654433211


Q ss_pred             ----------CcccccCCCCCCC---CcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          283 ----------NYTEFKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       283 ----------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                                .+....+......   +.........++++++||.+||.+||++|||+.|+|+||||+...++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence                      1111110000000   00011122357889999999999999999999999999999875544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-48  Score=356.80  Aligned_cols=279  Identities=32%  Similarity=0.563  Sum_probs=219.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcC-CCcEEEEEEeccch------hhHHHHHHHHHhC---CCCceeeecceeccCCCCCc
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~  120 (390)
                      +|++.+.||+|+||.||+|++.. +++.||+|++....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            69999999999999999999854 46889999875321      2234677777766   69999999998754433445


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..+++||||+++++..++....  ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            5688999999998877765422  3458899999999999999999998 9999999999999999888 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .............+|+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..+.+.++....+.+..+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            76554444445678999999999955 45899999999999999999999999999999999999988777765544221


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      .. .....+......+.... .+.+++.+++||.+||+.||++|||+.++|+||||
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VA-LPRQAFHSKSAQPIEKF-VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hc-ccchhccCCCCCCHHHH-ccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            10 00111111111222222 24578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.7e-48  Score=357.75  Aligned_cols=281  Identities=35%  Similarity=0.658  Sum_probs=228.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..+|.+.+.||+|+||.||+|+++.+++.||+|.+....     ....+|+.++++++||||+++++++.     .+...
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   79 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSL   79 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeE
Confidence            357999999999999999999999999999999885322     23457999999999999999999883     33458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||+++++...+..   ....+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        80 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  154 (309)
T cd07872          80 TLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (309)
T ss_pred             EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECccccceec
Confidence            89999999887666543   23457889999999999999999998 9999999999999999887 7999999998754


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+.++.+..+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence            3222 123346789999999987666689999999999999999999999999998888999999888888776654322


Q ss_pred             --CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 --NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                        .+..+.++.....++.... +.+++++++||.+||..||.+|+|+.++|+||||+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence              1122233333223332222 45789999999999999999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.1e-48  Score=365.54  Aligned_cols=286  Identities=31%  Similarity=0.538  Sum_probs=226.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  121 (390)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            35899999999999999999999999999999998542      1234579999999999999999988743322 2334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+|+||||+++++...+.      ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCC-cEEEEeCCCcc
Confidence            578999999998766553      347888899999999999999998 9999999999999999888 79999999997


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.+++..++.+..+.+..+.
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            6544433445678999999999965 458999999999999999999999999999999999999888888766544432


Q ss_pred             cC----------cccccCCCCC---CCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          282 PN----------YTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       282 ~~----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      ..          +..+.+....   ..++........+..+++||.+||+.||.+|||+.++|+||||....++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  328 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  328 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence            21          1111110000   00111111223467899999999999999999999999999998765544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.9e-48  Score=352.21  Aligned_cols=279  Identities=31%  Similarity=0.553  Sum_probs=220.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhC---CCCceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      +|++.+.||+|+||.||+|+++.+++.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5999999999999999999999999999999885321      2234677777665   799999999988655444556


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++++|||+.+++..++....  ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            688999999988877665422  2458999999999999999999998 9999999999999999888 79999999997


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ............+|..|+|||++.+. .++.++||||+||++|+|++|.+||.+....+.+.++....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            66444444456779999999999654 48999999999999999999999999988888888888877766554432210


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                       ......+......++.... +.++..+.+||.+||++||++|||+.+++.||||
T Consensus       236 -~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 -TLPRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             -cccccccCCCCCCchHHhC-cCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence             0000111111122222222 4578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=360.57  Aligned_cols=256  Identities=32%  Similarity=0.558  Sum_probs=217.8

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCC-CCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  119 (390)
                      -...|.+.+.||.|.||.||+|.++.+|+.||+|++.+..       ....+|+.+|+++. |||||.++++|     +.
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~  107 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED  107 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence            3457999999999999999999999999999999986543       25678999999998 99999999999     34


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC---CcEEEe
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLC  195 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~~vkl~  195 (390)
                      ..++++|||+|.| .|.+.+...     .+++..+..++.|++.|++|||+ .||+||||||+|+|+....   ..+|++
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEe
Confidence            4468999999995 555555432     39999999999999999999998 9999999999999996442   279999


Q ss_pred             ecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          196 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       196 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      |||++.....+......+||+.|+|||++.. ..|+..+|+||+|+++|.|++|.+||.+.+......++.+.       
T Consensus       182 DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-------  253 (382)
T KOG0032|consen  182 DFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-------  253 (382)
T ss_pred             eCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-------
Confidence            9999998777666778899999999999953 56999999999999999999999999999988887766652       


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                .+   .+...+|     +.++..+++||++||..||.+|+|+.++|+|||++...
T Consensus       254 ----------~~---~f~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  254 ----------DF---DFTSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             ----------CC---CCCCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence                      11   1112222     56899999999999999999999999999999998753

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-47  Score=363.33  Aligned_cols=284  Identities=35%  Similarity=0.586  Sum_probs=224.8

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+++++.++|+||+++++++...........|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            378899999999999999999999999999988532      12345799999999999999999988543322223678


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+.+++...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            9999999887665543    4578999999999999999999998 9999999999999999888 79999999997543


Q ss_pred             cCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          205 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       205 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+...++.+..+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            221  123346788999999997766689999999999999999999999999999999999999999888766543221


Q ss_pred             Ccccc--cCCCCCC-CCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTEF--KFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      .....  ..+.... ......+....++++.+||.+||++||++|||+.++|+||||++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            11000  0000000 0000112345688999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-49  Score=327.74  Aligned_cols=252  Identities=29%  Similarity=0.456  Sum_probs=218.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      .-+.|.+++.||+|-||.||+|+.+.++-.||+|++.+..       ....+|++|...|+||||+++|++|     -+.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence            3458999999999999999999999999999999985432       3445899999999999999999999     444


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+|+++||.. |.+...++..  ...++++.....++.|++.||.|+|. ++++||||||+|+|++.++ .+||+|||.
T Consensus        95 ~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~-~lkiAdfGw  170 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAG-ELKIADFGW  170 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCC-CeeccCCCc
Confidence            55899999998 5776666532  24679999999999999999999998 9999999999999999998 799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.... .....+.+||..|.+||+..+ ..++..+|+|++|++.||++.|.+||...+..+.+++|.+.           
T Consensus       171 sV~~p-~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-----------  237 (281)
T KOG0580|consen  171 SVHAP-SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-----------  237 (281)
T ss_pred             eeecC-CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----------
Confidence            86544 556678899999999999955 45899999999999999999999999998888888888773           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                            .+.            ++..++.+++|||.+||.++|.+|++..|++.|||+...
T Consensus       238 ------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 ------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                  222            335789999999999999999999999999999999764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-48  Score=354.04  Aligned_cols=248  Identities=27%  Similarity=0.412  Sum_probs=207.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|+||.||+|.++.+++.||+|++...       .....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            699999999999999999999999999999998532       12345799999999999999998877     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+.+ +|.+++..    ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            899999985 67666643    4568999999999999999999998 9999999999999999887 799999999976


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...              
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--------------  213 (291)
T cd05612         151 LRD--RTWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--------------  213 (291)
T ss_pred             ccC--CcccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence            533  2334578999999999955 44899999999999999999999999988766655555431              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                         ..            .++..+++.+++||++||+.||.+|++     +.++++||||+.+.+
T Consensus       214 ---~~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         214 ---KL------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             ---Cc------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence               00            122456889999999999999999995     999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-49  Score=357.06  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=225.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      -|.+.+.||+|.|+.|-+|+|..||+.||||++.+.+      ....+|++.|+.++|||||++|++.     +....+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTKly   93 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTKLY   93 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccceEE
Confidence            5999999999999999999999999999999996543      3345899999999999999999987     3333489


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ||+|+-++ +|.+++-.+   ...+.+..+++++.||+.|+.|+|+ ..+|||||||+|+.+-+.-+-|||+|||++..+
T Consensus        94 LiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            99999885 887777654   4679999999999999999999998 999999999999987666558999999999999


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ..+....+.+|+..|.|||++++..+..+++||||||+|||.|+||++||...++.+.+..|+..               
T Consensus       170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC---------------  234 (864)
T KOG4717|consen  170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC---------------  234 (864)
T ss_pred             CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc---------------
Confidence            99999999999999999999999987789999999999999999999999999999999888763               


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                        .+.            +|..++.+++|||.+||..||.+|.+.+++..|+|++.+..
T Consensus       235 --KYt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  235 --KYT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             --ccc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence              222            33578999999999999999999999999999999998754

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.9e-47  Score=360.43  Aligned_cols=284  Identities=32%  Similarity=0.546  Sum_probs=224.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            58999999999999999999999999999999885421      233479999999999999999998754322 22345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .|+||||+++++...+.      ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        97 ~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~-~~kl~Dfg~~~~  168 (355)
T cd07874          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_pred             eEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCC-CEEEeeCccccc
Confidence            78999999988765553      357888899999999999999998 9999999999999999888 799999999986


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.+..+....+.+
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            5444444556789999999999654 589999999999999999999999999998888888888888887665544332


Q ss_pred             Cc----------ccccCCCCCC---CCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          283 NY----------TEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       283 ~~----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ..          ....++....   .+.........+.++++||.+||..||++|||+.|+|+||||....++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            21          1111111100   011111223356789999999999999999999999999999876443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-47  Score=357.38  Aligned_cols=249  Identities=30%  Similarity=0.437  Sum_probs=207.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...|++.+.||+|+||.||+|+++.+++.||+|++....       ....+|+.+++.++||||+++++++.     ...
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence            458999999999999999999999999999999985432       23457999999999999999999883     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ++|+||||+.+ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  165 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKG-HVKVTDFGFA  165 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence            58899999985 66555543    4578899999999999999999998 9999999999999999888 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...            
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------  230 (329)
T PTZ00263        166 KKVPD--RTFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------------  230 (329)
T ss_pred             eEcCC--CcceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence            76532  23346789999999999654 4799999999999999999999999887766555544321            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~  340 (390)
                           ...            ++..++..+++||++||+.||.+|++     ++++++||||.+..
T Consensus       231 -----~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        231 -----RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             -----CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence                 011            12347889999999999999999997     79999999998754

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-47  Score=359.59  Aligned_cols=284  Identities=35%  Similarity=0.619  Sum_probs=227.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      .+|.+.+.||.|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            47999999999999999999999999999999986432      223479999999999999999998743221 22234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .|++++++++++..++.     ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||+++.
T Consensus        95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCC-CEEEcCCcccee
Confidence            68999999888876654     3569999999999999999999998 9999999999999999888 799999999976


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+.....
T Consensus       168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            533  334567899999999997656689999999999999999999999999888888888888888777665544322


Q ss_pred             Cccc---ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          283 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       283 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      ....   ...+......+...+ ...++.+.+||.+||..||++|||+.++|+||||....++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             hhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence            1110   011222222222222 34678899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.2e-47  Score=350.94  Aligned_cols=256  Identities=23%  Similarity=0.370  Sum_probs=206.4

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+++++++.     ...+.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence            3889999999999999999999999999999885321       12347999999999999999998883     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ++||||+++ +|...+...  ....+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRG-HIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeCCCcEE
Confidence            899999985 665554432  23468999999999999999999998 9999999999999999887 799999999976


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...+..           
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------  219 (285)
T cd05631         152 IPEGETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-----------  219 (285)
T ss_pred             cCCCCeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-----------
Confidence            544444445678999999999965 45899999999999999999999999876643333222221100           


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                                    ....++..+++++.+||++||..||.+|++     ++++++||||+.+++
T Consensus       220 --------------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         220 --------------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             --------------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                          001123467999999999999999999997     899999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-49  Score=341.45  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=215.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhh-------HHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-------KNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+.|..+++||+|.||+|-+|+.+.+++.||+|+++++...       ...|-++|+..+||.+..+...|.     ...
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-----t~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ-----TQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc-----cCc
Confidence            35799999999999999999999999999999998765322       235889999999999999888873     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+||||++| .|...+.    ....+++...+++...|+.||.|||+ ++||+||||.+|+|+|.||+ +||+|||++
T Consensus       242 rlCFVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGH-IKitDFGLC  315 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGH-IKITDFGLC  315 (516)
T ss_pred             eEEEEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCc-eEeeecccc
Confidence            48999999996 4433333    25679999999999999999999998 99999999999999999995 999999999


Q ss_pred             ccc-ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.- ..+....+++|||.|+|||++. ...|+.++|+|.+|+++|||+||+.||...+....+..|+..           
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------  383 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------  383 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence            853 3455567789999999999994 556999999999999999999999999998877777776652           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCCCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPN  343 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~~~  343 (390)
                            +++            ||.+++++++.|+..+|.+||.+|..     +.++.+|+||..+++..
T Consensus       384 ------d~k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 ------DLK------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             ------hcc------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                  233            34689999999999999999999994     78999999999987643

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.2e-47  Score=348.53  Aligned_cols=282  Identities=32%  Similarity=0.615  Sum_probs=226.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      -.+|.+.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++.     ...+.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence            357999999999999999999999999999999885322     23457999999999999999999983     34458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||+++++...+..   ....+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||++...
T Consensus        80 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence            89999999888666643   23568899999999999999999998 9999999999999999887 7999999998754


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            3222 122345688999999987666688999999999999999999999999888888888888887777665543211


Q ss_pred             --CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          283 --NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       283 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                        .+.....+....... ......+++++++||.+||+.||.+|||+.++|+||||+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence              112222222211111 1123467899999999999999999999999999999988764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.6e-46  Score=366.27  Aligned_cols=282  Identities=22%  Similarity=0.383  Sum_probs=212.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCC------ceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHP------NIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++....   .....|+.+++.++|.      ++++++++|..    .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            458999999999999999999999999999999985432   2334688888877554      57788777632    2


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC---------
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---------  190 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---------  190 (390)
                      ..++|+|||+++++|..++..    .+.+++..++.++.||+.||+|||+..|||||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            345789999998888776653    3578999999999999999999996249999999999999986542         


Q ss_pred             ------cEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 016401          191 ------QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  264 (390)
Q Consensus       191 ------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  264 (390)
                            .+||+|||.+...  ........||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  4999999988543  2233456789999999999654 489999999999999999999999999988888888


Q ss_pred             HHHHhCCCCHHHHhhcCcC-----ccccc--CCCCCCCCccccc------ccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          265 IIKVLGTPTREEIKCMNPN-----YTEFK--FPQIKPHPWHKVF------QKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                      +.+.++.++..........     +....  .+......+....      ....++.+.|||++||++||++|||++|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            8888887765443211000     00000  0000000000000      001246788999999999999999999999


Q ss_pred             cCCcccccCC
Q 016401          332 VHPFFDELRD  341 (390)
Q Consensus       332 ~hp~f~~~~~  341 (390)
                      +||||+....
T Consensus       437 ~Hp~~~~~~~  446 (467)
T PTZ00284        437 THPYVLKYYP  446 (467)
T ss_pred             cCccccccCC
Confidence            9999987543

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-47  Score=364.18  Aligned_cols=276  Identities=24%  Similarity=0.350  Sum_probs=212.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....  ....+|+.+++.++||||++++++|.     ...+.|+|||
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEEe
Confidence            3579999999999999999999999999999997543  34568999999999999999999883     3345789999


Q ss_pred             cccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC--
Q 016401          129 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--  206 (390)
Q Consensus       129 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~--  206 (390)
                      ++.+++...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|......  
T Consensus       164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA  237 (391)
T ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence            999887666543    3568899999999999999999998 8999999999999999887 7999999998643221  


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHHHhh
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+       ...++..++...+.++.+....
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            22234578999999999965 458999999999999999999998775432       3456666777666544321000


Q ss_pred             ----cCcCc----cc-ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          280 ----MNPNY----TE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       280 ----~~~~~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                          +...+    .. ...+. ....|...  ..++.++.+||.+||++||++|||+.|+|+||||+.+..
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPG-SRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCC-CCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence                00000    00 00000 00111111  135778999999999999999999999999999988643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.8e-48  Score=357.66  Aligned_cols=245  Identities=27%  Similarity=0.443  Sum_probs=201.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      +.||+|+||.||+|+++.+|+.||||++....       ....+|+.+++.++||||+++++++     ....++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986432       2234689999999999999999888     33446889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc-C
Q 016401          129 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  206 (390)
Q Consensus       129 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~-~  206 (390)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9985 56555443    4678999999999999999999998 9999999999999999888 799999999875322 2


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  286 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (390)
                      .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  211 (323)
T ss_pred             CcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence            23345678999999999955 45899999999999999999999999887655544433220                 0


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                      .            .++..+++++.+||++||..||++||     ++.++++||||+.+.+
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             C------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            1            12346799999999999999999999     8999999999988643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.8e-48  Score=335.24  Aligned_cols=286  Identities=34%  Similarity=0.583  Sum_probs=228.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCC----cEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ....|++.+.||+|.||.||+|..++++    +.||||.++.++      ....||+.+++.++|||++.+..+|+..  
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--   99 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--   99 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc--
Confidence            3458999999999999999999665543    379999997552      3345899999999999999999998643  


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhh-cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC----CCcE
Q 016401          118 KEELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQL  192 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~----~~~v  192 (390)
                        +..+++++||.+.+|+.++..+... ...++...++.+++||+.|+.|||+ +=|+||||||.|||+..+    | .|
T Consensus       100 --d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG-~V  175 (438)
T KOG0666|consen  100 --DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERG-RV  175 (438)
T ss_pred             --CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccC-ee
Confidence              5568999999999999999866543 3468889999999999999999998 789999999999999877    6 79


Q ss_pred             EEeecCCccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------hH
Q 016401          193 KLCDFGSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---------GV  259 (390)
Q Consensus       193 kl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---------~~  259 (390)
                      ||+|||+++.+.+.-..    ...+.|.+|+|||.+++...|+.+.|||++|||+.||++-.+.|.+..         ..
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            99999999877554322    345669999999999999999999999999999999999999998643         35


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcC--cCcc----cccCCCCCCCCcccccc--cCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          260 DQLVEIIKVLGTPTREEIKCMN--PNYT----EFKFPQIKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                      +++.+|++.+|.|....|..+.  +.+.    .+.........+..++.  ..-++.+.+|+.+||++||-+|+|++++|
T Consensus       256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl  335 (438)
T KOG0666|consen  256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL  335 (438)
T ss_pred             HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence            7899999999999987765442  1110    01101111111122221  22356699999999999999999999999


Q ss_pred             cCCccccc
Q 016401          332 VHPFFDEL  339 (390)
Q Consensus       332 ~hp~f~~~  339 (390)
                      +|+||..-
T Consensus       336 eh~yF~~d  343 (438)
T KOG0666|consen  336 EHPYFTED  343 (438)
T ss_pred             cccccccC
Confidence            99999863

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.5e-47  Score=350.28  Aligned_cols=277  Identities=29%  Similarity=0.516  Sum_probs=209.0

Q ss_pred             eeeeeecCceEEEEEEEc--CCCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           55 EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      .++||+|+||.||+|+++  .+++.||+|.+....  ....+|+.++++++||||+++++++..   .....+|++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEecc
Confidence            467999999999999975  467899999886432  345689999999999999999998743   2334588999999


Q ss_pred             cccHHHHHHHhhh-----hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc----CCCCcEEEeecCCcc
Q 016401          131 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAK  201 (390)
Q Consensus       131 ~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~----~~~~~vkl~Dfg~a~  201 (390)
                      ++++..++.....     ....+++..++.++.||+.||+|||+ .||+||||||+|||++    .++ .+||+|||++.
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence            9988777654321     12358899999999999999999998 9999999999999994    334 79999999997


Q ss_pred             ccccCC----CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHH
Q 016401          202 VLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKV  268 (390)
Q Consensus       202 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~i~~~  268 (390)
                      ......    ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.....         .+++..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            653322    123457799999999997766689999999999999999999999975432         3567778888


Q ss_pred             hCCCCHHHHhhcCcCcc------ccc---CCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          269 LGTPTREEIKCMNPNYT------EFK---FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~~~------~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      ++.+....+........      .+.   ........+........+.++.+||++||++||.+|+|++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            88777665543321100      000   000000000001112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.7e-47  Score=357.22  Aligned_cols=253  Identities=27%  Similarity=0.445  Sum_probs=204.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|+||+||+|+++.+++.||||++.+..       ....+|+.++..++|+||+++++.+     .+..++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            6999999999999999999999999999999986432       2345699999999999999999988     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++ +|..++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            899999985 66666543    4678999999999999999999998 9999999999999999888 799999999875


Q ss_pred             cccCC------------------------------------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHH
Q 016401          203 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  246 (390)
Q Consensus       203 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  246 (390)
                      .....                                    .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence            42210                                    01235789999999999654 589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc---
Q 016401          247 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL---  323 (390)
Q Consensus       247 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~---  323 (390)
                      ++|.+||.+.+..+.+.++.....               ...+|.          ...+++++++||.+|+. +|.+   
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKE---------------TLIFPP----------EVPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcC---------------cccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence            999999998887766666553100               011111          02368999999999875 5554   


Q ss_pred             CCCHHHHhcCCcccccCC
Q 016401          324 RCTALEACVHPFFDELRD  341 (390)
Q Consensus       324 R~s~~~~l~hp~f~~~~~  341 (390)
                      ||+++++++||||+++.+
T Consensus       284 r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         284 APGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCCHHHHhCCCCCCCCCH
Confidence            579999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-46  Score=348.33  Aligned_cols=286  Identities=34%  Similarity=0.657  Sum_probs=227.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+|.+.+.||+|++|.||+|.+..+|+.||||.+...     .....+|+.+++.++|+||+++++++...........|
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            4799999999999999999999999999999988532     12234699999999999999999887544434445678


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +++||+++++...+.     ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        85 lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~  157 (336)
T cd07849          85 IVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD  157 (336)
T ss_pred             EEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence            999999988766554     3568999999999999999999998 9999999999999999888 79999999987653


Q ss_pred             cCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          205 KGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       205 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .....    ....+|+.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+...++.+..+.+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32211    23467889999999866556899999999999999999999999998888888888888888777665443


Q ss_pred             CcCccc-c--cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          281 NPNYTE-F--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       281 ~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      ...... +  ..+.....++... .+..++++.+||.+||..||++|||+.++++||||..+.++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~  302 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS  302 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCC
Confidence            211110 0  1111112222221 135688999999999999999999999999999999887653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=351.93  Aligned_cols=256  Identities=30%  Similarity=0.482  Sum_probs=209.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++     ....+.
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999986432       2344799999999999999999888     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++ +|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            899999975 77666643    4568999999999999999999998 9999999999999999888 799999999975


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......           
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------  216 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-----------  216 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence            533  33456789999999999655 5899999999999999999999999988776665554431100           


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                          ...+...      .....+++++.+||.+||..+|.+|+++.++++||||.++..
T Consensus       217 ----~~~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         217 ----LQRPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             ----ccCCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence                0001000      000257899999999999999999999999999999998643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.6e-47  Score=353.50  Aligned_cols=251  Identities=29%  Similarity=0.429  Sum_probs=207.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCC-cEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      .-.+|.+.+.||+|+||.||+|.++.++ ..||+|++....       ....+|+.+++.++||||+++++++     ..
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence            3458999999999999999999976654 689999885321       2334799999999999999999988     33


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ..++|+||||+.+ +|..++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~ikL~DFG  176 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDG-FIKMTDFG  176 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEecCC
Confidence            4458899999974 67666543    4578999999999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          199 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       199 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ++.....  ......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+...          
T Consensus       177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~----------  243 (340)
T PTZ00426        177 FAKVVDT--RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG----------  243 (340)
T ss_pred             CCeecCC--CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC----------
Confidence            9976532  2345678999999999965 44899999999999999999999999988766555555431          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                             ..            .++..+++.++++|++||+.||++|+     ++.++++||||.++.+
T Consensus       244 -------~~------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        244 -------II------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             -------CC------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                   01            12245789999999999999999996     8999999999998653

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-46  Score=356.07  Aligned_cols=253  Identities=32%  Similarity=0.519  Sum_probs=205.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            6999999999999999999999999999999986431       2245799999999999999999988     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+.+ +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            899999975 66555543    4568999999999999999999998 9999999999999999988 799999999865


Q ss_pred             cccCCC---------------------------------------CcceeeccccccchhhcCCCCCCCchhHHHHHHHH
Q 016401          203 LVKGEP---------------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVM  243 (390)
Q Consensus       203 ~~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  243 (390)
                      ......                                       ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHH
Confidence            422110                                       112468999999999955 4589999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc
Q 016401          244 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL  323 (390)
Q Consensus       244 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  323 (390)
                      |+|++|.+||.+.+..+....+....               ..+.++.          ...+++++++||++||. ||.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~----------~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWK---------------ETLQFPD----------EVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCC---------------CccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence            99999999999887766555544310               0011110          02468999999999997 9999


Q ss_pred             CCC---HHHHhcCCcccccCC
Q 016401          324 RCT---ALEACVHPFFDELRD  341 (390)
Q Consensus       324 R~s---~~~~l~hp~f~~~~~  341 (390)
                      |++   +.++++||||++..+
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCH
Confidence            998   999999999988653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.9e-46  Score=339.46  Aligned_cols=276  Identities=35%  Similarity=0.560  Sum_probs=216.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|++|.||+|+++.+|+.||+|.+....      ....+|+.+++.++|+||+++++++.     +..+.|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence            4899999999999999999999999999999885321      23457999999999999999999883     334588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +++||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            9999999887665543   23568999999999999999999998 9999999999999999887 79999999987543


Q ss_pred             cCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          205 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       205 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... .....++..|+|||.+.+...++.++||||+||++|+|++|..| |.+.+..+.+..+.+..+.+....+..+..
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            3221 22345688999999987766689999999999999999998877 556666677777777777766554433221


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      .......+............+.+++++++||++||..||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111111111111111112234688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-47  Score=339.63  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=220.8

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      .-..+-+|++.+.||+|.||+|-+|+....|+.||||.++++.       ..+.+|++||..|+||||+.+|++|     
T Consensus        48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----  122 (668)
T KOG0611|consen   48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----  122 (668)
T ss_pred             ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----
Confidence            3345569999999999999999999999999999999886543       2346899999999999999999999     


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      ++...+.+||||.. |.|++++..    .+.+++..++.+++||..|+.|+|. ++++|||||.+|||+|.++ ++||+|
T Consensus       123 ENkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~-NiKIAD  196 (668)
T KOG0611|consen  123 ENKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNN-NIKIAD  196 (668)
T ss_pred             cCCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCC-Ceeeec
Confidence            44445889999998 577777765    5789999999999999999999998 9999999999999999988 899999


Q ss_pred             cCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          197 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       197 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ||++..+.......+++|+|.|.+||++.+..+-++.+|-||||++||.|+.|..||.|.+....+.+|...        
T Consensus       197 FGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G--------  268 (668)
T KOG0611|consen  197 FGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG--------  268 (668)
T ss_pred             cchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--------
Confidence            999988877777889999999999999977776789999999999999999999999999877777776552        


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                               .+.-             +.-+.++.-||+.||..||++|.|+.++..|=|..
T Consensus       269 ---------aYrE-------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  269 ---------AYRE-------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ---------cccC-------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                     1111             34578899999999999999999999999998874

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-47  Score=358.52  Aligned_cols=252  Identities=30%  Similarity=0.500  Sum_probs=202.8

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|+||.||+|.++.+++.||||++.+..       ....+|+++++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence            6999999999999999999999999999999885432       2345699999999999999999988     344568


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||++ ++|..++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            99999997 477666543    3568999999999999999999998 9999999999999999888 799999999863


Q ss_pred             cccCC------------------------------------------------CCcceeeccccccchhhcCCCCCCCch
Q 016401          203 LVKGE------------------------------------------------PNVSYICSRYYRAPELIFGATEYTTAI  234 (390)
Q Consensus       203 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  234 (390)
                      .....                                                .....+||+.|+|||++.+ ..++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCce
Confidence            21100                                                0012468999999999965 4589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHH
Q 016401          235 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  314 (390)
Q Consensus       235 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  314 (390)
                      |||||||++|||++|.+||.+.+..+.+..+....               ....++.          ...++.++++||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dli~  284 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR---------------ETLYFPD----------DIHLSVEAEDLIR  284 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC---------------CccCCCC----------CCCCCHHHHHHHH
Confidence            99999999999999999998887766665554310               0011111          0246899999999


Q ss_pred             HhcccCCCcC---CCHHHHhcCCcccccC
Q 016401          315 RFFQYSPNLR---CTALEACVHPFFDELR  340 (390)
Q Consensus       315 ~~L~~dP~~R---~s~~~~l~hp~f~~~~  340 (390)
                      +||. +|.+|   +++.+++.||||++..
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            9998 77765   5999999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.5e-46  Score=355.90  Aligned_cols=254  Identities=28%  Similarity=0.469  Sum_probs=201.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .|++++.||+|+||+||+|+++.+++.||||++....       ....+|+.+++.++|+||+++++++.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            5899999999999999999999999999999985432       23457999999999999999999883     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++ +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            899999975 67666543    3568999999999999999999998 9999999999999999887 799999998753


Q ss_pred             cccCC------------------------------------------------CCcceeeccccccchhhcCCCCCCCch
Q 016401          203 LVKGE------------------------------------------------PNVSYICSRYYRAPELIFGATEYTTAI  234 (390)
Q Consensus       203 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  234 (390)
                      .....                                                ......||+.|+|||++.+ ..++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCcc
Confidence            21000                                                0123468999999999965 4589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHH
Q 016401          235 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  314 (390)
Q Consensus       235 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  314 (390)
                      |||||||++|||++|.+||...+..+....+.....               ....+.          ...+++++++||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------TLHIPP----------QVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------ccCCCC----------CCCCCHHHHHHHH
Confidence            999999999999999999988776555544432100               011110          1247899999999


Q ss_pred             HhcccCC--CcCCCHHHHhcCCcccccCC
Q 016401          315 RFFQYSP--NLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       315 ~~L~~dP--~~R~s~~~~l~hp~f~~~~~  341 (390)
                      +||..++  ..|+++.++++||||+++.+
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            9765544  45999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.6e-46  Score=356.10  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=203.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .|++++.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++|+||+++++++.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            5999999999999999999999999999999985432       23457999999999999999999983     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++ +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            899999985 66665543    3568899999999999999999998 9999999999999999888 799999999753


Q ss_pred             cccC------------------------------------------------CCCcceeeccccccchhhcCCCCCCCch
Q 016401          203 LVKG------------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAI  234 (390)
Q Consensus       203 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~  234 (390)
                      ....                                                ......+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001234689999999999654 589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHH
Q 016401          235 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  314 (390)
Q Consensus       235 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  314 (390)
                      |||||||++|||++|++||.+.+..+....+.....               ....+          ....+++++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p----------~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------SLHIP----------PQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------CcCCC----------CcccCCHHHHHHHH
Confidence            999999999999999999998876665555443100               00111          01357899999999


Q ss_pred             HhcccCCCcCCC---HHHHhcCCcccccCC
Q 016401          315 RFFQYSPNLRCT---ALEACVHPFFDELRD  341 (390)
Q Consensus       315 ~~L~~dP~~R~s---~~~~l~hp~f~~~~~  341 (390)
                      +|+ .||++|++   +.++++||||+.+..
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            986 59999997   999999999988643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-46  Score=352.41  Aligned_cols=253  Identities=32%  Similarity=0.550  Sum_probs=208.4

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|.+.+.||+|+||.||+|++..+++.||||++....       ....+|+.++..++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            6999999999999999999999999999999985432       2345799999999999999999887     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+.+ +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            899999974 77666654    3678999999999999999999998 9999999999999999988 799999999876


Q ss_pred             cccCC------------------------------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 016401          203 LVKGE------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  252 (390)
Q Consensus       203 ~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  252 (390)
                      .....                              ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence            54332                              12345689999999999654 589999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-HHHHh
Q 016401          253 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEAC  331 (390)
Q Consensus       253 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-~~~~l  331 (390)
                      |.+.+..+...++....               .....+.          ...+++++.+||.+||. ||.+|++ +.+++
T Consensus       230 f~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         230 FYSDTLQETYNKIINWK---------------ESLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCHHHHHHHHhccC---------------CcccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            99887665555544310               0011111          02368999999999997 9999999 99999


Q ss_pred             cCCcccccCC
Q 016401          332 VHPFFDELRD  341 (390)
Q Consensus       332 ~hp~f~~~~~  341 (390)
                      +||||+++.+
T Consensus       284 ~hp~~~~~~~  293 (350)
T cd05573         284 SHPFFKGIDW  293 (350)
T ss_pred             cCCCcCCCCH
Confidence            9999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.3e-46  Score=338.60  Aligned_cols=276  Identities=34%  Similarity=0.634  Sum_probs=216.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .|++.+.||+|++|.||+|++..+++.||||++...      .....+|+.+++.++||||+++++++.     ...+.|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            489999999999999999999999999999988532      123457999999999999999999884     334588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+++++...+.... ....+++..++.++.||+.||+|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999988776665422 23568999999999999999999998 9999999999999999888 79999999987543


Q ss_pred             cCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .... .....+++.|+|||++.+...++.++|+|||||++|+|++|++||.+.+..+....+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            2211 123356888999999876666789999999999999999999999998888877777777666654433221100


Q ss_pred             cccc--cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          284 YTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       284 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                       ..+  ..+......... ....+++++++||++||..||++|||+.++++||||
T Consensus       233 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 -PDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             -HHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence             000  011111111111 124578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=325.36  Aligned_cols=259  Identities=30%  Similarity=0.473  Sum_probs=210.0

Q ss_pred             ccEEEe-eeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ..|.+. ++||-|-.|+|..|.++.|++.+|+|++.. ....++|+++.... .|||||.++++|.... .+..++-+||
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVm  138 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVM  138 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeee
Confidence            467765 478999999999999999999999998754 44456899987776 6999999999984433 4567788999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC--CCcEEEeecCCccccc
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLV  204 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~Dfg~a~~~~  204 (390)
                      |.++| .|.+-++.  +..+.+++..+..|+.||+.|+.|||+ .+|.||||||+|+|....  ...+||+|||+|+...
T Consensus       139 E~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  139 ECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             ecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            99996 55444443  335679999999999999999999998 999999999999999644  2369999999999876


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHhhc
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV----DQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ......+.+.||+|.|||++ +...|+..+|+||+||++|-|+||.+||......    .+-.+|..             
T Consensus       216 ~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~-------------  281 (400)
T KOG0604|consen  216 EPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT-------------  281 (400)
T ss_pred             CCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc-------------
Confidence            66666777889999999999 6667999999999999999999999999875532    22222222             


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                          ..+.+|+   ..|     ..+|.+++|+|+++|..+|.+|+|+.++++|||+...
T Consensus       282 ----gqy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  282 ----GQYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             ----cCccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence                1222222   222     4579999999999999999999999999999999764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-46  Score=346.34  Aligned_cols=242  Identities=31%  Similarity=0.529  Sum_probs=198.9

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.     ...+.|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence            699999999999999999999999885421       22346999999999999999998883     344588999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC-CC
Q 016401          131 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  208 (390)
Q Consensus       131 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~-~~  208 (390)
                      ++ +|...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            85 66555543    4578999999999999999999998 9999999999999999888 7999999998753222 22


Q ss_pred             CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 016401          209 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  288 (390)
Q Consensus       209 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  288 (390)
                      .....||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+.+..+...                 .. 
T Consensus       150 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~-  210 (312)
T cd05585         150 TNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PL-  210 (312)
T ss_pred             cccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CC-
Confidence            334568999999999965 45899999999999999999999999887766555444321                 01 


Q ss_pred             CCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC---CHHHHhcCCcccccC
Q 016401          289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELR  340 (390)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---s~~~~l~hp~f~~~~  340 (390)
                                 .++..+++++++||.+||..||++|+   ++.++++||||....
T Consensus       211 -----------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         211 -----------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             -----------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                       12246789999999999999999997   589999999998763

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.7e-46  Score=347.92  Aligned_cols=244  Identities=27%  Similarity=0.440  Sum_probs=200.0

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      +.||+|+||.||+|+++.+|+.||+|++....       ....+|+.+++.++||||+++++++.     ....+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence            46999999999999999999999999986431       22346999999999999999998883     3345889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC-
Q 016401          129 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  206 (390)
Q Consensus       129 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~-  206 (390)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9985 55444432    4578999999999999999999998 9999999999999999887 7999999998753222 


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  286 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (390)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E  211 (323)
T ss_pred             CccccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            22234568999999999955 45899999999999999999999999887765555444321                 0


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccC
Q 016401          287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  340 (390)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~  340 (390)
                      ..            ++..+++++.+||.+||..||++|+     ++.++++||||....
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            11            2246789999999999999999998     899999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.8e-46  Score=346.47  Aligned_cols=245  Identities=30%  Similarity=0.520  Sum_probs=199.7

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|+++.+++.||||++.+..       ....+|..++..+ +||||+++++++     .....+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999986432       2233577788776 799999999988     3344588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc-
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  205 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~-  205 (390)
                      ||+++ +|...+..    ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99985 66544433    4578999999999999999999998 9999999999999999888 799999999875322 


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-----------------  211 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------------  211 (320)
T ss_pred             CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            223344568999999999954 45899999999999999999999999988776665555431                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH------HHHhcCCcccccCC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  341 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~------~~~l~hp~f~~~~~  341 (390)
                      ..            .++..+++++.+||++||+.||++|+++      +++++||||+.+.+
T Consensus       212 ~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         212 EV------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             CC------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            00            1123578999999999999999999998      89999999988753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.3e-46  Score=349.93  Aligned_cols=259  Identities=28%  Similarity=0.484  Sum_probs=208.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||.||+|+++.+++.||+|++.+.       .....+|+.+++.++||||+++++++     ...
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            446899999999999999999999999999999998532       22345799999999999999999988     344


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .++|+||||+++ +|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~-~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEEeccc
Confidence            568899999974 77766643     458899999999999999999998 9999999999999999888 799999999


Q ss_pred             ccccccCCC--CcceeeccccccchhhcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKGEP--NVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +........  .....||+.|+|||++.+.   ..++.++|+||+||++|+|++|.+||.+.+....+.++.....    
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~----  264 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN----  264 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----
Confidence            976533221  2345689999999999543   2378999999999999999999999998877666665544210    


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc--CCCHHHHhcCCcccccCCCC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~s~~~~l~hp~f~~~~~~~  343 (390)
                                 ...++.          ...++..++++|.+||..++.+  |+++.++++||||+...+.+
T Consensus       265 -----------~~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~~  314 (370)
T cd05621         265 -----------SLNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNW  314 (370)
T ss_pred             -----------ccCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcCh
Confidence                       011111          0246899999999999866544  88999999999998754433

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-48  Score=348.74  Aligned_cols=252  Identities=27%  Similarity=0.436  Sum_probs=209.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ....|+..++||+|+||.||+|.+..+++.||+|++.-+.     ...++|+.+|..++++||.++|+.|+....     
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----   85 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----   85 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----
Confidence            4457999999999999999999999999999999985432     345689999999999999999999965544     


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ++++||||.| ++..++..    ...+.+..+..++++++.||.|||. .+.+|||||+.|||+..++ .|||+|||.+.
T Consensus        86 LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g-~vkl~DfgVa~  159 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESG-DVKLADFGVAG  159 (467)
T ss_pred             HHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccC-cEEEEecceee
Confidence            8899999995 65555543    3445888889999999999999998 8999999999999999997 89999999987


Q ss_pred             ccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....... ..+++|||.|||||++. ...|+.++||||||++.+||++|.+|+....+...+..|-+             
T Consensus       160 ql~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------------  225 (467)
T KOG0201|consen  160 QLTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------------  225 (467)
T ss_pred             eeechhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-------------
Confidence            6654432 37889999999999996 45599999999999999999999999988776433332221             


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                 ..+..    +...+++.+++||..||.+||+.||+|.++|+|+|++..
T Consensus       226 -----------~~PP~----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  226 -----------SAPPR----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             -----------CCCCc----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                       11111    123679999999999999999999999999999999863

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.7e-46  Score=351.21  Aligned_cols=257  Identities=28%  Similarity=0.475  Sum_probs=209.4

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||.||+|+++.+++.||+|++.+..       ....+|+.+++.++||||+++++++     ...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            4468999999999999999999999999999999985421       2345799999999999999999888     344


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .++|+||||+++ +|..++..     ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~~kL~DfG~  188 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCC-CEEEEeccc
Confidence            568899999974 77666543     458899999999999999999998 9999999999999999888 799999999


Q ss_pred             ccccccCC--CCcceeeccccccchhhcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKGE--PNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +.......  ......||+.|+|||++.+.   ..++.++|||||||++|+|++|.+||.+.+....+.++....     
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-----  263 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK-----  263 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-----
Confidence            97653322  12345689999999998543   247899999999999999999999999887766665554310     


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc--CCCHHHHhcCCcccccCC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  341 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~s~~~~l~hp~f~~~~~  341 (390)
                                ....++.          ...++.++++||++||..+|.+  |++++++++||||+...+
T Consensus       264 ----------~~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         264 ----------NSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             ----------CcCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                      0011111          1247899999999999999988  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.5e-46  Score=346.12  Aligned_cols=248  Identities=28%  Similarity=0.473  Sum_probs=201.3

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHH---HhCCCCceeeecceeccCCCCCce
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM---QMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      |++.+.||+|+||.||+|.+..+++.||||++....       ....+|++++   +.++||||+++++++.     ...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            788999999999999999999999999999986432       2233455554   5668999999999883     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..|+||||+++ +|...+.     ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            58899999986 5544332     3578999999999999999999998 9999999999999999988 7999999998


Q ss_pred             ccccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...           
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----------  216 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-----------  216 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence            64322 222344678999999999965 45899999999999999999999999988776665554431           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                            ..            .++..+++++.+||++||..||.+||     ++.++++||||+++..
T Consensus       217 ------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         217 ------EV------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             ------CC------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                  00            12245789999999999999999999     6999999999988643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.7e-46  Score=348.53  Aligned_cols=244  Identities=26%  Similarity=0.422  Sum_probs=198.9

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     .....+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986432       2334689999999999999998887     33445889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC-
Q 016401          129 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  206 (390)
Q Consensus       129 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~-  206 (390)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9985 55444432    4568999999999999999999998 9999999999999999888 7999999998753222 


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  286 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (390)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D  211 (328)
T ss_pred             cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence            222345689999999999554 5899999999999999999999999877655444333210                 0


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccC
Q 016401          287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  340 (390)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~  340 (390)
                      .            .++..+++++.+||++||..||++|+     ++.++++||||....
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         212 I------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             c------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            1            12346789999999999999999997     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-45  Score=344.06  Aligned_cols=317  Identities=34%  Similarity=0.622  Sum_probs=238.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|.+.+.||+|+||.||+|++..+++.||||.+...      .....+|+.+++.++|+||+++++++...........
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4799999999999999999999999999999987532      1234479999999999999999998754433333457


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+++||++++|...+..    ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++...
T Consensus        85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~  158 (337)
T cd07858          85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANC-DLKICDFGLARTT  158 (337)
T ss_pred             EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence            89999999887666643    3568999999999999999999998 9999999999999999887 7999999999765


Q ss_pred             ccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ... .......++..|+|||.+.....++.++|+|||||++|+|++|++||.+.+....+..+....+.+..+.+.....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            433 2223456788999999986555589999999999999999999999998887777888888777776655432211


Q ss_pred             Cc-ccc--cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCC
Q 016401          283 NY-TEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  359 (390)
Q Consensus       283 ~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  359 (390)
                      .. ..+  ..+......+.. ..+.+++++.+||++||+.||++|||+.++++||||..++++.....    .+..+.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~----~~~~~~~~  313 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV----CQTPFSFD  313 (337)
T ss_pred             hhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc----CCCccchh
Confidence            10 000  011111111111 12468899999999999999999999999999999998876653211    11222222


Q ss_pred             CCCCCCCChHHHhhhCcHH
Q 016401          360 PPELSGIPPETINRLIPEH  378 (390)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~  378 (390)
                       .+...+..+.+++++-.+
T Consensus       314 -~~~~~~~~~~~~~~~~~~  331 (337)
T cd07858         314 -FEEDALTEEDIKELIYNE  331 (337)
T ss_pred             -hhhhhcCHHHHHHHHHHH
Confidence             223335555666555443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.8e-45  Score=338.32  Aligned_cols=284  Identities=36%  Similarity=0.574  Sum_probs=223.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...+|++.+.||+|+||.||+|.++.+|+.||+|.+....      ....+|+.++++++|+||+++++++..   ....
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCC
Confidence            3458999999999999999999999999999999885321      123479999999999999999998743   2223


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+++||||+++++..++...   ...+++..+..++.||+.||+|||+ .|++||||||+||+++.++ .+||+|||.+.
T Consensus        82 ~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~  156 (309)
T cd07845          82 SIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKG-CLKIADFGLAR  156 (309)
T ss_pred             eEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccceee
Confidence            47899999998887766542   3568999999999999999999998 9999999999999999887 79999999997


Q ss_pred             ccccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            654332 2223345788999999876666899999999999999999999999999998999888888877765544322


Q ss_pred             C--cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 N--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      .  +....+..+......+...+ ...++.+.+||++||.+||++|||+.+++.||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             hcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence            1  11111122211111111111 23688999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2e-46  Score=350.01  Aligned_cols=255  Identities=27%  Similarity=0.478  Sum_probs=208.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|.+.+.||+|+||.||+|+++.+++.||+|++....       ....+|+.+++.++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            6999999999999999999999999999999986432       2345789999999999999999887     334458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||++ ++|..++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            89999997 4776666542   3578999999999999999999998 9999999999999999888 799999999976


Q ss_pred             cccCCCC--cceeeccccccchhhcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          203 LVKGEPN--VSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       203 ~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      .......  ....||+.|+|||++..     ...++.++|||||||++|+|++|..||.+.+..+.+.++....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------  225 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ------  225 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC------
Confidence            5433222  23467999999999853     3457899999999999999999999998887766665554320      


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                               ....++.          ...+++++.+||++||. ||.+|+|+.++++||||+.+.+
T Consensus       226 ---------~~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         226 ---------RFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             ---------CccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence                     0011111          13578999999999998 9999999999999999998654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=336.59  Aligned_cols=256  Identities=24%  Similarity=0.373  Sum_probs=206.4

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .|++.+.||+|+||+||++.+..+++.||+|++....       ....+|+.+++.++||||+++++++.     ...++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence            4899999999999999999999999999999885421       22346999999999999999998873     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+.+ +|...+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            899999985 665554431  23468999999999999999999998 9999999999999999887 799999999976


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+...+...          
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----------  220 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence            544433344578999999999965 458999999999999999999999998866544433333221100          


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                                     ...++..+++.+.+||.+||..||.+||     +++++++||||.....
T Consensus       221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05605         221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF  269 (285)
T ss_pred             ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence                           0112245789999999999999999999     8999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-45  Score=336.87  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ||+|+||+||+|.++.+++.||+|.+....       .....|+.+++.++|+||+++.+++     ......|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999985432       2234699999999999999998887     3334588999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCC-
Q 016401          131 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  208 (390)
Q Consensus       131 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~-  208 (390)
                      ++ +|...+.........+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            85 6666554433345678999999999999999999998 9999999999999999887 799999999876543322 


Q ss_pred             CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 016401          209 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  288 (390)
Q Consensus       209 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  288 (390)
                      .....||+.|+|||++.+. .++.++|+||+||++|+|++|+.||...........+.......                
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  216 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------  216 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence            2345688999999999654 58999999999999999999999998654322222222111000                


Q ss_pred             CCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                               ...++..+++++.+|+.+||..||++|+     +++++++||||+...+
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence                     0012345789999999999999999999     8899999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.4e-45  Score=343.41  Aligned_cols=250  Identities=27%  Similarity=0.440  Sum_probs=202.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCC-ceeeecceeccCCCCCceE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~  122 (390)
                      .|++.+.||+|+||.||+|++..+++.||||++.+..       .....|.+++..+.|+ +|+.+++++.     ....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            4899999999999999999999999999999986432       2234688899999775 5777877773     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||||+++ +|...+..    ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            8899999985 66555543    3568899999999999999999998 9999999999999999888 79999999986


Q ss_pred             cccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+...            
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------  216 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------  216 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence            4322 2223345689999999999654 4899999999999999999999999988776666555431            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH-----HHHhcCCcccccCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  341 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~-----~~~l~hp~f~~~~~  341 (390)
                           ..            .++..++.++.+||++||..||.+|++.     .++++||||+.+.+
T Consensus       217 -----~~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         217 -----NV------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             -----CC------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                 00            1224578999999999999999999976     89999999988654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.8e-46  Score=353.59  Aligned_cols=252  Identities=28%  Similarity=0.464  Sum_probs=202.8

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .|++.+.||+|+||.||+|++..+++.||||++.+.       .....+|+++++.++|+||+++++.+     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            599999999999999999999999999999998542       22345799999999999999999988     334568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++ +|.+++..    .+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|..
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            899999974 77666654    3568899999999999999999998 9999999999999999888 799999999753


Q ss_pred             cccC--------------------------------------------CCCcceeeccccccchhhcCCCCCCCchhHHH
Q 016401          203 LVKG--------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWS  238 (390)
Q Consensus       203 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  238 (390)
                      ....                                            ......+||+.|+|||++.+ ..++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeee
Confidence            2100                                            00113468999999999955 45899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcc
Q 016401          239 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ  318 (390)
Q Consensus       239 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  318 (390)
                      |||++|+|++|+.||.+.+..+....+....               .....+          ....+++++.+||.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~----------~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIP----------SQAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCC----------CCCCCCHHHHHHHHHHh-
Confidence            9999999999999999887665544433210               000011          01357899999999977 


Q ss_pred             cCCCcCC---CHHHHhcCCcccccC
Q 016401          319 YSPNLRC---TALEACVHPFFDELR  340 (390)
Q Consensus       319 ~dP~~R~---s~~~~l~hp~f~~~~  340 (390)
                      .+|.+|+   ++.++++||||+.+.
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            5999999   999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.2e-45  Score=340.01  Aligned_cols=277  Identities=29%  Similarity=0.516  Sum_probs=206.2

Q ss_pred             eeeeeecCceEEEEEEEcC--CCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           55 EHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ...||+|+||.||+|+++.  ++..||+|.+....  ....+|+.+++.++||||+++++++..   .....+++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEeee
Confidence            3579999999999999754  56889999886532  245689999999999999999998754   2334578999999


Q ss_pred             cccHHHHHHHhhh-----hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc----CCCCcEEEeecCCcc
Q 016401          131 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAK  201 (390)
Q Consensus       131 ~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~----~~~~~vkl~Dfg~a~  201 (390)
                      ++++..++.....     ....+++..++.++.||+.||.|||+ .||+||||||+|||+.    .++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence            9988777653321     12357889999999999999999998 9999999999999993    334 79999999997


Q ss_pred             ccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHH
Q 016401          202 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKV  268 (390)
Q Consensus       202 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~i~~~  268 (390)
                      .......    .....+|+.|+|||++.+...++.++||||+||++|+|++|.+||.....         ..++..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6543221    23456799999999997666689999999999999999999999975432         3456666777


Q ss_pred             hCCCCHHHHhhcCcC--cccc----cCCCCCCCC---cccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          269 LGTPTREEIKCMNPN--YTEF----KFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      ++.+....+......  +...    .........   .........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            776665554332111  0000    000000000   0011112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.1e-45  Score=344.29  Aligned_cols=283  Identities=32%  Similarity=0.566  Sum_probs=223.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||.+.+.      .....+|+.++++++|+||+++++++..... .+..+
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            5799999999999999999999999999999988532      1233479999999999999999998753322 22345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .|+||||+.+++...+..      .+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus        96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~  167 (353)
T cd07850          96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  167 (353)
T ss_pred             EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCcccee
Confidence            789999999887666542      38888999999999999999998 8999999999999999988 799999999986


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+...++...++.+..+.......
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         168 AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            544433344567889999999965 4589999999999999999999999999988888888888888887665443322


Q ss_pred             Ccccc--cCCCCCCCCccccc------------ccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          283 NYTEF--KFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       283 ~~~~~--~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      ....+  ..+.....++...+            ....+..+++||.+||++||++|||+.++|.||||+...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence            11111  00101111111111            1234677999999999999999999999999999987544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.2e-46  Score=347.88  Aligned_cols=246  Identities=28%  Similarity=0.431  Sum_probs=199.1

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|+++++.++||||+++++++     ....++|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986432       2234688999999999999999887     33445889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc-C
Q 016401          129 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  206 (390)
Q Consensus       129 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~-~  206 (390)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||+..||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC
Confidence            9985 55444432    457899999999999999999999526999999999999999888 799999999875322 2


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  286 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (390)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~  212 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  212 (325)
T ss_pred             cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            223345689999999999554 5899999999999999999999999887655544433220                 0


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                      .            .++..+++++.+||++||+.||++|+     ++.++++||||....+
T Consensus       213 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         213 I------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             C------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            1            12245789999999999999999997     8999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-46  Score=346.66  Aligned_cols=253  Identities=26%  Similarity=0.451  Sum_probs=221.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|.+++++|+|+||.+++++++.++..|++|.+.-.      .+...+|+.+++++.|||||.+.+.|.    .++.++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            5799999999999999999999999999999988432      334568999999999999999999883    445558


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ||||+||+| ++.+.+....  ...+++..+..|+.|++.|++|||+ .+|+|||||+.||+++.++ .|||+|||+|+.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~  155 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDK-KVKLGDFGLAKI  155 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccC-ceeecchhhhhh
Confidence            999999996 7766666543  5679999999999999999999998 9999999999999999998 689999999998


Q ss_pred             cccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          203 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       203 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ..... ...+..||+.|++||++. +.+|+.++|||||||++|||++-+++|.+.+......+|.+....|         
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~-d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P---------  225 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILS-DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP---------  225 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhC-CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---------
Confidence            87665 567789999999999995 5569999999999999999999999999999888888888753222         


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                         ++...+.+++.+|+.||..+|+.||++.++|.+|.++..
T Consensus       226 -------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  226 -------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             -------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                               234678999999999999999999999999999998753

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.9e-45  Score=335.24  Aligned_cols=285  Identities=35%  Similarity=0.614  Sum_probs=221.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.+. |+||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6999999999999999999999999999999875332      23457999999995 6999999988855443344557


Q ss_pred             EEEEecccccHHHHHHHhhhh-cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++++...+...... ...+++..++.++.||+.||.|||+ .||+||||||+||+++.+...+||+|||++..
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999999887777543322 3468999999999999999999998 99999999999999998334899999999875


Q ss_pred             cccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          203 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       203 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ..... ......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+..+.+.++.+.++.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            43221 12233568889999998665668999999999999999999999999988888888888877766654432211


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                      .......++......... ..+.++.++.+||.+||..||.+||++.+++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            111111122211111111 1235789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-47  Score=373.70  Aligned_cols=259  Identities=29%  Similarity=0.491  Sum_probs=222.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc-------chhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ....|.++++||+|+||.|.+++++.|++.||+|++.+       +...+..|..+|--.+.+-|+.++..|     .++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            44689999999999999999999999999999999865       234456799999999999999999998     777


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .|+|+||||++| +|..++..+    ..+++.++++++..|+.||.-||+ .|+|||||||+|||||..|| +||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GH-ikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGH-IKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCc-Eeeccchh
Confidence            889999999985 787777764    279999999999999999999998 99999999999999999995 99999999


Q ss_pred             ccccccCCCC--cceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          200 AKVLVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       200 a~~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      |-.+......  ...+|||.|++||++..    ...|++.+|+||+||++|||+.|..||....-.+.+.+|+..-    
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----  297 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----  297 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence            9777543332  45689999999999942    2568999999999999999999999999999999999998741    


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC---HHHHhcCCcccccCCCC
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDPN  343 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~~~l~hp~f~~~~~~~  343 (390)
                                 ..+.+|+.          ..+|.++++||++++ .+|+.|..   +.++.+||||.++.|..
T Consensus       298 -----------~~l~FP~~----------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~  348 (1317)
T KOG0612|consen  298 -----------ESLSFPDE----------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDN  348 (1317)
T ss_pred             -----------hhcCCCcc----------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhh
Confidence                       23444421          248999999999988 57889998   99999999999987643

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-45  Score=348.12  Aligned_cols=277  Identities=23%  Similarity=0.346  Sum_probs=205.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEec
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      ..|++.+.||+|+||.||+|++..+++.||+|+....  ....|+.+++.++|+||+++++++..     ....|+|||+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEc
Confidence            4799999999999999999999999999999975432  34579999999999999999998843     3457899999


Q ss_pred             ccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC
Q 016401          130 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  209 (390)
Q Consensus       130 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~  209 (390)
                      +.+++...+..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++........
T Consensus       139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence            99988776653   24568999999999999999999998 9999999999999999888 7999999999754433344


Q ss_pred             cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHHhCCCCHHHHhh
Q 016401          210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESG---------VDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       210 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ....||+.|+|||++.+. .++.++|||||||++|||+++. ++|.....         ...+..++..++..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            456789999999999654 5899999999999999999855 44443221         223344444443322211100


Q ss_pred             cCcCc--ccccCCCCCCCCc---ccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 MNPNY--TEFKFPQIKPHPW---HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 ~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      .....  ...........++   ...-..+++.++.+||.+||++||++|||+.|+|+||||+.+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            00000  0000000000011   011113568899999999999999999999999999999863

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-47  Score=339.89  Aligned_cols=270  Identities=27%  Similarity=0.401  Sum_probs=220.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+.|+.-++||+|+||.|+-|.-+.||+.||.|.+.+.       .....+|..||.+++.+.||.+-..|.+...   
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~---  259 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA---  259 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc---
Confidence            446799999999999999999999999999999987432       2223479999999999999999888844333   


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                        +|+|+..|+| +|.-.+.+.  ....+++..+++++.+|+.||++||. .+||+|||||+|||+|+.| .|+|+|+|+
T Consensus       260 --LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~G-hvRISDLGL  333 (591)
T KOG0986|consen  260 --LCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHG-HVRISDLGL  333 (591)
T ss_pred             --eEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCC-CeEeeccce
Confidence              8899999996 554444443  34689999999999999999999998 9999999999999999999 599999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      |..+..+.+....+||..|||||++.+.. |+...|+|||||+||||+.|+.||........-.++-+.....       
T Consensus       334 Avei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-------  405 (591)
T KOG0986|consen  334 AVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-------  405 (591)
T ss_pred             EEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-------
Confidence            99998888888889999999999996555 9999999999999999999999997655433332222221111       


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCCCCCCCCCCCCCCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPNTRLPNGRPLPP  354 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~~~~~~~~~~~~~~  354 (390)
                                        ...+++++|+++++|++.+|++||++|..     +.++.+||||+++++.  .+..+...||
T Consensus       406 ------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~--rleagml~PP  465 (591)
T KOG0986|consen  406 ------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR--RLEAGMLEPP  465 (591)
T ss_pred             ------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh--HHhccCCCCC
Confidence                              12244689999999999999999999984     7899999999998753  4444444444

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.3e-46  Score=345.13  Aligned_cols=245  Identities=27%  Similarity=0.447  Sum_probs=196.9

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccchh-------hHHHHH-HHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||+||+|+++.+++.||||++.....       ...+|. .+++.++||||+++++++.     .....|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            469999999999999999999999999854321       112333 3567899999999998873     344588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99985 66555543    4578999999999999999999998 9999999999999999888 7999999998753222


Q ss_pred             -CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------  211 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-----------------  211 (323)
T ss_pred             CCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             22334568999999999965 45899999999999999999999999887766655554431                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH----HHHhcCCcccccCC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  341 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~----~~~l~hp~f~~~~~  341 (390)
                      ..            .+++.+++.+.+||++||+.||.+|+++    .++++||||..+.+
T Consensus       212 ~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         212 PL------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             CC------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            00            1124578999999999999999999987    69999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-45  Score=343.60  Aligned_cols=254  Identities=30%  Similarity=0.469  Sum_probs=200.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccch--------hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      .|++.+.||+|+||.||+|++.   .+++.||+|++.+..        ....+|+.+++.+ .|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4899999999999999999864   478999999985421        2234689999999 589999998887     3


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      ....+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCC-CEEEeeC
Confidence            44558899999985 66555543    4568999999999999999999998 9999999999999999888 7999999


Q ss_pred             CCccccccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          198 GSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       198 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      |+++.......  .....||+.|+|||++.+...++.++|||||||++|+|++|..||...........+...+      
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------  223 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI------  223 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH------
Confidence            99876433222  2345789999999999765557899999999999999999999997543221111111110      


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  340 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~  340 (390)
                        ..                 ....++..+++.+++||.+||..||++|+     ++.++++||||++..
T Consensus       224 --~~-----------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         224 --LK-----------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             --hc-----------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence              00                 00112245789999999999999999999     888999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=340.89  Aligned_cols=247  Identities=31%  Similarity=0.462  Sum_probs=201.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcE-EEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEI-VAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ....+.+.||+|+||+||+|...  |+. ||||++...      ...+.+|+.+|.+++|||||++++++.....    .
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~  114 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----S  114 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----c
Confidence            35566777999999999999986  555 999998643      2356789999999999999999999843321    4


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-cccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~-ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      +++||||++ |+|..++...  ....++...+..++.||+.||+|||+ .+ ||||||||+|||++.++..+||||||++
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            789999999 5777777653  35789999999999999999999998 89 9999999999999988646999999999


Q ss_pred             cccccC-CCCcceeeccccccchhhcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          201 KVLVKG-EPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       201 ~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      +..... .......||+.|||||++.+ ...|+.++||||||+++|||+||..||.+.........+.....+|      
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp------  265 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP------  265 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC------
Confidence            866543 33444789999999999964 3569999999999999999999999999988744444443321111      


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                           .++..+++.+..|+.+||..||++||+..+++.
T Consensus       266 ---------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  266 ---------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ---------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                 122447899999999999999999999988763

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-45  Score=348.30  Aligned_cols=277  Identities=22%  Similarity=0.323  Sum_probs=210.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEc--CCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .+|.+.+.||+|+||.||+|...  .+++.||+|.+... ....+|+++++.++||||+++++++     ......|++|
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv~  165 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMVM  165 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEEe
Confidence            47999999999999999999764  35678999988653 3456899999999999999999887     3344588999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCC
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  207 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~  207 (390)
                      |++.+++...+.    ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .++|+|||++.......
T Consensus       166 e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEccCccccccCccc
Confidence            999988876663    24678999999999999999999998 9999999999999999888 79999999987554332


Q ss_pred             C---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          208 P---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       208 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..   ....+..+.+.++..+.+......
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            2   234568999999999954 458999999999999999999999997754   345666666665544322110000


Q ss_pred             ----cCcccccCCCCCCCCcccc-cccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          282 ----PNYTEFKFPQIKPHPWHKV-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       282 ----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                          ..+..+.........+... ....++.++.+||++||.+||++|||+.++|+||||++.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                0000011000000011111 112467889999999999999999999999999999763

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.6e-45  Score=332.74  Aligned_cols=276  Identities=40%  Similarity=0.748  Sum_probs=224.7

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|++|.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     ...+.|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence            5899999999999999999999999999999885432      24557999999999999999999883     345588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||++++|...+...   ...+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .++|+|||.+....
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            99999977887776542   2568999999999999999999998 9999999999999999887 79999999987654


Q ss_pred             cCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          205 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       205 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  .....++..|+|||.+.+...++.++||||+||++|+|++|.++|.+.++.+.+..+...++.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            3321  23456788999999987666679999999999999999999999998888888888888888877655543221


Q ss_pred             --CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          283 --NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       283 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                        .+....++.....++...+ ++.+.++.+||.+||..||++|||++++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              1222233333333333333 45679999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.1e-45  Score=340.57  Aligned_cols=276  Identities=26%  Similarity=0.435  Sum_probs=205.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .++|++.+.||+|+||.||+|++..++..||+|.+..+.     ....+|+++++.++||||+++++++..     ....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence            458999999999999999999999999999999885431     235579999999999999999998843     3357


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  153 (331)
T cd06649          79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (331)
T ss_pred             EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccc
Confidence            899999985 77666653    356899999999999999999999723699999999999999888 799999999875


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh---
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---  279 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---  279 (390)
                      .... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.. .+.   +.+.......   
T Consensus       154 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~~---~~~~~~~~~~~~~  227 (331)
T cd06649         154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AIF---GRPVVDGEEGEPH  227 (331)
T ss_pred             cccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHh---cccccccccCCcc
Confidence            5332 23345689999999999654 5899999999999999999999999876654322 221   1111000000   


Q ss_pred             -cCcCc----cc---ccCCC------------CCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 -MNPNY----TE---FKFPQ------------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 -~~~~~----~~---~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                       ..+..    ..   .....            +............+++++++||.+||++||++|||+.++++||||+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence             00000    00   00000            000000000112468899999999999999999999999999999875


Q ss_pred             C
Q 016401          340 R  340 (390)
Q Consensus       340 ~  340 (390)
                      .
T Consensus       308 ~  308 (331)
T cd06649         308 E  308 (331)
T ss_pred             c
Confidence            4

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.8e-45  Score=339.91  Aligned_cols=245  Identities=29%  Similarity=0.510  Sum_probs=197.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHh-CCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|++..+++.||||++....       .....|..+++. ++||||+++++++.     ...++|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986432       223357777776 49999999999883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+++ +|...+..    ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99985 76655543    3568899999999999999999998 9999999999999999888 7999999998753222


Q ss_pred             -CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                       .......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-----------------  211 (316)
T ss_pred             CCceeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Confidence             22344568999999999965 45899999999999999999999999887765554443220                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHH-HHhcCCcccccCC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  341 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~-~~l~hp~f~~~~~  341 (390)
                      .            ..++..++.++++||.+||+.||++|+++. ++++||||+.+.+
T Consensus       212 ~------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         212 N------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             C------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence            0            011234788999999999999999999996 8999999988753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-45  Score=342.74  Aligned_cols=245  Identities=30%  Similarity=0.493  Sum_probs=200.3

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|+++.+++.||||++..+.       .....|.+++..+ +||||+++++++.     ....+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence            46999999999999999999999999986432       1233688888766 7999999999983     344588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99985 66555443    4568999999999999999999998 9999999999999999988 7999999998753222


Q ss_pred             -CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-----------------  211 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-----------------  211 (321)
T ss_pred             CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             22344568999999999954 45899999999999999999999999988877666655431                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-------CHHHHhcCCcccccCC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-------TALEACVHPFFDELRD  341 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-------s~~~~l~hp~f~~~~~  341 (390)
                      ..            .++..++.++.+||++||..||++|+       ++.++++||||..+.+
T Consensus       212 ~~------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         212 DV------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             CC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence            01            11234789999999999999999999       8999999999987643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.1e-45  Score=340.89  Aligned_cols=250  Identities=27%  Similarity=0.423  Sum_probs=203.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHHHHHhC-CCCceeeecceeccCCCCCceE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .|.+.+.||+|+||.||+|+++.+++.||||++.+...       ....|..++..+ .|++|+++++++     .....
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            48899999999999999999999999999999864321       223577777777 578888898887     33345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||||+++ +|...+..    ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            8899999984 66555543    3568999999999999999999998 9999999999999999988 79999999987


Q ss_pred             cccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...            
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------  216 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------  216 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence            5432 222334578999999999965 45899999999999999999999999988776666555431            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                           ..            .++..++.++.+||.+||+.||++|++     ..++++||||+.+.+
T Consensus       217 -----~~------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         217 -----NV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             -----CC------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence                 01            122457899999999999999999998     489999999988653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3e-45  Score=339.79  Aligned_cols=244  Identities=27%  Similarity=0.489  Sum_probs=196.6

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHh-CCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|+++.+++.||+|++....       .....|..++.. ++||||+++++++     ....++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986432       223357777765 4899999999988     3345688999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+.+ +|...+..    ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++......
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99985 66555443    4578999999999999999999998 9999999999999999888 7999999998643222


Q ss_pred             -CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                       .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~--------------  212 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T--------------  212 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence             223445689999999999654 5899999999999999999999999887765544433220  0              


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH-HHHhcCCcccccC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELR  340 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~-~~~l~hp~f~~~~  340 (390)
                                   ..++..++.++++||++||+.||++|+++ +++++||||+...
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         213 -------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence                         01123478999999999999999999997 5888999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.5e-45  Score=348.04  Aligned_cols=253  Identities=28%  Similarity=0.464  Sum_probs=204.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .|++.+.||+|+||.||+|.++.+++.||||++....       ....+|+.++..++|+||+++++.+     ....++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999985321       2345699999999999999999988     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++ +|..++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            899999985 66666543    4578999999999999999999998 9999999999999999888 799999999864


Q ss_pred             cccCC------------------------------------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHH
Q 016401          203 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  246 (390)
Q Consensus       203 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  246 (390)
                      .....                                    .....+||+.|+|||++.+ ..++.++|||||||++|||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeec
Confidence            32110                                    0123468999999999965 4589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC
Q 016401          247 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  326 (390)
Q Consensus       247 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s  326 (390)
                      ++|.+||.+.+..+.+..+....               ....++.          ...+++++++||.+|+ .||.+|++
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~  283 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWK---------------ETLVFPP----------EVPISEKAKDLILRFC-TDSENRIG  283 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCC---------------CceecCC----------CCCCCHHHHHHHHHhc-cChhhcCC
Confidence            99999999887766655554310               0001110          0136889999999987 59999984


Q ss_pred             ---HHHHhcCCcccccCC
Q 016401          327 ---ALEACVHPFFDELRD  341 (390)
Q Consensus       327 ---~~~~l~hp~f~~~~~  341 (390)
                         +.++++||||+++.+
T Consensus       284 ~~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         284 SNGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             CCCHHHHhcCCCCCCCCH
Confidence               799999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-45  Score=340.57  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=205.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|+||.||++++..+++.||+|++.+.       .....+|+.+++.++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence            699999999999999999999999999999998542       12245789999999999999999988     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+.+ +|..++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            999999974 77666643   24568999999999999999999998 9999999999999999888 799999999875


Q ss_pred             cccCCCC--cceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          203 LVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       203 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      .......  ....||+.|+|||++..    ...++.++||||+||++|+|++|+.||.+.+..+....+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------  225 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence            5433222  23468999999999953    24478899999999999999999999988776666555443100      


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc--CCCHHHHhcCCcccccCC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  341 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~s~~~~l~hp~f~~~~~  341 (390)
                               .+.++.         ....+++++++||++||..++++  |+++.++++||||..+.+
T Consensus       226 ---------~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         226 ---------HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             ---------cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence                     011110         01347899999999999765554  789999999999987653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.7e-45  Score=346.16  Aligned_cols=260  Identities=28%  Similarity=0.470  Sum_probs=208.1

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ......+|++.+.||+|+||.||+|+++.+++.||+|++.+.       .....+|+.+++.++||||+++++++     
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----  112 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----  112 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence            334457999999999999999999999999999999998532       12345789999999999999999888     


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      ....++|+||||+++ +|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~-~ikL~D  185 (371)
T cd05622         113 QDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLAD  185 (371)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCC-CEEEEe
Confidence            344568899999974 77666643     458899999999999999999998 9999999999999999888 799999


Q ss_pred             cCCccccccCC--CCcceeeccccccchhhcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016401          197 FGSAKVLVKGE--PNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       197 fg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      ||++.......  ......||+.|+|||++.+.   ..++.++|||||||++|+|++|.+||.+.+....+.++..... 
T Consensus       186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-  264 (371)
T cd05622         186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-  264 (371)
T ss_pred             CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-
Confidence            99997654322  12345789999999999543   2378999999999999999999999998877666655543110 


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc--CCCHHHHhcCCcccccCC
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  341 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~s~~~~l~hp~f~~~~~  341 (390)
                                    ...++.          ...++..+++||.+||..++.+  |+++.++++||||++...
T Consensus       265 --------------~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         265 --------------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             --------------cccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                          011111          1357999999999999844433  789999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-44  Score=332.81  Aligned_cols=281  Identities=37%  Similarity=0.648  Sum_probs=221.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh---------hHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      +|.+.+.||+|++|.||+|.+..+++.||||.+.....         ...+|+++++.++|+||+++++++.+     ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            48899999999999999999998999999999864322         23469999999999999999998833     45


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +.++||||+.++|..++...   ...+++..+..++.||+.||.|||+ +||+|+||+|+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            68899999987887776542   1368999999999999999999998 9999999999999999887 79999999997


Q ss_pred             ccccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.++|.+.++.+.+.++....+.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            654432 2223356788999999866566899999999999999999999999988888888888877777665554322


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ...............+... .....+..+.+||.+||.+||++|||+.+++.||||++...+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence            1111111111111111111 224568899999999999999999999999999999985443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-44  Score=348.82  Aligned_cols=276  Identities=25%  Similarity=0.327  Sum_probs=206.4

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ....|.+.+.||+|+||.||+|.+..+++.||||...  .....+|+++|++++|+|||++++++..     ....|+||
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~  239 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVL  239 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEE
Confidence            3457999999999999999999999999999999643  2335689999999999999999998732     34478999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCC
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  207 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~  207 (390)
                      |++.++|...+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++......
T Consensus       240 e~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        240 PKYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSW  314 (461)
T ss_pred             EccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCC-CEEEcccCCceeccccc
Confidence            99998887766532   3468999999999999999999998 9999999999999999887 79999999997553321


Q ss_pred             C---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHH-
Q 016401          208 P---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREE-  276 (390)
Q Consensus       208 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~-  276 (390)
                      .   .....||+.|+|||++.+. .++.++|||||||++|||++|..++....       ...++.++++..+....+. 
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            1   1234689999999999654 58999999999999999999875543221       1244555554433221110 


Q ss_pred             -------HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          277 -------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       277 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                             .............+......|...  ..++.++.+||++||++||.+|||+.|+|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                   000000000011111122223222  246789999999999999999999999999999964

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.8e-45  Score=339.53  Aligned_cols=245  Identities=29%  Similarity=0.488  Sum_probs=199.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||+||+|+++.+++.||||++.+..       ....+|.++++.+ +||||+++++++.     ....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999986432       2234688888887 7999999999883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc-
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  205 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~-  205 (390)
                      ||+++ +|...+..    ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99985 66544433    3579999999999999999999998 9999999999999999988 799999999864322 


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      ........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            222334568999999999965 45899999999999999999999999887765554444321                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH-----HHHhcCCcccccCC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  341 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~-----~~~l~hp~f~~~~~  341 (390)
                      ..            .++..++.++.+||++||..||.+||++     .++++||||....+
T Consensus       212 ~~------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         212 EV------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             CC------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            00            1224578999999999999999999999     99999999988643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.9e-45  Score=340.30  Aligned_cols=246  Identities=26%  Similarity=0.493  Sum_probs=195.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|+++.+++.||||++++..       ....+|..+++.+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46999999999999999999999999986431       2244788899888 799999999988     3344588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc-c
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  205 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~-~  205 (390)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++... .
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99985 66544432    4679999999999999999999998 9999999999999999887 79999999987432 2


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  277 (390)
                      ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.....        .+.+.+.+..         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            233345678999999999965 4589999999999999999999999963211        1111111110         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC------HHHHhcCCcccccCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRD  341 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s------~~~~l~hp~f~~~~~  341 (390)
                             ...            .++..++.++.+||++||..||.+|++      +.++++||||..+.+
T Consensus       220 -------~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         220 -------KQI------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             -------CCC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                   000            123457899999999999999999997      789999999987643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3e-45  Score=339.81  Aligned_cols=244  Identities=29%  Similarity=0.502  Sum_probs=196.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHh-CCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|++..+++.||||+++.+.       .....|..++.. ..||||+++++++     ....++|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999986432       112346666664 4899999999887     3344588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+++ +|...+..    ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.....
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99975 66555543    4578999999999999999999998 9999999999999999888 7999999999754332


Q ss_pred             -CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-----------------  211 (316)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             223445789999999999654 4899999999999999999999999988766555544321                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH-HHHhcCCcccccC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELR  340 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~-~~~l~hp~f~~~~  340 (390)
                                  ...++..++.++.+||.+||..||++|+++ .++++||||..+.
T Consensus       212 ------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         212 ------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence                        001224578999999999999999999986 5888999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.9e-45  Score=340.18  Aligned_cols=244  Identities=31%  Similarity=0.488  Sum_probs=198.4

Q ss_pred             eeeeecCceEEEEEEEc---CCCcEEEEEEeccch--------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           56 HVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +.||+|+||.||+|++.   .+++.||||++....        ....+|+.+++.++||||+++++++.     .+..+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence            67999999999999864   468899999985421        22346999999999999999999883     334588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+.+ +|...+..    ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++..
T Consensus        77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            99999986 66554433    4568888999999999999999998 9999999999999999888 7999999998743


Q ss_pred             ccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+...              
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--------------  215 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--------------  215 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence            222 223345689999999999654 4789999999999999999999999887766555554431              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~  340 (390)
                         ..            .++..+++++.+||++||+.||++|+     ++.++++||||....
T Consensus       216 ---~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         216 ---KL------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             ---CC------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence               01            12245789999999999999999999     899999999998753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.7e-44  Score=330.25  Aligned_cols=283  Identities=35%  Similarity=0.606  Sum_probs=219.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ++|++.+.||.|++|.||+|.++.+++.||+|.+....      ....+|+++++.++|+||+++++++.     ...+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            36999999999999999999999999999999875321      23457999999999999999999883     33458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||+++++...+...  ....+++..++.++.||+.||+|||+ +|++|+||+|+||+++.++..+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            899999998776665432  12336788899999999999999998 899999999999999865557999999999754


Q ss_pred             ccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..... .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||...+..+.+.++....+.+....+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            33221 23345688999999987656689999999999999999999999998888888888887777776554432110


Q ss_pred             Cccc-ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          283 NYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       283 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      .... ...+..... ......+.+++++.++|.+||+.||++||++.++++||||.++..
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        234 LPDYKSAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             chhhhhhcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            0000 001111111 011123467899999999999999999999999999999998653

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-44  Score=337.63  Aligned_cols=288  Identities=37%  Similarity=0.672  Sum_probs=230.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||.|++|.||+|++..+++.||||++....      ....+|+.+++.++|+||+++.+++..........+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5899999999999999999999899999999885422      3455799999999999999999988554433334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ++|||+++++...+..    ...+++..++.++.||+.||+|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            9999999877665543    3478999999999999999999998 9999999999999999987 79999999998664


Q ss_pred             cCC----CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          205 KGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       205 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...    ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            443    2334567889999999976646899999999999999999999999999998989888888888776655421


Q ss_pred             CcC-cccc--cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCC
Q 016401          281 NPN-YTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  345 (390)
Q Consensus       281 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~  345 (390)
                      ... ...+  ..+.....++...+ +.++.++.+||.+||++||++||++.+++.||||+.++++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence            111 1100  11112222232222 4578999999999999999999999999999999998775443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-44  Score=352.64  Aligned_cols=262  Identities=24%  Similarity=0.333  Sum_probs=212.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC---C
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD---K  118 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~  118 (390)
                      ...+|++.+.||+|+||+||+|++..+++.||||++...      .....+|+.++..++|+||++++..+.....   .
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            345899999999999999999999999999999998543      1234578999999999999998877643221   1


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      ....+++||||++ |+|.+.+.........+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~-~vkL~DF  187 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNG-LVKLGDF  187 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCC-CEEEEec
Confidence            2235789999998 58877776655555679999999999999999999998 9999999999999999888 7999999


Q ss_pred             CCccccccC---CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          198 GSAKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       198 g~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      |+++.....   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....     
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-----  261 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-----  261 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-----
Confidence            998754322   12234578999999999965 458999999999999999999999998877655554443210     


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                             ...++..+++++.+||.+||..||.+||++.++++|||++...
T Consensus       262 -----------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        262 -----------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                                   0012356789999999999999999999999999999998653

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.7e-44  Score=326.54  Aligned_cols=276  Identities=36%  Similarity=0.633  Sum_probs=212.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|++|.||+|+++.+++.||+|++....      ....+|+.+++.++|+|++++++++.     ...+.+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEEE
Confidence            6999999999999999999999999999999875321      23457999999999999999999883     344588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+++++.....   .....+++..++.++.||+.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        77 ~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07847          77 LVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQG-QIKLCDFGFARILT  151 (286)
T ss_pred             EEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCC-cEEECccccceecC
Confidence            999999976543332   224568999999999999999999998 9999999999999999888 79999999997654


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  281 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  281 (390)
                      ... ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+...........  
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            433 22344578889999998765668899999999999999999999999888777776666554433322111110  


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      .-+.....+............+.++..+.+||.+||..||++||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0001111111110000111123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-44  Score=328.40  Aligned_cols=276  Identities=35%  Similarity=0.669  Sum_probs=215.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ++|++.+.||+|++|.||+|.++.+++.||||.+....     ....+|+++++.++|+||+++++++.     ...+.|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeEE
Confidence            57999999999999999999999899999999885432     23457999999999999999999883     344688


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||++++|..++...   ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        80 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~  154 (291)
T cd07844          80 LVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence            99999998887766532   3468899999999999999999998 9999999999999999888 79999999986542


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ... ......++..|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+.+..+.+..+.+..+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            211 11223467889999998765668999999999999999999999998765 5566677777777776655433221


Q ss_pred             C--cccccCCCCCCCCcccccccCCC--hhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 N--YTEFKFPQIKPHPWHKVFQKRLP--PEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      .  +.....+.....+..... ..++  .++.++|.+||.+||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1  111222222222221111 1344  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-44  Score=341.06  Aligned_cols=252  Identities=26%  Similarity=0.376  Sum_probs=196.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      -..|+..+.||+|+||.||+|++..+++.||||++....     ..+.+|+++++.++|+||+++++++     .....+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence            357999999999999999999999999999999985432     3345799999999999999999988     334458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||+.+...   ..    .....+..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus       148 ~lv~e~~~~~~L---~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~  218 (353)
T PLN00034        148 QVLLEFMDGGSL---EG----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAK-NVKIADFGVSRIL  218 (353)
T ss_pred             EEEEecCCCCcc---cc----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEcccccceec
Confidence            899999986321   11    1335677888999999999999998 9999999999999999887 7999999999765


Q ss_pred             ccCC-CCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      .... ......||..|+|||++..    ....+.++|||||||++|||++|+.||......+....+......       
T Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-------  291 (353)
T PLN00034        219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-------  291 (353)
T ss_pred             ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-------
Confidence            4322 2234578999999998732    223456899999999999999999999743322221111111000       


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                               .         ....+..++.++++||.+||..||++|||+.++++||||.+-
T Consensus       292 ---------~---------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        292 ---------Q---------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ---------C---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                     0         001124578999999999999999999999999999999874

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-44  Score=326.71  Aligned_cols=252  Identities=35%  Similarity=0.564  Sum_probs=203.7

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhh------HHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      |++.+.||+|+||+||+|++..+++.||+|++......      ..+|+.+++.++||||+++++++..     ..+.++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            89999999999999999999999999999998654321      1248999999999999999999844     455789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc-
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-  203 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~-  203 (390)
                      ||||+.+ +|..++.    ....+++..+..++.||+.||++||+ .||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccccc
Confidence            9999997 8877776    24778999999999999999999998 9999999999999999877 7999999998753 


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ..........++..|+|||++.....++.++|+||||+++|+|++|..||......+....+.+...........     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence            222333456678999999998635568999999999999999999999998874444444433322111110000     


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                       .....+..+.++|++||+.||++||++.++++||||
T Consensus       225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                             001124799999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.8e-44  Score=331.23  Aligned_cols=279  Identities=38%  Similarity=0.625  Sum_probs=223.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..|++.+.||.|++|.||+|.+..+++.+|+|.++...      ....+|+.++++++||||+++++++...   ...+.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            47999999999999999999999999999999885322      1234799999999999999999987432   22458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||++++|..++...   ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRG-ILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence            899999998887766542   2368999999999999999999998 8999999999999999887 7999999998765


Q ss_pred             ccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ... .......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.+....+.+.++....+.+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            443 2223456788899999987665578999999999999999999999999988888888888888777665543211


Q ss_pred             --CcccccCCCCCCCCcccccccC-CChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 --NYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                        ..............+...++.. +++.+.+||++||..||++|||+.|+|.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              0011111112222333444444 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-44  Score=333.23  Aligned_cols=281  Identities=34%  Similarity=0.591  Sum_probs=214.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcC--CCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      +|.+.+.||+|++|.||+|.++.  +++.||+|.+....       ....+|+.+++.++||||+++++++..   ....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            48999999999999999999988  89999999986532       234579999999999999999998843   2235


Q ss_pred             EEEEEEecccccHHHHHHHhhhhc-CCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC----CCCcEEEee
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP----HTHQLKLCD  196 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~----~~~~vkl~D  196 (390)
                      .+|+||||+++++...+....... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            688999999988877765544333 378999999999999999999998 99999999999999998    66 799999


Q ss_pred             cCCccccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 016401          197 FGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---------DQLV  263 (390)
Q Consensus       197 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~  263 (390)
                      ||++........    .....++..|+|||++.+...++.++|+|||||++|+|++|++||.+.+..         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876533222    223456888999999877666899999999999999999999999865532         3456


Q ss_pred             HHHHHhCCCCHHHHhhcCc--Cccc----ccCCCCCCCCccccccc--CCChhHHHHHHHhcccCCCcCCCHHHHhcCCc
Q 016401          264 EIIKVLGTPTREEIKCMNP--NYTE----FKFPQIKPHPWHKVFQK--RLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  335 (390)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~  335 (390)
                      .++..++.+....+.....  .+..    ..............+..  ..+.++.++|.+||.+||++|||+.++++|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            6666666665543322111  1100    00000000111111112  56789999999999999999999999999999


Q ss_pred             c
Q 016401          336 F  336 (390)
Q Consensus       336 f  336 (390)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.5e-44  Score=327.27  Aligned_cols=275  Identities=36%  Similarity=0.631  Sum_probs=217.7

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh-----hHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      |++.+.||+|+||.||+|.+..+++.||+|+++....     ...+|+.+++++. |+|++++++++.+.   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            6789999999999999999999999999998864321     2236888888885 99999999988542   2245789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      ||||+++++.+.+...   ...+++..+..++.|++.||+|||+ .|++||||+|+||+++. + .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            9999998877665432   2568999999999999999999998 99999999999999998 5 799999999986654


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-c
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y  284 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  284 (390)
                      ........++..|+|||.+.....++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444445567889999998766566789999999999999999999999999888888888887777766543322111 1


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      ..+.++......+.. ....++.++.+||.+||..||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            112222222111111 124578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-44  Score=336.54  Aligned_cols=257  Identities=26%  Similarity=0.416  Sum_probs=205.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|+||.||+++++.+++.||+|++.+..       ....+|+.++..++|+||+++++++.     +...+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCEE
Confidence            6999999999999999999999999999999985321       22456889999999999999998883     34458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+. |+|..++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            89999997 5776666532   3568999999999999999999998 9999999999999999887 799999999875


Q ss_pred             cccCCCC--cceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          203 LVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       203 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      .......  ....||+.|+|||++..    ...++.++|||||||++|||++|+.||.+.+..+.+..+....       
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-------  224 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-------  224 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-------
Confidence            4332221  23468999999999852    3457899999999999999999999999887766666554310       


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc--CCCHHHHhcCCcccccCC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  341 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~s~~~~l~hp~f~~~~~  341 (390)
                              ..+.++.         ....+++++++||++||..++.+  |+++.++++||||+++.+
T Consensus       225 --------~~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         225 --------ERFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             --------ccccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence                    0011111         01357899999999999776555  689999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.7e-44  Score=328.53  Aligned_cols=275  Identities=36%  Similarity=0.668  Sum_probs=216.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||.|++|.||+|+++.+++.||||.+..+.      ....+|++++++++||||+++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence            4899999999999999999999999999999885332      23557999999999999999999873     334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+.+++...+...  ....+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            99999988776665432  23568899999999999999999998 9999999999999999888 79999999987543


Q ss_pred             cCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 016401          205 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  282 (390)
Q Consensus       205 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  282 (390)
                      .... .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+.+.++.+..+.+....+..... 
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            3221 22334678899999987666578999999999999999999999999888888888888777765433211100 


Q ss_pred             -CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                       .+ ...++.......... .+.++++++++|.+||+.||.+|||+.++++||||
T Consensus       232 ~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDY-KPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHH-HhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence             00 001111111111111 23578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.5e-44  Score=335.43  Aligned_cols=286  Identities=36%  Similarity=0.664  Sum_probs=227.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|.+.+.||.|++|.||+|.++.+++.||+|++....      ....+|+.+++.++||||+++++++.... ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            47999999999999999999999999999999885432      22346999999999999999998774332 344568


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||+.+++...+..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            89999999877665542    4568999999999999999999998 9999999999999999988 7999999998754


Q ss_pred             ccCCC-----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          204 VKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       204 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      .....     .....++..|+|||.+.+...++.++|+||+||++|+|++|++||.+.+....+..+....+.++...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     1234678899999998665568999999999999999999999999998888888888888888766554


Q ss_pred             hcCcCccc---ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          279 CMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       279 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      ........   ..++.....+|... .+..+.++.++|++||+.||++||++.+++.||||.....+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKI-FPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHH-cccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence            32211100   01122222222222 245789999999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2e-44  Score=329.64  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=203.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|++++.+++.+.     ...+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence            3788999999999999999999999999999885321       22346999999999999999988873     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+.+ +|...+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHG-HIRISDLGLAVH  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeccceee
Confidence            899999975 676655432  23468999999999999999999998 9999999999999999887 799999999876


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........|+..|+|||++.+ ..++.++|+||+||++|+|++|..||..................           
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-----------  219 (285)
T cd05630         152 VPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-----------  219 (285)
T ss_pred             cCCCccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----------
Confidence            544433344578999999999965 45899999999999999999999999865432111111110000           


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                                    ....++..+++++++||++||+.||++|+|     +.++++||||+.+..
T Consensus       220 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         220 --------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             --------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence                          001122457899999999999999999999     999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-44  Score=362.58  Aligned_cols=262  Identities=27%  Similarity=0.415  Sum_probs=211.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...+|++.+.||+|+||+||+|++..+++.||+|++...      ...+.+|+.+++.++|||||+++++|..   ....
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~~   87 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KANQ   87 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCCC
Confidence            345899999999999999999999999999999988532      2234579999999999999999998754   2334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-------cccccCCCCcEEEcCCC----
Q 016401          122 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-------ICHRDIKPQNLLVNPHT----  189 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~-------ivH~Dlkp~NIll~~~~----  189 (390)
                      .+|+||||++ ++|..++.........+++..++.|+.||+.||+|||+ .+       ||||||||+||||+.+.    
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-cccccccCCceeccCcHHHeEeecCccccc
Confidence            5889999998 48888877655445679999999999999999999997 44       99999999999996421    


Q ss_pred             ------------CcEEEeecCCccccccCCCCcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 016401          190 ------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGE  256 (390)
Q Consensus       190 ------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~  256 (390)
                                  ..+||+|||++.............||+.|+|||++.+. ..++.++|||||||+||+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                        14899999999766444444456789999999998542 45789999999999999999999999877


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          257 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      +....+...+...  +               ..+           ....+.++.+||..||..||.+||++.++|.||||
T Consensus       247 ~~~~qli~~lk~~--p---------------~lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        247 NNFSQLISELKRG--P---------------DLP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             CcHHHHHHHHhcC--C---------------CCC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            6655544433210  0               000           02468899999999999999999999999999999


Q ss_pred             cccCC
Q 016401          337 DELRD  341 (390)
Q Consensus       337 ~~~~~  341 (390)
                      +.+..
T Consensus       299 k~i~~  303 (1021)
T PTZ00266        299 KNVGP  303 (1021)
T ss_pred             hhcCC
Confidence            87654

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.6e-45  Score=338.25  Aligned_cols=245  Identities=28%  Similarity=0.506  Sum_probs=193.1

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|+++.+++.||+|++.+..       ....+|+.++..+ +||||+++++++.     ....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986431       2234688888776 8999999999883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc-
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  205 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~-  205 (390)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99985 55444432    4679999999999999999999998 9999999999999999988 799999999875322 


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCCHHHH
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--------GVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||....        ..+.+.+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            222344678999999999965 458999999999999999999999995311        11111111110         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC------HHHHhcCCcccccC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELR  340 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s------~~~~l~hp~f~~~~  340 (390)
                             ..            ..++..++..+.+||++||..||++|++      ..++++||||+.+.
T Consensus       220 -------~~------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         220 -------KQ------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             -------CC------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                   00            0123567899999999999999999998      57999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=350.87  Aligned_cols=248  Identities=25%  Similarity=0.433  Sum_probs=198.4

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCC-CCceeeecce-eccCCCCC-ceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKHC-FFSTTDKE-ELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~~-~~~~~~~~-~~~~  123 (390)
                      +++|.+.|.+|+|+.||+|.+...|..||+|++...    -....+|+.+|++|+ |+|||.+++. ........ ..-+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            899999999999999999999888899999987432    233458999999996 9999999994 33222233 2446


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--cccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .|+||||. |+|.+++..+.  ..+|++.++++|++++|+|+++||. ..  |||||||-+||||+.++ ..||||||.|
T Consensus       118 llLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g-~~KLCDFGSa  193 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG-NYKLCDFGSA  193 (738)
T ss_pred             EeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC-CEEeCccccc
Confidence            68999999 69988887654  4559999999999999999999997 66  99999999999999998 7999999998


Q ss_pred             cccccCCCC----------cceeeccccccchhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016401          201 KVLVKGEPN----------VSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  268 (390)
Q Consensus       201 ~~~~~~~~~----------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  268 (390)
                      +........          .....|+.|+|||++.  ....+++|+|||+|||+||-|+....||.+.....    |+. 
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln-  268 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN-  268 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe-
Confidence            654332211          1234589999999983  34558999999999999999999999997653211    111 


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                      ..+.+|..          ++++..+++||+.||+.||++||++.+++.+
T Consensus       269 ----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  269 ----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                            12344432          4689999999999999999999999988753

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.4e-45  Score=340.15  Aligned_cols=244  Identities=28%  Similarity=0.465  Sum_probs=195.6

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHH-HHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||+||+|+++.+|+.||+|++.+..       ....+|. .+++.++||||+++++++.     ....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence            46999999999999999999999999985431       1122343 3567789999999998883     344588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc-
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  205 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~-  205 (390)
                      ||+.+ +|...+.    ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99986 5544443    24678999999999999999999998 9999999999999999888 799999999875322 


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------  211 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------  211 (325)
T ss_pred             CCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            222345578999999999955 45899999999999999999999999887766655544331                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH----HHHhcCCcccccC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELR  340 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~----~~~l~hp~f~~~~  340 (390)
                      ..            .+++..+..+.++|++||..||.+||++    .++++||||....
T Consensus       212 ~~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         212 PL------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             Cc------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            00            1124578899999999999999999976    5999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-45  Score=339.38  Aligned_cols=244  Identities=30%  Similarity=0.483  Sum_probs=199.6

Q ss_pred             eeeeecCceEEEEEEE---cCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           56 HVVGTGSFGVVFQAKC---RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      +.||+|+||.||++++   ..+|+.||+|++....      ....+|++++++++||||+++++++.     ....+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            5799999999999986   3578999999986432      22346999999999999999999883     34458899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+.+ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            999974 66555533    4568999999999999999999998 9999999999999999888 799999999876543


Q ss_pred             C-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          206 G-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       206 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      . .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...                
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------  213 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------  213 (318)
T ss_pred             CCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC----------------
Confidence            3 22344578999999999954 45789999999999999999999999887766655554331                


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccC
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  340 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~  340 (390)
                       ...            ++..+++++.+||++||+.||++||+     +.+++.||||+.+.
T Consensus       214 -~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         214 -KLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             -CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence             011            12457899999999999999999999     78899999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.1e-44  Score=333.95  Aligned_cols=285  Identities=29%  Similarity=0.519  Sum_probs=216.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCC-------
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-------  118 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-------  118 (390)
                      .+|.+.+.||.|+||.||+|.++.+++.||+|.+....    ....+|+++++.++||||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            47999999999999999999999999999999885432    3345799999999999999999876432211       


Q ss_pred             --CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          119 --EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       119 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                        +..+.|+||||+++++...+.     ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++..++|+|
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence              123578999999987765553     3568999999999999999999998 99999999999999986655789999


Q ss_pred             cCCccccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016401          197 FGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       197 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      ||.+........    .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999875432111    1223568889999988665568899999999999999999999999888877777776655444


Q ss_pred             CHHHHhhcCcCcccc-c-CCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          273 TREEIKCMNPNYTEF-K-FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      ............... . .......+... +.+.++.++.+||++||..||++|||+.++++||||+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            332222111100000 0 00001111111 12457899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.8e-44  Score=328.54  Aligned_cols=250  Identities=25%  Similarity=0.387  Sum_probs=196.0

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ||+|+||.||++.++.+|+.||+|.+....       .....|+++++.++||||+++++++     ....+.|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999885321       2234599999999999999999888     3345688999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC
Q 016401          131 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  209 (390)
Q Consensus       131 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~  209 (390)
                      ++ +|...+...  ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            85 665555332  23458888899999999999999998 9999999999999999887 7999999998766544333


Q ss_pred             cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 016401          210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  289 (390)
Q Consensus       210 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  289 (390)
                      ....+++.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.........+......             .....
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------DEVKF  217 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------ccccc
Confidence            4456789999999996554 899999999999999999999999765432221122111000             00000


Q ss_pred             CCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH----HHHhcCCcccccCC
Q 016401          290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  341 (390)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~----~~~l~hp~f~~~~~  341 (390)
                                 ....+++++++||++||..||++||++    .+++.||||+.+..
T Consensus       218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence                       113578999999999999999999999    67889999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.1e-45  Score=338.41  Aligned_cols=244  Identities=25%  Similarity=0.433  Sum_probs=196.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccchh-------hHHHH-HHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRE-LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|++..+++.||+|++.....       ...+| ..+++.++||||+++++++.     ....+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence            469999999999999999999999999854321       11223 34567889999999998883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc-
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  205 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~-  205 (390)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99986 66555543    4568889999999999999999998 9999999999999999888 799999999875322 


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------  211 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------------  211 (325)
T ss_pred             CCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------------
Confidence            222345578999999999965 45899999999999999999999999988776665555431                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHH----HHhcCCcccccC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL----EACVHPFFDELR  340 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~----~~l~hp~f~~~~  340 (390)
                      ..            .+++.+++.+.++|.+||+.||.+|+++.    ++++|+||....
T Consensus       212 ~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         212 PL------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             Cc------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence            00            11246789999999999999999999875    899999997754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3e-44  Score=334.16  Aligned_cols=250  Identities=27%  Similarity=0.439  Sum_probs=201.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCC-CceeeecceeccCCCCCceE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .|...+.||+|+||.||+|+++.+++.||+|++.++.       .....|..+++.+.| ++|+++++++.     ....
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCE
Confidence            3788999999999999999999999999999986432       123468888888865 66777887773     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||||+++ +|...+..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEecccccc
Confidence            8899999985 66555543    4578999999999999999999998 9999999999999999888 79999999987


Q ss_pred             ccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ..... .......||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.+.......+...            
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------  216 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------  216 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence            53222 22234568999999999955 45899999999999999999999999988766665555431            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                           ...            ++..++.++.+|+.+||..||.+|++     ..++++||||+.+.+
T Consensus       217 -----~~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         217 -----NVS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             -----CCC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                 011            22457899999999999999999997     579999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-45  Score=340.69  Aligned_cols=244  Identities=28%  Similarity=0.478  Sum_probs=195.2

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHHHHHhC---CCCceeeecceeccCCCCCceEEEEEE
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ||+|+||+||+|+++.+++.||||++.....       ....|..++..+   .||||++++.++.     ....+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-----~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-----TDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-----cCCeEEEEE
Confidence            6999999999999999999999999854221       122456666655   6999999998883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99985 66555442    4678999999999999999999998 9999999999999999888 7999999998754322


Q ss_pred             -CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                       .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------  212 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------  212 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             22345678999999999976556899999999999999999999999887765554444321                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC----CHHHHhcCCcccccC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELR  340 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----s~~~~l~hp~f~~~~  340 (390)
                      ...++           ...+++++.+||++||..||.+|+    ++.++++||||....
T Consensus       213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            11111           124689999999999999999998    689999999998753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-45  Score=309.74  Aligned_cols=261  Identities=25%  Similarity=0.409  Sum_probs=212.0

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhH-----HHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      .....+..+.+..||+|+.|.|++++.+.+|...|||.+.+.....     ...+.++.+- ++|+||+.+++|....+ 
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-  165 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-  165 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-
Confidence            3344566778899999999999999999999999999886543221     1233333333 58999999999966554 


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          119 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       119 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                          +++.||.|..-+..++..   ..++++|..+-.+...++.||.||.+.+||+|||+||+|||+|+.| ++||||||
T Consensus       166 ----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFG  237 (391)
T KOG0983|consen  166 ----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFG  237 (391)
T ss_pred             ----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeeccc
Confidence                668899887544444443   3578999999999999999999999878999999999999999988 89999999


Q ss_pred             CccccccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHH
Q 016401          199 SAKVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       199 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~  275 (390)
                      .+..+......+...|.+.|||||.+.-  ...|+.++||||||++++||.||+.||.+. .+.+.+.+++..  .|+. 
T Consensus       238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~-  314 (391)
T KOG0983|consen  238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL-  314 (391)
T ss_pred             ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC-
Confidence            9998888888888899999999999942  345899999999999999999999999984 566777777652  1110 


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                   +          ....++++++++|+..||++|+.+||...++|+|||+..+.
T Consensus       315 -------------L----------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  315 -------------L----------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             -------------C----------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                         0          01135899999999999999999999999999999998764

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-44  Score=337.38  Aligned_cols=258  Identities=27%  Similarity=0.411  Sum_probs=205.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+..       ....+|..++..++|+||+.+++++     ....+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            36999999999999999999999999999999885421       2244688999999999999999988     34456


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .|+||||+.+ +|..++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~  150 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNG-HIRLADFGSCL  150 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCC-CEEEEecccee
Confidence            8899999974 776666532   3568999999999999999999998 9999999999999999888 79999999987


Q ss_pred             ccccCCCC--cceeeccccccchhhcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          202 VLVKGEPN--VSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       202 ~~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ........  ....||+.|+|||++.+.    ..++.++|+||+||++|+|++|+.||.+.+..+.+..+.....     
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----  225 (331)
T cd05624         151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-----  225 (331)
T ss_pred             eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-----
Confidence            65433221  234689999999998542    3478899999999999999999999988776665555443100     


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc--CCCHHHHhcCCcccccCC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  341 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~s~~~~l~hp~f~~~~~  341 (390)
                                .+.++.        . ...++.++++||.+||..++.+  |++++++++||||+.+.+
T Consensus       226 ----------~~~~p~--------~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         226 ----------RFQFPS--------H-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             ----------cccCCC--------c-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence                      001110        0 1346899999999999976655  568999999999988654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-47  Score=316.67  Aligned_cols=284  Identities=31%  Similarity=0.519  Sum_probs=229.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--h----hhHHHHHHHHHhCCCCceeeecceeccCCC---CCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--K----RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~  120 (390)
                      ..|....+||+|.||.||+|+.+.+|+.||+|++.-+  +    ....+|+++|..++|+|++.+++.+-+...   .+.
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4688899999999999999999999999999976432  1    123489999999999999999988754433   344


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..+|+||.+|+.+|..++.+.   ..+++...++.++.++++||.|+|+ ..|+|||+|++|+||+.++ .+||+|||++
T Consensus        97 ~t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dg-ilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDG-ILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCc-eEEeeccccc
Confidence            568999999999888777653   3679999999999999999999998 8999999999999999998 7999999999


Q ss_pred             cccccCCC-----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          201 KVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       201 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      +.+.....     .+..+.|.+|++||.+++...|+++.|||..||++.||+++.+.|.++++..++..|...+|....+
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            76654332     2334569999999999999999999999999999999999999999999999999999999988877


Q ss_pred             HHhhcC--cCcccccCCCCCCCCcc---ccc-ccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          276 EIKCMN--PNYTEFKFPQIKPHPWH---KVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       276 ~~~~~~--~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      -|..+.  +-+...+.+..+.....   +.. +-.-++++.||+.+||..||.+|++++++|+|.||..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            665442  11122222211111111   111 1122568999999999999999999999999999964

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=325.46  Aligned_cols=281  Identities=28%  Similarity=0.538  Sum_probs=217.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHH---HHHHHHHhCCC--C----ceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDH--P----NIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~E~~~l~~l~h--~----~iv~~~~~~~~~~~~~  119 (390)
                      .++|.+...+|+|.||.|..|.+..++..||||+++.-.++.+   -|+++|+++.+  |    .++.+.++|     +-
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            4689999999999999999999999999999999865444332   48999999932  2    367787777     55


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC----------C-
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP----------H-  188 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~----------~-  188 (390)
                      ..+.|+|+|.++-++.+.+....  -.+++...++.+.+||+.++++||+ .+++|-||||+|||+.+          . 
T Consensus       163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence            66699999999878877776533  3568999999999999999999998 99999999999999831          1 


Q ss_pred             --------CCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 016401          189 --------THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  260 (390)
Q Consensus       189 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  260 (390)
                              ...|+|+|||.|+..  .+.....+.|..|+|||++++-+ ++..+||||+||||+|+.+|...|++.++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    125999999999754  44456778899999999998765 9999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhhcC-cCcc---cccCCCC-----------CCCCccccc--ccCCChhHHHHHHHhcccCCCc
Q 016401          261 QLVEIIKVLGTPTREEIKCMN-PNYT---EFKFPQI-----------KPHPWHKVF--QKRLPPEAVDLVCRFFQYSPNL  323 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~-~~~~---~~~~~~~-----------~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~  323 (390)
                      .+..+-..+|..+...+.... ..+-   .+..++.           ...+.....  .+.-..++.|||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            998888888866665554431 1100   0011100           011111111  0111235889999999999999


Q ss_pred             CCCHHHHhcCCcccccC
Q 016401          324 RCTALEACVHPFFDELR  340 (390)
Q Consensus       324 R~s~~~~l~hp~f~~~~  340 (390)
                      |+|+.|+|.||||+.+.
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998753

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.9e-44  Score=325.02  Aligned_cols=276  Identities=36%  Similarity=0.664  Sum_probs=220.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|++.+.||.|++|.||+|++..+++.||||.+...     .....+|+.+++.++|+||+++++++..     ....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            489999999999999999999999999999988543     2234579999999999999999998843     334789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      ||||+++++..++..... ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            999999988776654321 2468999999999999999999998 9999999999999999887 799999999875433


Q ss_pred             CC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          206 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       206 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      .. ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+.++......+....+..+. ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            21 12234568889999998766667899999999999999999999999988888888888887777766554332 11


Q ss_pred             cc--ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          285 TE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       285 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      ..  ..++......... +.+..++.++++|.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11  1122222222211 223568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.7e-44  Score=349.91  Aligned_cols=254  Identities=27%  Similarity=0.366  Sum_probs=208.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC-CcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..|.+.+.||+|++|.||+|.+..+ ++.||+|.+....    ....+|+.+++.++||||+++++++.     ....+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEE
Confidence            3599999999999999999998877 7889999764322    23457999999999999999999883     334588


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||++ ++|...+.........+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCC-cEEEEeCcCceec
Confidence            9999997 58877776554445678999999999999999999998 9999999999999999888 7999999999865


Q ss_pred             ccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .....   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....           
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-----------  287 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-----------  287 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            43221   234568999999999955 458999999999999999999999998877666555544310           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                            .           ..++..+++++++||.+||..||++||++.+++.|||++..
T Consensus       288 ------~-----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        288 ------Y-----------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             ------C-----------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                  0           01123578999999999999999999999999999999753

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-43  Score=332.39  Aligned_cols=315  Identities=34%  Similarity=0.614  Sum_probs=237.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  121 (390)
                      .++|.+.+.||+|++|.||+|++..+++.||||++...      .....+|+.+++.++|+|++++.+++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            35799999999999999999999999999999987532      1223469999999999999999887743322 2334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ..|+|+||++++|.+++..     ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~  166 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEccccccc
Confidence            4789999998888776653     568999999999999999999998 9999999999999999887 79999999997


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .....  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+....
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            65332  3445678899999998665567899999999999999999999999988888888888877777665544332


Q ss_pred             cCccc-c--cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCC
Q 016401          282 PNYTE-F--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  358 (390)
Q Consensus       282 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  358 (390)
                      ..... +  ..+......+...+ ...++.+.+||++||..||++|||+.++++||||+...++...     ..++.++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~-----~~~~~~~~  318 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE-----PVAPPYDQ  318 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc-----ccccccCc
Confidence            11100 0  01111111111212 3468999999999999999999999999999999987655321     11222221


Q ss_pred             CCCCCCCCChHHHhhhCcHHH
Q 016401          359 KPPELSGIPPETINRLIPEHA  379 (390)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~  379 (390)
                      . .....++-+.+++++..++
T Consensus       319 ~-~~~~~~~~~~~~~~~~~~~  338 (343)
T cd07851         319 S-FESRDLTVDEWKELVYKEI  338 (343)
T ss_pred             c-hhhhhcCHHHHHHHhHHHH
Confidence            1 2233455666666665543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-44  Score=336.03  Aligned_cols=245  Identities=27%  Similarity=0.436  Sum_probs=194.8

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHH-HHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|. .+++.++||||+++++++     ......|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999985432       1122333 467889999999999887     3344588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc-
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  205 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~-  205 (390)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99985 55444432    4568899999999999999999998 9999999999999999988 799999999875322 


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------  211 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-----------------  211 (321)
T ss_pred             CCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            222334568999999999954 45899999999999999999999999887765554443321                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH----HHHhcCCcccccCC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  341 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~----~~~l~hp~f~~~~~  341 (390)
                      ..            .++...+.++.++|.+||+.||.+|+++    .++++||||..+.+
T Consensus       212 ~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         212 PL------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             CC------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            00            1224568899999999999999999975    59999999987643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.6e-43  Score=329.27  Aligned_cols=286  Identities=35%  Similarity=0.601  Sum_probs=225.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCC--CcEEEEEEeccc------hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRET--GEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      +|++.+.||+|+||.||++.+..+  +..||+|++...      .....+|+.+++++ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            489999999999999999999888  899999988532      12345799999999 5999999988653322 2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+|++++|++++|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            4679999999888766643    4678999999999999999999998 9999999999999999887 79999999997


Q ss_pred             ccccCCC-----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          202 VLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       202 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      .......     .....+|..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+..++..++.+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            5533211     22346789999999886655689999999999999999999999999988889999999988887765


Q ss_pred             HhhcCcCccc---ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCC
Q 016401          277 IKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  344 (390)
Q Consensus       277 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~  344 (390)
                      +..+......   ..........+... .+..+..+.+||.+||+.||++|||+.+++.||||+.++++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~  303 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD  303 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc
Confidence            5443221100   01111111122221 2346889999999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.5e-44  Score=333.70  Aligned_cols=279  Identities=25%  Similarity=0.407  Sum_probs=203.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++....     ....+|+++++.++|+||+++++++..     ..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence            358999999999999999999999999999999875431     234589999999999999999999843     3458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+.+ +|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~  153 (333)
T cd06650          79 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchh
Confidence            899999975 77776653    456889999999999999999999724799999999999999887 799999999875


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHhhcC
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPTREEIKCMN  281 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  281 (390)
                      .... ......+|..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+........ .+.+.........
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         154 LIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhhh-ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence            4322 2234568899999999965 45899999999999999999999999876543222111100 0000000000000


Q ss_pred             -------cCcccccCCCC--------CCCCccccc-ccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          282 -------PNYTEFKFPQI--------KPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       282 -------~~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                             ..+..-..+..        ........+ ...++.++++||.+||++||++|||+.+++.||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                   00000000000        000000000 12357889999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-43  Score=324.95  Aligned_cols=255  Identities=25%  Similarity=0.384  Sum_probs=206.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+.+.+++.     .....
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEE
Confidence            3788999999999999999999999999999885321       22457999999999999999988873     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |++|||+.+ +|...+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~  151 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYG-HIRISDLGLAVK  151 (285)
T ss_pred             EEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCC-CEEEecCCccee
Confidence            899999985 565544331  23469999999999999999999998 9999999999999999887 799999999876


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........|+..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.........+.......          
T Consensus       152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05632         152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET----------  220 (285)
T ss_pred             cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc----------
Confidence            5443333445789999999999654 58999999999999999999999998876554444433321110          


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~  340 (390)
                                     ...++..++.++.+|+.+||..||++||+     +.++++|+||+...
T Consensus       221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         221 ---------------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             ---------------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence                           00122457889999999999999999999     89999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5e-43  Score=321.36  Aligned_cols=277  Identities=36%  Similarity=0.618  Sum_probs=210.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||+++++++.     ...+.|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEE
Confidence            57999999999999999999999999999999885332     23457999999999999999999873     334578


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+.+++...+..   ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||+++...
T Consensus        80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  154 (291)
T cd07870          80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence            9999999887665432   13457788899999999999999998 8999999999999999887 79999999987543


Q ss_pred             cC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC-
Q 016401          205 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMN-  281 (390)
Q Consensus       205 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~-  281 (390)
                      .. .......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+ ..+.+.++....+.|......... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            22 122334568899999998665567899999999999999999999997654 345566666666666655432221 


Q ss_pred             -cCcccccCCCCCCCCcccccc-cCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          282 -PNYTEFKFPQIKPHPWHKVFQ-KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       282 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                       +.+.....+............ -..++++.+++.+||..||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             111111111111111111000 0136789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.2e-44  Score=332.60  Aligned_cols=246  Identities=27%  Similarity=0.475  Sum_probs=195.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++.++ .||||+.+++++.     ....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986432       2234688888888 6999999999883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc-
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  205 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~-  205 (390)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99985 66554432    4579999999999999999999998 9999999999999999888 799999999875322 


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhh
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....      ..+.+.+....  .        
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~--------  218 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K--------  218 (327)
T ss_pred             CCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence            223345678999999999965 458999999999999999999999996422      11222222110  0        


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC------HHHHhcCCcccccCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRD  341 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s------~~~~l~hp~f~~~~~  341 (390)
                            .            ..++..++..+.++|++||..||.+|++      ..++++||||..+.+
T Consensus       219 ------~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         219 ------P------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             ------C------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence                  0            0123457899999999999999999998      579999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.8e-43  Score=323.30  Aligned_cols=276  Identities=37%  Similarity=0.656  Sum_probs=212.7

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+....      ....+|+++++.++||||+++++++     ....+.|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            6999999999999999999999899999999875322      2345799999999999999999988     3445688


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+++++.....   .....+++..+..++.|++.||+|||+ .|++|+||+|+||++++++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDLE---KYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            999999975533222   223458999999999999999999998 8999999999999999888 79999999987653


Q ss_pred             cCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 016401          205 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  281 (390)
Q Consensus       205 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  281 (390)
                      .... .....++..|+|||++.+...++.++||||+||++|+|++|.+||...+..+....+....+...........  
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            3322 2334578899999998665667899999999999999999999998888777777777665543322211110  


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      +.......+............+.++..+.+|+++||..||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            1011111221111111111224678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=322.19  Aligned_cols=255  Identities=29%  Similarity=0.464  Sum_probs=213.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ...-|.++++||+|+||.||+|.|+.+|..+|||.+..+.  ..+-+|+.++++++.|++|++|+.|+-..+     +++
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWI  105 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWI  105 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEe
Confidence            3457899999999999999999999999999999986543  445589999999999999999999976665     899


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      |||||+ |+..++++..   +.++++..+..++...+.||+|||. ..-+|||||..|||++.+| ..||+|||.|....
T Consensus       106 VMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLT  180 (502)
T ss_pred             ehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccc-hhhhhhccccchhh
Confidence            999999 6887777653   5789999999999999999999998 8899999999999999999 59999999986553


Q ss_pred             cC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .. ....+..|||.|||||++..- .|+.++||||||++..||.-|++||.+-.+...+                     
T Consensus       181 DTMAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------------------  238 (502)
T KOG0574|consen  181 DTMAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------------------  238 (502)
T ss_pred             hhHHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCccccccccee---------------------
Confidence            32 234677899999999999554 4999999999999999999999999876543222                     


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                         |-.|..++..+.+  +...+.++.|||++||.+.|++|.|+.++++|||++..
T Consensus       239 ---FMIPT~PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  239 ---FMIPTKPPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             ---EeccCCCCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence               2223333222222  23468899999999999999999999999999999763

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=343.47  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=212.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+-|.|+..||.|+||+||+|.++.++..-|.|+|....    ....-|++||..++||+||++++.|+....     ++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eE
Confidence            356889999999999999999999999888999884322    122359999999999999999999865444     88


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc-
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-  203 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~-  203 (390)
                      ++.|||+|+-.+.+-  ...+..+++.+++.+++|+|.||.|||+ .+|||||||..|||++-+| .++|+|||.+... 
T Consensus       106 iliEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~  181 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNK  181 (1187)
T ss_pred             EEEeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecC-cEeeecccccccch
Confidence            999999975433322  2346789999999999999999999998 8999999999999999998 7999999986432 


Q ss_pred             ccCCCCcceeeccccccchhh----cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          204 VKGEPNVSYICSRYYRAPELI----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      .......+++|||+|||||+.    ....+|+.++||||||++|.||..+.+|-...++...+.+|.+.           
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-----------  250 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-----------  250 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-----------
Confidence            223445678999999999998    34567999999999999999999999999998888888777652           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                     .|..-.-|.+.+..+.||+.+||.+||..||+++++|+||||+..
T Consensus       251 ---------------ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  251 ---------------EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             ---------------CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                           111112234568899999999999999999999999999999854

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.4e-43  Score=324.45  Aligned_cols=282  Identities=30%  Similarity=0.507  Sum_probs=213.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC---CCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~  120 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.++++++||||+++++++.....   ...
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            47999999999999999999999999999999885321      123479999999999999999998754322   123


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ...++||||+++++...+..   ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++
T Consensus        92 ~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~  166 (310)
T cd07865          92 GSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDG-ILKLADFGLA  166 (310)
T ss_pred             ceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCC-cEEECcCCCc
Confidence            45689999999887666543   23468999999999999999999998 8999999999999999887 7999999998


Q ss_pred             cccccCCCC-----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          201 KVLVKGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       201 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      .........     ....++..|+|||.+.+...++.++|+||+|+++|+|++|++||.+.+.......+....+..+.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            755332211     233567889999998665557899999999999999999999999888777666666665554443


Q ss_pred             HHhhcC--cCcccccCCCCCCCCccccc-ccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          276 EIKCMN--PNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       276 ~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      .+....  ..+.....+........... +...++.+.+||.+||..||++|||++++|+||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            322110  00111111111111111111 11246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-43  Score=330.07  Aligned_cols=276  Identities=36%  Similarity=0.585  Sum_probs=217.0

Q ss_pred             ccEE-EeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh------------------hHHHHHHHHHhCCCCceeeecc
Q 016401           50 VSYI-AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------YKNRELQIMQMLDHPNIVALKH  110 (390)
Q Consensus        50 ~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~E~~~l~~l~h~~iv~~~~  110 (390)
                      .+|. +.+.||.|+||.||+|.+..+++.||||++.....                  ...+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4676 45789999999999999999999999998854321                  2457999999999999999999


Q ss_pred             eeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC
Q 016401          111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  190 (390)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  190 (390)
                      ++.     ...+.|++|||+++++...+..    ...+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++ 
T Consensus        88 ~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~-  156 (335)
T PTZ00024         88 VYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKG-  156 (335)
T ss_pred             EEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCC-
Confidence            883     3345889999999988776653    4568999999999999999999998 9999999999999999888 


Q ss_pred             cEEEeecCCccccccC---------------CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016401          191 QLKLCDFGSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  255 (390)
Q Consensus       191 ~vkl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  255 (390)
                      .++|+|||.+......               .......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            7999999998755311               1112234578899999997666679999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcC--cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          256 ESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .+..+.+..+...++.+....+....  +.+..+  ....+..... .....+.++.++|.+||..||++|||++++|.|
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            99888888888887777654332211  001100  0000111111 123568899999999999999999999999999


Q ss_pred             Cccccc
Q 016401          334 PFFDEL  339 (390)
Q Consensus       334 p~f~~~  339 (390)
                      |||+..
T Consensus       314 ~~~~~~  319 (335)
T PTZ00024        314 EYFKSD  319 (335)
T ss_pred             cccCCC
Confidence            999864

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-43  Score=328.64  Aligned_cols=282  Identities=36%  Similarity=0.625  Sum_probs=221.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4799999999999999999999989999999988542      1224579999999999999999998754322 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+|+||+..++....      ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||+++.
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence            6799999987654432      2468899999999999999999998 9999999999999999888 799999999875


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            422  233456788999999986655689999999999999999999999999888888888888777666555443321


Q ss_pred             Ccc-c--ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          283 NYT-E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       283 ~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ... .  ...+......+...+ +..++++.+||.+||+.||++||++.+++.||||+.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            100 0  011111122222222 3578899999999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=321.50  Aligned_cols=274  Identities=35%  Similarity=0.657  Sum_probs=215.5

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      |++.+.||.|++|.||+|.++.+|+.||+|++..+.      ....+|+++++.++|+|++++++++.     +..+.|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            678899999999999999999999999999885332      23457999999999999999999883     3355889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      +|||+++++...+....  ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            99999888776665421  1368999999999999999999998 8999999999999999877 799999999875432


Q ss_pred             CC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--c
Q 016401          206 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P  282 (390)
Q Consensus       206 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~  282 (390)
                      .. ......++..|+|||++.+...++.++|+||+|+++|+|++|.+||.+.+..+.+.++.+..+.+....+....  +
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            22 11233557889999988665567899999999999999999999999988888888888877777655432211  0


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      ++. ..++........ ...+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus       232 ~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYK-PTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhh-hhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            000 011111111111 1234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-45  Score=323.65  Aligned_cols=252  Identities=28%  Similarity=0.468  Sum_probs=212.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhH-------HHHHHHHHhC-CCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQML-DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..|..+.+||+|+||+|.+|..+.+.+.||||+++++....       -.|.++|... +-|.+++++.+|.+...    
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR----  424 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR----  424 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh----
Confidence            47889999999999999999999999999999987653221       2577787776 56788899988854333    


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                       +|+||||++| +|-..+++    -+.+.+..+.+++.+|+-||-+||+ +||++||||.+|||+|.+|+ +||+|||++
T Consensus       425 -LyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGH-iKi~DFGmc  497 (683)
T KOG0696|consen  425 -LYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMC  497 (683)
T ss_pred             -eeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCc-eEeeecccc
Confidence             7899999996 55444444    3678888999999999999999998 99999999999999999995 999999999


Q ss_pred             cccc-cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.-. .+....+++|||.|+|||++. ..+|+..+|+||+|++||||+.|++||.+.++.+.++.|.+.           
T Consensus       498 KEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-----------  565 (683)
T KOG0696|consen  498 KENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-----------  565 (683)
T ss_pred             cccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-----------
Confidence            7543 334456788999999999994 566999999999999999999999999999999999999874           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH-----HHHhcCCcccccCCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDP  342 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~-----~~~l~hp~f~~~~~~  342 (390)
                                        ...++..+|.++.++++.+|.+.|.+|...     .++-.||||+.+.+.
T Consensus       566 ------------------nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe  615 (683)
T KOG0696|consen  566 ------------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE  615 (683)
T ss_pred             ------------------cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence                              122446789999999999999999999964     689999999998753

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-43  Score=331.26  Aligned_cols=285  Identities=36%  Similarity=0.699  Sum_probs=225.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|.+..+++.+|+|++...      .....+|+.+++++ +|+||+++++++..   .+...
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~~   83 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDKD   83 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCce
Confidence            4799999999999999999999989999999987432      12344799999999 99999999998733   23345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .|+||||++++|...+..     ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||.+..
T Consensus        84 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~  156 (337)
T cd07852          84 IYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDC-RVKLADFGLARS  156 (337)
T ss_pred             EEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccchhc
Confidence            789999999887665543     367888889999999999999998 9999999999999999988 799999999875


Q ss_pred             cccCC------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          203 LVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       203 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      .....      ......++..|+|||.+.+...++.++|+||+||++|+|++|++||.+....+...++....+.+..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            53322      123356788999999886666688999999999999999999999999888888888888877777665


Q ss_pred             HhhcCcCcccc---cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCC
Q 016401          277 IKCMNPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  345 (390)
Q Consensus       277 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~  345 (390)
                      +..+.......   ........+....+ +.++.++.+||.+||+.||++|||+.++++||||+....+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~  307 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE  307 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCC
Confidence            54432211110   11111111122222 3478999999999999999999999999999999998665443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=319.81  Aligned_cols=288  Identities=26%  Similarity=0.441  Sum_probs=227.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHH---HHHHHHHhCC--------CCceeeecceeccCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD--------HPNIVALKHCFFSTT  116 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~E~~~l~~l~--------h~~iv~~~~~~~~~~  116 (390)
                      ...+|.+.++||.|.|++||+|.+..+.+.||+|+.+...-+.+   .|+++|+.++        ..+||++++.|.. .
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh-s  154 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH-S  154 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee-c
Confidence            33689999999999999999999999999999999977655443   5999999983        2479999998844 4


Q ss_pred             CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc----------
Q 016401          117 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN----------  186 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~----------  186 (390)
                      +....++|||+|+++.+|..++....  .+.++...++.|++||+.||.|||...||||-||||+|||+.          
T Consensus       155 GpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             CCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence            46788899999999999988887654  367999999999999999999999878999999999999983          


Q ss_pred             --------------------------------------------------------------------------------
Q 016401          187 --------------------------------------------------------------------------------  186 (390)
Q Consensus       187 --------------------------------------------------------------------------------  186 (390)
                                                                                                      
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence                                                                                            


Q ss_pred             ------------------------CC---------------------------------------------------CCc
Q 016401          187 ------------------------PH---------------------------------------------------THQ  191 (390)
Q Consensus       187 ------------------------~~---------------------------------------------------~~~  191 (390)
                                              ..                                                   ..+
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                    00                                                   003


Q ss_pred             EEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC------CChHHHHHHH
Q 016401          192 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG------ESGVDQLVEI  265 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~------~~~~~~~~~i  265 (390)
                      |||+|||-|...  ....+.-+.|+.|+|||++++.. |++.+||||++|++|||+||..+|..      ..+++.++.|
T Consensus       393 vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  393 VKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             EEEeeccchhhh--hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            778888887654  23334556799999999999876 99999999999999999999999953      2367899999


Q ss_pred             HHHhCCCCHHHHhhcCcCcccc-------cCCCCCCCCccccc------ccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          266 IKVLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHKVF------QKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ++.+|.-+...........+.|       ....+++.++.+++      +..-..++.|||.-||+++|++|+||.++|+
T Consensus       470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence            9999988876655433322222       12222333333322      1222356889999999999999999999999


Q ss_pred             CCcccccCC
Q 016401          333 HPFFDELRD  341 (390)
Q Consensus       333 hp~f~~~~~  341 (390)
                      |||+..+-.
T Consensus       550 hPwLn~~~~  558 (590)
T KOG1290|consen  550 HPWLNPVAG  558 (590)
T ss_pred             CccccCCCC
Confidence            999987644

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.5e-43  Score=321.07  Aligned_cols=261  Identities=24%  Similarity=0.369  Sum_probs=207.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|.+.+.||+|+||.||+|.+..+++.+|+|.+...   .....+|+.+++++ +|||++++++++...........|
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            45799999999999999999999999999999988542   23445799999998 899999999988654433345678


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|.+++.........+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            99999975 7777766544445678999999999999999999998 8999999999999999887 7999999998754


Q ss_pred             ccCC-CCcceeeccccccchhhcCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      .... ......++..|+|||.+....    .++.++|+||+||++|+|++|++||...+..+.+..+.+..  +      
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~------  250 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--P------  250 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--C------
Confidence            3322 123346788899999985332    26889999999999999999999998776555444332210  0      


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                                 +       ....+...+..+.+||.+||.+||++||++.++++||||+
T Consensus       251 -----------~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 -----------P-------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -----------C-------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                       0       0001134677899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-43  Score=328.56  Aligned_cols=285  Identities=35%  Similarity=0.589  Sum_probs=223.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-CCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  121 (390)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.++++++|+||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            358999999999999999999999999999999885432      234469999999999999999988743221 1223


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ..|++++++++++..++.     ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus        96 ~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~  168 (345)
T cd07877          96 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLAR  168 (345)
T ss_pred             cEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCC-CEEEecccccc
Confidence            467999999888766554     2468999999999999999999998 9999999999999999888 79999999987


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ...  .......++..|+|||.+.+...++.++||||+||++|+|++|++||...+....+..+....+.+.......+.
T Consensus       169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             ccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            542  233445678899999998665568899999999999999999999999888878888887777776665554332


Q ss_pred             cCcccc---cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          282 PNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       282 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      ......   ..+......+.... ...++++.+||.+||..||.+|+++.+++.||||++...+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence            211000   01111111111111 24688999999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5e-43  Score=320.61  Aligned_cols=276  Identities=40%  Similarity=0.702  Sum_probs=218.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|++|.||+|.+..+++.||+|++...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            699999999999999999999999999999987532      1334579999999999999999999843     34588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ++|||+++++...+..   ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++....
T Consensus        77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            9999999876544332   23568999999999999999999998 8999999999999999887 79999999987654


Q ss_pred             cCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 016401          205 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  281 (390)
Q Consensus       205 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  281 (390)
                      ...  ......++..|+|||++.+...++.++|+||+|+++|+|++|++||.+.+..+.+..+....+........... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            443  23345678899999999766468999999999999999999999999888777777777766655543332221 


Q ss_pred             -cCcccccCCCCC-CCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          282 -PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       282 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                       ..+....++... ...+...++..++.++.+||++||..||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             111111122111 1112233444568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=311.40  Aligned_cols=257  Identities=25%  Similarity=0.432  Sum_probs=203.2

Q ss_pred             cEEE-eeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIA-EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      -|++ .+.||+|+|+.|.-|.+..+|+.||||++.+..    ....+|++++..+ .|+||++++++|     +++..+|
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FY  152 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFY  152 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEE
Confidence            3544 468999999999999999999999999996643    3345899999999 599999999999     5555688


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEEEeecCCcc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAK  201 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~a~  201 (390)
                      ||||-|.| .+...+..    ...+++..+.+++.+|+.||.|||. +||.||||||+|||-..-.  ..||||||.++.
T Consensus       153 LVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             EEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccc
Confidence            99999985 55555544    4679999999999999999999998 9999999999999985432  369999999875


Q ss_pred             ccccC--------CCCcceeeccccccchhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH----------
Q 016401          202 VLVKG--------EPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV----------  259 (390)
Q Consensus       202 ~~~~~--------~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------  259 (390)
                      .+...        ....+.+|+..|||||+..    ....|+.++|.||||+|+|-||+|.+||.|.-..          
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C  307 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC  307 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence            43221        1224567888999999972    3456899999999999999999999999874321          


Q ss_pred             -----HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCC
Q 016401          260 -----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  334 (390)
Q Consensus       260 -----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp  334 (390)
                           ..+..|.+                 ..+.+|+   ..|     ..++.+++|||+.+|..|+..|.++.++++||
T Consensus       308 r~CQ~~LFesIQE-----------------GkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  308 RVCQNKLFESIQE-----------------GKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             HHHHHHHHHHHhc-----------------cCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence                 11222222                 1233332   223     45899999999999999999999999999999


Q ss_pred             cccccCCC
Q 016401          335 FFDELRDP  342 (390)
Q Consensus       335 ~f~~~~~~  342 (390)
                      |++.....
T Consensus       363 w~~~~~~e  370 (463)
T KOG0607|consen  363 WVQRCAPE  370 (463)
T ss_pred             cccccchh
Confidence            99987643

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.5e-43  Score=323.01  Aligned_cols=282  Identities=34%  Similarity=0.590  Sum_probs=218.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC---CC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  119 (390)
                      ..+|++.+.||.|++|.||+|.++.+++.||||++....      ....+|+++++.++|+||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            458999999999999999999999999999999874321      234579999999999999999988754332   23


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..++++||||+.+++...+..   ....+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            446789999999877655543   23569999999999999999999998 9999999999999999988 799999999


Q ss_pred             ccccccCCC------------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016401          200 AKVLVKGEP------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       200 a~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  267 (390)
                      +........            .....+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            875432211            12335688899999986666689999999999999999999999999888888888887


Q ss_pred             HhCCCCHHHHhhcC--cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          268 VLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       268 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      ..+.+....+....  +..................+ ..+++.+.+||++||..||++|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            77766554432211  11110000000111111111 3456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-43  Score=325.03  Aligned_cols=258  Identities=29%  Similarity=0.508  Sum_probs=208.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+....       ....+|+++++.++|+||+++++.+     ....+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            6999999999999999999999999999999886432       2345799999999999999999887     344568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+.+ +|..++...  ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            899999975 776665431  23568999999999999999999998 9999999999999999887 799999999865


Q ss_pred             cccCCC------------------------------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 016401          203 LVKGEP------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  252 (390)
Q Consensus       203 ~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  252 (390)
                      ......                              .....||..|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence            422111                              1123578889999999654 479999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC----HH
Q 016401          253 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT----AL  328 (390)
Q Consensus       253 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s----~~  328 (390)
                      |.+.+....+.++...                 ....+.          ...+++++.++|.+||..||++|||    +.
T Consensus       232 f~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            9888766655544321                 000110          0226899999999999999999999    99


Q ss_pred             HHhcCCcccccCCCCCC
Q 016401          329 EACVHPFFDELRDPNTR  345 (390)
Q Consensus       329 ~~l~hp~f~~~~~~~~~  345 (390)
                      ++|+||||+...++...
T Consensus       285 ~ll~~~~~~~~~~~~~~  301 (316)
T cd05574         285 EIKQHPFFRGVNWALIR  301 (316)
T ss_pred             HHHcCchhhcCChhhcc
Confidence            99999999987655443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-43  Score=316.98  Aligned_cols=248  Identities=28%  Similarity=0.453  Sum_probs=201.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..|.+.+.||+|++|.||+|.+..+++.||+|.+....         ....+|+++++.++||||+++++++.     ..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence            36999999999999999999999999999999875321         23457999999999999999999883     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ...++|+||+++ ++.+.+..    ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~-~~~l~dfg~  150 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGA  150 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccc
Confidence            368899999985 66555543    3568889999999999999999998 9999999999999999887 799999999


Q ss_pred             ccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          200 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       200 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      +.........    ....++..|+|||++.+. .++.++||||+|+++|+|++|+.||...+..+...++....      
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------  223 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------  223 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC------
Confidence            8754322111    234567889999999654 48999999999999999999999998765544443332210      


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                           ....++..++..+.+||++||..||.+|||+.++++||||
T Consensus       224 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 ---------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ---------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                 0111234678999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=312.90  Aligned_cols=280  Identities=32%  Similarity=0.556  Sum_probs=229.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  120 (390)
                      ...+|.-.+.+|.|+- .|..|.+..++++||+|+....      .+...+|..++..++|+||++++.+|..... ...
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3458999999999999 8999999999999999987443      3445689999999999999999999854332 223


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .-+|+|||++..+|...+.      ..++...+..+++|++.|++|||+ .||+||||||+||++..+. .+||+|||+|
T Consensus        94 ~e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~-~lKi~dfg~a  165 (369)
T KOG0665|consen   94 QEVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDC-TLKILDFGLA  165 (369)
T ss_pred             HhHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchh-heeeccchhh
Confidence            3378999999998877665      357778899999999999999998 9999999999999999887 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ......-..+.++.|+.|+|||++.+.. |.+.+||||+||++.||++|...|+|.+..++..++.+.+|.|....++.+
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            8665554567788899999999998876 999999999999999999999999999999999999999999999988776


Q ss_pred             CcCcccc--cCCCCCCCCccccccc-----------CCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          281 NPNYTEF--KFPQIKPHPWHKVFQK-----------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       281 ~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                      .+....+  ..++.....+.+.|++           .-+..++||+.+||..||++|.++.++|+||||+
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            5443222  1111111111221111           2245689999999999999999999999999998

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-44  Score=330.46  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=197.8

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  120 (390)
                      .+..|++.++||+|+.+.||++.... .+.||+|++...      ...+.+|+.+|.+| .|.+||+++++-     -.+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d  432 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTD  432 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccC
Confidence            44589999999999999999999753 466787766422      23345899999999 589999999986     446


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .++|+||||-+.+|..++....   ...+.-++++++.||+.|+.++|. .||||.||||.|+|+-. | .+||+|||.|
T Consensus       433 ~~lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlVk-G-~LKLIDFGIA  506 (677)
T KOG0596|consen  433 GYLYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLVK-G-RLKLIDFGIA  506 (677)
T ss_pred             ceEEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEEe-e-eEEeeeechh
Confidence            7899999999989999888643   233434899999999999999998 89999999999999875 4 6999999999


Q ss_pred             cccccCCCC---cceeeccccccchhhcCCC----------CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016401          201 KVLVKGEPN---VSYICSRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       201 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  267 (390)
                      ..+......   .+.+||+.||+||.+....          ..++++||||||||||+|+.|++||..-   ......+.
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---~n~~aKl~  583 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---INQIAKLH  583 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---HHHHHHHH
Confidence            877554433   4578999999999983211          2578999999999999999999999542   11222222


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      .+..|.           .++.+|++.           -..++.++++.||.+||.+||++.++|+|||++-.
T Consensus       584 aI~~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  584 AITDPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             hhcCCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            222221           122333321           12239999999999999999999999999999863

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.8e-43  Score=320.68  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=202.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHH-HHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .|++.+.||+|+||.||+|.++.+|+.||||++....     .....|..+ ++.+.||||+++++++..     ....|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcEE
Confidence            6999999999999999999999999999999886432     122245554 666799999999998843     33488


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++|||+++++..++.........+++..++.++.|++.||+|||+ + +++||||||+||+++.++ .+||+|||++...
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~  154 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL  154 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence            999999998888776654445679999999999999999999998 6 999999999999999888 7999999998765


Q ss_pred             ccCCCCcceeeccccccchhhcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhh
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ..........++..|+|||.+.+.   ..++.++|+||+||++|+|++|+.||.... ..+.+..+....  .       
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-------  225 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--S-------  225 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--C-------
Confidence            433333335678889999988542   346889999999999999999999996532 223333322210  0       


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                             ...           ....++.++.+||.+||..||.+||++.++++||||+...
T Consensus       226 -------~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         226 -------PQL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -------CCC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                   000           0124688999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-42  Score=325.77  Aligned_cols=284  Identities=35%  Similarity=0.639  Sum_probs=221.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCC-Cce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~  121 (390)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            457999999999999999999999999999999885321      2244799999999999999999987433221 123


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+++||||+++++..++.     ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            468999999888766654     2568999999999999999999998 9999999999999999887 79999999987


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ....  ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+.++.+..+.+..+....+.
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            5532  22344668899999999664558899999999999999999999999888877787777766665544333222


Q ss_pred             cCcc-c--ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          282 PNYT-E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       282 ~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      .... .  ...+......+. .+.+.+++++.++|.+||..||++|||+.+++.||||+..++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             chhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            1100 0  011111111111 1224678899999999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=320.50  Aligned_cols=274  Identities=40%  Similarity=0.733  Sum_probs=220.2

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++|+||+++++++..     ....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence            678899999999999999999899999999885432      234579999999999999999998743     345789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      ||||+++++...+...   ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            9999998886666542   3578999999999999999999998 9999999999999999887 799999999876544


Q ss_pred             CC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 016401          206 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  282 (390)
Q Consensus       206 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  282 (390)
                      .. ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.+..+.+..+...++.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            33 223345788899999997654689999999999999999999999999988888888888877776655444322  


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      ......++......... ..+.++.++.+||.+||..||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            11122222222222211 224578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.6e-43  Score=318.88  Aligned_cols=261  Identities=23%  Similarity=0.320  Sum_probs=206.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ...+|++.+.||+|+||.||+|.++.+++.||+|++....   ....+|+.+++.+ +|+||+++++++.........+.
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            4458999999999999999999999999999999875422   3455799999999 69999999998765444445568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ++||||+++ +|.+++.........+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .++|+|||++..
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~  173 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQ  173 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCC-CEEEccCCceee
Confidence            899999985 7777666544445678899999999999999999998 8999999999999999887 699999999876


Q ss_pred             cccCC-CCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          203 LVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       203 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ..... ......+++.|+|||++..    ...++.++|+||+||++|+|++|..||...+....+.++...         
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---------  244 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---------  244 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---------
Confidence            53322 2234467899999998842    234788999999999999999999999876543333222110         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                ..       .....+..++.++.+||.+||..||++|||+.++++|+||
T Consensus       245 ----------~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 ----------PP-------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ----------CC-------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                      00       0001123457889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=332.46  Aligned_cols=248  Identities=31%  Similarity=0.527  Sum_probs=209.2

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      .+.||+|.||+||-|+++.+|+.||||++.+      .....++|+.||+.+.||.||.+...|.+     ...+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-----~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-----PERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-----CceEEEEeh
Confidence            6799999999999999999999999999854      23556689999999999999998777632     333789999


Q ss_pred             cccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC--CCcEEEeecCCccccccC
Q 016401          129 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       129 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~Dfg~a~~~~~~  206 (390)
                      -+.|++...+-..  ..+++++...++++.||+.||.|||. ++|+|+||||+|||+.+.  ..++||||||+|+.+.+.
T Consensus       644 Kl~GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  644 KLHGDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hhcchHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            9999887766543  35789999999999999999999998 999999999999999643  448999999999999887


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      .-..+.+|||.|+|||++... .|...-|+||+|+|+|--+.|..||....+ .+++++.                    
T Consensus       721 sFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA--------------------  779 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA--------------------  779 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhcc--------------------
Confidence            777889999999999999654 599999999999999999999999965432 2333221                    


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      .|-   +++.+|     ..+++++.|||+.+|+..=++|.|++..|.|||+++.
T Consensus       780 aFM---yPp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  780 AFM---YPPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ccc---cCCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            121   234555     4579999999999999999999999999999999975

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=299.97  Aligned_cols=258  Identities=25%  Similarity=0.328  Sum_probs=204.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|++.+.||+|+|+.||++++..++..||+|++...    .....+|++..++++|||+++++++.+....+.....|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            34899999999999999999999999999999988532    33445899999999999999999987766555667789


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--cccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ++++|.. |++.+.+......+..+++..+..|+.+++.||++||+ ..  ++||||||.|||+.+.+ .++|.|||.++
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~  177 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSG-LPVLMDLGSAT  177 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCC-ceEEEeccCcc
Confidence            9999887 68999998888777789999999999999999999998 88  99999999999999877 79999999987


Q ss_pred             ccccCCC----------CcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016401          202 VLVKGEP----------NVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  269 (390)
Q Consensus       202 ~~~~~~~----------~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  269 (390)
                      .....-.          .....+|..|+|||.+.-  ....++++|||||||+||+|+.|..||...-         ...
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~G  248 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQG  248 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcC
Confidence            5432111          123467899999999832  2236889999999999999999999994211         000


Q ss_pred             CCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      +....      .-.-..+++|+.          ..+|..+.+||+.||+.||.+||++.+++.+
T Consensus       249 gSlaL------Av~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  249 GSLAL------AVQNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CeEEE------eeeccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            00000      000011222221          3479999999999999999999999999864

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1e-42  Score=319.21  Aligned_cols=248  Identities=30%  Similarity=0.490  Sum_probs=206.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|++|.||++.+..+++.||+|.+...       .....+|++++++++||||+++++++.     +....
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence            699999999999999999999999999999988542       123457999999999999999999883     34458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||++ ++|...+..    ...+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999995 677666554    3678999999999999999999998 9999999999999999888 799999999876


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+...++...              
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------  213 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--------------  213 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Confidence            5433  3345678899999998544 5789999999999999999999999877754444443320              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                         ..            .++..++..++++|.+||..||.+|+     +++++++||||+.+.+
T Consensus       214 ---~~------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         214 ---KV------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             ---Cc------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence               00            12245689999999999999999999     8999999999988753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.9e-42  Score=321.39  Aligned_cols=282  Identities=36%  Similarity=0.713  Sum_probs=222.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .++|.+.+.||.|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||+++.+++...    ...
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CCc
Confidence            45799999999999999999999999999999987432      23345799999999999999999987432    224


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .|++|||+++++..++.     ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||.+..
T Consensus        85 ~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENC-DLKICDFGLARI  157 (328)
T ss_pred             EEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence            77999999888766654     2467888899999999999999998 9999999999999999887 799999999875


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+.......+.+.++.++.+.......
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            422  223456788899999886655689999999999999999999999998887777777777777777655443211


Q ss_pred             Ccc-c--ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCC
Q 016401          283 NYT-E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  344 (390)
Q Consensus       283 ~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~  344 (390)
                      .-. .  ...+.....+..... +.+++.+.++|++||+.||++||++.+++.||||+..+.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~  299 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD  299 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence            100 0  011111111222222 457899999999999999999999999999999998776543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=317.48  Aligned_cols=275  Identities=39%  Similarity=0.692  Sum_probs=219.5

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      |++.+.||+|++|+||+|....+++.||||.+....     ....+|+..+++++ |+|++++++++..     ....|+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            678999999999999999998889999999885432     22346889999998 9999999998843     344789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      ||||+++++...+....  ...+++..+..++.|++.+|.|||+ +|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888876665422  2468999999999999999999998 9999999999999999887 799999999986654


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC--
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--  283 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--  283 (390)
                      ........++..|+|||++.+...++.++|+||||+++|+|++|++||......+.+.++...++.+....+......  
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            444445667889999999866666899999999999999999999999999888888888888887766543221100  


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      ......+..........+ +..+.++.+||++||..||++|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            011122222211122222 2347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=318.69  Aligned_cols=277  Identities=34%  Similarity=0.611  Sum_probs=216.3

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      |++.+.||+|++|.||+|.+..+++.+|+|++....      ....+|+.+++.++|+|++++++++...   .....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            788999999999999999999999999999986542      2345799999999999999999988432   1255889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      ||||+++++..++...   ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            9999998776665432   2478999999999999999999998 8999999999999999988 799999999876544


Q ss_pred             CCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          206 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       206 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ...  .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+..+.+..+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            321  223456788999998866566899999999999999999999999998888888888877766655443321110


Q ss_pred             --cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          284 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       284 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                        .................+...+++.+.++|++||.+||++||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00000000001111122222348899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-42  Score=315.32  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=202.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhC-CCCceeeecceeccCCCC-CceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~~  124 (390)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++...   .....+|+.+++++ +|+||+++++++...... ....+|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            4699999999999999999999999999999998543   23456799999998 699999999988654322 234678


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++|||+++ +|..++...  ....+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++ .++|+|||++...
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~  161 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  161 (272)
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCC-CEEEccCCCceec
Confidence            99999985 776666542  23568899999999999999999998 8999999999999999888 7999999998754


Q ss_pred             ccC-CCCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ... .......++..|+|||++.+    ...++.++|+||+||++|+|++|..||...........+...          
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~----------  231 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----------  231 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC----------
Confidence            322 22234567889999999853    234788999999999999999999999765543333222110          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                       .........++.++.+||.+||..||.+|||+.++++||||
T Consensus       232 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 -----------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -----------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                             00011123568899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=333.74  Aligned_cols=251  Identities=28%  Similarity=0.437  Sum_probs=214.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..|.-++.||+|+||.||-|++..+.+.||||++.-.       -..+.+|++.|++++|||++.+.+||+-..+     
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----  100 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----  100 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----
Confidence            4688899999999999999999999999999988422       1234479999999999999999999954333     


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .+||||||-|+-.+++....   .++.+..+..|..+.+.||+|||+ .+.||||||..|||+++.+ .|||+|||.|..
T Consensus       101 aWLVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi  175 (948)
T KOG0577|consen  101 AWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPG-LVKLADFGSASI  175 (948)
T ss_pred             HHHHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCC-eeeeccccchhh
Confidence            77999999998888887653   678899999999999999999998 8999999999999999988 799999999975


Q ss_pred             cccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .   .+..+++|||+|||||+++.  .+.|+-++||||||++..||.-.+||+...+....+.-|..-            
T Consensus       176 ~---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN------------  240 (948)
T KOG0577|consen  176 M---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------  240 (948)
T ss_pred             c---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc------------
Confidence            4   35567899999999999953  456999999999999999999999999999988888877652            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                             .-|.+..        ...+..+++||..||++-|.+|||++++|+|+|...-+
T Consensus       241 -------esPtLqs--------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  241 -------ESPTLQS--------NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             -------CCCCCCC--------chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                   1111111        23578899999999999999999999999999997643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-45  Score=330.44  Aligned_cols=253  Identities=27%  Similarity=0.415  Sum_probs=223.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ...++..||-|+||.|-++........+|+|++++..       .....|..+|..+..|.||++|..|     .++.|+
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv  495 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV  495 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence            5678889999999999999876555568999886432       2334699999999999999999998     778889


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |++||-|- |.++.+++.    .+.|++..+++++..+++|++|||+ +|||+|||||+|.+++.+| .+||.|||+|+.
T Consensus       496 YmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~G-y~KLVDFGFAKk  569 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRG-YLKLVDFGFAKK  569 (732)
T ss_pred             hhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCC-ceEEeehhhHHH
Confidence            99999775 688888776    5779999999999999999999998 9999999999999999999 699999999999


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      +..+....+++|||.|.|||++++.. .+.++|.||||+++|||++|.+||.+.++...+..|++.+.            
T Consensus       570 i~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------------  636 (732)
T KOG0614|consen  570 IGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------------  636 (732)
T ss_pred             hccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh------------
Confidence            99999999999999999999998765 79999999999999999999999999999999999998642            


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP  342 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~~  342 (390)
                         .+.            +|..++..+.+||++++..+|.+|..     +.++.+|.||.+..+.
T Consensus       637 ---~i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  637 ---KIE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             ---hhh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence               122            33578999999999999999999996     7899999999988753

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-44  Score=328.13  Aligned_cols=244  Identities=25%  Similarity=0.383  Sum_probs=200.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ....+++++.||+|.||.||.|.... ...||+|.++..   ...+.+|+.+|++|+|+|||++++++..     +.-+|
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piy  277 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIY  277 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceE
Confidence            34467788999999999999999864 347999988642   3445689999999999999999999832     22488


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ||||||. |+|.++++.  .....+.......++.|||+||+||.+ +++|||||-..||||+++. .+||+|||+|+..
T Consensus       278 IVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDL-VVKISDFGLARLI  353 (468)
T ss_pred             EEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCc-eEEEccccccccc
Confidence            9999998 788888876  345778999999999999999999998 9999999999999999988 7999999999944


Q ss_pred             ccCCCCcceee---ccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          204 VKGEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       204 ~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      .++. .....+   ...|.|||.+.- ..++.+|||||||++||||+| |+.||.+.+..+.+..+-+.           
T Consensus       354 ~d~~-Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-----------  420 (468)
T KOG0197|consen  354 GDDE-YTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-----------  420 (468)
T ss_pred             CCCc-eeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-----------
Confidence            3322 222222   456999999954 459999999999999999998 99999999888877776552           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                             +++|.          |+.+|+++.+++..||+.+|++|||.+.+.
T Consensus       421 -------yRlp~----------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  421 -------YRLPR----------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -------CcCCC----------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                   22322          367999999999999999999999998664

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-43  Score=344.59  Aligned_cols=282  Identities=21%  Similarity=0.284  Sum_probs=197.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCc-EEEEE------------------Eeccc---hhhHHHHHHHHHhCCCCceee
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGE-IVAIK------------------KVLQD---KRYKNRELQIMQMLDHPNIVA  107 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK------------------~~~~~---~~~~~~E~~~l~~l~h~~iv~  107 (390)
                      .+|++.+.||+|+||+||+|..+.... ..++|                  .+...   .....+|+.+|+.++|+||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            579999999999999999987643321 11211                  11111   123457999999999999999


Q ss_pred             ecceeccCCCCCceEEEEEEecccccHHHHHHHhh-hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc
Q 016401          108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  186 (390)
Q Consensus       108 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~  186 (390)
                      +++++..     ....|++++++.+++...+.... ..........++.++.||+.||+|||+ +||+||||||+|||++
T Consensus       228 l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl~  301 (501)
T PHA03210        228 IEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFLN  301 (501)
T ss_pred             EeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC
Confidence            9998833     33478999999887766654321 112334466788899999999999998 9999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCC-CC--CChHHH
Q 016401          187 PHTHQLKLCDFGSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PG--ESGVDQ  261 (390)
Q Consensus       187 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~--~~~~~~  261 (390)
                      .++ .+||+|||+++.......  .....||..|+|||++.+. .++.++|||||||++|||++|..++ .+  .+...+
T Consensus       302 ~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        302 CDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            888 799999999976543322  2345789999999999654 5899999999999999999987544 32  234456


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcc---cccCCCCCCCCccccc-ccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          262 LVEIIKVLGTPTREEIKCMNPNYT---EFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                      +.+++..++....+.......-+.   ...+... .......+ ...++.++.++|.+||.+||.+|||+.|+|.||||.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            666665554332211000000000   0000000 00111111 124678899999999999999999999999999998


Q ss_pred             ccC
Q 016401          338 ELR  340 (390)
Q Consensus       338 ~~~  340 (390)
                      ...
T Consensus       459 ~~~  461 (501)
T PHA03210        459 AEE  461 (501)
T ss_pred             cCC
Confidence            743

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.2e-43  Score=324.90  Aligned_cols=276  Identities=21%  Similarity=0.370  Sum_probs=198.7

Q ss_pred             Eeeeeeec--CceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           54 AEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        54 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +.++||+|  +|++||++.++.+|+.||+|++..+.      ....+|+.+++.++||||+++++++..     +...|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence            46789999  68899999999999999999986432      234579999999999999999998843     345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ ++.+++....  ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            9999984 7766665422  3458899999999999999999998 9999999999999999887 79999998654322


Q ss_pred             cCCC--------CcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC---
Q 016401          205 KGEP--------NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP---  272 (390)
Q Consensus       205 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---  272 (390)
                      ....        .....++..|+|||++.+. ..++.++||||+||++|+|++|..||............... ..+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~  231 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLL  231 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC-Cccccc
Confidence            1111        1123456779999999653 35899999999999999999999999876544433332221 000   


Q ss_pred             -----CHHHHhhcCcCcc--cccCCC------C---CCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          273 -----TREEIKCMNPNYT--EFKFPQ------I---KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       273 -----~~~~~~~~~~~~~--~~~~~~------~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                           +.+.+. +.....  ......      .   ........+...+++.+.+||++||++||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         232 DTTTIPAEELT-MKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             cccchhhhhcc-cCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence                 000000 000000  000000      0   00000111223567899999999999999999999999999999


Q ss_pred             cccC
Q 016401          337 DELR  340 (390)
Q Consensus       337 ~~~~  340 (390)
                      +.+.
T Consensus       311 ~~~~  314 (327)
T cd08227         311 KQIK  314 (327)
T ss_pred             hhcc
Confidence            8764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.4e-42  Score=317.46  Aligned_cols=282  Identities=31%  Similarity=0.506  Sum_probs=217.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-----
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-----  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----  117 (390)
                      ..+|++.+.||+|++|.||+|.++.+++.||+|.+....      ....+|+.+++.++||||+++++++.+..+     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            458999999999999999999999999999999885322      234579999999999999999988754331     


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          118 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      ....++|+||||+++++...+...   ...+++..+..++.|++.||+|||+ .||+|+||||+||+++.++ .+||+||
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~kl~df  160 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKG-QIKLADF  160 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-cEEeCcc
Confidence            122368899999998776655431   3468999999999999999999998 8999999999999999888 7999999


Q ss_pred             CCccccccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          198 GSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       198 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      |++........  .....++..|+|||.+.+...++.++||||+||++|+|++|++||...+..+.+..+.+..+.+...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            99876543321  1223457789999998665567899999999999999999999999888888888888877766654


Q ss_pred             HHhhcCc--CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          276 EIKCMNP--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       276 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      .+.....  .+............+.. ....++..+.++|.+||..||.+||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            4322210  00000000000011111 123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=314.88  Aligned_cols=274  Identities=41%  Similarity=0.711  Sum_probs=222.4

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      |++.+.||+|.+|.||+|++..+++.||+|++....      ....+|+.+++.++|+|++++++++..     ..+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence            677889999999999999999999999999886431      233469999999999999999998843     345889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      ||||++++|..++....   ..+++..+..++.|++.||++||+ .||+||||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            99999988877776421   468999999999999999999998 8999999999999999887 799999999876543


Q ss_pred             CC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          206 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       206 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      .. .......+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....+..+....
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 22234457789999999766568999999999999999999999999998888888888888888776665432221


Q ss_pred             -ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          285 -TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       285 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                       ....++..........+ +.++..+.++|++||..||++||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             12233333333333333 3458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5e-42  Score=308.78  Aligned_cols=249  Identities=28%  Similarity=0.437  Sum_probs=201.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .|++.+.||+|++|.||++.++.+++.||+|.+..+.      ....+|++++++++|+|++++++.+.    ..+..+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4999999999999999999999999999999885321      23457999999999999999987762    2234578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++|||+++ ++...+...  ....+++..++.++.|++.||++||+ .||+|+||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999985 676666532  23468999999999999999999998 9999999999999999887 7999999998765


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... ......+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||...+.......+....             
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-------------  218 (257)
T ss_pred             cccCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence            3322 2233457889999999855 458899999999999999999999998766544444333210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                            .+         ..+..+++++.+||.+||..||++||++.++++||||
T Consensus       219 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 ------LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ------CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  00         0123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.6e-43  Score=326.63  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=191.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      ++|++.+.||+|+||.||+|.+.     .+++.||||++....     ....+|+.+++.+ +||||+++++++..    
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----   82 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK----   82 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC----
Confidence            58999999999999999999752     345789999985422     2345799999999 89999999998742    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh------------------------------------------------------
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSR------------------------------------------------------  143 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------------------------  143 (390)
                      ....+++||||++ |+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            2234779999998 477777654211                                                      


Q ss_pred             ----hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCC---Ccceeecc
Q 016401          144 ----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSR  216 (390)
Q Consensus       144 ----~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~  216 (390)
                          ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.......   .....++.
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCc
Confidence                02347788889999999999999998 9999999999999999887 799999999975432211   11223467


Q ss_pred             ccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCC
Q 016401          217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH  295 (390)
Q Consensus       217 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (390)
                      .|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+...+... .              .         
T Consensus       241 ~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~--------------~---------  295 (338)
T cd05102         241 KWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG-T--------------R---------  295 (338)
T ss_pred             cccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC-C--------------C---------
Confidence            8999999965 458999999999999999997 999998765444333322210 0              0         


Q ss_pred             CcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          296 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       296 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                         ...+...++++.+||.+||..||++|||+.++++
T Consensus       296 ---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 ---MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence               0012457889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=313.53  Aligned_cols=261  Identities=26%  Similarity=0.405  Sum_probs=208.1

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhC-CCCceeeecceeccCCC-CCceE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      ..++|++.+.||+|++|.||+|.++.+++.|++|++....   ....+|+.+++++ .|+||+++++++..... ....+
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            3468999999999999999999999899999999886432   3456799999999 79999999999865443 34566


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||||+++ +|.+++.........+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~  161 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNA-EVKLVDFGVSA  161 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCC-eEEECCCccce
Confidence            8899999995 7766665544335678999999999999999999998 9999999999999999887 79999999987


Q ss_pred             ccccCC-CCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          202 VLVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       202 ~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ...... ......++..|+|||++..    ...++.++|||||||++|+|++|.+||...+....+.++....       
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------  234 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP-------  234 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC-------
Confidence            543322 2234567889999998843    2346789999999999999999999998765544444433210       


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                  .+..       ..+...+.++++||++||..||++|||+.++++|||+
T Consensus       235 ------------~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 ------------PPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ------------CCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                        0000       0112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.2e-42  Score=317.27  Aligned_cols=257  Identities=28%  Similarity=0.430  Sum_probs=203.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..|++.+.||.|+||.||+|++..+++.||+|.+....    ....+|+.+++.++|+||+++++++..     +...|+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            46999999999999999999999999999999986432    234469999999999999999998832     345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ ++..++..   ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            9999996 44343332   23568999999999999999999998 9999999999999999877 79999999986543


Q ss_pred             cC-CCCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          205 KG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       205 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      .. .......+++.|+|||++.+    ...++.++|+|||||++|+|++|.+||...+......++...   .       
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~-------  231 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---E-------  231 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---C-------
Confidence            22 12234567889999999842    334688999999999999999999999876654443333211   0       


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                               .+       ....+..++.++.+||++||..||++||++.++++||||..+...
T Consensus       232 ---------~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         232 ---------PP-------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ---------Cc-------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                     00       001123567899999999999999999999999999999887543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.4e-44  Score=296.60  Aligned_cols=283  Identities=31%  Similarity=0.574  Sum_probs=230.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc-chhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+.|++.+.+|+|-|+.||.|.+..+++.++||+++. ....+.+|+++|+.|. ||||++++++..+   .......+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchhH
Confidence            3579999999999999999999999999999999864 3455679999999996 9999999998844   334445689


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          127 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       127 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      +||++..-...+      -+.++...++.++.+++.||.|+|+ .||.|||+||.|++||.....++|+|||+|.....+
T Consensus       114 FE~v~n~Dfk~l------y~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQL------YPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHH------hhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            999986322222      2467888899999999999999998 999999999999999988778999999999988777


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHh-----hc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIK-----CM  280 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~  280 (390)
                      ......+.+.+|--||.+.....|+..-|+|||||++..|+..+-| |.|.+..+++.+|.+.+|.......-     .+
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            7767777899999999998888899999999999999999987755 47888999999999999886654321     13


Q ss_pred             CcCcccccCCCCCCCCccccccc----CCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ++.|..+ +......+|...+++    -.++++.||+.++|.+|..+|+|+.|++.||||..+...
T Consensus       267 dp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  267 DPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             ChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence            3444332 111223344433322    246999999999999999999999999999999876543

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5e-42  Score=315.44  Aligned_cols=252  Identities=26%  Similarity=0.405  Sum_probs=203.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|++.+.||+|++|.||+|.+..+++.||+|.+...    .....+|+.+++.++|+|++++++.+..     ....|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence            35899999999999999999999999999999988543    2344579999999999999999998843     34588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+.+ +|..++..     ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~  166 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (296)
T ss_pred             EeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEECccccchhc
Confidence            99999985 67665542     457888999999999999999998 9999999999999999887 7999999998754


Q ss_pred             ccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+.......+... +.+          
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~----------  234 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP----------  234 (296)
T ss_pred             cccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC----------
Confidence            33221 223467889999999854 44789999999999999999999999877654433322110 000          


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                     ....+..++..+.+||.+||..||++||++.++++||||...
T Consensus       235 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         235 ---------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             ---------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                           000123578899999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=314.34  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=204.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+..+.     ....+|+.+++.++|+||+++++++.     +..+.|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence            6899999999999999999999999999999885432     23457999999999999999999873     3356889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      |+||+.+ +|.+.+..     ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  149 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEG-DVKLADFGVSGQLT  149 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence            9999985 66665543     378999999999999999999998 9999999999999999987 79999999997664


Q ss_pred             cC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .. .......+++.|+|||.+.+.. ++.++|+||+||++|+|++|.+||...+.......+....              
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------  214 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--------------  214 (274)
T ss_pred             ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------------
Confidence            43 2233456788899999996544 8999999999999999999999997766444333322210              


Q ss_pred             cccccCCCCCCCCcccccccC-CChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                           .+         .+... ++.++.++|.+||..||++|||+.++++||||++..
T Consensus       215 -----~~---------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         215 -----PP---------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             -----CC---------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                 00         01112 688999999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-42  Score=316.56  Aligned_cols=251  Identities=26%  Similarity=0.445  Sum_probs=196.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..+.     ....+|++++++++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            5889999999999999999999999999999885431     234479999999999999999998843     344779


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      ||||+++......       ..+++..+..++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999997432211       347888899999999999999998 9999999999999999988 799999999975533


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      . ......+|..|+|||++.+. .++.++|+||+||++|+|++|..||......+.   ...........          
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  215 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE----------  215 (279)
T ss_pred             c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc----------
Confidence            2 23345788999999999654 489999999999999999999999965322110   00111110000          


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                           ..+        .......++++.+||.+||+.||++||++.++++||||+...
T Consensus       216 -----~~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         216 -----DPP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             -----CCC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence                 000        001134688999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.3e-42  Score=311.87  Aligned_cols=252  Identities=28%  Similarity=0.503  Sum_probs=200.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      +|+..+.||+|++|.||++.+..+++.||+|.+....          ....+|+++++.++|+||+++++++.     +.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence            4888999999999999999999999999999885322          23457999999999999999999883     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ...++||||+.+ +|.+++..    ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++..++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            457899999985 67666653    3568899999999999999999998 99999999999999988765799999999


Q ss_pred             ccccccCCC-----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +........     .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+.+....   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  226 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---  226 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence            876543211     123456888999999855 45899999999999999999999999755433333222221000   


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                                           .....++..+++++.+++.+||..||++||++.++++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                 001112345789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.4e-42  Score=316.73  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=203.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ...+|++.+.||+|++|.||+|.+..+++.||+|.+...    .....+|+.+++.++|+||+++++++.     ...+.
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~   91 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL   91 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEE
Confidence            345899999999999999999999999999999988532    233457999999999999999999883     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++ ++..++..     ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++..
T Consensus        92 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~  164 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQ  164 (297)
T ss_pred             EEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEECcCccceE
Confidence            899999985 66555532     467888999999999999999998 9999999999999999887 799999999875


Q ss_pred             cccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          203 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       203 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ...... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+... +.+         
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~---------  233 (297)
T cd06656         165 ITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP---------  233 (297)
T ss_pred             ccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCC---------
Confidence            433222 223467889999999955 45889999999999999999999999776543322211110 000         


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                      ....+..++..+++||.+||..||++||++.++++||||+..+
T Consensus       234 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         234 ----------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence                            0011245788999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.5e-42  Score=313.88  Aligned_cols=253  Identities=28%  Similarity=0.447  Sum_probs=204.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|++.+.||.|++|.||+|.+..+++.||+|.+...    .....+|+.+++.++|+||+++++.+.     .....|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEE
Confidence            34799999999999999999999999999999988532    233457999999999999999999883     334588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +|+||+.+ +|...+.     ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~  165 (296)
T cd06655          93 VVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQI  165 (296)
T ss_pred             EEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccchhc
Confidence            99999985 6655543     2468999999999999999999998 9999999999999999887 7999999998754


Q ss_pred             ccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+... ..+.         
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------  234 (296)
T cd06655         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------  234 (296)
T ss_pred             ccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc---------
Confidence            33322 223457888999999854 44889999999999999999999999887765544433221 0000         


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                      ...+..+++.+.+||++||..||++||++.+++.||||+..+
T Consensus       235 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 ----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             ----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                            001235788999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-42  Score=312.75  Aligned_cols=278  Identities=34%  Similarity=0.604  Sum_probs=215.3

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhC---CCCceeeecceeccCCCCCceE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      |++.+.||+|++|.||+|+++.+++.||+|++....      ....+|+.+++++   +|+|++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            788999999999999999998889999999985321      1234677777666   6999999999986544444455


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ++++|||+++++...+....  ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            88999999988776665422  2358999999999999999999998 8999999999999999987 799999999977


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........++..|+|||++.+. .++.++|+||+||++|+|++|.+||.+....+.+.++.+....+....+.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV-  234 (287)
T ss_pred             ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence            6544444445678889999999654 48999999999999999999999999988888888887766554433221110 


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                      ......++......+.. ..+.+++.+.+||.+||..||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhh-hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            00001111111111211 113567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-43  Score=327.44  Aligned_cols=258  Identities=28%  Similarity=0.411  Sum_probs=217.0

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ..+....|.+.+.||+|.|++|.+|++..++..||||++.+..      ....+|+++|+.++|||||+++.+..+..  
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~--  128 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA--  128 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc--
Confidence            3344568999999999999999999999999999999986542      22458999999999999999999984433  


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                         .+|+||||+.+ .+.+++..    .++..+..++.++.|+..|++|||+ ++|||||||++||||+.+. ++||+||
T Consensus       129 ---~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~m-nikIaDf  199 (596)
T KOG0586|consen  129 ---TLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENM-NIKIADF  199 (596)
T ss_pred             ---eeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccccc-ceeeecc
Confidence               38999999985 55555554    5667778999999999999999998 9999999999999999998 7999999


Q ss_pred             CCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          198 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       198 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      |++..+..+....+++|++.|.|||++.+..+.++++|+||+|+++|.|++|.+||.+.+-.+.-...+.          
T Consensus       200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----------  269 (596)
T KOG0586|consen  200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----------  269 (596)
T ss_pred             ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------
Confidence            9999888888888999999999999998888789999999999999999999999988763322211111          


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                             ..+.            ++--++.++.+||+++|..+|.+|++.+++.+|.|.-.....
T Consensus       270 -------gk~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 -------GKYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             -------eeec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                   0111            123478899999999999999999999999999999765543

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-42  Score=316.55  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=203.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.++++++|+||+++++++.     ...+.|+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence            6899999999999999999999999999999885421     23457999999999999999999873     3456889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ ++..++... .....+++..+..++.|++.||.|||+..||+|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence            9999986 665555431 11347899999999999999999999625999999999999999877 79999999987553


Q ss_pred             cCCCCcceeeccccccchhhcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          205 KGEPNVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      .. ......+++.|+|||.+.+..     .++.++|+||+||++|+|++|..||...+.......+......+       
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------  226 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-------  226 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-------
Confidence            22 223345778899999984432     35889999999999999999999997655433332222211100       


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                                        ...++..++.++.+||.+||..||++||++.++++||||...+..
T Consensus       227 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         227 ------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             ------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                              001224578999999999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.5e-42  Score=310.85  Aligned_cols=250  Identities=28%  Similarity=0.448  Sum_probs=197.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..|++.+.||+|+||.||+|.+..++..||+|.+...         .....+|+.+++.++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            3699999999999999999999999999999987532         1234579999999999999999987743   223


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..++++|||+++ +|...+..    ...+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++ .++|+|||+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~-~~~l~dfg~  152 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGA  152 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCCC
Confidence            457899999985 67666643    3458889999999999999999998 9999999999999999887 799999999


Q ss_pred             ccccccCC----CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          200 AKVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       200 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      +.......    ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+.......+...   +   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~---  225 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---P---  225 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---C---
Confidence            87543211    1123457888999999965 45899999999999999999999999876544433322210   0   


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                                           ....++..+++.++++| +||..||++||+++++++||||+
T Consensus       226 ---------------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         226 ---------------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---------------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                 00112235688899999 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-42  Score=310.71  Aligned_cols=246  Identities=34%  Similarity=0.546  Sum_probs=198.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------------hhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+....             ....+|+.++++++||||+++++++.    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence            4788899999999999999998899999999875321             22457999999999999999999873    


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                       ...+.+++|||+++ +|..++..    ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++ .++|+|
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          77 -DADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             -eCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCC-CEEecc
Confidence             33457899999975 66666643    3568889999999999999999998 9999999999999999887 799999


Q ss_pred             cCCccccccCC-------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016401          197 FGSAKVLVKGE-------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  269 (390)
Q Consensus       197 fg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  269 (390)
                      ||.++......       ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+.++... 
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  227 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-  227 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-
Confidence            99987654211       1122356788999999855 44789999999999999999999999876554433322210 


Q ss_pred             CCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                        ..         ..++..++..+.++|++||+.||.+||++.++++||||
T Consensus       228 ------------------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 ------------------AS---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ------------------CC---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                              00         01224578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=326.64  Aligned_cols=236  Identities=23%  Similarity=0.397  Sum_probs=200.6

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEeccc-cc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ET  133 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~  133 (390)
                      ++-||+|+.|.||+|+..  ++.||||+++.   ..+.+++-|++|+|+||+.+.++|     ....++|||||||. |-
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            567999999999999975  78899998743   345789999999999999999999     55667999999998 67


Q ss_pred             HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCCccee
Q 016401          134 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI  213 (390)
Q Consensus       134 l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~  213 (390)
                      |..+++.    .+.++......|..+|+.|++|||. +.|||||||.-||||..+. .|||+|||-++.........+++
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence            7777765    5678888999999999999999998 8999999999999999887 79999999999887777788899


Q ss_pred             eccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCC
Q 016401          214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  293 (390)
Q Consensus       214 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (390)
                      ||..|||||++. ..+.+.++|||||||+|||||||..||.+-+....+.-                           ..
T Consensus       273 GTVaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG---------------------------VG  324 (904)
T KOG4721|consen  273 GTVAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG---------------------------VG  324 (904)
T ss_pred             hhHhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchheeEEe---------------------------cc
Confidence            999999999995 45699999999999999999999999976543222110                           11


Q ss_pred             CCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCC
Q 016401          294 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  334 (390)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp  334 (390)
                      ...+.-..+..+|+.++-||+.||.-.|..||+..++|.|=
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            12223335578899999999999999999999999999884

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.4e-42  Score=313.02  Aligned_cols=256  Identities=25%  Similarity=0.377  Sum_probs=202.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhC-CCCceeeecceeccCCC-CCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~~  124 (390)
                      ..|++.+.||.|+||.||+|.+..+++.||+|++....   .....|+.+++++ +|+||+++++++..... ....++|
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            47999999999999999999999999999999885432   2345688889888 79999999998854322 2345688


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++|||+++ ++..++....  ...+++..+..++.||+.||+|||+ .||+|+||+|+||+++.++ .++|+|||++...
T Consensus        96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~  171 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  171 (282)
T ss_pred             EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCcchhhh
Confidence            99999985 7766665422  3457888899999999999999998 9999999999999999888 7999999998754


Q ss_pred             ccC-CCCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ... .......+++.|+|||++..    ...++.++|+|||||++|+|++|..||...........+....         
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---------  242 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---------  242 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC---------
Confidence            322 22234567889999999852    2347889999999999999999999997665433332221100         


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                        ........++.++.+||++||..||.+||++.++++||||
T Consensus       243 ------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 ------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                              0001113578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=314.47  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=204.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+....    ....+|+++++.++|+||+++++.+.     .....|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence            47999999999999999999998899999999885432    23447999999999999999999884     3345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ +|..++..   ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCC-CEEEccCccchhhc
Confidence            9999986 66565543   23568999999999999999999998 9999999999999999887 79999999886543


Q ss_pred             cCC-CCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          205 KGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ... ......+++.|+|||.+..    ...++.++|+||+||++|+|++|.+||.+.+....+.++...  .        
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~--------  224 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--E--------  224 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--C--------
Confidence            222 2234567889999999842    334678999999999999999999999877654444333220  0        


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                               .+.       ...+..++.++.++|.+||+.||.+||++.++++||||....
T Consensus       225 ---------~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         225 ---------PPT-------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             ---------CCC-------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                     000       001235788999999999999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.5e-42  Score=306.68  Aligned_cols=249  Identities=27%  Similarity=0.456  Sum_probs=204.7

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+...      .....+|+++++.++|||++++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            589999999999999999999999999999988543      223457999999999999999998873     344578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|.+++....  ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999985 7777665421  3458899999999999999999998 999999999999999876657899999999876


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ..........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+....              
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT--------------  217 (256)
T ss_pred             CCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC--------------
Confidence            55444445667889999999854 447899999999999999999999998776555444443210              


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                    ...++..+++++.++|.+||..||++|||+.++++||||
T Consensus       218 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         218 --------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             --------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                          001124578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-43  Score=328.27  Aligned_cols=243  Identities=30%  Similarity=0.459  Sum_probs=199.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ..+|.+...+|.|+|+.|-.|.+..+++.+++|++.+......+|+.++... +||||+++.+++     .+....|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeeee
Confidence            3579999999999999999999999999999999988777777888777666 799999999998     6666799999


Q ss_pred             ecccccH-HHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc-CCCCcEEEeecCCcccccc
Q 016401          128 EYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       128 e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |++.|.. .+-+.     ..+.....+..|+++|+.|+.|||+ +|+|||||||+|||++ ..+ .++|+|||.++....
T Consensus       396 e~l~g~ell~ri~-----~~~~~~~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIR-----SKPEFCSEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHH-----hcchhHHHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCC-cEEEEEechhhhCch
Confidence            9999733 22221     1223336777899999999999998 9999999999999994 666 799999999986543


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      .  ..+.+-|..|.|||++. ...|++++||||||++||+||+|+.||......   .++...++.+.            
T Consensus       469 ~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~------------  530 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK------------  530 (612)
T ss_pred             h--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc------------
Confidence            3  33445688899999996 556999999999999999999999999876544   22333322221            


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                     +...+|+.++|||++||+.||.+|+++.+++.||||
T Consensus       531 ---------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 ---------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ---------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                           114589999999999999999999999999999999

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.5e-42  Score=310.63  Aligned_cols=255  Identities=27%  Similarity=0.406  Sum_probs=203.8

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|++.+.||.|++|+||+|....++..+|+|++....     ....+|+++++.++|+||+++++.+.     .....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEEE
Confidence            6999999999999999999998899999999885432     34457999999999999999998873     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||++.+ ++...+..... ...+++..+..++.|++.||++||+ .|++|+||+|+||++++++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence            9999985 66666553221 2468899999999999999999998 9999999999999999887 79999999987654


Q ss_pred             cCCCC-----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          205 KGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       205 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      .....     ....++..|+|||++.....++.++|+|||||++|+|++|..||...+....+.++...  .+.      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------  225 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP------  225 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC------
Confidence            43222     33467889999999966546899999999999999999999999877655544443321  000      


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                              ..+.       ......+++.+.+|+.+||..||++||++.++++||||
T Consensus       226 --------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         226 --------SLET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             --------CcCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                    0000       00013578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.7e-43  Score=321.42  Aligned_cols=280  Identities=33%  Similarity=0.549  Sum_probs=225.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhh---HHHHHHHHHhCC------CCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLD------HPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~~  120 (390)
                      .+|.+....|+|-|++|.+|.+..-|..||||+|......   ..+|+++|++|+      .-|+++++..|     ...
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk  506 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK  506 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence            4799999999999999999999998999999999765433   347999999995      35788888888     444


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .++|||||.+.-+|..++..+.. .-.+....++.++.||..||..|.. .||+|.||||+|||+++....+||||||.|
T Consensus       507 nHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  507 NHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             ceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccc
Confidence            55999999999999999988765 4568889999999999999999998 899999999999999988778999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .....++ .+.+..+..|+|||++++.. |+...|+||+||+||||.||+.+|+|.+..+++...+..-|..+...+...
T Consensus       585 ~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             ccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            8664443 45566688899999998865 999999999999999999999999999999999998888888777655432


Q ss_pred             CcC---------c--ccc----------cCCCCCC-CCccccc--ccCCC-------hhHHHHHHHhcccCCCcCCCHHH
Q 016401          281 NPN---------Y--TEF----------KFPQIKP-HPWHKVF--QKRLP-------PEAVDLVCRFFQYSPNLRCTALE  329 (390)
Q Consensus       281 ~~~---------~--~~~----------~~~~~~~-~~~~~~~--~~~~~-------~~~~~li~~~L~~dP~~R~s~~~  329 (390)
                      ...         |  .+.          .+...++ ..+...+  .++++       ..+++||.+||..||++|.|+.+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence            111         1  000          0111111 1111111  01122       35889999999999999999999


Q ss_pred             HhcCCcccc
Q 016401          330 ACVHPFFDE  338 (390)
Q Consensus       330 ~l~hp~f~~  338 (390)
                      +|+||||+.
T Consensus       743 AL~HpFi~~  751 (752)
T KOG0670|consen  743 ALKHPFITE  751 (752)
T ss_pred             HhcCCcccC
Confidence            999999975

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-41  Score=305.37  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=202.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .|.+.+.||+|++|.||+|.++.+++.|++|.+...      .....+|+++++.++||||+++++++.     .....|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            388999999999999999999999999999987532      233447999999999999999999883     334588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+.+ +|..++...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            99999974 777766542  23578899999999999999999998 9999999999999999887 7999999998765


Q ss_pred             ccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..... .....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+....             
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------------  217 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            43322 2234578899999999654 48899999999999999999999998777555444433210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                            .+         .++..++..+.++|.+||+.+|++||++.++++|||+
T Consensus       218 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 ------FP---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------CC---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                  00         1113468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.9e-42  Score=316.31  Aligned_cols=277  Identities=26%  Similarity=0.421  Sum_probs=202.4

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|++.+.||+|+||.||++.+..++..||+|.+..+.     ....+|+++++.++||||+++++++.     ...++|+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEEE
Confidence            6999999999999999999999999999999885431     22457999999999999999999983     3345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ +|..++..    ...+++..+..++.|++.||.|||+..+++|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 77666654    366899999999999999999999624899999999999999887 79999999986543


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-HHHH-hhcCc
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT-REEI-KCMNP  282 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~-~~~~~  282 (390)
                      .. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+... ...+........ .... .....
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DS-MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             cc-ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence            22 2234567889999999855 448899999999999999999999997665322 222221100000 0000 00000


Q ss_pred             Cccc----c---cCC-CCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTE----F---KFP-QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~----~---~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ....    .   ... ..........-...++.++++||.+||..||++|||+.++++||||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            0000    0   000 00000000000123678899999999999999999999999999998743

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-41  Score=307.65  Aligned_cols=252  Identities=26%  Similarity=0.446  Sum_probs=205.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+...      .....+|+.+++.++|+||+++++.+..   ......|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            489999999999999999999999999999987532      1234468999999999999999887643   2344578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH-----hcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-----NCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH-----~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ++|||+++ +|..++.........+++..++.++.||+.||+|||     + .+++|+||+|+||+++.++ .+||+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCC-CEEEeccc
Confidence            99999984 787777665444567899999999999999999999     8 8999999999999999887 79999999


Q ss_pred             CccccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          199 SAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       199 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ++........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+...         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------  225 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---------  225 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---------
Confidence            9986644332 334567899999999955 44889999999999999999999999877643333322210         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                ..         ..++..++..+.+++.+||..||++||++.++++|||+
T Consensus       226 ----------~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ----------KF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ----------CC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                      00         11224578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.2e-42  Score=315.47  Aligned_cols=261  Identities=23%  Similarity=0.372  Sum_probs=202.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .|...+.||+|+||.||++.+..+++.||+|.+...     .....+|+.++.++. |+||+++++++..     ....+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence            577788999999999999999999999999988542     223457888999985 9999999998743     23367


Q ss_pred             EEEecccccHHHHHHHh-hhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++|||++.++..+.... ......+++..+..++.|++.||+|||+..+|+||||||+||+++.++ .++|+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            99999987765544322 222467999999999999999999999634999999999999999887 7999999999765


Q ss_pred             ccCCCCcceeeccccccchhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ..........++..|+|||++.+.  ..++.++||||+||++|+|++|++||.....  ....+.+.....         
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~---------  227 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD---------  227 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC---------
Confidence            444433445678899999999654  3689999999999999999999999976541  222222111000         


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                             .+..     ....+..++.++.+||.+||..||++|||+.++++||||+...
T Consensus       228 -------~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         228 -------PPIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             -------CCcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence                   0000     0111135789999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.7e-42  Score=308.72  Aligned_cols=246  Identities=28%  Similarity=0.455  Sum_probs=202.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+.+..       ....+|++++++++||||+++++++     .+..+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            4899999999999999999999999999999885432       3345799999999999999999887     344558


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+|+||+.+ +|...+..    ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            899999986 66555543    2578999999999999999999998 8999999999999999988 799999999876


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.  .+.+.+....            
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence            6544334455678889999999554 489999999999999999999999987664  2222211110            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH--HHHhcCCcc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFF  336 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~--~~~l~hp~f  336 (390)
                                      ....++..++.++.++|.+||..||.+|++.  .++++||||
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            0111234578999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-43  Score=329.64  Aligned_cols=248  Identities=31%  Similarity=0.504  Sum_probs=203.2

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecccc
Q 016401           57 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE  132 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~  132 (390)
                      +||+|.||+||.|++..|...+|||-+...    .....+|+.+.+.|+|.|||++++++     .++.++-+.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            799999999999999999999999988532    23345899999999999999999987     566678899999985


Q ss_pred             -cHHHHHHHhhhhcCCC--cHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCC-
Q 016401          133 -TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  208 (390)
Q Consensus       133 -~l~~~~~~~~~~~~~~--~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~-  208 (390)
                       +|..+++..   -+++  ++..+.++..||++||.|||+ ..|||||||-+|+||+.-.+.+||+|||-+++...-.+ 
T Consensus       657 GSLSsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             787777642   3566  788999999999999999998 89999999999999998877899999999987644333 


Q ss_pred             CcceeeccccccchhhcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 016401          209 NVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  287 (390)
Q Consensus       209 ~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  287 (390)
                      ..++.||..|||||++.. ...|+.++|||||||++.||.||++||........  .+++.                ..+
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkV----------------Gmy  794 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKV----------------GMY  794 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhh----------------cce
Confidence            345779999999999953 44599999999999999999999999976543221  11111                011


Q ss_pred             cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      +     .   +..+|..++.++++||.+|+..||.+||+|.++|..||++.-
T Consensus       795 K-----v---HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  795 K-----V---HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             e-----c---CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            1     1   112345678899999999999999999999999999999875

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-41  Score=307.45  Aligned_cols=247  Identities=28%  Similarity=0.469  Sum_probs=197.4

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      +|++.+.||.|+||.||+|.+ .+++.+|+|.+....          ....+|+++++.++|+||+++++++.     ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence            488999999999999999987 478899999875321          23457999999999999999999883     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .+.+++|||+.+ +|..++..    ...+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCC-eEEeccchh
Confidence            568899999985 66666543    3568899999999999999999998 8999999999999999887 799999999


Q ss_pred             ccccccC-------CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016401          200 AKVLVKG-------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       200 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      +......       .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....+  
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--  225 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--  225 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC--
Confidence            8754221       11123457888999999854 4588999999999999999999999987654443332222100  


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                              ....++..++.++.++|++||..||++||++.++++||||
T Consensus       226 ------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         226 ------------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ------------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                    0011224578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.1e-42  Score=312.28  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=202.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +-|++.+.||.|+||.||+|.+..++..+++|.+....    ....+|+++++.++|+|++++++.+..     ....|+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~   79 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   79 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEE
Confidence            34788999999999999999999999999999885432    234569999999999999999998843     345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ ++...+..   ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~  154 (282)
T cd06643          80 LIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  154 (282)
T ss_pred             EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCC-CEEEcccccccccc
Confidence            9999986 44443332   23568999999999999999999998 9999999999999999887 79999999986543


Q ss_pred             cCC-CCcceeeccccccchhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          205 KGE-PNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ... ......++..|+|||++.    ....++.++|+||+||++|+|++|.+||...+..+....+.....         
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---------  225 (282)
T cd06643         155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP---------  225 (282)
T ss_pred             ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC---------
Confidence            221 123346788999999984    233477899999999999999999999988776555544433100         


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                +       ....+..++.++++||.+||..||.+||++.++++||||...
T Consensus       226 ----------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         226 ----------P-------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ----------C-------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                      0       001123578899999999999999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-41  Score=306.11  Aligned_cols=250  Identities=29%  Similarity=0.447  Sum_probs=202.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+....  ....+|+++++.++|+||+++++++..     ..+.|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence            57999999999999999999999889999999986543  345689999999999999999998843     35588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+++ +|.+++..   ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            99985 66665543   23568999999999999999999998 8999999999999999888 7999999998765443


Q ss_pred             C-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      . ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...+..+....+...                 
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------  214 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-----------------  214 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC-----------------
Confidence            3 22334578889999998554 5899999999999999999999999876543322211110                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                        ..+       ....+..++..+.++|.+||+.||++|||+.++|.||||
T Consensus       215 --~~~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         215 --PPP-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             --CCC-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence              000       000123467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-41  Score=305.01  Aligned_cols=248  Identities=34%  Similarity=0.538  Sum_probs=201.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      +|+..+.||+|++|+||+|.+..+++.|++|.+....         ....+|+.+++.++|+||+++++++.     ...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence            4788899999999999999998899999999875322         23457999999999999999998873     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+++||+++ +|.+++..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||.+
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            57899999985 77666543    3468899999999999999999998 9999999999999999887 7999999998


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .............++..|+|||.+.....++.++|+||+||++|+|++|+.||......+....+....           
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----------  218 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-----------  218 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-----------
Confidence            765444333445678899999998544347899999999999999999999997765444333322210           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                             ..         ..++..+++++.+|+++||..||.+||++.+++.|||+
T Consensus       219 -------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 -------EL---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -------cC---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                   00         01224578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=301.45  Aligned_cols=285  Identities=26%  Similarity=0.442  Sum_probs=222.6

Q ss_pred             cCCCccceEEeeecccCCCCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHh
Q 016401           27 VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM   99 (390)
Q Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~   99 (390)
                      ++..+..+.....++.......-..|.+.++||+|+|++|.+++++.|.+.||+|+++++-       ...+.|..+...
T Consensus       227 ~~~~~~~a~~~m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~  306 (593)
T KOG0695|consen  227 DSEDLKPAIDGMDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ  306 (593)
T ss_pred             CccchhhhhhhccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHh
Confidence            3444444555555555444455568999999999999999999999999999999986532       234568888777


Q ss_pred             C-CCCceeeecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 016401          100 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  177 (390)
Q Consensus       100 l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~D  177 (390)
                      . +||.+|.++.+|     ..+..+++|.||++| +|--.++    ....++++.++++...|+.||.|||+ +|||+||
T Consensus       307 asn~pflvglhscf-----qtesrlffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~-rgiiyrd  376 (593)
T KOG0695|consen  307 ASNNPFLVGLHSCF-----QTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHE-RGIIYRD  376 (593)
T ss_pred             ccCCCeEEehhhhh-----cccceEEEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeee
Confidence            6 799999999999     334458899999996 4422222    24679999999999999999999998 9999999


Q ss_pred             CCCCcEEEcCCCCcEEEeecCCcccc-ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCC--
Q 016401          178 IKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP--  254 (390)
Q Consensus       178 lkp~NIll~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~--  254 (390)
                      ||.+|+|+|..+ .+||+|+|+++.- ..+....+++|||.|+|||++.+. .|+..+|+|+||++++||+.|+.||.  
T Consensus       377 lkldnvlldaeg-hikltdygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  377 LKLDNVLLDAEG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             ccccceEEccCC-ceeecccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCccee
Confidence            999999999999 5999999999753 344556778999999999999765 49999999999999999999999995  


Q ss_pred             -----CCChHHHHHHHH-HHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC--
Q 016401          255 -----GESGVDQLVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT--  326 (390)
Q Consensus       255 -----~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s--  326 (390)
                           ..+.++.+.+++ +.                             +-.++..++..+..+++..|.+||.+|..  
T Consensus       455 gm~n~d~ntedylfqvilek-----------------------------qiriprslsvkas~vlkgflnkdp~erlgc~  505 (593)
T KOG0695|consen  455 GMDNPDMNTEDYLFQVILEK-----------------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCR  505 (593)
T ss_pred             cCCCcccchhHHHHHHHhhh-----------------------------cccccceeehhhHHHHHHhhcCCcHHhcCCC
Confidence                 122334443332 21                             11133567888999999999999999984  


Q ss_pred             ----HHHHhcCCcccccCCCCCCCCCCCCCCC
Q 016401          327 ----ALEACVHPFFDELRDPNTRLPNGRPLPP  354 (390)
Q Consensus       327 ----~~~~l~hp~f~~~~~~~~~~~~~~~~~~  354 (390)
                          ..++..|+||+.+.  |..+.+.+..||
T Consensus       506 ~~~g~~dik~h~ffr~id--wd~leqk~v~pp  535 (593)
T KOG0695|consen  506 PQTGFSDIKSHAFFRSID--WDLLEQKQVLPP  535 (593)
T ss_pred             cccchhhhhcchhhhhCC--HHHHhhcccCCC
Confidence                68999999999876  444555555555

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-41  Score=309.52  Aligned_cols=247  Identities=25%  Similarity=0.381  Sum_probs=190.2

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHh---CCCCceeeecceeccCCCCCceEEEEE
Q 016401           57 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM---LDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      +||+|+||.||++.+..+++.||+|.+.+..       ....+|..+++.   ..||||+.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            4899999999999999999999999885421       112234444433   479999999888732     3347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+++ +|...+..    ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999985 66554442    4568999999999999999999998 9999999999999999887 799999999865433


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      . ......++..|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....               
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---------------  212 (279)
T cd05633         150 K-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---------------  212 (279)
T ss_pred             c-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------
Confidence            2 2233468999999999865555899999999999999999999999764322111 1111000               


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                                .....++..+++++.++|++||..||.+|+     |+.++++||||++++.
T Consensus       213 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         213 ----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             ----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence                      000112345789999999999999999999     6999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.7e-42  Score=309.09  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=197.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++||||+++++++..     ....|+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence            3799999999999999999999999999999988532    2335579999999999999999998832     345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ +|..++..    ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNG-DVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence            9999985 66665543    3568999999999999999999998 9999999999999999887 79999999997653


Q ss_pred             cCC-CCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KGE-PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ... ......+++.|+|||.+..  ...++.++|+||+||++|+|++|..||...+..+....+...             
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------  224 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------  224 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence            322 1234567889999998842  334788999999999999999999999655433222111110             


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  335 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~  335 (390)
                          .+..+.     +.  ....++..+.+||++||..||++|||++++++|+|
T Consensus       225 ----~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 ----NFQPPK-----LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ----CCCCCC-----Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                000000     00  11346889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=305.33  Aligned_cols=252  Identities=29%  Similarity=0.418  Sum_probs=202.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      .+|++.+.||.|++|.||+|.+..+++.+|+|.+...    .....+|+.+++.++||||+++++++.     ....+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEEE
Confidence            5799999999999999999999989999999988643    234567999999999999999998873     3445889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|||+++ ++..++...   ...+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||.+....
T Consensus        78 ~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999986 665554431   2578999999999999999999998 9999999999999999887 79999999987654


Q ss_pred             cCC-CCcceeeccccccchhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ... ......++..|+|||.+.+.  ..++.++|+||+||++|+|++|.+||.+.+.......+....            
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~------------  220 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN------------  220 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------
Confidence            322 22344678889999998543  257889999999999999999999998876555444332210            


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  335 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~  335 (390)
                           +..+.       .......+.++.+||++||..||.+|||+.+++.|+|
T Consensus       221 -----~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         221 -----FPPPK-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             -----CCCcc-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                 00000       0011345788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.7e-41  Score=306.34  Aligned_cols=245  Identities=29%  Similarity=0.470  Sum_probs=198.4

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ||.|++|.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++.+.     +..++|++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            689999999999999999999999885422       23457999999999999999999873     334588999998


Q ss_pred             c-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC
Q 016401          131 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  209 (390)
Q Consensus       131 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~  209 (390)
                      + ++|.+.+..    ...+++..+..++.||+.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            7 477666654    3458899999999999999999998 9999999999999999888 7999999999866544333


Q ss_pred             cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 016401          210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  287 (390)
Q Consensus       210 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  287 (390)
                      ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||....  ..+...++....               .  
T Consensus       150 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~--  211 (262)
T cd05572         150 WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------G--  211 (262)
T ss_pred             ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------C--
Confidence            44567889999999854 448999999999999999999999998765  333333332100               0  


Q ss_pred             cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                                ...++...++++.++|.+||..||++|++     +.|+++||||++..+
T Consensus       212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence                      01122345889999999999999999999     999999999998643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-41  Score=308.58  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=197.4

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ||+|+||+||+|.+..+|+.||+|.+...       .....+|+++++.++||||+++++++     ......|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            68999999999999999999999988532       12234699999999999999999887     3334578999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC
Q 016401          131 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  209 (390)
Q Consensus       131 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~  209 (390)
                      ++ +|...+....  ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            85 6766655322  2468999999999999999999998 9999999999999999888 7999999998765443333


Q ss_pred             cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 016401          210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  289 (390)
Q Consensus       210 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  289 (390)
                      ....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...........+....                 .  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~--  211 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-----------------L--  211 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-----------------c--
Confidence            4456678899999986544 8999999999999999999999997655322111111110                 0  


Q ss_pred             CCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCCC
Q 016401          290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  342 (390)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~~  342 (390)
                            .....++..+++.+.++|++||+.||++||     ++.++++||||..+.+.
T Consensus       212 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         212 ------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             ------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence                  000112245789999999999999999999     89999999999887643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.1e-42  Score=310.64  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=199.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++.+.     ...+.|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence            47999999999999999999999999999999885432    23457999999999999999999873     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|||+++ +|..++..    .+.+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06645          84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNG-HVKLADFGVSAQIT  157 (267)
T ss_pred             EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence            9999985 77665543    4578999999999999999999998 8999999999999999887 79999999986543


Q ss_pred             cCC-CCcceeeccccccchhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KGE-PNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ... ......|+..|+|||++.  ....++.++|+|||||++|+|++|..||........+......             
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-------------  224 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-------------  224 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-------------
Confidence            221 123456889999999874  2334789999999999999999999999765543333222110             


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  335 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~  335 (390)
                          ....+     .+..  ...++..+.+||.+||..||++||++.++++|||
T Consensus       225 ----~~~~~-----~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         225 ----NFQPP-----KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ----CCCCC-----cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                00000     0000  0246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=303.96  Aligned_cols=290  Identities=33%  Similarity=0.540  Sum_probs=228.7

Q ss_pred             CcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           46 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+....+-.+.||.|+||.||.+.+..+|+.||+|++..-      .+...+|+++|.-++|.|++..+++.....-.-
T Consensus        49 Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df  128 (449)
T KOG0664|consen   49 PQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF  128 (449)
T ss_pred             ccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence            33444667788999999999999999999999999987432      234458999999999999999888763322111


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      -.-+|+++|++..+|..++-.    .+.++...++-+++||++||+|||+ .||.||||||.|.|++++. .+||||||+
T Consensus       129 FqEiYV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNC-vLKICDFGL  202 (449)
T KOG0664|consen  129 FQELYVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNC-ILKICDFGL  202 (449)
T ss_pred             HHHHHHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCc-eEEeccccc
Confidence            112568889888777666543    5678889999999999999999998 9999999999999999986 799999999


Q ss_pred             ccccccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          200 AKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       200 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      |+.......  .+..+-|.+|+|||++.+...|+.+.||||+|||+.||+..+..|...++.+++..|.+.+|.|..+.+
T Consensus       203 ARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM  282 (449)
T KOG0664|consen  203 ARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM  282 (449)
T ss_pred             ccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence            986543322  234456899999999999999999999999999999999999999999999999999999999999988


Q ss_pred             hhcCcCcccccCCCCC-CCCccccc----ccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          278 KCMNPNYTEFKFPQIK-PHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      +.-+......-+..-. ...+...+    +..-..+..+++.++|.+||++|.+.++++.|++..+.+-
T Consensus       283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence            6443332221111111 11111111    1133457889999999999999999999999999987653

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.6e-41  Score=303.09  Aligned_cols=248  Identities=27%  Similarity=0.443  Sum_probs=202.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|+||.||++.+..+++.||+|.+...      .....+|+.+++.++|+||+++++++     ....+.|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            599999999999999999999999999999987532      12345799999999999999999987     3344688


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+.+ ++.+.+...  ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999975 776655431  12457889999999999999999998 9999999999999999887 7999999998755


Q ss_pred             ccCCCC-cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...... ....+++.|+|||++.+. .++.++|+||+||++|+|++|..||...+..+....+....             
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-------------  217 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-------------
Confidence            332211 234578889999998554 48899999999999999999999998776666555443310             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                            .         ...+..++.++.++|.+||..||.+||++.++++||||
T Consensus       218 ------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         218 ------Y---------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ------C---------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                  0         01124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.2e-41  Score=304.33  Aligned_cols=250  Identities=28%  Similarity=0.448  Sum_probs=198.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..|++.+.||+|+||.||+|.+..+++.||||.+..+         .....+|+.+++.+.||||+++++++.+   ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence            3699999999999999999999999999999987422         1234569999999999999999987732   223


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..++++|||+++ +|.+.+..    ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~Dfg~  152 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVG-NVKLGDFGA  152 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCC-CEEECcCcc
Confidence            457899999985 67665543    3457888899999999999999998 8999999999999999887 799999999


Q ss_pred             ccccccC----CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          200 AKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       200 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      +......    .......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+......++..   .+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~---  225 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QP---  225 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CC---
Confidence            8754321    11223457888999999965 4589999999999999999999999987654443332221   00   


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                                           .....+..++..+.++|++|| .+|++||+++++++|||+.
T Consensus       226 ---------------------~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         226 ---------------------TNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------------CCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence                                 001122456788999999999 4999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.2e-41  Score=308.74  Aligned_cols=253  Identities=28%  Similarity=0.498  Sum_probs=201.8

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .|.+.+.||+|+||.||++.+..+++.||+|.+....       ....+|+++++.++||||+++++.+     ....++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            6999999999999999999999999999999885432       2334799999999999999999887     334468


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++ +|..++..    ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            899999985 77666644    3568999999999999999999998 9999999999999999887 799999998863


Q ss_pred             cccCC----------------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016401          203 LVKGE----------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  266 (390)
Q Consensus       203 ~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  266 (390)
                      .....                ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            11000                0012346778999999865 458999999999999999999999998876555444443


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC---HHHHhcCCcccccCC
Q 016401          267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRD  341 (390)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~~~l~hp~f~~~~~  341 (390)
                      ...                 ...+.         ....++.++.++|++||..||++||+   +.++|+||||.....
T Consensus       230 ~~~-----------------~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         230 SDD-----------------IEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             hcc-----------------cCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            310                 00010         01247889999999999999999998   799999999977543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.8e-41  Score=301.71  Aligned_cols=248  Identities=31%  Similarity=0.472  Sum_probs=203.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||.|+||.||.+++..+++.+++|.+....      ....+|+.++++++|+||+++++++..     ....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            5999999999999999999999999999999875321      234579999999999999999999843     34588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++|||+++ +|...+....  ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            99999984 7776665321  3568899999999999999999998 8999999999999999888 7999999998765


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+....+...  ..          
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~----------  218 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NY----------  218 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CC----------
Confidence            3332 22345678999999998654 4789999999999999999999999887766655554321  00          


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                             +         ..+..++.++.++|.+||..||++||++.++++|||+
T Consensus       219 -------~---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         219 -------T---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -------C---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                   0         0113578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.1e-41  Score=305.75  Aligned_cols=262  Identities=26%  Similarity=0.424  Sum_probs=202.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|...+.||.|++|.||+|.+..+++.||+|.+....     ....+|+++++.++||||+++++++..   .....+|+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEEE
Confidence            6999999999999999999999999999999886432     234579999999999999999988743   23345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ +|.+++.........+++..+..++.||+.||+|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  156 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV  156 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence            9999985 7776665544445668999999999999999999998 9999999999999999887 79999999986543


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHhhc
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.....    .........   .....     
T Consensus       157 ~~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~-----  226 (287)
T cd06621         157 NSL-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV---NMPNP-----  226 (287)
T ss_pred             ccc-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh---cCCch-----
Confidence            322 223456788999999854 4589999999999999999999999976522    111111111   00000     


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                             ..+.   ...   .....++.+.+||.+||..||++|||+.|++.||||+...
T Consensus       227 -------~~~~---~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         227 -------ELKD---EPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             -------hhcc---CCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                   0000   000   0012467899999999999999999999999999996643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-41  Score=311.67  Aligned_cols=254  Identities=28%  Similarity=0.425  Sum_probs=203.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..|.....||+|+||.||++.+..+++.||||.+...    .....+|+.+++.++|+||+++++.+.     ...+.|+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEE
Confidence            4677788899999999999999999999999987532    223457999999999999999999873     3345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ ++..++.     ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus        97 v~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~  169 (292)
T cd06658          97 VMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVS  169 (292)
T ss_pred             EEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEccCcchhhcc
Confidence            9999986 5545443     2468899999999999999999998 9999999999999999887 79999999986543


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ... ......++..|+|||.+.+ ..++.++|+||+|+++|||++|..||.+.+....+..+.......           
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  237 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-----------  237 (292)
T ss_pred             cccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-----------
Confidence            222 2234567899999999854 458999999999999999999999998776655444332211000           


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                           .          ......+..+.++|.+||..||.+|||+.++++||||+....+
T Consensus       238 -----~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         238 -----V----------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             -----c----------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence                 0          0012468899999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.8e-41  Score=304.54  Aligned_cols=252  Identities=33%  Similarity=0.529  Sum_probs=198.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--------------hhHHHHHHHHHhCCCCceeeecceeccCC
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+....              ....+|+.+++.++|+|++++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            6999999999999999999998899999999874211              12346999999999999999998873   


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEe
Q 016401          117 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  195 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  195 (390)
                        .....++||||+.+ +|...+..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCC-eEEEe
Confidence              33457899999975 67666654    2568899999999999999999998 9999999999999999887 79999


Q ss_pred             ecCCccccccCC---CCcceeeccccccchhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016401          196 DFGSAKVLVKGE---PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       196 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      |||++.......   ......++..|+|||.+.... .++.++|+||||+++|++++|..||...+..+.+.++....  
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--  228 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--  228 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--
Confidence            999987543221   122345788899999986543 47899999999999999999999997655433332221100  


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                           ....+.......++..+.++|.+||..||++|||++++|+||||
T Consensus       229 ---------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 ---------------------SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ---------------------cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                 00001111223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.2e-41  Score=300.45  Aligned_cols=249  Identities=28%  Similarity=0.421  Sum_probs=201.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|.+.+.||+|+||.||++.++.++..||+|.+...      .....+|+.+++.++|+||+++++.+     ......|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            489999999999999999999999999999988532      23445899999999999999999987     3344588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +|+||+.+ +|...+...  ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999975 776655432  12357899999999999999999998 999999999999999988656799999998765


Q ss_pred             ccCCCC-cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...... ....+++.|+|||++.+. .++.++|+||+|+++|+|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            433221 233578889999988544 48899999999999999999999998776555444332210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                            .         ....+.++.++.++|.+||..+|++|||+.++++||||
T Consensus       219 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  0         01123568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-41  Score=302.19  Aligned_cols=246  Identities=33%  Similarity=0.522  Sum_probs=193.4

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHHH-HHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|++|.||+|.+..+++.||+|.+.....       ....|..+ ....+|+|++++++++.     .....|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            568999999999999999999999998854321       11234443 34458999999999883     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+++ +|..++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99985 77666643    3568999999999999999999998 8999999999999999887 799999999875432 


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  286 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (390)
                        .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+..+....+....                 
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  209 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-----------------  209 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-----------------
Confidence              22345788899999986554 8999999999999999999999998877655444332210                 


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC---HHHHhcCCcccccCC
Q 016401          287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRD  341 (390)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~~~l~hp~f~~~~~  341 (390)
                      .        .+.......+++++.++|.+||..||++||+   +.|+++||||+++++
T Consensus       210 ~--------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         210 I--------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             c--------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            0        0111112357899999999999999999995   579999999988653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-41  Score=306.11  Aligned_cols=255  Identities=30%  Similarity=0.523  Sum_probs=200.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|++.+.||.|++|.||+|.++.+++.+|+|.+....     ....+|+++++.++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            5888999999999999999999999999999885432     234579999999999999999988843     355889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ++||++ ++|.+++...   ...+++..+..++.|++.||+|||+..|++|+||||+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~  152 (265)
T cd06605          77 CMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhH
Confidence            999999 5777666542   267889999999999999999999636999999999999999887 79999999987553


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHH-hCCCCHHHHhhcCc
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKV-LGTPTREEIKCMNP  282 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~~  282 (390)
                      ..... ...++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+. .+......+. ...+          
T Consensus       153 ~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  220 (265)
T cd06605         153 NSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP----------  220 (265)
T ss_pred             HHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC----------
Confidence            32222 26678889999998554 589999999999999999999999976421 1111111111 0000          


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                            .+..        ....++.++.++|.+||..||++|||+.+++.||||+...
T Consensus       221 ------~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         221 ------PPRL--------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ------CCCC--------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                  0000        0012688999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9.3e-41  Score=304.90  Aligned_cols=240  Identities=17%  Similarity=0.212  Sum_probs=192.5

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      ..||+|+++.||+|..  +|+.||||.+....       ....+|+.+|++++||||+++++++.+.. ....++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            6799999999999997  58999999986432       23448999999999999999999885422 22345789999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCC
Q 016401          129 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  207 (390)
Q Consensus       129 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~  207 (390)
                      |+++ +|.+++..    ...+++.....++.|++.||.|||+..+++||||||+||+++.++ .+||+|||+++....  
T Consensus       103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~--  175 (283)
T PHA02988        103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS--  175 (283)
T ss_pred             eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc--
Confidence            9995 67666654    356888899999999999999999734899999999999999988 799999999875432  


Q ss_pred             CCcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 016401          208 PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  286 (390)
Q Consensus       208 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (390)
                      ......++..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......               
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~---------------  240 (283)
T PHA02988        176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS---------------  240 (283)
T ss_pred             ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence            22345678899999998542 45899999999999999999999999887766655544331100               


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .            .++..+++++++||.+||+.||++|||+.++++
T Consensus       241 ~------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        241 L------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             C------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            0            012357899999999999999999999999974

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.9e-41  Score=304.73  Aligned_cols=245  Identities=25%  Similarity=0.399  Sum_probs=190.7

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHH---HHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           57 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNREL---QIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .||+|+||.||+|.+..+++.||+|.+.+..       .....|.   .+++...||+|+.+++++     ......|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            4899999999999999999999999885421       1122333   344446899999998887     333458899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+.| +|...+..    ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999985 55544432    4578999999999999999999998 9999999999999999887 799999999875433


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHhhcCcC
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ--LVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      . ......|+..|+|||++.+...++.++|+||+||++|+|++|+.||.+......  .......               
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  213 (278)
T cd05606         150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------  213 (278)
T ss_pred             c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc---------------
Confidence            2 223456899999999996555589999999999999999999999977532211  1111100               


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                                   ....++..++.++.++|.+||..||.+|+     ++.++++||||++..+
T Consensus       214 -------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         214 -------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             -------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence                         00112235689999999999999999999     9999999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.3e-41  Score=309.79  Aligned_cols=249  Identities=28%  Similarity=0.418  Sum_probs=201.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+++++.++||||+++.+++..     ...
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence            46999999999999999999999899999999885321       234579999999999999999998843     334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .|+||||+.+++...+...   ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPG-TVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCC-CEEEeecCccee
Confidence            7899999999876665432   3468999999999999999999998 9999999999999999888 799999999865


Q ss_pred             cccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...   .....++..|+|||++.+  ...++.++||||+|+++|+|++|.+||.+.+.......+...  .         
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~---------  230 (307)
T cd06607         165 VSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--D---------  230 (307)
T ss_pred             cCC---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--C---------
Confidence            422   234467888999998842  345789999999999999999999999877655443332210  0         


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                              .+.        ......+..+.++|.+||..||++||++.+++.||||..
T Consensus       231 --------~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         231 --------SPT--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             --------CCC--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                    000        001235788999999999999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5e-41  Score=305.87  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=200.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      .|+..+.||.|+||.||+|.+..+++.||+|.+....     ....+|+.+++.+.|+||+++++++.     +..+.|+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            5889999999999999999999899999999885432     23457999999999999999999883     3446889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ +|.+++.     ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999985 6665554     2568889999999999999999998 9999999999999999887 79999999987654


Q ss_pred             cCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .... .....++..|+|||++.+. .++.++|+|||||++|+|++|.+||...+.......+...               
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------  216 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN---------------  216 (277)
T ss_pred             CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC---------------
Confidence            3221 2234568889999998654 4899999999999999999999999876644333222110               


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                          .         ...+...++..+.++|.+||..||++||++.++++||||...
T Consensus       217 ----~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         217 ----N---------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             ----C---------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence                0         001123467889999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-40  Score=307.42  Aligned_cols=254  Identities=20%  Similarity=0.279  Sum_probs=191.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC----------------CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceee
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVA  107 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~  107 (390)
                      ..+|++.+.||+|+||.||+|.+..                ++..||+|.+....     ..+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3579999999999999999998532                34579999885432     23457999999999999999


Q ss_pred             ecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhh---------------cCCCcHHHHHHHHHHHHHHHHHHHhcC
Q 016401          108 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRI---------------HQRMPLIYVKLYTYQICRALAYIHNCI  171 (390)
Q Consensus       108 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~---------------~~~~~~~~~~~~~~ql~~al~~LH~~~  171 (390)
                      +++++..     ....|+||||+.+ +|..++......               ...+++..+..++.||+.||.|||+ .
T Consensus        84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~  157 (304)
T cd05096          84 LLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-L  157 (304)
T ss_pred             EEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-C
Confidence            9998843     2347899999974 777776542211               1246778889999999999999998 8


Q ss_pred             CcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh
Q 016401          172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL  248 (390)
Q Consensus       172 ~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  248 (390)
                      ||+||||||+|||++.++ .+||+|||+++........   ....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus       158 ~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         158 NFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             CccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHH
Confidence            999999999999999887 7999999999765332211   122346789999998654 48999999999999999986


Q ss_pred             --CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC
Q 016401          249 --GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  326 (390)
Q Consensus       249 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s  326 (390)
                        +..||.+.+..+.+..+.........                     ......++.++..+.+|+.+||..||++|||
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs  294 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGR---------------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPS  294 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhccc---------------------cccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence              56788776655554443332100000                     0000112357889999999999999999999


Q ss_pred             HHHHh
Q 016401          327 ALEAC  331 (390)
Q Consensus       327 ~~~~l  331 (390)
                      +.++.
T Consensus       295 ~~~i~  299 (304)
T cd05096         295 FSDIH  299 (304)
T ss_pred             HHHHH
Confidence            99994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-42  Score=319.02  Aligned_cols=259  Identities=27%  Similarity=0.466  Sum_probs=204.7

Q ss_pred             CcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhh-------HHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           46 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-------KNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      +..+-.|..++.||-|+||+|.+++...|...||+|.+.+..-.       ...|..||...+.+-||++|..|     .
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----Q  699 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----Q  699 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----c
Confidence            34455799999999999999999999999999999988654322       23599999999999999999888     3


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      +...+|+||+|++| ++-.++-.    -+-|.|..+++++.++..|+++.|. .|+|||||||+|||||.||+ +||+||
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGH-IKLTDF  773 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGH-IKLTDF  773 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCc-eeeeec
Confidence            34448899999996 66555543    3568999999999999999999998 99999999999999999995 999999


Q ss_pred             CCccccc---------cCCCC----------------------------------cceeeccccccchhhcCCCCCCCch
Q 016401          198 GSAKVLV---------KGEPN----------------------------------VSYICSRYYRAPELIFGATEYTTAI  234 (390)
Q Consensus       198 g~a~~~~---------~~~~~----------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~  234 (390)
                      |+|+.+.         .+...                                  -..+||+.|+|||++... .|+-.+
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~c  852 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLC  852 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-Cccccc
Confidence            9986431         00000                                  135789999999999654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHH
Q 016401          235 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  314 (390)
Q Consensus       235 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  314 (390)
                      |+||.|||||||+.|++||...+..+.-.+++.-         .         .       .++-.+..++++++.+||.
T Consensus       853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw---------~---------~-------~l~~~~~~~ls~e~~~li~  907 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINW---------R---------N-------FLHIPYQGNLSKEALDLIQ  907 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh---------h---------h-------ccccccccccCHHHHHHHH
Confidence            9999999999999999999887765543333220         0         0       0111223578999999999


Q ss_pred             HhcccCCCcCCC---HHHHhcCCcccccCCC
Q 016401          315 RFFQYSPNLRCT---ALEACVHPFFDELRDP  342 (390)
Q Consensus       315 ~~L~~dP~~R~s---~~~~l~hp~f~~~~~~  342 (390)
                      +++ .+++.|+.   ++++..||||+.+...
T Consensus       908 kLc-~sad~RLGkng~d~vKaHpfFkgIDfs  937 (1034)
T KOG0608|consen  908 KLC-CSADSRLGKNGADQVKAHPFFKGIDFS  937 (1034)
T ss_pred             HHh-cChhhhhcccchhhhhcCccccccchH
Confidence            875 67888885   6789999999988643

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.8e-41  Score=308.06  Aligned_cols=252  Identities=27%  Similarity=0.426  Sum_probs=201.8

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .|.....||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|||++++++++..     ....|++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEE
Confidence            466677899999999999999989999999988432    2334579999999999999999998733     3457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+++ ++..++.     ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++.....
T Consensus        97 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~  169 (297)
T cd06659          97 MEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK  169 (297)
T ss_pred             EecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCC-cEEEeechhHhhccc
Confidence            999985 5555443     2568899999999999999999998 9999999999999999888 799999999875433


Q ss_pred             CC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          206 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       206 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      .. ......++..|+|||++.+. .++.++|+||+||++|+|++|..||...+..+.+..+...   +.           
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-----------  234 (297)
T cd06659         170 DVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-----------  234 (297)
T ss_pred             ccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-----------
Confidence            22 22345678999999999554 4899999999999999999999999877655544433210   00           


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                                ..+  .....++..+.++|++||+.||++||++.++++||||.+...
T Consensus       235 ----------~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         235 ----------PKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             ----------CCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence                      000  011357889999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-41  Score=309.14  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=200.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..|...+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++.     .....|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceE
Confidence            35788899999999999999999899999999875332     23457999999999999999999883     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ ++...+.     ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~  151 (277)
T cd06642          79 IIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQG-DVKLADFGVAGQL  151 (277)
T ss_pred             EEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCC-CEEEccccccccc
Confidence            99999985 6655443     3568899999999999999999998 9999999999999999887 7999999998765


Q ss_pred             ccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...              
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------  216 (277)
T cd06642         152 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------  216 (277)
T ss_pred             cCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------------
Confidence            43221 1233568889999999554 5899999999999999999999999765543332221110              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                           .         ...+...++.++.++|.+||..+|++||++.++++||||....
T Consensus       217 -----~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 -----S---------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             -----C---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                 0         0011234678899999999999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.5e-40  Score=298.74  Aligned_cols=251  Identities=31%  Similarity=0.518  Sum_probs=204.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|.+.+.||.|++|.||+|.+..+++.||+|++...     .....+|+.++..++|+|++++++++..     ....++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEEE
Confidence            689999999999999999999999999999988654     2345579999999999999999998833     355889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||++ ++|..++..    ...+++..+..++.|++.||+|||+..|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~  151 (264)
T cd06623          77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLE  151 (264)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecc
Confidence            999999 577666654    267899999999999999999999527999999999999999888 79999999987664


Q ss_pred             cCCCCc-ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--h-HHHHHHHHHHhCCCCHHHHhhc
Q 016401          205 KGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--G-VDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       205 ~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~-~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+  . .+....+...   .        
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~--------  219 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---P--------  219 (264)
T ss_pred             cCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---C--------
Confidence            433332 45678899999998554 58999999999999999999999997764  2 2222222110   0        


Q ss_pred             CcCcccccCCCCCCCCcccccccC-CChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                              .+         ..+.. ++..+.++|.+||..+|++||++.++++||||+..+
T Consensus       220 --------~~---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         220 --------PP---------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             --------CC---------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                    00         01123 788999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=303.70  Aligned_cols=251  Identities=27%  Similarity=0.481  Sum_probs=200.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCC---CCceeeecceeccCCCCCceE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...     .....+|+.+++.+.   |||++++++++.     ...+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            488899999999999999999999999999987532     223557899999986   999999999873     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .|++|||+.+ +|..++..     ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            7899999975 66555432     468899999999999999999998 9999999999999999877 79999999987


Q ss_pred             ccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....... .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+..             
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------------  216 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-------------  216 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-------------
Confidence            6544322 23346788999999986655678999999999999999999999976653322211100             


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                            ...+.        .....++.++.+++.+||..||++||++.++++||||++..
T Consensus       217 ------~~~~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         217 ------SKPPR--------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             ------CCCCC--------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                  00000        00123688999999999999999999999999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.6e-41  Score=317.44  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=191.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  117 (390)
                      ..+|.+.+.||+|+||.||+|++..+     ++.||+|++....     ....+|+.+++.+ +|+||+++++++..   
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~---  113 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH---  113 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC---
Confidence            34799999999999999999986443     3579999986432     2345799999999 89999999998833   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh-----------------------------------------------------
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSR-----------------------------------------------------  143 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  143 (390)
                        ...+|+||||+. |+|.+.+.....                                                     
T Consensus       114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence              334789999998 477776643211                                                     


Q ss_pred             -------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC-
Q 016401          144 -------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-  209 (390)
Q Consensus       144 -------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~-  209 (390)
                                   ...++++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence                         01247788899999999999999998 9999999999999999877 7999999998765332211 


Q ss_pred             --cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 016401          210 --VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  286 (390)
Q Consensus       210 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (390)
                        ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||........+.+.....                 
T Consensus       270 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-----------------  331 (374)
T cd05106         270 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-----------------  331 (374)
T ss_pred             eccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-----------------
Confidence              11223567999999955 458999999999999999997 999998765444333333210                 


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ..          ...+...++++.++|.+||..||.+|||+.++++
T Consensus       332 ~~----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         332 YQ----------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             cC----------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00          0011346899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-40  Score=301.39  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=191.8

Q ss_pred             ccEEEeeee--eecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVV--GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      +.|.+.+.+  |+|+||.||++.++.+++.+|+|.+..... ...|+.....+ +|+||+++++++..     ....|+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEE
Confidence            356676666  999999999999999999999998864322 12244444333 79999999998843     3358899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||++ ++|..++..    ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++..++|+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         88 MDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            99997 477766654    3478999999999999999999998 99999999999999998875799999999875432


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCcCc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      .   ....++..|+|||++.+ ..++.++|+||+|+++|+|++|..||......+. ..........             
T Consensus       163 ~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  225 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------------  225 (267)
T ss_pred             C---ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-------------
Confidence            2   23457889999999955 4589999999999999999999999986543321 1111111000             


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-HHHHhcCCccc
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFD  337 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-~~~~l~hp~f~  337 (390)
                                   .....+.+++.+.+||.+||+.||.+|++ .+++|+||||.
T Consensus       226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        226 -------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             -------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence                         00111357999999999999999999996 59999999996

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.6e-40  Score=302.41  Aligned_cols=254  Identities=30%  Similarity=0.462  Sum_probs=203.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..|...+.||+|++|.||++.+..+++.+|+|.+....    ....+|+.+++.++|+|++++++++..     ..+.|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~   93 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWV   93 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEE
Confidence            35777789999999999999998899999999874322    234579999999999999999998743     344789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ++||+.+ +|.+.+..     ..+++..+..++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||.+....
T Consensus        94 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~  166 (285)
T cd06648          94 VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVS  166 (285)
T ss_pred             EEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCC-cEEEcccccchhhc
Confidence            9999975 76665543     468889999999999999999998 9999999999999999887 79999999886543


Q ss_pred             cCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+.... .            
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~------------  232 (285)
T cd06648         167 KEVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-P------------  232 (285)
T ss_pred             cCCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-C------------
Confidence            3221 2234578899999998554 48999999999999999999999998776555544433210 0            


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                            +.       ......++..+.+||++||..||++||++.++++||||+..+++
T Consensus       233 ------~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         233 ------PK-------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             ------CC-------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                  00       00112368899999999999999999999999999999986643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-40  Score=306.26  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=201.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|.+.+.||+|+||.||++.+..++..||+|.+...    .....+|+.+++.++|||++++++.+..     ....|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence            35899999999999999999999889999999987532    2234579999999999999999998843     33478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +|+||+++ ++.+++..     ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence            99999985 66665542     457888899999999999999998 9999999999999999887 7999999988654


Q ss_pred             ccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..... .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||...+..+.+..+.. .+.           
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~-----------  232 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT-----------  232 (293)
T ss_pred             cccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCC-----------
Confidence            33221 223457888999999855 4588999999999999999999999987654433222111 000           


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                             +.     +  ..+..++..++++|++||..||++||++.+++.||||+..+
T Consensus       233 -------~~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         233 -------PE-----L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             -------CC-----C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                   00     0  01234678899999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-40  Score=299.27  Aligned_cols=250  Identities=29%  Similarity=0.464  Sum_probs=193.2

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ......||+|+||.||+|.+..++..||+|.+...    .....+|+.+++.++|+||+++++++.     ...+.++|+
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   84 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFM   84 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEE
Confidence            33446899999999999999999999999987543    234558999999999999999999873     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCC--cHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          128 EYVPE-TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~--~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||+.+ +|...+...   ...+  ++..+..++.||+.||+|||+ .||+||||||+||+++.+...++|+|||.+....
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99984 777666542   1234  778889999999999999998 9999999999999998744479999999987553


Q ss_pred             cCCC-CcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          205 KGEP-NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       205 ~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||................             
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  227 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-------------  227 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-------------
Confidence            3222 2234578899999998543 337899999999999999999999997643221111000000             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                   .....++..+++++.+|+++||..+|.+|||+.+++.||||
T Consensus       228 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 -------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                         00011234578899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.2e-40  Score=296.67  Aligned_cols=250  Identities=29%  Similarity=0.487  Sum_probs=204.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|.+.+.||.|++|.||++.+..+++.||+|++...      .....+|+++++.++|+|++++.+.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            589999999999999999999989999999998543      2334579999999999999999998843     25588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +|+||+++ +|...+.........+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 7777666543334679999999999999999999998 8999999999999999877 7999999998765


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.........             
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  219 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------  219 (258)
T ss_pred             ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence            4332 22335678899999998554 48899999999999999999999997766444333322210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                            .         ..++..++..+.+++++||..||++|||+.++|+||||
T Consensus       220 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ------Y---------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ------C---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                  0         01123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-40  Score=297.88  Aligned_cols=245  Identities=27%  Similarity=0.424  Sum_probs=197.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +|++.+.||.|+||.||++.++.+++.||+|.+...     .....+|+.+++.++|+||+++++.+     ....++|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            489999999999999999999999999999987532     12345799999999999999999988     33446889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|||+++ ++...+...  ....+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999985 665555431  23458899999999999999999998 9999999999999999887 79999999987553


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ... ......+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...+.......+....              
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  216 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS--------------  216 (255)
T ss_pred             ccccccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC--------------
Confidence            322 1234567889999999854 448999999999999999999999998776544444332210              


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                    ...++..++..+.+||.+||..||++||++.+++.-
T Consensus       217 --------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 --------------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --------------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                          001123468899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.5e-41  Score=312.59  Aligned_cols=277  Identities=21%  Similarity=0.314  Sum_probs=196.6

Q ss_pred             eeeeec--CceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ..||.|  +||+||+|++..+|+.||+|++....      ....+|+.+++.++||||++++++|.     ...+.|+||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            356666  99999999999999999999885322      33457889999999999999999983     334578999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+.+ ++..++....  ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99985 7766665432  3458899999999999999999998 9999999999999999887 7999999865332211


Q ss_pred             CCC--------cceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 016401          207 EPN--------VSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--  275 (390)
Q Consensus       207 ~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  275 (390)
                      ...        ....++..|+|||++.+. ..++.++||||+||++|+|++|.+||.+......+..+.......+..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            111        011235569999999653 347899999999999999999999998876555544433211110000  


Q ss_pred             -------HHhhcCcCcc----cccC-----CCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          276 -------EIKCMNPNYT----EFKF-----PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       276 -------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                             ........+.    ....     .......+.......+++.+.+||++||++||++|||+.++|+||||..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                   0000000000    0000     00000011111223467889999999999999999999999999999887


Q ss_pred             CC
Q 016401          340 RD  341 (390)
Q Consensus       340 ~~  341 (390)
                      ..
T Consensus       315 ~~  316 (328)
T cd08226         315 KE  316 (328)
T ss_pred             HH
Confidence            54

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=297.51  Aligned_cols=249  Identities=28%  Similarity=0.452  Sum_probs=199.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..|++.+.||+|++|.||+|.+..+++.||+|.+..+         .....+|+++++.++|+||+++++++.+   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            3699999999999999999999999999999987421         1234579999999999999999998733   223


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..++++|||+++ +|.+.+..    ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~  152 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGA  152 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcccc
Confidence            457799999975 66655543    3458889999999999999999998 8999999999999999887 799999999


Q ss_pred             ccccccC----CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          200 AKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       200 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ++.....    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||......+...++..   .+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~---  225 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QP---  225 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CC---
Confidence            8754321    111234578899999999654 478999999999999999999999987655444433321   11   


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                           ....++..+++.+.++|++||. +|.+||++.+++.|||.
T Consensus       226 ---------------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         226 ---------------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ---------------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                 1112345688999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=315.97  Aligned_cols=245  Identities=19%  Similarity=0.269  Sum_probs=192.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+..+...||+|+||+||+|++..   .||||++..+      ...+.+|+.++++-+|.||+-+.+++     ....+ 
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~~-  462 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPPL-  462 (678)
T ss_pred             HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCce-
Confidence            456789999999999999999864   4999998543      23456899999999999999999998     33443 


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .+|+.+|+| +|+..+...   ...|.......|+.|++.|+.|||. ++|||||||..||++.+++ +|||+|||++..
T Consensus       463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~-kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDL-KVKIGDFGLATV  537 (678)
T ss_pred             eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCC-cEEEecccceee
Confidence            799999998 776666543   3568888999999999999999998 9999999999999999887 899999999863


Q ss_pred             cc--c-CCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          203 LV--K-GEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       203 ~~--~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      -.  . ........|...|||||++..  ..+|++.+|||||||++|||++|..||...+....+..+-+....+..   
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~---  614 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL---  614 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc---
Confidence            21  1 122233456778999999954  346899999999999999999999999955543333222221111111   


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                           .....+++.++++|+..||.+++++||...+||.
T Consensus       615 ---------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  615 ---------------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ---------------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                 0112467889999999999999999999998875

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-40  Score=305.20  Aligned_cols=250  Identities=29%  Similarity=0.448  Sum_probs=202.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..|...+.||+|+||+||+|++..+++.||+|++....       ....+|+++++.++|||++++++++.+     ...
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~   95 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHT   95 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCE
Confidence            45778889999999999999999999999999885321       234579999999999999999998843     345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .|+||||+.+++...+..   ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..
T Consensus        96 ~~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~  170 (313)
T cd06633          96 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASK  170 (313)
T ss_pred             EEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCC-CEEEeecCCCcc
Confidence            789999999887666543   23568899999999999999999998 9999999999999999887 799999999864


Q ss_pred             cccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ..   ......++..|+|||.+..  ...++.++|+|||||++|+|++|.+||...+.......+... .          
T Consensus       171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~----------  236 (313)
T cd06633         171 SS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-D----------  236 (313)
T ss_pred             cC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-C----------
Confidence            32   2234567889999999842  345788999999999999999999999887765555444321 0          


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                              .+        ......++..+++||.+||+.||.+||++.+++.||||+..
T Consensus       237 --------~~--------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         237 --------SP--------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             --------CC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                    00        00113467889999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-40  Score=315.77  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=191.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      .+|++.+.||+|+||.||+|.+     ..++..||||+++...     ....+|+.+++.+ +||||+++++++..    
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~----  110 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV----  110 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc----
Confidence            4799999999999999999974     3456789999885432     2345799999999 89999999998833    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh------------------------------------------------------
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSR------------------------------------------------------  143 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------------------------  143 (390)
                       ....++||||++ |+|...+.....                                                      
T Consensus       111 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         111 -GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             -CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence             334789999998 477766653210                                                      


Q ss_pred             -----------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          144 -----------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       144 -----------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                                       ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGR-ITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCC-cEEEecCccceeccCc
Confidence                             01246788899999999999999998 9999999999999999877 7999999999765332


Q ss_pred             CCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          207 EPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       207 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...   ....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+.+.+...             
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  333 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG-------------  333 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-------------
Confidence            211   112235679999999654 58999999999999999998 899998765444443333210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                          ..          ...+...+.++++||.+||..||++|||+.++++.
T Consensus       334 ----~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         334 ----YR----------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----cc----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                00          00113457899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-40  Score=304.13  Aligned_cols=258  Identities=29%  Similarity=0.436  Sum_probs=199.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+|++.+.||+|+||+||++.+..+++.||+|++....     ....+|+++++.++||||+++++++..     ...+|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence            47999999999999999999999999999999875432     234579999999999999999998843     34588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|..++..    .+.+++..+..++.+++.||.|||+..+++||||+|+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~  154 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGEL  154 (284)
T ss_pred             EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccch
Confidence            99999985 66555443    356899999999999999999999635899999999999999887 7999999998654


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCHHHHhh
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ----LVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~  279 (390)
                      .... .....++..|+|||++.+. .++.++|+||+||++|+|++|..||......+.    ...+...        +..
T Consensus       155 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~  224 (284)
T cd06620         155 INSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--------LQQ  224 (284)
T ss_pred             hhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH--------HHH
Confidence            3222 2234678899999998654 589999999999999999999999986543211    1111100        000


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      ...    ...+.        .....++.++.+||.+||..||++|||+.++++||||..-
T Consensus       225 ~~~----~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         225 IVQ----EPPPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             Hhh----ccCCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            000    00000        0001367889999999999999999999999999999663

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.4e-40  Score=297.20  Aligned_cols=250  Identities=30%  Similarity=0.517  Sum_probs=196.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+....      ....+|+.+++.++|+||+++++.+.     .....+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence            5899999999999999999998899999999985432      23457999999999999999998763     334478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +|+||+++ +|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999985 66665543    3457888999999999999999998 9999999999999999877 7999999998765


Q ss_pred             ccCCCCc-----ceeeccccccchhhcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          204 VKGEPNV-----SYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       204 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      .......     ...++..|+|||++.+..  .++.++||||+|+++|++++|+.||...+........... +..    
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~----  224 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK----  224 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC----
Confidence            4332221     245678899999985432  3789999999999999999999999765432222211110 000    


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                ...+.          ...+++.+.+||++||+.||++||++.+++.|||+
T Consensus       225 ----------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         225 ----------PPIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ----------CCCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                      00010          02358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.2e-40  Score=300.41  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=197.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ..+|++.+.||+|+||.||+|.++.     .+..||+|.+....     ....+|+.+++.++|+||+++++++..    
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   80 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK----   80 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC----
Confidence            3589999999999999999997652     34579999875332     123468999999999999999998732    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhh------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCc
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  191 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~  191 (390)
                       ....|+||||+. ++|.+.+......      ....+...+..++.|++.||.|||+ +||+||||||+||+++.++ .
T Consensus        81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~-~  157 (288)
T cd05061          81 -GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDF-T  157 (288)
T ss_pred             -CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCC-c
Confidence             234789999997 5888777653221      1234567788999999999999998 9999999999999999887 7


Q ss_pred             EEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016401          192 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  267 (390)
                      ++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+.+..+....+..
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD  236 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999875433221   111234567999999854 458999999999999999998 7899987665544433322


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc------CCcccccC
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDELR  340 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~------hp~f~~~~  340 (390)
                      . +               ..            ..+...++.+.+++.+||..||++|||+.++++      ||||.++.
T Consensus       237 ~-~---------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         237 G-G---------------YL------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             C-C---------------CC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            0 0               00            011346789999999999999999999999986      99998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.5e-40  Score=300.30  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=199.8

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      -|++.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.+++.++||||+++++++.     ...+.|+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence            4888999999999999999998899999999875322     23457999999999999999999883     3445889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ ++..++.     ...+++..+..++.|++.|+.+||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCC-CEEEeecccceecc
Confidence            9999986 6655553     2468899999999999999999998 9999999999999999887 79999999987553


Q ss_pred             cCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .... .....++..|+|||.+.+ ...+.++|+||+||++|+|++|..||...+.......+... .             
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-------------  217 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N-------------  217 (277)
T ss_pred             cchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C-------------
Confidence            3221 123456888999999854 45789999999999999999999999766544333322110 0             


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                           .         ..+...++.++.++|.+||..||.+||++.++++||||...
T Consensus       218 -----~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         218 -----P---------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             -----C---------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                 0         01123578899999999999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.3e-40  Score=299.72  Aligned_cols=244  Identities=21%  Similarity=0.261  Sum_probs=191.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.+....     ..+.+|+.++++++||||+++++++..     ..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----GN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----CC
Confidence            47999999999999999999865   446789999886432     234579999999999999999998743     33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..++||||+++ +|..++...   ...+++..+..++.||+.||+|||+ .|++||||||+||+++.++ .++++|||.+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~-~~~l~dfg~~  154 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDL-VCKISGFRRL  154 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCC-cEEECCCccc
Confidence            47899999986 665555432   3468999999999999999999998 9999999999999999887 7999999987


Q ss_pred             cccccCCCCc--ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          201 KVLVKGEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       201 ~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ..........  ...++..|+|||.+.+ ..++.++||||+||++|++++ |..||.+.+..+.+..+...         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---------  224 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG---------  224 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---------
Confidence            5432221111  1233567999999855 458999999999999999775 99999887765544433221         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                               ...          ..+..++..+.+++.+||..||++||++.++++
T Consensus       225 ---------~~~----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         225 ---------FRL----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ---------CCC----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                     000          012457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.7e-40  Score=298.48  Aligned_cols=244  Identities=33%  Similarity=0.580  Sum_probs=196.9

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ||.|+||.||+|++..+++.||+|.+....       ....+|+++++.++|+||+++++.+     ......|++|||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999999899999999885432       2345789999999999999998887     3345588999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCC--
Q 016401          131 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--  207 (390)
Q Consensus       131 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~--  207 (390)
                      .+ +|..++..    ...+++..+..++.||+.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            75 77666654    2478999999999999999999998 9999999999999999988 79999999987543331  


Q ss_pred             -------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          208 -------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       208 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                             ......++..|+|||.+.... ++.++|+||||+++|+|++|..||...+..+....+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------  216 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG------------  216 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------
Confidence                   122345678899999986544 889999999999999999999999877755544443220            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH---HHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~---~~~l~hp~f~~~~  340 (390)
                           ....+.          ...++..+.+||.+||+.||.+|||+   .++|+||||.++.
T Consensus       217 -----~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         217 -----KIEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             -----CcCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence                 001110          01248999999999999999999999   9999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-40  Score=304.13  Aligned_cols=257  Identities=24%  Similarity=0.408  Sum_probs=199.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+.|++.+.||+|++|.||+|.+..+++.||||.+....     ....+|+.++.+. .|+||+++++++.+     ...
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCe
Confidence            357999999999999999999999889999999986432     1223466656555 59999999998833     345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .|++|||+++.+..+....   ...+++..+..++.|++.||+|||+..||+||||+|+||+++.++ .+||+|||++..
T Consensus        89 ~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~  164 (296)
T cd06618          89 VFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGR  164 (296)
T ss_pred             EEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchh
Confidence            8899999988776665442   357889999999999999999999624999999999999999887 799999999876


Q ss_pred             cccCCCCcceeeccccccchhhcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHh
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ...........++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||..... .+.+..+...   .      
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~------  235 (296)
T cd06618         165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---E------  235 (296)
T ss_pred             ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---C------
Confidence            5443333444567889999998543   2378899999999999999999999976432 2222222210   0      


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                .+..   +    ....++.++.+||.+||..||++||++.+++.||||+..+
T Consensus       236 ----------~~~~---~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         236 ----------PPSL---P----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             ----------CCCC---C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence                      0000   0    0024688999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.6e-40  Score=300.29  Aligned_cols=245  Identities=33%  Similarity=0.596  Sum_probs=201.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      +|.+.+.||+|++|.||+|.+..+++.||+|++...       .....+|+.+++.+. |+||+++++++     .....
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            699999999999999999999999999999988542       133457899999998 99999999987     33445


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+++|||+. ++|.+.+..    ...+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            889999995 677766654    3479999999999999999999998 9999999999999999888 79999999987


Q ss_pred             ccccCCC---------------------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 016401          202 VLVKGEP---------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  260 (390)
Q Consensus       202 ~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  260 (390)
                      .......                     .....++..|+|||++.. ..++.++|+||||++++++++|+.||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            5533221                     122346788999999854 448899999999999999999999998877555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH----HHHhcCCcc
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFF  336 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~----~~~l~hp~f  336 (390)
                      .+..+...                 .+            .++..+++.+.+||.+||..||.+||++    .++++||||
T Consensus       230 ~~~~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKL-----------------EY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhc-----------------CC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44443321                 01            1224568999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.5e-40  Score=294.24  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=202.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+...      .....+|+++++.++|+||+++.+++..     ....|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            489999999999999999999999999999987532      1233478999999999999999988843     34578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|...+.........+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999975 7777776544445678999999999999999999998 9999999999999999877 7999999999766


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+....+...               
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------  216 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------  216 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence            444 2333457889999999955 45889999999999999999999999877654433332210               


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                          .++         ..+...+.+++++|.+||..+|++||++.++++||++
T Consensus       217 ----~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 ----KYP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ----CCC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                000         0113468899999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.6e-40  Score=296.68  Aligned_cols=245  Identities=21%  Similarity=0.352  Sum_probs=195.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ..|.+.+.||+|++|.||+|.++.+++.||+|++..+..   ...+|+++++.++|+||+++++++.     ....++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence            469999999999999999999999999999999865432   3457999999999999999999873     23347899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||++ ++|.+.+...  ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            99997 4776666432  23458888999999999999999998 9999999999999999887 799999999876543


Q ss_pred             CCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...              
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--------------  221 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG--------------  221 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--------------
Confidence            2211  11223567999998854 458999999999999999998 99999887654443333211              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                          +          ....+..++.++.++|.+||..||++||++.++++
T Consensus       222 ----~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         222 ----Y----------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ----C----------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                0          00122457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.8e-40  Score=330.83  Aligned_cols=250  Identities=22%  Similarity=0.359  Sum_probs=192.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++..+       .....+|+++++.++||||+++++++.     +...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            3799999999999999999999999999999998542       123457999999999999999999873     3345


Q ss_pred             EEEEEecccc-cHHHHHHHhhh-------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          123 LNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                      .|++|||++| +|..++.....       .....+...+..++.||+.||+|||+ .||+||||||+||+++.++ .++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCC-CEEE
Confidence            7899999985 77777654321       12345667788999999999999998 9999999999999999888 7999


Q ss_pred             eecCCccccccCC-------------------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016401          195 CDFGSAKVLVKGE-------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  255 (390)
Q Consensus       195 ~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  255 (390)
                      +|||+++......                   ......||+.|+|||++.+. .++.++||||+||++|+|++|..||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999997551110                   01124689999999998654 589999999999999999999999977


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          256 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .+..+....  .....+.              ..     .+     ...+++.+.+++.+||..||++|++..+.+.+
T Consensus       234 ~~~~ki~~~--~~i~~P~--------------~~-----~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        234 KKGRKISYR--DVILSPI--------------EV-----AP-----YREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             cchhhhhhh--hhccChh--------------hc-----cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            543322211  1000000              00     00     13578999999999999999999987665543

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.3e-40  Score=305.60  Aligned_cols=249  Identities=28%  Similarity=0.418  Sum_probs=202.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..|...+.||+|+||.||++++..++..||+|.+....       ....+|+.+++.++|+|++++++++..     ...
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~   99 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHT   99 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCe
Confidence            35899999999999999999999999999999885321       234479999999999999999998843     334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .++||||+.+++.+.+...   ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++ .++|+|||++..
T Consensus       100 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~  174 (317)
T cd06635         100 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASI  174 (317)
T ss_pred             EEEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCC-CEEEecCCCccc
Confidence            7899999999876665432   3568899999999999999999998 9999999999999999887 799999999864


Q ss_pred             cccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...   .....++..|+|||.+.+  ...++.++|+||+||++|+|++|..||...+.......+......         
T Consensus       175 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~---------  242 (317)
T cd06635         175 ASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------  242 (317)
T ss_pred             cCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC---------
Confidence            322   234467888999999842  345789999999999999999999999877655555544431100         


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                        .......++.+++||.+||..||.+||++.++++|+|+..
T Consensus       243 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         243 ------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                              0011346788999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3e-40  Score=301.59  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=195.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCC-----cEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ....+|+.+++.++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            47999999999999999999976554     679999885432     23457999999999999999999873     2


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhh------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  186 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~------------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~  186 (390)
                      ....|++|||++ ++|.+++......            ...+++..+..++.|++.||.|||+ .|++|+||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence            334789999998 4777766543211            1457888999999999999999998 9999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 016401          187 PHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  262 (390)
Q Consensus       187 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  262 (390)
                      .++ .++|+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+..
T Consensus       159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 799999999875433221   1233457889999998554 48999999999999999998 99999887765544


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ..+....                   .         ...+..+++++.+|+.+||..||.+||++.+++++
T Consensus       237 ~~i~~~~-------------------~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSRQ-------------------L---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCC-------------------c---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4433210                   0         00124678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.5e-40  Score=296.71  Aligned_cols=249  Identities=24%  Similarity=0.434  Sum_probs=197.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc---------chhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      +|.+.+.||+|+||.||++++..++..+++|+++.         +.....+|+.+++.++||||+++++++..     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            58999999999999999999987777777776532         11223468899999999999999998743     23


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..++||||+.+ ++..++.........+++..++.++.|++.||+|||+ .|++|+||+|+||+++.+  .++|+|||.+
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~~--~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKNN--LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeecC--CEeecccCce
Confidence            47899999985 7777776655555679999999999999999999998 999999999999999853  5999999998


Q ss_pred             cccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+...  .        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~--------  221 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--P--------  221 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--C--------
Confidence            76533222 223456888999998854 44788999999999999999999999766544433332210  0        


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                               .         ..++..++.++.++|.+||..||++||++.++++||||
T Consensus       222 ---------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ---------T---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ---------C---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                     0         01124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.3e-40  Score=304.40  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=191.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcE--EEEEEeccc-----hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      +.|.+.+.||+|+||.||+|.++.++..  +|+|.+...     .....+|++++.++ +|+||+++++++.     ...
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CCC
Confidence            4799999999999999999999877754  577766432     12345799999999 8999999999883     334


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC
Q 016401          122 YLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  188 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  188 (390)
                      +.|+||||++ ++|..++.....            ....+++..++.++.||+.||+|||+ .|++||||||+|||++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCC
Confidence            5789999997 577777654321            12357889999999999999999998 999999999999999988


Q ss_pred             CCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016401          189 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       189 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  267 (390)
                      + .+||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       161 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             C-cEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            7 799999999864321111112223567999998854 458999999999999999998 9999987665443332211


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .                  ..          ...+..+++++.+||.+||..||++||++.+++.+
T Consensus       239 ~------------------~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 G------------------YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             C------------------Cc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                  00          00113468899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.2e-40  Score=296.90  Aligned_cols=248  Identities=26%  Similarity=0.435  Sum_probs=195.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||+|+||.||+|+++.+++.||||.+...       .....+|+++++.++||||+++++++.+     ....
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNEL   77 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCeE
Confidence            699999999999999999999999999999976431       1234579999999999999999998743     2347


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +++|||+++ +|..++.........+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~  155 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF  155 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCC-CEEECcccccee
Confidence            899999995 7777776554445568899999999999999999998 9999999999999999887 799999999876


Q ss_pred             cccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhc
Q 016401          203 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||..... ...+...+...+.++       
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------  227 (267)
T cd08228         156 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP-------  227 (267)
T ss_pred             ccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC-------
Confidence            533221 1234578889999998654 478999999999999999999999965432 122222221111100       


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                         ......+..+.++|.+||..||++||++.++++
T Consensus       228 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 -------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             -------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                               011246788999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.3e-40  Score=309.56  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=192.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      .+|++.+.||+|+||.||+|....     +++.||+|++....     ....+|+.+++++ +|+||+++++++..    
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~----   82 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK----   82 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec----
Confidence            489999999999999999997543     45789999885322     2234699999999 89999999987743    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhh------------------------------------------------------
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSR------------------------------------------------------  143 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  143 (390)
                      ....++++|||+++ +|...+.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            23347799999985 77666643211                                                      


Q ss_pred             ---hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCC---Ccceeeccc
Q 016401          144 ---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRY  217 (390)
Q Consensus       144 ---~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~  217 (390)
                         ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .++|+|||++........   .....++..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence               12367889999999999999999998 9999999999999999887 799999999976533221   112334667


Q ss_pred             cccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCC
Q 016401          218 YRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP  296 (390)
Q Consensus       218 y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (390)
                      |+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+....                          
T Consensus       241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------------------  293 (337)
T cd05054         241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--------------------------  293 (337)
T ss_pred             ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--------------------------
Confidence            9999999654 58999999999999999998 9999987554444433332100                          


Q ss_pred             cccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          297 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       297 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                       ....+...++++.+++.+||+.+|++||++.++++|
T Consensus       294 -~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         294 -RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             -CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             001123468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-41  Score=314.68  Aligned_cols=249  Identities=27%  Similarity=0.430  Sum_probs=201.9

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEe------ccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~------~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+...+||+|+|-+||+|.+..+|..||-=.+      ....  ..+..|+.+|+.|+||||+++|+.+.+.   ...++
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~i  118 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTI  118 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCcee
Confidence            34567899999999999999999988874222      1222  4456799999999999999999998653   33668


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC--CcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--GICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~--~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+|++. |+|..+...    .+..+...++.|++||+.||.|||+ +  -|||||||.+||+|+.+.+.|||+|+|+|
T Consensus       119 n~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             eeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHH
Confidence            89999998 566555544    5678889999999999999999998 5  59999999999999998779999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      +...... ....+|||.|||||++.  ..|+..+||||||+.+.||+|+..||..-....++++.+-. |..+..     
T Consensus       194 tl~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~s-----  264 (632)
T KOG0584|consen  194 TLLRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAA-----  264 (632)
T ss_pred             HHhhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHH-----
Confidence            8664443 34479999999999994  56999999999999999999999999987666665554432 222111     


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                      +.    .--.+++++||.+||.. .++|+|+.|+|+||||+.
T Consensus       265 ----------------l~----kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  265 ----------------LS----KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             ----------------hh----ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                            11    12378999999999999 999999999999999986

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=292.38  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=206.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHh-CCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ...+-+..||.|+||+|++..++.+|+..|||+++...     ..+..|.+...+ -+.||||++|+..+...+     .
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c  138 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C  138 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence            34566778999999999999999999999999986432     223345554444 378999999999865444     7


Q ss_pred             EEEEecccccHHHHHH-HhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPETVNRIAR-NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ++.||+|+-++..+-. .+.-....++|..+..+....+.||+||.+...|||||+||+|||++..| .|||||||.+..
T Consensus       139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHh
Confidence            7999999977654432 33344567999999999999999999999878999999999999999998 799999999987


Q ss_pred             cccCCCCcceeeccccccchhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHHHhhc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  280 (390)
                      ...+-..+.-.|...|||||.+.... .|+.+||+||||++|||+.||..||.+.+.  .+.++.... |.|+.-..   
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~---  292 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF---  292 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC---
Confidence            76666666677888899999995433 389999999999999999999999988654  344443332 22221000   


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                                        ..-.-+++..+..+|..||.+|-+.||...+++++||++....
T Consensus       293 ------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  293 ------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             ------------------cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence                              0000247899999999999999999999999999999987643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.8e-40  Score=329.52  Aligned_cols=141  Identities=26%  Similarity=0.440  Sum_probs=122.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++|+||++++.++     ....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            47999999999999999999999999999999986432       3456799999999999999999877     33445


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||||+. ++|..++..    ...+++..++.++.||+.||+|||. .||+||||||+|||++.++ .+||+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            889999996 477766654    3568889999999999999999998 8999999999999999887 79999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.8e-40  Score=301.26  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=195.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ..+|.+.+.||+|+||.||+|.+..     +++.||+|.+....     ....+|+++++.++|+||+++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence            3479999999999999999998743     36789999986432     3455799999999999999999988432   


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhh----------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYS----------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  187 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~  187 (390)
                        ...+++|||+++ +|..++....          .....+++..+..++.|++.||+|||+ .|++||||||+||+++.
T Consensus        81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~  157 (280)
T cd05049          81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY  157 (280)
T ss_pred             --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC
Confidence              447899999984 7777765432          112457888999999999999999998 99999999999999998


Q ss_pred             CCCcEEEeecCCccccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 016401          188 HTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  263 (390)
Q Consensus       188 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  263 (390)
                      ++ .++|+|||++.......   ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       158 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         158 DL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             CC-eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            87 79999999987543221   1123345678999999955 458999999999999999998 999998776655444


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+...  .                 .         ...+..++..+.+|+++||..||++||++.++++
T Consensus       236 ~~~~~--~-----------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         236 CITQG--R-----------------L---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHcC--C-----------------c---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            43321  0                 0         0112357899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-39  Score=291.41  Aligned_cols=250  Identities=35%  Similarity=0.535  Sum_probs=201.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|++|.||+|.+..+++.|++|++....      ....+|+.++++++|+||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            4889999999999999999999899999999885443      34557999999999999999998874321   25578


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +++||++ ++|.+++..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999995 577666654    2378999999999999999999998 9999999999999999877 7999999998866


Q ss_pred             ccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .....   .....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+....  .......          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc----------
Confidence            55442   3445678889999998554 489999999999999999999999987652111  1111000          


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                    ......++...+..+.+||.+||..||++||++.++++||||
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                          000111234568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.7e-40  Score=304.38  Aligned_cols=279  Identities=19%  Similarity=0.293  Sum_probs=195.2

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      |.+.+.+|.  ++.||.+++..+++.||||++...      .....+|+.+++.++|+||+++++++..     ....++
T Consensus         4 ~~i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (314)
T cd08216           4 TLIGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYV   76 (314)
T ss_pred             hhhhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEE
Confidence            334444444  455666666678999999998543      1345679999999999999999998843     344789


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|||++ +++..++...  ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||.+....
T Consensus        77 ~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~  152 (314)
T cd08216          77 VSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMI  152 (314)
T ss_pred             EEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCC-ceEEecCccceeec
Confidence            999998 4676666543  23468899999999999999999998 8999999999999999887 79999999886543


Q ss_pred             cCCC--------CcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          205 KGEP--------NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       205 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ....        .....++..|+|||++... ..++.++|+||+||++|+|++|..||........+.+...........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (314)
T cd08216         153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD  232 (314)
T ss_pred             cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccc
Confidence            2211        1223457789999998543 347899999999999999999999998766544433322211000000


Q ss_pred             --HHhhcCcCccc----ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          276 --EIKCMNPNYTE----FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       276 --~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                        ...........    ...+ .............++.++.+|+.+||.+||++|||+.++|+||||+.++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         233 KSTYPLYEDSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             cCchhhhcCCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence              00000000000    0000 000111112223456789999999999999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.8e-40  Score=301.07  Aligned_cols=251  Identities=27%  Similarity=0.428  Sum_probs=200.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .|.....||+|+||.||++.++.+++.||||.+...    .....+|+.+++.++|+||+++++.+.     ...+.+++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   95 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVV   95 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEE
Confidence            455567899999999999999999999999987432    223457999999999999999999883     33457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+++ ++..++.     ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~  168 (292)
T cd06657          96 MEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSK  168 (292)
T ss_pred             EecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEcccccceeccc
Confidence            999986 5544432     2468899999999999999999998 8999999999999999887 799999998865533


Q ss_pred             CC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          206 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       206 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      .. ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+.....              
T Consensus       169 ~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--------------  233 (292)
T cd06657         169 EVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--------------  233 (292)
T ss_pred             ccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--------------
Confidence            22 1233467889999998854 4578999999999999999999999987765554433322110              


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                ..+.  ....+++.+.+++.+||..||.+||++.++++||||.+..
T Consensus       234 ----------~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         234 ----------PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             ----------cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence                      0000  0134688999999999999999999999999999998865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-39  Score=296.89  Aligned_cols=249  Identities=21%  Similarity=0.295  Sum_probs=192.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ..+|++.+.||+|+||.||+|.+.     .++..||+|++....     ....+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----   79 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----
Confidence            457999999999999999999864     235679999875322     22447999999999999999998873     


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhh------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCc
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  191 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~  191 (390)
                      .....++||||++ ++|.+++......      ...++...+..++.|++.||+|||+ .|++|+||||+||+++.++ .
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~-~  157 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T  157 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCC-C
Confidence            3344789999998 4777776543211      1235677889999999999999998 9999999999999999887 7


Q ss_pred             EEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016401          192 LKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  267 (390)
                      ++|+|||++.........   ....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999998754332211   11234677999999854 448999999999999999999 7899987765544433322


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      . .                  .+         ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus       237 ~-~------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 G-G------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             C-C------------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1 0                  00         0123568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.8e-40  Score=299.36  Aligned_cols=255  Identities=27%  Similarity=0.466  Sum_probs=199.8

Q ss_pred             cEEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccch--------hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      .|++.+.||.|+||.||+|++.   .+|+.||+|++....        ....+|+.+++.+ .|+||+.+++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4889999999999999999975   478999999885421        2345799999999 589999998887     3


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      .+..+|+||||+++ +|...+..    ...+++..+..++.|++.||.|||+ .|++||||+|+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCC-CEEEeeC
Confidence            34568899999985 66555543    3568899999999999999999998 9999999999999999887 7999999


Q ss_pred             CCccccccCC--CCcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          198 GSAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       198 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      |++.......  ......++..|+|||.+... ..++.++||||||+++|+|++|..||...........+.+.+...  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            9987653322  12234578899999998543 346789999999999999999999997543322222222211000  


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                                             ...++..+++.+.+|+++||..||++|+     ++.++++||||+..++
T Consensus       228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence                                   0012245788999999999999999997     8999999999998875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-39  Score=289.80  Aligned_cols=248  Identities=29%  Similarity=0.485  Sum_probs=200.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .|.+.+.||+|++|.||++.+..+++.+++|++....    ....+|+++++.++|+|++++++++..     ....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence            3889999999999999999998899999999986543    345689999999999999999998833     3447899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      +||++ ++|.+++...   ...+++..+..++.|++.||++||+ .|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence            99999 5776665542   2578999999999999999999998 9999999999999999887 799999999876654


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      ........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......+... ..              
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~--------------  214 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GP--------------  214 (253)
T ss_pred             cccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CC--------------
Confidence            4323455678899999999654 4889999999999999999999999876544443332220 00              


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCc
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  335 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~  335 (390)
                          +..       .....++..+.++|.+||..||++|||+.++++|||
T Consensus       215 ----~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         215 ----PGL-------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ----CCc-------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                000       001124789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.1e-40  Score=302.88  Aligned_cols=251  Identities=26%  Similarity=0.402  Sum_probs=202.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...|...+.||+|++|.||+|+++.+++.+|+|.+....       ....+|+++++.++|+|++++.+++..     ..
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   88 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH   88 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CC
Confidence            346888999999999999999999999999999875321       123469999999999999999998843     33


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ..++||||+.+++...+...   ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++ .++|+|||++.
T Consensus        89 ~~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~  163 (308)
T cd06634          89 TAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSAS  163 (308)
T ss_pred             eeEEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCC-cEEECCcccce
Confidence            47899999998876665432   3468899999999999999999998 9999999999999999887 79999999987


Q ss_pred             ccccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ....   .....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+....          
T Consensus       164 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------  230 (308)
T cd06634         164 IMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----------  230 (308)
T ss_pred             eecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC----------
Confidence            5432   234467889999999842  3447889999999999999999999997765544444333210          


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                               .+        ......++..+.+||++||..+|++||++.++++|||+...
T Consensus       231 ---------~~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         231 ---------SP--------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ---------CC--------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                     00        00113468889999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=290.82  Aligned_cols=246  Identities=35%  Similarity=0.584  Sum_probs=201.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +|++.+.||+|++|.||++.+..+++.||+|.+....      ....+|++++++++|+|++++++++.     ...+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            4899999999999999999999899999999885443      23457999999999999999998873     334588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++|||+++ +|.+++..    ...+++..+..++.|++.||.+||+ .||+|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999986 66555543    3678999999999999999999998 9999999999999999877 7999999999766


Q ss_pred             ccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+......+....              
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------  214 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------  214 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence            44332 13346788899999985544 889999999999999999999999876644333332210              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                    ....++..++..+.+++.+||..||++|||+.+++.||||
T Consensus       215 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 --------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                          0011234678999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=296.10  Aligned_cols=251  Identities=20%  Similarity=0.292  Sum_probs=193.5

Q ss_pred             EEEeeeeeecCceEEEEEEEcCC---CcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-CCce
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  121 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  121 (390)
                      |++.+.||+|+||.||+|....+   +..||+|++..+.      ....+|+++++.++|+||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            57889999999999999987643   4789999886432      234579999999999999999988754332 2344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhh--hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      +.+++|||+.+ +|..++.....  ....+++..+..++.|++.||+|||+ .|++||||||+||++++++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCC-eEEECCcc
Confidence            57899999984 77666644321  22468899999999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          199 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       199 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +++........   .....+..|+|||.+. ...++.++|||||||++|||++ |.+||.+.+..+.+..+...      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~------  231 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG------  231 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------
Confidence            99765433211   1122356799999984 4458999999999999999999 89999876655444333220      


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                ...            ..+..++.++.+++.+||..||.+|||+.+++++
T Consensus       232 ----------~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         232 ----------NRL------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ----------CCC------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      000            0124578999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.3e-40  Score=300.89  Aligned_cols=248  Identities=22%  Similarity=0.297  Sum_probs=191.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCc--EEEEEEeccc-----hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ++|++.+.||+|+||.||+|..+.++.  .+++|.++..     .....+|+.++.++ +||||+++++++.     ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence            369999999999999999999877765  4688877532     12345799999999 7999999999873     333


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC
Q 016401          122 YLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  188 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  188 (390)
                      ..|++|||++ ++|.+++.....            ....+++..+..++.|++.||+|||+ .||+||||||+|||++.+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCC
Confidence            4789999997 577777754221            11358889999999999999999998 999999999999999988


Q ss_pred             CCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016401          189 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       189 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  267 (390)
                      + .+||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 L-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             C-eEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            7 799999999864322111111222456999999854 458999999999999999997 9999988776555444322


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ..                            ....+..++..+.+||.+||..||.+||+++++++.
T Consensus       234 ~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GY----------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            10                            000123578999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-39  Score=298.26  Aligned_cols=248  Identities=24%  Similarity=0.352  Sum_probs=194.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...|.+.+.||+|+||+||++.+.     .++..+|+|.+....    ....+|+.++++++||||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence            457999999999999999999853     345679999885432    23457999999999999999999883     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhh---------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSR---------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  189 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~  189 (390)
                      ..+.++||||++ ++|.+++.....         ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC
Confidence            345789999998 577776654321         12348999999999999999999998 9999999999999999888


Q ss_pred             CcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016401          190 HQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  265 (390)
Q Consensus       190 ~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  265 (390)
                       .++|+|||++........   .....++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||...+..+.+..+
T Consensus       158 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         158 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             -cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             799999999875533221   112234678999999854 458999999999999999998 99999877665544444


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          266 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ....                   .+         ..+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       236 ~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         236 TQGR-------------------VL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HcCC-------------------cC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3210                   00         011356889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-39  Score=321.04  Aligned_cols=280  Identities=23%  Similarity=0.289  Sum_probs=184.4

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCC----CcEEEEEEeccchhhHHHHHHHHHhC---CCCceeeecceeccCCC-CC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRET----GEIVAIKKVLQDKRYKNRELQIMQML---DHPNIVALKHCFFSTTD-KE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~-~~  119 (390)
                      ..++|.+.+.||+|+||.||+|++..+    +..||||++.....   .|..+..++   .+.++..+...+..... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            456899999999999999999999988    89999998754321   233222222   23333333333322111 33


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhh----------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSR----------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~----------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                      ...+++||||+++ +|.+++.....                .........+..++.||+.||+|||+ .||+||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence            4457899999985 67666643210                00112234567899999999999998 999999999999


Q ss_pred             EEEcCCCCcEEEeecCCccccccCC--CCcceeeccccccchhhcCCC---------------------CCCCchhHHHH
Q 016401          183 LLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGAT---------------------EYTTAIDIWST  239 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diwsl  239 (390)
                      ||++.+...+||+|||+|+......  ......+|+.|+|||.+....                     .++.++||||+
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9998654479999999997543322  224567899999999763221                     23456799999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhccc
Q 016401          240 GCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY  319 (390)
Q Consensus       240 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  319 (390)
                      ||++|||+++..+  ..+....+..++...+.+.........+...    ++.  ...... ....+..+.+||++||++
T Consensus       366 GviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~-~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        366 GLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVAWRKLVEPRAS----PDL--RRGFEV-LDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHHHHHhhccccc----hhh--hhhhhh-ccccchHHHHHHHHHccC
Confidence            9999999986654  3444455555555444332222111111100    000  000000 012345677999999999


Q ss_pred             CCCcCCCHHHHhcCCcccccC
Q 016401          320 SPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       320 dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ||++|||+.++|+||||+...
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCC
Confidence            999999999999999998754

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-42  Score=341.75  Aligned_cols=256  Identities=28%  Similarity=0.468  Sum_probs=207.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..++.....||.|.||.||.|.+..+|+..|+|-+.-.      .....+|..+|..++|||+|+++++-.+...     
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek----- 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK----- 1308 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----
Confidence            35788889999999999999999999999999976421      2334589999999999999999998754433     


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ++|.||||.+ +|.+++..    ++-.++...+.+..|++.|++|||+ .|||||||||+||+++.+| .+|++|||.|.
T Consensus      1309 v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNG-LIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCC-cEEeeccccee
Confidence            7799999995 76666654    4456777788889999999999998 8999999999999999988 79999999998


Q ss_pred             ccccCC-----CCcceeeccccccchhhcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCC
Q 016401          202 VLVKGE-----PNVSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPT  273 (390)
Q Consensus       202 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~  273 (390)
                      .+....     ......||+.|||||++.+..  ....+.|||||||++.||+||+.||...+ ++..+.....      
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------ 1456 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------ 1456 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc------
Confidence            775542     124578999999999996643  35779999999999999999999997644 3333333222      


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                                   ...|+         +|.+++++.+|||.+||+.||.+|+++.|+|+|-|-+...+.+
T Consensus      1457 -------------gh~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1457 -------------GHKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred             -------------cCCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence                         11122         3456899999999999999999999999999999987665543

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=295.31  Aligned_cols=248  Identities=23%  Similarity=0.311  Sum_probs=194.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      .++|++.+.||+|+||.||+|.++..     +..||+|.+....     ....+|+.+++.++|+||+++++++..    
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST----   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence            45899999999999999999998643     3789999875432     234579999999999999999998833    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhh------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCc
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  191 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~  191 (390)
                       ..+.++||||++ ++|..++......      ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .
T Consensus        81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~-~  157 (277)
T cd05032          81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDL-T  157 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCC-C
Confidence             345789999997 5887777543221      2346788899999999999999998 9999999999999999988 7


Q ss_pred             EEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016401          192 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  267 (390)
                      +||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|++++ |.+||.+.+..+....+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            99999999875533221   122345678999999854 448999999999999999998 9999987765544433321


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                       ..               ..            .++..++..+.+||.+||..||++|||+.++++
T Consensus       237 -~~---------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 -GG---------------HL------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -CC---------------CC------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             00               00            112346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-39  Score=295.92  Aligned_cols=250  Identities=21%  Similarity=0.297  Sum_probs=193.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ..+|.+.+.||+|++|.||+|.+..     ++..||+|.+....     ....+|+.+++.++|+||+++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            3579999999999999999999977     77889999875322     2345799999999999999999987432   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhh---cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcE
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQL  192 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~v  192 (390)
                        ...++||||+. ++|..++......   ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++  ..+
T Consensus        82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence              23679999997 5887777553211   1258889999999999999999998 8999999999999998653  258


Q ss_pred             EEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 016401          193 KLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  268 (390)
Q Consensus       193 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~  268 (390)
                      ||+|||+++.......   ......+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999976522211   1112234579999999654 48999999999999999997 99999877655443322210


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                       .               ..            ..+..++..+.+++.+||..||++||++.++++|
T Consensus       238 -~---------------~~------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 -G---------------RL------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -C---------------cC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             0               00            1124578999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.1e-39  Score=290.57  Aligned_cols=243  Identities=22%  Similarity=0.316  Sum_probs=192.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ..|++.+.||+|+||.||++..+ .+..+|+|.+...   .....+|+.++++++||||+++++++.     .....++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence            46999999999999999999875 4567999987543   234567999999999999999999873     33347899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||++ ++|.+.+...   ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            99997 4676655431   2458889999999999999999998 9999999999999999887 799999999875433


Q ss_pred             CCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  ....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |+.||...+..+.+..+.....            
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------------  219 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------------  219 (256)
T ss_pred             CceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence            2221  12234567999999854 458999999999999999999 9999988776655555433100            


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                      ...+...+..+.+|+.+||..||.+||++.++++
T Consensus       220 ----------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         220 ----------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            0011235788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-39  Score=302.22  Aligned_cols=245  Identities=22%  Similarity=0.368  Sum_probs=190.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcE----EEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...|++.+.||+|+||.||+|.+..+++.    ||+|.+....     ....+|+.+++.++||||+++++++...    
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC----
Confidence            34799999999999999999998666654    8999885322     2345789999999999999999987431    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                        ..++++||+. |++.+.+...   ...++...+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        82 --~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~-~~kl~DfG  154 (316)
T cd05108          82 --TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQ-HVKITDFG  154 (316)
T ss_pred             --CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCC-cEEEcccc
Confidence              1458999988 4676665532   3457888899999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCCCcc---eeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          199 SAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       199 ~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +++..........   ..++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+ +..+....     
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~-----  227 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKG-----  227 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCC-----
Confidence            9986543332211   223567999999955 458999999999999999997 999997765433 23332210     


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                  ...+          .+..++.++.+++.+||..||++||++.+++.+
T Consensus       228 ------------~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         228 ------------ERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ------------CCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                        0000          113467889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.6e-39  Score=291.90  Aligned_cols=245  Identities=24%  Similarity=0.337  Sum_probs=193.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+|++.+.||+|++|.||+|.+. ++..||+|.+....   ....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence            358999999999999999999974 56779999875432   34457999999999999999988873     3334789


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|||+. ++|.+++...  ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESL-MCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCC-cEEECCCccceecC
Confidence            999997 4777766532  23567888899999999999999998 9999999999999999887 79999999997654


Q ss_pred             cCCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .....  ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+...             
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-------------  220 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-------------  220 (261)
T ss_pred             CCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-------------
Confidence            32211  12234667999999854 448899999999999999998 99999877655544443321             


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                           +..+          ....++.++.+++.+||..||++||+++++++
T Consensus       221 -----~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         221 -----YRMP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -----CCCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                 0000          11347889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.9e-39  Score=294.48  Aligned_cols=251  Identities=20%  Similarity=0.268  Sum_probs=190.3

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCc--EEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.++..      .....+|+.+++.++|+||+++++.++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999877765  6999987532      2234569999999999999999987644322 12234


Q ss_pred             EEEEEeccc-ccHHHHHHHhh--hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          123 LNLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .+++|||+. ++|...+....  .....+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCC-CEEECCCCc
Confidence            678999998 47766553221  112347899999999999999999998 9999999999999999887 799999999


Q ss_pred             ccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          200 AKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       200 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ++.......   .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+... .     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~-----  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-N-----  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-C-----
Confidence            986543321   112234667999999854 458999999999999999999 89999876654433332210 0     


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                  .          ...+..++..+.++|.+||+.||++|||+.+++++
T Consensus       232 ------------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         232 ------------R----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ------------C----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                        0          00123578899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.4e-39  Score=291.36  Aligned_cols=244  Identities=20%  Similarity=0.291  Sum_probs=192.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ..|++.+.||+|++|.||+|.... +..+|+|.+....   ....+|+.+++.++||||+++++++..     ..+.+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEEE
Confidence            479999999999999999998753 4569999886432   334679999999999999999998732     2347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+.+ +|.+.+...   ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05113          78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence            999975 666655432   2368999999999999999999998 9999999999999999887 799999999875533


Q ss_pred             CCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+......           
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-----------  220 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence            2211  122345679999999544 48999999999999999998 99999876655544444321000           


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                       ..+...+..+++++.+||..||.+||++.+++++
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                             0112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-39  Score=291.25  Aligned_cols=238  Identities=23%  Similarity=0.313  Sum_probs=184.8

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      +.||+|+||.||+|.++.+++.||+|.+...     .....+|+++++.++||||+++++++..     ....|+||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            3689999999999999999999999987532     1335679999999999999999998843     33478999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC
Q 016401          131 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  209 (390)
Q Consensus       131 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~  209 (390)
                      .+ +|.+++..   ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++.........
T Consensus        76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            75 66665543   23458899999999999999999998 9999999999999999887 7999999998754322111


Q ss_pred             c---ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          210 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       210 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      .   ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+....                
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~----------------  213 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV----------------  213 (252)
T ss_pred             ccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------------
Confidence            0   1112356999999854 448999999999999999997 889997655433322221100                


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                  ....+...+..+.+|+.+||..||++|||+.++++
T Consensus       214 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         214 ------------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ------------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        00112356889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-39  Score=294.58  Aligned_cols=248  Identities=28%  Similarity=0.461  Sum_probs=195.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +|++.+.||.|++|.||+|.+..+++.||||.+...       .....+|+.+++.++|+||+++++++.     .....
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~   77 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNEL   77 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCeE
Confidence            689999999999999999999999999999987431       123447999999999999999999884     33457


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +++|||+++ +|.+++.........+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~  155 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGRF  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEECcchhhhc
Confidence            899999985 7877776544445668999999999999999999998 9999999999999999887 799999999875


Q ss_pred             cccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhc
Q 016401          203 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.... ....+....            
T Consensus       156 ~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------  222 (267)
T cd08229         156 FSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ------------  222 (267)
T ss_pred             cccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc------------
Confidence            533222 123467889999999954 44889999999999999999999999764421 111111110            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                            ...+.        .....+++.+++||.+||..||++|||+.++++
T Consensus       223 ------~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         223 ------CDYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ------CCCCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                  00000        011347889999999999999999999997753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.7e-39  Score=307.86  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=191.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEeccch-----hhHHHHHHHHHhCC-CCceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  117 (390)
                      ..+|++.+.||+|+||.||+|.+...     +..||||++....     ....+|+++++++. ||||+++++++.    
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~----  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT----  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence            45899999999999999999987433     3579999985432     23457999999996 999999999983    


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh-----------------------------------------------------
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSR-----------------------------------------------------  143 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  143 (390)
                       .....|+|||||+ |+|.+++.....                                                     
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence             3344889999998 477766643211                                                     


Q ss_pred             ---------------------------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEE
Q 016401          144 ---------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  184 (390)
Q Consensus       144 ---------------------------------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIl  184 (390)
                                                             ....+++..+..++.|++.||+|||+ .+|+||||||+|||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence                                                   01347788889999999999999998 99999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 016401          185 VNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  260 (390)
Q Consensus       185 l~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  260 (390)
                      ++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+
T Consensus       270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99887 799999999875533221   122345678999999965 458999999999999999997 999998755433


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+...+...                 ...          ..+..++.++.+++.+||..||++||++.++.+
T Consensus       348 ~~~~~~~~~-----------------~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYNKIKSG-----------------YRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHhcC-----------------CCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333322210                 000          012357889999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.8e-39  Score=290.40  Aligned_cols=250  Identities=29%  Similarity=0.490  Sum_probs=196.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.++..       .....+|++++++++|+|++++++++..     ...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            3799999999999999999999989999999987421       2334579999999999999999998843     345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++||||+++ +|..++.........+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999985 8877776544445668999999999999999999998 9999999999999999888 79999999987


Q ss_pred             ccccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||......  .....+.+.          
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~----------  221 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIE----------  221 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhh----------
Confidence            543322 1233467888999999865 44899999999999999999999999654311  111111100          


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                           ....+.        .....++..+.++|.+||..+|++|||+.++++
T Consensus       222 -----~~~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         222 -----KCDYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -----cCCCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                 000000        001256789999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.9e-39  Score=295.62  Aligned_cols=256  Identities=30%  Similarity=0.456  Sum_probs=206.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ....|.+.+.||+|++|.||+|.+..++..||+|++....   ....+|+++++.++|+|++++++++..     ....|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-----GDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEE
Confidence            4457999999999999999999999889999999986543   345579999999999999999998843     34588


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +++||++ ++|.+++....   ..+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDG-SVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCC-CEEECccchhhhh
Confidence            9999999 58877776532   378999999999999999999998 9999999999999999887 7999999988654


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+... +.+.         
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~---------  235 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP---------  235 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC---------
Confidence            3221 1123356788999999855 45899999999999999999999999876655444333221 0000         


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                      ......++..+++||.+||..||.+||++.++++||||....
T Consensus       236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         236 ----------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             ----------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                            001134688999999999999999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=289.44  Aligned_cols=238  Identities=35%  Similarity=0.592  Sum_probs=194.5

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ||.|++|.||++.+..+++.||+|.+....       ....+|+.+++.++|+||+++++.+     ....+.|++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            689999999999998889999999885432       2445799999999999999999887     4455688999999


Q ss_pred             c-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC-CC
Q 016401          131 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  208 (390)
Q Consensus       131 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~-~~  208 (390)
                      . ++|.+.+..    ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            5 677666654    3468999999999999999999998 9999999999999999887 7999999998765433 12


Q ss_pred             CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 016401          209 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  288 (390)
Q Consensus       209 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  288 (390)
                      .....++..|+|||.+.+. ..+.++|+||||+++|++++|..||...+.......+..                 ... 
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----------------~~~-  210 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-----------------DPL-  210 (250)
T ss_pred             ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------CCC-
Confidence            3345668889999998554 478899999999999999999999977665333333322                 001 


Q ss_pred             CCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH---HHHhcCCcc
Q 016401          289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF  336 (390)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~---~~~l~hp~f  336 (390)
                                 .++..++..+.++|++||..||++||++   .++++||||
T Consensus       211 -----------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         211 -----------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                       1224568999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-40  Score=330.03  Aligned_cols=261  Identities=28%  Similarity=0.422  Sum_probs=196.1

Q ss_pred             CcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccC-----
Q 016401           46 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFST-----  115 (390)
Q Consensus        46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  115 (390)
                      ++....|+..+.||+|+||.||+++++-+|+.||||+|...     .....+|+++|.+|+|||||+++..+...     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            45667899999999999999999999999999999998543     23345899999999999999988765300     


Q ss_pred             -------------------------------------------------C------------------------------
Q 016401          116 -------------------------------------------------T------------------------------  116 (390)
Q Consensus       116 -------------------------------------------------~------------------------------  116 (390)
                                                                       .                              
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                              


Q ss_pred             -----------------------CCC-------ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHH
Q 016401          117 -----------------------DKE-------ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY  166 (390)
Q Consensus       117 -----------------------~~~-------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~  166 (390)
                                             ..+       ..++||-||||+..+.+.+-.......  ....++++++||++||.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                   000       156899999999866555443222111  356789999999999999


Q ss_pred             HHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc-------------------cCCCCcceeeccccccchhhcCC
Q 016401          167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-------------------KGEPNVSYICSRYYRAPELIFGA  227 (390)
Q Consensus       167 LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~  227 (390)
                      +|+ .|||||||||.||+++++. .|||+|||+|+...                   .....+..+||..|+|||++.+.
T Consensus       713 IH~-~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  713 IHD-QGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HHh-CceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            998 9999999999999999887 79999999998621                   01133567899999999999665


Q ss_pred             C--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCC
Q 016401          228 T--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL  305 (390)
Q Consensus       228 ~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (390)
                      .  .|+.|+|+||||++++||+.   ||...  .+....+ ..+..+               .+|.    +  .-|..+-
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL-~~LR~g---------------~iP~----~--~~f~~~~  843 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASIL-TNLRKG---------------SIPE----P--ADFFDPE  843 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHH-HhcccC---------------CCCC----C--ccccccc
Confidence            5  69999999999999999985   46443  2322222 211111               1110    0  1111223


Q ss_pred             ChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          306 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       306 ~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                      -+.-..+|+.||..||.+||||.|+|++.||.
T Consensus       844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  844 HPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             chHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            45677899999999999999999999999997

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-39  Score=290.33  Aligned_cols=242  Identities=26%  Similarity=0.392  Sum_probs=195.1

Q ss_pred             eeeeecCceEEEEEEEcCC---CcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|.+...   +..||+|.+....     ....+|+++++.++|+||+++++++..     ...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4689999999999999865   8899999986432     344579999999999999999998843     44588999


Q ss_pred             eccc-ccHHHHHHHhhhh-----cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          128 EYVP-ETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       128 e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ||+. ++|...+......     ...+++..+..++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCC-cEEEccccccc
Confidence            9995 6887776653211     3678999999999999999999998 9999999999999999987 79999999998


Q ss_pred             ccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          202 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       202 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ......   ......++..|+|||.+... .++.++|+|||||++|+|++ |..||...+..+....+...         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------  223 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---------  223 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence            664432   12334567889999998554 58999999999999999999 69999887655544443320         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                         .....+..++.++.+++.+||..||++|||+.+++++
T Consensus       224 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 -------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                               0011224568999999999999999999999999865

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-39  Score=297.91  Aligned_cols=247  Identities=20%  Similarity=0.265  Sum_probs=192.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..|++.+.||+|+||.||+|.+..+     ++.||||++....     ....+|+.++..++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-----   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence            3688999999999999999987543     5789999986432     234578999999999999999998833     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  186 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~  186 (390)
                      ....++++||+.+ +|..++....            .....+++..+..++.|++.||+|||+ +||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~  158 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVF  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEec
Confidence            2347799999984 6666653211            112357888899999999999999998 9999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 016401          187 PHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  262 (390)
Q Consensus       187 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  262 (390)
                      .++ .+||+|||+++........   ....+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+....+.+
T Consensus       159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 7999999998754332211   223346789999998654 48999999999999999998 88999887665554


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ..+....                            ...++..++..+.+|+.+||+.||++||++++++.
T Consensus       237 ~~i~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         237 EMIRNRQ----------------------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            4443310                            00112457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.2e-39  Score=296.00  Aligned_cols=248  Identities=20%  Similarity=0.318  Sum_probs=192.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEc----CCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..|++.+.||+|+||.||+|.+.    .+++.||+|.+....     ....+|+.+++.++||||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            46899999999999999999853    456789999886322     234579999999999999999998733     2


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhh-------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSR-------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  186 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~-------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~  186 (390)
                      ...|++|||+.+ +|.+++.....             ....+++..+..++.|++.||+|||+ +|++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence            347899999984 77666642210             12347788899999999999999998 9999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 016401          187 PHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  262 (390)
Q Consensus       187 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  262 (390)
                      .++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+..
T Consensus       159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 799999999976533221   1223346679999998554 48999999999999999998 99999876654433


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ..+... ..                 .          ..+..+++.+.+++.+||+.||++||++.+++++
T Consensus       237 ~~~~~~-~~-----------------~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKR-QL-----------------L----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcC-Cc-----------------C----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            333221 00                 0          0124578999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-39  Score=290.57  Aligned_cols=244  Identities=22%  Similarity=0.321  Sum_probs=192.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|++|.||+|.+. +++.||+|.+....   ....+|+.++++++|+||+++++++.     .....|++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeeee
Confidence            47999999999999999999975 45789999986432   34567999999999999999998873     23347899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+. ++|.+.+....  ...+++..+..++.|++.||.+||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence            99995 67877665422  3468899999999999999999998 9999999999999999888 799999999976542


Q ss_pred             CCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+....+..+...              
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------  220 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG--------------  220 (261)
T ss_pred             CcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence            2111  11122357999998854 458999999999999999999 99999887655544433221              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                          +..          ..+...+..+.+++.+||..||++||++.++++
T Consensus       221 ----~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         221 ----YRM----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ----CCC----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                000          011346889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.8e-39  Score=296.77  Aligned_cols=249  Identities=22%  Similarity=0.332  Sum_probs=194.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  117 (390)
                      ..+|++.+.||+|+||.||++.+...     ...+|+|.+....     ....+|+.+++++ +|+||+++++++.    
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----   86 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT----   86 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence            35899999999999999999997643     3789999886432     2244799999999 8999999999873    


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEE
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  184 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIl  184 (390)
                       ....++++|||+. ++|..++....            .....+++..+..++.|++.||+|||+ .||+||||||+||+
T Consensus        87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil  164 (293)
T cd05053          87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL  164 (293)
T ss_pred             -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence             2334789999997 47777765421            224568899999999999999999998 99999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 016401          185 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  260 (390)
Q Consensus       185 l~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  260 (390)
                      ++.++ .+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+
T Consensus       165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99887 7999999999765432211   11223567999999854 458999999999999999997 999998776555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ....+....                            ....+...+..+.+|+.+||..||++|||+.+++++
T Consensus       243 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGY----------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            443332210                            000123568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.4e-39  Score=290.09  Aligned_cols=243  Identities=25%  Similarity=0.361  Sum_probs=190.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|+||.||+|.+..+ ..||+|++....   ....+|+.+++.++|+||+++++.+.     . .+.|+|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence            4799999999999999999998655 469999886532   23567999999999999999987652     1 225799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+++ +|.+++...  ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            999985 776666532  23457889999999999999999998 9999999999999999887 799999999975533


Q ss_pred             CCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  ....++..|+|||...+ ..++.++|+|||||++|+|++ |.+||.+....+....+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  220 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------  220 (262)
T ss_pred             cccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-------------
Confidence            3221  12334667999998854 448999999999999999999 889998776555444332210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                           ..          .....++..+.+|+.+||+.||++||++.++++
T Consensus       221 -----~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         221 -----RM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----CC----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                 00          011347889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-39  Score=293.38  Aligned_cols=246  Identities=21%  Similarity=0.324  Sum_probs=197.1

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ....|++.+.||.|+||.||+|.+.. ++.+|+|.+....    ....+|+.+++.++|+||+++++++.     .....
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence            44579999999999999999999977 8899999986443    34557999999999999999998873     33347


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ++||||+++ +|.+++...  ....+++..+..++.||+.||+|||+ .||+|+||||+||+++.++ .+||+|||.+..
T Consensus        78 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~  153 (261)
T cd05148          78 YIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARL  153 (261)
T ss_pred             EEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCc-eEEEccccchhh
Confidence            899999985 887776542  23568899999999999999999998 9999999999999999888 799999999875


Q ss_pred             cccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          203 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+..+.+..+....           
T Consensus       154 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------  221 (261)
T cd05148         154 IKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-----------  221 (261)
T ss_pred             cCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-----------
Confidence            532211 112234667999999854 458999999999999999998 899998877655555443210           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                             ..          ..+...++.+.+++.+||..||.+|||+.++++
T Consensus       222 -------~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         222 -------RM----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -------cC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                   00          012357899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.4e-39  Score=294.59  Aligned_cols=247  Identities=23%  Similarity=0.346  Sum_probs=193.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+....    ....+|+.+++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            46999999999999999999854     345679999885432    34568999999999999999999883     33


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  187 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~  187 (390)
                      ...++||||++ ++|.+++.....            ....+++..+..++.||+.||+|||+ +||+||||||+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence            34789999997 577777754321            12347889999999999999999998 99999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 016401          188 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  263 (390)
Q Consensus       188 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  263 (390)
                      ++ .++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+...
T Consensus       159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 799999999875433221   123345778999999865 458999999999999999998 999998776555443


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+...                   ..+         ..+..++..+.+|+.+||..||++|||+.++++
T Consensus       237 ~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQG-------------------RVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCC-------------------CCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            32210                   000         011346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-39  Score=289.69  Aligned_cols=244  Identities=22%  Similarity=0.323  Sum_probs=191.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ..|++.+.||+|+||.||+|.++ ++..+|+|++....   ....+|+++++.++|+||+++++++.     ...+.|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEE
Confidence            46999999999999999999985 46789999885432   23457999999999999999998873     33457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+++ +|.+.+...   ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||+++....
T Consensus        78 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~  152 (256)
T cd05059          78 TEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLD  152 (256)
T ss_pred             EecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCC-cEEECCcccceeccc
Confidence            999975 676665432   2468899999999999999999998 9999999999999999888 799999999875533


Q ss_pred             CCCCc--ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .....  ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-------------  218 (256)
T ss_pred             ccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            22111  1122456999999865 458999999999999999998 899998766555443332210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                           .          ...+...+..+.+++.+||..+|++|||+.++++.
T Consensus       219 -----~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         219 -----R----------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -----c----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                 0          01113468999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.1e-39  Score=293.47  Aligned_cols=254  Identities=20%  Similarity=0.208  Sum_probs=184.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC---CcEEEEEEeccchhhHH---------------HHHHHHHhCCCCceeeecce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN---------------RELQIMQMLDHPNIVALKHC  111 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~---------------~E~~~l~~l~h~~iv~~~~~  111 (390)
                      .+|++.+.||+|+||.||+|.+..+   +..+|+|+.........               .+...+..+.|++++.++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4799999999999999999998777   66778886432221111               12234455689999999887


Q ss_pred             eccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCc
Q 016401          112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  191 (390)
Q Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~  191 (390)
                      ..... ....+.+++++++..++...+..    ....++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~-~  164 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNN-R  164 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-c
Confidence            53322 22345678999887776555543    2346788889999999999999998 9999999999999999887 7


Q ss_pred             EEEeecCCccccccCC--------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 016401          192 LKLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  263 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  263 (390)
                      ++|+|||+|+......        ......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999997653221        1123468999999999865 458999999999999999999999998764322222


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ...+.      +.+..+...               ....+..++.+.++++.|+..+|++||+..++++
T Consensus       244 ~~~~~------~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKC------DFIKRLHEG---------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHH------HHHHHhhhh---------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11110      000000000               0001346889999999999999999999999864

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-39  Score=293.44  Aligned_cols=257  Identities=26%  Similarity=0.367  Sum_probs=188.8

Q ss_pred             cE-EEeeeeeecCceEEEEEE----EcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           51 SY-IAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        51 ~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      +| ++.+.||+|+||+||++.    ...+++.||+|.+....     ....+|+++++.++||||+++++++..   ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence            45 999999999999998865    34568899999886432     234579999999999999999987643   233


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .+++++|||+++ +|.+.+..     ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~  153 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDR-LVKIGDFGL  153 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCC-cEEEeeccc
Confidence            457899999985 66655543     468999999999999999999998 9999999999999999887 799999999


Q ss_pred             ccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCH
Q 016401          200 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPTR  274 (390)
Q Consensus       200 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~  274 (390)
                      +.........    ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......  +...... .+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~  230 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV  230 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch
Confidence            8765432211    11234567999999854 44899999999999999999999998654321  1111110 000000


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ..+...            .........+..++.++.+++.+||..||++|||++++++
T Consensus       231 ~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         231 VRLIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000            0000011123457899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.9e-39  Score=293.45  Aligned_cols=255  Identities=29%  Similarity=0.459  Sum_probs=196.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccch--------hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      .|++.+.||+|++|.||++.+.   .+++.||||.+....        ....+|+.++.++ .|+||+++++++     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            3889999999999999999864   467889999885321        2234799999999 599999998887     3


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      .....|+||||+.+ +|...+..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEG-HVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEEEC
Confidence            34457899999985 66555432    3568899999999999999999998 9999999999999999887 7999999


Q ss_pred             CCccccccCCC--CcceeeccccccchhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          198 GSAKVLVKGEP--NVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       198 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      |++........  .....++..|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...+.......+.+....   
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---  226 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK---  226 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence            99876533322  12345788999999985432 3688999999999999999999999654322222222111000   


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC---HHHHhcCCcccccCC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRD  341 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~~~l~hp~f~~~~~  341 (390)
                                .            ....+..++..+.++|.+||..||++|||   +.++|+||||+.+.+
T Consensus       227 ----------~------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         227 ----------S------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             ----------c------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence                      0            00112457889999999999999999998   567899999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-39  Score=289.49  Aligned_cols=245  Identities=25%  Similarity=0.347  Sum_probs=192.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC---CcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+|++.+.||+|+||.||+|.++.+   ...||||.+....     ....+|+.+++.++||||+++++.+.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            4799999999999999999998644   4579999875432     23346999999999999999999873     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..+++|||+.+ +|.+++...   ...+++..+..++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-CEEECccchh
Confidence            47899999985 776666432   2468999999999999999999998 9999999999999999887 7999999999


Q ss_pred             cccccCCCCc---ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          201 KVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       201 ~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ..........   ...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+...        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~--------  224 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG--------  224 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC--------
Confidence            8664221111   1223567999999854 458999999999999999998 99999776654443333221        


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                ...+          .+...+..+.+|+.+||..||++||++.+++++
T Consensus       225 ----------~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         225 ----------YRLP----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ----------CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                      0000          113468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-38  Score=286.55  Aligned_cols=242  Identities=23%  Similarity=0.337  Sum_probs=191.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .+|++.+.||+|+||.||++...  +..||+|.+..+.  ....+|+.++++++|+|++++++++..    .....|++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence            47999999999999999999864  7889999886543  234579999999999999999987632    223468999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+++ +|.+++...  ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||++......
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            99984 777666542  12347889999999999999999998 9999999999999999887 7999999998754332


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      .  ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+...                 
T Consensus       156 ~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-----------------  215 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----------------  215 (256)
T ss_pred             C--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            2  22334567999999854 458999999999999999997 99999876544433332210                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                       .          ....++.+++.+.++|.+||..||++|||+.++++
T Consensus       216 -~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         216 -Y----------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -C----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             0          00112457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.2e-39  Score=295.36  Aligned_cols=249  Identities=22%  Similarity=0.322  Sum_probs=191.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC-------CCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  115 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  115 (390)
                      ..+|.+.+.||+|+||.||+|++..       +...+|+|.+..+.     ....+|+++++.+ +|+||+++++++.  
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence            3589999999999999999998643       23579999886432     2244699999999 7999999999883  


Q ss_pred             CCCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          116 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       116 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                         .....|+||||+++ +|.+++.....            ....+++..+..++.|++.||+|||+ .|++||||||+|
T Consensus        95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N  170 (307)
T cd05098          95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  170 (307)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence               23357899999984 78777764321            12357888999999999999999998 999999999999


Q ss_pred             EEEcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016401          183 LLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  258 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  258 (390)
                      |+++.++ .+||+|||.+.........   ....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+.
T Consensus       171 ill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         171 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             eEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            9999887 7999999998755322111   11123467999999865 448999999999999999998 8899976654


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          259 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .+....+...                  .          ....+..++.++.+||.+||..+|++|||+.+++++
T Consensus       249 ~~~~~~~~~~------------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         249 EELFKLLKEG------------------H----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHcC------------------C----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3333322210                  0          001124578899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.9e-39  Score=293.48  Aligned_cols=254  Identities=19%  Similarity=0.257  Sum_probs=193.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCC----------------cEEEEEEeccch-----hhHHHHHHHHHhCCCCceeee
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETG----------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL  108 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~  108 (390)
                      .+|++.+.||+|+||.||+|.+..++                ..||+|.+....     ....+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            47999999999999999999876543                568999886432     234579999999999999999


Q ss_pred             cceeccCCCCCceEEEEEEecccc-cHHHHHHHhhh-------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCC
Q 016401          109 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  180 (390)
Q Consensus       109 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp  180 (390)
                      ++++..     +...+++|||+.+ +|..++.....       ....+++..++.++.|++.||+|||+ .||+||||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp  158 (296)
T cd05051          85 LGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccch
Confidence            998833     2457899999974 77776654321       11258899999999999999999998 9999999999


Q ss_pred             CcEEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 016401          181 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  255 (390)
Q Consensus       181 ~NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~  255 (390)
                      +||+++.++ .++|+|||++........   .....++..|+|||.+.+. .++.++|||||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999887 799999999875433221   1223446789999998654 48999999999999999998  7788877


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          256 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+..+.+..........               ....      ....+..++.++.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~---------------~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDD---------------GRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhccccc---------------cccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            66555544443211000               0000      00012356789999999999999999999999953

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-38  Score=286.24  Aligned_cols=243  Identities=24%  Similarity=0.323  Sum_probs=191.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|.+.+.||+|++|.||+|.+..+ ..+|+|.+....   ....+|+.+++.++|+|++++++++.     . ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence            4799999999999999999998654 469999876432   23457999999999999999988762     1 125799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+.+ +|.+++...  ....+++..+..++.|++.||.|||+ .|++|+||||+||++++++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 787766542  23457888999999999999999998 9999999999999999887 799999999975533


Q ss_pred             CCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....+....+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  220 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-------------  220 (260)
T ss_pred             CcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2211  12334667999998854 448999999999999999999 999998877655544432210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                           .          ...+...+..+.+++++||..||++||+++++++
T Consensus       221 -----~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         221 -----R----------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----C----------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                 0          0112357889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-38  Score=293.19  Aligned_cols=248  Identities=24%  Similarity=0.363  Sum_probs=193.1

Q ss_pred             ccccEEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  116 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  116 (390)
                      ..++|.+.+.||+|+||.||+|.+     ..++..||+|.++...     ....+|+.+++++ +|+||+++++++..  
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  110 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--  110 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence            345899999999999999999975     2345689999886432     2345799999999 79999999998733  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEe
Q 016401          117 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  195 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  195 (390)
                         ....|++|||+. ++|..++...  ....+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++ .++|+
T Consensus       111 ---~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~  183 (302)
T cd05055         111 ---GGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGK-IVKIC  183 (302)
T ss_pred             ---CCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCC-eEEEC
Confidence               334789999998 5776666431  12338999999999999999999998 8999999999999999877 79999


Q ss_pred             ecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 016401          196 DFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       196 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      |||++........   .....++..|+|||.+.+. .++.++||||+||++|+|++ |..||.+....+.+.+.....  
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~--  260 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG--  260 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC--
Confidence            9999875533221   1122346789999998654 48999999999999999998 999998776555444433210  


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                     ..          ...+...++++.+|+.+||..||++|||+.++++
T Consensus       261 ---------------~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 ---------------YR----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---------------Cc----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                           00          0011346889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-38  Score=286.84  Aligned_cols=234  Identities=25%  Similarity=0.348  Sum_probs=183.4

Q ss_pred             eeeecCceEEEEEEE--cCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           57 VVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      .||+|+||.||+|.+  ..++..+|+|+++...      ....+|+.+++.++||||+++++++.     .. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence            589999999999964  4667899999885432      23457899999999999999988762     12 2579999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCC
Q 016401          129 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  207 (390)
Q Consensus       129 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~  207 (390)
                      |+++ +|..++..    ...+++..+..++.|++.||+|||+ +||+||||||.||+++.++ .+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9985 67666543    3568999999999999999999998 9999999999999999887 79999999987654332


Q ss_pred             CC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          208 PN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       208 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..    ....++..|+|||.+.. ..++.++|+|||||++|||++ |.+||.+.+..+....+.+..             
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-------------  215 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------  215 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            21    11223568999998854 458899999999999999998 999998776554444332210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                         ..            ..+..+++++.+||.+||..||++||++.++.
T Consensus       216 ---~~------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~  249 (257)
T cd05116         216 ---RM------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVE  249 (257)
T ss_pred             ---CC------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHH
Confidence               00            01245789999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.5e-39  Score=292.84  Aligned_cols=246  Identities=21%  Similarity=0.372  Sum_probs=189.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....     ....+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            47889999999999999998753     23568899875432     23457999999999999999999873     23


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh--------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK  179 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlk  179 (390)
                      ...+++|||+. ++|..++.....                    ....+++..+..++.|++.||.|||+ .||+|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence            34779999998 577776654211                    12357888999999999999999998 999999999


Q ss_pred             CCcEEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 016401          180 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG  255 (390)
Q Consensus       180 p~NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  255 (390)
                      |+||+++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999887 799999999875433221   112234567999999854 458999999999999999998 9999987


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          256 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ....+....+...                  +..          ..+..++.++.+|+.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~------------------~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTG------------------YRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCC------------------CCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            6644433222110                  000          012457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.9e-39  Score=287.50  Aligned_cols=228  Identities=25%  Similarity=0.320  Sum_probs=180.8

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecccc-cHHHHHH
Q 016401           61 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIAR  139 (390)
Q Consensus        61 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  139 (390)
                      |.+|.||+|+++.+++.||+|.+..... ..+|...+....||||+++++++.     .....|++|||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            8899999999999999999999866432 345666666678999999999873     33457899999985 7766664


Q ss_pred             HhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCCcceeeccccc
Q 016401          140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR  219 (390)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~  219 (390)
                      .    ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||.+......  .....++..|+
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            3    2458999999999999999999998 9999999999999999988 6999999987654322  22334567799


Q ss_pred             cchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCccc
Q 016401          220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK  299 (390)
Q Consensus       220 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (390)
                      |||.+.+ ..++.++|+||+||++|+|++|..||......     +..                ...+            
T Consensus       150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~----------------~~~~------------  195 (237)
T cd05576         150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----INT----------------HTTL------------  195 (237)
T ss_pred             CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc----------------cccc------------
Confidence            9998844 44789999999999999999999887432110     000                0000            


Q ss_pred             ccccCCChhHHHHHHHhcccCCCcCCCH-----HHHhcCCcc
Q 016401          300 VFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFF  336 (390)
Q Consensus       300 ~~~~~~~~~~~~li~~~L~~dP~~R~s~-----~~~l~hp~f  336 (390)
                      .++..+++.+++||.+||+.||++|+++     .++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1224578999999999999999999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=284.64  Aligned_cols=241  Identities=25%  Similarity=0.372  Sum_probs=192.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ..|++.+.||.|++|.||+|...  |+.||+|.+.....   ...+|+.+++.++|+||+++++++..     ....|+|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence            47999999999999999999874  78999999876543   44579999999999999999998843     3337899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||++ ++|.+.+....  ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||.++....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCC-CEEEccccccccccc
Confidence            99998 47777665421  2368999999999999999999998 9999999999999999887 799999999976532


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      ..  .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+...                
T Consensus       155 ~~--~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------------  215 (256)
T cd05039         155 GQ--DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG----------------  215 (256)
T ss_pred             cc--ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------
Confidence            22  12334567999999854 458899999999999999997 99999776544433222110                


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                        +          ....+..+++.+.++|.+||..+|++||++.++++
T Consensus       216 --~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         216 --Y----------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             --C----------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence              0          00112356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-38  Score=285.60  Aligned_cols=244  Identities=25%  Similarity=0.340  Sum_probs=193.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+|++.+.||+|++|.||+|.+. +++.||||.+...   .....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence            458999999999999999999975 4578999988643   234568999999999999999998873     2334789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENL-VCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCC-CEEECccccceecc
Confidence            9999985 776666542  23468899999999999999999998 8999999999999999887 79999999987654


Q ss_pred             cCCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .....  .....+..|+|||.+.+ ..++.++|+||+|+++|+|++ |+.||.+.+....+..+....            
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------  221 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY------------  221 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence            32111  12223567999999864 458999999999999999998 999998877665555543311            


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                            ..          ..+...+.++.+++.+||..||++||++++++
T Consensus       222 ------~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  255 (261)
T cd05034         222 ------RM----------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQ  255 (261)
T ss_pred             ------CC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence                  00          01134578999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.3e-38  Score=290.21  Aligned_cols=244  Identities=21%  Similarity=0.315  Sum_probs=189.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCc----EEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||.||+|.+..++.    .||+|.+....     ....+|+.+++.+.|+||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            4589999999999999999999877766    48999875322     2344789999999999999999887421    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                        ..++++||++ |++.+.+...   ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~-~~kL~dfG  154 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPN-HVKITDFG  154 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCC-cEEECCCC
Confidence              2568999998 5776655432   3468999999999999999999998 9999999999999998877 79999999


Q ss_pred             CccccccCCCCc---ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          199 SAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       199 ~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +++.........   ...++..|+|||.+.+. .++.++|||||||++|||++ |..||......... ..+.....+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~--  230 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERL--  230 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcC--
Confidence            997654322211   12235679999999554 48999999999999999998 89999765543322 222211000  


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                               ..+...+.++.++|.+||..||++||++.+++.
T Consensus       231 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 -------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     011346889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-38  Score=286.81  Aligned_cols=242  Identities=23%  Similarity=0.329  Sum_probs=190.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|++|.||+|.+. .+..+|+|.+...   .....+|+.++++++|+|++++++++.    .  ...|++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----E--EPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----C--CCcEEE
Confidence            47999999999999999999875 5667999988643   234568999999999999999988762    1  125799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+++ +|.+++...  ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence            999985 776666532  23458899999999999999999998 9999999999999999887 799999999976533


Q ss_pred             CCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+..+....+....             
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------  220 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-------------  220 (260)
T ss_pred             cccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2211  12234567999999854 458999999999999999999 899998876555444432210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                           ..          ..+...+..+.+|+.+||..||++|||+.+++
T Consensus       221 -----~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         221 -----RM----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             -----CC----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                 00          01235688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=292.88  Aligned_cols=255  Identities=21%  Similarity=0.289  Sum_probs=191.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCC--------------cEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeec
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETG--------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALK  109 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~  109 (390)
                      ..+|++.+.||+|+||.||+|++..++              ..||+|.+....     ....+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            358999999999999999999875432              358999886432     2345799999999999999999


Q ss_pred             ceeccCCCCCceEEEEEEecccc-cHHHHHHHhhh--------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCC
Q 016401          110 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR--------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  180 (390)
Q Consensus       110 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp  180 (390)
                      +++..     ....++||||+.+ +|.+++.....        ....+++..+..++.|++.||+|||+ .|++|+||||
T Consensus        84 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp  157 (295)
T cd05097          84 GVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT  157 (295)
T ss_pred             EEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence            98843     3347899999985 77776643211        01236788899999999999999998 9999999999


Q ss_pred             CcEEEcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 016401          181 QNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  255 (390)
Q Consensus       181 ~NIll~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~  255 (390)
                      +||+++.++ .+||+|||++.........   ....++..|+|||.+.+. .++.++|+|||||++|+|++  |..||..
T Consensus       158 ~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         158 RNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999887 7999999998754332211   122336689999998654 48999999999999999988  6788887


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          256 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+..+.+..+.+......            ....         ...++..++.+.+|+.+||..||++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~------------~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         236 LSDEQVIENTGEFFRNQG------------RQIY---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cChHHHHHHHHHhhhhcc------------cccc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            666555544433210000            0000         0012346889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.3e-39  Score=288.35  Aligned_cols=242  Identities=26%  Similarity=0.395  Sum_probs=186.9

Q ss_pred             EEeeeeeecCceEEEEEEEc----CCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           53 IAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+.+.||.|+||.||+|...    ..+..|+||.+...     ...+.+|++.+++++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46789999999999999987    44678999999542     2345579999999999999999999863222     7


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ++||||+. |+|.+++...  ....+++..+..++.||+.||.|||+ .+++|+||+++||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccc
Confidence            79999998 5888877763  13578999999999999999999998 8999999999999999988 899999999876


Q ss_pred             cccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          203 LVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       203 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ......   .........|+|||.+.... ++.++||||||+++||+++ |+.||...+..+....+.+.          
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~----------  221 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG----------  221 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT----------
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc----------
Confidence            522211   12234567899999995544 8999999999999999999 78999888766655555321          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                              ..          ...+..++..+.++|.+||..||++|||+.++++
T Consensus       222 --------~~----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  222 --------QR----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------EE----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------cc----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                    00          0122467899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-38  Score=289.86  Aligned_cols=247  Identities=24%  Similarity=0.367  Sum_probs=191.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+...    .....+|+++++.++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence            37899999999999999999743     34678999987542    2345679999999999999999988732     3


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh-----------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  188 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  188 (390)
                      ...+++|||+. ++|..++.....           ....+++..+..++.|++.||+|||+ .|++||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCC
Confidence            34789999998 477777654321           01347889999999999999999998 999999999999999987


Q ss_pred             CCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 016401          189 THQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  264 (390)
Q Consensus       189 ~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  264 (390)
                      + .+||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+.+..
T Consensus       159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            7 799999999875432211   1223346789999998654 48999999999999999998 9999987666555444


Q ss_pred             HHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      +....  +                          ...+..+++.+.+||.+||+.||++||++.++++
T Consensus       237 ~~~~~--~--------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGR--E--------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCc--c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            33210  0                          0111357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.6e-38  Score=293.25  Aligned_cols=248  Identities=22%  Similarity=0.327  Sum_probs=191.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC-------CCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  115 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  115 (390)
                      ..+|.+.+.||+|+||.||+|.+..       ....+|+|.+....     ....+|+.+++.+ +||||+++++++.  
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence            4589999999999999999998632       34579999876432     2234799999999 6999999999883  


Q ss_pred             CCCCceEEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          116 TDKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       116 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                         ...+.|++|||+. ++|..++.....            ....+++..+..++.|++.||.|||+ +|++||||||+|
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N  164 (314)
T cd05099          89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARN  164 (314)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecccccee
Confidence               3345789999998 478777765321            12457888999999999999999998 999999999999


Q ss_pred             EEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016401          183 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  258 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  258 (390)
                      |+++.++ .+||+|||+++.......   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         165 VLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             EEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999887 799999999975532211   111223457999999855 458999999999999999999 8999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          259 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+.+..+...                  .          ....+..++.++++||.+||..||++|||+.++++
T Consensus       243 ~~~~~~~~~~------------------~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         243 EELFKLLREG------------------H----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHcC------------------C----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            5444433220                  0          00112457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-38  Score=285.57  Aligned_cols=244  Identities=22%  Similarity=0.317  Sum_probs=192.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      .+.|++.+.||+|+||.||+|..+ +++.||+|.+....   ....+|+.+++.++|+||+++++++.     . ...++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEE
Confidence            357999999999999999999864 57889999886533   34567999999999999999988752     1 23679


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|||+. ++|.+.+...  ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  153 (260)
T cd05067          78 ITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETL-CCKIADFGLARLIE  153 (260)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCC-CEEEccCcceeecC
Confidence            999997 4776665432  23468889999999999999999998 9999999999999999887 79999999987553


Q ss_pred             cCCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .....  ....++..|+|||.+.. ..++.++|+||||+++|+|++ |++||.+.+..+....+....            
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------  220 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY------------  220 (260)
T ss_pred             CCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC------------
Confidence            22211  12234667999999854 448899999999999999999 999998776555444332210            


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                            ..          ..+...+.++.++|.+||..||++||+++++++
T Consensus       221 ------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         221 ------RM----------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ------CC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                  00          011346789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-38  Score=292.47  Aligned_cols=250  Identities=23%  Similarity=0.330  Sum_probs=193.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc-------CCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceecc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS  114 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~  114 (390)
                      ...+|.+.+.||+|+||.||+|++.       ..+..||+|.+....     ....+|+.+++.+ +||||+++++++. 
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-   91 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-   91 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence            3468999999999999999999752       234579999875421     2345799999999 8999999999883 


Q ss_pred             CCCCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCC
Q 016401          115 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  181 (390)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~  181 (390)
                          .....|++|||+.+ +|..++.....            ....++...+..++.||+.||.|||+ .||+||||||+
T Consensus        92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~  166 (304)
T cd05101          92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR  166 (304)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence                33457899999984 88777765321            12357788899999999999999998 99999999999


Q ss_pred             cEEEcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 016401          182 NLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  257 (390)
Q Consensus       182 NIll~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  257 (390)
                      ||+++.++ .+||+|||+++........   ....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+
T Consensus       167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999887 7999999999765332211   12234567999999955 458999999999999999998 889998776


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          258 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ..+....+....                  .          ...+..++..+++||.+||..+|.+|||+.++++.
T Consensus       245 ~~~~~~~~~~~~------------------~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKEGH------------------R----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcCC------------------c----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            555444332100                  0          00123578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.2e-38  Score=285.87  Aligned_cols=244  Identities=24%  Similarity=0.348  Sum_probs=191.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCc---EEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..|+..+.||+|+||.||+|.++.+++   .+|+|.+....     ....+|+++++.++|+|++++.+++.     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence            479999999999999999999876654   79999875431     23457999999999999999999883     233


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..|+||||+++ +|..++..   ....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNL-ECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCC-cEEECCCccc
Confidence            47899999985 66665543   23568899999999999999999998 9999999999999999887 7999999998


Q ss_pred             cccccCCCCc----ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          201 KVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       201 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ..........    ....+..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+....      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~------  227 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF------  227 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC------
Confidence            7554322111    1112456999999855 448999999999999999997 999998776655444443210      


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                  ..+          .....+.++.+|+.+||..||++||++.++++
T Consensus       228 ------------~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         228 ------------RLP----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ------------CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                        000          01246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=288.60  Aligned_cols=241  Identities=24%  Similarity=0.341  Sum_probs=184.3

Q ss_pred             eeeeecCceEEEEEEEcCCCc--EEEEEEeccc-----hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|.++.++.  .+|+|.+...     .....+|+.+++++ .||||+++++++.     ...+.|++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence            368999999999999988775  4688877532     12345799999999 8999999999883     333478999


Q ss_pred             eccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          128 EYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       128 e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                      ||+. ++|.+++.....            ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~-~~kl  153 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY-VAKI  153 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCC-eEEE
Confidence            9997 578777754321            11347889999999999999999998 9999999999999999888 7999


Q ss_pred             eecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          195 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      +|||++..............+..|+|||++.. ..++.++|+|||||++|+|++ |..||.+.+..+....+...     
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----  227 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-----  227 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----
Confidence            99999853322111112223567999999844 458999999999999999997 99999776654443332210     


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                   ...          ..+..++.++.+|+.+||..||.+|||+.++++
T Consensus       228 -------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 -------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                         000          011346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-38  Score=299.01  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=189.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      .+|++.+.||+|+||.||+|.+     ..+++.||||++....     ....+|+.++..+ .|+||+++++++..    
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK----   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec----
Confidence            4799999999999999999984     3467899999986422     2345799999999 68999999987732    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhh------------------------------------------------------
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSR------------------------------------------------------  143 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  143 (390)
                      ....++++|||+++ +|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            23347799999984 77776653210                                                      


Q ss_pred             ---------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC---cc
Q 016401          144 ---------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VS  211 (390)
Q Consensus       144 ---------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~---~~  211 (390)
                               ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++.........   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence                     01236778888999999999999998 9999999999999999887 7999999998754322111   11


Q ss_pred             eeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 016401          212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  290 (390)
Q Consensus       212 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  290 (390)
                      ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+........               ..   
T Consensus       241 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------~~---  301 (343)
T cd05103         241 ARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------RM---  301 (343)
T ss_pred             CCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---------------CC---
Confidence            234567999999865 458999999999999999997 9999977543333322221100               00   


Q ss_pred             CCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                               ..+...++++.+++.+||..||++|||+.++++|
T Consensus       302 ---------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         302 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                     0112357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.1e-38  Score=287.25  Aligned_cols=249  Identities=21%  Similarity=0.378  Sum_probs=195.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcC-CCcEEEEEEeccch--------------hhHHHHHHHHHh-CCCCceeeecceecc
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK--------------RYKNRELQIMQM-LDHPNIVALKHCFFS  114 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--------------~~~~~E~~~l~~-l~h~~iv~~~~~~~~  114 (390)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++.+ ++||||+++++++. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            38889999999999999999987 67899999874211              112357777764 79999999999883 


Q ss_pred             CCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEE
Q 016401          115 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  193 (390)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  193 (390)
                          ...+.+++|||+++ ++.+++.........+++..++.++.|++.||.|||+..|++|+||+|+||+++.++ .++
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence                34458899999985 777776654444567899999999999999999999526899999999999999888 799


Q ss_pred             EeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          194 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       194 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      |+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+......  
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  231 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--  231 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--
Confidence            999999976544433345567888999999965 44899999999999999999999999776554443333221000  


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                               ......+++.+.++|.+||..||++||++.++.++
T Consensus       232 -------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         232 -------------------------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -------------------------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                     00012468899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4e-39  Score=311.70  Aligned_cols=244  Identities=25%  Similarity=0.365  Sum_probs=201.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      +....+.||+|+||+||+|+..     .....||||.++...     ..++||++++..++|||||++++++.     +.
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~~  561 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----EG  561 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----cC
Confidence            5677889999999999999853     334679999986543     44679999999999999999999994     33


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhh------cC----CCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRI------HQ----RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  189 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~------~~----~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~  189 (390)
                      ..+|+|+|||. |+|.+.+......      +.    +++..+...++.||+.||.||-+ +.+|||||-..|+||.++.
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccce
Confidence            44889999998 7998888754321      12    27888999999999999999998 8999999999999999988


Q ss_pred             CcEEEeecCCccccccCCCCc---ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016401          190 HQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  265 (390)
Q Consensus       190 ~~vkl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  265 (390)
                       .|||+|||+++.....+...   ...-..+|||||.+.-. .++++|||||+||+|||+++ |..||.+....+.+.-+
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence             79999999998764433221   22336779999999654 49999999999999999997 89999999888887776


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHH
Q 016401          266 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  330 (390)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~  330 (390)
                      .+.                ..+..            ++++|.++.+|+..||..+|.+||+++||
T Consensus       719 ~~g----------------~lL~~------------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  719 RAG----------------QLLSC------------PENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HcC----------------CcccC------------CCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            652                11111            36799999999999999999999999988

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-38  Score=300.74  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=193.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHhCC-CCceeeecceeccCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTT  116 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  116 (390)
                      ...+|.+.+.||+|+||.||+|++.     .+++.||||++....     ....+|+++|.++. ||||+++++++..  
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence            4457999999999999999999864     345789999986432     23457999999997 9999999998843  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhh----------------------------------------------------
Q 016401          117 DKEELYLNLVLEYVP-ETVNRIARNYSR----------------------------------------------------  143 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~----------------------------------------------------  143 (390)
                         ....++||||+. |+|.+++.....                                                    
T Consensus       113 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         113 ---GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             ---CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence               234789999998 587777753211                                                    


Q ss_pred             ------------------------------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCC
Q 016401          144 ------------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  181 (390)
Q Consensus       144 ------------------------------------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~  181 (390)
                                                                ....+++..+..++.||+.||+|||+ .+|+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~  268 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR  268 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence                                                      01235677788999999999999998 99999999999


Q ss_pred             cEEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 016401          182 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  257 (390)
Q Consensus       182 NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  257 (390)
                      |||++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++||||+||++|||++ |..||....
T Consensus       269 NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         269 NVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             eEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999877 799999999975432211   123456788999999955 458999999999999999998 899997765


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          258 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ..+.+...+...                 ..          ...+..++.++.+|+.+||..||++||++.++++.
T Consensus       347 ~~~~~~~~~~~~-----------------~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         347 MNEQFYNAIKRG-----------------YR----------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             chHHHHHHHHcC-----------------CC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            544443333210                 00          01123578999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.4e-38  Score=286.68  Aligned_cols=244  Identities=27%  Similarity=0.387  Sum_probs=191.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCc---EEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+|++.+.||+|+||.||+|.++.++.   .+|+|.+....     ....+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            479999999999999999999865443   79999875422     23457999999999999999999873     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      +.|+||||+++ +|.+.+...   ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~-~~~l~dfg~~  153 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence            57899999985 676666432   3468889999999999999999998 9999999999999999887 7999999999


Q ss_pred             cccccCCCCc----ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          201 KVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       201 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ..........    ...++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.+.       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-------  225 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-------  225 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-------
Confidence            7654332111    1122457999999954 448999999999999999886 99999877655544433321       


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                 ...+          .+..+++.+.+++.+||+.+|.+||++.++++
T Consensus       226 -----------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         226 -----------YRLP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -----------CcCC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                       0000          11346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.3e-38  Score=290.02  Aligned_cols=248  Identities=24%  Similarity=0.319  Sum_probs=192.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+.+++.++||||+++++++..    
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~----   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV----   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence            3579999999999999999998753     67889999886432     335579999999999999999988732    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhh------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCC
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSR------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK  179 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlk  179 (390)
                       ....|++|||+++ +|..++.....                  ....+++..+..++.|++.||+|||+ .|++|||||
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~  157 (288)
T cd05050          80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA  157 (288)
T ss_pred             -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence             3347899999984 77777754221                  11246788899999999999999998 999999999


Q ss_pred             CCcEEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 016401          180 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG  255 (390)
Q Consensus       180 p~NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~  255 (390)
                      |+||+++.++ .++|+|||++........   ......+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus       158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999888 799999999875432211   1122345679999998554 58999999999999999997 8889987


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          256 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+..+....+...                   ...         ..+..++.++.+||.+||..||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~-------------------~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         236 MAHEEVIYYVRDG-------------------NVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCHHHHHHHHhcC-------------------CCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            7665544333220                   000         012356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-38  Score=283.26  Aligned_cols=236  Identities=25%  Similarity=0.352  Sum_probs=184.6

Q ss_pred             eeeeecCceEEEEEEEcCCC---cEEEEEEeccchh-----hHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|....++   ..||+|.+.....     ...+|+.+++.++|+||+++++++.     .. ..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence            46999999999999876554   7899998864432     3457999999999999999998762     12 267999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+++ +|.+.+..    ...+++..+..++.|++.||+|||. .|++|+||||+||+++.++ .+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            99974 77666654    3468999999999999999999998 8999999999999999888 7999999999765433


Q ss_pred             CCCc----ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          207 EPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       207 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ....    ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+... .           
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~-----------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-E-----------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-C-----------
Confidence            3221    1112457999999854 458999999999999999998 99999877654433333210 0           


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                            .          ...+..++..++++|.+||..||++||++.++++
T Consensus       216 ------~----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 ------R----------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ------c----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                  0          0112457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.2e-38  Score=287.82  Aligned_cols=249  Identities=18%  Similarity=0.260  Sum_probs=193.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC----CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||.||+|.+..    ++..|++|++....     ....+|+.+++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            4589999999999999999999875    35789999875432     2245799999999999999999976432    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhc----CCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIH----QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~----~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                      ....+++++|++ ++|..++.......    ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCC-cEEE
Confidence            233678999987 57777765532211    458899999999999999999998 9999999999999999887 7999


Q ss_pred             eecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016401          195 CDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  270 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  270 (390)
                      +|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|++++ |++||...+..+....+...  
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--  235 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG--  235 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC--
Confidence            999999755332211   12234667999999955 458999999999999999998 99999877654433222210  


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                      ...+          .+..+++++.+++.+||..||++|||+.++++
T Consensus       236 ----------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 ----------------YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ----------------CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                            0000          11346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3e-38  Score=295.31  Aligned_cols=248  Identities=22%  Similarity=0.319  Sum_probs=191.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC-------CcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  116 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  116 (390)
                      .+|++.+.||+|+||.||+|.+...       +..||+|.+....     ....+|+.+++++ +||||+++++++.   
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT---   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence            4799999999999999999986432       2368999876422     2345799999999 8999999999883   


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcE
Q 016401          117 DKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  183 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NI  183 (390)
                        ....++++|||+++ +|..++.....            ....++...+..++.|++.||+|||+ .||+||||||+||
T Consensus        89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni  165 (334)
T cd05100          89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARNV  165 (334)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceE
Confidence              23347899999985 77777654321            12347778889999999999999998 9999999999999


Q ss_pred             EEcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 016401          184 LVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  259 (390)
Q Consensus       184 ll~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  259 (390)
                      +++.++ .+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus       166 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         166 LVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             EEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999887 7999999998755332211   11223467999999955 458999999999999999998 88999877655


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          260 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      +....+....                  .          ...+..++.++.+|+.+||..+|++||++.+++++
T Consensus       244 ~~~~~~~~~~------------------~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         244 ELFKLLKEGH------------------R----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHcCC------------------C----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5444332210                  0          00123568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=309.86  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=216.1

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..+.|++.+.||.|.+|+||+++++.+++..|+|+...+   ...++.|.++|+.. .|||++.++++|.-........+
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            345799999999999999999999999999999987543   34456788999888 69999999999876555556669


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +||||||+| +..++.+...  +.++.|+.+..|++.++.||.+||. ..++|||||-.|||++.++ .|||+|||.+..
T Consensus        97 WLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  172 (953)
T ss_pred             EEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccC-cEEEeeeeeeee
Confidence            999999995 7777777655  7889999999999999999999998 8999999999999999998 799999999876


Q ss_pred             cccC-CCCcceeeccccccchhhcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          203 LVKG-EPNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       203 ~~~~-~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      .... ....+.+|||+|||||++...    ..|+.++|+||||++..||.-|.+|+-+..+...+..|.+   .|+    
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPP----  245 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP----  245 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCC----
Confidence            5433 344677899999999999442    3477899999999999999999999988776555443322   111    


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                       ..+.  -+.+.+.++.+||..||.+|.++||+..++|.|||+.+.
T Consensus       246 -----------------PkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  246 -----------------PKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             -----------------cccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                             1111  124568899999999999999999999999999999753

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.8e-38  Score=289.72  Aligned_cols=254  Identities=20%  Similarity=0.297  Sum_probs=189.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcC----------------CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeee
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL  108 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~  108 (390)
                      .+|++.+.||+|+||.||++.+..                ++..||+|.+....     ....+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            479999999999999999986532                34579999886432     234579999999999999999


Q ss_pred             cceeccCCCCCceEEEEEEeccc-ccHHHHHHHhhhh-------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCC
Q 016401          109 KHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRI-------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  180 (390)
Q Consensus       109 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp  180 (390)
                      ++++..     ....+++|||+. ++|..++......       ...+++..+..++.|++.||+|||+ .|++|+||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp  158 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence            998833     234789999997 4777776543211       1236778899999999999999998 8999999999


Q ss_pred             CcEEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 016401          181 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  255 (390)
Q Consensus       181 ~NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~  255 (390)
                      +||+++.++ .++|+|||++........   ......+..|++||...+. .++.++|+|||||++|||++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999887 799999999875533221   1112335679999988554 48999999999999999998  7789977


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          256 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+..+.+.......        ...   ......+          .+..+++.+.+|+.+||+.||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~--------~~~---~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFF--------RDQ---GRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHH--------hhc---cccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66544443322110        000   0000000          11346789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.2e-38  Score=285.35  Aligned_cols=244  Identities=26%  Similarity=0.407  Sum_probs=190.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCc---EEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..|++.+.||+|+||.||+|.++.+++   .||||.+...     ...+.+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence            369999999999999999999877665   5999988643     123457999999999999999999873     333


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..++||||+++ +|..++...   ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~-~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCC-cEEECCCccc
Confidence            47899999985 666655432   3568899999999999999999998 9999999999999999887 7999999998


Q ss_pred             cccccCCCCcce---e---eccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          201 KVLVKGEPNVSY---I---CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       201 ~~~~~~~~~~~~---~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      ............   .   .+..|+|||.+.+ ..++.++||||+||++|||++ |..||...+..+....+...     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-----  227 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-----  227 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-----
Confidence            754332211111   1   1346999999854 458999999999999999886 99999877655444433211     


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                   +..+          .+..++..+.+++.+||..||.+||++.+++.
T Consensus       228 -------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         228 -------------YRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -------------CcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         0111          11346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.6e-38  Score=285.38  Aligned_cols=249  Identities=23%  Similarity=0.314  Sum_probs=193.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      .+|++.+.||.|+||.||+|+.+.     +.+.|++|.+....     ....+|++++++++|+||+++++++     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            479999999999999999999754     34679999875432     2356799999999999999999987     33


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhc-----CCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEE
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIH-----QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  193 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  193 (390)
                      ..+.|+||||++ ++|.+++.......     ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCC-cEE
Confidence            345789999998 57777765432111     158999999999999999999998 8999999999999999888 799


Q ss_pred             EeecCCccccccCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016401          194 LCDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  270 (390)
Q Consensus       194 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  270 (390)
                      |+|||++.......  ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+......+..+...  
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--  234 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--  234 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence            99999986432211  12233557789999998554 47899999999999999998 88899766554433332210  


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                     ...          ...+..++..+.+++.+||..||++||++.+++++
T Consensus       235 ---------------~~~----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 ---------------KLE----------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ---------------CcC----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                           000          01124578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.4e-38  Score=285.19  Aligned_cols=246  Identities=21%  Similarity=0.297  Sum_probs=183.0

Q ss_pred             eeeeecCceEEEEEEEcC--CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           56 HVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      +.||+|+||.||+|....  ....+|+|.+....     ....+|+.+++.++|+||+++++.+..     ....|+|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEE
Confidence            358999999999996532  34578999775322     234579999999999999999998843     334789999


Q ss_pred             cccc-cHHHHHHHhhh-hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          129 YVPE-TVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       129 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      |+++ +|.+++..... .....++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~  153 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPE  153 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCC-cEEEeccccccccccc
Confidence            9984 88777765322 12335677889999999999999998 9999999999999999988 7999999998643222


Q ss_pred             CC---CcceeeccccccchhhcC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          207 EP---NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       207 ~~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ..   .....++..|+|||++..      ...++.++|||||||++|+|++ |..||......+.+..+......     
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-----  228 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI-----  228 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc-----
Confidence            11   122234667999999742      2346889999999999999999 78899877666655544432100     


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                 ..+       ....+..+++.+.+++..|+ .||++|||++++++
T Consensus       229 -----------~~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         229 -----------KLP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -----------cCC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                       000       11123457889999999998 59999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.3e-38  Score=286.94  Aligned_cols=261  Identities=25%  Similarity=0.382  Sum_probs=188.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEE----cCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+|++.+.||+|+||.||+|..    ..+++.||+|.+....    ..+.+|+++++.++||||+++++++...   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            4799999999999999999973    4578899999985432    2345799999999999999998876432   223


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+++||||++ ++|..++...   ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESEN-RVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCC-eEEECCCccc
Confidence            4789999997 5777766432   2458899999999999999999998 9999999999999999887 7999999999


Q ss_pred             cccccCCCCc----ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHH
Q 016401          201 KVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-TPTRE  275 (390)
Q Consensus       201 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~  275 (390)
                      ..........    ...++..|+|||.+.+ ..++.++|+|||||++|||++|..++..... .....+..... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  233 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchH
Confidence            8654322211    1122445999999854 4589999999999999999998876643321 11100000000 00000


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+......  ....          ..+..++.++.+||.+||..||++|||+.++++
T Consensus       234 ~~~~~~~~--~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 HLIELLKN--NGRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHhc--CCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            00000000  0000          112457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.5e-38  Score=282.06  Aligned_cols=239  Identities=25%  Similarity=0.348  Sum_probs=188.6

Q ss_pred             eeeeecCceEEEEEEEcC-CC--cEEEEEEeccchh-----hHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRE-TG--EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|++|.||+|.+.. ++  ..||||.+..+..     ...+|+.++++++||||+++++.+..      ...+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999865 33  3699999865433     34579999999999999999988743      4578999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||++ ++|...+.....  ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9997 577776654321  468899999999999999999998 9999999999999999887 7999999998765432


Q ss_pred             CCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          207 EPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       207 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ...    ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+....            
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------  217 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG------------  217 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------
Confidence            211    12345678999999854 458999999999999999998 999998776666554443210            


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                         ...            ..+...+..+.+++.+||..+|++||++.++++
T Consensus       218 ---~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         218 ---ERL------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ---CcC------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence               000            011346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-37  Score=280.46  Aligned_cols=244  Identities=20%  Similarity=0.325  Sum_probs=191.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ..|++.+.||.|+||.||+|.+. ++..+|+|.+...   .....+|+++++.++|||++++++++.     .....|++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEE
Confidence            37999999999999999999885 4678999988643   234567999999999999999998873     33357899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+.+ +|.+++..   ....+++..+..++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence            999985 66555442   12457889999999999999999998 8999999999999999877 799999999875432


Q ss_pred             CCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.+..             
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-------------  218 (256)
T ss_pred             CcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-------------
Confidence            211  112234567999999865 458999999999999999998 999998766554444332210             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                     ....+...+..+.+|+.+||..+|++|||+.+++++
T Consensus       219 ---------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 ---------------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                           000113367899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.8e-38  Score=281.72  Aligned_cols=242  Identities=27%  Similarity=0.393  Sum_probs=192.4

Q ss_pred             EEeeeeeecCceEEEEEEEcCCC----cEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           53 IAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ++.+.||.|+||.||+|.+..++    ..||+|.+....     ....+|+.+++.++|+||+++++++..     ....
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCee
Confidence            56789999999999999998766    889999986433     244579999999999999999998843     2458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |++|||+.+ ++.+.+....  ...+++..+..++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~  152 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENL-VVKISDFGLSRD  152 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCC-eEEEcccCCcee
Confidence            899999975 7766665422  1228999999999999999999998 8999999999999999887 799999999976


Q ss_pred             cccCCCCc--ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          203 LVKGEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       203 ~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ........  ...++..|+|||.+. ...++.++|+||+||++|+|++ |.+||...+..+....+....          
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------  221 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY----------  221 (258)
T ss_pred             cccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------
Confidence            54432211  123567899999984 4558999999999999999998 889998766555544433210          


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                        ....+...+.++.+++.+||..||++|||+.++++
T Consensus       222 ------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      222 ------------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ------------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                              00112347899999999999999999999999975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=308.64  Aligned_cols=203  Identities=28%  Similarity=0.431  Sum_probs=170.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCC-CCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTT-DKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~  124 (390)
                      -+...+.||+|+||.||+++++.+|+.||||.+...     .....+|+++|++++|+|||++.++-.+.. ..-...-.
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            478889999999999999999999999999988542     334457999999999999999987652221 00022245


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc--CCC-CcEEEeecCCc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--PHT-HQLKLCDFGSA  200 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~--~~~-~~vkl~Dfg~a  200 (390)
                      ++||||.| +|...+..-. ...++++..+..++..++.||.|||+ +|||||||||.||++-  .+| ...||+|||.|
T Consensus        94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            89999995 7777665433 35679999999999999999999998 9999999999999983  222 35799999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  255 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  255 (390)
                      +....+..-.+.+||+.|.+||++-....|+..+|.||+||++|+.+||..||..
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9998888889999999999999996557799999999999999999999999964

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6e-38  Score=282.46  Aligned_cols=236  Identities=24%  Similarity=0.298  Sum_probs=182.6

Q ss_pred             eeeecCceEEEEEEEc--CCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEec
Q 016401           57 VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      .||+|+||.||+|.+.  ..+..||+|++....     ....+|+.++++++|+||+++++++.     . ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            3899999999999765  445679999885432     23457999999999999999998762     1 236799999


Q ss_pred             ccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCC
Q 016401          130 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  208 (390)
Q Consensus       130 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~  208 (390)
                      +++ +|...+..   ....+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            985 66655542   23568999999999999999999998 9999999999999999887 799999999875433221


Q ss_pred             C----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          209 N----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       209 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .    ....++..|+|||.+.. ..++.++|||||||++|++++ |..||.+....+....+.... .            
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R------------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C------------
Confidence            1    11122467999999854 448999999999999999996 999998776555433332210 0            


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                     ...+...++++.++|.+||..||++||++.++.+
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0112457899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.8e-39  Score=288.40  Aligned_cols=236  Identities=19%  Similarity=0.264  Sum_probs=180.7

Q ss_pred             eeeeecCceEEEEEEEcCCCc-------EEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +.||+|+||.||+|.+...+.       .+|+|.+....    ....+|+.+++.++|||++++++++...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            368999999999999865544       48888775432    2345789999999999999999988432     2367


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCc-------EEEee
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-------LKLCD  196 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~-------vkl~D  196 (390)
                      +||||+++ +|..++...   ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++..       ++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999985 666665432   2357889999999999999999998 999999999999999876532       79999


Q ss_pred             cCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          197 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       197 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ||++.....   .....++..|+|||++.+...++.++|||||||++|+|++|. +||...+...... ....       
T Consensus       152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-------  220 (258)
T cd05078         152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-------  220 (258)
T ss_pred             cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-------
Confidence            999865432   223457888999999966556899999999999999999984 6665544333221 1110       


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                ..            .++...+.++.+||.+||+.||++|||++++++.
T Consensus       221 ----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ----------RH------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----------cc------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                      00            1123456789999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=295.17  Aligned_cols=261  Identities=26%  Similarity=0.377  Sum_probs=191.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..+.|.-...||+|+||.||+|.... +..||||++...    ...+.+|++++.+++|||+|+++++|.+...    ..
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~  147 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR  147 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence            44678888999999999999999854 489999988543    2447899999999999999999999954321    36


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC--CcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--GICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~--~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      +||+||+. |+|.+.+......  .++|....+|+.+++.||+|||+..  .||||||||+|||+|++. +.||+|||+|
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa  224 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLA  224 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCc
Confidence            79999999 6887777642211  7899999999999999999999733  399999999999999998 7999999999


Q ss_pred             ccccc-CCCCcce-eeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHH-HHhCCCCHH
Q 016401          201 KVLVK-GEPNVSY-ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEII-KVLGTPTRE  275 (390)
Q Consensus       201 ~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~-~~~~~~~~~  275 (390)
                      +.... ....... .||..|+|||.+.. ...+.++||||+|+++.||++|+.+.....  ....+.... ..+......
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~  303 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR  303 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh
Confidence            76544 3322333 78999999999954 458999999999999999999998776432  111122221 111111000


Q ss_pred             HHhhcCcCcccccCCCCCCCCccccccc-CCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                      +  -+++.        +..    ..++. ..-..+..+..+|++.+|.+||+..+++
T Consensus       304 e--iiD~~--------l~~----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv  346 (361)
T KOG1187|consen  304 E--IVDPR--------LKE----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV  346 (361)
T ss_pred             h--eeCCC--------ccC----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence            0  00111        000    00100 0112366788899999999999999874

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-37  Score=281.02  Aligned_cols=244  Identities=24%  Similarity=0.367  Sum_probs=191.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+|++.+.||+|+||.||++.+. .+..+|+|.+....   ....+|+.+++.++|+||+++++++..      ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence            358999999999999999999864 45679999886533   234579999999999999999888733      23679


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|||++ +++.+++...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  153 (260)
T cd05073          78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVIE  153 (260)
T ss_pred             EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCCcceeecc
Confidence            999997 4777766542  23457888899999999999999998 9999999999999999887 79999999987553


Q ss_pred             cCCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .....  ....++..|+|||++.. ..++.++|+|||||++|++++ |..||.+.+..+....+...             
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-------------  219 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------------  219 (260)
T ss_pred             CCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-------------
Confidence            32211  12234567999999854 458999999999999999998 99999877655444333221             


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                           +..+          .+...+.++.+++.+||..||++||++.++++
T Consensus       220 -----~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         220 -----YRMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             -----CCCC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                 0000          11346889999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.4e-37  Score=281.98  Aligned_cols=246  Identities=20%  Similarity=0.248  Sum_probs=181.8

Q ss_pred             eeeeecCceEEEEEEEc--CCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           56 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      +.||+|+||.||+|...  .++..+|+|.+....     ....+|+.+++.++||||+++++++.+     ....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence            36899999999999864  355779999885432     234579999999999999999988733     334789999


Q ss_pred             ccc-ccHHHHHHHhhhh-cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          129 YVP-ETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       129 ~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      |++ ++|.+++...... ....++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||.++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            998 5777777543321 2345677788999999999999998 9999999999999999887 7999999998654322


Q ss_pred             CC---CcceeeccccccchhhcCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          207 EP---NVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       207 ~~---~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ..   .....++..|+|||++.+.      ..++.++|+||+||++|+|++ |..||...+..+.........       
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------  226 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ-------  226 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc-------
Confidence            11   1223457789999998432      135789999999999999996 999998766544433222110       


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                               ....+       ...+....++.+.+++.+|+ .||++|||+++++.
T Consensus       227 ---------~~~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         227 ---------QLKLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ---------cCCCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                     00000       00111236788999999998 68999999999973

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-37  Score=278.89  Aligned_cols=237  Identities=24%  Similarity=0.364  Sum_probs=184.3

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ++||+|+||.||+|... ++..||+|.+....     ....+|+.+++.++||||+++++++..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            36899999999999864 68899999875432     234579999999999999999998733     33478999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC
Q 016401          131 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  209 (390)
Q Consensus       131 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~  209 (390)
                      ++ +|...+..   ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||++.........
T Consensus        75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            84 66555532   23457889999999999999999998 9999999999999999887 7999999998654322111


Q ss_pred             --cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 016401          210 --VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  286 (390)
Q Consensus       210 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (390)
                        ....++..|+|||++.+ ..++.++|+||||+++|++++ |..||.+.+.......+...                  
T Consensus       150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~------------------  210 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG------------------  210 (250)
T ss_pred             cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC------------------
Confidence              11223567999999854 458999999999999999998 99999877654443333210                  


Q ss_pred             ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .          ...++..++..+.+|+.+||..||++||++.++++
T Consensus       211 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         211 Y----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             C----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            0          00112457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.6e-38  Score=282.59  Aligned_cols=236  Identities=17%  Similarity=0.194  Sum_probs=177.2

Q ss_pred             eeeeecCceEEEEEEEcC------------CCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           56 HVVGTGSFGVVFQAKCRE------------TGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      +.||+|+||.||+|+...            ....+|+|.+....    ....+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            368999999999998532            23358899875432    233468899999999999999998743     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC------cE
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QL  192 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~------~v  192 (390)
                      ....+++|||+++ .+..++..   ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++.      .+
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCcee
Confidence            2336799999996 44444332   23568999999999999999999998 99999999999999976542      28


Q ss_pred             EEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCC
Q 016401          193 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       193 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      +++|||++......   ....++..|+|||.+.....++.++|||||||++|+|+ .|..||......+.. .....   
T Consensus       152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---  224 (262)
T cd05077         152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---  224 (262)
T ss_pred             EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---
Confidence            99999998654322   23456788999998865566899999999999999998 588888765432221 11110   


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                    ...            .....++++.+||.+||..||++||+..+++++
T Consensus       225 --------------~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 --------------QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --------------Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                          000            002246789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=283.33  Aligned_cols=244  Identities=25%  Similarity=0.342  Sum_probs=191.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCc----EEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||.||+|.++.+++    .+|+|.+....     ....+|+.+++.++|+||+++++++..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            3579999999999999999999876665    58999875442     234579999999999999999998743     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                       ...++||||+. ++|.+.+...   ...+++..+..++.|++.||+|||+ .||+|+||||+||+++.++ .+||+|||
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kL~dfg  154 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQ-HVKITDFG  154 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCC-eEEECCCc
Confidence             23679999997 4776665432   3458999999999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCCCcc---eeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          199 SAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       199 ~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      .++..........   ..++..|+|||.+.. ..++.++|+||+||++||+++ |..||.+.+..+....+... .    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~----  228 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-E----  228 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-C----
Confidence            9976543322211   112467999998854 458999999999999999998 99999877654443333221 0    


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                 ..            ..+...+.++.+++.+||..||.+||++.++++
T Consensus       229 -----------~~------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         229 -----------RL------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             -----------CC------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                       00            112346788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.2e-38  Score=284.23  Aligned_cols=235  Identities=17%  Similarity=0.236  Sum_probs=177.9

Q ss_pred             eeeecCceEEEEEEEcCC------------------------CcEEEEEEeccch----hhHHHHHHHHHhCCCCceeee
Q 016401           57 VVGTGSFGVVFQAKCRET------------------------GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVAL  108 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~  108 (390)
                      .||+|+||.||+|....+                        ...||+|++....    ....+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999975321                        2458899875432    234468889999999999999


Q ss_pred             cceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC
Q 016401          109 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  187 (390)
Q Consensus       109 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~  187 (390)
                      ++++..     ..+.++||||+++ +|..++..   ....+++.++..++.|++.||+|||+ +||+||||||+|||++.
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence            998843     3347899999996 55444432   23568899999999999999999998 99999999999999975


Q ss_pred             CC------CcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHH
Q 016401          188 HT------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD  260 (390)
Q Consensus       188 ~~------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~  260 (390)
                      ++      ..+|++|||.+......   ....++..|+|||.+.+...++.++|+|||||++|||+ +|..||.+....+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            43      13899999987543222   22356778999999866566899999999999999995 7999997765433


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ... ....                 ...            ++...++++.++|.+||..||++|||+.+++++
T Consensus       230 ~~~-~~~~-----------------~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KER-FYEK-----------------KHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHH-HHHh-----------------ccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            221 1110                 000            112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=278.54  Aligned_cols=237  Identities=25%  Similarity=0.365  Sum_probs=185.0

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ++||.|++|.||+|.+.. ++.||+|++....     ....+|+++++.++|+||+++++++..     ..+.++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcC
Confidence            468999999999999977 9999999875432     234579999999999999999988733     33478999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC
Q 016401          131 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  209 (390)
Q Consensus       131 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~  209 (390)
                      .+ ++.+++..   ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            74 66665543   23467888999999999999999998 9999999999999999887 7999999998754322111


Q ss_pred             ---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          210 ---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       210 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                         .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........+...                 
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-----------------  211 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-----------------  211 (251)
T ss_pred             eccccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-----------------
Confidence               11122556999999854 458999999999999999999 88999776654433332210                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                       .          ....+..++.++.+++.+||..+|.+|||+.++++
T Consensus       212 -~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         212 -Y----------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -C----------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence             0          00112356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.9e-38  Score=285.86  Aligned_cols=256  Identities=23%  Similarity=0.367  Sum_probs=188.3

Q ss_pred             cEEEeeeeeecCceEEEEEEE----cCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      -|++.+.||+|+||.||+|+.    ..++..||+|.+....     ....+|+.+++.++|||++++++++..   .+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence            589999999999999999974    4578899999885331     334579999999999999999887743   2234


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      +.++||||+++ +|..++...   ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCC-CEEECCCccc
Confidence            47899999974 776665431   2358899999999999999999998 9999999999999999887 7999999998


Q ss_pred             cccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC---
Q 016401          201 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT---  273 (390)
Q Consensus       201 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  273 (390)
                      .........    ....++..|+|||.+.+. .++.++|||||||++|+|+++..|+....  ....   +..+...   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~--~~~~---~~~~~~~~~~  230 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPM--TLFL---KMIGPTHGQM  230 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCcccc--chhh---hhcccccccc
Confidence            765433221    123456679999998654 48999999999999999999876653321  1111   1000000   


Q ss_pred             -H-HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          274 -R-EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       274 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                       . .....+...             .....+..++..+.+||.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 TVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             0 000000000             0001124578999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.1e-37  Score=280.92  Aligned_cols=244  Identities=27%  Similarity=0.376  Sum_probs=190.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCC---CcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+|.+.+.||+|+||.||+|.+...   ...||||.+....     ....+|+.+++.++||||+++++++..     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C
Confidence            34799999999999999999987543   3568999875432     234579999999999999999987732     1


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                       ..|+||||++ ++|.+++...   ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||+
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~  153 (270)
T cd05056          80 -PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPD-CVKLGDFGL  153 (270)
T ss_pred             -CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCC-CeEEccCce
Confidence             2569999998 4776666542   2358999999999999999999998 9999999999999999887 799999999


Q ss_pred             ccccccCCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          200 AKVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       200 a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      +.........  ....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..+....+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------  225 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------  225 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------
Confidence            8755333211  11223457999998854 458999999999999999986 999998877655544332210       


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                 .          ...+..++..+.++|.+||..+|++|||+.+++.
T Consensus       226 -----------~----------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         226 -----------R----------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             -----------c----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       0          0112457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-37  Score=279.61  Aligned_cols=240  Identities=23%  Similarity=0.363  Sum_probs=189.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ..|++.+.||+|+||.||++..  +++.||+|.+..+  .....+|+.+++.++|||++++++++..     +. .+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~-~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----NG-LYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----CC-cEEEE
Confidence            4799999999999999999874  6888999988643  2345679999999999999999988732     11 57999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+. ++|..++....  ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            9998 48877765421  2457888999999999999999998 9999999999999999887 7999999998754322


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                        ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||...+..+....+.+.                 
T Consensus       154 --~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----------------  213 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-----------------  213 (254)
T ss_pred             --CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-----------------
Confidence              122233567999998854 458999999999999999997 99999877654433322210                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                       +..          ..+..++..+.+++++||..+|++||++.+++.
T Consensus       214 -~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         214 -YRM----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -CCC----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             000          011357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-37  Score=282.65  Aligned_cols=243  Identities=21%  Similarity=0.300  Sum_probs=187.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCc----EEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      .+|++.+.||+|+||.||+|.+..+++    .+++|.+....     .....|+.++..++||||+++++++.     +.
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence            479999999999999999999877776    47777764321     22345777888999999999998762     11


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                       ..++++||+. ++|.+++...   ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence             2568899987 5777666532   3568999999999999999999998 9999999999999999887 799999999


Q ss_pred             ccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          200 AKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       200 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ++........   ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+...... .+++.....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~----  229 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGER----  229 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCc----
Confidence            9765333221   223456689999999554 48999999999999999998 9999987654332 222221000    


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                 ..            .+...+.++.+++.+||..||++|||+.++++
T Consensus       230 -----------~~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         230 -----------LA------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             -----------CC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                       00            01235778999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-37  Score=281.61  Aligned_cols=242  Identities=23%  Similarity=0.346  Sum_probs=185.7

Q ss_pred             eeeeecCceEEEEEEEcCCC------cEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           56 HVVGTGSFGVVFQAKCRETG------EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +.||+|+||.||+|+++...      +.+|||.+...     .....+|+.+++.++||||+++++++..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            36899999999999986544      68999987543     2234579999999999999999998743     23478


Q ss_pred             EEEeccc-ccHHHHHHHhhh---hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC----CcEEEee
Q 016401          125 LVLEYVP-ETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCD  196 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----~~vkl~D  196 (390)
                      +||||++ ++|...+.....   ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999998 477777754322   12347888999999999999999998 9999999999999998754    2599999


Q ss_pred             cCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016401          197 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       197 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      ||++........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... .  
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~--  230 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G--  230 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C--
Confidence            999875533211   1122346789999999554 58999999999999999998 99999877655544333210 0  


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                   ..            ..+..++..+.+||.+||..+|.+||++.++++
T Consensus       231 -------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -------------RL------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -------------cc------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                         00            112357889999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.3e-37  Score=278.62  Aligned_cols=245  Identities=19%  Similarity=0.256  Sum_probs=181.3

Q ss_pred             eeeecCceEEEEEEEcCC--CcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEec
Q 016401           57 VVGTGSFGVVFQAKCRET--GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      .||+|+||.||++.....  ...+++|.+....     ....+|+.+++.++||||+++++.+..     ....|+||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEec
Confidence            589999999999975433  3456777664322     344578899999999999999998843     3447899999


Q ss_pred             ccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCC-
Q 016401          130 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  207 (390)
Q Consensus       130 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~-  207 (390)
                      +++ +|..++..........++..++.++.||+.||+|||+ .+++||||||+|||++.++ .++|+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence            984 7777776533223456777888999999999999998 9999999999999999888 69999999975432211 


Q ss_pred             --CCcceeeccccccchhhcCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          208 --PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       208 --~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                        ......++..|+|||++...      ..++.++|||||||++|||++ |..||...+..+.+..+......       
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-------  227 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV-------  227 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc-------
Confidence              12234567889999987421      235789999999999999996 57888777666555554432100       


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                               ..       +...+...+++.+.+++..|| .||++||++.++++
T Consensus       228 ---------~~-------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 ---------KL-------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ---------cc-------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                     00       011112346788999999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.9e-37  Score=278.60  Aligned_cols=239  Identities=22%  Similarity=0.344  Sum_probs=179.4

Q ss_pred             eeeeecCceEEEEEEEcC---CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           56 HVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +.||+|+||.||+|.+..   .+..+|+|.+....     ....+|+.+++.++||||+++++++..    .+...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence            468999999999998643   34579999874321     234468999999999999999986632    223367999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||+. ++|..++...   ....++..+..++.|++.||+|||+ .+++||||||+|||++.++ .+||+|||+++.....
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            9998 4776666432   2345677788899999999999998 9999999999999999887 7999999998754321


Q ss_pred             CC-----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          207 EP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       207 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ..     .....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+...  .         
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~---------  219 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--R---------  219 (262)
T ss_pred             cceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--C---------
Confidence            11     112234668999999855 458999999999999999999 56777766544433322110  0         


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                           ..            ..+..+++.+.+++.+||..||++||++.++++
T Consensus       220 -----~~------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         220 -----RL------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             -----CC------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                 00            011346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.2e-37  Score=280.07  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=188.4

Q ss_pred             EEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCC-ce
Q 016401           52 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-EL  121 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-~~  121 (390)
                      |++.+.||+|+||.||+|...   .+++.||||++..+.      ....+|+.+++.++||||+++++++....... ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678889999999999999864   357899999885432      22457999999999999999999875433222 22


Q ss_pred             EEEEEEeccc-ccHHHHHHHhh--hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          122 YLNLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ..++++||+. +++...+....  .....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCC-CEEECccc
Confidence            3468889987 46655543211  112247888999999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          199 SAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       199 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +++.......   .....+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+... .    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~----  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-N----  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-C----
Confidence            9876533221   122234567999999854 458899999999999999999 89999876654433332210 0    


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                 ...            .+...+..+.+++.+||..+|++|||+.+++.
T Consensus       233 -----------~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         233 -----------RLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             -----------cCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       000            11346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.8e-37  Score=284.90  Aligned_cols=245  Identities=22%  Similarity=0.342  Sum_probs=189.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCc----EEEEEEeccchh-----hHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|+..+.||+|+||.||+|.+..+++    .+|+|.+.....     ...+|+.+++.++||||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            3579999999999999999999877775    478887754321     345789999999999999999987421    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                        ..++++||++ |++.+.+..   ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        82 --~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~-~~kL~Dfg  154 (303)
T cd05110          82 --TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPN-HVKITDFG  154 (303)
T ss_pred             --CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCC-ceEEcccc
Confidence              1458999998 567665543   13458888999999999999999998 9999999999999998877 79999999


Q ss_pred             CccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          199 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       199 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+ ...+.....    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~----  228 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGE----  228 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCC----
Confidence            99765432221   12234678999999854 458999999999999999997 899997765333 222222100    


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                   ..+          .+...+..+.+++.+||..||++||++.++++.
T Consensus       229 -------------~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         229 -------------RLP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -------------CCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         000          113467889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=289.02  Aligned_cols=260  Identities=26%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----------hhHHHHHHHHHhCCCCceeeecceeccCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      ..++|.++.+||+|+|+.||+|.+....+.||+|+-...+           ....+|.+|.+.|+||.||++|++|.-  
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl--  538 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL--  538 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee--
Confidence            3468999999999999999999999889999999752211           112379999999999999999999832  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc-CCcccccCCCCcEEEcCC--CCcE
Q 016401          117 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPH--THQL  192 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~-~~ivH~Dlkp~NIll~~~--~~~v  192 (390)
                        +...+|-|+|||+| +|+-++..    ...+++..++.|+.||+.||.||.+- -.|||-||||.|||+-..  .+.+
T Consensus       539 --DtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  539 --DTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             --ccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence              23337899999998 66666654    46789999999999999999999961 369999999999998533  1279


Q ss_pred             EEeecCCccccccCCCC--------cceeeccccccchhhcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 016401          193 KLCDFGSAKVLVKGEPN--------VSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  261 (390)
Q Consensus       193 kl~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  261 (390)
                      ||+|||+++.+......        ....||.||++||.+.-   ....+.++||||+|||+|..+.|+.||..+.....
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd  692 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD  692 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence            99999999987544322        23468999999998842   34578999999999999999999999976543322


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      +.+.-..+             +..+..+|..          +.++.++++||++||.+.-+.|..+.++..||+|.-
T Consensus       693 ILqeNTIl-------------kAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  693 ILQENTIL-------------KATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHhhhchh-------------cceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            21111110             1123344432          458999999999999999999999999999999964

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.6e-37  Score=276.69  Aligned_cols=234  Identities=20%  Similarity=0.228  Sum_probs=179.3

Q ss_pred             eeeeecCceEEEEEEEcCCC----------cEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           56 HVVGTGSFGVVFQAKCRETG----------EIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ....+|+.+++.++||||+++++++..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            46899999999999998776          358888775433   345579999999999999999998744      12


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC------cEEEe
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QLKLC  195 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~------~vkl~  195 (390)
                      .++||||+.+ +|..++...   ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++.      .+||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeC
Confidence            5799999985 666655542   2268899999999999999999998 99999999999999987652      49999


Q ss_pred             ecCCccccccCCCCcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          196 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       196 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      |||++.....   .....++..|+|||++.+. ..++.++|+|||||++|+|++ |..||...+..+.......      
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~------  221 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD------  221 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc------
Confidence            9999876533   2233456779999998654 358999999999999999999 5788866543222111110      


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                  ...            .+......+.++|.+||..||.+|||+.++++
T Consensus       222 ------------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 ------------QHR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ------------CCC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                        000            00112378999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-38  Score=293.13  Aligned_cols=243  Identities=23%  Similarity=0.360  Sum_probs=192.7

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCc---E-EEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGE---I-VAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      +-.+.+.||+|+||.||+|..+..+.   . ||+|..+.+.       ..+-+|+++|+.++|||||+++++....    
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~----  233 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE----  233 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC----
Confidence            45566999999999999999865422   3 8999876321       2234799999999999999999988433    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                       ..+++|||+|.| +|.++++..   ...++......++.+.+.||+|||+ ++++||||-..|+|++.++ .+||+|||
T Consensus       234 -~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~-~vKISDFG  307 (474)
T KOG0194|consen  234 -EPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKG-VVKISDFG  307 (474)
T ss_pred             -CccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCC-eEEeCccc
Confidence             338899999995 887777753   2358999999999999999999998 9999999999999999877 58999999


Q ss_pred             CccccccCCCCc-ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          199 SAKVLVKGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       199 ~a~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      +++......... ..--...|+|||.+... .|++++||||+||++||+++ |..||.+....+...++...        
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~--------  378 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN--------  378 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc--------
Confidence            987543111111 11124679999999554 69999999999999999998 88999999988777777442        


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                               .+          ....+...+.++..++.+|+..||+.|++..++.
T Consensus       379 ---------~~----------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~  414 (474)
T KOG0194|consen  379 ---------GY----------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK  414 (474)
T ss_pred             ---------Cc----------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence                     11          1122346788999999999999999999998885

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=308.02  Aligned_cols=248  Identities=20%  Similarity=0.345  Sum_probs=200.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCC-----cEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ...-+..+.||+|+||.||.|......     ..||||.+.+.     ...+.+|..+|+.++|||||++++++++... 
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC-
Confidence            347889999999999999999875432     24999988543     3345589999999999999999999976333 


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhh---cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                          .++++|||. |+|..+++..+..   ...++...+..++.||+.|++||++ +++|||||...|+||+... .|||
T Consensus       770 ----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r-~VKI  843 (1025)
T KOG1095|consen  770 ----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERR-VVKI  843 (1025)
T ss_pred             ----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccC-cEEE
Confidence                679999999 5888888764211   3458888999999999999999998 9999999999999999987 8999


Q ss_pred             eecCCccccccCCCCcc---eeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016401          195 CDFGSAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  270 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  270 (390)
                      +|||+|+.+...+....   ..-...|||||.+.. ..++.++|||||||++||+++ |..||.+.+..+.+.-..+.. 
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-  921 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-  921 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence            99999996543322211   122456999999954 569999999999999999998 899999988877776555421 


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                       +++          .+..+|..+.+++..||+.+|++||+...+++
T Consensus       922 -----------------RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 -----------------RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -----------------ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                             111          23578999999999999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.6e-36  Score=290.75  Aligned_cols=272  Identities=21%  Similarity=0.294  Sum_probs=181.8

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc----------------CCCcEEEEEEeccchh------------------hHHHH
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR----------------ETGEIVAIKKVLQDKR------------------YKNRE   93 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~------------------~~~~E   93 (390)
                      ..++|.+.++||+|+||.||+|...                ..++.||||++.....                  ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                2356799999854321                  11236


Q ss_pred             HHHHHhCCCCce-----eeecceeccCCC---CCceEEEEEEecccc-cHHHHHHHhh-----------h---------h
Q 016401           94 LQIMQMLDHPNI-----VALKHCFFSTTD---KEELYLNLVLEYVPE-TVNRIARNYS-----------R---------I  144 (390)
Q Consensus        94 ~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~---------~  144 (390)
                      +.++.+++|.++     +++++++.....   ......++||||+++ +|.+++....           .         .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777776654     455555532211   112346799999984 7766664311           0         0


Q ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCCcc--eeeccccccch
Q 016401          145 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAPE  222 (390)
Q Consensus       145 ~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~t~~y~aPE  222 (390)
                      ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||++...........  ..+|+.|+|||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            1234567789999999999999998 8999999999999999887 799999999975543322222  23478999999


Q ss_pred             hhcCCCC-------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          223 LIFGATE-------------------Y--TTAIDIWSTGCVMAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       223 ~~~~~~~-------------------~--~~~~DiwslG~il~ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ++.....                   +  ..+.|+||+||++|+|++|.. ||.+......   ..+...... ..+...
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~~~~~-~~~r~~  456 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQYDNDL-NRWRMY  456 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhccchH-HHHHhh
Confidence            9853211                   1  234799999999999999875 6654321111   111000000 001000


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCC---CcCCCHHHHhcCCccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP---NLRCTALEACVHPFFD  337 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~R~s~~~~l~hp~f~  337 (390)
                      ..  ..+.++          .....++.++||+++||..+|   .+|+|+.|+|+||||.
T Consensus       457 ~~--~~~~~~----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        457 KG--QKYDFS----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             cc--cCCCcc----------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            00  001111          124578999999999999876   6899999999999995

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-36  Score=275.56  Aligned_cols=260  Identities=25%  Similarity=0.357  Sum_probs=189.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEc----CCCcEEEEEEeccchh-----hHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..|++.+.||+|+||.||+|...    .+++.||||.+.....     .+.+|+++++.+.|+||+++++++..   ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            36888999999999999999864    3478999999864433     45689999999999999999887633   234


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .+.+++|||+++ +|..++...   ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESED-LVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEccccc
Confidence            457899999974 777666542   2358899999999999999999998 9999999999999999887 799999999


Q ss_pred             ccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCH
Q 016401          200 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-VLGTPTR  274 (390)
Q Consensus       200 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~  274 (390)
                      +.........    ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||........  .+.. ..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~  232 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--RMIGIAQGQMIV  232 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhc--cccccccccccH
Confidence            9766422211    112335569999998554 589999999999999999999999865432110  0000 0000000


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ..+......  ....          ..+..++.++.+|+.+||..||++|||+.++++
T Consensus       233 ~~~~~~~~~--~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         233 TRLLELLKE--GERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHc--CCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000000  0000          011346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=250.47  Aligned_cols=217  Identities=24%  Similarity=0.414  Sum_probs=179.3

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      .+-..+....+..||+|++|.|-+.++..+|...|+|.+...-     ....+|+.+..+. .+|++|.+++.++...+ 
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-
Confidence            3444556777888999999999999999999999999985332     2233466655444 79999999998855444 


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          119 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       119 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                          +++.||.|.-++..+-..-...++.++|..+-+++..++.||.|||+...++|||+||+||||+.+| +||+||||
T Consensus       120 ----vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFG  194 (282)
T KOG0984|consen  120 ----VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFG  194 (282)
T ss_pred             ----EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccc
Confidence                8899999998888777777777889999999999999999999999877999999999999999999 79999999


Q ss_pred             CccccccCCCCcceeeccccccchhhcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 016401          199 SAKVLVKGEPNVSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIK  267 (390)
Q Consensus       199 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~  267 (390)
                      .+....++-..+...|...|||||.+..   ...|+.++||||||+++.||.+++.||.. .++.+++.++.+
T Consensus       195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            9987666555555677788999999832   34689999999999999999999999975 456677777665

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=295.59  Aligned_cols=250  Identities=30%  Similarity=0.449  Sum_probs=191.7

Q ss_pred             cEEEeeeeeecCce-EEEEEEEcCCCcEEEEEEeccchh-hHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           51 SYIAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        51 ~y~~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      -|.-.+++|.|+.| .||+|..  .|+.||||++-.+.. ..++|+..|+.- +|||||+++..-     .+..+.|+..
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIal  582 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIAL  582 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEe
Confidence            46667789999998 5699986  488999999866544 667999999998 699999987654     6778899999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC---CC-CcEEEeecCCcccc
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HT-HQLKLCDFGSAKVL  203 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~-~~vkl~Dfg~a~~~  203 (390)
                      |.|..+|.+++...............+.++.|++.||++||+ .+||||||||.||||+.   ++ -+++|+|||+++..
T Consensus       583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            999999999987631111112224567888999999999998 99999999999999976   33 37999999999987


Q ss_pred             ccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          204 VKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       204 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ..+...    ....||-.|+|||++.... -+.++||||+||++|+.++| ..||...  .+.-.+|+..          
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~----------  728 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTG----------  728 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcC----------
Confidence            655332    3456899999999996554 57799999999999999986 8999543  2222333321          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                          ++.-..+.            +.-..++.|||.+|+..||..||+|.++|.||+|=
T Consensus       729 ----~~~L~~L~------------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  729 ----NYTLVHLE------------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             ----ccceeeec------------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                00000000            11122899999999999999999999999999993

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=280.12  Aligned_cols=255  Identities=22%  Similarity=0.295  Sum_probs=200.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ....+.++||+|.||.|.+|.-. .+..||+|+++.+.     ..+.+|+++|.+|+||||+.++++|...     ..+|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchH
Confidence            46789999999999999999864 46899999986542     4456899999999999999999998432     2378


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +|+||++ |+|.+.+.....  ..........++.||+.||+||.+ .++|||||.+.|+|++.++ ++||+|||+++..
T Consensus       612 mI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~l  687 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCccccccc
Confidence            9999998 688777765432  123445566799999999999998 8999999999999999998 7999999999866


Q ss_pred             ccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          204 VKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL--LGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       204 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ..+...   ...+-...|||||.++..+ +++++|+|++|+++||++  |...||...++.+...+....+..+....  
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--  764 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--  764 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce--
Confidence            544332   1233467899999997655 999999999999999986  67899988887776666555433222111  


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                             ...            -|+-++..+.+|+.+||..|-++||+.+++  |-+|++
T Consensus       765 -------~l~------------~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq~  803 (807)
T KOG1094|consen  765 -------VLS------------RPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQE  803 (807)
T ss_pred             -------ecc------------CCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence                   111            124578999999999999999999999998  566654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=5.2e-37  Score=275.04  Aligned_cols=281  Identities=30%  Similarity=0.482  Sum_probs=210.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcC---CCcEEEEEEecc--chhhHHHHHHHHHhC-CCCceeeecceeccCCCCCce
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQ--DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+.|.++++||+|+|++||++.+..   ..+.||+|.+..  ......+|+++|..+ .+.||+++.+++     ..+.
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCC
Confidence            34579999999999999999999877   688999998743  345577999999999 589999999988     4444


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..++|+||++. ...++.       ..++...++.+++.++.||+++|. .|||||||||.|+|.+.....-.|+|||+|
T Consensus       109 ~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhH
Confidence            58899999985 333322       347788999999999999999998 999999999999999988778899999998


Q ss_pred             ccccc-------------------C--------------------------CCCcceeeccccccchhhcCCCCCCCchh
Q 016401          201 KVLVK-------------------G--------------------------EPNVSYICSRYYRAPELIFGATEYTTAID  235 (390)
Q Consensus       201 ~~~~~-------------------~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  235 (390)
                      .....                   +                          .......||++|+|||++.....-++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            62100                   0                          00012468999999999988777899999


Q ss_pred             HHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhcC------------------cCcccccCCCCCC-C
Q 016401          236 IWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMN------------------PNYTEFKFPQIKP-H  295 (390)
Q Consensus       236 iwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~-~  295 (390)
                      |||.|+|+..+++++.||. ..++.+.+.++....|...-.......                  ..|.......+.. .
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            9999999999999998875 456666666666655443322221111                  1111110001100 0


Q ss_pred             ---CcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          296 ---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       296 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                         .+.....+.++..+.||+.+||+.||.+|+|++++|+||||.+...
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence               1122222345678999999999999999999999999999986543

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=282.56  Aligned_cols=242  Identities=29%  Similarity=0.449  Sum_probs=191.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC--C--cEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET--G--EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~--~--~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ....+.++||+|.||.||.|....-  |  --||||..+.+     ...+..|..+|+.++||||+++++++.+.     
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-----  463 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-----  463 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-----
Confidence            3455678999999999999975322  2  34889988653     23345799999999999999999998332     


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                       ..++|||+++ |.|..+++..   ...++...+..+++||+.||.|||+ .++|||||-..|||+.+.. .|||+|||+
T Consensus       464 -P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~-CVKLaDFGL  537 (974)
T KOG4257|consen  464 -PMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQ-CVKLADFGL  537 (974)
T ss_pred             -ceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcc-eeeecccch
Confidence             2779999998 6776666653   4568889999999999999999998 9999999999999999888 699999999


Q ss_pred             ccccccCCCCcceee--ccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          200 AKVLVKGEPNVSYIC--SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       200 a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ++.+..........|  ..-|||||.+ +...++.++|||.||+.+||++. |..||.+-...+.+..+-+.        
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG--------  608 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG--------  608 (974)
T ss_pred             hhhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC--------
Confidence            997765544333333  4569999999 56679999999999999999975 99999886554443322211        


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                              +            +-..|+++|+.+..|+.+||.+||.+||...++.
T Consensus       609 --------e------------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  609 --------E------------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             --------C------------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                    0            0113478999999999999999999999987654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=280.31  Aligned_cols=242  Identities=22%  Similarity=0.412  Sum_probs=197.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ....+.++||.|.||.||.|.++.....||||.++.+..   .+..|+.+|+.++|||+|+++++|.     .+.-+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPFYIi  341 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPFYII  341 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCeEEE
Confidence            456778899999999999999999999999999976654   3457999999999999999999993     33348899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      +|||. |+|.++++...+  ..++.-.+..++.||..|++||.. +++|||||-..|.|+.++. .||++|||+++.+. 
T Consensus       342 TEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnh-iVKvADFGLsRlMt-  416 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-IVKVADFGLSRLMT-  416 (1157)
T ss_pred             EecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccc-eEEeeccchhhhhc-
Confidence            99987 799888887543  446677788889999999999998 9999999999999999886 79999999998663 


Q ss_pred             CCCCcceee---ccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          206 GEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       206 ~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      +...+...|   ..-|.|||.+ ....++.++|||+||++|||+.| |..||++-+....+ ..++.             
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsL-AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-~LLEk-------------  481 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESL-AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-GLLEK-------------  481 (1157)
T ss_pred             CCceecccCccCcccccCcccc-cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-HHHhc-------------
Confidence            444444444   4569999998 44458999999999999999997 88999998754443 33331             


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHH
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  330 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~  330 (390)
                          .+++.          -++.+++...+|++.||+|.|..||+.+++
T Consensus       482 ----gyRM~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  482 ----GYRMD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             ----ccccc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                11111          136799999999999999999999999877

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.4e-35  Score=261.10  Aligned_cols=238  Identities=38%  Similarity=0.634  Sum_probs=191.0

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecccc-cHH
Q 016401           62 SFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVN  135 (390)
Q Consensus        62 ~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  135 (390)
                      +||.||+|.+..+++.+|+|++...     .....+|++.+++++|+|++++++.+..     ....++++||+++ +|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            5899999999988999999998543     3455689999999999999999988733     3457899999997 777


Q ss_pred             HHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCCcceeec
Q 016401          136 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS  215 (390)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t  215 (390)
                      .++..    ...++...+..++.+++.++.+||+ .+++|+||+|.||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            66654    2338889999999999999999998 8999999999999999887 7999999999876554344456678


Q ss_pred             cccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCC
Q 016401          216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH  295 (390)
Q Consensus       216 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (390)
                      ..|++||.+.+ ..++.++|+||+|+++|+|++|..||......+...+.......                ..      
T Consensus       150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~----------------~~------  206 (244)
T smart00220      150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP----------------PF------  206 (244)
T ss_pred             cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC----------------CC------
Confidence            88999999854 44788999999999999999999999774444433333221000                00      


Q ss_pred             CcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          296 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       296 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                         ......++.++.+++.+||..||++||++.++++||||
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence               00001167899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-36  Score=269.01  Aligned_cols=273  Identities=23%  Similarity=0.290  Sum_probs=200.2

Q ss_pred             ccccCCCccceEEeeecccCCCCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEec-cchhhHHHHHHHHHhC--
Q 016401           24 IDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQML--  100 (390)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~E~~~l~~l--  100 (390)
                      ..|+|++.+-++++++..+         ..+.+.||+|.||.||+|+++  |+.||||++. .+.....+|.+|.+.+  
T Consensus       194 tSGSGSGlplLVQRTiarq---------I~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmL  262 (513)
T KOG2052|consen  194 TSGSGSGLPLLVQRTIARQ---------IVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVML  262 (513)
T ss_pred             cCCCCCCchhHhHHhhhhe---------eEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHh
Confidence            3477788888888888865         889999999999999999986  8899999985 4566677888888774  


Q ss_pred             CCCceeeecceeccCCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc-------CC
Q 016401          101 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------IG  172 (390)
Q Consensus       101 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~-------~~  172 (390)
                      +|+||+.++..-.... ..-..++||++|.+ |+|.+++..     ..++...+.+++..++.||+|||..       -.
T Consensus       263 RHENILgFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPa  336 (513)
T KOG2052|consen  263 RHENILGFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPA  336 (513)
T ss_pred             ccchhhhhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCch
Confidence            9999999877643222 22334889999998 799888874     6788999999999999999999941       25


Q ss_pred             cccccCCCCcEEEcCCCCcEEEeecCCccccccCC-----CCcceeeccccccchhhcCCCCC-----CCchhHHHHHHH
Q 016401          173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-----PNVSYICSRYYRAPELIFGATEY-----TTAIDIWSTGCV  242 (390)
Q Consensus       173 ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwslG~i  242 (390)
                      |.|||||..|||+.+++ ..-|+|+|+|.......     .....+||..|||||++...-+.     -..+||||||.+
T Consensus       337 IAHRDlKSKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV  415 (513)
T KOG2052|consen  337 IAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV  415 (513)
T ss_pred             hhccccccccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence            99999999999999998 79999999997654432     23557899999999999543221     136899999999


Q ss_pred             HHHHHhC----------CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHH
Q 016401          243 MAELLLG----------QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL  312 (390)
Q Consensus       243 l~ell~g----------~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  312 (390)
                      +||++..          ++||.+-.+.           .|..+++.+      .+....+++.....|.....=..+..+
T Consensus       416 lWEiarRc~~ggi~eey~~Pyyd~Vp~-----------DPs~eeMrk------VVCv~~~RP~ipnrW~s~~~l~~m~kl  478 (513)
T KOG2052|consen  416 LWEIARRCESGGIVEEYQLPYYDVVPS-----------DPSFEEMRK------VVCVQKLRPNIPNRWKSDPALRVMAKL  478 (513)
T ss_pred             HHHHHHHhhcCCEehhhcCCcccCCCC-----------CCCHHHHhc------ceeecccCCCCCcccccCHHHHHHHHH
Confidence            9999852          4777653221           111111111      011111111111222211122356688


Q ss_pred             HHHhcccCCCcCCCHHHHh
Q 016401          313 VCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       313 i~~~L~~dP~~R~s~~~~l  331 (390)
                      ++.||..+|.-|.|+-.+.
T Consensus       479 MkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  479 MKECWYANPAARLTALRIK  497 (513)
T ss_pred             HHHhhcCCchhhhHHHHHH
Confidence            9999999999999997664

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=287.46  Aligned_cols=245  Identities=26%  Similarity=0.404  Sum_probs=205.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCc---EEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      .....|.++||.|.||.|++|+.+..|+   .||||.++..     .+.+..|+.||-+++||||+++.++.     ...
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks  702 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKS  702 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecC
Confidence            3467899999999999999999987764   5999998642     34455799999999999999999988     334


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .-+.+|+|||+ |+|+..++..   .++++..++.-+++.|+.|++||-+ .|+|||||-..|||++.+- ..|++|||+
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGL  777 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGL  777 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEeccccc
Confidence            44789999998 6888888764   3679999999999999999999998 9999999999999999998 799999999


Q ss_pred             ccccccCC-CCcceee---ccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKGE-PNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~~-~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      ++...++. ...+..|   ...|.|||.+ ....++.++||||+|++|||.++ |..||.+....+.+..|.+..     
T Consensus       778 SRvledd~~~~ytt~GGKIPiRWTAPEAI-a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy-----  851 (996)
T KOG0196|consen  778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY-----  851 (996)
T ss_pred             eeecccCCCccccccCCccceeecChhHh-hhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc-----
Confidence            99765544 2223333   4679999999 45569999999999999999885 999999999989888887643     


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                   .+|.          |..+|..+.+|+..||++|-.+||...++++
T Consensus       852 -------------RLPp----------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  852 -------------RLPP----------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             -------------CCCC----------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                         3332          2468999999999999999999999999886

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=278.92  Aligned_cols=245  Identities=24%  Similarity=0.332  Sum_probs=199.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC-C--cEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+.++.++||+|+||.|++|.++.. |  ..||||.+..+.     ..+.+|+.+|.+|+|+|++++|++..+.      
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------  183 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------  183 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------
Confidence            3677889999999999999988643 3  359999986543     3466899999999999999999998542      


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      -+.+|||++. |+|.+.+..  .....|....+..++.||+.||.||.+ +++|||||-..|+|+-... .|||||||+.
T Consensus       184 p~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllaspr-tVKI~DFGLm  259 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPR-TVKICDFGLM  259 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccc-eeeeecccce
Confidence            1568999998 677766665  335678888999999999999999998 9999999999999998765 7999999999


Q ss_pred             cccccCCCCcceee----ccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          201 KVLVKGEPNVSYIC----SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       201 ~~~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      +....++..+....    ...|+|||.+.. ..++.++|+|++||+||||++ |.-||.|....+.+.+|-+.       
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-------  331 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-------  331 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-------
Confidence            98877766553332    345999999954 459999999999999999997 78999999877776665421       


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                               +.+.            -++.++.++.+++..||..+|++|||..+|.+.
T Consensus       332 ---------erLp------------RPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  332 ---------ERLP------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ---------ccCC------------CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                     0011            125689999999999999999999999888543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-34  Score=304.96  Aligned_cols=252  Identities=21%  Similarity=0.294  Sum_probs=182.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecc
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      .|...+.||+|+||.||+|+++.++..||||++........+|++++++++|||||++++++...     ...|+||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            45667789999999999999998999999999876555556789999999999999999998432     3367999999


Q ss_pred             c-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH---hcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          131 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH---NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       131 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH---~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      + ++|.+++.       .+++..+..++.|++.||+|||   + .+|+||||||+||+++.++ ..++. |+.+..... 
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence            8 47766663       3788889999999999999999   5 6999999999999999876 56664 665433211 


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                        .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+.+..+..-....  .       .
T Consensus       835 --~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~-------~  902 (968)
T PLN00113        835 --DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH--L-------D  902 (968)
T ss_pred             --CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc--h-------h
Confidence              123367899999999854 4589999999999999999999999854221 1111111111000000  0       0


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .+.-+.....   .........++.+++.+||+.||++|||+.++++.
T Consensus       903 ~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        903 MWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             heeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0000000000   00011123467899999999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-34  Score=257.50  Aligned_cols=264  Identities=25%  Similarity=0.327  Sum_probs=190.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc-chhhHHHHHHHHHhC--CCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQML--DHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ....+.++||+|.||.||+|...  ++.||||++.. ++..+.+|.+|....  +|+||++++..-..... ...-++||
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLV  286 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLV  286 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEE
Confidence            45778899999999999999975  69999999964 456667788887764  89999998776533222 23346799


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc--------CCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--------IGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~--------~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      ++|.+ |+|.+++..     ..+++....+++..+++||+|||+.        ..|+|||||..||||..|. +..|+||
T Consensus       287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDF  360 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADF  360 (534)
T ss_pred             eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeecc
Confidence            99998 799888875     5689999999999999999999962        3599999999999999998 7999999


Q ss_pred             CCccccccCCCC---cceeeccccccchhhcCCCCCC-----CchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHH
Q 016401          198 GSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYT-----TAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKV  268 (390)
Q Consensus       198 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~  268 (390)
                      |+|..+..+...   ...+||..|||||++.+.-+..     .+.||||+|.+||||++....+. +..+.-++-=-.+.
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            999877654333   3468899999999996654444     46899999999999998764443 22211111111122


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHH
Q 016401          269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  328 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~  328 (390)
                      ...|..+++..+...  ....|.+ +..|..   ......+++.+..||+.||+.|+|+.
T Consensus       441 G~hPt~e~mq~~VV~--kK~RP~~-p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVR--KKQRPKI-PDAWRK---HAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             cCCCCHHHHHHHHHh--hccCCCC-hhhhhc---CccHHHHHHHHHHHcCCchhhhhhhH
Confidence            334445544432110  0000110 111222   12345688999999999999999985

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=264.42  Aligned_cols=196  Identities=29%  Similarity=0.451  Sum_probs=169.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHH------------HHHHHHHhCC---CCceeeecceecc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------RELQIMQMLD---HPNIVALKHCFFS  114 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~E~~~l~~l~---h~~iv~~~~~~~~  114 (390)
                      ..|...+.+|+|+||.|++|.++.+...|+||.+.+++-...            -|+.||..++   |+||++++++|  
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF--  638 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF--  638 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--
Confidence            469999999999999999999999999999999876543322            4999999997   99999999999  


Q ss_pred             CCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          115 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                         +++.|+|++||-.+.++ + +-.+......++|..++.|+.|++.|+++||+ .||||||||-+|+.++.+| -+||
T Consensus       639 ---Eddd~yyl~te~hg~gI-D-LFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g-~~kl  711 (772)
T KOG1152|consen  639 ---EDDDYYYLETEVHGEGI-D-LFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNG-FVKL  711 (772)
T ss_pred             ---ecCCeeEEEecCCCCCc-c-hhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCC-eEEE
Confidence               77778999999887532 1 22334457889999999999999999999998 9999999999999999999 6999


Q ss_pred             eecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016401          195 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  255 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  255 (390)
                      +|||.|... .+.+...+.||..|.|||++.+..+.+..-|||+||++||.++....||..
T Consensus       712 idfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  712 IDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999998744 455667889999999999998877778999999999999999999988864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=270.06  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=206.9

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ...+.|.+...+|+|.||.||+|+++.+++..|+|+++-+    -...++|+-+++..+|||||.+++.|....     .
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----k   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----K   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----C
Confidence            3456899999999999999999999999999999998654    344568999999999999999999985433     3


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +++.||||+| +|.++    ....+.+++.++..+.+..+.||+|||+ .|=+|||||-.|||+++.+ .+|+.|||.+-
T Consensus        87 lwicMEycgggslQdi----y~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~g-DvklaDfgvsa  160 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDI----YHVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEG-DVKLADFGVSA  160 (829)
T ss_pred             cEEEEEecCCCcccce----eeecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccC-ceeecccCchh
Confidence            7899999996 44332    2346889999999999999999999998 8999999999999999888 69999999876


Q ss_pred             ccccC-CCCcceeeccccccchhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          202 VLVKG-EPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       202 ~~~~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      .+... .+..++.||++|||||+..  ....|...+|+|++|++..|+---++|-....+...+....+..         
T Consensus       161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~---------  231 (829)
T KOG0576|consen  161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG---------  231 (829)
T ss_pred             hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC---------
Confidence            54332 3446789999999999872  23458999999999999999988888776666555554444321         


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                              +.-|..+.       +.+.++.+.+|++.+|.++|.+||+++.+|.|||...
T Consensus       232 --------~qpp~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  232 --------FQPPTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             --------CCCCcccC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                    11111111       1235788999999999999999999999999999863

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-31  Score=266.59  Aligned_cols=246  Identities=25%  Similarity=0.385  Sum_probs=189.8

Q ss_pred             cEEEeeeeeecCceEEEEEEEc---C----CCcEEEEEEeccc-----hhhHHHHHHHHHhC-CCCceeeecceeccCCC
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCR---E----TGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  117 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~---~----~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  117 (390)
                      +..+.+.||+|.||.|++|...   .    ....||||.++..     ......|+++|+.+ .|+||+.+.+++..   
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---  373 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---  373 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence            4466779999999999999743   1    1457999987543     34455799999998 69999999999843   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhh---hhc---------CCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEE
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYS---RIH---------QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  184 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~---------~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIl  184 (390)
                        ...+++|+||+. |+|..+++...   ...         ..++...+..+++||+.|++||++ .++|||||-..|||
T Consensus       374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVL  450 (609)
T ss_pred             --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEE
Confidence              445789999998 68888887654   111         128888999999999999999998 89999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCCcc--ee--eccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 016401          185 VNPHTHQLKLCDFGSAKVLVKGEPNVS--YI--CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  259 (390)
Q Consensus       185 l~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~--~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  259 (390)
                      +..+. .+||+|||+|+..........  ..  -...|||||.+.. ..|+.++||||+|++|||+++ |..||++-...
T Consensus       451 i~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  451 ITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             ecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99886 799999999986544332221  11  1334999999965 569999999999999999997 88999885423


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          260 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                      ..+.+.++..                 .+.          ..|..+++++.++++.||..+|++||+..++.
T Consensus       529 ~~l~~~l~~G-----------------~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  529 EELLEFLKEG-----------------NRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             HHHHHHHhcC-----------------CCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            3333333311                 000          12356899999999999999999999998875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.4e-33  Score=236.17  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=187.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      -.+.|.|.+.||+|-||.+.+|+|+.+++.+++|.+....   +.+.+|...--.| -|.||+.-|++-+...+    ++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----AY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----eE
Confidence            3468999999999999999999999999999999886543   3445676655555 58999998887654433    56


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE-cCCCCcEEEeecCCcc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAK  201 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll-~~~~~~vkl~Dfg~a~  201 (390)
                      ++++||++ |+|.+-+.     ..++.+...+.++.|+++|+.|||+ +++||||||.+|||| +.|..+|||||||..+
T Consensus        98 vF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeeccccc
Confidence            68999999 56644333     2568888999999999999999998 999999999999998 6677799999999987


Q ss_pred             ccccCCCCcceeeccccccchhhcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHH
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREE  276 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~  276 (390)
                      .....-...  -.+..|.+||++...    -...+.+|+|.||+++|.++||.+||......+. +.+..+-.+..    
T Consensus       172 k~g~tV~~~--~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk----  245 (378)
T KOG1345|consen  172 KVGTTVKYL--EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK----  245 (378)
T ss_pred             ccCceehhh--hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc----
Confidence            543222111  224559999987432    2257789999999999999999999974332221 22222111000    


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC---CHHHHhcCCcccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDE  338 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---s~~~~l~hp~f~~  338 (390)
                               ....|        +.| ..+++.+..+.++-|..+|++|.   +++.-.+.-|...
T Consensus       246 ---------~~~~P--------~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  246 ---------NPALP--------KKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             ---------CccCc--------hhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence                     00111        112 35789999999999999999994   4555555666643

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=255.68  Aligned_cols=242  Identities=25%  Similarity=0.358  Sum_probs=192.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCc----EEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+..++||+|+||+||+|.+-..|+    +||||++...     ...+.+|+-+|..++|||++++++++....    
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----  771 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----  771 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch----
Confidence            356678899999999999999866655    5888877432     334457999999999999999999984322    


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                        +.||++|++ |.|.++++..   ...+.......|.+||+.||.|||. ++++||||-..|||+.+-. .+||.|||+
T Consensus       772 --~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~-hvkitdfgl  844 (1177)
T KOG1025|consen  772 --LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPN-HVKITDFGL  844 (1177)
T ss_pred             --HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCC-eEEEEecch
Confidence              558999999 6787777663   4678888999999999999999998 9999999999999999877 599999999


Q ss_pred             ccccccCCCCcceee---ccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          200 AKVLVKGEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       200 a~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ++............+   .+.|||=|.+.. ..|+.++||||+||++||++| |..|+.+....+. .+.++..      
T Consensus       845 a~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~g------  916 (1177)
T KOG1025|consen  845 AKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEKG------  916 (1177)
T ss_pred             hhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhcc------
Confidence            998766555544433   456899998854 559999999999999999997 8899987664332 2222210      


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                               ..++.            |+.++.++.-++.+||..|+..||+++++-
T Consensus       917 ---------eRLsq------------PpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  917 ---------ERLSQ------------PPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             ---------ccCCC------------CCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence                     11111            256899999999999999999999998774

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.3e-29  Score=219.87  Aligned_cols=207  Identities=35%  Similarity=0.584  Sum_probs=173.7

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEeccc-
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-  131 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-  131 (390)
                      ||+|++|.||++.+..+++.+++|++....     ....+|+..++.++|++++++++++..     ....+++||+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            689999999999998889999999987654     346789999999999999999988833     245789999999 


Q ss_pred             ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC-CCCcEEEeecCCccccccCC-CC
Q 016401          132 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PN  209 (390)
Q Consensus       132 ~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~Dfg~a~~~~~~~-~~  209 (390)
                      ++|..++....   ..++...+..++.+++.+|++||+ .|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            57777665421   468889999999999999999998 89999999999999998 56 79999999987553332 12


Q ss_pred             cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 016401          210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  289 (390)
Q Consensus       210 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  289 (390)
                      ....+...|++||.+.....++.+.|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3345677899999985543578999999999999999                                           


Q ss_pred             CCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCC
Q 016401          290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  334 (390)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp  334 (390)
                                       ..+.+++.+||..||++||++.++++|+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1366899999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.6e-29  Score=220.04  Aligned_cols=200  Identities=36%  Similarity=0.581  Sum_probs=165.4

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...     .....+|++.++.++|+|++++++.+..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            67889999999999999999888999999998643     3445679999999999999999988733     2347799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCC-CcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~-~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +|++++ +|...+...    .. +++..+..++.+++.++.+||+ .+++|+||+|.||+++.++ .++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDG-LVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence            999997 777666542    23 7889999999999999999998 8999999999999999886 79999999988665


Q ss_pred             cCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHH
Q 016401          205 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQL  262 (390)
Q Consensus       205 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~  262 (390)
                      ...  ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+....+
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~  210 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLL  210 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence            442  234456788899999884444578899999999999999999999977 4444333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=8.2e-31  Score=270.81  Aligned_cols=207  Identities=16%  Similarity=0.170  Sum_probs=145.8

Q ss_pred             hCCC-CceeeecceeccCCC--CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccc
Q 016401           99 MLDH-PNIVALKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  175 (390)
Q Consensus        99 ~l~h-~~iv~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH  175 (390)
                      .++| .||+.+++.|-....  .....++++||+++++|..++..   ....+++..++.++.||+.||+|||+ +||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence            4455 577777776522211  12234678899999998887753   23568999999999999999999998 99999


Q ss_pred             ccCCCCcEEEcCCC------------------CcEEEeecCCccccccCC-----------------CCcceeecccccc
Q 016401          176 RDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNVSYICSRYYRA  220 (390)
Q Consensus       176 ~Dlkp~NIll~~~~------------------~~vkl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~a  220 (390)
                      |||||+||||+..+                  ..+|++|||+++......                 ......+|++|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999995422                  246777777765321100                 0012357889999


Q ss_pred             chhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccc
Q 016401          221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV  300 (390)
Q Consensus       221 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (390)
                      ||++.+. .++.++|||||||+||||++|.+|+....  ..+..+.... .++.                          
T Consensus       184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~--------------------------  233 (793)
T PLN00181        184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ--------------------------  233 (793)
T ss_pred             hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh--------------------------
Confidence            9998654 48999999999999999999988875321  1111111110 0000                          


Q ss_pred             cccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          301 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       301 ~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      . ....+...+++.+||..||.+||++.++|+||||....
T Consensus       234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            0 01235567999999999999999999999999998753

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-28  Score=218.32  Aligned_cols=249  Identities=18%  Similarity=0.261  Sum_probs=190.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEeccchhhH-----HHHHHHHHhCCCCceeeecceeccCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-----~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      +..+++...++-+|.||.||+|.+...     .+.|-+|.+++....+     ..|.-++..+.|||++.+.++..... 
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-  360 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-  360 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-
Confidence            456788999999999999999976533     2346667665543332     35777888889999999988875422 


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh----hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcE
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSR----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  192 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v  192 (390)
                         ...++++.+++ |+|...+...+-    ..+.++..++..++.|++.|++|||+ .|+||.||-..|.+||+.- +|
T Consensus       361 ---~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~L-qV  435 (563)
T KOG1024|consen  361 ---ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQL-QV  435 (563)
T ss_pred             ---CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhhe-eE
Confidence               22456778877 677777764331    12346667788899999999999998 9999999999999999876 89


Q ss_pred             EEeecCCccccccCCCCc---ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 016401          193 KLCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  268 (390)
Q Consensus       193 kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~  268 (390)
                      ||+|=.+++.........   .......||+||.+.. ..|+.++|+||||+++|||+| |+.|+..-++.++..-+.+.
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            999999998765543321   1122456999999954 559999999999999999997 99999988887766544431


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                                        +++.          -|-++|+++..++..||..+|++||+..|+.
T Consensus       515 ------------------yRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  515 ------------------YRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             ------------------ceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence                              1111          1247999999999999999999999999886

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-27  Score=207.37  Aligned_cols=207  Identities=23%  Similarity=0.310  Sum_probs=171.4

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEec--cchhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .|+++++||+|+||.++.|.+.-++++||||.-.  .+.-....|.+..+.|. .+.|..+|.+-     .+..+-.||+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence            7999999999999999999999999999999653  33445567999999884 68888876544     5566777999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC----CCCcEEEeecCCcccc
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP----HTHQLKLCDFGSAKVL  203 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~----~~~~vkl~Dfg~a~~~  203 (390)
                      |+++.+|.+++...   ...|+..++..++.|++.-++++|+ +.+|.|||||+|+||..    +-+.+.|+|||+|+..
T Consensus       104 dLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  104 DLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            99999998887653   5689999999999999999999998 99999999999999953    3336999999999876


Q ss_pred             ccCCC--------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHH
Q 016401          204 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIK  267 (390)
Q Consensus       204 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~  267 (390)
                      .....        ..+..||..||+=-..++.+ -+.+.|+-|||-++++.|.|.+||.|..   ..+.+.+|-+
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence            54432        24567899999988887765 6999999999999999999999998743   4455555544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=4.2e-28  Score=205.52  Aligned_cols=167  Identities=22%  Similarity=0.183  Sum_probs=124.5

Q ss_pred             ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCCcc
Q 016401          132 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS  211 (390)
Q Consensus       132 ~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~  211 (390)
                      |+|.+++...   ...+++..++.++.|++.||+|||+ .+      ||+|||++.++ .+|+  ||.+......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            4566666532   3569999999999999999999998 77      99999999888 6888  9998755332    2


Q ss_pred             eeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 016401          212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFKFP  290 (390)
Q Consensus       212 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  290 (390)
                      ..||+.|+|||++.+. .++.++||||+||++|||++|..||........ +..+........                +
T Consensus        64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~  126 (176)
T smart00750       64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------P  126 (176)
T ss_pred             CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------c
Confidence            3678999999999654 589999999999999999999999976544322 222222110000                0


Q ss_pred             CCCCCCcccccccCCCh--hHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          291 QIKPHPWHKVFQKRLPP--EAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       291 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      .      .......++.  +++++|.+||..||++||++.++++|+|+..
T Consensus       127 ~------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      127 R------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             c------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            0      0000012333  6999999999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.8e-28  Score=240.08  Aligned_cols=257  Identities=24%  Similarity=0.342  Sum_probs=188.7

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEec----cchhh------HHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           53 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .....+|.|++|.|+.+......+.++.|.+.    .....      ...|+.+-..+.|+|++.....++....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            46778999999988888877666666666443    11100      2246666677899999887766643322     


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .+-+||||+++|..++..    ...+....+..++.|++.|++|||+ .||.||||||+|++++.++ .+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCC-ceEEeecCccee
Confidence            223499999866655543    2468888899999999999999998 9999999999999999998 899999999876


Q ss_pred             cccCCC-----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHH
Q 016401          203 LVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV-EIIKVLGTPTREE  276 (390)
Q Consensus       203 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~  276 (390)
                      ......     ....+|+..|+|||++.+........||||.|++++.|++|+.||.-....+... .....        
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~--------  541 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS--------  541 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc--------
Confidence            654433     2456789999999999777766678999999999999999999997654332221 00000        


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                              ....   ....  ...+...++...+.+|.+||++||.+|.|+++|++.+||+.+..
T Consensus       542 --------~~~~---~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  542 --------DQRN---IFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             --------cccc---cccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence                    0000   0000  01111346888999999999999999999999999999998753

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-26  Score=192.83  Aligned_cols=202  Identities=24%  Similarity=0.329  Sum_probs=164.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh--hHHHHHHHHHhCCC-CceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ..|++++.||+|+||.+|+|.+..+|+.||||.-++..+  ....|.++.+.|++ ..|..+..+.     .+..|-.+|
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlV   89 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLV   89 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceee
Confidence            469999999999999999999999999999997755433  34579999999975 4555555544     455567799


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC--CCCcEEEeecCCccccc
Q 016401          127 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       127 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~Dfg~a~~~~  204 (390)
                      |++++.+|.+++...   ...++..++..++-|++.-++|+|. +++|||||||+|+|..-  ..+.+.|+|||+|+...
T Consensus        90 MdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            999999998877653   4679999999999999999999998 99999999999999743  33479999999998765


Q ss_pred             cCCC--------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 016401          205 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  261 (390)
Q Consensus       205 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  261 (390)
                      ....        .....||..|.+=-...+.. -+.+.|+-|+|.+|..+..|..||.+......
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk  229 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATK  229 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence            4322        24567899999877765543 58899999999999999999999998654433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-25  Score=207.42  Aligned_cols=251  Identities=20%  Similarity=0.199  Sum_probs=189.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCC-cEEEEEEeccch----hhHHHHHHHHHhCCC----CceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK----RYKNRELQIMQMLDH----PNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~----~~~~~E~~~l~~l~h----~~iv~~~~~~~~~~~~~~~  121 (390)
                      +|.+.+.||+|+||.||.|.+..++ +.+|+|......    .....|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987764 678999765432    145679999998873    57777766552    3455


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC----CcEEEeec
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDF  197 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----~~vkl~Df  197 (390)
                      +.|+||+.++.+|.++.....  .+.++..++..++.|++.+|++||+ .|++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999988776544  5789999999999999999999998 9999999999999997543    47999999


Q ss_pred             CCcc--ccccCC--------C-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016401          198 GSAK--VLVKGE--------P-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  266 (390)
Q Consensus       198 g~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  266 (390)
                      |+|+  ......        . .....||..|.++.+..+.. .+++.|+||++.++.+++.|..||.+........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  321111        1 12355899999999996554 8999999999999999999999997765433332222


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      +.....               ....         +....+.++.++...+-..+...+|....+...
T Consensus       251 ~~~~~~---------------~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKL---------------LTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhh---------------cccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            210000               0000         112346778888888888899999988766544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1e-25  Score=208.64  Aligned_cols=157  Identities=20%  Similarity=0.285  Sum_probs=118.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC-CCcEEEEEEeccc---------hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ..+|.+.+.||+|+||+||+|.++. +++.||||++...         ...+.+|+++|+.++|+|++..+..+   .  
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~--   91 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G--   91 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C--
Confidence            3479999999999999999999876 6778899986422         22356899999999999998533221   1  


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccC-CCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dl-kp~NIll~~~~~~vkl~Df  197 (390)
                         ..|+||||++|.......       ...   ...++.|++.||.|||+ .||+|||| ||+|||++.++ .+||+||
T Consensus        92 ---~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~-~ikLiDF  156 (365)
T PRK09188         92 ---KDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDG-EAAVIDF  156 (365)
T ss_pred             ---CcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCC-CEEEEEC
Confidence               257999999874322111       111   14578899999999998 99999999 99999998877 7999999


Q ss_pred             CCccccccCCC---------Ccceeeccccccchhhc
Q 016401          198 GSAKVLVKGEP---------NVSYICSRYYRAPELIF  225 (390)
Q Consensus       198 g~a~~~~~~~~---------~~~~~~t~~y~aPE~~~  225 (390)
                      |+|+.......         .....+++.|+|||.+.
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99986543321         12345677899999883

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=5.5e-25  Score=195.46  Aligned_cols=237  Identities=23%  Similarity=0.319  Sum_probs=146.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhH-------HHHHHHHHhCC----------CCceeeecceec
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLD----------HPNIVALKHCFF  113 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~E~~~l~~l~----------h~~iv~~~~~~~  113 (390)
                      .+...+.||.|+++.||.+.+..|++.+|||++.......       .+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            6889999999999999999999999999999874332211       12222222221          212222222211


Q ss_pred             --------cCCCCCceE----EEEEEecccccHHHHHHHhhhhcCC---CcHHHHHHHHHHHHHHHHHHHhcCCcccccC
Q 016401          114 --------STTDKEELY----LNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDI  178 (390)
Q Consensus       114 --------~~~~~~~~~----~~lv~e~~~~~l~~~~~~~~~~~~~---~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dl  178 (390)
                              ........+    .+++|+-+.++|..++.........   +.......+..|++..+++||+ .|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence                    111111111    4678999998888877654433332   2222334555899999999998 99999999


Q ss_pred             CCCcEEEcCCCCcEEEeecCCccccccCCCCcceeeccccccchhhcCC-------CCCCCchhHHHHHHHHHHHHhCCC
Q 016401          179 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQP  251 (390)
Q Consensus       179 kp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~ell~g~~  251 (390)
                      +|+|++++.+| .+.|+||+.......  .......+..|.|||.....       ..++.+.|.|+||+++|.|+||..
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999998 799999987754322  21112335779999987332       247889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcC
Q 016401          252 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR  324 (390)
Q Consensus       252 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  324 (390)
                      ||.........                       .+        .|..+  .++|+..++||+.+|++||++|
T Consensus       249 Pf~~~~~~~~~-----------------------~~--------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADP-----------------------EW--------DFSRC--RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTS-----------------------GG--------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccc-----------------------cc--------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence            99754321000                       00        12222  2689999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=8.6e-27  Score=219.68  Aligned_cols=236  Identities=31%  Similarity=0.457  Sum_probs=188.3

Q ss_pred             eeeecCceEEEEEEE---cCCCcEEEEEEeccc------hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEEE
Q 016401           57 VVGTGSFGVVFQAKC---RETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|.|+||.|++++.   ...+..||+|+..+.      ......|..++..++ ||.+|++...+.+..     ..+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-----kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-----KLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-----chhHh
Confidence            378999999998753   345778999977432      122335888888886 999999998884433     37799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      +++..| .+...+.    ....+.+...+.+...++.+++++|+ .+|+|||+|++||+++.+| .+++.|||+++....
T Consensus        76 ld~~rgg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~G-hi~~tdfglske~v~  149 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVK  149 (612)
T ss_pred             hhhcccchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccC-ccccCCchhhhHhHh
Confidence            999886 4322222    24567888899999999999999998 9999999999999999999 599999999987655


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                      ....   +||..|||||++.   ....++|+||+|+++++|++|..||.+    +....|.+.                 
T Consensus       150 ~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-----------------  202 (612)
T KOG0603|consen  150 EKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-----------------  202 (612)
T ss_pred             hhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-----------------
Confidence            4433   8899999999995   368899999999999999999999987    556666552                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH-----HHHhcCCcccccCCC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDP  342 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~-----~~~l~hp~f~~~~~~  342 (390)
                      .+.            ++..++..+++++..++..+|..|...     .++++|+||+.+.+.
T Consensus       203 ~~~------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  203 ELE------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ccC------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            111            224578899999999999999999964     799999999998654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.4e-23  Score=194.61  Aligned_cols=260  Identities=34%  Similarity=0.507  Sum_probs=194.3

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCC-ceeeecceeccCCCCCceEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~  123 (390)
                      |.+.+.||.|+|+.||++.+.   ..+++|.+...       .....+|+.++..+.|+ +++++.+.+.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            789999999999999999986   77899988533       23355789999999988 7999999882     22226


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +++++++.+ .+...+...... ..+.......++.|++.++.|+|+ .+++|||+||+||+++..+..++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            799999996 444333321100 268899999999999999999998 89999999999999998764599999999875


Q ss_pred             cccCC-------CCcceeeccccccchhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 016401          203 LVKGE-------PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG  270 (390)
Q Consensus       203 ~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~  270 (390)
                      .....       ......+|..|++||.+.+.  ..++...|+|++|++++++++|..||.....   .......+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            43332       23566889999999999663  4689999999999999999999999877664   334444333222


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      .+             ....+.      ...........+.+++.+++..+|..|.+..+...++|.....
T Consensus       232 ~~-------------~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         232 TP-------------SLASPL------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             Cc-------------cccccc------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence            11             000000      0000011236789999999999999999999999887776543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=2.7e-25  Score=219.54  Aligned_cols=229  Identities=28%  Similarity=0.498  Sum_probs=170.5

Q ss_pred             CCCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           44 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        44 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ........|..+++|..|+||.||.++|+.+.+.+|+| +.++....++   ++.....|.+|                 
T Consensus        77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCccee-----------------
Confidence            34445568999999999999999999999999999995 4443332222   22222333332                 


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                              |+...++..    -+.++.        +++.+++|||+ .||+|||+||+|.+|+.-| .+|++|||+.+..
T Consensus       136 --------gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 --------GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKG  193 (1205)
T ss_pred             --------chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecc-cccccchhhhhhh
Confidence                    222222222    122332        34889999998 9999999999999999888 5999999998653


Q ss_pred             ccCCC----------------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016401          204 VKGEP----------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       204 ~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  267 (390)
                      .....                ....+|||.|+|||++.... |+..+|+|++|+|+||.+.|..||.+.+.++.+...+.
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis  272 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  272 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence            21111                12347899999999997654 99999999999999999999999999999998887766


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC---CHHHHhcCCcccccCCC
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDP  342 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---s~~~~l~hp~f~~~~~~  342 (390)
                      ..                 ..+++        - ....+++++++|.++|+.+|..|.   .+.++.+|+||+.+.+.
T Consensus       273 d~-----------------i~wpE--------~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  273 DD-----------------IEWPE--------E-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             hh-----------------ccccc--------c-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            31                 11111        1 135789999999999999999998   46788899999998754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-24  Score=214.38  Aligned_cols=241  Identities=29%  Similarity=0.408  Sum_probs=171.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHH---HHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKN---RELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .|...+.||++.|=+|.+|++. .|. |+||++.+..     +.+.   +|++ ...+++||.+.+..+.     ..+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            6899999999999999999985 455 8999885432     1111   3444 5667999999876654     33344


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .|||-+|+..+|.+-+..    ..-+.+.+.+.|+.||+.||..+|. .||+|+|||.+||||++=. .+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWN-W~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWN-WLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeec-hhhhhcccccCC
Confidence            668888888877665543    3446777888999999999999998 9999999999999998654 799999986554


Q ss_pred             cccCCCC---cce-eec----cccccchhhcCC---------C-CCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 016401          203 LVKGEPN---VSY-ICS----RYYRAPELIFGA---------T-EYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  263 (390)
Q Consensus       203 ~~~~~~~---~~~-~~t----~~y~aPE~~~~~---------~-~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  263 (390)
                      ..-.+..   ..+ +-|    .+|+|||.+...         . ..+++.||||+||+++||++ |++||.-    .++.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence            3222221   122 222    469999998431         1 15778999999999999987 7999942    2333


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      +..... ....+.+.+                       .--+..+++||..|++.||++|.++++.|+-
T Consensus       246 aYr~~~-~~~~e~~Le-----------------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQLLE-----------------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccC-ccCHHHHHH-----------------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            322211 111111111                       1124579999999999999999999999974

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-23  Score=186.95  Aligned_cols=207  Identities=22%  Similarity=0.324  Sum_probs=147.8

Q ss_pred             CCCceeeecceeccCC----------------------CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHH
Q 016401          101 DHPNIVALKHCFFSTT----------------------DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY  158 (390)
Q Consensus       101 ~h~~iv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  158 (390)
                      +|||||.+...|.+..                      -.....+|+||.....+|..++..     +..+......++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            6999999988875321                      123456899999998888777764     5566777888899


Q ss_pred             HHHHHHHHHHhcCCcccccCCCCcEEEc--CCC-CcEEEeecCCcccccc-------CCCCcceeeccccccchhhcCCC
Q 016401          159 QICRALAYIHNCIGICHRDIKPQNLLVN--PHT-HQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRAPELIFGAT  228 (390)
Q Consensus       159 ql~~al~~LH~~~~ivH~Dlkp~NIll~--~~~-~~vkl~Dfg~a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~  228 (390)
                      |+++|+.|||+ +||.|||+|.+|||+.  +|. ..+.|+|||.+-.-..       .......-|....||||+...-.
T Consensus       349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999998 8999999999999983  332 2689999998743221       12233445677799999884321


Q ss_pred             C-----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCccccccc
Q 016401          229 E-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK  303 (390)
Q Consensus       229 ~-----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (390)
                      .     .-.++|.|+.|.+.||++....||....+.-.-                  ...|.+-.+|.         +++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------------------~r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------------------TRTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------------------hhhhhhhhCCC---------Ccc
Confidence            1     124889999999999999999999874321100                  00111122222         336


Q ss_pred             CCChhHHHHHHHhcccCCCcCCCHH---HHhc------CCcccccC
Q 016401          304 RLPPEAVDLVCRFFQYSPNLRCTAL---EACV------HPFFDELR  340 (390)
Q Consensus       304 ~~~~~~~~li~~~L~~dP~~R~s~~---~~l~------hp~f~~~~  340 (390)
                      .+++.+++||..+|+.||++|+++.   .+|+      |.|++...
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~  526 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMM  526 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhc
Confidence            7899999999999999999999964   4443      55555543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=3.7e-23  Score=176.45  Aligned_cols=135  Identities=18%  Similarity=0.218  Sum_probs=102.3

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccchh------------------------------hHHHHHHHHHhCCCCc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHPN  104 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------------------~~~~E~~~l~~l~h~~  104 (390)
                      .+.||+|++|.||+|.+. +|+.||||+++....                              ...+|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999996 899999999854311                              1124899999998777


Q ss_pred             eeeecceeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHH-HhcCCcccccCCCCcE
Q 016401          105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGICHRDIKPQNL  183 (390)
Q Consensus       105 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~L-H~~~~ivH~Dlkp~NI  183 (390)
                      +.......     ...  .++||||++|+......   .....+++..+..++.|++.+|.+| |+ .||+||||||+||
T Consensus        81 v~~p~~~~-----~~~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL-----LKS--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE-----ecC--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence            64332221     111  26999999974321111   1135788999999999999999999 67 8999999999999


Q ss_pred             EEcCCCCcEEEeecCCcccc
Q 016401          184 LVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       184 ll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |++. + .++|+|||+|...
T Consensus       150 li~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEC-C-cEEEEEccccccC
Confidence            9984 4 6999999999744

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.3e-22  Score=175.06  Aligned_cols=169  Identities=12%  Similarity=0.149  Sum_probs=123.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhh---------HHHHHHHHHhCCCCceeeecceeccCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRY---------KNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      .+|++.++||.|+||.||++..  ++..+|||.+...    ...         .++|+..+.++.|++|..+.+++....
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            5799999999999999999765  4668999998532    111         457888999999999999988764321


Q ss_pred             CC---CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcE
Q 016401          117 DK---EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  192 (390)
Q Consensus       117 ~~---~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v  192 (390)
                      ..   .....+++|||++| +|.+..        .+++    ....+++.+|..||+ .|++|||+||+||+++.++  +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g--i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG--L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC--E
Confidence            11   12336799999998 453331        1222    235699999999998 9999999999999999876  9


Q ss_pred             EEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHH
Q 016401          193 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL  247 (390)
Q Consensus       193 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  247 (390)
                      +|+|||.......... ..          ..++. ..|..++|+||||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a-~d----------~~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKA-KD----------RIDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhh-HH----------HHHHH-hHhcccccccceeEeehHHH
Confidence            9999998764422111 10          12223 23668999999999987554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=8.3e-22  Score=168.73  Aligned_cols=134  Identities=16%  Similarity=0.231  Sum_probs=104.0

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccchh------------------------------hHHHHHHHHHhCCCCc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHPN  104 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------------------~~~~E~~~l~~l~h~~  104 (390)
                      .+.||+|++|.||+|.+. +|+.||||++.....                              ...+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999987 899999998864310                              1246889999999988


Q ss_pred             eeeecceeccCCCCCceEEEEEEeccccc-HHH-HHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          105 IVALKHCFFSTTDKEELYLNLVLEYVPET-VNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       105 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~-~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                      +.....+...     .  .|+||||++|. +.. .+.     ...++...+..++.|++.+|.+||+..||+||||||+|
T Consensus        81 i~~p~~~~~~-----~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N  148 (190)
T cd05145          81 VPVPEPILLK-----K--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN  148 (190)
T ss_pred             CCCceEEEec-----C--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence            7544333211     1  36999999974 221 121     24577888999999999999999963799999999999


Q ss_pred             EEEcCCCCcEEEeecCCcccc
Q 016401          183 LLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+++ ++ .++|+|||++...
T Consensus       149 Ill~-~~-~~~liDFG~a~~~  167 (190)
T cd05145         149 ILYH-DG-KPYIIDVSQAVEL  167 (190)
T ss_pred             EEEE-CC-CEEEEEcccceec
Confidence            9998 55 7999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.6e-21  Score=164.82  Aligned_cols=182  Identities=16%  Similarity=0.120  Sum_probs=132.6

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh--------hHHHHHHHHHhCC-CCceeeecceeccCCCCCceE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+...|++|+||+|+++..  .+..++.+.+.....        ...+|+++|++|. |+++++++++.    .     
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~-----   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G-----   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C-----
Confidence            34678899999999998775  577888777654332        3568999999995 47788886642    1     


Q ss_pred             EEEEEeccccc-HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccC-CCCcEEEcCCCCcEEEeecCCc
Q 016401          123 LNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       123 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dl-kp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .|++|||+.|. |....          +.. ...++.|++.+|.++|+ .||+|||| ||+|||++.++ .++|+|||+|
T Consensus        73 ~~lvmeyI~G~~L~~~~----------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A  139 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRP----------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDG-SPAVIDFQLA  139 (218)
T ss_pred             EEEEEeeecCccHHhhh----------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCC-CEEEEECCCc
Confidence            57999999874 32111          001 13467899999999998 99999999 79999999887 7999999999


Q ss_pred             cccccCCCC--------------cceeeccccccchhhcCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 016401          201 KVLVKGEPN--------------VSYICSRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGES  257 (390)
Q Consensus       201 ~~~~~~~~~--------------~~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~  257 (390)
                      .........              .-...++.|++|+...-....+ ...++++.|+-+|.++|+..++.+.+
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            854433211              0012467788887653322233 56788899999999999998886654

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=7e-20  Score=157.74  Aligned_cols=136  Identities=21%  Similarity=0.239  Sum_probs=102.1

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhC-----CCCceeeecceeccCCCCCceE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-----DHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      +.-.+.||+|+++.||.  +..++.. +||++...    .....+|+.+++.+     .||||+++++++.+..  +..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence            33457899999999995  7667665 69987543    34567899999999     6799999999985432  2234


Q ss_pred             -EEEEEeccc---ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHH-HHHHhcCCcccccCCCCcEEEcCC---CCcEEE
Q 016401          123 -LNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL-AYIHNCIGICHRDIKPQNLLVNPH---THQLKL  194 (390)
Q Consensus       123 -~~lv~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al-~~LH~~~~ivH~Dlkp~NIll~~~---~~~vkl  194 (390)
                       +.+||||++   ++|.+++..     ..+++.  ..++.|++.++ +|||+ .+|+||||||+|||++..   ...++|
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEE
Confidence             347899955   588777753     235555  35678888888 99998 999999999999999743   226999


Q ss_pred             eecCCc
Q 016401          195 CDFGSA  200 (390)
Q Consensus       195 ~Dfg~a  200 (390)
                      +||+.+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.83  E-value=8.3e-21  Score=161.85  Aligned_cols=238  Identities=16%  Similarity=0.203  Sum_probs=176.0

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      +..+..+|.+...|..|+|+++  |..+++|++.-      ..+.+++|.-.|+.+.||||+.+++.+-.     ...+.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCce
Confidence            4566778899999999999987  44566776632      23556789999999999999999999843     33477


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccc-cCCCCcEEEcCCCCcEEE--eecCCc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR-DIKPQNLLVNPHTHQLKL--CDFGSA  200 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~-Dlkp~NIll~~~~~~vkl--~Dfg~a  200 (390)
                      +|..|++ |+|..++....  .--.+..++.+++.+++.|++|||+-..++-| -|....++||++. +.+|  +|--++
T Consensus       264 ~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfs  340 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFS  340 (448)
T ss_pred             EeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceee
Confidence            8999999 68877776422  12356677889999999999999983345554 5888999999886 4554  343222


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      .      ........|.|++||.+.....  .-.++|+|||++++|||.|...||.+..+.+.--++.-.          
T Consensus       341 f------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale----------  404 (448)
T KOG0195|consen  341 F------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE----------  404 (448)
T ss_pred             e------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc----------
Confidence            1      1112234788999999954332  236899999999999999999999988776655444321          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                                       -++..+++.++..+..|++-|+.-||.+||..+.+.
T Consensus       405 -----------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  405 -----------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -----------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                             112335578899999999999999999999887653

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.5e-19  Score=182.13  Aligned_cols=194  Identities=25%  Similarity=0.373  Sum_probs=145.2

Q ss_pred             CcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhh-HHHHHHHHHhCC---CCceeeecceeccCCCCCce
Q 016401           46 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQMLD---HPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~  121 (390)
                      +.....|.|.+.||+|+||+||+|.+.. |+.||||+-+..... +.==..++.+|+   -+-|+.+..++...+.    
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~----  768 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA----  768 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc----
Confidence            3345689999999999999999999876 999999975432211 111123344444   2344444444432222    


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc------CCCCcEEE
Q 016401          122 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------PHTHQLKL  194 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~------~~~~~vkl  194 (390)
                       -++|+||.+ |+|.+++.    ..+.+++..+.++..|++.-+++||. .+|||+||||+|.||.      .+..-++|
T Consensus       769 -S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 -SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             -ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEE
Confidence             348999999 78877776    35678999999999999999999998 8999999999999983      22235999


Q ss_pred             eecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCC
Q 016401          195 CDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP  251 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  251 (390)
                      +|||.+..+.-...   .....+|-.+-++|+..+ ..++.+.|.|.|+-+++-||.|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999876543333   334456888999999955 559999999999999999999973

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=5.2e-20  Score=162.39  Aligned_cols=138  Identities=16%  Similarity=0.134  Sum_probs=103.6

Q ss_pred             cEEEeeeeeecCceEEEEEE-EcCCCcEEEEEEeccch----------------------------hhHHHHHHHHHhCC
Q 016401           51 SYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDK----------------------------RYKNRELQIMQMLD  101 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~----------------------------~~~~~E~~~l~~l~  101 (390)
                      -|.+.+.||+|++|.||+|. +..+|+.||||++....                            ....+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58899999999999999999 67789999999885321                            11347999999997


Q ss_pred             CCceeeecceeccCCCCCceEEEEEEeccccc-HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-cccccCC
Q 016401          102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIK  179 (390)
Q Consensus       102 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~-ivH~Dlk  179 (390)
                      +.. +.+...+.. .   .  .++||||++|. +....    .....+....+..++.|++.+|.+||+ .| |+|||||
T Consensus       109 ~~~-i~~p~~~~~-~---~--~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dik  176 (237)
T smart00090      109 EAG-VPVPKPIAW-R---R--NVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLS  176 (237)
T ss_pred             hcC-CCCCeeeEe-c---C--ceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCC
Confidence            532 222222211 1   1  36999999983 32211    112345566678899999999999998 89 9999999


Q ss_pred             CCcEEEcCCCCcEEEeecCCccc
Q 016401          180 PQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       180 p~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||+++ ++ .++|+|||.+..
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhc
Confidence            9999999 55 799999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=8.1e-20  Score=169.62  Aligned_cols=180  Identities=28%  Similarity=0.483  Sum_probs=130.8

Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ..|+|+.|++|.. +|.+++.. .+.....+....+.++.|+..|++|    +|.+|+|+||.||+...+. .+||.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhh
Confidence            4468899999984 66665543 2334556777889999999999999    4899999999999998776 79999999


Q ss_pred             CccccccCC-------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhC
Q 016401          199 SAKVLVKGE-------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLG  270 (390)
Q Consensus       199 ~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~  270 (390)
                      +........       ..+...||.+||+||.+.+. .|+.++||||||++|+|++.- ...|      +.......   
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d---  471 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQF------ERIATLTD---  471 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhh---
Confidence            988765555       45677899999999999665 599999999999999999972 1111      11111000   


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                                           +....|...+..+ -+.-.+|+..||...|.+||++.+.--|+|.+
T Consensus       472 ---------------------~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  472 ---------------------IRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             ---------------------hhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                                 0000111000011 24566999999999999999888877787753

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.9e-17  Score=144.33  Aligned_cols=129  Identities=19%  Similarity=0.332  Sum_probs=100.1

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      +.||+|++|.||+|.+  .|..+++|+.....            ....+|+.++..+.|+++.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5799999999999987  57789999754211            12346899999999988876555543222     25


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +++|||++| +|..++...       .. ....++.+++.+|.+||+ .|++|+|++|.|||++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            689999986 666555421       11 677889999999999998 9999999999999999 44 699999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.1e-17  Score=144.26  Aligned_cols=131  Identities=18%  Similarity=0.178  Sum_probs=99.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--------------------------hhHHHHHHHHHhCCCCc
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------------RYKNRELQIMQMLDHPN  104 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------------~~~~~E~~~l~~l~h~~  104 (390)
                      .|.+.+.||+|+||.||++.+. +|+.||||++....                          ....+|..++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4888999999999999999875 79999999864321                          11346888888887774


Q ss_pred             e--eeecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCC
Q 016401          105 I--VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  181 (390)
Q Consensus       105 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~  181 (390)
                      +  +..++.         ...++||||++| ++..+..          ......++.+++.++.++|+ .||+|+||||+
T Consensus        95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~  154 (198)
T cd05144          95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEF  154 (198)
T ss_pred             CCCCceeec---------CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCcc
Confidence            3  332221         114699999997 3322111          13356788899999999998 99999999999


Q ss_pred             cEEEcCCCCcEEEeecCCcccc
Q 016401          182 NLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       182 NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ||+++.++ .++|+|||.+...
T Consensus       155 Nill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         155 NILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             cEEEcCCC-cEEEEECCccccC
Confidence            99999877 7999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=2.4e-19  Score=177.02  Aligned_cols=257  Identities=23%  Similarity=0.288  Sum_probs=191.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC-CcEEEEEEeccch---hh---HHHHHHHHHhCC-CCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDK---RY---KNRELQIMQMLD-HPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~---~~---~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..|.+.+.||+|+|+.|-++....+ ...+|+|.+....   ..   ...|..+-+.+. |.|++.+++..     .+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence            4799999999999999999887544 4457777664332   11   224777778886 99999998876     4555


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH-hcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH-~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      +.+++++|..| ++...+.  .......+...+..++.|+..++.|+| . .++.|+||||+|.+++..+..+++.|||+
T Consensus        95 ~~~~~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             ccccccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchh
Confidence            57799999775 3322221  111125667778899999999999999 7 89999999999999998764699999999


Q ss_pred             cccccc-CCCC---cceee-ccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVK-GEPN---VSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~-~~~~---~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      |..... ....   ...+| ++.|+|||...+........|+||+|+++..+++|..|+......+...           
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------  240 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------  240 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------
Confidence            987765 2222   34567 9999999999776667899999999999999999999986554322110           


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                  ..+.... ..+.......++....+++.+++..+|..|.+.+++..+||+..
T Consensus       241 ------------~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 ------------SSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ------------eeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                        0011110 11112223568899999999999999999999999999999988

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.73  E-value=1.1e-17  Score=158.14  Aligned_cols=208  Identities=27%  Similarity=0.341  Sum_probs=147.4

Q ss_pred             HHhCCCCceeeecceeccCCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccc
Q 016401           97 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  175 (390)
Q Consensus        97 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH  175 (390)
                      |+.+.|.|+.++++.+++..     .+++|.+||. |+|.+.+..   ....++..+...++++|+.||+|||.+....|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            45689999999999986653     3779999999 688777765   34678888899999999999999998333399


Q ss_pred             ccCCCCcEEEcCCCCcEEEeecCCccccccC---CCCcceeeccccccchhhcCCCC------CCCchhHHHHHHHHHHH
Q 016401          176 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAEL  246 (390)
Q Consensus       176 ~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwslG~il~el  246 (390)
                      +.++..|.++|... .+||+|||+.......   .......-...|.|||.+.....      .+.+.|+||+|++++|+
T Consensus        73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            99999999999998 8999999998654320   11111222455999999965311      36679999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC
Q 016401          247 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  326 (390)
Q Consensus       247 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s  326 (390)
                      ++..-||..........+++..+..                 ......+|..... ..+++++..+++.||.-+|++||+
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~-----------------~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs  213 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKK-----------------GGSNPFRPSIELL-NELPPELLLLVARCWEEIPEKRPS  213 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHh-----------------cCCCCcCcchhhh-hhcchHHHHHHHHhcccChhhCcc
Confidence            9999999764322211222211100                 0000001110000 135668999999999999999999


Q ss_pred             HHHHh
Q 016401          327 ALEAC  331 (390)
Q Consensus       327 ~~~~l  331 (390)
                      ++++-
T Consensus       214 ~~~i~  218 (484)
T KOG1023|consen  214 IEQIR  218 (484)
T ss_pred             HHHHH
Confidence            98874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=6.6e-17  Score=139.64  Aligned_cols=125  Identities=18%  Similarity=0.332  Sum_probs=92.8

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           57 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .||+|++|.||+|..  ++..+++|......            ....+|+++++.+.|+++.....++..   ..  ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---~~--~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD---PD--NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE---CC--CCE
Confidence            489999999999984  57889999853211            223469999999988765443333321   11  246


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +||||++| ++...+...    .       ..++.+++.+|.+||+ .|++|+|++|.||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~----~-------~~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----N-------DELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhc----H-------HHHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            99999986 554443321    0       0678899999999998 9999999999999999 55 799999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=1.7e-16  Score=157.21  Aligned_cols=131  Identities=18%  Similarity=0.263  Sum_probs=98.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEe-ccc-----------hhhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~-~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ..|...+.||+|+||.||++....  ..+++|+. .+.           .....+|+++++.++|++++....+....  
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--  408 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--  408 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence            355778999999999999998753  33444432 110           12245799999999999988765544321  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                         ...++||||++| +|.+.+.            ....++.|++.+|.+||+ .|++||||||+|||++ ++ .++|+|
T Consensus       409 ---~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~-~~-~~~liD  470 (535)
T PRK09605        409 ---EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR-DD-RLYLID  470 (535)
T ss_pred             ---CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE-CC-cEEEEe
Confidence               125699999986 6554443            246688899999999998 9999999999999994 44 699999


Q ss_pred             cCCccc
Q 016401          197 FGSAKV  202 (390)
Q Consensus       197 fg~a~~  202 (390)
                      ||+++.
T Consensus       471 FGla~~  476 (535)
T PRK09605        471 FGLGKY  476 (535)
T ss_pred             Cccccc
Confidence            999864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=4.4e-16  Score=133.05  Aligned_cols=131  Identities=20%  Similarity=0.188  Sum_probs=90.2

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhH----------------------------HHHHHHHHhCCCCc--
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK----------------------------NRELQIMQMLDHPN--  104 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~E~~~l~~l~h~~--  104 (390)
                      .+.||+|+||+||+|.+. +++.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 89999999875432111                            13444444443332  


Q ss_pred             eeeecceeccCCCCCceEEEEEEecccccHH--HHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          105 IVALKHCFFSTTDKEELYLNLVLEYVPETVN--RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       105 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                      +.+.+.+.         ..++||||+++...  ..+....     . ...++.++.+++.++.++|...||+|+||||+|
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            22222211         14699999997211  1121111     1 155788899999999999964799999999999


Q ss_pred             EEEcCCCCcEEEeecCCcccc
Q 016401          183 LLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+++ ++ .++|+|||.+...
T Consensus       146 ili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         146 ILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             EEEE-CC-cEEEEECcccccc
Confidence            9999 55 7999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=2.3e-16  Score=149.44  Aligned_cols=256  Identities=25%  Similarity=0.241  Sum_probs=193.5

Q ss_pred             cCCCCcccccEEEeeeeee--cCceEEEEEEE--cCCCcEEEEEEec------cchhhHHHHHHHHHhC-CCCceeeecc
Q 016401           42 RNGNSKQKVSYIAEHVVGT--GSFGVVFQAKC--RETGEIVAIKKVL------QDKRYKNRELQIMQML-DHPNIVALKH  110 (390)
Q Consensus        42 ~~~~~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~------~~~~~~~~E~~~l~~l-~h~~iv~~~~  110 (390)
                      ....+.....+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+      .......+|+...+++ .|+|.++.+.
T Consensus       106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~  185 (524)
T KOG0601|consen  106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP  185 (524)
T ss_pred             CCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence            3334445567889999999  99999999998  8889999999732      2233345688777777 5899998666


Q ss_pred             eeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHH----HHHHHHhcCCcccccCCCCcEEEc
Q 016401          111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIHNCIGICHRDIKPQNLLVN  186 (390)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~----al~~LH~~~~ivH~Dlkp~NIll~  186 (390)
                      .+     .+....++-+|+|+.++..+...   ...-+++..++..+.+...    ||.++|+ .+++|-|+||+||++.
T Consensus       186 ~~-----e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~  256 (524)
T KOG0601|consen  186 AW-----EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTT  256 (524)
T ss_pred             cc-----ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecc
Confidence            55     45555889999999766544432   2344788888999999999    9999998 8999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCCCcc------eeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--Ch
Q 016401          187 PHTHQLKLCDFGSAKVLVKGEPNVS------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE--SG  258 (390)
Q Consensus       187 ~~~~~vkl~Dfg~a~~~~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~  258 (390)
                      .+....+++|||+...+..+.....      ..+...|++||+..+  .++...|++++|.++.+..++..++...  +.
T Consensus       257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~  334 (524)
T KOG0601|consen  257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSS  334 (524)
T ss_pred             cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence            9844799999999887765542221      145677999999843  4799999999999999999987666544  22


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          259 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      +.++...                              .....+....+.++...+..|++.||..|+++..+++|+++..
T Consensus       335 W~~~r~~------------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  335 WSQLRQG------------------------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             ccccccc------------------------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            2222111                              1122233456777888999999999999999999999999875

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=2.7e-15  Score=132.69  Aligned_cols=133  Identities=15%  Similarity=0.246  Sum_probs=95.8

Q ss_pred             eeee-ecCceEEEEEEEcCCCcEEEEEEeccc-----------------hhhHHHHHHHHHhCCCCce--eeecceeccC
Q 016401           56 HVVG-TGSFGVVFQAKCRETGEIVAIKKVLQD-----------------KRYKNRELQIMQMLDHPNI--VALKHCFFST  115 (390)
Q Consensus        56 ~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~  115 (390)
                      ..|| .|+.|+||.+...  +..++||.+...                 .....+|++++..+.|++|  +..+.+....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 7888899988864  778999977421                 1223469999999998875  4555443221


Q ss_pred             CCCCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEE
Q 016401          116 TDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  193 (390)
Q Consensus       116 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  193 (390)
                       .......++|||+++|  +|..++..     ..+++..    +.|++.+|.+||+ .||+||||||.|||++.++ .++
T Consensus       115 -~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        115 -HGLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             -cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCC-CEE
Confidence             1111223599999996  66555432     3344433    5689999999998 9999999999999999877 799


Q ss_pred             EeecCCccc
Q 016401          194 LCDFGSAKV  202 (390)
Q Consensus       194 l~Dfg~a~~  202 (390)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=1.6e-15  Score=124.52  Aligned_cols=129  Identities=20%  Similarity=0.268  Sum_probs=100.5

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHhCCC--CceeeecceeccCCCCCceEEEEEEec
Q 016401           54 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      +.+.||+|.++.||++....  ..+++|......  ....+|..+++.+.+  .++++++..+..     ....+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES-----DGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEEEEEe
Confidence            45789999999999999853  789999886554  256789999999976  477777666522     2347799999


Q ss_pred             ccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC---CcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          130 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       130 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~---~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +.+....          .++......++.+++.+|+.||. .   +++|+|++|+||+++..+ .++++|||.+.
T Consensus        75 ~~g~~~~----------~~~~~~~~~~~~~~~~~l~~lh~-~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~  137 (155)
T cd05120          75 IEGETLD----------EVSEEEKEDIAEQLAELLAKLHQ-LPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAG  137 (155)
T ss_pred             cCCeecc----------cCCHHHHHHHHHHHHHHHHHHhC-CCceEEEecCCCcceEEEECCc-EEEEEeccccc
Confidence            9863211          11444566778899999999997 4   699999999999999865 79999999885

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=7.4e-16  Score=153.43  Aligned_cols=258  Identities=24%  Similarity=0.275  Sum_probs=186.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      +.+.+.+-+-+|+++.++.++-..+|-..++|.....       ......+-.++-...+|.++.....+     ....-
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP  878 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSP  878 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCC
Confidence            4677778899999999999987777766666654322       22222344444444556666543332     12223


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+|+++|+++ ++...+..    .+..+....+.++..+..++++||. ..+.|+|++|.|+++..++ ..++.||+...
T Consensus       879 ~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~  952 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDG-HRPLTDFGTLS  952 (1205)
T ss_pred             cchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccC-CcccCcccccc
Confidence            6799999974 65555554    3456677778888899999999998 6799999999999999888 59999998432


Q ss_pred             ccccC--------------------------------CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC
Q 016401          202 VLVKG--------------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  249 (390)
Q Consensus       202 ~~~~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  249 (390)
                      ....-                                .......+|+.|.+||.+.+.. ....+|+|++|++++|.++|
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcC
Confidence            21000                                0112346799999999997755 78889999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHH-
Q 016401          250 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-  328 (390)
Q Consensus       250 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~-  328 (390)
                      .+||........+..|....                         .+|.. -+...+.++++++.++|..+|.+|..+. 
T Consensus      1032 ~pp~na~tpq~~f~ni~~~~-------------------------~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRD-------------------------IPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred             CCCCCCcchhhhhhccccCC-------------------------CCCCC-CccccChhhhhhhhhhhccCchhccCccc
Confidence            99999888777776665421                         11211 1235789999999999999999999987 


Q ss_pred             --HHhcCCcccccCCCCCC
Q 016401          329 --EACVHPFFDELRDPNTR  345 (390)
Q Consensus       329 --~~l~hp~f~~~~~~~~~  345 (390)
                        ++..||||+.+.+....
T Consensus      1086 ~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1086 AAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred             ccccccCCccCCCCccccc
Confidence              88899999998765443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.48  E-value=9.6e-13  Score=126.34  Aligned_cols=180  Identities=22%  Similarity=0.301  Sum_probs=128.7

Q ss_pred             cEEEeeeeeecCceEEE-EEEEcCCCcEEEEEEeccchh----hHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVF-QAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~-~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      -|.+ ...+-++.+ +| .|..+.++.+|.|..++....    ...+-++-|+.++||||+++++.+     ..+..+|+
T Consensus        14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl   86 (690)
T KOG1243|consen   14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL   86 (690)
T ss_pred             Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence            4666 444444444 44 466678889999988754433    245678899999999999999988     44446899


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          126 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       126 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |+|-+.. |..++..       +....+...++||+.||.|||...+++|++|.-+.|+++..| ..||++|.++.....
T Consensus        87 vTErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~  157 (690)
T KOG1243|consen   87 VTERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASG  157 (690)
T ss_pred             Eeecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEecccc
Confidence            9999864 2222332       235667888899999999998547999999999999999998 799999998754432


Q ss_pred             CCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC
Q 016401          206 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  249 (390)
Q Consensus       206 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  249 (390)
                      ... .....---.|..|+.+...   .-..|.|.|||++++++.|
T Consensus       158 ~~~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  158 FNAPAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CCcccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            221 1111112236777765221   2456999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=2.2e-13  Score=119.85  Aligned_cols=211  Identities=18%  Similarity=0.222  Sum_probs=146.1

Q ss_pred             HHHhCCCCceeeecceeccCCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc-CCc
Q 016401           96 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGI  173 (390)
Q Consensus        96 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~-~~i  173 (390)
                      -|..+.|.|||+++.++-+....+.....++.||+. |++...++...+....+.....++|+.||+.||.|||++ --|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            344557999999998886655545555778999998 688888888777778889999999999999999999983 259


Q ss_pred             ccccCCCCcEEEcCCCCcEEEeecCCcc--cccc---CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh
Q 016401          174 CHRDIKPQNLLVNPHTHQLKLCDFGSAK--VLVK---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL  248 (390)
Q Consensus       174 vH~Dlkp~NIll~~~~~~vkl~Dfg~a~--~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  248 (390)
                      +|+++..+-|++..++ -+|+.--.-..  ....   ........+-++|.+||.= .....+.++|||++|+...+|..
T Consensus       200 ihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHHH
Confidence            9999999999999776 56664321111  0000   0011122345779999965 33446789999999999999988


Q ss_pred             CCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH
Q 016401          249 GQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA  327 (390)
Q Consensus       249 g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~  327 (390)
                      +..--..... .+.-..+...+                               + .--..--++++.+||+-.|..||++
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i-------------------------------~-~len~lqr~~i~kcl~~eP~~rp~a  325 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVI-------------------------------I-GLENGLQRGSITKCLEGEPNGRPDA  325 (458)
T ss_pred             heeccCCCcceeehhhhhhhhe-------------------------------e-eccCccccCcCcccccCCCCCCcch
Confidence            7643222111 11111111100                               0 0012234579999999999999999


Q ss_pred             HHHhcCCcccccC
Q 016401          328 LEACVHPFFDELR  340 (390)
Q Consensus       328 ~~~l~hp~f~~~~  340 (390)
                      .++|-||-+-++.
T Consensus       326 r~llfHpllfeVh  338 (458)
T KOG1266|consen  326 RLLLFHPLLFEVH  338 (458)
T ss_pred             hhhhcCceeeecc
Confidence            9999999987653

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=1.2e-12  Score=110.78  Aligned_cols=132  Identities=17%  Similarity=0.191  Sum_probs=92.7

Q ss_pred             eeeeeecCceEEEEEEEcC------CCcEEEEEEecc--------------chh------------hH----HHHHHHHH
Q 016401           55 EHVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQ--------------DKR------------YK----NRELQIMQ   98 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~--------------~~~------------~~----~~E~~~l~   98 (390)
                      ...||.|--+.||.|....      .+..+|||+++.              +.+            ..    ++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998643      357899997621              100            11    26899998


Q ss_pred             hCCC--CceeeecceeccCCCCCceEEEEEEeccccc-HH-HHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHH-HhcCCc
Q 016401           99 MLDH--PNIVALKHCFFSTTDKEELYLNLVLEYVPET-VN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGI  173 (390)
Q Consensus        99 ~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~L-H~~~~i  173 (390)
                      ++..  -++..++.+.    .     .++||||++++ +. ..+.     ...++......+..+++.+|..| |. .||
T Consensus        82 rl~~~Gv~vP~pi~~~----~-----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVLK----K-----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNL  146 (197)
T ss_pred             HHHHcCCCCCeEEEec----C-----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence            8843  3444444321    1     45899999863 11 1121     12344556677889999999998 87 899


Q ss_pred             ccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          174 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       174 vH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ||+||++.|||++. + .+.|+|||.+...
T Consensus       147 VHGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         147 VHADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             ecCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            99999999999984 3 6999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=1.4e-12  Score=125.32  Aligned_cols=136  Identities=22%  Similarity=0.273  Sum_probs=88.6

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccch-hh-------------------------------------------H
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RY-------------------------------------------K   90 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~-------------------------------------------~   90 (390)
                      .+.||+|++|+||+|+.+ +|+.||||+..... ..                                           .
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            467999999999999974 78999999874321 00                                           1


Q ss_pred             HHHHHHHHhC----CCCceeeecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHH-HH
Q 016401           91 NRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR-AL  164 (390)
Q Consensus        91 ~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~-al  164 (390)
                      .+|...+.++    ++.+-+.+..++.+..+    ..++||||++| .+.+.....   .....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHH
Confidence            1244444443    23333444444422211    14699999987 444433221   11121   2344555555 46


Q ss_pred             HHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       165 ~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ..+|. .|++|+|+||.||+++.++ .++|+|||++...
T Consensus       271 ~ql~~-~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l  307 (437)
T TIGR01982       271 NQVLR-DGFFHADLHPGNIFVLKDG-KIIALDFGIVGRL  307 (437)
T ss_pred             HHHHh-CCceeCCCCcccEEECCCC-cEEEEeCCCeeEC
Confidence            78898 8999999999999999887 7999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=2e-12  Score=108.49  Aligned_cols=124  Identities=16%  Similarity=0.163  Sum_probs=89.5

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCcee-eecceeccCCCCCceEEEEEEecc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      .+.|+.|.++.||++...  ++.|++|......   ....+|+.+++.+.+.+++ +++...     ...  .++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            467899999999999874  7889999875543   3456899999998665544 333322     111  25899999


Q ss_pred             cccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCc-----ccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          131 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI-----CHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       131 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~i-----vH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|......           ......++.+++.+|+.||. .++     +|+|++|.||+++ ++ .++++||+.+.
T Consensus        74 ~G~~l~~~-----------~~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          74 EGSELLTE-----------DFSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCCccccc-----------cccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            97321100           01123456789999999998 775     9999999999999 44 69999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=5.5e-13  Score=129.61  Aligned_cols=139  Identities=19%  Similarity=0.245  Sum_probs=86.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh--------------------------------------h---
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------------------Y---   89 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------------------~---   89 (390)
                      .|.. +.||+|++|+||+|+.+.+|+.||||+......                                      .   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4565 789999999999999988899999998853210                                      0   


Q ss_pred             ---HHHHHHHHHhC----CCCceeeecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhc---CCCcHHHHHHHHH
Q 016401           90 ---KNRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIH---QRMPLIYVKLYTY  158 (390)
Q Consensus        90 ---~~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~---~~~~~~~~~~~~~  158 (390)
                         ..+|+..+.++    .+.+.+.+..++.+..    ...++||||+.| .+.++... ...+   ..+.+..+..++.
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHH
Confidence               01233333333    2333344434432211    124599999997 44332211 1101   1233344444444


Q ss_pred             HHHHHHHHHHhcCCcccccCCCCcEEEcCCC---CcEEEeecCCcccc
Q 016401          159 QICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFGSAKVL  203 (390)
Q Consensus       159 ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~~vkl~Dfg~a~~~  203 (390)
                      |++       . .|++|+|+||.||+++.++   ..++++|||++...
T Consensus       275 Qif-------~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        275 QVF-------R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HHH-------h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            544       4 7999999999999998775   26999999998765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.34  E-value=5.5e-13  Score=126.66  Aligned_cols=250  Identities=22%  Similarity=0.195  Sum_probs=173.9

Q ss_pred             CcccccEEEeeeeeecCceEEEEEEEc-CCCcEEEEEEeccchhhH------HHHHHHHHhC-CCCceeeecceeccCCC
Q 016401           46 SKQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYK------NRELQIMQML-DHPNIVALKHCFFSTTD  117 (390)
Q Consensus        46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------~~E~~~l~~l-~h~~iv~~~~~~~~~~~  117 (390)
                      .....+|..+..||.|.|+.|+.+... .++..|++|...+.....      ..|+-+...+ .|.+++..+..+..   
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~---  337 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ---  337 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc---
Confidence            344568999999999999999988755 678899999775433222      2466665555 58888887666532   


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          118 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                        ....|+-.|||.+....+-.   ....-+.+...+.+..|++.++.++|+ ..++|+|+||+||++..++...++.||
T Consensus       338 --~r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  338 --LRQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             --cccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccc
Confidence              22255888999753322222   223456777788999999999999998 999999999999999876447899999


Q ss_pred             CCccccccCCCCcceeeccccc-cchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          198 GSAKVLVKGEPNVSYICSRYYR-APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       198 g~a~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      |..+.+.  .........-++. .+|++.....+..+.|++|||..+.+.++|.+.-......   ..+...        
T Consensus       412 ~~~t~~~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~--------  478 (524)
T KOG0601|consen  412 GCWTRLA--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSG--------  478 (524)
T ss_pred             ccccccc--eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecc--------
Confidence            9886421  1112222333445 3666767777899999999999999999987543322211   111100        


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                 ..+.          .+....++..+.+.++..|+..|+.+.++..|.=|..
T Consensus       479 -----------~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  479 -----------DTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -----------cccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                       0000          0233477889999999999999999999988876644

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.29  E-value=2.4e-10  Score=106.90  Aligned_cols=214  Identities=16%  Similarity=0.215  Sum_probs=148.9

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecccc--cHHH
Q 016401           63 FGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNR  136 (390)
Q Consensus        63 ~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~  136 (390)
                      -.+.|+|....+|..|++|++.-++    ...-.-+++++++.|.|+|++.++|.+. ..++..+++|++|.++  +|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCchHHH
Confidence            3578999999999999999983221    1122468899999999999999998733 3566678999999985  4443


Q ss_pred             HHHHh-----------hhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          137 IARNY-----------SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       137 ~~~~~-----------~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      +--..           ...+...++..+|.++.||..||.++|+ .|+.-+-|.|.+||++.+. +++|+..|.......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence            32111           1112347789999999999999999998 8999999999999999887 799888776654432


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCCHHHHhhcCcCc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI-IKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~  284 (390)
                      ..           .  |.+.+    --+-|.=.||.+++.|.||..-=...+   ..++. ++.                
T Consensus       446 d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d---~~~~s~~~~----------------  489 (655)
T KOG3741|consen  446 DP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTD---STQSSHLTR----------------  489 (655)
T ss_pred             CC-----------C--cchhH----HhhhhHHHHHHHHHHHhhccccccccc---chHHHHHHH----------------
Confidence            22           0  11211    235689999999999999963211111   11111 111                


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                      +....+.+++++|.-+..-++++ -++.+++.
T Consensus       490 ----------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  490 ----------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             ----------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence                            01346778888888888777775 56666654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=8.3e-11  Score=96.00  Aligned_cols=140  Identities=19%  Similarity=0.253  Sum_probs=97.1

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEe-ccc-----------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           54 AEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~-~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...+|-+|+-+.|+++...  |+.++||.- .+.           .....+|+++|.++.--.|....-++.+..   . 
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~---~-   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY---G-   84 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC---C-
Confidence            6778899999999999864  888888843 111           122346999998885444332222232222   2 


Q ss_pred             EEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcE--EEeec
Q 016401          122 YLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL--KLCDF  197 (390)
Q Consensus       122 ~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v--kl~Df  197 (390)
                       -+++|||++|  ++.+.+....  .......-...++.+|-+.+.-||. .+|||+||..+||++.+++..+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence             3489999998  5555444322  2223333336788899999999998 9999999999999998776555  89999


Q ss_pred             CCcccc
Q 016401          198 GSAKVL  203 (390)
Q Consensus       198 g~a~~~  203 (390)
                      |++...
T Consensus       161 gls~~s  166 (229)
T KOG3087|consen  161 GLSSVS  166 (229)
T ss_pred             cchhcc
Confidence            998643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=3.6e-12  Score=122.88  Aligned_cols=154  Identities=20%  Similarity=0.312  Sum_probs=111.9

Q ss_pred             HHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCC--------cc--eeeccccccchhhcCCC
Q 016401          159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--------VS--YICSRYYRAPELIFGAT  228 (390)
Q Consensus       159 ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~--------~~--~~~t~~y~aPE~~~~~~  228 (390)
                      ++..||.|+|.+.++||++|.|++|.++..+ ..||+.|+++.........        ..  ..-...|.|||.+.. .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3449999999878999999999999999988 7999999998644331110        00  112456999999965 5


Q ss_pred             CCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCCh
Q 016401          229 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP  307 (390)
Q Consensus       229 ~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (390)
                      ..+.++|+||+||++|.+. .|+..+...........-...                         ..--...+..+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~-------------------------~~~~~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL-------------------------LNAGAFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc-------------------------cccccccccccCcH
Confidence            5899999999999999998 566555444322211111000                         00001122357899


Q ss_pred             hHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          308 EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       308 ~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      ++++=|.++|..|+..||++..++..|||++.
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            99999999999999999999999999999874

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=3.3e-10  Score=92.90  Aligned_cols=124  Identities=15%  Similarity=0.298  Sum_probs=84.6

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEe-ccc-----------hhhHHHHHHHHHhCCCCcee--eecceeccCCCCCce
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD-----------KRYKNRELQIMQMLDHPNIV--ALKHCFFSTTDKEEL  121 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~-~~~-----------~~~~~~E~~~l~~l~h~~iv--~~~~~~~~~~~~~~~  121 (390)
                      ..+++|+-+.++.+...  |..+++|.- ++.           .....+|++++.++.--.|.  .++++.     ... 
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-----~~~-   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-----PDN-   73 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCC-
Confidence            35789999999999653  555777742 211           11223699999888543333  333332     222 


Q ss_pred             EEEEEEecccccHHH-HHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                       ..++|||++|.+.. .+..    .       ...++..+-.-+.-||. .||||+||.++||++..+  .+.++|||++
T Consensus        74 -~~I~me~I~G~~lkd~l~~----~-------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~--~i~~IDfGLg  138 (204)
T COG3642          74 -GLIVMEYIEGELLKDALEE----A-------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGG--RIYFIDFGLG  138 (204)
T ss_pred             -CEEEEEEeCChhHHHHHHh----c-------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCC--cEEEEECCcc
Confidence             33899999986532 3332    1       13456677777888998 999999999999999965  4999999998


Q ss_pred             cc
Q 016401          201 KV  202 (390)
Q Consensus       201 ~~  202 (390)
                      ..
T Consensus       139 ~~  140 (204)
T COG3642         139 EF  140 (204)
T ss_pred             cc
Confidence            63

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.12  E-value=3.3e-10  Score=95.68  Aligned_cols=121  Identities=21%  Similarity=0.248  Sum_probs=76.2

Q ss_pred             EEEEEEEcCCCcEEEEEEeccc--------------h----------------hhHHHHHHHHHhCCCC--ceeeeccee
Q 016401           65 VVFQAKCRETGEIVAIKKVLQD--------------K----------------RYKNRELQIMQMLDHP--NIVALKHCF  112 (390)
Q Consensus        65 ~V~~~~~~~~~~~vavK~~~~~--------------~----------------~~~~~E~~~l~~l~h~--~iv~~~~~~  112 (390)
                      .||.|.. .+|..+|||+.+..              .                ....+|.+.|.++...  ++.+++.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899987 46789999987321              0                1123699999999765  445554432


Q ss_pred             ccCCCCCceEEEEEEeccc--ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHH-HHhcCCcccccCCCCcEEEcCCC
Q 016401          113 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY-IHNCIGICHRDIKPQNLLVNPHT  189 (390)
Q Consensus       113 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~-LH~~~~ivH~Dlkp~NIll~~~~  189 (390)
                          .     .++||||++  |.....+..     ..++......++.+++..+.. +|. .||+|+||.+.|||++.+ 
T Consensus        80 ----~-----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 ----R-----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             ----T-----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred             ----C-----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence                1     348999999  633222222     111233456677788886655 577 899999999999999976 


Q ss_pred             CcEEEeecCCcccc
Q 016401          190 HQLKLCDFGSAKVL  203 (390)
Q Consensus       190 ~~vkl~Dfg~a~~~  203 (390)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             5999999998654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.08  E-value=7.4e-09  Score=94.87  Aligned_cols=262  Identities=17%  Similarity=0.189  Sum_probs=154.2

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh-hHHHHHHHHHhC-CCCceee----ecceeccCCCCCceEEEEE
Q 016401           53 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML-DHPNIVA----LKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~E~~~l~~l-~h~~iv~----~~~~~~~~~~~~~~~~~lv  126 (390)
                      ...+.||+|+-+.+|-.-.-   ...+.|++....- ...+.+..|... .||-+-.    ..... ... .....+.++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L-~G~-~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATL-HGG-RRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh---hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHh-hCC-CccceeEEe
Confidence            35667999999999865432   2245687754332 222334444433 4553322    11111 111 222337789


Q ss_pred             Eeccccc--HHHHHH--HhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          127 LEYVPET--VNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       127 ~e~~~~~--l~~~~~--~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+.+.|-  ...+..  ...+......+..+.++.+.|+.+.+.||. .|.+-+|++++|+|+.+++ .|.|.|=..-..
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi  166 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQI  166 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCc-eEEEEcccceee
Confidence            9988862  211111  111122346788999999999999999998 8999999999999999887 799987554333


Q ss_pred             cccCCCCcceeeccccccchhhc----CCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          203 LVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ..++......+|...|.+||.-.    ....-+...|.|.||+++++++.| +.||.|-..      +.. -..|.+..+
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~------~~~-ap~p~E~~I  239 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL------ISD-APNPLETDI  239 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc------cCC-CCCcchhhh
Confidence            33344444556788999999762    122246789999999999999986 999987321      000 001111122


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccC--CCcCCCHHH
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS--PNLRCTALE  329 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d--P~~R~s~~~  329 (390)
                      ......+..-..+..++.+.. +-..-+++++..|..+|+..-  +.-|||++.
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~-~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRS-IPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             hcceeeechhccCCCCCCCCC-CChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            111111111111111111111 111346889999999998643  568999753

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.03  E-value=8.9e-09  Score=92.22  Aligned_cols=132  Identities=12%  Similarity=0.123  Sum_probs=88.2

Q ss_pred             EEEEEEEcCCCcEEEEEEeccch---------------hhHHHHHHHHHhCCCCceeee--cceeccCCCCCceEEEEEE
Q 016401           65 VVFQAKCRETGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVAL--KHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        65 ~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~--~~~~~~~~~~~~~~~~lv~  127 (390)
                      .|.++..  .|+.|.||......               ....+|...+.++...+|...  +.+.....+.....-++||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555543  46678888652211               135689998888854443332  2222221222223356999


Q ss_pred             ecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC------CCcEEEeecCC
Q 016401          128 EYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH------THQLKLCDFGS  199 (390)
Q Consensus       128 e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~------~~~vkl~Dfg~  199 (390)
                      |++++  ++.+++....  ....+......++.+++..+.-||. .||+|+|+++.|||++.+      ...+.|+||+.
T Consensus       115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            99997  5666654321  2345667778899999999999998 999999999999999752      23799999998


Q ss_pred             cc
Q 016401          200 AK  201 (390)
Q Consensus       200 a~  201 (390)
                      +.
T Consensus       192 ~~  193 (268)
T PRK15123        192 AQ  193 (268)
T ss_pred             cc
Confidence            74

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.02  E-value=3.1e-09  Score=93.12  Aligned_cols=138  Identities=14%  Similarity=0.168  Sum_probs=87.9

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCc--eeeecceeccCCCCCceEEEEEEe
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      +.|+.|..+.||++... +|+.|++|.....     .....+|+++++.+.+..  +.+++.+....  ......++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence            56899999999999874 3688999987543     234578999999997633  45554443211  11123569999


Q ss_pred             ccccc-HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 016401          129 YVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--------------------------------------  169 (390)
Q Consensus       129 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~--------------------------------------  169 (390)
                      |++|. +.....     ...+++.....++.+++.+|..||+                                      
T Consensus        81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99863 211110     0123333344444444444444442                                      


Q ss_pred             -----------------cCCcccccCCCCcEEEcCC-CCcEEEeecCCcc
Q 016401          170 -----------------CIGICHRDIKPQNLLVNPH-THQLKLCDFGSAK  201 (390)
Q Consensus       170 -----------------~~~ivH~Dlkp~NIll~~~-~~~vkl~Dfg~a~  201 (390)
                                       ...++|+|++|.||+++.+ ...+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                             1357999999999999873 2258999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.90  E-value=1.2e-08  Score=88.79  Aligned_cols=132  Identities=20%  Similarity=0.177  Sum_probs=93.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--------------------------hhhHHHHHHHHHhCCCC-
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------------------KRYKNRELQIMQMLDHP-  103 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------------------~~~~~~E~~~l~~l~h~-  103 (390)
                      -+.++..||.|--+.||.|.+. .|.++|||.-+-.                          ....++|.++|++|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            4668899999999999999985 7899999953110                          11224799999998644 


Q ss_pred             -ceeeecceeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          104 -NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       104 -~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                       .+.+.++.        +. .++|||+++|..   +..     -+++......++..|+.-+..+-. .||||+|+.+-|
T Consensus       171 ~~VP~P~~~--------nR-HaVvMe~ieG~e---L~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefN  232 (304)
T COG0478         171 VKVPKPIAW--------NR-HAVVMEYIEGVE---LYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFN  232 (304)
T ss_pred             CCCCCcccc--------cc-ceeeeehcccce---eec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchhe
Confidence             55554332        22 458999999833   111     111233344555566666666556 799999999999


Q ss_pred             EEEcCCCCcEEEeecCCccc
Q 016401          183 LLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~  202 (390)
                      |++++|+ .+.++||-.+..
T Consensus       233 IlV~~dg-~~~vIDwPQ~v~  251 (304)
T COG0478         233 ILVTEDG-DIVVIDWPQAVP  251 (304)
T ss_pred             EEEecCC-CEEEEeCccccc
Confidence            9999998 699999987753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=1.2e-07  Score=81.99  Aligned_cols=107  Identities=21%  Similarity=0.318  Sum_probs=75.6

Q ss_pred             HHHHHHHHHhCCCCcee--eecceeccCCCCCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHH
Q 016401           90 KNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  165 (390)
Q Consensus        90 ~~~E~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~  165 (390)
                      ..+|...+..|....|.  ..+.+........ ...++|+|++++  +|..++...    ...+......++.+++..++
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHH
Confidence            45788888887543332  2333322222222 445799999986  565555542    22566677889999999999


Q ss_pred             HHHhcCCcccccCCCCcEEEcCCC--CcEEEeecCCccc
Q 016401          166 YIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  202 (390)
Q Consensus       166 ~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~a~~  202 (390)
                      -||. .||+|+|+++.|||++.+.  ..+.|+||+-++.
T Consensus       133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9998 9999999999999998764  3589999997753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.75  E-value=3.8e-07  Score=77.70  Aligned_cols=137  Identities=11%  Similarity=0.078  Sum_probs=95.4

Q ss_pred             eecCceEEEEEEEcCCCcEEEEEEec----------cchhhHHHHHHHHHhCCCCce--eeecceeccCCCCCceEEEEE
Q 016401           59 GTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        59 g~G~~g~V~~~~~~~~~~~vavK~~~----------~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv  126 (390)
                      |.|+-+.|++....  |+.|-+|.-.          -....+.+|+..++.+...++  .++. ++..........-+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            56788888887653  4468888542          123345689999999854433  3333 2211222334556799


Q ss_pred             Eecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC-CcEEEeecCCcc
Q 016401          127 LEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-HQLKLCDFGSAK  201 (390)
Q Consensus       127 ~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~~vkl~Dfg~a~  201 (390)
                      +|-+++  +|..++....  ..+.+......++.+++.++.-||. .|+.|+|+.+.||+++.++ ..++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            998884  7766654321  1345677778899999999999998 9999999999999998655 149999998664

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.69  E-value=2.3e-07  Score=80.20  Aligned_cols=134  Identities=16%  Similarity=0.145  Sum_probs=88.3

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccchhh----------------------------HHHHHHHHHhCC--CCc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY----------------------------KNRELQIMQMLD--HPN  104 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------~~~E~~~l~~l~--h~~  104 (390)
                      ...|.+|--+.||+|.. .++..+|+|++......                            ..+|+.-|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            33677777889999986 56889999988432111                            124777777774  333


Q ss_pred             eeeecceeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEE
Q 016401          105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  184 (390)
Q Consensus       105 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIl  184 (390)
                      +.+.+.+.     .    ..|||||++...   ...-....-++....+..+..+++..+.-|-...|+||+||..-|||
T Consensus       132 vP~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL  199 (268)
T COG1718         132 VPEPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL  199 (268)
T ss_pred             CCCceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence            44444333     1    348999998531   00000001122333567777888888887764479999999999999


Q ss_pred             EcCCCCcEEEeecCCcccc
Q 016401          185 VNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       185 l~~~~~~vkl~Dfg~a~~~  203 (390)
                      +. ++ .+.|+||+.|...
T Consensus       200 ~~-~~-~p~iID~~QaV~~  216 (268)
T COG1718         200 VH-DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             EE-CC-eEEEEECcccccc
Confidence            99 44 6999999998654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.69  E-value=4.4e-07  Score=77.57  Aligned_cols=135  Identities=17%  Similarity=0.198  Sum_probs=83.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHH-------------HHHHHHHhCCCC---ceeeecceec
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------------RELQIMQMLDHP---NIVALKHCFF  113 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------~E~~~l~~l~h~---~iv~~~~~~~  113 (390)
                      .+|.+.+++-......|.+..-  +|+.+++|.........+             +++..+.++...   ....++-+..
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            4788999998888888887764  578899997754332222             233333333221   1111111110


Q ss_pred             cCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcE
Q 016401          114 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  192 (390)
Q Consensus       114 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v  192 (390)
                      -....-....+++|||++| .+.+..        .+++    .+...+..++.-||+ .|++|+|.+|.|++++.++  +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~~--i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNNG--I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECCc--E
Confidence            0011112235589999998 332211        1222    233467788999998 9999999999999999664  9


Q ss_pred             EEeecCCcc
Q 016401          193 KLCDFGSAK  201 (390)
Q Consensus       193 kl~Dfg~a~  201 (390)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.63  E-value=4.5e-09  Score=100.86  Aligned_cols=249  Identities=18%  Similarity=0.179  Sum_probs=164.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCc-eeeecceeccCCCCCceEEEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN-IVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      +...|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++     ..+.+.+..+.
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~  312 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIP  312 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchh
Confidence            4456778888999999999999987765555 7776554 44456899999999999 333322     22556678899


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          127 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       127 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      |+++++.=.. ..........+..-+...+.+.-+.++++||+ .-=+|+|    ||+..+.  ..+..||+........
T Consensus       313 ~~i~s~~rs~-~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  313 MRICSTGRSS-ALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSEE--EVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhhhcCCccc-cccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccccc--ccccccccCCcccCcc
Confidence            9999853000 00000011123333445556667888999997 5458888    8888764  5899999988766555


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  286 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (390)
                      ....+..+|+.++|||+..++. +....|+|++|.-..+|.-|-+|-.....  ..    ...+..              
T Consensus       385 ~~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~----~~~g~~--------------  443 (829)
T KOG0576|consen  385 MKPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VL----PMIGNG--------------  443 (829)
T ss_pred             cccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc--cc----CCCCCC--------------
Confidence            4566778899999999985544 88999999999887777777766543110  00    000000              


Q ss_pred             ccCCCCCC-CCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          287 FKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       287 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      ..-+.... ..|...++       .++...|+..-|..|+....++.|.+|.+.
T Consensus       444 p~s~~L~~~~aw~~~~~-------~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  444 PNSPMLTDKSAWSPVFH-------RDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             CCccccchhhhcCcccc-------cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            00011101 12222221       167888999999999999999999988753

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.62  E-value=1.8e-07  Score=90.82  Aligned_cols=136  Identities=22%  Similarity=0.261  Sum_probs=82.0

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccchh--------------------------------------------hHH
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------------------------YKN   91 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------------------------~~~   91 (390)
                      ..|+.++-|+||+|+.+ +|+.||||+....-.                                            ...
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999985 599999998632100                                            001


Q ss_pred             HHHHHHHhC----CCCceeeecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHH
Q 016401           92 RELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY  166 (390)
Q Consensus        92 ~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~  166 (390)
                      +|..-+.++    +...-+.+-.+|.+.+..    -.++|||++| .+.+.....   ....+...+.....++.  +..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q  280 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQ  280 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHH
Confidence            355444444    233333344444221111    3489999998 333332221   13344322222222111  222


Q ss_pred             HHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       167 LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +-. .|++|.|.+|.||+++.++ .+.+.|||.....
T Consensus       281 ~~~-dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l  315 (517)
T COG0661         281 LLR-DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRL  315 (517)
T ss_pred             HHh-cCccccCCCccceEEecCC-cEEEEcCcceecC
Confidence            223 6999999999999999998 7999999997654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.56  E-value=7.1e-07  Score=91.58  Aligned_cols=204  Identities=19%  Similarity=0.287  Sum_probs=134.2

Q ss_pred             HHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh
Q 016401           91 NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  169 (390)
Q Consensus        91 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~  169 (390)
                      +-|.+.+.++.|+|++.++.+-+.....+ ..+.+..++|.. ++...+..    -...+...++.+..+++.||+++|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            35778889999999999877764433322 223344566664 44444433    4668888999999999999999998


Q ss_pred             cCCcccccCCCC---cEEEcCCCCcEEEe--ecCCccccccCCCCcceeeccccccchhhcCCC-CCCCchhHHHHHHHH
Q 016401          170 CIGICHRDIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVM  243 (390)
Q Consensus       170 ~~~ivH~Dlkp~---NIll~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il  243 (390)
                       ....|.-+...   +--.+.++ .+.++  ||+..+.............+..+.++|...... ......|+|++|...
T Consensus       305 -~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  305 -LSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -hccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence             65554444333   22334444 45555  888877665555555555566788888774322 123447999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc
Q 016401          244 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL  323 (390)
Q Consensus       244 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  323 (390)
                      ..+..|..+-.-.   ......+                                   +........+++.+|+.-|+++
T Consensus       383 ~~~~~~~~i~~~~---~~~~~~l-----------------------------------~~~~~~~~~d~~~~~~~~~~~~  424 (1351)
T KOG1035|consen  383 LQLSQGEDISEKS---AVPVSLL-----------------------------------DVLSTSELLDALPKCLDEDSEE  424 (1351)
T ss_pred             hhhhhcCcccccc---cchhhhh-----------------------------------ccccchhhhhhhhhhcchhhhh
Confidence            9998876432110   0000000                                   0112237889999999999999


Q ss_pred             CCCHHHHhcCCccccc
Q 016401          324 RCTALEACVHPFFDEL  339 (390)
Q Consensus       324 R~s~~~~l~hp~f~~~  339 (390)
                      |+++.+++.|+|....
T Consensus       425 Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  425 RLSALELLTHPFLRFP  440 (1351)
T ss_pred             ccchhhhhhchhcccc
Confidence            9999999999998753

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.34  E-value=3.2e-06  Score=82.00  Aligned_cols=138  Identities=22%  Similarity=0.300  Sum_probs=80.3

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhh-----------------------------------------HHH
Q 016401           54 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-----------------------------------------KNR   92 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------------------------------------~~~   92 (390)
                      -.+.||..+.|+|++|+.+. |+.||||+-...-..                                         +.+
T Consensus       165 ~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~  243 (538)
T KOG1235|consen  165 DEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK  243 (538)
T ss_pred             CcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence            34689999999999999865 999999975321000                                         002


Q ss_pred             HHHHH----HhCCCCc---eeeecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHH
Q 016401           93 ELQIM----QMLDHPN---IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL  164 (390)
Q Consensus        93 E~~~l----~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al  164 (390)
                      |++-.    +.++|-+   -|.+-.+|.+...    .-.|+||||+| -+.++...   ....++...+.   ..+.++.
T Consensus       244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~---~~l~~~~  313 (538)
T KOG1235|consen  244 EAKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAI---DKRGISPHDIL---NKLVEAY  313 (538)
T ss_pred             HHHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHH---HHcCCCHHHHH---HHHHHHH
Confidence            33222    2233444   2223333322111    14599999997 22222111   12344444333   3333332


Q ss_pred             HH-HHhcCCcccccCCCCcEEEcC---CCCcEEEeecCCcccc
Q 016401          165 AY-IHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  203 (390)
Q Consensus       165 ~~-LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~Dfg~a~~~  203 (390)
                      .. |-. .|++|+|-+|.||+++.   .+..+.+-|||+....
T Consensus       314 ~~qIf~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  314 LEQIFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHHHHh-cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            22 222 69999999999999984   3458999999998654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.30  E-value=7.2e-06  Score=72.19  Aligned_cols=74  Identities=16%  Similarity=0.201  Sum_probs=50.0

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCc--eeeecceeccCCCCCceEEEEEEecc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....  +.+++...  ..+......+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            5679999999999999854  58999987554  345568999988885332  34444322  1122333477999999


Q ss_pred             cc
Q 016401          131 PE  132 (390)
Q Consensus       131 ~~  132 (390)
                      +|
T Consensus        78 ~g   79 (239)
T PF01636_consen   78 PG   79 (239)
T ss_dssp             SS
T ss_pred             cc
Confidence            87

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.26  E-value=1.1e-05  Score=70.71  Aligned_cols=135  Identities=18%  Similarity=0.156  Sum_probs=75.2

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCce--eeecceeccCCCCCceEEEEEEeccc
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVP  131 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~  131 (390)
                      ..||+|..+.||+..    +..+++|.....  .....+|.++++.+..-.+  .+.+.+.     ......++|||+++
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            568999999999842    456889987542  2345789999988854333  3333333     12222568999999


Q ss_pred             cc--HHH-----------HHHH----hhhhcC----CCcHHH-HHHHHH----------HHHHH-HHHHHh---cCCccc
Q 016401          132 ET--VNR-----------IARN----YSRIHQ----RMPLIY-VKLYTY----------QICRA-LAYIHN---CIGICH  175 (390)
Q Consensus       132 ~~--l~~-----------~~~~----~~~~~~----~~~~~~-~~~~~~----------ql~~a-l~~LH~---~~~ivH  175 (390)
                      |.  +..           +...    ..+.+.    ...... ...+..          .+... ..+|..   ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            83  110           1110    011111    111111 011100          01111 122221   135789


Q ss_pred             ccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          176 RDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       176 ~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+.|.||++++++  +.|+||+.+.
T Consensus       158 gD~~~~Nii~~~~~--~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG--TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC--cEEEechhcC
Confidence            99999999999765  8999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.09  E-value=2.3e-05  Score=64.29  Aligned_cols=127  Identities=21%  Similarity=0.352  Sum_probs=84.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEe
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  128 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  128 (390)
                      .-++.+.|++|.+|.||++...  |..+|+|+-..+  ....+.|+++|..++..++-.=+..+ .   .    .++.||
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me   92 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRME   92 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhh
Confidence            3456789999999999999975  668999976544  45567899999999766554322111 1   1    225699


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCC--CcEEEcCCCCcEEEeecCCcc
Q 016401          129 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP--QNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       129 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp--~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      |+.| .|......       .+    ++-+..++++.--|-. .||-|+.|.-  .||++. +. .+.|+||..|+
T Consensus        93 ~i~G~~L~~~~~~-------~~----rk~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At  154 (201)
T COG2112          93 YIDGRPLGKLEIG-------GD----RKHLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVN-DR-DVYIIDFDSAT  154 (201)
T ss_pred             hhcCcchhhhhhc-------cc----HHHHHHHHHHHHHHHH-hccchhhhcCCceeEEec-CC-cEEEEEccchh
Confidence            9998 54332221       01    2223456666444555 8999999864  455555 44 69999999887

>PLN02876 acyl-CoA dehydrogenase

Probab=97.97  E-value=8.9e-05  Score=77.60  Aligned_cols=78  Identities=15%  Similarity=0.191  Sum_probs=51.0

Q ss_pred             EeeeeeecCceEEEEEEEcCCC--cEEEEEEecc-----chhhHHHHHHHHHhCC-CCce--eeecceeccCCCCCceEE
Q 016401           54 AEHVVGTGSFGVVFQAKCRETG--EIVAIKKVLQ-----DKRYKNRELQIMQMLD-HPNI--VALKHCFFSTTDKEELYL  123 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~-----~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~  123 (390)
                      -.+.|+.|.+..+|+......+  ..+++|+...     ......+|+++++.+. |.++  .+++.++.+.  ......
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCc
Confidence            3567899999999998765332  4688887633     2235678999999995 6664  4544444221  111235


Q ss_pred             EEEEeccccc
Q 016401          124 NLVLEYVPET  133 (390)
Q Consensus       124 ~lv~e~~~~~  133 (390)
                      |+||||++|.
T Consensus       120 flVME~v~G~  129 (822)
T PLN02876        120 FYIMEYLEGR  129 (822)
T ss_pred             eEEEEecCCc
Confidence            6899999874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.97  E-value=7.4e-05  Score=66.48  Aligned_cols=68  Identities=15%  Similarity=0.095  Sum_probs=42.2

Q ss_pred             eeecCc-eEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEEEEecccc
Q 016401           58 VGTGSF-GVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVPE  132 (390)
Q Consensus        58 lg~G~~-g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~  132 (390)
                      |-.|.. +.||++...  +..+.||+.... .....+|+++++.+. +-.+.+++.+..     .....++|||+++|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEEeeCC
Confidence            444444 789999753  467888976442 134568999998884 323334444431     11235689999987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.92  E-value=6.6e-05  Score=63.63  Aligned_cols=126  Identities=28%  Similarity=0.372  Sum_probs=85.9

Q ss_pred             ccEEEeeeeeecCc-eEEEEEEEcCCCcEEEEEEecc---------------ch----------hhHHHHHHHHHhC---
Q 016401           50 VSYIAEHVVGTGSF-GVVFQAKCRETGEIVAIKKVLQ---------------DK----------RYKNRELQIMQML---  100 (390)
Q Consensus        50 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~---------------~~----------~~~~~E~~~l~~l---  100 (390)
                      ..++..+.||.|.- |.||+++.  .|+.||||++..               ..          ..+..|-+..-+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            47999999999999 99999997  478999998311               00          1122455555554   


Q ss_pred             CCCce--eeecceeccCCC-------------CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHH
Q 016401          101 DHPNI--VALKHCFFSTTD-------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  165 (390)
Q Consensus       101 ~h~~i--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~  165 (390)
                      .+..+  |++++++.-..+             .......||.||+...-            .+...    -+.+|++-|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHH
Confidence            45555  788887643311             11222457888876422            12222    2457888899


Q ss_pred             HHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       166 ~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|. .||+-+|+++.|..      .-+|+|||.+
T Consensus       179 ~~~k-~gI~~~Dv~~~ny~------~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHK-LGIVPRDVKPRNYR------GGKLVDFSSS  206 (207)
T ss_pred             HHHH-CCeeeccCcccccc------CCEEEecccC
Confidence            9998 99999999999986      2489999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.84  E-value=2.4e-05  Score=82.73  Aligned_cols=214  Identities=14%  Similarity=-0.031  Sum_probs=137.4

Q ss_pred             HHHHHHhCCCCceeeecceeccCCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC
Q 016401           93 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI  171 (390)
Q Consensus        93 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~  171 (390)
                      |...++...|+++...+.-.....   ..-.+..++|+. |.+..++-.-......+....+-....+.+.+..-+|+..
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~---s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSE---STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCC---ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            555566678999887655443222   222457888887 4666666554443444555555544455477788877622


Q ss_pred             C----cccccCCCCcEEEcCCCCcEEEeecCCccc-cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHH
Q 016401          172 G----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  246 (390)
Q Consensus       172 ~----ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~-~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  246 (390)
                      +    -+|+++|+.|.+|..+. ++|++++|+.+. ...........+++.|+.|++.. .-.++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence            2    68999999999999887 799999999982 22222224456788899999873 34477789999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC
Q 016401          247 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  326 (390)
Q Consensus       247 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s  326 (390)
                      ..|..+|.     ..++.+++.           .-.+...++.+            ...|.++......+|-+.-..||.
T Consensus      1434 s~~n~~fi-----~flq~~Lkg-----------iidn~tf~sIe------------~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKG-----------IIDNHTFFSIE------------KLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             hcccHHHH-----HHHHHHHcC-----------ccccccccccc------------ccCCCcccHHHHHHHHHHhhhcch
Confidence            98887762     223322221           11111111211            122455555666666677778999


Q ss_pred             HHHHhcCCccccc
Q 016401          327 ALEACVHPFFDEL  339 (390)
Q Consensus       327 ~~~~l~hp~f~~~  339 (390)
                      -...+..+.|...
T Consensus      1486 q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1486 QYISLSRDHFAVG 1498 (2724)
T ss_pred             hhhhccccccccc
Confidence            9999988887643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.83  E-value=0.00016  Score=63.91  Aligned_cols=30  Identities=33%  Similarity=0.407  Sum_probs=24.8

Q ss_pred             CCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+++|+|+.+.||+++.+. ..-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            3589999999999998654 45799999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.82  E-value=0.00032  Score=59.91  Aligned_cols=125  Identities=21%  Similarity=0.290  Sum_probs=81.0

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccch--------------------hhHHHHHHHHHhCC------CCceeee
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------RYKNRELQIMQMLD------HPNIVAL  108 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------------~~~~~E~~~l~~l~------h~~iv~~  108 (390)
                      ...||+|+.=.||.--   .....+||+.....                    ....+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3578999999988543   34456789876544                    33446777666665      7888888


Q ss_pred             cceeccCCCCCceEEEEEEeccc---c----cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCC
Q 016401          109 KHCFFSTTDKEELYLNLVLEYVP---E----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  181 (390)
Q Consensus       109 ~~~~~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~  181 (390)
                      ++...+..+     ..+|+|.+.   |    +|.+++.     .+.+++ .+.   ..+-.-.++|-+ .+|+.+|++|.
T Consensus        83 ~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~---~~L~~f~~~l~~-~~Iv~~dl~~~  147 (199)
T PF10707_consen   83 YGFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELR---QALDEFKRYLLD-HHIVIRDLNPH  147 (199)
T ss_pred             eEEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHH---HHHHHHHHHHHH-cCCeecCCCcc
Confidence            888744333     557777764   3    4444443     344555 222   233344567777 89999999999


Q ss_pred             cEEEcCC--CC-cEEEeec
Q 016401          182 NLLVNPH--TH-QLKLCDF  197 (390)
Q Consensus       182 NIll~~~--~~-~vkl~Df  197 (390)
                      ||++...  +. .+.|+|-
T Consensus       148 NIv~~~~~~~~~~lvlIDG  166 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDG  166 (199)
T ss_pred             cEEEEecCCCceEEEEEeC
Confidence            9999543  22 5777773

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.78  E-value=0.00026  Score=62.50  Aligned_cols=69  Identities=19%  Similarity=0.328  Sum_probs=44.4

Q ss_pred             eeeeeecCceEEEEEEEcC-CCcEEEEEEeccch---hhHHHHHHHHHhCCCCcee-eecceeccCCCCCceEEEEEEec
Q 016401           55 EHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      .+.|..|-...+|++.... .++.|++|+.....   ...++|..+++.+....++ +++..+     . .   .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~-~---~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----Q-N---GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----C-C---cEEEEe
Confidence            4567888888999997543 35789999775432   1234799999988544433 333222     1 1   279999


Q ss_pred             ccc
Q 016401          130 VPE  132 (390)
Q Consensus       130 ~~~  132 (390)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            886

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.75  E-value=0.00015  Score=65.06  Aligned_cols=131  Identities=22%  Similarity=0.274  Sum_probs=73.0

Q ss_pred             eeecCceEEEEEEEcCCCcEEEEEEeccchh----hHHHHHHHHHhCCCCcee-eecceeccCCCCCceEEEEEEecccc
Q 016401           58 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYVPE  132 (390)
Q Consensus        58 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~~~  132 (390)
                      +..|-...+|+..  .+++.+++|.......    ...+|.++++.+....+. +++...     .    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4567778889887  3467888997643322    346799999998643332 222221     1    1479999986


Q ss_pred             cHH------------HHHHHhhhhcC------CCcH-HHHHHHHHHH---------HHHHHHHHh-------cCCccccc
Q 016401          133 TVN------------RIARNYSRIHQ------RMPL-IYVKLYTYQI---------CRALAYIHN-------CIGICHRD  177 (390)
Q Consensus       133 ~l~------------~~~~~~~~~~~------~~~~-~~~~~~~~ql---------~~al~~LH~-------~~~ivH~D  177 (390)
                      ...            .+.....+.+.      +++. ..+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            221            11211111111      1111 1112222111         111222211       02589999


Q ss_pred             CCCCcEEEcCCCCcEEEeecCCcc
Q 016401          178 IKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       178 lkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +.|.||+++.++  +.|+||..|.
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~  174 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYAS  174 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccC
Confidence            999999999765  7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.54  E-value=8e-05  Score=67.04  Aligned_cols=131  Identities=16%  Similarity=0.146  Sum_probs=85.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc----------ch----------------hhHHHHHHHHHhCC-C
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DK----------------RYKNRELQIMQMLD-H  102 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----------~~----------------~~~~~E~~~l~~l~-h  102 (390)
                      .-|.++..||-|--+.||.+-+ ..|+++++|.-.-          ..                -...+|+..|+.|. |
T Consensus        92 ~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~  170 (465)
T KOG2268|consen   92 SVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER  170 (465)
T ss_pred             hhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence            3577899999999999999988 4688999994311          00                01126888888874 3


Q ss_pred             Cc-eeeecceeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCC
Q 016401          103 PN-IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  181 (390)
Q Consensus       103 ~~-iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~  181 (390)
                      -. +.+.+++         ...|+|||++.|--.....      .-.+...   +...++.-+--|-. +|+||+|..-=
T Consensus       171 gfpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~-~GlIHgDFNEF  231 (465)
T KOG2268|consen  171 GFPVPKPIDH---------NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLAN-HGLIHGDFNEF  231 (465)
T ss_pred             CCCCCCcccc---------cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHH-cCceecccchh
Confidence            33 2233222         2256899999873211111      1122222   23344455556666 89999999999


Q ss_pred             cEEEcCCCCcEEEeecCCcc
Q 016401          182 NLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       182 NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ||++++++ .++++||-...
T Consensus       232 Nimv~dd~-~i~vIDFPQmv  250 (465)
T KOG2268|consen  232 NIMVKDDD-KIVVIDFPQMV  250 (465)
T ss_pred             eeEEecCC-CEEEeechHhh
Confidence            99999877 69999997654

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.54  E-value=0.00021  Score=68.03  Aligned_cols=172  Identities=20%  Similarity=0.249  Sum_probs=109.7

Q ss_pred             HHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh
Q 016401           90 KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  169 (390)
Q Consensus        90 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~  169 (390)
                      ..-...+++.+.|+|....+++-..   ..+. ..+|||+++-++.+++....     +-..       +++       .
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~---~~~r-~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~   85 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRG---KHER-VIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A   85 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecC---ccce-EEEEehhhccchHHHHHhcc-----cchh-------hhc-------c
Confidence            3456788999999999988776422   2222 66899999988887776421     1100       111       1


Q ss_pred             cCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC
Q 016401          170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  249 (390)
Q Consensus       170 ~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  249 (390)
                       +|+.|-     |        .++.+| -++.   .            |  |-      ...+++||||+|.++.++..|
T Consensus        86 -~~~~~~-----~--------~~~~td-~~~t---~------------~--~~------~~~pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   86 -HGVLHL-----N--------IIYITD-HFLT---K------------Y--PS------PIGPKSDVWSLGFIILELYLG  127 (725)
T ss_pred             -ccccee-----h--------hhhccc-cccc---c------------C--CC------CCCcchhhhhHHHHHHHHHHh
Confidence             233331     2        233444 1110   0            0  11      122599999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHH
Q 016401          250 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE  329 (390)
Q Consensus       250 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~  329 (390)
                      ...+......+.+..+.+..-.+..-....+.                 ..+.-.++....++..+|+-..|..||...+
T Consensus       128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-----------------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  128 ISLEAELTESEYLEILLKYYTDDQELLSTAME-----------------HLIQLLADKKRLPLLKKCLWLEPIIRPLPME  190 (725)
T ss_pred             hHHHHHHHHHHHHHHHHHhccCchhHHHHHHH-----------------HHHHHhhhHhHHHHhccCCccccccccchhH
Confidence            98888877777777766654333221111100                 0111246778889999999999999999999


Q ss_pred             HhcCCccccc
Q 016401          330 ACVHPFFDEL  339 (390)
Q Consensus       330 ~l~hp~f~~~  339 (390)
                      +.+++-|.++
T Consensus       191 ~~k~~i~~ev  200 (725)
T KOG1093|consen  191 LSKRCSFTEV  200 (725)
T ss_pred             HhcCccHHHH
Confidence            9999999875

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.53  E-value=0.00048  Score=63.16  Aligned_cols=136  Identities=18%  Similarity=0.200  Sum_probs=90.7

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------h-----------------------hhHHHHHHHHHhCCC
Q 016401           53 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------K-----------------------RYKNRELQIMQMLDH  102 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~-----------------------~~~~~E~~~l~~l~h  102 (390)
                      .+..+|..|--+.||.|.. .+|..+|||+++..       .                       ...++|++-|+++..
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            3667788888899999986 56888999987321       0                       011358888888865


Q ss_pred             CceeeecceeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          103 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       103 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                      ..|...--+++       ....|||++++..-+-.-   ......++...+..+-.|++.-+.-|-+.+++||.||.--|
T Consensus       226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCCCceee-------ecceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            55432221111       013489999984321111   11123466666777777788878777655799999999999


Q ss_pred             EEEcCCCCcEEEeecCCcc
Q 016401          183 LLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~  201 (390)
                      +|+.. | .+.|+|.+.+.
T Consensus       296 ~Lyhd-G-~lyiIDVSQSV  312 (520)
T KOG2270|consen  296 LLYHD-G-KLYIIDVSQSV  312 (520)
T ss_pred             heEEC-C-EEEEEEccccc
Confidence            99985 4 69999998874

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.51  E-value=0.00061  Score=62.49  Aligned_cols=143  Identities=14%  Similarity=0.108  Sum_probs=77.5

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEecc-chhhHHHHHHHHHhCCCCc--eeeecceeccCC--CCCceEEEEEEec
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLDHPN--IVALKHCFFSTT--DKEELYLNLVLEY  129 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~--~~~~~~~~lv~e~  129 (390)
                      .+.|..|....+|+....  +..+++|+... .......|+++++.+.+..  +.+++... ...  .......++|+++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADR-DGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCC-CCcEeeeeCCceEEEEEe
Confidence            556778888899998653  45799998763 2334557888888885433  33332211 000  0111235689999


Q ss_pred             ccccHH---------HHHHHhhhhc---CCCc--------HHHHHH------------HHHHHHHHHHHHHh------cC
Q 016401          130 VPETVN---------RIARNYSRIH---QRMP--------LIYVKL------------YTYQICRALAYIHN------CI  171 (390)
Q Consensus       130 ~~~~l~---------~~~~~~~~~~---~~~~--------~~~~~~------------~~~ql~~al~~LH~------~~  171 (390)
                      ++|...         .+.+...+.+   ..+.        ......            ....+..++.++..      ..
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            986211         1111111100   0000        010000            01112233334332      14


Q ss_pred             CcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       172 ~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ++||+|+.|.||+++.++ .+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            799999999999999765 46899999774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.51  E-value=0.0015  Score=60.31  Aligned_cols=146  Identities=11%  Similarity=0.044  Sum_probs=78.2

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCc--eeeecceeccC-CCCCceEEEEEE
Q 016401           53 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFST-TDKEELYLNLVL  127 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~lv~  127 (390)
                      ...+.++.|....+|++.. . +..+++|+....  ......|.+++..|....  +.+++...-.. ........++++
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             eeccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            3456677888889999874 2 346889987542  334456788888774322  23332211000 001123457899


Q ss_pred             ecccccH------H------HHHHHhhhhcCCC--------c-HHHH----H----------HHHHHHHHHHHHHHh---
Q 016401          128 EYVPETV------N------RIARNYSRIHQRM--------P-LIYV----K----------LYTYQICRALAYIHN---  169 (390)
Q Consensus       128 e~~~~~l------~------~~~~~~~~~~~~~--------~-~~~~----~----------~~~~ql~~al~~LH~---  169 (390)
                      +|++|..      .      ..+...-.....+        . ..+.    .          .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            9987611      0      1111110000110        0 0000    0          001112334444432   


Q ss_pred             ---cCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          170 ---CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       170 ---~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                         ..++||+|+++.||+++.++ .+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence               25899999999999999876 56899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.49  E-value=0.0025  Score=59.10  Aligned_cols=30  Identities=27%  Similarity=0.286  Sum_probs=25.4

Q ss_pred             CCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++||+|+.|.||+++.+. ..-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            4899999999999998654 45799999874

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.47  E-value=0.0037  Score=59.32  Aligned_cols=71  Identities=20%  Similarity=0.279  Sum_probs=47.1

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEecc-----------chhhHHHHHHHHHhCC---CCceeeecceeccCCCCCc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~  120 (390)
                      .+.||.|.+..||++.+...++.++||.-..           .......|.+.|+.+.   ..++++++.+-     .+.
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC
Confidence            4678999999999999864446899997321           1222346888888863   24456665542     211


Q ss_pred             eEEEEEEecccc
Q 016401          121 LYLNLVLEYVPE  132 (390)
Q Consensus       121 ~~~~lv~e~~~~  132 (390)
                        .++|||++++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              4589999874

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.27  E-value=0.0008  Score=57.13  Aligned_cols=101  Identities=25%  Similarity=0.234  Sum_probs=73.7

Q ss_pred             HHHHHHHHhCCC-CceeeecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH
Q 016401           91 NRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH  168 (390)
Q Consensus        91 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH  168 (390)
                      +.|.-+++.+.+ ++++++++.+     .    ..+++||++. .+...-..... -...++....+++.+++..+.+|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHh
Confidence            468899999976 6899999887     1    2368999984 33211000000 123678889999999999999999


Q ss_pred             hc--CCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          169 NC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       169 ~~--~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ..  ..+.-.|++|+|+-++.++ ++|++|...+..
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~  111 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV  111 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence            51  1366779999999999887 799999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.20  E-value=0.0056  Score=56.28  Aligned_cols=69  Identities=19%  Similarity=0.263  Sum_probs=42.2

Q ss_pred             eeeeeecCceEEEEEEEcC------CCcEEEEEEeccch---hhHHHHHHHHHhCCCCcee-eecceeccCCCCCceEEE
Q 016401           55 EHVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~  124 (390)
                      ++.|..|-...+|++....      +++.|++|+.....   ....+|.++++.+....+. +++..+     .+    .
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~----~   73 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF-----PN----G   73 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe-----CC----C
Confidence            3456667777888887533      25789999875432   3346799999988543333 333332     11    1


Q ss_pred             EEEecccc
Q 016401          125 LVLEYVPE  132 (390)
Q Consensus       125 lv~e~~~~  132 (390)
                      +|+||++|
T Consensus        74 ~v~e~i~G   81 (302)
T cd05156          74 RIEEFIPS   81 (302)
T ss_pred             chhheeCC
Confidence            47788765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.05  E-value=0.0053  Score=57.22  Aligned_cols=29  Identities=28%  Similarity=0.473  Sum_probs=25.1

Q ss_pred             cccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       173 ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ++|+|+.+.|||+++++..++++||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            79999999999997554379999999875

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.00  E-value=0.0096  Score=55.41  Aligned_cols=69  Identities=20%  Similarity=0.255  Sum_probs=42.7

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEecc-----------chhhHHHHHHHHHhCC--CC-ceeeecceeccCCCCCceE
Q 016401           57 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~~  122 (390)
                      .||.|....||++.+...++.++||.-..           ......-|.+.|+...  .| .+++++.+      ..+. 
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~------D~e~-   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF------DTEM-   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE------cccc-
Confidence            47999999999999854446899995311           1122235888887763  24 34455443      2222 


Q ss_pred             EEEEEecccc
Q 016401          123 LNLVLEYVPE  132 (390)
Q Consensus       123 ~~lv~e~~~~  132 (390)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            3389999853

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.00  E-value=0.011  Score=55.40  Aligned_cols=140  Identities=17%  Similarity=0.266  Sum_probs=75.0

Q ss_pred             EEeeeeeecCceEEEEEEEcC----CCcEEEEEEeccchh---hHHHHHHHHHhCCCCcee-eecceeccCCCCCceEEE
Q 016401           53 IAEHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~  124 (390)
                      .-...|-.|-...+|++....    .++.|++|+......   ...+|..+++.+...++- ++++.+     .+.    
T Consensus        39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~g----  109 (344)
T PLN02236         39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PNG----  109 (344)
T ss_pred             EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-----CCc----
Confidence            334456568888999987432    246899998754321   235799999888543333 333333     111    


Q ss_pred             EEEecccc-cHH-----------HHHHHhhhhcC---C----C-cHHHHHHHHHHH-----------------HHHHHHH
Q 016401          125 LVLEYVPE-TVN-----------RIARNYSRIHQ---R----M-PLIYVKLYTYQI-----------------CRALAYI  167 (390)
Q Consensus       125 lv~e~~~~-~l~-----------~~~~~~~~~~~---~----~-~~~~~~~~~~ql-----------------~~al~~L  167 (390)
                      .|.+|+++ .+.           .+.....+.+.   +    . ....+..++.++                 ...+..|
T Consensus       110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L  189 (344)
T PLN02236        110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL  189 (344)
T ss_pred             eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence            46777764 111           11111111111   0    1 112222222111                 1112222


Q ss_pred             H---h----cCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          168 H---N----CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       168 H---~----~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .   .    ...++|+|+++.|||++.+...+.|+||..|.
T Consensus       190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1   1    13689999999999998643379999999875

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.91  E-value=0.018  Score=53.16  Aligned_cols=29  Identities=28%  Similarity=0.592  Sum_probs=25.0

Q ss_pred             CCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++||+|+.+.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            47899999999999987 4 58999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.80  E-value=0.013  Score=55.16  Aligned_cols=70  Identities=16%  Similarity=0.190  Sum_probs=44.7

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEecc----------chhhHHHHHHHHHhCC--CC-ceeeecceeccCCCCCce
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DKRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~  121 (390)
                      .+.||.|.-..||++.+...++.++||.-..          ......-|.+.|+.+.  .| .+++++.+      ..+.
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------D~e~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------DSVM  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------CcHH
Confidence            6778999999999999843356799995311          1122345888888763  34 44455443      2222


Q ss_pred             EEEEEEeccc
Q 016401          122 YLNLVLEYVP  131 (390)
Q Consensus       122 ~~~lv~e~~~  131 (390)
                       ..+|||+++
T Consensus       108 -~~~vMEdL~  116 (409)
T PRK12396        108 -NCCVMEDLS  116 (409)
T ss_pred             -hhHHHHhCc
Confidence             337999985

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.72  E-value=0.023  Score=52.40  Aligned_cols=30  Identities=13%  Similarity=0.190  Sum_probs=26.6

Q ss_pred             CCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++||+|+.+.|+|++.++ .+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETR-GGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence            3799999999999999877 68999999875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.70  E-value=0.019  Score=52.03  Aligned_cols=30  Identities=27%  Similarity=0.508  Sum_probs=24.9

Q ss_pred             CcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       172 ~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++|+|++|.|||++.++..+-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            489999999999999755335699999875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.65  E-value=0.033  Score=52.85  Aligned_cols=70  Identities=16%  Similarity=0.187  Sum_probs=45.6

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEecc-----------chhhHHHHHHHHHhCC---CCceeeecceeccCCCCC
Q 016401           54 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+.||.|....||+..+.  +..|+||.-..           .......|.+.|+.+.   ..++.+++.+.     .+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence            4677899999999999873  45689996431           1222235777777664   24666666654     22


Q ss_pred             ceEEEEEEecccc
Q 016401          120 ELYLNLVLEYVPE  132 (390)
Q Consensus       120 ~~~~~lv~e~~~~  132 (390)
                      .  .+++||++++
T Consensus       109 ~--~vlvME~L~~  119 (418)
T PLN02756        109 M--ALIGMRYLEP  119 (418)
T ss_pred             C--CEEEEeecCC
Confidence            2  3478999965

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.52  E-value=0.037  Score=50.78  Aligned_cols=30  Identities=27%  Similarity=0.524  Sum_probs=26.8

Q ss_pred             CcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       172 ~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      .++|+|+.+.||+++.++ .+-|.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            489999999999999887 499999999864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.35  E-value=0.012  Score=54.16  Aligned_cols=75  Identities=19%  Similarity=0.273  Sum_probs=58.2

Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          118 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      .+..|.|++|++-++.+..+        .....+++..++.+.+.-+.-+...-..-|||+...||||+ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            56778899999987654221        22445667778888888777777645789999999999999 66 7999999


Q ss_pred             CCccc
Q 016401          198 GSAKV  202 (390)
Q Consensus       198 g~a~~  202 (390)
                      -+++.
T Consensus       366 klsRl  370 (488)
T COG5072         366 KLSRL  370 (488)
T ss_pred             eeeec
Confidence            99984

>PTZ00384 choline kinase; Provisional

Probab=96.29  E-value=0.053  Score=51.48  Aligned_cols=29  Identities=28%  Similarity=0.389  Sum_probs=24.6

Q ss_pred             CCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ...+|.|+-+.||+.+.+  .+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence            367999999999998755  49999998874

>PRK10593 hypothetical protein; Provisional

Probab=95.84  E-value=0.098  Score=47.94  Aligned_cols=106  Identities=10%  Similarity=-0.015  Sum_probs=65.9

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc--chhhHHHHHHHHHhCCC---CceeeecceeccCCCCCceEEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      -.-.+.||.|..+.||+.... ++ .+.+|..+.  ......+|.+.|+.+..   -.+.++++++....  ....-++|
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEE
Confidence            345668999999999999753 23 477787544  23467899999999853   34556665542211  12225699


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh
Q 016401          127 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  169 (390)
Q Consensus       127 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~  169 (390)
                      ||+++|....   .     ...+......+..+++.+|+-||+
T Consensus        92 mE~i~G~~~~---~-----~~~~~~~~~~l~~~l~~~La~LH~  126 (297)
T PRK10593         92 LERLRGVSVE---A-----PARTPERWEQLKDQIVEGLLAWHR  126 (297)
T ss_pred             EeccCCEecC---C-----CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            9999973211   0     011223344555677788888885

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.73  E-value=0.21  Score=46.42  Aligned_cols=28  Identities=25%  Similarity=0.367  Sum_probs=23.7

Q ss_pred             CCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++||+|+.+.|||++ +  .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            4789999999999995 4  37899999774

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.35  E-value=0.32  Score=44.21  Aligned_cols=73  Identities=12%  Similarity=0.116  Sum_probs=43.3

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHhCC---CCceeeecceeccCCCCCceEEEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .+-.+.|+.|....+|+..  .+++.|.||+-... ...++.|.+-|+.|.   --.+.+++.+....   +.  -+|||
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~---~~--~fLll   91 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD---DD--AFLLL   91 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S---SC--CEEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec---CC--ceEEE
Confidence            4566788999999999988  56788999977532 345678999988883   23344555544221   11  26999


Q ss_pred             eccc
Q 016401          128 EYVP  131 (390)
Q Consensus       128 e~~~  131 (390)
                      ||++
T Consensus        92 e~l~   95 (288)
T PF03881_consen   92 EFLE   95 (288)
T ss_dssp             E---
T ss_pred             Eeec
Confidence            9986

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=94.44  E-value=0.63  Score=50.18  Aligned_cols=31  Identities=32%  Similarity=0.470  Sum_probs=25.4

Q ss_pred             CCcccccCCCCcEEEcCCC--CcEEEeecCCcc
Q 016401          171 IGICHRDIKPQNLLVNPHT--HQLKLCDFGSAK  201 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~a~  201 (390)
                      .++||+|+.+.|||++.+.  ...-|+|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999998764  234599999875

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.39  E-value=0.12  Score=48.59  Aligned_cols=59  Identities=25%  Similarity=0.271  Sum_probs=37.9

Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  188 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  188 (390)
                      ++-+|..| ++...+.     ....+++..+.++.-...|+.-+---.+++|.|++|.||++..+
T Consensus       322 l~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  322 LVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             eeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            45556665 4444443     24455666677766666666544322589999999999999543

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.18  E-value=0.04  Score=46.42  Aligned_cols=29  Identities=28%  Similarity=0.340  Sum_probs=25.0

Q ss_pred             CcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       172 ~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      -.+|+|+.|.||++++++  ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            469999999999998765  89999998853

>PTZ00296 choline kinase; Provisional

Probab=93.94  E-value=1  Score=43.78  Aligned_cols=70  Identities=14%  Similarity=0.161  Sum_probs=42.7

Q ss_pred             EeeeeeecCceEEEEEEEcC--------CCcEEEEEEeccchh---hHHHHHHHHHhCCCCcee-eecceeccCCCCCce
Q 016401           54 AEHVVGTGSFGVVFQAKCRE--------TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEEL  121 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~  121 (390)
                      -.+.|..|-.-.+|++....        .++.|.+|+.-....   ...+|..+++.+....|- ++++.+     .   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~---  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----S---  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----C---
Confidence            56667777778889887542        146799998744322   234688888888644433 333333     1   


Q ss_pred             EEEEEEecccc
Q 016401          122 YLNLVLEYVPE  132 (390)
Q Consensus       122 ~~~lv~e~~~~  132 (390)
                       -+.|.+|++|
T Consensus       181 -gg~I~efi~g  190 (442)
T PTZ00296        181 -GGRIEEWLYG  190 (442)
T ss_pred             -CCEEEEeeCC
Confidence             1246777764

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.63  E-value=0.11  Score=46.86  Aligned_cols=48  Identities=29%  Similarity=0.412  Sum_probs=34.4

Q ss_pred             HHHHHHHHHHHHHHHhc-CCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          154 KLYTYQICRALAYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       154 ~~~~~ql~~al~~LH~~-~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ...+..+-.++.-.+.. .-+||+|+.|+|++.++.+ .++|+||..|..
T Consensus       135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            33444444555555541 2489999999999999866 699999998753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.48  E-value=0.068  Score=46.26  Aligned_cols=29  Identities=41%  Similarity=0.764  Sum_probs=19.5

Q ss_pred             CcccccCCCCcEEE-cCCCCcEEEeecCCcc
Q 016401          172 GICHRDIKPQNLLV-NPHTHQLKLCDFGSAK  201 (390)
Q Consensus       172 ~ivH~Dlkp~NIll-~~~~~~vkl~Dfg~a~  201 (390)
                      .++|+|+.|.|||+ +.++ .++|+||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDG-EVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSS-CEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCC-eEEEecHHHHh
Confidence            58999999999999 5455 79999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	390
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-132
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-132
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-132
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-132
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-132
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-131
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-131
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-131
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-130
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-130
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-130
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-130
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-130
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-130
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-130
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-129
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-129
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-129
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-128
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-128
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-127
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-124
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-86
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-79
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-43
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-42
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-42
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-42
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-42
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-42
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-42
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-42
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-42
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-42
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-42
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-42
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-42
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-42
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-42
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-42
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-42
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-42
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-42
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-42
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-42
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-42
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-42
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-42
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-42
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-42
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-42
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-42
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-42
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-42
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-42
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-42
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-42
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-42
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-42
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-42
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-42
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-41
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-41
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-41
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-41
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-41
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-41
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-41
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-41
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-41
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-41
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-41
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-40
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-40
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-40
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-40
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-40
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-40
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-40
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-40
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-40
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-40
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-40
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-40
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-40
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-40
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-40
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-40
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-40
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-40
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-40
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-40
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-40
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-39
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-39
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-39
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-39
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-39
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-39
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-38
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-38
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-38
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-38
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-37
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-37
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-37
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-37
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-37
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-37
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-37
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-37
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-37
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-37
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-37
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-37
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-37
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-37
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-37
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-37
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-37
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-37
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-37
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-37
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-37
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-37
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-37
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-37
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-37
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-37
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-37
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-37
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-37
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-37
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-37
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-37
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-37
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-37
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-37
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-37
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-37
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-37
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-37
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-37
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-37
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-37
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-37
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-37
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-37
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-37
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-37
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-37
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-37
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-37
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-37
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-37
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-36
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-36
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-36
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-36
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-36
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-36
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-36
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-36
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-36
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-35
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-34
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-32
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-32
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-31
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-31
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-30
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-30
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-30
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-30
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-30
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-30
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-30
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-30
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-30
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-30
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-29
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-29
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-29
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-29
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-29
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-29
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-29
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-29
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-29
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-29
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-29
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-29
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-29
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-29
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-29
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-29
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-29
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-29
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-29
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-29
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-29
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-29
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-29
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-29
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-29
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-29
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-29
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-29
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-29
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-29
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-29
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-28
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-28
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-28
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-28
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-28
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-28
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-28
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-28
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-28
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-28
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-28
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-28
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-28
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-28
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-28
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-28
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		8e-28
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-28
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-28
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-28
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-26
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-26
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-26
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-26
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-26
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-26
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-26
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-26
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-26
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-26
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-26
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-24
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-24
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-24
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-23
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-23
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-22
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-22
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-22
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-21
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-20
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-20
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-19
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-19
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-19
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-18
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		9e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-17
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-16
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-14
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-14
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-14
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-14
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-14
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-14
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-13
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
3soa_A	444	Full-Length Human Camkii Length = 444		5e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		8e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		8e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-05
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-05
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-05
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-04
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-04
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  467 bits (1201), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 25  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 82
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 83  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 142
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 143 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 321
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 322 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 379

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  467 bits (1201), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  466 bits (1200), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 33  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 90
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 91  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 150
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 151 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 329
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 330 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 387

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  466 bits (1200), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 35  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 92
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 93  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 152
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 153 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 331
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 332 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 389

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  466 bits (1199), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 76  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 133
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 134 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 193
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 194 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 372
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 373 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 430

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  465 bits (1197), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 233/359 (64%), Positives = 275/359 (76%), Gaps = 7/359 (1%)
Query: 28  GAETGHVIRTTIG--GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 85
           GA +   + T +   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 1   GAMSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 60
Query: 86  DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 144
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 61  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 120
Query: 145 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 204
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV
Sbjct: 121 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 179
Query: 205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 264
           +GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 180 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 239
Query: 265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 240 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299
Query: 325 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
            T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 300 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 356

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  465 bits (1197), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 364

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  464 bits (1194), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  462 bits (1190), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 363

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  462 bits (1189), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 363

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  462 bits (1189), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 370

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  462 bits (1189), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 85  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 143
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 324 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 359

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  462 bits (1188), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 229/342 (66%), Positives = 268/342 (78%), Gaps = 5/342 (1%)
Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 100
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 380
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  460 bits (1183), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 231/357 (64%), Positives = 274/357 (76%), Gaps = 7/357 (1%)
Query: 26  GVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 85
            +G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 2   AMGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 59
Query: 86  DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 144
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 60  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 119
Query: 145 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 204
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV
Sbjct: 120 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 178
Query: 205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 264
           +GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 179 RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238
Query: 265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 239 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298
Query: 325 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 380
            T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 299 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 353

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  459 bits (1182), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 229/344 (66%), Positives = 268/344 (77%), Gaps = 5/344 (1%)
Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 100
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 351

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  459 bits (1180), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 267/342 (78%), Gaps = 5/342 (1%)
Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 100
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 12  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 71
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 132 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 190
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 250
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 251 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 310
Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 380
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 311 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 350

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  458 bits (1179), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 267/342 (78%), Gaps = 5/342 (1%)
Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 100
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 380
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  458 bits (1179), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 267/342 (78%), Gaps = 5/342 (1%)
Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 100
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 380
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  456 bits (1173), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 227/342 (66%), Positives = 266/342 (77%), Gaps = 5/342 (1%)
Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 100
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 380
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  455 bits (1171), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 227/344 (65%), Positives = 266/344 (77%), Gaps = 5/344 (1%)
Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 100
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 382
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  451 bits (1161), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 225/342 (65%), Positives = 264/342 (77%), Gaps = 5/342 (1%)
Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 100
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 380
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  442 bits (1138), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 216/352 (61%), Positives = 268/352 (76%), Gaps = 4/352 (1%)
Query: 34  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 93
           VI+          +++++Y    V+G GSFGVVFQAK  E+ E VAIKKVLQDKR+KNRE
Sbjct: 24  VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 94  LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIY 152
           LQIM+++ HPN+V LK  F+S  DK               TV R +R+Y+++ Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPNVS 
Sbjct: 143 IKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 272
           ICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 332
           +RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R  +Y+P+ R TA+EA  
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 333 HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 384
           HPFFDELR    R+PNGR LPPLFN+   ELS + P+ I+RL+P+HA  + L
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVPQHAEAELL 372

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  317 bits (811), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 162/369 (43%), Positives = 228/369 (61%), Gaps = 43/369 (11%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHC 111
           Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH NI+ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 112 FFSTTDK---------------------------------XXXXXXXXXXXXXXTVNRIA 138
           F++T D+                                               T++++ 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 139 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 198
           +++ R  + +P+  + +Y YQ+ RA+ +IH  +GICHRDIKPQNLLVN   + LKLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 199 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 258
           SAK L+  EP+V+ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+PLF GE+ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 259 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 318
           +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+DL+ +  +
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 319 YSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKPPELSGIPPE 369
           Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P ELS IP  
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 370 TINRLIPEH 378
            +NR++P++
Sbjct: 368 VLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  291 bits (744), Expect = 5e-79,   Method: Compositional matrix adjust.
 Identities = 153/327 (46%), Positives = 203/327 (62%), Gaps = 10/327 (3%)
Query: 47  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ---MLDHP 103
           K+   +  E + G G+FG V   K + TG  VAIKKV+QD R++NRELQIMQ   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 104 NIVALKHCFFS--TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           NIV L+  F++    D+              T++R  RNY R     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 162 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
           R++  +H   + +CHRDIKP N+LVN     LKLCDFGSAK L   EPNV+YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 281 NPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
           NP++T+      K  PW  VF     +   EA DL+    QY P  R    EA  HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 338 ELRDPNTRLPNGRPLP-PLFNFKPPEL 363
           EL DP T+LPN + LP  LF F P E+
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLPNEI 346

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/345 (31%), Positives = 179/345 (51%), Gaps = 28/345 (8%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIV 106
           Y     +G G++G+V  A        VAIKK+   + + Y  R   E+QI+    H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            ++    ++T +               + ++ ++     Q++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-----QQLSNDHICYFLYQILRGLKY 159
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPE 222
           IH+   + HRD+KP NLL+N  T  LK+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 280
           ++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 281 --NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
               NY +   P      W K+F K    +A+DL+ R   ++PN R T  EA  HP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 339 LRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
             DP        P    F F   EL  +P E +  LI  E AR Q
Sbjct: 336 YYDPTDEPVAEEP----FTFA-MELDDLPKERLKELIFQETARFQ 375

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 110/321 (34%), Positives = 166/321 (51%), Gaps = 56/321 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 171
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 228
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 229 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 331 CVHPFFDELRDPNTRLPNGRP 351
             HPFF ++  P   L   RP
Sbjct: 286 LAHPFFQDVTKPVPHLRLERP 306

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 174
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 231
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 232 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 288
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 289 LAHPFFQDVTKP 300

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/320 (31%), Positives = 170/320 (53%), Gaps = 29/320 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 111
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----------YICSRYYRA 220
            + HRD+KP NLL+N +   LK+CDFG A+++ +   + S           Y+ +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 279
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 280 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 337 DELRDPNTRLPNGRPLPPLF 356
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 174
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 231
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 232 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 288
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 289 LAHPFFQDVTKP 300

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 103/320 (32%), Positives = 171/320 (53%), Gaps = 29/320 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 111
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------VSYICSRYYRA 220
            + HRD+KP NLL+N +   LK+CDFG A+++ +      EP       V ++ +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 279
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 280 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 337 DELRDPNTRLPNGRPLPPLF 356
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 166
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 168
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 171
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 228
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 229 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 286 LAHPFFQDVTKP 297

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 166
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 73  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 235
Query: 289 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 289 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 111/344 (32%), Positives = 172/344 (50%), Gaps = 26/344 (7%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKHC 111
           +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 112 FFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIH 168
              T                 + +++I      IH   PL   +V+ + YQ+ R L Y+H
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYMH 175
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----VSYICSRYYRAPEL 223
           +   + HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL
Sbjct: 176 SA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           +    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +   
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 293
Query: 284 YTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
                    P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  +  
Sbjct: 294 RVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352
Query: 341 DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 384
           DP+       P    F+ +      I    +  +   HAR++ +
Sbjct: 353 DPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGI 396

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + L++ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLSFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEHVDQDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 289 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 72  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 234
Query: 289 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 289 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 106/308 (34%), Positives = 161/308 (52%), Gaps = 56/308 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDE 338
             HPFF +
Sbjct: 282 LAHPFFQD 289

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 172/345 (49%), Gaps = 26/345 (7%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
            +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 111 CFFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYI 167
               T                 + +++I      IH   PL   +V+ + YQ+ R L Y+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYM 175
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----VSYICSRYYRAPE 222
           H+   + HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPE
Sbjct: 176 HSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           L+    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +  
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 293
Query: 283 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
                     P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  + 
Sbjct: 294 ERVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 352
Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 384
            DP+       P    F+ +      I    +  +   HAR++ +
Sbjct: 353 HDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGI 397

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 162/312 (51%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 162/312 (51%), Gaps = 56/312 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 159
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 216
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 277 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 330
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 331 CVHPFFDELRDP 342
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/320 (31%), Positives = 169/320 (52%), Gaps = 29/320 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 111
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----------YICSRYYRA 220
            + HRD+KP NLL+N +   LK+CDFG A+++ +   + S            + +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 279
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 280 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 337 DELRDPNTRLPNGRPLPPLF 356
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/294 (35%), Positives = 155/294 (52%), Gaps = 31/294 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 108
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              F   ++                +  I ++ S +   +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLH 129
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 225
               I HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPN 283
           GA  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 284 YTEFK-FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           Y  FK FP I   P H +F      + +DL+   F ++P  R TA +A    +F
Sbjct: 246 YVTFKSFPGI---PLHHIFSAA-GDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 104/326 (31%), Positives = 158/326 (48%), Gaps = 49/326 (15%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 104
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 155
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 85  VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS 124
Query: 156 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
                   YQ+ + L YIH+  G+ HRD+KP NL VN    +LK+ DFG A+        
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEM 180
Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
             Y+ +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV 
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
Query: 270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCT 326
           G P  E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R T
Sbjct: 241 GVPGTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 327 ALEACVHPFFDELRDPNTRLPNGRPL 352
           A +A  HPFF+  RDP       +P 
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPF 325

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 155/308 (50%), Gaps = 29/308 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 112 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           F  +T+ +               +N I ++     Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKS-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            GI HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 151 -GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 291 QIKPHPWHKVFQKRLP-------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
            + P P     QK L        P A+DL+ R      + R +A EA  H +F +  DP 
Sbjct: 267 SLPPMP-----QKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321
Query: 344 TRLPNGRP 351
              P   P
Sbjct: 322 DE-PEAEP 328

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 339 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 375

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 104/326 (31%), Positives = 158/326 (48%), Gaps = 49/326 (15%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 104
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 155
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 103 VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGMEFS 142
Query: 156 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
                   YQ+ + L YIH+  G+ HRD+KP NL VN    +LK+ DFG A+        
Sbjct: 143 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEM 198
Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
             Y+ +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV 
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCT 326
           G P  E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R T
Sbjct: 259 GVPGTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317
Query: 327 ALEACVHPFFDELRDPNTRLPNGRPL 352
           A +A  HPFF+  RDP       +P 
Sbjct: 318 AAQALTHPFFEPFRDPEEETEAQQPF 343

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 339 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 375

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 266 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 324 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 360

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 320
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 321 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 267 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 324
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 325 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 361

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 258 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 315
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 316 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 352

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 317 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 353

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 269 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 326
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 363

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 105/341 (30%), Positives = 173/341 (50%), Gaps = 32/341 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---MNP 282
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C   +  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
                  P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  DP
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321
Query: 343 NTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           +       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 322 SDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 154/308 (50%), Gaps = 29/308 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 112 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            GI HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 151 -GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 291 QIKPHPWHKVFQKRLP-------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
            + P P     QK L        P A+DL+ R      + R +A EA  H +F +  DP 
Sbjct: 267 SLPPMP-----QKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321
Query: 344 TRLPNGRP 351
              P   P
Sbjct: 322 DE-PEAEP 328

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 175/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 317 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 353

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/342 (30%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAI+K+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 175/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 321 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 160/297 (53%), Gaps = 26/297 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 286
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
             F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKC-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 160/297 (53%), Gaps = 26/297 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 286
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
             F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 174/342 (50%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/339 (30%), Positives = 174/339 (51%), Gaps = 28/339 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPELIFGAT 228
           + HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 284
            YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+ 
Sbjct: 268 L-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 345 RLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
                 P    F F   EL  +P E +  LI  E AR Q
Sbjct: 326 EPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/339 (30%), Positives = 174/339 (51%), Gaps = 28/339 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPELIFGAT 228
           + HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 284
            YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+ 
Sbjct: 269 L-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 345 RLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
                 P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 EPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 360

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 153/308 (49%), Gaps = 29/308 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 112 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
            GI HRD+KP N+ VN    +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 143 -GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 198
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 199 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 258
Query: 291 QIKPHPWHKVFQKRLP-------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
            + P P     QK L        P A+DL+ R      + R +A EA  H +F +  DP 
Sbjct: 259 SLPPMP-----QKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 313
Query: 344 TRLPNGRP 351
              P   P
Sbjct: 314 DE-PEAEP 320

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 100/333 (30%), Positives = 168/333 (50%), Gaps = 57/333 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLD-HPNIVALKH 110
           +G G++G+V+++  R TGE+VA+KK+        D +   RE+ I+  L  H NIV L +
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
              +  D+               V R A     +H++    YV    YQ+ + + Y+H+ 
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIR-ANILEPVHKQ----YV---VYQLIKVIKYLHSG 128
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK---------------------GEPN 209
            G+ HRD+KP N+L+N   H +K+ DFG ++  V                       +P 
Sbjct: 129 -GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 210 VS-YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++QL  II V
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 269 LGTPTREEIKCMNPNYTEFKFPQIKPH-------------PWHKVFQKRLP-----PEAV 310
           +  P+ E+++ +   + +     +K                W  +  K  P      EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 311 DLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           DL+ +  Q++PN R +A +A  HPF     +PN
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 101/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM-----------PLIYVKLYTYQI 160
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 217
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLW 165
Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 275
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 276 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 332 VHPFFDE 338
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 106/342 (30%), Positives = 173/342 (50%), Gaps = 34/342 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRY---KNRELQIMQMLDHPNIVALKHCF 112
           +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 225
           + HRD+KP NLL+N  T  LK+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 281
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 342 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 382
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 101/297 (34%), Positives = 159/297 (53%), Gaps = 27/297 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 111
           +G GS+GVVF+ + R+TG+IVAIKK L+       K+   RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--N 169
           F                      + +     R  + +P   VK  T+Q  +A+ + H  N
Sbjct: 71  F--------RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 226
           CI   HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G
Sbjct: 123 CI---HRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVG 176
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNY 284
            T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  +
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
           +  K P  +     ++    +   A+ L+       P  R T  +   HP+F+ +R+
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM-----------PLIYVKLYTYQI 160
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 217
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLW 165
Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 275
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 276 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 332 VHPFFDE 338
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM-----------PLIYVKLYTYQI 160
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 217
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLW 165
Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 275
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 276 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 332 VHPFFDE 338
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 104/318 (32%), Positives = 160/318 (50%), Gaps = 25/318 (7%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  +   ++G  +A+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  +T+ +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 172
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 345
               PQ+    +  VF     P AVDL+ +      + R TA EA  HP+F +  DP+  
Sbjct: 289 N-SLPQMPKRNFADVFIGA-NPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE 346
Query: 346 LPNGRPLPPLFNFKPPEL 363
            P   P    F  +  E+
Sbjct: 347 -PESEPYDQSFESRQLEI 363

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++  A  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I ++     Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKS-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN  + +LK+ DFG  +     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 279 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 103/320 (32%), Positives = 159/320 (49%), Gaps = 29/320 (9%)
Query: 41  GRNGNSKQKVSYIAEHV---------VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKR 88
            R+G  +Q+V+  A  V         VG+G++G V  A    TG  VAIKK+    Q + 
Sbjct: 7   ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 89  YKNR---ELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 145
           +  R   EL++++ + H N++ L   F  T D+                  + +     H
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVF--TPDETLDDFTDFYLVMPFMGTDLGKLMK--H 122
Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           +++    ++   YQ+ + L YIH   GI HRD+KP NL VN    +LK+ DFG A+    
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--A 178
Query: 206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 265
                  + +R+YRAPE+I     YT  +DIWS GC+MAE++ G+ LF G   +DQL EI
Sbjct: 179 DSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 266 IKVLGTPTREEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           +KV GTP  E ++ +      NY +   P+++   +  +      P AV+L+ +      
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMK-GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDA 296
Query: 322 NLRCTALEACVHPFFDELRD 341
             R TA EA  HP+F+ L D
Sbjct: 297 EQRVTAGEALAHPYFESLHD 316

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 153
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 209
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 210 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 269
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 270 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/308 (31%), Positives = 155/308 (50%), Gaps = 23/308 (7%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
           +YI    +G G++  V++ K + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L       T+K                     N   +H       VKL+ +Q+ R LA
Sbjct: 63  VTLHDIIH--TEKSLTLVFEYLDKDLKQYLDDCGNIINMHN------VKLFLFQLLRGLA 114
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 222
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 280
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
           N  +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPFF  L 
Sbjct: 231 NEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 341 DPNTRLPN 348
           +   +LP+
Sbjct: 290 ERIHKLPD 297

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 103/301 (34%), Positives = 154/301 (51%), Gaps = 34/301 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 229 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 288 KFPQIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
           K P  KP+P +           +L     DL+    + +P  R +A EA  HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 342 P 342
           P
Sbjct: 292 P 292

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 95/290 (32%), Positives = 154/290 (53%), Gaps = 21/290 (7%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 110
           +VG GS+G+V + + ++TG IVAIKK L+       K+   RE+++++ L H N+V L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL-- 89
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
                  K               ++ +    + +  ++    V+ Y +QI   + + H+ 
Sbjct: 90  --LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQV----VQKYLFQIINGIGFCHSH 143
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGATE 229
             I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +
Sbjct: 144 -NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEF 287
           Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG   P  +E+   NP +   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 288 KFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + P+IK   P  + + K L    +DL  +     P+ R    E   H FF
Sbjct: 262 RLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 222
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 152/298 (51%), Gaps = 34/298 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KPQNLL+N    +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 229 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
            Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 288 KFPQIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           K P  KP+P +           +L     DL+    + +P  R +A EA  HP+F + 
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 158/311 (50%), Gaps = 25/311 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 345
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 346 LPNGRPLPPLF 356
            P   P    F
Sbjct: 318 -PVADPFDQSF 327

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 141
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 142 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 257
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 258 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 279 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMH 222
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 142
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 198
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 199 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 258
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 259 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 206
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +       ++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----AKLTDDHVQFLIYQILRGLKYIHS 139
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ D+G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMH 219
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DF  A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+  FG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 110
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 111 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 285
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 95/297 (31%), Positives = 148/297 (49%), Gaps = 26/297 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 112
           +G G++  V++   + TG  VA+K+V  D          RE+ +M+ L H NIV L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
            +                    +R   N  R    + L  VK + +Q+ + LA+ H    
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPR---GLELNLVKYFQWQLLQGLAFCHEN-K 128
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYT 231
           I HRD+KPQNLL+N    QLKL DFG A+   +      S + + +YRAP+++ G+  Y+
Sbjct: 129 ILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYS 187
Query: 232 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNPNYT 285
           T+IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP         ++   NPN  
Sbjct: 188 TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN-- 245
Query: 286 EFKFPQIKPHPWHKVFQ----KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                Q  P    +V Q    + L    +D +    Q +P++R +A +A  HP+F E
Sbjct: 246 ---IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 154/297 (51%), Gaps = 24/297 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 113
           +G G  G+VF A   +  + VAIKK++    Q  ++  RE++I++ LDH NIV +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 114 STTDKXXXXXXXXXXXXXXTVNR--IARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 169
            +  +               + +  +  + + + ++ PL+  + +L+ YQ+ R L YIH+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS 138
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-------ICSRYYRAPE 222
              + HRD+KP NL +N     LK+ DFG A+++   +P+ S+       + +++YR+P 
Sbjct: 139 A-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHLSEGLVTKWYRSPR 194
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTREEIKC 279
           L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+   +E I V+    R+E+  
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + P Y   +    +PH         +  EAVD + +   +SP  R TA EA  HP+ 
Sbjct: 255 VIPVY--IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 146/313 (46%), Gaps = 32/313 (10%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 96
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 153
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           + + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y+
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYV 194
Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
             R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 274 REEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 329
            E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQ 313
Query: 330 ACVHPFFDELRDP 342
           A  HP+F+ L DP
Sbjct: 314 ALRHPYFESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 146/313 (46%), Gaps = 32/313 (10%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 96
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 153
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           + + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y+
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYV 194
Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
             R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 274 REEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 329
            E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQ 313
Query: 330 ACVHPFFDELRDP 342
           A  HP+F+ L DP
Sbjct: 314 ALRHPYFESLFDP 326

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 154/312 (49%), Gaps = 41/312 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 165
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 282
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 331
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 332 VHPFFDELRDPN 343
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 337 DELRDP 342
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 154/312 (49%), Gaps = 41/312 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 165
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 282
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 331
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 332 VHPFFDELRDPN 343
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 165
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 282
           G   Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 331
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 332 VHPFFDELRDPN 343
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 110/398 (27%), Positives = 166/398 (41%), Gaps = 79/398 (19%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNI 105
           Y   H++GTGS+G V +A  +    +VAIKK+L+      D +   RE+ I+  L+H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V +         +                 ++ R    + +    +++K   Y +   + 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVGVK 170
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------------- 211
           Y+H+  GI HRD+KP N LVN     +K+CDFG A+ +   E   S              
Sbjct: 171 YVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 212 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL---------- 247
                         ++ +R+YRAPELI     YT AID+WS GC+ AELL          
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 248 -LGQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
               PLFPG S                      DQL  I  +LGTP+ E+I+ +     +
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELR--- 340
            ++ +I P        +R P  + D   L+ R   ++PN R T  E   HPFF E+R   
Sbjct: 349 -RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407
Query: 341 -DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPE 377
            + N       P     N   P+L     + I R  PE
Sbjct: 408 VETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 137
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 138 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 337 DELRDP 342
           +   DP
Sbjct: 315 NVWYDP 320

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 337 DELRDP 342
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 337 DELRDP 342
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 165
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 282
           G   Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 331
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 332 VHPFFDELRDPN 343
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 165
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 282
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 331
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 332 VHPFFDELRDPN 343
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 142/291 (48%), Gaps = 23/291 (7%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALKHCFFST 115
           +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L       
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL------- 97
Query: 116 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 175
            D                VN    ++ +++Q +    ++ Y Y+I +AL Y H  +GI H
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNT--DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMH 154
Query: 176 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 235
           RD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 236 IWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKF 289
           +WS GC++A ++   +P F G    DQLV I KVLGT    +        ++P + +   
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-L 273
Query: 290 PQIKPHPW----HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            +     W    H   Q  + PEA+D + +  +Y    R TA EA  HP+F
Sbjct: 274 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 165
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 282
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 331
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 332 VHPFFDELRDPN 343
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 151/305 (49%), Gaps = 21/305 (6%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 98
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 99  MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 154
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 155 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 214
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 335 FFDEL 339
           +F +L
Sbjct: 299 YFQDL 303

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 337 DELRDP 342
           +   DP
Sbjct: 323 NVWYDP 328

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 148 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 206
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 207 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 266
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 267 ------DGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 320
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 321 RYDHQERLTALEAMTHPYFQQVR 343

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 151/305 (49%), Gaps = 21/305 (6%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 98
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 99  MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 154
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 155 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 214
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 335 FFDEL 339
           +F +L
Sbjct: 299 YFQDL 303

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 337 DELRDP 342
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 337 DELRDP 342
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 137
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 138 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 337 DELRDP 342
           +   DP
Sbjct: 315 NVWYDP 320

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 337 DELRDP 342
           +   DP
Sbjct: 323 NVWYDP 328

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 337 DELRDP 342
           +   DP
Sbjct: 316 NVWYDP 321

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 183 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 337 DELRDP 342
           +   DP
Sbjct: 360 NVWYDP 365

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 337 DELRDP 342
           +   DP
Sbjct: 316 NVWYDP 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 143
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 144 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 200
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320
Query: 337 DELRDP 342
           +   DP
Sbjct: 321 NVWYDP 326

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 183 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 337 DELRDP 342
           +   DP
Sbjct: 360 NVWYDP 365

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 149/308 (48%), Gaps = 33/308 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 287 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 336 FDELRDPN 343
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 129 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 187
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 188 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 247
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 248 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 301
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 302 RYDHQERLTALEAMTHPYFQQVR 324

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 144/301 (47%), Gaps = 31/301 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 337 D 337
           +
Sbjct: 322 N 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 271
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 272 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 317
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E
Sbjct: 202 YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                   KF ++ P    P      K    +A DL+ +     P+ R +  EA  HP+ 
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321
Query: 337 DELRDP 342
               DP
Sbjct: 322 TVWYDP 327

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 149/302 (49%), Gaps = 21/302 (6%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 98
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 99  MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 154
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 155 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 214
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 335 FF 336
           +F
Sbjct: 299 YF 300

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 149/308 (48%), Gaps = 33/308 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 94  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 146
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+        V ++ +RYYRAPE+I G   
Sbjct: 147 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG- 203
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 204 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 263
Query: 287 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 264 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 322
Query: 336 FDELRDPN 343
            +   DP+
Sbjct: 323 INVWYDPS 330

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 93  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 145
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262
Query: 287 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 263 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321
Query: 336 FDELRDPN 343
            +   DP+
Sbjct: 322 INVWYDPS 329

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 287 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 336 FDELRDPN 343
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 145/306 (47%), Gaps = 31/306 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 112 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 142
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 143 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG- 199
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E
Sbjct: 200 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 287 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+ 
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319
Query: 337 DELRDP 342
               DP
Sbjct: 320 TVWYDP 325

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 90/305 (29%), Positives = 149/305 (48%), Gaps = 50/305 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK-- 109
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 110 -------HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
                  H  F   +                     + Y   +  + +  +K + YQ+  
Sbjct: 102 IHHNHRLHLIFEYAENDL------------------KKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 163 ALAYIHN--CIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNVSY---I 213
            + + H+  C+   HRD+KPQNLL++      T  LK+ DFG A+    G P   +   I
Sbjct: 144 GVNFCHSRRCL---HRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEI 198
Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
            + +YR PE++ G+  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P 
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258
Query: 274 REEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
                 +   P++ +  FP+ +     +V    L  E +DL+    +  P  R +A  A 
Sbjct: 259 DTTWPGVTALPDWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
Query: 332 VHPFF 336
            HP+F
Sbjct: 318 EHPYF 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+L++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 102/354 (28%), Positives = 162/354 (45%), Gaps = 75/354 (21%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 104
           +YI +H++G GS+G V+ A  + T + VAIKKV      L D +   RE+ I+  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQI 160
           I+ L                         V  IA +  +   + P+     ++K   Y +
Sbjct: 87  IIRLYDLIIPDD--------LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNV--------- 210
                +IH   GI HRD+KP N L+N     +K+CDFG A+ +  + + N+         
Sbjct: 139 LLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 211 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQ------ 250
                        S++ +R+YRAPELI     YT +IDIWSTGC+ AELL + Q      
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 251 ----PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
               PLFPG                 +S  DQL  I  ++GTPT +++K +N      K+
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV-IKY 315
Query: 290 PQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
            ++ PH      +++ P    + ++L+    +++PN R T  +A  HP+  ++R
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 125 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 183
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 184 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 243
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 244 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 302
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 303 LDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 118 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 295
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 296 LDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +      +   W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR-WERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ ++ Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLRQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 259 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 309
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 310 VDLVCRFFQYSPNLRCTALEACVHPFF 336
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 18/210 (8%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G 
Sbjct: 121 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 179
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+     +     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 180 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 239
Query: 259 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 306
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 240 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 295
Query: 307 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 296 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 18/210 (8%)
Query: 140 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 199
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G 
Sbjct: 126 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 184
Query: 200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 258
           A+     +     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 185 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 244
Query: 259 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 306
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 245 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 300
Query: 307 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 301 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 93/308 (30%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 287 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 336 FDELRDPN 343
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 97  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 149
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 150 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 206
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 207 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 266
Query: 287 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 267 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 325
Query: 336 FDELRDPN 343
            +   DP+
Sbjct: 326 INVWYDPS 333

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 86  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 138
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 196 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 255
Query: 287 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 256 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 314
Query: 336 FDELRDPN 343
            +   DP+
Sbjct: 315 INVWYDPS 322

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP    +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVE 261
Query: 287 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 336 FDELRDPN 343
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 226
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 287 FKFPQIKPHPWHKVFQKRL-----PPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 104
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 105 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 161
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 162 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 226
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 287 FKFPQIKPHPWHKVFQKRL-----PPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 104
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 105 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 161
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 162 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 226
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 287 FKFPQIKPHPWHKVFQKRL-----PPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 143
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 226
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 144 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 202
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 261
Query: 287 FKFPQIKPHPWHKVFQKRL-----PPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 262 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 111
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG- 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 286
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 287 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 336 FDELRDPN 343
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 105/372 (28%), Positives = 158/372 (42%), Gaps = 80/372 (21%)
Query: 40  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRE 93
           G    N K   +Y  +H++G GS+G V+ A  +   + VAIKKV      L D +   RE
Sbjct: 18  GAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILRE 77
Query: 94  LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-- 151
           + I+  L    I+ L H      D                V  IA +  +   + P+   
Sbjct: 78  ITILNRLKSDYIIRL-HDLIIPED-------LLKFDELYIVLEIADSDLKKLFKTPIFLT 129
Query: 152 --YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
             +VK   Y +     +IH   GI HRD+KP N L+N     +K+CDFG A+  +  + +
Sbjct: 130 EQHVKTILYNLLLGEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKD 186
Query: 210 V---------------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCV 242
           +                           S++ +R+YRAPELI     YT +IDIWSTGC+
Sbjct: 187 IHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCI 246
Query: 243 MAELLLGQ-----------PLFPG-----------------ESGVDQLVEIIKVLGTPTR 274
            AELL              PLFPG                 +S  DQL  I  V+GTP  
Sbjct: 247 FAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPE 306
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKR---LPPEAVDLVCRFFQYSPNLRCTALEAC 331
           E++KC+       K+ ++ P        K+   +  E +DL+    +++   R T  +A 
Sbjct: 307 EDLKCITKQEV-IKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKAL 365
Query: 332 VHPFFDELRDPN 343
            HP+  ++R  N
Sbjct: 366 SHPYLKDVRKEN 377

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 104
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 105 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 161
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 162 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 140/299 (46%), Gaps = 35/299 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------------RELQIMQMLD--- 101
           +G G++G V++A+   +G  VA+K V    R  N             RE+ +++ L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 102 HPNIVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTY 158
           HPN+V L   C  S TD+               V++  R Y        +P   +K    
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 159 QICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 217
           Q  R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +
Sbjct: 128 QFLRGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
           YRAPE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++ 
Sbjct: 185 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243
Query: 278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
              + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 244 P-RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 99/351 (28%), Positives = 150/351 (42%), Gaps = 61/351 (17%)
Query: 42  RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQ 98
           +NG  K    Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E+++++
Sbjct: 28  KNG-EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 99  MLDHPN------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY 152
           +++  +      IV LK  F                      N   R  S       L  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNL 139
Query: 153 VKLYTYQICRALAYIHN-CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
            + +  Q+C AL ++    + I H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 211 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWH----KVFQKRLPPEAV---------------- 310
            P    I    P   +F F ++    W+    K  ++   P                   
Sbjct: 257 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 314
Query: 311 -----------------DLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                            DL+ R   Y P  R     A  H FF +  D  T
Sbjct: 315 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGT 365

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 124/242 (51%), Gaps = 22/242 (9%)
Query: 42  RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQ 98
           +NG  K    Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E+++++
Sbjct: 47  KNG-EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 99  MLDHPN------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY 152
           +++  +      IV LK  F                      N   R  S       L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNL 158
Query: 153 VKLYTYQICRALAYIHN-CIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNV 210
            + +  Q+C AL ++    + I H D+KP+N+L+ NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 211 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 271 TP 272
            P
Sbjct: 276 IP 277

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 124/242 (51%), Gaps = 22/242 (9%)
Query: 42  RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQ 98
           +NG  K    Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E+++++
Sbjct: 47  KNG-EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 99  MLDHPN------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY 152
           +++  +      IV LK  F                      N   R  S       L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNL 158
Query: 153 VKLYTYQICRALAYIHN-CIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNV 210
            + +  Q+C AL ++    + I H D+KP+N+L+ NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 211 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 271 TP 272
            P
Sbjct: 276 IP 277

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 133/285 (46%), Gaps = 44/285 (15%)
Query: 92  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQR---M 148
           RE+ +++ L HPN+++L+  F S  D+               + +  R  S+ +++   +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA-SKANKKPVQL 125
Query: 149 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV--- 202
           P   VK   YQI   + Y+H    + HRD+KP N+LV    P   ++K+ D G A++   
Sbjct: 126 PRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 203 ----LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF----- 253
               L   +P V    + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F     
Sbjct: 185 PLKPLADLDPVV---VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241
Query: 254 ----PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFKFPQ---------IKPHPW 297
                     DQL  I  V+G P     E+IK M  + T  K  +         IK    
Sbjct: 242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301
Query: 298 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
           HKV   +   +A  L+ +     P  R T+ +A   P+F  L DP
Sbjct: 302 HKV---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/326 (26%), Positives = 144/326 (44%), Gaps = 63/326 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 116
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H              
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH----------LRKQ 153
Query: 117 DKXXXXXXXXXXXXXXTVNRIARNYSRIH------------QRMPLIYVKLYTYQICRAL 164
           DK                N I   +  +             Q   L  V+ + + I + L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
             +H    I H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRAPE+
Sbjct: 214 DALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEV 270
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +
Sbjct: 271 ILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDAS 326
Query: 284 YTEFKFPQIKPHPWH------------------KVFQKRLPPEA---------------V 310
                F   K +P +                  +  + R PPE+               +
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 311 DLVCRFFQYSPNLRCTALEACVHPFF 336
           D + +  ++ P +R T  +A  HP+ 
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/326 (26%), Positives = 144/326 (44%), Gaps = 63/326 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 116
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H              
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH----------LRKQ 153
Query: 117 DKXXXXXXXXXXXXXXTVNRIARNYSRIH------------QRMPLIYVKLYTYQICRAL 164
           DK                N I   +  +             Q   L  V+ + + I + L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
             +H    I H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRAPE+
Sbjct: 214 DALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEV 270
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +
Sbjct: 271 ILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDAS 326
Query: 284 YTEFKFPQIKPHPWH------------------KVFQKRLPPEA---------------V 310
                F   K +P +                  +  + R PPE+               +
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 311 DLVCRFFQYSPNLRCTALEACVHPFF 336
           D + +  ++ P +R T  +A  HP+ 
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 104
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I+ L   F    DK                + I    SR  +R   +       Q+   +
Sbjct: 111 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEI---ISR--KRFSEVDAARIIRQVLSGI 162
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 163 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 222 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 265
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 266 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 104
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I+ L   F    DK                + I    SR  +R   +       Q+   +
Sbjct: 112 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEI---ISR--KRFSEVDAARIIRQVLSGI 163
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 164 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 223 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 266
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 267 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 104
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 140 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 104
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 94  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 145
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 146 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 205 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 248
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 249 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 141/326 (43%), Gaps = 63/326 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 116
           V+G G FG V +A   +  + VA+K V  +KR+  +  + +++L+H              
Sbjct: 104 VIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH----------LRKQ 153
Query: 117 DKXXXXXXXXXXXXXXTVNRIARNYSRIH------------QRMPLIYVKLYTYQICRAL 164
           DK                N I   +  +             Q   L  V+ + + I + L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
             +H    I H D+KP+N+L+       +K+ DFGS+    + +     I SR+YRAPE+
Sbjct: 214 DALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEV 270
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P +   K ++ +
Sbjct: 271 ILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ---KLLDAS 326
Query: 284 YTEFKFPQIKPHPWH------------------KVFQKRLPPEA---------------V 310
                F   K +P +                  +  + R PPE+               +
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 311 DLVCRFFQYSPNLRCTALEACVHPFF 336
           D + +  ++ P +R T  +A  HP+ 
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 124/293 (42%), Gaps = 45/293 (15%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 104
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I  L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IXKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
            Y H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 140 TYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            YT F+ PQ     W KV        A DL+ +   Y P+ R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 98/358 (27%), Positives = 150/358 (41%), Gaps = 51/358 (14%)
Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 100
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 101 DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 149
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 204
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------ 258
             E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 259 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRL 305
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 306 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 356
             E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 98/358 (27%), Positives = 150/358 (41%), Gaps = 51/358 (14%)
Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 100
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 101 DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 149
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 204
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------ 258
             E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 259 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRL 305
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 306 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 356
             E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 52/298 (17%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQMLDHPNIV 106
           ++I   V+G+G+F  VF  K R TG++ A+K + +   +++  L+    +++ + H NIV
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQICR 162
            L+  + STT                        + RI +R   +Y +    L   Q+  
Sbjct: 70  TLEDIYESTTHYYLVMQLVSG----------GELFDRILERG--VYTEKDASLVIQQVLS 117
Query: 163 ALAYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSR-YYR 219
           A+ Y+H   GI HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE +     Y+ A+D WS G +   LL G P F  E+   +L E IK            
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------------ 220
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
               Y EF+ P          F   +   A D +C   +  PN R T  +A  HP+ D
Sbjct: 221 --EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 137/308 (44%), Gaps = 52/308 (16%)
Query: 43  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQI 96
            G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++I
Sbjct: 17  QGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEI 76
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIY 152
           M+ LDHPNI+ L   F   TD                V   R+ R  + +RI +      
Sbjct: 77  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------ 130
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
                  +  A+AY H  + + HRD+KP+N   L +     LKL DFG A     G+   
Sbjct: 131 ------DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 183
Query: 211 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
           + + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  G
Sbjct: 184 TKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--G 239
Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 330
           T               F FP+     W  V      P+A  L+ R    SP  R T+L+A
Sbjct: 240 T---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 276
Query: 331 CVHPFFDE 338
             H +F++
Sbjct: 277 LEHEWFEK 284

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 137/307 (44%), Gaps = 52/307 (16%)
Query: 44  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIM 97
           G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIYV 153
           + LDHPNI+ L   F   TD                V   R+ R  + +RI +       
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------- 113
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
                 +  A+AY H  + + HRD+KP+N   L +     LKL DFG A     G+   +
Sbjct: 114 -----DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
            + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  GT
Sbjct: 168 KVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT 223
Query: 272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
                          F FP+     W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 224 ---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260
Query: 332 VHPFFDE 338
            H +F++
Sbjct: 261 EHEWFEK 267

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 49/308 (15%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 109
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                ++                 +  I R     H    +I       Q+   + Y+H 
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIK------QVFSGITYMHK 139
Query: 170 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 227
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 347
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+   ++  ++  P
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 348 NGRPLPPL 355
               LP L
Sbjct: 289 TISDLPSL 296

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 284
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSASKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 338
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 339 LRDPN 343
           +   N
Sbjct: 297 VTWEN 301

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 98
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 77  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 127
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 216
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 217 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 229
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 230 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 282
Query: 335 FFDE 338
           +  +
Sbjct: 283 WLQD 286

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 98
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 216
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 217 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQV-SLKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 335 FFDE 338
           +  +
Sbjct: 277 WLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 98
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 70  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 120
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 216
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 217 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 222
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 223 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 275
Query: 335 FFDE 338
           +  +
Sbjct: 276 WLQD 279

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 98
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 216
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 217 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 335 FFDE 338
           +  +
Sbjct: 277 WLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 98
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 216
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 217 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 335 FFDE 338
           +  +
Sbjct: 277 WLQD 280

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 132/305 (43%), Gaps = 60/305 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 44  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 103
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            CF                      N     Y R          + YT +I  AL Y+H 
Sbjct: 104 FCF--------QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 156 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 284
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 214 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 254
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 338
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 255 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 301
Query: 339 LRDPN 343
           +   N
Sbjct: 302 VTWEN 306

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 152 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 284
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 250
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 338
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 251 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297
Query: 339 LRDPN 343
           +   N
Sbjct: 298 VTWEN 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 134/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 205 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 246
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 247 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292
Query: 338 ELRDPN 343
            +   N
Sbjct: 293 SVTWEN 298

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 284
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSAXKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL---------------- 249
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 338
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 339 LRDPN 343
           +   N
Sbjct: 297 VTWEN 301

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 46/288 (15%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 109
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 170 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 227
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 46/288 (15%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 109
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 170 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 227
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 134/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 247
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 248 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 338 ELRDPN 343
            +   N
Sbjct: 294 SVTWEN 299

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 112
           +G G+ GVV + + R +G I+A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +S  +               +++++ +   RI + +    +   +  + R LAY+     
Sbjct: 84  YSDGE----ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLREKHQ 135
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE + G T Y+ 
Sbjct: 136 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERLQG-THYSV 192
Query: 233 AIDIWSTGCVMAELLLGQ 250
             DIWS G  + EL +G+
Sbjct: 193 QSDIWSMGLSLVELAVGR 210

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 98
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 246
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 216
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 217 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
            Y APE++   G   Y  A+D WS G ++   L G P F        L           +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
           ++I     N+         P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 355 DQITSGKYNFI--------PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 401
Query: 335 FFDE 338
           +  +
Sbjct: 402 WLQD 405

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 135/307 (43%), Gaps = 64/307 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-- 206
Query: 227 ATEYTT--AIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNP 282
            TE +   + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+              
Sbjct: 207 -TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL-------------- 249
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFF 336
              E+ FP+            +  P+A DLV +      +  L C  +E       HPFF
Sbjct: 250 ---EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294
Query: 337 DELRDPN 343
           + +   N
Sbjct: 295 ESVTWEN 301

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 98
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 260
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 216
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 217 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 362
Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 363 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 415
Query: 335 FFDE 338
           +  +
Sbjct: 416 WLQD 419

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 247
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 248 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 338 ELRDPN 343
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 284
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 338
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 339 LRDPN 343
           +   N
Sbjct: 297 VTWEN 301

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 284
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 338
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 339 LRDPN 343
           +   N
Sbjct: 297 VTWEN 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 247
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 248 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 338 ELRDPN 343
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 152 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 284
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 250
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 338
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 251 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297
Query: 339 LRDPN 343
           +   N
Sbjct: 298 VTWEN 302

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 284
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 338
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 339 LRDPN 343
           +   N
Sbjct: 297 VTWEN 301

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 74  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 126 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 184 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 225
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 226 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
Query: 338 ELRDPN 343
            +   N
Sbjct: 272 SVTWEN 277

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 14  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 73  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 124
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 125 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 183 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 224
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 225 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 270
Query: 338 ELRDPN 343
            +   N
Sbjct: 271 SVTWEN 276

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 21  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 80  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 131
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 132 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 190 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 231
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 232 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 277
Query: 338 ELRDPN 343
            +   N
Sbjct: 278 SVTWEN 283

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 16  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 75  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 126
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 127 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 185 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 226
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 227 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 272
Query: 338 ELRDPN 343
            +   N
Sbjct: 273 SVTWEN 278

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 205 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 246
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 247 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292
Query: 338 ELRDPN 343
            +   N
Sbjct: 293 SVTWEN 298

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 17  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 76  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 127
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 128 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 186 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 227
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 228 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 273
Query: 338 ELRDPN 343
            +   N
Sbjct: 274 SVTWEN 279

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 46/323 (14%)
Query: 57  VVGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 115
            +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 116 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGI 173
                             +     ++ + +  +P  L +++   YQIC+++ ++H+   +
Sbjct: 81  QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KL 139
Query: 174 CHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
            H D+KP+N+L                     +NP    +K+ DFGSA      E + + 
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHSTL 194
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-- 270
           + +R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG  
Sbjct: 195 VSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 271 -------TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 317
                  T  R+       ++ E      +     KP     + Q        DL+ +  
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y P  R T  EA  HPFFD L+
Sbjct: 314 EYDPAKRITLREALKHPFFDLLK 336

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 40/287 (13%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYK---NRELQIMQMLDHPNIVALKHCF 112
           V+G G++G+V+  +       +AIK++ + D RY    + E+ + + L H NIV     +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 70
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             +  +              +++ + R+ +  +      I    YT QI   L Y+H+  
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN- 127
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIF-GATE 229
            I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           Y  A DIWS GC + E+  G+P F                        +   P    FK 
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKV 224
Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
              K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 225 GMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 40/287 (13%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYK---NRELQIMQMLDHPNIVALKHCF 112
           V+G G++G+V+  +       +AIK++ + D RY    + E+ + + L H NIV     +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 84
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
             +  +              +++ + R+ +  +      I    YT QI   L Y+H+  
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN- 141
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIF-GATE 229
            I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           Y  A DIWS GC + E+  G+P F                        +   P    FK 
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKV 238
Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
              K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 239 GMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 132/306 (43%), Gaps = 62/306 (20%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 108
           ++G GSF     A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 37  ILGEGSFSTTVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 225
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 283
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 247
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 337
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 248 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 338 ELRDPN 343
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 42/295 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 106
           +I +  +G+G+FG V   + R +G    IK + +D+          E+++++ LDHPNI+
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            +   F    D                + RI    +R  + +   YV     Q+  ALAY
Sbjct: 84  KIFEVF---EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAY 139
Query: 167 IHNCIGICHRDIKPQNLL---VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
            H+   + H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y APE+
Sbjct: 140 FHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
                + T   DIWS G VM  LL G   F G S    L E+        +++     PN
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKEPN 243
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
           Y      + +P          L P+AVDL+ +     P  R +A +   H +F +
Sbjct: 244 YA----VECRP----------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 134/323 (41%), Gaps = 46/323 (14%)
Query: 57  VVGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 115
            +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 116 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGI 173
                             +     ++ + +  +P  L +++   YQIC+++ ++H+   +
Sbjct: 81  QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KL 139
Query: 174 CHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
            H D+KP+N+L                     +NP    +K+ DFGSA      E + + 
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHSTL 194
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-- 270
           +  R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG  
Sbjct: 195 VXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 271 -------TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 317
                  T  R+       ++ E      +     KP     + Q        DL+ +  
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 318 QYSPNLRCTALEACVHPFFDELR 340
           +Y P  R T  EA  HPFFD L+
Sbjct: 314 EYDPAKRITLREALKHPFFDLLK 336

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 132/305 (43%), Gaps = 60/305 (19%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 42  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 100
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 101 --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 226
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 154 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 284
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 212 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 252
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 338
            E+ FP                P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 253 -EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 299
Query: 339 LRDPN 343
           +   N
Sbjct: 300 VTWEN 304

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 187
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFP 230
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++ + R T  E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 47  KQKVSYIAEH------VVGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRE 93
           KQKV  + +        +G G+ GVVF+   + +G ++A       IK  ++++    RE
Sbjct: 59  KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RE 116
Query: 94  LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYV 153
           LQ++   + P IV     F+S  +               +++++ +   RI +++    +
Sbjct: 117 LQVLHECNSPYIVGFYGAFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----L 168
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
              +  + + L Y+     I HRD+KP N+LVN    ++KLCDFG +  L+    N S++
Sbjct: 169 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFV 226
Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
            +R Y +PE + G T Y+   DIWS G  + E+ +G+
Sbjct: 227 GTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 112
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 233 AIDIWSTGCVMAELLLGQ-PLFPGESGVDQ 261
             DIWS G  + E+ +G+ P+ P ++  D 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 16/214 (7%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 112
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 93  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 144
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 145 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 201
Query: 233 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
             DIWS G  + E+ +G+      SG   + E++
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 47  KQKVSYIAEH------VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQ 95
           KQKV  + +        +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ
Sbjct: 24  KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 83
Query: 96  IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL 155
           ++   + P IV     F+S  +               +++++ +   RI +++    +  
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGK 135
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
            +  + + L Y+     I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGT 193
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y +PE + G T Y+   DIWS G  + E+ +G+
Sbjct: 194 RSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 112
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 233 AIDIWSTGCVMAELLLGQ 250
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 112
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 233 AIDIWSTGCVMAELLLGQ 250
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-H 187
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFP 230
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++ + R T  E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 112
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 233 AIDIWSTGCVMAELLLGQ 250
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 112
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 233 AIDIWSTGCVMAELLLGQ 250
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 48/284 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 109
            +G GSFG V   +  +T ++ A+K     K ++    +N  +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 165
           + F    D                V+ +     R H +  + +    VKL+  ++  AL 
Sbjct: 82  YSFQDEED------------MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           Y+ N   I HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+  
Sbjct: 130 YLQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187
Query: 226 G--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TRE 275
                 Y+ A+D WS G    ELL G+  +   S      EI+    T         ++E
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQE 246
Query: 276 EI----KCMNPN----YTEFK----FPQIKPHPWHKVFQKRLPP 307
            +    K + PN    +++      FP +    W  VFQKRL P
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ + +  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F  +T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDST----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -KVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 183
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  D    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EFTFP 226
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 112
           +GTG FG V +   ++TGE VAIK+  Q+   KNRE     +QIM+ L+HPN+V+ +   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 80
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 170
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 171 IGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
             I HRD+KP+N+++ P   +L  K+ D G AK L +GE    ++ +  Y APEL+    
Sbjct: 141 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 198
Query: 229 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 288 KFPQIKPHPWH 298
           KF  + P P H
Sbjct: 255 KFSSVLPTPNH 265

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 112
           +GTG FG V +   ++TGE VAIK+  Q+   KNRE     +QIM+ L+HPN+V+ +   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 81
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 170
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 171 IGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
             I HRD+KP+N+++ P   +L  K+ D G AK L +GE    ++ +  Y APEL+    
Sbjct: 142 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 199
Query: 229 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 255
Query: 288 KFPQIKPHPWH 298
           KF  + P P H
Sbjct: 256 KFSSVLPTPNH 266

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 131/329 (39%), Gaps = 60/329 (18%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 107
           Y     +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L   F    D                  ++A  ++++ +   + Y++    Q+C+ L ++
Sbjct: 219 LHDAF---EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHM 271
Query: 168 HNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 272 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 330
Query: 227 A-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               Y T  D+WS G +   LL G   F GE+  + L              +K  + N  
Sbjct: 331 KPVGYYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMD 376
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--N 343
           +  F  I               +  D + +     PN R T  +A  HP+      P  +
Sbjct: 377 DSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423
Query: 344 TRLPNGR-----------------PLPPL 355
           +++P+ R                 PLPPL
Sbjct: 424 SQIPSSRYTKIRDSIKTKYDAWPEPLPPL 452

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 57  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 107
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 165
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 91  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 224
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 141 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 272
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 199 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 117/281 (41%), Gaps = 39/281 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFST 115
           +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V     +F  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 116 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 175
           TD                +    RN +     +  I          + L Y+H    I H
Sbjct: 97  TDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATIL-----QSTLKGLEYLHFMRKI-H 148
Query: 176 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEYTTAI 234
           RDIK  N+L+N   H  KL DFG A  L       +  I + ++ APE+I     Y    
Sbjct: 149 RDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI-QEIGYNCVA 206
Query: 235 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 294
           DIWS G    E+  G+P +        +  +  +   PT       NP  T F+    KP
Sbjct: 207 DIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT-------NPPPT-FR----KP 248
Query: 295 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
             W   F         D V +    SP  R TA +   HPF
Sbjct: 249 ELWSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 131/329 (39%), Gaps = 60/329 (18%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 107
           Y     +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V 
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L   F    D                  ++A  ++++ +   + Y++    Q+C+ L ++
Sbjct: 113 LHDAF---EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHM 165
Query: 168 HNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 166 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 224
Query: 227 A-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               Y T  D+WS G +   LL G   F GE+  + L              +K  + N  
Sbjct: 225 KPVGYYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMD 270
Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--N 343
           +  F  I               +  D + +     PN R T  +A  HP+      P  +
Sbjct: 271 DSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 317
Query: 344 TRLPNGR-----------------PLPPL 355
           +++P+ R                 PLPPL
Sbjct: 318 SQIPSSRYTKIRDSIKTKYDAWPEPLPPL 346

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 154 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 209
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 252
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 253 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 137/310 (44%), Gaps = 51/310 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G+G++G V   + + T    AIK + +     +       E+ ++++LDHPNI+ L + 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL-YD 103
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHN 169
           FF   DK                + I      IH RM    +   +   Q+   + Y+H 
Sbjct: 104 FFE--DKRNYYLVMECYKGGELFDEI------IH-RMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 170 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 227
              I HRD+KP+NLL+        +K+ DFG + V    +     + + YY APE++   
Sbjct: 155 H-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--R 211
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
            +Y    D+WS G ++  LL G P F G++  DQ  EI++          K     YT F
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR----------KVEKGKYT-F 256
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 347
             P+     W     K +   A DL+ +  Q+    R +A +A  HP+  E+    ++  
Sbjct: 257 DSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM---CSKKE 303
Query: 348 NGRPLPPLFN 357
           +G  LP L N
Sbjct: 304 SGIELPSLAN 313

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 22/227 (9%)
Query: 57  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 107
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L H  F T  K              T  R+++      +      VK Y  ++  AL ++
Sbjct: 91  L-HYAFQTEGKLYLILDFLRGGDLFT--RLSKEVMFTEED-----VKFYLAELALALDHL 142
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIFG 226
           H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++  
Sbjct: 143 HS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-N 199
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 272
              +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 22/227 (9%)
Query: 57  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 107
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L H  F T  K              T  R+++      +      VK Y  ++  AL ++
Sbjct: 92  L-HYAFQTEGKLYLILDFLRGGDLFT--RLSKEVMFTEED-----VKFYLAELALALDHL 143
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIFG 226
           H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++  
Sbjct: 144 HS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-N 200
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 272
              +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 93  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 144
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 145 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 200
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 243
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 244 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 121/287 (42%), Gaps = 45/287 (15%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 110
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 89  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 171 IGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
             I HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE++    
Sbjct: 141 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 197
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K +                +F 
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRV-------------EKGKFS 240
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 241 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 121/287 (42%), Gaps = 45/287 (15%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 110
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 72  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 171 IGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
             I HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE++    
Sbjct: 124 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 180
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K +                +F 
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRV-------------EKGKFS 223
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 224 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 75  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 126
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 127 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 182
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 225
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 226 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 131
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 187
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 230
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 183
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 183
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 188
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 51  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 103
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 131
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 182
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 222
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 183 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 240
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 241 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 284
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 285 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333
Query: 343 NTRLP 347
            + +P
Sbjct: 334 ASIVP 338

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 51  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 103
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 88
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 139
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 222
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 140 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 197
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 198 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 241
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 242 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 290
Query: 343 NTRLP 347
            + +P
Sbjct: 291 ASIVP 295

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 186
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 112
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 77  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 128
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
           I HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T Y+ 
Sbjct: 129 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-THYSV 185
Query: 233 AIDIWSTGCVMAELLLGQ 250
             DIWS G  + E+ +G+
Sbjct: 186 QSDIWSMGLSLVEMAVGR 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 184
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 227
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 228 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 188
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 51  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 103
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 86
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 137
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 222
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 138 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 195
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 196 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 239
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 240 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 288
Query: 343 NTRLP 347
            + +P
Sbjct: 289 ASIVP 293

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 130/314 (41%), Gaps = 51/314 (16%)
Query: 38  TIGGRNGNSKQKVSYIAEHV---------VGTGSFGVVFQAKCRETGEIVAIK----KVL 84
           ++   NG S       AE +         +GTG+F  V  A+ + TG++ A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 85  QDKRYK-NRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSR 143
           + K      E+ +++ + H NIVAL+  + S                   +  + + +  
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI--VEKGFYT 118
Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL--CDFGSAK 201
                 LI       Q+  A+ Y+H  +GI HRD+KP+NLL      + K+   DFG +K
Sbjct: 119 EKDASTLIR------QVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK 171
Query: 202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
           +  KG+   +   +  Y APE +     Y+ A+D WS G +   LL G P F  E+    
Sbjct: 172 MEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKL 230
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
             +I+K                  E++F    P+ W  +        A D +    +  P
Sbjct: 231 FEQILK-----------------AEYEFDS--PY-WDDI-----SDSAKDFIRNLMEKDP 265
Query: 322 NLRCTALEACVHPF 335
           N R T  +A  HP+
Sbjct: 266 NKRYTCEQAARHPW 279

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 183
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 51  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 103
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 77
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 128
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 222
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 129 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 186
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 187 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 230
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 231 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279
Query: 343 NTRLP 347
            + +P
Sbjct: 280 ASIVP 284

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRM-H 183
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 51  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 103
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 81
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 132
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 222
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 133 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 190
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 191 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 234
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 235 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 283
Query: 343 NTRLP 347
            + +P
Sbjct: 284 ASIVP 288

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRM-H 183
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 183
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 154 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-H 209
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 252
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 253 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 120/291 (41%), Gaps = 42/291 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIV 106
           Y    V+GTG+F  V  A+ + T ++VAI    KK L+ K      E+ ++  + HPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           AL   + S                   +        R   R+         +Q+  A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKY 131
Query: 167 IHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           +H+ +GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK----------------- 232
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            E++F    P+ W  +        A D +    +  P  R T  +A  HP+
Sbjct: 233 AEYEFDS--PY-WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 129/305 (42%), Gaps = 48/305 (15%)
Query: 51  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 103
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 208
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 259
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPE 222
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P     + + Y+ APE
Sbjct: 260 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 317
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 318 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 361
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 362 NLP----PRLK--NLHKVS-----PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410
Query: 343 NTRLP 347
            + +P
Sbjct: 411 ASIVP 415

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRX-H 188
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-H 184
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 227
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 228 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 183
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 111
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 228
            + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I       
Sbjct: 174 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y+   DIWS G  M EL + +  FP +S            GTP ++             
Sbjct: 233 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 266
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 267 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 186
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 73  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 124
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 125 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 180
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 223
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 224 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 107
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 37  EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
               F    +                ++R+ +++ +  + +P   V  Y  Q+C AL ++
Sbjct: 97  YYASFIEDNE----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFG 226
           H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE I  
Sbjct: 153 HS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 209
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
              Y    DIWS GC++ E+   Q  F G+
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 130 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 185
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 228
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 62/292 (21%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFG-------SAKVLVKGEPNVSYICSRYYRAPEL 223
             + HRDIKP+NLL+     +LK+ DFG       S +  + G  +        Y  PE+
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLPPEM 178
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           I G   +   +D+WS G +  E L+G+P F   +  +    I +V               
Sbjct: 179 IEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------- 222
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
             EF FP              +   A DL+ R  +++P+ R    E   HP+
Sbjct: 223 --EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-H 186
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 110
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIH 168
           C+                         A +   +H++ PL  V++   T+   + LAY+H
Sbjct: 122 CYLREHTAWLVMEYCLGS---------ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 171
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 229 E--YTTAIDIWSTGCVMAELLLGQP 251
           E  Y   +D+WS G    EL   +P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 43  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQ 98
           +G+++  +S  +  E  +G G+  +V++ K + T +  A+K  K   DK+    E+ ++ 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L HPNI+ LK  F + T+                 +RI        +R     VK    
Sbjct: 104 RLSHPNIIKLKEIFETPTE---ISLVLELVTGGELFDRIVEK-GYYSERDAADAVK---- 155
Query: 159 QICRALAYIHNCIGICHRDIKPQNLL-VNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSR 216
           QI  A+AY+H   GI HRD+KP+NLL   P     LK+ DFG +K+ V+ +  +  +C  
Sbjct: 156 QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVCGT 213
Query: 217 -YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
             Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ +          R 
Sbjct: 214 PGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------FRR 262
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            + C      E+ F      PW       +   A DLV +     P  R T  +A  HP+
Sbjct: 263 ILNC------EYYFIS----PWW----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 137/339 (40%), Gaps = 76/339 (22%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 101
           Y  +  +G GS+GVV  A   +T  I AIK + ++K          R K  E+++M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 102 HPNIVALKHCF--------------------------FSTTDKXXXXXXXXXXXXXXTVN 135
           HPNI  L   +                            +T K                N
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 136 RIARNYSRIHQRMPLIYV---KLYT---YQICRALAYIHNCIGICHRDIKPQNLLVNPH- 188
             A N S    R  L +V   KL +    QI  AL Y+HN  GICHRDIKP+N L + + 
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNK 205
Query: 189 THQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELIFGATE-YTTAIDIWSTGCV 242
           + ++KL DFG +K   K      Y  +      Y+ APE++    E Y    D WS G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 243 MAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ 302
           +  LL+G   FPG +  D + +++        +++   NPNY                  
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN----------------- 301
Query: 303 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
             L P A DL+      + + R  A+ A  HP+  +  D
Sbjct: 302 -VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 179
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 180 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 234
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 110
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIH 168
           C+                         A +   +H++ PL  V++   T+   + LAY+H
Sbjct: 83  CYLREHTAWLVMEYCLGS---------ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 132
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 229 E--YTTAIDIWSTGCVMAELLLGQP 251
           E  Y   +D+WS G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G   +
Sbjct: 130 -RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 185
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 228
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALK 109
            +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F    D                 + +     R  QR P    K Y  ++C AL Y+H+
Sbjct: 73  GTF---QDAQQIFMIMDYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSR-YYRAPELIFGA 227
              I +RD+KP+N+L++ + H +K+ DFG AK +    P+V+Y +C    Y APE++   
Sbjct: 125 K-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV-ST 177
Query: 228 TEYTTAIDIWSTGCVMAELLLG 249
             Y  +ID WS G ++ E+L G
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAG 199

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 151
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 152 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 23  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 82
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 83  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 134
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 135 AQIVLTFEYLH-SLDLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 189
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 190 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 120/291 (41%), Gaps = 42/291 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIV 106
           Y    V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           AL   + S                   +        R   R+         +Q+  A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKY 131
Query: 167 IHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           +H+ +GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK----------------- 232
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            E++F    P+ W  +        A D +    +  P  R T  +A  HP+
Sbjct: 233 AEYEFDS--PY-WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 120/291 (41%), Gaps = 42/291 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIV 106
           Y    V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           AL   + S                   +        R   R+         +Q+  A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKY 131
Query: 167 IHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           +H+ +GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK----------------- 232
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            E++F    P+ W  +        A D +    +  P  R T  +A  HP+
Sbjct: 233 AEYEFDS--PY-WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 57  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 116
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 117 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 168
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 217
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  
Sbjct: 169 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPE 224
Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
           Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 225 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 120/291 (41%), Gaps = 42/291 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIV 106
           Y    V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           AL   + S                   +        R   R+         +Q+  A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKY 131
Query: 167 IHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           +H+ +GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK----------------- 232
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            E++F    P+ W  +        A D +    +  P  R T  +A  HP+
Sbjct: 233 AEYEFDS--PY-WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 37  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 148
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 203
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 57  VVGTGSFGVVFQAKCR---ETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVA 107
           V+G GSFG VF  +     ++G + A+K +      ++D+     E  I+  ++HP +V 
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 165
           L H  F T  K                 R    ++R+ + +      VK Y  ++   L 
Sbjct: 95  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 224
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 145 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 272
                ++ + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 203 -NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 111
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 228
            + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I       
Sbjct: 130 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y+   DIWS G  M EL + +  FP +S            GTP ++             
Sbjct: 189 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 222
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
            + + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SKG 214
Query: 230 YTTAIDIWSTGCVMAELLLGQPLF 253
           Y  A+D W+ G ++ E+  G P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
            + + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SKG 214
Query: 230 YTTAIDIWSTGCVMAELLLGQPLF 253
           Y  A+D W+ G ++ E+  G P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 188
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/335 (23%), Positives = 137/335 (40%), Gaps = 48/335 (14%)
Query: 57  VVGTGSFGVVFQ-AKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPNIVALKHC- 111
            +G G+FG V Q    R  G  VA+K +   ++YK     E+ +++ ++  +      C 
Sbjct: 40  TLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCV 99
Query: 112 -FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
             F   D               T + +  N    +   P+  V+   +Q+C+A+ ++H+ 
Sbjct: 100 QMFDWFDYHGHMCISFELLGLSTFDFLKDNN---YLPYPIHQVRHMAFQLCQAVKFLHDN 156
Query: 171 IGICHRDIKPQNLLVNPHTHQL------------------KLCDFGSAKVLVKGEPNVSY 212
             + H D+KP+N+L     ++L                  ++ DFGSA      E + + 
Sbjct: 157 -KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--DHEHHSTI 213
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-T 271
           + +R+YRAPE+I     ++   D+WS GC++ E  +G  LF      + L  + ++LG  
Sbjct: 214 VSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 272
Query: 272 PTREEIKCMNPNY--------------TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 317
           P+R   K     Y                +     KP   +   +     +  DL+    
Sbjct: 273 PSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESML 332
Query: 318 QYSPNLRCTALEACVHPFFDELRD--PNTRLPNGR 350
           +Y P  R T  EA  HPFF  LR   PN    + R
Sbjct: 333 EYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 41  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 91
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 92  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 151
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
             +    QI  A+ Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE   +
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRT 169
Query: 212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
              S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 48/285 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRM-H 188
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R ++  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FAEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 144
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 145 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--LCGTPEYLAPEIIL-SK 199
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--LCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 41  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 91
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 92  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 151
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
             +    QI  A+ Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE    
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRD 169
Query: 212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
              S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 39/284 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQ----IMQMLDHPNIVALKHC 111
           +G G++G V +   + +G+I+A+K++    D++ + + L     +M+  D P IV     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   D               + ++  +  YS +   +P   +   T    +AL ++   
Sbjct: 90  LFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 229
           + I HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +   
Sbjct: 145 LKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 230 --YTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTP---TREEIKCMNPN 283
             Y    D+WS G  + EL  G+  +P  + V DQL +++K  G P   +  E +  +P+
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQLSNSEEREFSPS 261
Query: 284 YTEF-------------KFPQIKPHPWHKVFQKRLPPEAVDLVC 314
           +  F             K+ ++  HP+  ++++R    AV++ C
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFILMYEER----AVEVAC 301

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 151
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 152 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ ++  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 34/291 (11%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH 110
            +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F +                          + +   +  L     Y  +I   L ++H+ 
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATE 229
            GI +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +
Sbjct: 138 -GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QK 194
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           Y  ++D WS G ++ E+L+GQ  F G+   +                I+  NP Y  +  
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPFYPRW-- 240
Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDEL 339
                          L  EA DL+ + F   P  R     +   HP F E+
Sbjct: 241 ---------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 59/301 (19%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-RYKN------------- 91
           SY     +G+G++G V    C+E        I  IKK   DK RY +             
Sbjct: 37  SYFKVRKLGSGAYGEVLL--CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 92  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 151
            E+ +++ LDHPNI+ L   F    DK                 +I  N  +  +     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVF---EDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAAN 150
Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPN 209
            +K    QI   + Y+H    I HRDIKP+N+L+      L  K+ DFG +    K    
Sbjct: 151 IMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
              + + YY APE++    +Y    D+WS G +M  LL G P F G++  D + ++ K  
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-- 261
Query: 270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 329
                         Y +F       + W     K +  EA +L+     Y  N RCTA E
Sbjct: 262 -----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 330 A 330
           A
Sbjct: 299 A 299

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 113/245 (46%), Gaps = 41/245 (16%)
Query: 28  GAETGHVIRTTIGGRNGNSK-QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 86
           G +TG++   TIGG+   ++   +  + E  +G+G+ G V++ + R+TG ++A+K++   
Sbjct: 7   GKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM--- 58
Query: 87  KRYKNRELQ---------IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRI 137
           +R  N+E           +++  D P IV     F + TD                +  +
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD------------VFIAMELM 106
Query: 138 ARNYSRIHQRM----PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 193
                ++ +RM    P   +   T  I +AL Y+    G+ HRD+KP N+L++    Q+K
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIK 165
Query: 194 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG 249
           LCDFG +  LV  +          Y APE I        +Y    D+WS G  + EL  G
Sbjct: 166 LCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 250 QPLFP 254
           Q  FP
Sbjct: 226 Q--FP 228

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 52  YIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPN 104
           Y+A  + +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N
Sbjct: 46  YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V +   +    +                V          H RM    +      + RAL
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIATVCLSVLRAL 154
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPEL 223
           +Y+HN  G+ HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+
Sbjct: 155 SYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEV 212
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQP 251
           I     Y T +DIWS G ++ E++ G+P
Sbjct: 213 I-SRLPYGTEVDIWSLGIMVIEMIDGEP 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 57  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 116
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 117 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 168
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 169 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 223
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 224 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 31  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 90
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 91  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 142
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 143 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 197
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 198 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 40/299 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLDHPNIVALKHCFF 113
           +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF- 117
Query: 114 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 173
              DK                +RIA    ++ +   + Y++    Q C  L ++H    I
Sbjct: 118 --EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHEH-SI 170
Query: 174 CHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
            H DIKP+N++        +K+ DFG A  L   E       +  + APE++        
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGF 229
Query: 233 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 292
             D+W+ G +   LL G   F GE  ++ L            + +K  +  + E  F  +
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDAFSSV 277
Query: 293 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD-ELRDPNTRLPNGR 350
            P             EA D +    Q  P  R T  +A  HP+   +  +  +R+P+ R
Sbjct: 278 SP-------------EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 323

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H+ + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 190
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 150 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 208
Query: 191 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 209 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 265
Query: 248 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 294
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 266 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 325
Query: 295 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF
Sbjct: 326 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            Y AP +I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 104
           YI    +G GSFG V  A   +T + VA+K + +    K+       RE+  +++L HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I+ L     + TD                V +         +RM     + +  QI  A+
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEK---------KRMTEDEGRRFFQQIICAI 121
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            Y H    I HRD+KP+NLL++ + + +K+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
            G       +D+WS G V+  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 190
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 127 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 185
Query: 191 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 186 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYY 242
Query: 248 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 294
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 243 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 302
Query: 295 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF
Sbjct: 303 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 41/289 (14%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHC 111
            ++G G FG V + +   TG  +A K +    ++DK     E+ +M  LDH N++ L   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           F S  D                 +RI      + +   ++++K    QIC  + ++H   
Sbjct: 155 FESKND---IVLVMEYVDGGELFDRIIDESYNLTELDTILFMK----QICEGIRHMHQMY 207
Query: 172 GICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI-FGATE 229
            I H D+KP+N+L VN    Q+K+ DFG A+     E       +  + APE++ +    
Sbjct: 208 -ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           + T  D+WS G +   LL G   F G++  + L  I+        EE             
Sbjct: 267 FPT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE------------- 311
Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                      FQ  +  EA + + +      + R +A EA  HP+  +
Sbjct: 312 -----------FQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQML-DHPNIVAL 108
           V+G GSFG V  A+ +ETG++ A+K + +D   ++ +++       I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             C F T D+                 + +R +     R        Y  +I  AL ++H
Sbjct: 90  -FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR-------FYAAEIISALMFLH 141
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGA 227
           +  GI +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I   
Sbjct: 142 D-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQE 198
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
             Y  A+D W+ G ++ E+L G   F  E+  D L E I
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDH 102
           +Y  +  +G G+F  V  A+   TG  VA+K +  DK   N        RE++IM++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 103 PNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           PNIV L    F   +                V     +Y   H RM     +    QI  
Sbjct: 74  PNIVKL----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVS 125
Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
           A+ Y H    I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APE
Sbjct: 126 AVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAAPE 183
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
           L  G       +D+WS G ++  L+ G   F G++
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 190
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 191 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 177 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYY 233
Query: 248 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 294
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 295 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 103
           YI    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q +++  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           +I+ L     + +D                + +  R   +  +R+          QI   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQQILSG 128
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
           + Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y APE+
Sbjct: 129 VDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNYAAPEV 186
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLG 249
           I G       +DIWS+G ++  LL G
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 57  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 105
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 161
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRA 220
            AL ++H   GI +RD+KP+N+++N H   +KL DFG  K  +  G    ++  +  Y A
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
           PE++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 57  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 105
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 161
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRA 220
            AL ++H   GI +RD+KP+N+++N H   +KL DFG  K  +         C    Y A
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMA 189
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
           PE++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 47/297 (15%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 111
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           +    +                V+++  N  +I               + +ALAY+H   
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI---------ATVCEAVLQALAYLH-AQ 160
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATEY 230
           G+ HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
            T +DIWS G ++ E++ G+P +  +S V  +            + ++   P       P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------P 259
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 347
           ++K    HKV      P   D + R     P  R TA E   HPF  +   P   +P
Sbjct: 260 KLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 97
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 98  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 157
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 216
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
              APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLF 253
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 109
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGES 257
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 109
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGES 257
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 110
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 123 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGES 257
              +D+WS G ++  +L  +  F  ES
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 110
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 126
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 127 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGES 257
              +D+WS G ++  +L  +  F  ES
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 110
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 132
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 133 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGES 257
              +D+WS G ++  +L  +  F  ES
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 110
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 131
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 132 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGES 257
              +D+WS G ++  +L  +  F  ES
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 34/285 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 116
           ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H F +  
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 117 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 176
                                   + +   +  L     Y  +I   L ++H+  GI +R
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-GIVYR 143
Query: 177 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATEYTTAID 235
           D+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +Y  ++D
Sbjct: 144 DLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVD 201
Query: 236 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 295
            WS G ++ E+L+GQ  F G+   +                I+  NP Y  +        
Sbjct: 202 WWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPFYPRW-------- 241
Query: 296 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDEL 339
                    L  EA DL+ + F   P  R     +   HP F E+
Sbjct: 242 ---------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 277

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 126/320 (39%), Gaps = 60/320 (18%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 104
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 159
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 218
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE   +   +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKTLCGTPNY 208
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 339 LRDPNTRLPNG-RPLPPLFN 357
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 116/254 (45%), Gaps = 28/254 (11%)
Query: 30  ETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 89
           E    + T   G+  +S     +    V+G GS+  V   + ++T  I A++ V ++   
Sbjct: 32  EEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN 91
Query: 90  KNRELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNY 141
            + ++  +Q          +HP +V L  CF + +                 + R     
Sbjct: 92  DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----- 146
Query: 142 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
               +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L++   H +KL D+G  K
Sbjct: 147 ---QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCK 201
Query: 202 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF------- 253
             ++ G+   ++  +  Y APE++ G  +Y  ++D W+ G +M E++ G+  F       
Sbjct: 202 EGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
Query: 254 -PGESGVDQLVEII 266
            P ++  D L ++I
Sbjct: 261 NPDQNTEDYLFQVI 274

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 112/251 (44%), Gaps = 28/251 (11%)
Query: 33  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 92
             + T   G+  +S     +    V+G GS+  V   + ++T  I A+K V ++    + 
Sbjct: 3   EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE 62
Query: 93  ELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI 144
           ++  +Q          +HP +V L  CF + +                 + R        
Sbjct: 63  DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-------- 114
Query: 145 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 204
            +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L++   H +KL D+G  K  +
Sbjct: 115 QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGL 172
Query: 205 KGEPNVSYICSR-YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF--------PG 255
           +     S  C    Y APE++ G  +Y  ++D W+ G +M E++ G+  F        P 
Sbjct: 173 RPGDTTSXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 231
Query: 256 ESGVDQLVEII 266
           ++  D L ++I
Sbjct: 232 QNTEDYLFQVI 242

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 125/320 (39%), Gaps = 60/320 (18%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 104
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 159
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 218
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNY 208
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 339 LRDPNTRLPNG-RPLPPLFN 357
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 83/320 (25%), Positives = 126/320 (39%), Gaps = 60/320 (18%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 104
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 159
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 88  VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 134
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 218
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 135 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNY 192
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 193 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 229
Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
           C+   Y   K  +    P H      + P A  L+ R     P LR +  E     FF  
Sbjct: 230 CLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 282
Query: 339 LRDPNTRLPNG-RPLPPLFN 357
              P  RLP     +PP F+
Sbjct: 283 GYAP-MRLPTSCLTVPPRFS 301

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 109
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGES 257
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 108
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 127
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGA 227
              GI +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G 
Sbjct: 128 ER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 266
            +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 186 -DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 109
           +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGES 257
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 108
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 123
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGA 227
              GI +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G 
Sbjct: 124 ER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 266
            +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 182 -DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 125/320 (39%), Gaps = 60/320 (18%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 104
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 159
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 218
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKXLCGTPNY 208
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 339 LRDPNTRLPNG-RPLPPLFN 357
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 109
           +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 76
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 77  ---FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 130 K-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGES 257
               +D+WS G ++  L+ G   F G++
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 109
           +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+K +NLL++   + +K+ DFG +     G     +  S  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGES 257
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 127/295 (43%), Gaps = 46/295 (15%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDKRYKNRELQIMQMLDHPN 104
           Y+    +G G FG+V   +C ET        + V +K    D+    +E+ I+ +  H N
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRN 62
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I+ L   F S  +                  RI  +   +++R  + YV    +Q+C AL
Sbjct: 63  ILHLHESFESMEE---LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 165 AYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
            ++H+   I H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           +      +TA D+WS G ++  LL G   F  E+   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
           YT   F +       + F K +  EA+D V R        R TA EA  HP+  +
Sbjct: 220 YT---FDE-------EAF-KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKN--RELQIMQMLDHPNIV 106
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           AL+        K               +NR+        +R+P   +  +  QI R + Y
Sbjct: 70  ALRGVCL----KEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNY 120
Query: 167 IHN--CIGICHRDIKPQNLLV-------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 217
           +H+   + I HRD+K  N+L+       +     LK+ DFG A+   +    +S   +  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYA 179
Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 259
           + APE+I  A+ ++   D+WS G ++ ELL G+  F G  G+
Sbjct: 180 WMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSL------RDYLQAHAERIDHIKLLQYTSQICKGMEY 132
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 107
           V+G GSFG V  A+ +   E+    KVLQ K    K  E  IM       + + HP +V 
Sbjct: 45  VIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAY 166
           L H  F T DK               +N     Y    +R  L    + Y  +I  AL Y
Sbjct: 104 L-HFSFQTADKLYFVLDY--------INGGELFYHLQRERCFLEPRARFYAAEIASALGY 154
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIF 225
           +H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE + 
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VL 211
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLF 253
               Y   +D W  G V+ E+L G P F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
           V+G GSFG V  A  + T E+ AIK + +D   ++ +++       ++ +LD P  +   
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 167
           H  F T D+               VN     Y  I Q  +        Y  +I   L ++
Sbjct: 86  HSCFQTVDRLYFVMEY--------VNGGDLMY-HIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 226
           H   GI +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I  
Sbjct: 137 HKR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-A 193
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
              Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 25  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 136
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 137 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 191
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 192 APESL-TESKFSVASDVWSFGVVLYELF 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 126/321 (39%), Gaps = 60/321 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 165
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 224
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 188
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 226
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 227 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 278
Query: 345 RLP-NGRPLPPLFNFKPPELS 364
           RLP     +PP F+  P  L 
Sbjct: 279 RLPITCLTIPPXFSIAPSSLD 299

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 24  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 135
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 136 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 190
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 191 APESL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 22  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 133
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 134 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 188
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 189 APESL-TESKFSVASDVWSFGVVLYELF 215

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 56/309 (18%)
Query: 53  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 107
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 166
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 167 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 214
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 215 -----SRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
                +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 327
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 328 LEACVHPFF 336
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 49  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 161 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 215
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 216 APESL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 23  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 134
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 135 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 189
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 190 APESL-TESKFSVASDVWSFGVVLYELF 216

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWY 184
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 16  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 127
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 128 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 182
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 183 APESL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 184
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 56/309 (18%)
Query: 53  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 107
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 166
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 167 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 214
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 215 -----SRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
                +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 327
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 328 LEACVHPFF 336
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 17  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 128
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 129 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 183
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 184 APESL-TESKFSVASDVWSFGVVLYELF 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 148 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 202
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 203 APESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 148 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 202
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 203 APESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 109
           +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 80  ---FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G   
Sbjct: 133 K-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGES 257
               +D+WS G ++  L+ G   F G++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 184
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 126/321 (39%), Gaps = 60/321 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 165
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 224
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 188
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 226
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 227 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 278
Query: 345 RLP-NGRPLPPLFNFKPPELS 364
           RLP     +PP F+  P  L 
Sbjct: 279 RLPITCLTIPPRFSIAPSSLD 299

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 76
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 77  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 128
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 129 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 186
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 229
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 230 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 75
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 76  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 127
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 128 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 185
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 228
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGS------LREYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 74
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 75  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 126
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 127 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 184
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 227
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 228 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 126/321 (39%), Gaps = 60/321 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 165
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 88  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 135
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 224
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 136 YLHRN-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 192
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 193 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 230
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 231 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 282
Query: 345 RLP-NGRPLPPLFNFKPPELS 364
           RLP     +PP F+  P  L 
Sbjct: 283 RLPITCLTIPPRFSIAPSSLD 303

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 16/222 (7%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 105
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V  +  F    +                  RI      + Q   ++    +  QIC AL 
Sbjct: 86  VQYRESF---EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLALK 139
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELI 224
           ++H+   I HRDIK QN+ +      ++L DFG A+VL    E   + I + YY +PE I
Sbjct: 140 HVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPE-I 196
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
                Y    DIW+ GCV+ EL   +  F   S  + +++II
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 109
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 71
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
              F   +                V     +Y   H  M     +    QI  A+ Y H 
Sbjct: 72  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 125 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGES 257
               +D+WS G ++  L+ G   F G++
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 215 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 266
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 267 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDN 324
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 367
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 368 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 218 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 269
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 270 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDN 327
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 370
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 371 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 111
           +G G++GVV + +   +G+I A+K++      Q+++    +L I  + +D P  V     
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 102 LFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 228
            + HRD+KP N+L+N    Q+K CDFG +  LV           + Y APE I       
Sbjct: 157 SVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQK 215
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y+   DIWS G    EL + +  FP +S            GTP ++             
Sbjct: 216 GYSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ------------- 249
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 250 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 116/285 (40%), Gaps = 40/285 (14%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 114
           +G+G+FGV    + + T E+VA+K + +         RE+   + L HPNIV  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T                 +    R +S    R        +  Q+   ++Y H+ + IC
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGR-FSEDEAR-------FFFQQLLSGVSYCHS-MQIC 138
Query: 175 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 233
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYDGK 197
Query: 234 I-DIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 291
           I D+WS G  +  +L+G  P    E   D    I ++L                ++  P 
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------------VKYSIPD 243
Query: 292 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                       R+ PE   L+ R F   P  R +  E   H +F
Sbjct: 244 ----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 92  RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 150
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 151 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 207
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 178
Query: 208 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
              S   +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 239 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 273
Query: 323 LRCTALEACVHPFFDE 338
            R TA EA  HPFF +
Sbjct: 274 KRYTAEEALAHPFFQQ 289

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 131/305 (42%), Gaps = 59/305 (19%)
Query: 57  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 104
           V+GTG++G VF   +    +TG++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICR 162
           +V L + F + T                 +N     ++ + QR       V++Y  +I  
Sbjct: 121 LVTLHYAFQTET---------KLHLILDYING-GELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 220
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C    Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 221 PELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           P+++ G  + +  A+D WS G +M ELL G   F  +   +   EI       +R  +K 
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKS 281
Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 334
             P      +PQ             +   A DL+ R     P  R       A E   H 
Sbjct: 282 EPP------YPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
Query: 335 FFDEL 339
           FF ++
Sbjct: 324 FFQKI 328

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 125/321 (38%), Gaps = 60/321 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 165
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 106 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 153
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 224
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 154 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 210
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 211 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 248
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 249 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 300
Query: 345 RLP-NGRPLPPLFNFKPPELS 364
           RLP     +PP F+  P  L 
Sbjct: 301 RLPITCLTIPPRFSIAPSSLD 321

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 58  VGTGSFGVVFQ-----AKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           +G G+F VV +     A      +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 140
Query: 172 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 227
           G+ HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 198
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 199 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 241
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+
Sbjct: 242 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 281

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 23/228 (10%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 103
            Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
            +V L   F +  D                VN ++ NY      +P  + K YT ++  A
Sbjct: 136 WVVQL---FCAFQDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVLA 186
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS-AKVLVKGEPNV-SYICSRYYRAP 221
           L  IH+ +G+ HRD+KP N+L++ H H LKL DFG+  K+   G  +  + + +  Y +P
Sbjct: 187 LDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYISP 244
Query: 222 ELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
           E++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 125/321 (38%), Gaps = 60/321 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 165
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 108 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 224
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 156 YLHRN-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 212
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 250
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 251 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 302
Query: 345 RLP-NGRPLPPLFNFKPPELS 364
           RLP     +PP F+  P  L 
Sbjct: 303 RLPITCLTIPPRFSIAPSSLD 323

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 114
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 175 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 233
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 234 IDIWSTGCVMAELLLG 249
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ +++  IVA+K + + +  K        RE++I   L HPNI+ L +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F+   D+                  + ++ +   QR   I  +L       AL Y H  
Sbjct: 91  YFY---DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL-----ADALMYCHGK 142
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 143 -KVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRM-H 198
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-----LGTPTREE---IKCMNP 282
              +D+W  G +  ELL+G P F   S  +    I+KV        PT  +    K +  
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRH 258
Query: 283 NYTE-FKFPQIKPHPWHKVFQKR-LPPEAVDLVC 314
           N +E     Q+  HPW +   +R LPP A+  V 
Sbjct: 259 NPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA 292

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 103
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 130 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 180
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 220
           L  IH  +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 181 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 237
Query: 221 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 103
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 220
           L  IH  +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 186 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 242
Query: 221 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 58  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 107
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 19  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 166
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 130
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 219
           +     I HR++  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 131 LGTKRYI-HRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWY 185
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELL 247
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 186 APESL-TESKFSVASDVWSFGVVLYELF 212

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 118/296 (39%), Gaps = 48/296 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 107
           V+G G+F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 168 HNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 222
           H+   I HRD+KP+N+L+    ++  +KL DFG A  L  GE  +     + + ++ APE
Sbjct: 147 HDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 248 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 103
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 220
           L  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 186 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 242
Query: 221 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 136
Query: 175 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 233
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++         
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 196
Query: 234 IDIWSTGCVMAELLLG 249
            D+WS G  +  +L+G
Sbjct: 197 ADVWSCGVTLYVMLVG 212

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLD-HPNIVALKHC 111
           V+  G F  V++A+   +G   A+K++L ++  KNR    E+  M+ L  HPNIV     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL---IYVKLYTYQICRALAYIH 168
                ++                 ++     ++  R PL     +K++ YQ CRA+ ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF-YQTCRAVQHMH 153
Query: 169 NCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----------- 216
                I HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+   R           
Sbjct: 154 RQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSAQRRALVEEEITRN 211
Query: 217 ---YYRAPELIFGATEYTTA--IDIWSTGCVM 243
               YR PE+I   + +      DIW+ GC++
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALK 109
           ++G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F    +                +NR  +N  +          + + +QI   + Y+H+
Sbjct: 78  NYF----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE---ARHFMHQIITGMLYLHS 130
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGAT 228
             GI HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE I   +
Sbjct: 131 H-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRS 187
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            +    D+WS GC+   LL+G+P F  ++  + L +++                   +++
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------LADYE 230
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 345
            P              L  EA DL+ +  + +P  R +      HPF    R+ +T+
Sbjct: 231 MPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS--RNSSTK 273

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 68
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 69  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 219
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 220 KEKKTYLNPWKKI 232

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 124/317 (39%), Gaps = 60/317 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 110
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 165
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 82  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 224
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 130 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 186
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 224
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 225 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 276
Query: 345 RLP-NGRPLPPLFNFKP 360
           RLP     +PP F+  P
Sbjct: 277 RLPITCLTIPPRFSIAP 293

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 140/313 (44%), Gaps = 60/313 (19%)
Query: 53  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 107
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 166
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 167 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 214
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+ +     
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 215 -----SRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
                +  +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 324 RCTALEACVHPFF 336
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 110
           Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    D                +++I R      +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 171 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 224
            G+ HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 225 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
                Y    DIWS G ++  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
               KF  +    W+ V +      A DLV +     P+ R TA +   HP+  +
Sbjct: 244 ----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 121/307 (39%), Gaps = 56/307 (18%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 83  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 134
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G T +
Sbjct: 135 -KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-H 190
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
              +D+W  G +  E L+G P F   S  +    I+ V                 + KFP
Sbjct: 191 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DLKFP 233
Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 350
                         L   + DL+ +  +Y P  R        HP+       N+R    R
Sbjct: 234 PF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR----R 273
Query: 351 PLPPLFN 357
            LPP++ 
Sbjct: 274 VLPPVYQ 280

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFF-- 113
            ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH NIV    C+   
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 114 ----------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
                     S+  K              T+ +      R  +   ++ ++L+  QI + 
Sbjct: 77  DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFE-QITKG 134
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
           + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y +PE 
Sbjct: 135 VDYIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQ 192
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I  + +Y   +D+++ G ++AELL
Sbjct: 193 I-SSQDYGKEVDLYALGLILAELL 215

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 47/256 (18%)
Query: 92  RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 150
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 151 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 207
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 178
Query: 208 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
                  +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 239 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 273
Query: 323 LRCTALEACVHPFFDE 338
            R TA EA  HPFF +
Sbjct: 274 KRYTAEEALAHPFFQQ 289

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 110
           Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    D                +++I R      +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 171 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 224
            G+ HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 225 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
                Y    DIWS G ++  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
               KF  +    W+ V +      A DLV +     P+ R TA +   HP+
Sbjct: 244 ----KFT-LSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 29/267 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 110
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 82  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 133
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 230
             + HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G T +
Sbjct: 134 -KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-H 189
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTREEIKCMNPN 283
              +D+W  G +  E L+G P F   S  +    I+ V       L   +++ I  +   
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 249
Query: 284 YTEFKFP--QIKPHPWHKVFQKR-LPP 307
           +   + P   +  HPW K   +R LPP
Sbjct: 250 HPPQRLPLKGVMEHPWVKANSRRVLPP 276

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 167
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 279
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 280 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 324
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 325 IMQSTKVPQTPLHTSRVL 342

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 86  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 129
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 130 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 188
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 189 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 241
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 242 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 286
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 287 IMQSTKVPQTPLHTSRVL 304

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 112
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 14  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 167
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 72  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 168 HNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 176
Query: 226 GATEYTTAIDIWSTGCVMAELL 247
             + Y+   D++S G ++ E++
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVI 198

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 130 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 173
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 174 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 232
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 233 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 285
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 286 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 330
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 331 IMQSTKVPQTPLHTSRVL 348

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 112
           +G G+FG V++AK +ETG + A  KV++ K  +  E     ++I+   DHP IV L   +
Sbjct: 19  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 129
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI----FGA 227
           I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 130 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 228 TEYTTAIDIWSTGCVMAELLLGQP 251
           T Y    DIWS G  + E+   +P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEP 212

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 112
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 167
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 71  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 168 HNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 175
Query: 226 GATEYTTAIDIWSTGCVMAELL 247
             + Y+   D++S G ++ E++
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVI 197

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 47/256 (18%)
Query: 92  RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 150
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 108
Query: 151 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 207
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 109 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 165
Query: 208 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
                  +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 225
Query: 263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 226 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 260
Query: 323 LRCTALEACVHPFFDE 338
            R TA EA  HPFF +
Sbjct: 261 KRYTAEEALAHPFFQQ 276

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 85  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 128
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 129 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 187
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 188 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 240
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 241 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 285
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 286 IMQSTKVPQTPLHTSRVL 303

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 79  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 122
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 123 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 181
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 182 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 234
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 235 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 279
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 280 IMQSTKVPQTPLHTSRVL 297

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 112
           +G G+FG V++AK +ETG + A  KV++ K  +  E     ++I+   DHP IV L   +
Sbjct: 27  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 137
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI----FGA 227
           I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 138 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 228 TEYTTAIDIWSTGCVMAELLLGQP 251
           T Y    DIWS G  + E+   +P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEP 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 84  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 127
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 128 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 186
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 187 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 239
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 240 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 284
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 285 IMQSTKVPQTPLHTSRVL 302

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 180
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 94  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 137
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 138 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 196
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 197 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 249
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 250 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 294
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 295 IMQSTKVPQTPLHTSRVL 312

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 112
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 229
           I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 230 --YTTAIDIWSTGCVMAELLLGQP 251
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 112
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 229
           I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 230 --YTTAIDIWSTGCVMAELLLGQP 251
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF--F 113
            ++G+G FG VF+AK R  G+   I++V  +     RE++ +  LDH NIV    C+  F
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 77
Query: 114 STTDKXXXXXXXXXXXXXXTVNRIARNYSR-----------------IHQRM-----PLI 151
               +                   +R+ ++                 I +R       ++
Sbjct: 78  DYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 137
Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
            ++L+  QI + + YIH+   + HRD+KP N+ +   T Q+K+ DFG    L        
Sbjct: 138 ALELFE-QITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTR 194
Query: 212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
              +  Y +PE I  + +Y   +D+++ G ++AELL
Sbjct: 195 SKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 108
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++I ++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
               F   +                V     +Y   H R      +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVXEYASGGEV----FDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
               I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGES 257
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 139/313 (44%), Gaps = 60/313 (19%)
Query: 53  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 107
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 166
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 167 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 214
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 215 -----SRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
                +  +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 324 RCTALEACVHPFF 336
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 101/243 (41%), Gaps = 58/243 (23%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----------V 202
           V+ Y   + +AL  IH   GI HRD+KP N L N    +  L DFG A+           
Sbjct: 119 VREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 203 LVKGEP-------NVSYIC-SRY-----------YRAPELIFGATEYTTAIDIWSTGCVM 243
            V+ E        N   IC SR            +RAPE++      TTAID+WS G + 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 244 AELLLGQ-PLFPGESGVDQLVEIIKVLGT--------------------PTR------EE 276
             LL G+ P +     +  L +I+ + G+                    P +      E 
Sbjct: 238 LSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER 297
Query: 277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           ++ M+ +  +     I+ H  +      +P EA DL+ +    +P  R TA EA +HPFF
Sbjct: 298 LRGMDSSTPKLT-SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356
Query: 337 DEL 339
            ++
Sbjct: 357 KDM 359

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I  ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF-- 70
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK             +
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYT 180
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 45/256 (17%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 109
             +G G++G V  A  R T E VA+K ++  KR  +      +E+ I +ML+H N+V   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVKF- 70
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +    +                 +RI  +       MP    + + +Q+   + Y+H 
Sbjct: 71  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG 123
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELI 224
            IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+
Sbjct: 124 -IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELL 179
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                +   +D+WS G V+  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 285 TEFKFPQIKPHPWHKV 300
           +++K  +   +PW K+
Sbjct: 219 SDWKEKKTYLNPWKKI 234

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 45/256 (17%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 109
             +G G++G V  A  R T E VA+K ++  KR  +      +E+ I +ML+H N+V   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVKF- 69
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +    +                 +RI  +       MP    + + +Q+   + Y+H 
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG 122
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELI 224
            IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+
Sbjct: 123 -IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELL 178
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                +   +D+WS G V+  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 285 TEFKFPQIKPHPWHKV 300
           +++K  +   +PW K+
Sbjct: 218 SDWKEKKTYLNPWKKI 233

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 58  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 172 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 227
           GI HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 223
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 224 DFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 105
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 253
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 164
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 254 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 305 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 361
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 268
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 421
Query: 269 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 307
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 422 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 76
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 77  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 128
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 129 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 185
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 228
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 105
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 164
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 268
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 269 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 307
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVAL 108
           I   V+G G FG   +   RETGE++ +K+++    + +R   +E+++M+ L+HPN++  
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK- 71
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
              F     K              T+  I ++   +  + P      +   I   +AY+H
Sbjct: 72  ---FIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPN-------------VSYI 213
           + + I HRD+   N LV  + + + + DFG A+++V  K +P               + +
Sbjct: 126 S-MNIIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
            + Y+ APE+I G + Y   +D++S G V+ E++
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 105
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 164
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 268
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 269 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 307
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 105
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 164
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 268
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 269 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 307
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 74
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 75  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 126
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 127 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 183
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 226
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 227 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G+ G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 227
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 288 KFPQIKPHPWHKV 300
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 120/288 (41%), Gaps = 46/288 (15%)
Query: 58  VGTGSFGVVFQ-----AKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           +G G+F VV +     A       I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 129
Query: 172 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 227
           G+ HR++KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 187
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 230
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+
Sbjct: 231 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 270

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 58  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 172 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 227
           GI HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 223
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 224 DFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 175 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 233
           HRD+K +N L++     +LK+C FG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 234 IDIWSTGCVMAELLLG 249
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 45/256 (17%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 109
             +G G++G V  A  R T E VA+K ++  KR  +      +E+ I +ML+H N+V   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +    +                 +RI  +       MP    + + +Q+   + Y+H 
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG 122
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELI 224
            IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+
Sbjct: 123 -IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELL 178
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                +   +D+WS G V+  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE-------------------Y 217
Query: 285 TEFKFPQIKPHPWHKV 300
           +++K  +   +PW K+
Sbjct: 218 SDWKEKKTYLNPWKKI 233

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 180
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 228
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 180
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 336
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 108
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAY 166
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 222
            H   GI HRD+KP N+L++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 259
              G +      D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 57/306 (18%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYKNRELQIM-Q 98
           Y  + V+G G   VV +   R TG   A+K            ++ + +    RE  I+ Q
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLY 156
           +  HP+I+ L   + S++                 + R    +  + +++ L     +  
Sbjct: 156 VAGHPHIITLIDSYESSS----------FMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
              +  A++++H    I HRD+KP+N+L++ +  Q++L DFG +  L  GE       + 
Sbjct: 206 MRSLLEAVSFLH-ANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTP 263
Query: 217 YYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
            Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I      
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI------ 317
Query: 272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
                   M   Y +F  P+     W             DL+ R  Q  P  R TA +A 
Sbjct: 318 --------MEGQY-QFSSPE-----WDDR-----SSTVKDLISRLLQVDPEARLTAEQAL 358
Query: 332 VHPFFD 337
            HPFF+
Sbjct: 359 QHPFFE 364

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 225
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 286 EFKFPQIKPHPWHKV 300
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 110
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 225
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 286 EFKFPQIKPHPWHKV 300
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 112
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 229
           I HRD+K  N+L       +KL DFG SAK     +    +I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 230 --YTTAIDIWSTGCVMAELLLGQP 251
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 122/298 (40%), Gaps = 44/298 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 110
           Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    D                +++I R      +    +      + I + + Y+H  
Sbjct: 84  VY---DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-----FTITKTVEYLH-A 134
Query: 171 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 224
            G+ HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 191
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                Y  A DIWS G ++  +L G   F      D   EI+  +G+             
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSG------------ 238
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF---FDEL 339
              KF  +    W+ V        A DLV +     P+ R TA     HP+   +D+L
Sbjct: 239 ---KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 43  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQI 96
           N ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI 81
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 156
            + L HPNIV L       +                 +  +AR +         I     
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI----- 134
Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYIC 214
             QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  
Sbjct: 135 -QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           +  Y +PE +     Y+  +DIW+ G ++  LL+G P F  E   DQ             
Sbjct: 193 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQ---------HRLY 239
Query: 275 EEIKCMNPNYTEFKFPQIKPHP-WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
            +IK    +Y         P P W  V      PEA  L+      +P  R TA +A   
Sbjct: 240 AQIKAGAYDY---------PSPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 334 PFF 336
           P+ 
Sbjct: 286 PWI 288

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 108
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAY 166
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPE 222
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V+     I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 259
              G +      D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 108
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAY 166
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPE 222
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V+     I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
              G +      D++S GCV+ E+L G+P F G+S
Sbjct: 190 QARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 175 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 233
           HRD+K +N L++     +LK+C FG +K  V        + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKV 197
Query: 234 IDIWSTGCVMAELLLG 249
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 108
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAY 166
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 222
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 259
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 107
           Y+    +G G F  V   +    G   A+K++L    QD+    RE  + ++ +HPNI+ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 108 L-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIAR-----NYSRIHQRMPLIYVKLYTYQIC 161
           L  +C      K                N I R     N+    Q + L+        IC
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL------GIC 144
Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS---AKVLVKGEPNVSYI----- 213
           R L  IH   G  HRD+KP N+L+     Q  L D GS   A + V+G      +     
Sbjct: 145 RGLEAIH-AKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 214 --CSRYYRAPELIFGATEYTTA---IDIWSTGCVMAELLLGQ 250
             C+  YRAPEL F    +       D+WS GCV+  ++ G+
Sbjct: 203 QRCTISYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 124/298 (41%), Gaps = 44/298 (14%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 110
           Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            +    D                +++I R      +    +   L+T  I + + Y+H  
Sbjct: 84  VY---DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV---LFT--ITKTVEYLH-A 134
Query: 171 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 224
            G+ HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFVAPE-V 191
Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                Y  A DIWS G ++   L G   F      D   EI+  +G+             
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG------------ 238
Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF---FDEL 339
              KF  +    W+ V        A DLV +     P+ R TA     HP+   +D+L
Sbjct: 239 ---KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQL 287

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 108
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAY 166
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 222
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 259
              G +      D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 124/318 (38%), Gaps = 58/318 (18%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K  LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVXECLDG----------------GELFSRIQDRGDQAFTEREASEIX 167
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            YY APE + G  +Y  + D WS G +   LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR- 278
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
               +     EF  P+     W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 279 ----IRXGQYEFPNPE-----WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPW 324
Query: 336 FDE-LRDPNTRLPNGRPL 352
             +  + P T L   R L
Sbjct: 325 IXQSTKVPQTPLHTSRVL 342

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 108
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 94
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAY 166
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 148
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 222
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 149 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 259
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 207 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 13/196 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +G G+FGV    + ++  E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T                 +    R +S    R        +  Q+   ++Y H  + + 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYAH-AMQVA 137
Query: 175 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 233
           HRD+K +N L++     +LK+ DFG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKV 197
Query: 234 IDIWSTGCVMAELLLG 249
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/107 (39%), Positives = 64/107 (59%), Gaps = 7/107 (6%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YI 213
           +T QI   + + H+ + I HRDIKPQN+L++ +   LK+ DFG AK L +     +   +
Sbjct: 116 FTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQTNHVL 173
Query: 214 CSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 259
            +  Y +PE   G AT+  T  DI+S G V+ E+L+G+P F GE+ V
Sbjct: 174 GTVQYFSPEQAKGEATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 45/300 (15%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 98
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSR 216
           QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E   DQ              +
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQ---------HRLYAQ 218
Query: 277 IKCMNPNYTEFKFPQIKPHP-WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
           IK    +Y         P P W  V      PEA  L+      +P  R TA +A   P+
Sbjct: 219 IKAGAYDY---------PSPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 58  VGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           +G G+F VV +     TG     +I+  KK+  +D +   RE +I ++L H NIV L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
              + +                 + +AR Y         I       QI  A+ + H  +
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ-M 122
Query: 172 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 227
           G+ HRD+KP+NLL+        +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y   +DIW+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAY 223
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            FP  +   W  V      PEA +L+ +    +P  R TA EA  HP+
Sbjct: 224 DFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 53/230 (23%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQ-------------------- 191
           +KLY  +I +AL Y+   + + H D+KP+N+L++ P+  +                    
Sbjct: 139 IKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 192 ---LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 248
              +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  
Sbjct: 198 STGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYT 254
Query: 249 GQPLFPGESGVDQLVEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ------- 291
           G  LF     ++ L  +  ++           T T    K +N +  +  +P+       
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINS 313
Query: 292 ----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
                K  P +K+ +  L     D +    Q  P LR +  E   H F +
Sbjct: 314 IKHVKKCLPLYKIIKHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 37/307 (12%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 112
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 168
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 92  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 169 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           +   I HRD+KP+NLL         LKL DFG AK   +         + YY APE + G
Sbjct: 146 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE-VLG 202
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       +
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQ 249
Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTR 345
           + FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T 
Sbjct: 250 YGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
Query: 346 LPNGRPL 352
           L   R L
Sbjct: 302 LHTARVL 308

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 18/221 (8%)
Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 98
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 99  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 158
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSR 216
           QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E 
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPN 104
           +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I + L HPN
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV L       +                 +  +AR +         I       QI  ++
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------QQILESI 117
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
           AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y +PE
Sbjct: 118 AYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 176
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
            +     Y+  +DIW+ G ++  LL+G P F  E 
Sbjct: 177 -VLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 58  VGTGSFGVVFQAKCRE-----TGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 111
           +G G+F VV +   +        +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
              + +                 + +AR Y         I+      QI  ++ +IH   
Sbjct: 99  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH------QILESVNHIHQH- 149
Query: 172 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 227
            I HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPE-VLRK 207
Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y   +DIW+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAY 250
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            FP  +   W  V      PEA +L+ +    +P  R TA +A  HP+
Sbjct: 251 DFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 37/307 (12%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 112
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 13  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 72
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 168
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 73  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 169 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           +   I HRD+KP+NLL         LKL DFG AK   +         + YY APE + G
Sbjct: 127 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE-VLG 183
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       +
Sbjct: 184 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQ 230
Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTR 345
           + FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T 
Sbjct: 231 YGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 282
Query: 346 LPNGRPL 352
           L   R L
Sbjct: 283 LHTARVL 289

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 20/164 (12%)
Query: 156 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           Y++Q+ R + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 204 YSFQVARGMEFLSSRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 214 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 269
            +R    + APE IF    Y+T  D+WS G ++ E+  LG   +PG       V++ +  
Sbjct: 260 DTRLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDF 311
Query: 270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 313
            +  RE ++   P Y+  +  QI    WH+  ++R  P   +LV
Sbjct: 312 CSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELV 353

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 43/277 (15%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLD-HPNIVALKHCFF 113
           +G GSF +  +   +++ +  A+K +   KR +    +E+  +++ + HPNIV L   F 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 114 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 173
              D+                 RI +           I  KL +     A++++H+ +G+
Sbjct: 77  ---DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMHD-VGV 127
Query: 174 CHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEY 230
            HRD+KP+NLL       L  K+ DFG A++       +   C + +Y APEL+     Y
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGY 186
Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             + D+WS G ++  +L GQ  F            VEI+K +                +F
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-------------GDF 233
Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
            F   +   W  V Q     EA DL+       PN R
Sbjct: 234 SF---EGEAWKNVSQ-----EAKDLIQGLLTVDPNKR 262

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 112
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 145
Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYT 231
           I HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 232 TAIDIWSTGCVMAELLLGQP 251
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 51/324 (15%)
Query: 49  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 101
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
             L  +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y AP
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ + 
Sbjct: 355 EVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL- 400
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
                     +K  P  + + +R  P+A  L  +     P  R      +A E   HP F
Sbjct: 401 ----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 337 DELRDPNTRLPNGRPLPPLFNFKP 360
            +L     RL  G   PP   FKP
Sbjct: 449 KKLN--FKRLGAGMLEPP---FKP 467

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 112
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 170
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 123
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 229
             I HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 180
Query: 230 YTTAIDIWSTGCVMAELLLGQP 251
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 167
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 87  HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFG 226
            +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 138 QSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 194
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 114/296 (38%), Gaps = 48/296 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 107
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 93  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 148
Query: 168 HNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 222
           H+   I HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + ++ APE
Sbjct: 149 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 205
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 206 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 249
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 250 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 109
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 167
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 408 HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFG 226
            +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 459 QS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 515
Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 112
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 170
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 138
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 229
             I HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 139 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 195
Query: 230 YTTAIDIWSTGCVMAELLLGQP 251
           Y +  DIWS G    EL  G+P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 8/177 (4%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 329
             I+ C+    ++   F +I+ HPW +     LP E  ++        P+ +  ALE
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAAALE 291

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 114/296 (38%), Gaps = 48/296 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 107
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 168 HNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 222
           H+   I HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + ++ APE
Sbjct: 147 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 248 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 51/324 (15%)
Query: 49  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 101
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
             L  +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y AP
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ + 
Sbjct: 355 EVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL- 400
Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 336
                     +K  P  + + +R  P+A  L  +     P  R      +A E   HP F
Sbjct: 401 ----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 337 DELRDPNTRLPNGRPLPPLFNFKP 360
            +L     RL  G   PP   FKP
Sbjct: 449 KKLN--FKRLGAGMLEPP---FKP 467

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 112
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 170
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 123
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 229
             I HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 180
Query: 230 YTTAIDIWSTGCVMAELLLGQP 251
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 232
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 118 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 175
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 176 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 235
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 236 HLIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 264
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 142 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 199
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 200 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 234

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 134 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 191
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 251
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 252 HLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 212

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 132 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 189
Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGT 271
             +R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 249
Query: 272 PTREEIK-CMNPNYTEF-KFPQIKPHPW 297
             +  I+ C+    ++   F +I+ HPW
Sbjct: 250 ECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 154 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271
Query: 275 EEIK-CMNPNYTEF-KFPQIKPHPW 297
             I+ C+    ++   F +I+ HPW
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 99
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 100 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 160 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 214
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 275 EEIKCMNPNYTEF 287
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 134 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 191
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 135 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 192
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 167 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 224
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 225 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 259

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 13/210 (6%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
            Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNI
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V+    F    +                +  I          +    +     ++   L 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYR 219
           Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +  + 
Sbjct: 136 YLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLG 249
           APE++     Y    DIWS G    EL  G
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 13/210 (6%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
            Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNI
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V+    F    +                +  I          +    +     ++   L 
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYR 219
           Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +  + 
Sbjct: 131 YLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLG 249
           APE++     Y    DIWS G    EL  G
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 17/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 117
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 155
Query: 118 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 177
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 156 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 210
Query: 178 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 231
           +K  N+L++       LCDFG A  L       S +   Y      + APE++ G +   
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CD 269
Query: 232 TAIDIWSTGCVMAELLLG 249
             +D+WS+ C+M  +L G
Sbjct: 270 AKVDVWSSCCMMLHMLNG 287

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 50/302 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 106
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 72  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 123
Query: 167 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 124 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           +          D+WS G +   LL G   F GE+  + L              I  +N +
Sbjct: 183 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYD 229
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           + E  F                   A D + R     P  R T  ++  H +   +R  N
Sbjct: 230 FDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
Query: 344 TR 345
            R
Sbjct: 277 VR 278

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 38/246 (15%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 113
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 114 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 210
           +YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 211 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
            S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKL 241
Query: 270 GTPTRE 275
            + + E
Sbjct: 242 RSVSIE 247

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 99
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 100 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 160 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 214
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 179
Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 275 EEIKCMNPNYTEF 287
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 99
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 100 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 160 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 214
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVG 178
Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 275 EEIKCMNPNYTEF 287
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 47  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 96
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 10  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 155
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 119
Query: 156 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 206
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 120 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 175
Query: 207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 176 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 38/246 (15%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 113
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 114 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 210
           +YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 211 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
            S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKL 241
Query: 270 GTPTRE 275
            + + E
Sbjct: 242 RSVSIE 247

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 38/221 (17%)
Query: 47  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 96
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 9   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 155
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 118
Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 206
           Y+ QIC+ + Y+    C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 119 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 174
Query: 207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 175 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 142 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL---KLCD 196
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L   H +Q+   K+CD
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCE-HPNQVSPVKICD 157
Query: 197 FG-SAKVLVKGE------PNVSYIC-SRYYRAPELIFGATE----YTTAIDIWSTGCVMA 244
           FG  + + + G+      P +   C S  Y APE++   +E    Y    D+WS G ++ 
Sbjct: 158 FGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 245 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 304
            LL G P F G  G D   +  +    P  + +   +    +++FP      W       
Sbjct: 218 ILLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AH 267
Query: 305 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
           +   A DL+ +        R +A +   HP+       NT
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 99
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 100 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 160 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 214
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 178
Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 275 EEIKCMNPNYTEF 287
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 38/221 (17%)
Query: 47  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 96
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 22  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 155
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 131
Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 206
           Y+ QIC+ + Y+    C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 132 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 187
Query: 207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 188 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 117
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 120
Query: 118 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 177
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 175
Query: 178 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 231
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 234
Query: 232 TAIDIWSTGCVMAELLLG 249
             +DIWS+ C+M  +L G
Sbjct: 235 AKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 117
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 136
Query: 118 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 177
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 191
Query: 178 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 231
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 192 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 250
Query: 232 TAIDIWSTGCVMAELLLG 249
             +DIWS+ C+M  +L G
Sbjct: 251 AKVDIWSSCCMMLHMLNG 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 106
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 94  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + +   + HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LSDMSAV-HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G VM E++
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 148 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 207
           +P+  +K     +  + +YIHN   ICHRD+KP N+L++ +  ++KL DFG ++ +V  +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKK 206
Query: 208 PNVSYICSRYYRAPELIFGATEYTTA-IDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
              S   +  +  PE     + Y  A +DIWS G  +  +      F  +     LVE+ 
Sbjct: 207 IKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELF 262
Query: 267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR-------LPPEAVDLVCRFFQY 319
             + T   E             +P  + H  + +  K+       L  E +D +  F + 
Sbjct: 263 NNIRTKNIE-------------YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309
Query: 320 SPNLRCTALEACVHPFF-----DELRDPNTRLPNGR 350
           +P  R T+ +A  H +      ++LR+ +  L   R
Sbjct: 310 NPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 22/223 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 109
           V+G G+FG V   K +   ++ A+K + + +  K         E  ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           H  F   +               T+       S+   R+P    + Y  ++  A+  +H 
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTL------LSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 224
            +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++   
Sbjct: 194 -LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 225 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
             G   Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQMLDHPNIVALKHCFFSTT 116
           +G GS+G VF+ + +E G + A+K+ +   R  K+R  ++ ++  H  +     C     
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV--RL 122
Query: 117 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 176
           ++                  + ++       +P   V  Y      ALA++H+  G+ H 
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHL 181
Query: 177 DIKPQNLLVNPHTHQLKLCDFG--------SAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
           D+KP N+ + P   + KL DFG         A  + +G+P         Y APEL+ G+ 
Sbjct: 182 DVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPELLQGS- 231
Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 262
            Y TA D++S G  + E+     L  G  G  QL
Sbjct: 232 -YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 38/221 (17%)
Query: 47  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 96
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 6   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 155
           ++ L    IV  +   +                     +   R++ + H+ R+    + L
Sbjct: 62  LKALHSDFIVKYRGVSYGPG------RPELRLVMEYLPSGCLRDFLQRHRARLDASRLLL 115
Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 206
           Y+ QIC+ + Y+    C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 116 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVR 171
Query: 207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 172 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 106
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 73  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G VM E++
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 106
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 79  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G VM E++
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 28/234 (11%)
Query: 38  TIGG-RNGNSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE 93
           ++GG + G +++ V  +   ++G G FG V++       GE   VA+K   +D    N+E
Sbjct: 1   SMGGPQYGIAREDV--VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE 58
Query: 94  -----LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM 148
                  IM+ LDHP+IV L        ++                + + RN       +
Sbjct: 59  KFMSEAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSL 110
Query: 149 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
            ++ + LY+ QIC+A+AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E 
Sbjct: 111 KVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDED 167
Query: 209 NVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGES 257
                 +R    + +PE I     +TTA D+W     M E+L    QP F  E+
Sbjct: 168 YYKASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 99
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 100 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 159
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 160 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 214
           +CR    AL ++H+   + HR+IK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 215 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 275 EEIKCMNPNYTEF 287
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 117
           +G GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 134
Query: 118 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 177
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 189
Query: 178 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 231
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 248
Query: 232 TAIDIWSTGCVMAELLLG 249
             +DIWS+ C+M  +L G
Sbjct: 249 AKVDIWSSCCMMLHMLNG 266

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 117
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 136
Query: 118 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 177
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 191
Query: 178 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 231
           +K  N+L++       LCDFG A  L         +   Y      + APE++ G +   
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CD 250
Query: 232 TAIDIWSTGCVMAELLLG 249
             +D+WS+ C+M  +L G
Sbjct: 251 AKVDVWSSCCMMLHMLNG 268

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 25/221 (11%)
Query: 41  GRNGNSKQKVSYI-AEHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN-- 91
           GR+   + + S I  E ++G+G  G V   + R  G+      I A+K    +++ ++  
Sbjct: 39  GRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 92  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 151
            E  IM   DHPNI+ L+        +              +++   R +      M L+
Sbjct: 99  SEASIMGQFDHPNIIRLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
            +      +   + Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +
Sbjct: 155 GM---LRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAA 208
Query: 212 YICSR-----YYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
           Y  +       + APE I   T +++A D+WS G VM E+L
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 15/218 (6%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 104
            Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV         T+                +  +    ++  Q +   +V     Q+  AL
Sbjct: 67  IVRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 165 AYIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 219
              H        + HRD+KP N+ ++     +KL DFG A++L   E     ++ + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
           +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 34/208 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 112
           +G GSFG V++     T E+VAIK +       +     +E+ ++   D P I      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI--------YVKLYTYQICRAL 164
             +T                    I   Y      + L+        Y+     +I + L
Sbjct: 87  LKSTKLW-----------------IIMEYLGGGSALDLLKPGPLEETYIATILREILKGL 129
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPEL 223
            Y+H+   I HRDIK  N+L++     +KL DFG A  L   +     ++ + ++ APE+
Sbjct: 130 DYLHSERKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 187
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQP 251
           I   + Y    DIWS G    EL  G+P
Sbjct: 188 I-KQSAYDFKADIWSLGITAIELAKGEP 214

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 83/193 (43%), Gaps = 31/193 (16%)
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDF--GSAKVLVKG-----EPNV 210
           +  AL ++H   GI HRD+KP+N+L         +K+CDF  GS   L         P +
Sbjct: 120 VAAALDFLHT-KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 211 SYIC-SRYYRAPELI----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QL 262
           +  C S  Y APE++      AT Y    D+WS G V+  +L G P F G  G D     
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDR 238
Query: 263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 322
            E+ +V      E I+       +++FP      W       +  EA DL+ +       
Sbjct: 239 GEVCRVCQNKLFESIQ-----EGKYEFPD---KDW-----AHISSEAKDLISKLLVRDAK 285
Query: 323 LRCTALEACVHPF 335
            R +A +   HP+
Sbjct: 286 QRLSAAQVLQHPW 298

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 123/295 (41%), Gaps = 38/295 (12%)
Query: 43  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN------ 91
            G   QK S ++   +G+G+FG V+ A  +E  + V +K     KVL+D   ++      
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 92  -RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 150
             E+ I+  ++H NI+ +   F     +               ++  A  +   H R+  
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFA--FIDRHPRLDE 129
Query: 151 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
                   Q+  A+ Y+     I HRDIK +N+++      +KL DFGSA  L +G+   
Sbjct: 130 PLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFY 187
Query: 211 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVD--------- 260
           ++  +  Y APE++ G       +++WS G  +  L+  + P    E  V+         
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 261 --QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ---IKPHPWHKVFQKRLPPEAV 310
             +L+ ++  L  P  E    +    T+    Q   +  + W +VF+   P   V
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGV 302

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 53  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 104
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 27  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 86
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 87  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 138
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
           AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +P
Sbjct: 139 AYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 195
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGES 257
           E I     +TTA D+W     M E+L    QP F  E+
Sbjct: 196 ESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 53  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 104
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 11  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 70
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 71  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 122
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
           AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +P
Sbjct: 123 AYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 179
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGES 257
           E I     +TTA D+W     M E+L    QP F  E+
Sbjct: 180 ESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 50/302 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 106
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 93  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 144
Query: 167 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 145 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           +          D+WS G +   LL G   F GE+  + L              I  +N +
Sbjct: 204 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYD 250
Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
           + E  F                   A D + R     P  R    ++  H +   +R  N
Sbjct: 251 FDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297
Query: 344 TR 345
            R
Sbjct: 298 VR 299

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 58  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 108
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 89  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 142
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAPEL 223
                  HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ APE 
Sbjct: 143 -GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           +   +++  A D+WS G  + ELL
Sbjct: 201 LM-QSKFYIASDVWSFGVTLHELL 223

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALK 109
           V+G G+FG V   K + T  I A+K + + +  K         E  ++   D   I AL 
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 156
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 157 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 224
            +   HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++   
Sbjct: 210 -LHYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 225 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 310

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALK 109
           V+G G+FG V   K + T  I A+K + + +  K         E  ++   D   I AL 
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 140
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 141 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 224
            +   HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++   
Sbjct: 194 -LHYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 225 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 142 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL---KLCD 196
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L   H +Q+   K+CD
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCE-HPNQVSPVKICD 157
Query: 197 FG-SAKVLVKGE------PNVSYIC-SRYYRAPELIFGATE----YTTAIDIWSTGCVMA 244
           F   + + + G+      P +   C S  Y APE++   +E    Y    D+WS G ++ 
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 245 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 304
            LL G P F G  G D   +  +    P  + +   +    +++FP      W       
Sbjct: 218 ILLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AH 267
Query: 305 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
           +   A DL+ +        R +A +   HP+       NT
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 58  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 108
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 77  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 130
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAPEL 223
                  HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ APE 
Sbjct: 131 -GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           +   +++  A D+WS G  + ELL
Sbjct: 189 LM-QSKFYIASDVWSFGVTLHELL 211

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPN+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        +               ++   R +     +  +I +      I   + Y
Sbjct: 108 HLE----GVVTRGKPVMIVIEFMENGALDAFLRKHD---GQFTVIQLVGMLRGIAAGMRY 160
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + AP
Sbjct: 161 LAD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G VM E++
Sbjct: 218 EAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPNI+
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   +   +   +  +I +      I   + Y
Sbjct: 87  HLE----GVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMKY 139
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 140 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 196
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G VM E++
Sbjct: 197 EAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 2/95 (2%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +Q+  A+ + HN  G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 30/261 (11%)
Query: 58  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 106
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 161
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 218
           + + ++ +   I HRD+  +N+L++   + +K+CDFG A+ + K    V    +R    +
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRLKEGT 264
Query: 278 KCMNPNYTEFKFPQIKPHPWH 298
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 108 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 160
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 161 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 217
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 218 EAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 191
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL---------QIMQMLDHPNIVAL 108
           +G G FGVVF+AK +      AIK++    R  NREL         + +  L+HP IV  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 109 KHCFF--STTDKXXXXXXXXXXXXXXTVNR------IARNYSRIHQRMPLIYVKLYTYQI 160
            + +   +TT+K               + R             I +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL-QI 127
Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNVSY- 212
             A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 213 -----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
                + ++ Y +PE I G + Y+  +DI+S G ++ ELL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 98  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 150
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 151 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 207
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 208 EAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 191
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 113
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 114 STTDKXXXXXXXXXXXX---XXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
              +                  +V  + +N       +   ++     +I R L+++H  
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 148
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 225
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 149 -KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 205
Query: 226 --GATEYTTAIDIWSTGCVMAELLLGQP 251
              AT Y    D+WS G    E+  G P
Sbjct: 206 NPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 25/225 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 106
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 79  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 130
Query: 167 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           +          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 148 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 207
           + L ++  Y++Q+ + + ++ +   I HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 208 PNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLV 263
             V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I    ++T+A D+WS G V+ E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 111
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 167 IHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 219
           +HN    I HRD+K  NLLV+   + +K+CDFG +++         ++ S+       + 
Sbjct: 153 LHNRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWM 206
Query: 220 APELIFGATEYTTAIDIWSTGCVMAEL-LLGQP 251
           APE++        + D++S G ++ EL  L QP
Sbjct: 207 APEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 200
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 243
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 244 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 296
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 297 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 332

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 252
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 305
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 306 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 341

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 250
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 303
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 304 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 339

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 50  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 100
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 159
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 73  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 124
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 216
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 217 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
               + APE I    ++T+A D WS G VM E++
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 245
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 298
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 299 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 15/218 (6%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 104
            Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV         T+                +  +    ++  Q +   +V     Q+  AL
Sbjct: 67  IVRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 165 AYIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 219
              H        + HRD+KP N+ ++     +KL DFG A++L        +++ + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
           +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 117
           +G GSFG VF+     T ++VAIK +  D      E++ +Q      I  L  C  S   
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQ----EITVLSQCDSSYVT 84
Query: 118 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNCIGICH 175
           K                     +   + +  P    ++ T   +I + L Y+H+   I H
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI-H 143
Query: 176 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAI 234
           RDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + Y +  
Sbjct: 144 RDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKA 201
Query: 235 DIWSTGCVMAELLLGQP 251
           DIWS G    EL  G+P
Sbjct: 202 DIWSLGITAIELAKGEP 218

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 200
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 15/218 (6%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 104
            Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV         T+                +  +    ++  Q +   +V     Q+  AL
Sbjct: 67  IVRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 165 AYIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 219
              H        + HRD+KP N+ ++     +KL DFG A++L        +++ + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
           +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 200
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 101/260 (38%), Gaps = 72/260 (27%)
Query: 145 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN---------------------- 182
           +Q +P+  VK    Q+ + L Y+H+   I H DIKP+N                      
Sbjct: 134 YQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQK 193
Query: 183 ------------------LLVNP------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 218
                             LLVNP         ++K+ D G+A  + K       I +R Y
Sbjct: 194 AGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQY 251
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTP 272
           R+ E++ GA  Y+T  DIWST C+  EL  G  LF   SG       D +  II++LG+ 
Sbjct: 252 RSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSI 310
Query: 273 TREEIKCMNPNYTEFKF---------PQIKPHPWHKVFQKRL------PPEAVDLVCRFF 317
            R     ++  Y+   F          ++KP     V  ++         +  D +    
Sbjct: 311 PRH--FALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPML 368
Query: 318 QYSPNLRCTALEACVHPFFD 337
           +  P  R +A E   HP+ +
Sbjct: 369 EMVPEKRASAGECLRHPWLN 388

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 191
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 191
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 237
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 238 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 290
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 291 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGKFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 202
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 203 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 255
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 256 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 291

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILIGELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 148 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 200
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 55  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 106
           E ++G+G  G V   + R  G+      I A+K    +++ ++   E  IM   DHPNI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        +              +++   R +      M L+ +      +   + Y
Sbjct: 114 RLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMRY 166
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 221
           + + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +       + AP
Sbjct: 167 LSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWTAP 223
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E I   T +++A D+WS G VM E+L
Sbjct: 224 EAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 70/260 (26%)
Query: 145 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------------- 185
           +Q +PL  VK    Q+ + L Y+H    I H DIKP+N+L+                   
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 186 -----------------------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
                                        N    ++K+ D G+A  + K       I +R
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTR 257
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLG 270
            YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II++LG
Sbjct: 258 QYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 271 TPTREEIKCMNPNYTEFK-------FPQIKPHPWHKVFQKRLP---PEAV---DLVCRFF 317
              R+ I     +   F          ++KP    +V  ++      EA    D +    
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 376
Query: 318 QYSPNLRCTALEACVHPFFD 337
           +  P  R TA E   HP+ +
Sbjct: 377 ELIPEKRATAAECLRHPWLN 396

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGVFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 111
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 167 IHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 219
           +HN    I HR++K  NLLV+   + +K+CDFG +++        +++ S+       + 
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWM 206
Query: 220 APELIFGATEYTTAIDIWSTGCVMAEL-LLGQP 251
           APE++        + D++S G ++ EL  L QP
Sbjct: 207 APEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 70/260 (26%)
Query: 145 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------------- 185
           +Q +PL  VK    Q+ + L Y+H    I H DIKP+N+L+                   
Sbjct: 124 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 183
Query: 186 -----------------------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
                                        N    ++K+ D G+A  + K       I +R
Sbjct: 184 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTR 241
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLG 270
            YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II++LG
Sbjct: 242 QYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 300
Query: 271 TPTREEIKCMNPNYTEFK-------FPQIKPHPWHKVFQKRLP---PEAV---DLVCRFF 317
              R+ I     +   F          ++KP    +V  ++      EA    D +    
Sbjct: 301 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 360
Query: 318 QYSPNLRCTALEACVHPFFD 337
           +  P  R TA E   HP+ +
Sbjct: 361 ELIPEKRATAAECLRHPWLN 380

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 113
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 114 STTDKXXXXXXXXXXXXXXTVNRIARN---YSRIH------QRMPLIYVKLYTYQICRAL 164
              +                      N   Y  IH      QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 210
           +YIH+  GI HR++KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 211 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
            S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+K L
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNILKKL 241
Query: 270 GTPTRE 275
            + + E
Sbjct: 242 RSVSIE 247

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 100/231 (43%), Gaps = 18/231 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ----MLDHP 103
           Q+  +    V+G G+F  V   K ++TG++ A+K + +    K  E+   +    +L + 
Sbjct: 59  QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           +   +    F+  D+               +  +    S+  +R+P    + Y  +I  A
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMA 174
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGE-PNVSYICSRYYRAP 221
           +  +H  +G  HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +P
Sbjct: 175 IDSVHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 222 ELIFGATEYTTAI------DIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
           E++                D W+ G    E+  GQ  F  +S  +   +I+
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H+ + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 104
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 55  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           E V+G G FG V     +  G+    VAIK +      K R     E  IM   DHPN++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R       +  +I +      I   + Y
Sbjct: 98  HLE----GVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKY 150
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 220
           + + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 151 LAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELL 247
           PE I    ++T+A D+WS G VM E++
Sbjct: 209 PEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 55  EHVVGTGSFGVVFQAKCRETG---EI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 105
           + V+G G FG V++   + +    E+ VAIK +      K R     E  IM    H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           + L+        K               +++  R        + L+ +      I   + 
Sbjct: 109 IRLEGVI----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM---LRGIAAGMK 161
Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRA 220
           Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + A
Sbjct: 162 YLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTA 218
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELL 247
           PE I    ++T+A D+WS G VM E++
Sbjct: 219 PEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 58  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 108
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           K C                           R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 151
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYRAP 221
               I HRD+  +N+L++ +   +K+ DFG AK + +G       E   S +   ++ AP
Sbjct: 152 AQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FWYAP 206
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E +    ++  A D+WS G  + ELL
Sbjct: 207 ECL-KEYKFYYASDVWSFGVTLYELL 231

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 58  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 108
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 221
           +   I HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 135 SQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 189
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E +    ++  A D+WS G  + ELL
Sbjct: 190 ECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/332 (20%), Positives = 118/332 (35%), Gaps = 77/332 (23%)
Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------- 91
           G +G+  Q   Y  +  +G GS+GVV  A         A+K + + K  +          
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 92  ---------------------RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXX--- 127
                                +E+ I++ LDHPN+V L        +             
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 128 -XXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 186
                 T+  ++ + +R            Y   + + + Y+H    I HRDIKP NLLV 
Sbjct: 124 PVMEVPTLKPLSEDQAR-----------FYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG 171
Query: 187 PHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEYTT--AIDIWSTGCVM 243
              H +K+ DFG +      +  +S  + +  + APE +    +  +  A+D+W+ G  +
Sbjct: 172 EDGH-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 244 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 303
              + GQ  F                     E I C++         +IK        Q 
Sbjct: 231 YCFVFGQCPF-------------------MDERIMCLH--------SKIKSQALEFPDQP 263
Query: 304 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            +  +  DL+ R    +P  R    E  +HP+
Sbjct: 264 DIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 30/261 (11%)
Query: 58  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 106
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 161
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 218
           + + ++ +   I HRD+  +N+L++   + +K+ DFG A+ + K    V    +R    +
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXRRLKEGT 264
Query: 278 KCMNPNYTEFKFPQIKPHPWH 298
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 104
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 223
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           + G  EY  ++D ++ G  + E++
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 104
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 223
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           + G  EY  ++D ++ G  + E++
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 104
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 223
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           + G  EY  ++D ++ G  + E++
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 104
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 223
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           + G  EY  ++D ++ G  + E++
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 58  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 108
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 221
               I HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 135 AQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 189
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E +    ++  A D+WS G  + ELL
Sbjct: 190 ECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 128/300 (42%), Gaps = 47/300 (15%)
Query: 49  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIV 106
           K+S+  + V+G G+ G +      +  + VA+K++L +   + +RE+Q+++  D HPN++
Sbjct: 23  KISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVI 81
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
                 +  T+K              T+          H  +  I +     Q    LA+
Sbjct: 82  R-----YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL---LQQTTSGLAH 133
Query: 167 IHNCIGICHRDIKPQNLLVN-PHTH---QLKLCDFGSAKVLVKGEPNVSYIC----SRYY 218
           +H+ + I HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 219 RAPELIFGATEY--TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
            APE++    +   T  +DI+S GCV    ++ +   P    + +   I+  LG  +   
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS--- 246
Query: 277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + C++P                   +K     A +L+ +     P  R +A     HPFF
Sbjct: 247 LDCLHP-------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 121/318 (38%), Gaps = 79/318 (24%)
Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 101
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 102 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 162 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 215
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK    GE        
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE-------- 173
Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
                        +Y  + D+WS G +M  LL G P F    G    + I   + T  R 
Sbjct: 174 -------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIR- 215
Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                     +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 216 --------MGQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 259
Query: 336 -FDELRDPNTRLPNGRPL 352
                + P T L   R L
Sbjct: 260 IMQSTKVPQTPLHTSRVL 277

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 50  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 100
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 101 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 159
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 75  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 126
Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 216
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 217 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
               + APE I    ++T+A D WS G VM E++
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/215 (21%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G FG V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 9   ERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 69  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 122
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 123 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 179
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 255
           E +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 180 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 67/131 (51%), Gaps = 19/131 (14%)
Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-- 203
           Q++P+     Y  +I  AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +  
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINS 233
Query: 204 ---VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
              + G P         ++APE++   T  T A DI++ G  +A L L  P   G   VD
Sbjct: 234 FGYLYGTPG--------FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VD 282
Query: 261 QLVEIIKVLGT 271
            L E   VL T
Sbjct: 283 GLPEDDPVLKT 293

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 22/223 (9%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 106
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 107 ALKHCFFSTTDKXXXXXXXXXX-XXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
            L      TT +               TV     N   + +   LI ++     +   + 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVGGMN 126
Query: 166 YIHNCIGICHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
           ++    GI HR+IKP N++  +      + KL DFG+A+ L   E  VS   +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 223 LIFGAT-------EYTTAIDIWSTGCVMAELLLGQ-PLFPGES 257
           +   A        +Y   +D+WS G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 58  VGTGSFGVV----FQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIVAL 108
           +G G FG V    +      TGE+VA+K +      Q +    RE++I++ L H +IV  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSL------RDYLPRHC-VGLAQLLLFAQQICEGMAYLH 128
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 221
               I HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 129 AQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 183
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E +    ++  A D+WS G  + ELL
Sbjct: 184 ECL-KECKFYYASDVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 58  VGTGSFGVV----FQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIVAL 108
           +G G FG V    +      TGE+VA+K +      Q +    RE++I++ L H +IV  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSL------RDYLPRHC-VGLAQLLLFAQQICEGMAYLH 129
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 221
               I HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 130 AQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 184
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL 247
           E +    ++  A D+WS G  + ELL
Sbjct: 185 ECL-KECKFYYASDVWSFGVTLYELL 209

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK--------NRELQIMQMLDHP 103
           Y+   ++G GS+G V +    ET    A+K + + K  +         +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           N++ L    ++   +               +       S   +R P+     Y  Q+   
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD-----SVPEKRFPVCQAHGYFCQLIDG 121
Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRA 220
           L Y+H+  GI H+DIKP NLL+      LK+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 221 PELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--------LGT 271
           PE+  G   ++   +DIWS G  +  +  G   F G++ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 272 PTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 307
           P  + +K M    P    F   QI+ H W   F+K+ PP
Sbjct: 239 PLSDLLKGMLEYEPA-KRFSIRQIRQHSW---FRKKHPP 273

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 29/245 (11%)
Query: 41  GRNGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK---- 90
           G     +QKV   Y     +G+G F +V   KCRE  TG   A K  K  Q +  +    
Sbjct: 1   GMETFKQQKVEDFYDIGEELGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVC 58
Query: 91  ----NRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ 146
                RE+ I++ + HPNI+ L   + + TD                 + +A+  S + +
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSE 114
Query: 147 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL 203
                ++K    QI   + Y+H    I H D+KP+N+++   N     +KL DFG A  +
Sbjct: 115 EEATSFIK----QILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
             G    +   +  + APE++          D+WS G +   LL G   F G++  + L 
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 264 EIIKV 268
            I  V
Sbjct: 229 NITAV 233

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 97/223 (43%), Gaps = 17/223 (7%)
Query: 40  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQI 96
           G  +    ++     +H +G G +G V++   ++    VA+K + +D        +E  +
Sbjct: 1   GSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 60
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 156
           M+ + HPN+V L         +               +    R  +R  Q +  + +   
Sbjct: 61  MKEIKHPNLVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYM 114
Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
             QI  A+ Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  ++
Sbjct: 115 ATQISSAMEYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAK 171
Query: 217 Y---YRAPELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 255
           +   + APE +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 172 FPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 22/223 (9%)
Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 106
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 107 ALKHCFFSTTDKXXXXXXXXXX-XXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
            L      TT +               TV     N   + +   LI ++     +   + 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVGGMN 126
Query: 166 YIHNCIGICHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
           ++    GI HR+IKP N++  +      + KL DFG+A+ L   E  V    +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 223 LIFGAT-------EYTTAIDIWSTGCVMAELLLGQ-PLFPGES 257
           +   A        +Y   +D+WS G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 129
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 2/92 (2%)
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 218
           Q+  A+ + H+  G+ HRDIK +N+L++      KL DFGS   L+  EP   +  +R Y
Sbjct: 147 QVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVY 204
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
             PE I     +     +WS G ++ +++ G 
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ------IMQMLDHPN 104
           ++  ++++G G FG V++ +  + G +VA+K+ L+++R +  ELQ      ++ M  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGRLAD-GXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQI--CR 162
           ++ L+    + T++               +        R   + PL + K     +   R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 142
Query: 163 ALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY--Y 218
            LAY+H+     I HRD+K  N+L++     + + DFG AK++   + +V         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            APE +    + +   D++  G ++ EL+ GQ  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 168
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 223
           +     HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE 
Sbjct: 509 SK-RFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 563
Query: 224 IFGATEYTTAIDIWSTGCVMAELLL 248
           I     +T+A D+W  G  M E+L+
Sbjct: 564 I-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ------IMQMLDHPN 104
           ++  ++++G G FG V++ +  + G +VA+K+ L+++R +  ELQ      ++ M  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGRLAD-GTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQI--CR 162
           ++ L+    + T++               +        R   + PL + K     +   R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 150
Query: 163 ALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY--Y 218
            LAY+H+     I HRD+K  N+L++     + + DFG AK++   + +V         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 253
            APE +    + +   D++  G ++ EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 72  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 125
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 126 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 182
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 183 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 227

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 75  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 128
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 129 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 185
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 186 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 230

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 124
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 9   ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 69  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 122
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 123 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAP 179
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 255
           E +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 180 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 168
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 78  GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 223
           +     HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE 
Sbjct: 129 S-KRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 183
Query: 224 IFGATEYTTAIDIWSTGCVMAELLL 248
           I     +T+A D+W  G  M E+L+
Sbjct: 184 I-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 55  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           E V+G G FG V     +  G+    VAIK +      K R     E  IM   DHPN++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 107 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L+        K              +++   R       +  +I +      I   + Y
Sbjct: 72  HLE----GVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKY 124
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 220
           + + +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 125 LAD-MNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELL 247
           PE I    ++T+A D+WS G VM E++
Sbjct: 183 PEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 124
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 57  VVGTGSFGVVFQAKC---RETGEIVAIK-KVLQDKRYKNR------ELQIM-QMLDHPNI 105
           V+G+G+FG V  A      +TG  + +  K+L++K   +       EL++M Q+  H NI
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 106 VALK---------HCFFSTTDKXXXXXXXXXXXXXXTVNRIA-RNYSRIHQRMPLIYVKL 155
           V L          +  F                   + + I   N  R+ +   L  +  
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 156 -----YTYQICRALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 208
                + YQ+ + + ++   +C+   HRD+  +N+LV  H   +K+CDFG A+ ++    
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVT-HGKVVKICDFGLARDIMSDSN 227
Query: 209 NVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            V    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 224
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 225 FGATEYTTAIDIWSTGCVMAELLL 248
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 24  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 83
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 84  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 137
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 138 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 194
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 195 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 239

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 81  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 132
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 224
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 133 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 187
Query: 225 FGATEYTTAIDIWSTGCVMAELLL 248
                +T+A D+W  G  M E+L+
Sbjct: 188 -NFRRFTSASDVWMFGVCMWEILM 210

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 80  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 131
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 224
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 132 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 186
Query: 225 FGATEYTTAIDIWSTGCVMAELLL 248
                +T+A D+W  G  M E+L+
Sbjct: 187 -NFRRFTSASDVWMFGVCMWEILM 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 75  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 126
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 224
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 127 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 181
Query: 225 FGATEYTTAIDIWSTGCVMAELLL 248
                +T+A D+W  G  M E+L+
Sbjct: 182 -NFRRFTSASDVWMFGVCMWEILM 204

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 106 GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 157
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 224
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 158 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 212
Query: 225 FGATEYTTAIDIWSTGCVMAELLL 248
                +T+A D+W  G  M E+L+
Sbjct: 213 -NFRRFTSASDVWMFGVCMWEILM 235

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  + ++   +  +   +    Q  R + Y+H  
Sbjct: 72  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLH-A 126
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF-- 225
             I HRD+K  N+ ++   + +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 127 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 224
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 225 FGATEYTTAIDIWSTGCVMAELLL 248
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 83  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 134
Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 224
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 135 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 189
Query: 225 FGATEYTTAIDIWSTGCVMAELLL 248
                +T+A D+W  G  M E+L+
Sbjct: 190 -NFRRFTSASDVWMFGVCMWEILM 212

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 53  IAEHVVGTGSFGVVFQA--KCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNI 105
           IA+  +G G+FG V Q   + R+    VAIK + Q     D     RE QIM  LD+P I
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L     +                   V +         + +P+  V    +Q+   + 
Sbjct: 73  VRLIGVCQAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMGMK 124
Query: 166 YIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------- 217
           Y+       HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        
Sbjct: 125 YLEE-KNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 178
Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELL 247
           + APE I    ++++  D+WS G  M E L
Sbjct: 179 WYAPECI-NFRKFSSRSDVWSYGVTMWEAL 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 168
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 223
           +     HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE 
Sbjct: 509 SK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 563
Query: 224 IFGATEYTTAIDIWSTGCVMAELLL 248
           I     +T+A D+W  G  M E+L+
Sbjct: 564 I-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 278 LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 331
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HR++  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 332 EYLEKK-NFIHRNLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 388
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 389 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 433

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 39  IGGRNGNSKQKVSYIAEHV----------VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 88
           +G +N  S   + Y +  +          +GTG FGVV   K R   + VAIK + +   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM 61
Query: 89  YKN---RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 145
            ++    E ++M  L H  +V L   +   T +               +N +     R  
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
            +  L   K     +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++ 
Sbjct: 119 TQQLLEMCK----DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 172
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAEL 246
            E   S + S++   +  PE++   +++++  DIW+ G +M E+
Sbjct: 173 DEETSS-VGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEI 214

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 257 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 316
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 317 LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 370
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HR++  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 371 EYLEKK-NFIHRNLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 427
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 428 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 472

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 105
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----------L 155
           V L     + T                 +N + R  SR+ +  P   +            
Sbjct: 113 VNL---LGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTASTRDLLH 168
Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 169 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 214 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 225 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 105
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----------L 155
           V L     + T                 +N + R  SR+ +  P   +            
Sbjct: 113 VNL---LGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTLSTRDLLH 168
Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 169 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 214 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 225 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 105
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 166 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  + ++   +  LI +     Q  R + Y+H  
Sbjct: 84  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMK-KLIDI---ARQTARGMDYLH-A 138
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIF-- 225
             I HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 131/343 (38%), Gaps = 52/343 (15%)
Query: 57  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 108
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 76  RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 169 NCIGICHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 273
             L      Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 274 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 318
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 249 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 303
Query: 319 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 359
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 304 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 346

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 53  IAEHVVGTGSFGVVFQA--KCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNI 105
           IA+  +G G+FG V Q   + R+    VAIK + Q     D     RE QIM  LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L     +                   V +         + +P+  V    +Q+   + 
Sbjct: 399 VRLIGVCQAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMGMK 450
Query: 166 YIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------- 217
           Y+       HR++  +N LLVN   H  K+ DFG +K L   +   SY  +R        
Sbjct: 451 YLEE-KNFVHRNLAARNVLLVN--RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504
Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELL 247
           + APE I    ++++  D+WS G  M E L
Sbjct: 505 WYAPECI-NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 105
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 166 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 131/343 (38%), Gaps = 52/343 (15%)
Query: 57  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 108
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 92  RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 169 NCIGICHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 273
             L      Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 274 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 318
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 265 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 319
Query: 319 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 359
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 105
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 104
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 163
           V L                         + R A          PL    L  ++ Q+ + 
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 164
Query: 164 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 218
           +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +    +R    +
Sbjct: 165 MAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 221 MAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 105
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 166 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 105
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 163
           V L                         + R A          PL    L  ++ Q+ + 
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 172
Query: 164 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 218
           +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +    +R    +
Sbjct: 173 MAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 229 MAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 39  IGGRNGNSKQKVSYIAEHV----------VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 88
           +G +N  S   + Y +  +          +GTG FGVV   K R   + VAIK + +   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM 61
Query: 89  YKN---RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 145
            ++    E ++M  L H  +V L   +   T +               +N +     R  
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
            +  L   K     +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++ 
Sbjct: 119 TQQLLEMCK----DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 172
Query: 206 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAEL 246
            E   S + S++   +  PE++   +++++  DIW+ G +M E+
Sbjct: 173 DEYTSS-VGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEI 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   +   +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 183
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 105
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 166 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 105 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 72  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 125
Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 221
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   +   +++   + AP
Sbjct: 126 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 182
Query: 222 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 267
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 183 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 227

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 105
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 106 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 166 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 78
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 133
Query: 175 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 231
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 134 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 190
Query: 232 TAIDIWSTGCVMAEL 246
           +  DIW+ G +M E+
Sbjct: 191 SKSDIWAFGVLMWEI 205

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 71
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 126
Query: 175 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 231
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 127 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 183
Query: 232 TAIDIWSTGCVMAEL 246
           +  DIW+ G +M E+
Sbjct: 184 SKSDIWAFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 72
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 127
Query: 175 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 231
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 128 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 184
Query: 232 TAIDIWSTGCVMAEL 246
           +  DIW+ G +M E+
Sbjct: 185 SKSDIWAFGVLMWEI 199

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 114
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 67
Query: 115 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 122
Query: 175 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 231
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 123 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 179
Query: 232 TAIDIWSTGCVMAEL 246
           +  DIW+ G +M E+
Sbjct: 180 SKSDIWAFGVLMWEI 194

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 48  QKVSYIAEHVVGTGSFGVVF------QAKCRETGEIVAIKKVLQDKRYKN--RELQIMQM 99
           ++V   ++ V+G G FGVV+      QA+ R    I ++ ++ + ++ +   RE  +M+ 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 100 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-YTY 158
           L+HPN++AL                          +     + R  QR P +   + +  
Sbjct: 79  LNHPNVLALIGIMLPPEG-------LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 218
           Q+ R + Y+       HRD+  +N +++  +  +K+ DFG A+ ++  E   S    R+ 
Sbjct: 132 QVARGMEYLAEQ-KFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHRHA 188
Query: 219 RAPELIFGATE------YTTAIDIWSTGCVMAELL 247
           R P + + A E      +TT  D+WS G ++ ELL
Sbjct: 189 RLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 67/306 (21%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L     S T                 +  +  +   I  ++ L +      QI + + Y+
Sbjct: 105 LLGVCLSPT----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC----VQIAKGMMYL 156
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 224
                + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E I
Sbjct: 157 EER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 225 FGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
               ++T   D+WS G  + EL+   G+P                  G PTRE      P
Sbjct: 215 H-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTRE-----IP 252
Query: 283 NYTE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
           +  E   + PQ              PP     +C    Y   ++C  ++A   P F EL 
Sbjct: 253 DLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFKELA 293
Query: 341 DPNTRL 346
              +R+
Sbjct: 294 AEFSRM 299

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGXLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 39/232 (16%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 105
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 38  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 97
Query: 106 VAL--------------KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 151
           V L              ++C +                      +      +   R PL 
Sbjct: 98  VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR-PLE 156
Query: 152 YVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 207
              L  ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++   
Sbjct: 157 LRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDS 212
Query: 208 PNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
             +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 213 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 40  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQI 96
           GG      + ++++ E  +GTG FGVV   K R   + VAIK + +    ++    E ++
Sbjct: 1   GGSWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKV 57
Query: 97  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 156
           M  L H  +V L   +   T +               +N +     R   +  L   K  
Sbjct: 58  MMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK-- 112
Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
              +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++  E    Y  SR
Sbjct: 113 --DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDE----YTSSR 164
Query: 217 YYR-----APELIFGATEYTTAIDIWSTGCVMAEL 246
             +     +P  +   +++++  DIW+ G +M E+
Sbjct: 165 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 83  LLGICLTSTVQLIMQLMPFGXLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 134 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 192 ILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 67/306 (21%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L     S T                 +  +  +   I  ++ L +      QI + + Y+
Sbjct: 82  LLGVCLSPT----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW----CVQIAKGMMYL 133
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 224
                + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E I
Sbjct: 134 EER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 225 FGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
               ++T   D+WS G  + EL+   G+P                  G PTRE      P
Sbjct: 192 H-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTRE-----IP 229
Query: 283 NYTE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
           +  E   + PQ              PP     +C    Y   ++C  ++A   P F EL 
Sbjct: 230 DLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFKELA 270
Query: 341 DPNTRL 346
              +R+
Sbjct: 271 AEFSRM 276

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 137 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 195 ILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 48  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 104
           ++     +H +G G +G V+    ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 30  ERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 89
Query: 105 IVALKHC------FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--Y 156
           +V L         F+  T+                      +Y R   R  +  V L   
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLL--------------DYLRECNREEVTAVVLLYM 135
Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
             QI  A+ Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  ++
Sbjct: 136 ATQISSAMEYLEKK-NFIHRDLAARNCLVGEN-HVVKVADFGLSR-LMTGDTYTAHAGAK 192
Query: 217 Y---YRAPELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 255
           +   + APE +   T ++   D+W+ G ++ E+   G   +PG
Sbjct: 193 FPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPG 234

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   +                  + +  + ++   +  LI +     Q  R + Y+H  
Sbjct: 84  LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMK-KLIDI---ARQTARGMDYLH-A 138
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIF-- 225
             I HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MSLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 216 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 29/205 (14%)
Query: 58  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 109
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 168
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 78  GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 223
           +     HRDI  +N+LV+ +   +KL DFG ++ +   E +     S+      + APE 
Sbjct: 129 S-KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPES 183
Query: 224 IFGATEYTTAIDIWSTGCVMAELLL 248
           I     +T+A D+W  G  M E+L+
Sbjct: 184 I-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 137 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 195 ILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 171 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 214 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 227 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 17/154 (11%)
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICSR 216
           QI   + Y+H    I H D+KPQN+L++       +K+ DFG ++ +         + + 
Sbjct: 139 QILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
            Y APE I      TTA D+W+ G +   LL     F GE   +  + I +V    + E 
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256
Query: 277 IKCMNPNYTEF------KFPQIKP-------HPW 297
              ++   T+F      K P+ +P       H W
Sbjct: 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 92  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 143 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 201 ILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 83  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 134 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 192 ILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 107 LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 158 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 216 ILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 88  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 139 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 196
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 197 ILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 216 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   + + R       N+E+     +M  +D+P++  
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 116 LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 166
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 167 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 225 ILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 76  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 127 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 185 ILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 110
           +G GSF  V++    ET   VA  + LQD++    E Q        ++ L HPNIV    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            + ST                 T+    + Y +  +   +  ++ +  QI + L ++H  
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTL----KTYLKRFKVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 171 IG-ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              I HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE      +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EEK 205
Query: 230 YTTAIDIWSTG 240
           Y  ++D+++ G
Sbjct: 206 YDESVDVYAFG 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 216 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 71/321 (22%), Positives = 130/321 (40%), Gaps = 65/321 (20%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 100
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 68
Query: 101 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 149
           +  +++    C           K               +    R+     +  P      
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 207
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 186
Query: 208 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPGESGVDQLVE 264
                 +    + APE +     +TT+ D+WS G V+ E+  L  QP + G S  +Q+++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLK 243
Query: 265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
            +             M+  Y +      +P           P    DL+   +Q++PN+R
Sbjct: 244 FV-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPNMR 276
Query: 325 CTALEAC------VHPFFDEL 339
            T LE        +HP F E+
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEV 297

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 174 CHRDIKPQNLLVNPHTHQLKLCDFG--SAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 231
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 232 TAIDIWSTGCVMAELLLGQPLFPGE 256
              DI++  CV+ E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI   + Y
Sbjct: 79  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 130 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 188 ILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKN-RELQIMQMLDHPNIVALKHCF 112
           +G G+FG VF  + R    +VA+K   +    D + K  +E +I++   HPNIV L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C 170
              T K               +  +    +R+  +  L  V          + Y+ +  C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG----DAAAGMEYLESKCC 234
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE-LIFG 226
           I   HRD+  +N LV    + LK+ DFG ++    G    S    +    + APE L +G
Sbjct: 235 I---HRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 227 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 257
              Y++  D+WS G ++ E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNVS 211
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +
Sbjct: 172 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 212 Y------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 247
           Y      + ++ Y +PE I G   Y+  +DI+S G ++ ELL
Sbjct: 230 YATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------- 107
           V+G+G+FG V++      GE V I   ++  R         ++LD   ++A         
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 108 -LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L  C  ST                  ++ +  N  R+  +  L +      QI + ++Y
Sbjct: 84  LLGICLTSTV-----QLVTQLMPYGCLLDHVRENRGRLGSQDLLNW----CMQIAKGMSY 134
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + + + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E 
Sbjct: 135 LED-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     +T   D+WS G  + EL+
Sbjct: 193 IL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 109
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 96  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 170 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 220
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 251
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKN-RELQIMQMLDHPNIVALKHCF 112
           +G G+FG VF  + R    +VA+K   +    D + K  +E +I++   HPNIV L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 113 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C 170
              T K               +  +    +R+  +  L  V          + Y+ +  C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG----DAAAGMEYLESKCC 234
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 229
           I   HRD+  +N LV    + LK+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 235 I---HRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 230 -----YTTAIDIWSTGCVMAELL-LGQPLFPGES 257
                Y++  D+WS G ++ E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 109
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 96  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 170 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 220
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 251
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 109
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 110 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 90  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 138
Query: 170 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 220
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 139 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 251
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 198 PEALRG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 107
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 166
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 223
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 224 IFGATEYTTAIDIWSTGCVMAELL 247
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 70  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 124
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 125 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI  L  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
             +ST  +                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 70  MGYSTAPQLAIVTQWCEG------SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 95  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 149
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 150 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKK-VLQDKRYK----------NRELQIMQMLDHP 103
           E  +G G FG+V + +  +   +VAIK  +L D   +           RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           NIV L +       +               +++       +  R+ L         I   
Sbjct: 84  NIVKL-YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML--------DIALG 134
Query: 164 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNVSYICSRY- 217
           + Y+ N    I HRD++  N+ +        +C    DFG+++  V    +VS +   + 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLLGNFQ 191
Query: 218 YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLF 253
           + APE I GA E  YT   D +S   ++  +L G+  F
Sbjct: 192 WMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/321 (21%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 100
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 68
Query: 101 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 149
           +  +++    C           K               +    R+     +  P      
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 207
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 186
Query: 208 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPGESGVDQLVE 264
                 +    + APE +     +TT+ D+WS G V+ E+  L  QP + G S  +Q+++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLK 243
Query: 265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
            +             M+  Y +      +P           P    DL+   +Q++P +R
Sbjct: 244 FV-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMR 276
Query: 325 CTALEAC------VHPFFDEL 339
            T LE        +HP F E+
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEV 297

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 52/239 (21%)
Query: 47  KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDKRYK-----NRELQI 96
           +  + Y+ +  +G G+FG VFQA+       E   +VA+K + ++          RE  +
Sbjct: 46  RNNIEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 97  MQMLDHPNIVAL--------KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM 148
           M   D+PNIV L          C                     TV  ++ +      R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 149 ------PLIYVK--LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 200
                 PL   +      Q+   +AY+       HRD+  +N LV      +K+ DFG +
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVG-ENMVVKIADFGLS 221
Query: 201 KVLVKGEPNVSYICSRYYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 247
           + +   +         YY+A            PE IF    YTT  D+W+ G V+ E+ 
Sbjct: 222 RNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIF 270

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/321 (21%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 100
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 12  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 65
Query: 101 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 149
           +  +++    C           K               +    R+     +  P      
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 207
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 126 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 183
Query: 208 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPGESGVDQLVE 264
                 +    + APE +     +TT+ D+WS G V+ E+  L  QP + G S  +Q+++
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLK 240
Query: 265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
            +             M+  Y +      +P           P    DL+   +Q++P +R
Sbjct: 241 FV-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMR 273
Query: 325 CTALEAC------VHPFFDEL 339
            T LE        +HP F E+
Sbjct: 274 PTFLEIVNLLKDDLHPSFPEV 294

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 68/320 (21%), Positives = 129/320 (40%), Gaps = 63/320 (19%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 100
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 16  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 69
Query: 101 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 149
           +  +++    C           K               +    R+     +  P      
Sbjct: 70  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 207
           L  +     +I   +AY+ N     HR++  +N +V  H   +K+ DFG  + + + +  
Sbjct: 130 LQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 187
Query: 208 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 265
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 188 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 245
Query: 266 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 325
           +             M+  Y +      +P           P    DL+   +Q++PN+R 
Sbjct: 246 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPNMRP 278
Query: 326 TALEAC------VHPFFDEL 339
           T LE        +HP F E+
Sbjct: 279 TFLEIVNLLKDDLHPSFPEV 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 73/330 (22%), Positives = 131/330 (39%), Gaps = 83/330 (25%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 100
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 68
Query: 101 DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 149
           +  +++    C           K               +    R+     +  P      
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
           L  +     +I   +AY+ N     HR++  +N +V  H   +K+ DFG  + + +    
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---- 182
Query: 210 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPG 255
                + YYR            APE +     +TT+ D+WS G V+ E+  L  QP + G
Sbjct: 183 -----TDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQG 235
Query: 256 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 315
            S  +Q+++ +             M+  Y +      +P           P    DL+  
Sbjct: 236 LSN-EQVLKFV-------------MDGGYLD------QP--------DNCPERVTDLMRM 267
Query: 316 FFQYSPNLRCTALEAC------VHPFFDEL 339
            +Q++PN+R T LE        +HP F E+
Sbjct: 268 CWQFNPNMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 72/321 (22%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 95
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 14  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 96  IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 149
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 72  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 127
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 207
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 128 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 185
Query: 208 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPGESGVDQLVE 264
                 +    + APE +     +TT+ D+WS G V+ E+  L  QP + G S  +Q+++
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLK 242
Query: 265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
            +             M+  Y +      +P           P    DL+   +Q++P +R
Sbjct: 243 FV-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMR 275
Query: 325 CTALEAC------VHPFFDEL 339
            T LE        +HP F E+
Sbjct: 276 PTFLEIVNLLKDDLHPSFPEV 296

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 72/321 (22%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 95
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 96  IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 149
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 207
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 186
Query: 208 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPGESGVDQLVE 264
                 +    + APE +     +TT+ D+WS G V+ E+  L  QP + G S  +Q+++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLK 243
Query: 265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
            +             M+  Y +      +P           P    DL+   +Q++P +R
Sbjct: 244 FV-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMR 276
Query: 325 CTALEAC------VHPFFDEL 339
            T LE        +HP F E+
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEV 297

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 75/330 (22%), Positives = 130/330 (39%), Gaps = 83/330 (25%)
Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 95
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 96  IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 149
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + +    
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---- 182
Query: 210 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPG 255
                + YYR            APE +     +TT+ D+WS G V+ E+  L  QP + G
Sbjct: 183 -----TAYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQG 235
Query: 256 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 315
            S  +Q+++ +             M+  Y +      +P           P    DL+  
Sbjct: 236 LSN-EQVLKFV-------------MDGGYLD------QP--------DNCPERVTDLMRM 267
Query: 316 FFQYSPNLRCTALEAC------VHPFFDEL 339
            +Q++P +R T LE        +HP F E+
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 88  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 142
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 143 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 58  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 108
           +G G+FG VF A+C     E  +++   K L++     ++   RE +++ ML H +IV  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 107
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 158
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 108 ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 159 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 217
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 165 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 213
Query: 218 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 247
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 214 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 254

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 110
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 227
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 228 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 110
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 73
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 171 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 205
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 110
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 73
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 171 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 205
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 110
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 75
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 133
Query: 171 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 205
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 110
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 71
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 129
Query: 171 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 205
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 130 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR------ELQIMQMLDHPNIVA 107
           V+G+G FG V +      GE + I    KV++DK  +         +  +  LDH +IV 
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L                         ++ + ++   +  ++ L +      QI + + Y+
Sbjct: 98  L----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----GVQIAKGMYYL 149
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 224
               G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A E I
Sbjct: 150 EEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 225 -FGATEYTTAIDIWSTGCVMAELL 247
            FG  +YT   D+WS G  + EL+
Sbjct: 208 HFG--KYTHQSDVWSYGVTVWELM 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR------ELQIMQMLDHPNIVA 107
           V+G+G FG V +      GE + I    KV++DK  +         +  +  LDH +IV 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 108 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L                         ++ + ++   +  ++ L +      QI + + Y+
Sbjct: 80  L----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----GVQIAKGMYYL 131
Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 224
               G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A E I
Sbjct: 132 EEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 225 -FGATEYTTAIDIWSTGCVMAELL 247
            FG  +YT   D+WS G  + EL+
Sbjct: 190 HFG--KYTHQSDVWSYGVTVWELM 211

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 58  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 108
           +G G+FG VF A+C     E  +++   K L++     ++   RE +++ ML H +IV  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 84
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 158
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 85  ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 159 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 217
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 142 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 190
Query: 218 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 247
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 191 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 231

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 58  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 108
           +G G+FG VF A+C     E  +++   K L++     ++   RE +++ ML H +IV  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 78
Query: 109 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 158
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 79  ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 159 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 217
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 136 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 184
Query: 218 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 247
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 185 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 225

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKK-VLQDKRYK----------NRELQIMQMLDHP 103
           E  +G G FG+V + +  +   +VAIK  +L D   +           RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 104 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           NIV L     +                    +   R   + H     + ++L    I   
Sbjct: 84  NIVKLYGLMHNPP--------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIALG 134
Query: 164 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNVSYICSRY- 217
           + Y+ N    I HRD++  N+ +        +C    DFG ++  V    +VS +   + 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQ 191
Query: 218 YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLF 253
           + APE I GA E  YT   D +S   ++  +L G+  F
Sbjct: 192 WMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 58  VGTGSFGVVFQAKCRETGEI-VAIKKVL-----QDKRYKNRELQIMQMLDHPNIVALKHC 111
           +G+GSFG V++ K    G++ V I KV+     Q + ++N E+ +++   H NI+     
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL----L 96
Query: 112 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           F     K                  +    ++  Q   LI +     Q  + + Y+H   
Sbjct: 97  FMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKF-QMFQLIDI---ARQTAQGMDYLH-AK 151
Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSY-ICSRYYRAPELIFGAT 228
            I HRD+K  N+ ++     +K+ DFG A V  +  G   V     S  + APE+I    
Sbjct: 152 NIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 229 E--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
              ++   D++S G V+ EL+ G+  +   +  DQ++ ++
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 160 ICRALAYIHNCI---------GICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEP 208
           + R LAY+H  I          I HRDIK +N+L+    + L  C  DFG A     G+ 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKS 186
Query: 209 ---NVSYICSRYYRAPELIFGATEYTTA----IDIWSTGCVMAEL 246
                  + +R Y APE++ GA  +       ID+++ G V+ EL
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 59  GTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALKH 110
           G G FGVV++     T   VA+KK+         + K+  ++E+++     H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 111 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
               ++D                ++R+    S +    PL +     +  C+      N 
Sbjct: 87  -LGFSSDGDDLCLVYVYXPNGSLLDRL----SCLDGTPPLSW-----HXRCKIAQGAANG 136
Query: 171 IGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 221
           I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y AP
Sbjct: 137 INFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQP 251
           E + G  E T   DI+S G V+ E++ G P
Sbjct: 196 EALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 210
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 211 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNG 349
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 210
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 211 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNG 349
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 210
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 211 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------ 268
Query: 261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNG 349
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 210
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 211 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 261
Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNG 349
           P  R +  E   HP+      P  ++  G
Sbjct: 262 PKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 210
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 211 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 280
Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNG 349
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 210
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 211 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 224
Query: 261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 225 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 260
Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNG 349
           P  R +  E   HP+      P  ++  G
Sbjct: 261 PKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 210
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 211 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 224
Query: 261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 225 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 264
Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNG 349
           P  R +  E   HP+      P  ++  G
Sbjct: 265 PKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 80/209 (38%), Gaps = 42/209 (20%)
Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 210
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +      V   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKD 186
Query: 211 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 280
Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNG 349
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	390
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-102
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-99
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-98
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-96
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-94
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-93
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-92
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-92
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-90
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-90
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-90
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-90
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-89
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-88
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-87
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-87
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-85
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-85
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-85
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-81
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-63
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-60
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-60
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-59
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-58
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-58
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-58
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-58
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-57
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-56
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-56
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-55
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-55
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-54
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-54
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-54
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-53
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-53
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-52
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-52
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-52
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-52
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-52
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-52
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-51
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-51
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-51
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-51
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-51
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-51
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-51
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-51
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-50
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-50
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-50
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-50
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-49
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-49
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-49
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-49
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-49
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-49
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-49
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-49
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-49
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-49
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-49
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-49
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-48
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-48
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-48
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-48
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-48
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-48
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-48
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-47
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-46
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-46
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-46
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-45
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-45
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-44
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-44
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-43
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-43
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-43
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-43
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-43
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-43
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-42
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-42
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-41
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-41
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-41
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-40
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-40
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-40
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-40
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-40
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-40
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-40
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-40
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-40
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-39
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-39
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-38
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-38
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-38
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-38
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-38
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-38
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-37
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-37
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-37
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-37
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-37
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-37
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-36
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-36
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-36
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-36
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-34
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-33
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-31
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-29
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  625 bits (1613), Expect = 0.0
 Identities = 245/382 (64%), Positives = 292/382 (76%), Gaps = 5/382 (1%)

Query: 2   ASASLGNGGVGSSRSVNGFKNIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTG 61
            S +     V    +    K   D  G++   V+ T   G+  +  Q+VSY    V+G G
Sbjct: 8   TSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNG 65

Query: 62  SFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EE 120
           SFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ LDH NIV L++ F+S+ +K +E
Sbjct: 66  SFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125

Query: 121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 180
           +YLNLVL+YVPETV R+AR+YSR  Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKP
Sbjct: 126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKP 184

Query: 181 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG 240
           QNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS G
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 244

Query: 241 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 300
           CV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KV
Sbjct: 245 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 304

Query: 301 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP 360
           F+ R PPEA+ L  R  +Y+P  R T LEAC H FFDELRDPN +LPNGR  P LFNF  
Sbjct: 305 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTT 364

Query: 361 PELSGIPPETINRLIPEHARKQ 382
            ELS   P     LIP HAR Q
Sbjct: 365 QELS-SNPPLATILIPPHARIQ 385

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  620 bits (1600), Expect = 0.0
 Identities = 232/373 (62%), Positives = 292/373 (78%), Gaps = 7/373 (1%)

Query: 13  SSRSVNGFKNIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCR 72
           S+  +NG K  ++ +      +      G+ G  ++ ++Y    V+G GSFGVVFQAK  
Sbjct: 6   SNAPLNGVK--LNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLV 62

Query: 73  ETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-ELYLNLVLEYVP 131
           E+ E VAIKKVLQDKR+KNRELQIM+++ HPN+V LK  F+S  DK+ E++LNLVLEYVP
Sbjct: 63  ESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121

Query: 132 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ 191
           ETV R +R+Y+++ Q MP++ +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL++P +  
Sbjct: 122 ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGV 180

Query: 192 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 251
           LKL DFGSAK+L+ GEPNVSYICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQP
Sbjct: 181 LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240

Query: 252 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD 311
           LFPGESG+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+D
Sbjct: 241 LFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAID 300

Query: 312 LVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETI 371
           L+ R  +Y+P+ R TA+EA  HPFFDELR    R+PNGR LPPLFN+   ELS + P+ I
Sbjct: 301 LISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLI 359

Query: 372 NRLIPEHARKQNL 384
           +RL+P+HA  + L
Sbjct: 360 SRLVPQHAEAELL 372

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  593 bits (1532), Expect = 0.0
 Identities = 163/358 (45%), Positives = 224/358 (62%), Gaps = 12/358 (3%)

Query: 32  GHVIRTTIGGRNG--NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 89
           G ++           + K+   +  E + G G+FG V   K + TG  VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 90  KNRELQIMQML---DHPNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRI 144
           +NRELQIMQ L    HPNIV L+  F++    D+ ++YLN+V+EYVP+T++R  RNY R 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 145 HQRMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 203
               P I +K++ +Q+ R++  +H   + +CHRDIKP N+LVN     LKLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
              EPNV+YICSRYYRAPELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYS 320
           EI++VLG P+RE ++ +NP++T+      K  PW  VF     +   EA DL+    QY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP-LFNFKPPELSGIPPETINRLIPE 377
           P  R    EA  HP+FDEL DP T+LPN + LP  LF F P E+  +      +L+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  570 bits (1472), Expect = 0.0
 Identities = 171/382 (44%), Positives = 243/382 (63%), Gaps = 43/382 (11%)

Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP 103
           G       Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 104 NIVALKHCFFSTTDK---------------------------------EELYLNLVLEYV 130
           NI+ L   F++T D+                                 +  YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 131 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH 190
           P+T++++ +++ R  + +P+  + +Y YQ+ RA+ +IH+ +GICHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDN 179

Query: 191 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 250
            LKLCDFGSAK L+  EP+V+YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 251 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAV 310
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 311 DLVCRFFQYSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKPP 361
           DL+ +  +Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P 
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359

Query: 362 ELSGIPPETINRLIPEHARKQN 383
           ELS IP   +NR++P++     
Sbjct: 360 ELSIIPGNVLNRILPKNFSPNY 381

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  303 bits (779), Expect = e-102
 Identities = 106/312 (33%), Positives = 160/312 (51%), Gaps = 22/312 (7%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G GS+GVVF+ + R+TG+IVAIKK L+ +          RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
           F     K  L+L  V EY   TV      Y    + +P   VK  T+Q  +A+ + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 230
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 288
              +D+W+ GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 289 FPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 347
            P  +   P    F   +   A+ L+       P  R T  +   HP+F+ +R+    L 
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI-EDLA 298

Query: 348 NGRPLPPLFNFK 359
                P    + 
Sbjct: 299 KEHDKPAENLYF 310

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  297 bits (764), Expect = 1e-99
 Identities = 99/295 (33%), Positives = 154/295 (52%), Gaps = 21/295 (7%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           VG GS+G+V + + ++TG IVAIKK L+    K       RE+++++ L H N+V L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
                 K+  YL  V E+V  T+      +      +    V+ Y +QI   + + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 230
            I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 231 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 288
             A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 289 FPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
            P+IK   P  + +  +L    +DL  +     P+ R    E   H FF      
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  294 bits (756), Expect = 2e-98
 Identities = 99/324 (30%), Positives = 167/324 (51%), Gaps = 33/324 (10%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLD 101
           +YI    +G G++  V++ K + T  +VA+K++    R ++         RE+ +++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           H NIV L         ++ L L  V EY+ + + +   +       + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDDCG---NIINMHNVKLFLFQLL 110

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 218
           R LAY H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 275
           R P+++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            I      +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 336 FDELRDPNTRLPNGRPLPPLFNFK 359
           F  L +   +LP+   +  L   +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQ 308

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  294 bits (754), Expect = 1e-97
 Identities = 107/312 (34%), Positives = 158/312 (50%), Gaps = 33/312 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 108
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
               F         ++LV +++   +  I ++ S     +   ++K Y     + L Y+H
Sbjct: 78  -LDAFGHKSN----ISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH 129

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 225
               I HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 282
           GA  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
           +Y    F      P H +F      + +DL+   F ++P  R TA +A    +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299

Query: 343 NTRLPNGRPLPP 354
                   P P 
Sbjct: 300 GPTPGCQLPRPN 311

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  289 bits (742), Expect = 3e-96
 Identities = 88/303 (29%), Positives = 146/303 (48%), Gaps = 23/303 (7%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQIMQML-DHPNIVAL 108
           Y     +G G +  VF+A      E V +K +  ++ K+ K RE++I++ L   PNI+ L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
                    +       V E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 228
           +  GI HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+    
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 229 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYT 285
            Y  ++D+WS GC++A ++   +P F G    DQLV I KVLGT    +   K       
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 286 EFK--FPQIKPHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
            F     +     W +      Q  + PEA+D + +  +Y    R TA EA  HP+F  +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

Query: 340 RDP 342
              
Sbjct: 327 VKD 329

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  286 bits (735), Expect = 2e-95
 Identities = 101/294 (34%), Positives = 163/294 (55%), Gaps = 27/294 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           VG G++GVV++AK    G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
                 +  L L  V E++ + + ++          +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFMEKDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 285
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           +  F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  286 bits (734), Expect = 3e-95
 Identities = 89/315 (28%), Positives = 148/315 (46%), Gaps = 34/315 (10%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD----KR-YKNRELQIMQMLDHPNI 105
           Y+    +G G  G+VF A   +  + VAIKK+ L D    K     RE++I++ LDH NI
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 106 VALKHCF-----------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK 154
           V +                S T+   +Y+  V EY+   +  +          +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 155 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--- 211
           L+ YQ+ R L YIH+   + HRD+KP NL +N     LK+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 212 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
             + +++YR+P L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 271 TPTREEIKCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 328
               E+ + +      +          P  ++    +  EAVD + +   +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 329 EACVHPFFDELRDPN 343
           EA  HP+      P 
Sbjct: 302 EALSHPYMSIYSFPM 316

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  285 bits (732), Expect = 9e-95
 Identities = 90/313 (28%), Positives = 151/313 (48%), Gaps = 41/313 (13%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
                    L+L  + EY    + +        +  + +  +K + YQ+   + + H+  
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 172 GICHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 224
              HRD+KPQNLL++         LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 281
            G+  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
           P++ +  FP+ +     +V    L  E +DL+    +  P  R +A  A  HP+F     
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325

Query: 342 PNTRLPNGRPLPP 354
                       P
Sbjct: 326 ---------DFDP 329

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  282 bits (724), Expect = 4e-94
 Identities = 101/294 (34%), Positives = 158/294 (53%), Gaps = 28/294 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
                 K+ L L  V E++ + + ++          +  +  K +  Q+   +AY H+  
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 229 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 285
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           +  F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E 
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  282 bits (723), Expect = 5e-93
 Identities = 106/349 (30%), Positives = 180/349 (51%), Gaps = 39/349 (11%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQD-KR-YKNRELQIMQMLDHPN 104
           +  + ++G G++GVV  A  + TGEIVAIKK+          R    RE++I++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 105 IVALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           I+ + +     + +   E+Y+  + E +   ++R+        Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLR 123

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 211
           A+  +H    + HRD+KP NLL+N     LK+CDFG A+++ +   + S           
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
           ++ +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 272 PTREEI--KCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 327
           P  +       +P   E+    P     P  K+F + + P+ +DL+ R   + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

Query: 328 LEACVHPFFDELRDPNTRLPNGRPLPPL-FNFKPPELSGIPPETINRLI 375
            EA  HP+     DPN   P G P+PP  F F       +  + + +LI
Sbjct: 301 KEALEHPYLQTYHDPN-DEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  280 bits (718), Expect = 9e-93
 Identities = 97/318 (30%), Positives = 159/318 (50%), Gaps = 37/318 (11%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 108
           +G G++  V++   + TG  VA+K+V    +  +         RE+ +M+ L H NIV L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAY 166
                    + +L L  V E++   + +   +R      + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPEL 223
            H    I HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 280
           + G+  Y+T+IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 281 NPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            P Y      Q  P    +V Q      L    +D +    Q +P++R +A +A  HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 337 DELRDPNTRLPNGRPLPP 354
            E       +   R    
Sbjct: 298 AEYYHH-ASMGGSRSHHH 314

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  279 bits (715), Expect = 1e-92
 Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 28/298 (9%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
                  ++L L  V E+  + + +   + +     +    VK + +Q+ + L + H+  
Sbjct: 70  L---HSDKKLTL--VFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 228
            + HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 229 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 284
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
             +            V   +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 237 KPYPMYP-ATTSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  279 bits (717), Expect = 4e-92
 Identities = 92/336 (27%), Positives = 153/336 (45%), Gaps = 37/336 (11%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------------RELQI 96
           Y  +  + +GS+G V        G  VAIK+V                       RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 97  MQMLDHPNIVALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IY 152
           +    HPNI+ L+  F  F      +LYL  V E +   + ++        QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           ++ + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 272
           +  R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 273 TREEIKCM-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 328
             E++    +P   +Y       +    W  V      P A+DL+ +  +++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 329 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 364
           +A  HP+F+ L DP   L  G      F+F      
Sbjct: 313 QALRHPYFESLFDPL-DLTEGLSER--FHFDESVTD 345

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  276 bits (707), Expect = 1e-90
 Identities = 102/307 (33%), Positives = 164/307 (53%), Gaps = 31/307 (10%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 103
           Y++   VG+G++G V  A  + +GE VAIKK+    Q     KR Y  REL +++ + H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 104 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 160
           N++ L   F   +      + YL  V+ ++   + +I      +  +     ++   YQ+
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKI------MGLKFSEEKIQYLVYQM 135

Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYR 219
            + L YIH+  G+ HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YR
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYR 190

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ 
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250

Query: 280 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + +     +    PQ     + ++F  R  P+A DL+ +  +   + R TA +A  HPFF
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

Query: 337 DELRDPN 343
           +  RDP 
Sbjct: 310 EPFRDPE 316

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  276 bits (708), Expect = 1e-90
 Identities = 94/308 (30%), Positives = 166/308 (53%), Gaps = 28/308 (9%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQD----KR-YKNRELQIMQMLDHPN 104
           Y     +G G++G+V  A        VAIKK+   +     +R    RE++I+    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 105 IVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           I+ +       +    +++Y+  V + +   + ++ +      Q +   ++  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILR 139

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYY 218
            L YIH+   + HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+Y
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
           RAPE++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ 
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 279 CM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
           C+ N     +    P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 336 FDELRDPN 343
            ++  DP+
Sbjct: 317 LEQYYDPS 324

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  274 bits (702), Expect = 2e-90
 Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 32/304 (10%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQML---DHPNI 105
           +G G++G V++A+   +G  VA+K V                 RE+ +++ L   +HPN+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L     ++    E+ + LV E+V + +             +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLD 134

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 222
           ++H    I HRD+KP+N+LV      +KL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 283 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
                    FP   P P   V    +      L+     ++P+ R +A  A  H +  + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

Query: 340 RDPN 343
            + N
Sbjct: 304 -EGN 306

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  274 bits (703), Expect = 2e-90
 Identities = 95/330 (28%), Positives = 158/330 (47%), Gaps = 33/330 (10%)

Query: 42  RNGNSKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN-------RE 93
           ++G  +    Y     +G G++G VF+A+  +  G  VA+K+V      +        RE
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIRE 61

Query: 94  LQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL 150
           + +++ L   +HPN+V L      +    E  L LV E+V + +             +P 
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119

Query: 151 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
             +K   +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++       +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-M 174

Query: 211 SY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
           +    + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ 
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233

Query: 268 VLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
           V+G P  E+     P         F      P  K     +     DL+ +   ++P  R
Sbjct: 234 VIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKR 288

Query: 325 CTALEACVHPFFDELRDPNTRLPNGRPLPP 354
            +A  A  HP+F +L      L +   LPP
Sbjct: 289 ISAYSALSHPYFQDLERCKENLDS--HLPP 316

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  273 bits (701), Expect = 1e-89
 Identities = 97/305 (31%), Positives = 158/305 (51%), Gaps = 26/305 (8%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 105
           Y     VG+G++G V  A    TG  VAIKK+          +   REL++++ + H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 106 VALKHCFF---STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           + L   F    +  D  + YL  V+ ++   + ++ ++     +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLK 139

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAP 221
            L YIH   GI HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 280
           E+I     YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 281 NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
           +     +    P+++   +  +      P AV+L+ +        R TA EA  HP+F+ 
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

Query: 339 LRDPN 343
           L D  
Sbjct: 314 LHDTE 318

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  273 bits (701), Expect = 2e-89
 Identities = 98/337 (29%), Positives = 157/337 (46%), Gaps = 38/337 (11%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 103
           Y     +G+G+ G+V  A        VAIKK+    Q+    KR Y  REL +M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 104 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 160
           NI+ L + F      E   ++Y+  V+E +   + ++      I   +    +    YQ+
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQV------IQMELDHERMSYLLYQM 136

Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
              + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE+I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253

Query: 281 NPNYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTA 327
            P    +    P+   + + K+F            K    +A DL+ +      + R + 
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313

Query: 328 LEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 364
            EA  HP+ +   DP+       P  P       E +
Sbjct: 314 DEALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  269 bits (689), Expect = 6e-88
 Identities = 88/315 (27%), Positives = 139/315 (44%), Gaps = 26/315 (8%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 111
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 112 FFSTTDKEELYLN---LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             +             LV ++    +  +  N   +  +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNVSY---ICSRYYRAPEL 223
               I HRD+K  N+L+      LKL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 280
           + G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    +   
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 281 NPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
              Y + +  + +        +     P A+DL+ +     P  R  + +A  H FF   
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317

Query: 340 RDPNTRLPNGRPLPP 354
            DP      G     
Sbjct: 318 -DPMPSDLKGMLSTH 331

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  272 bits (696), Expect = 1e-87
 Identities = 96/331 (29%), Positives = 156/331 (47%), Gaps = 40/331 (12%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 103
           Y     +G+G+ G+V  A        VAIKK+ +        KR Y  REL +M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 104 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 160
           NI++L + F      E   ++YL  V+E +   + ++      I   +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQV------IQMELDHERMSYLLYQM 173

Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
              + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE+I G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 281 NPNYTEF--KFPQIKPHPWHKVF-----------QKRLPPEAVDLVCRFFQYSPNLRCTA 327
            P    +    P+     + K+F            K    +A DL+ +     P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 328 LEACVHPFFDELRDPNTRLPNGRPLPPLFNF 358
            +A  HP+ +   DP        P P +++ 
Sbjct: 351 DDALQHPYINVWYDPAEVEA---PPPQIYDK 378

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  268 bits (688), Expect = 1e-87
 Identities = 104/307 (33%), Positives = 161/307 (52%), Gaps = 30/307 (9%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 103
           Y     VG+G++G V  A   +TG  VA+KK+ +        KR Y  REL++++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 104 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 160
           N++ L   F      E   ++YL  V   +   +N I +      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 161 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYR 219
            R L YIH+   I HRD+KP NL VN    +LK+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE++     Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 280 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           + + +   +     Q+    +  VF     P AVDL+ +      + R TA +A  H +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 337 DELRDPN 343
            +  DP+
Sbjct: 316 AQYHDPD 322

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  263 bits (675), Expect = 2e-85
 Identities = 97/373 (26%), Positives = 176/373 (47%), Gaps = 65/373 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---QD----KR-YKNRELQIMQ-MLDH 102
           Y     +G G++G+V+++  R TGE+VA+KK+    Q+    +R +  RE+ I+  +  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 103 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
            NIV L +   +  D++ +YL  V +Y+   ++ + R        +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIK 120

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 211
            + Y+H+  G+ HRD+KP N+L+N   H +K+ DFG ++  V      +           
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 212 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 261 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLP----------- 306
           QL  II V+  P+ E+++ + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 307 ----PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPE 362
                EA+DL+ +  Q++PN R +A +A  HPF     +PN           +      +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN----EEPNCDHIITIPIND 354

Query: 363 LSGIPPETINRLI 375
                 +    L+
Sbjct: 355 NVKHSIDDYRNLV 367

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  265 bits (680), Expect = 3e-85
 Identities = 107/366 (29%), Positives = 160/366 (43%), Gaps = 87/366 (23%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 103
           Y   H++GTGS+G V +A  +    +VAIKK+L+        KR    RE+ I+  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 104 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 159
           ++V +            +ELY+  VLE       ++          + L  +++K   Y 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYV--VLEIADSDFKKL------FRTPVYLTELHIKTLLYN 164

Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 211
           +   + Y+H+  GI HRD+KP N LVN     +K+CDFG A+ +   E   S        
Sbjct: 165 LLVGVKYVHSA-GILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 212 --------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--- 248
                               ++ +R+YRAPELI     YT AID+WS GC+ AELL    
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 249 --------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM 280
                     PLFPG S                      DQL  I  +LGTP+ E+I+ +
Sbjct: 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342

Query: 281 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
              +   +   FP+ +     + F      +A+ L+ R   ++PN R T  E   HPFF 
Sbjct: 343 EKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401

Query: 338 ELRDPN 343
           E+R   
Sbjct: 402 EVRIAE 407

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  264 bits (677), Expect = 4e-85
 Identities = 104/358 (29%), Positives = 159/358 (44%), Gaps = 79/358 (22%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQD-KR-YKNRELQIMQMLDHP 103
           YI +H++G GS+G V+ A  + T + VAIKKV      L D KR    RE+ I+  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 104 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 159
            I+ L            +ELY+  VLE     + ++          + L   ++K   Y 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKL------FKTPIFLTEEHIKTILYN 137

Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 211
           +     +IH   GI HRD+KP N L+N     +K+CDFG A+ +   +            
Sbjct: 138 LLLGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 212 ---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ------ 250
                          ++ +R+YRAPELI     YT +IDIWSTGC+ AELL         
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 251 -----PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF 287
                PLFPG S                   DQL  I  ++GTPT +++K +  P   ++
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315

Query: 288 --KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
              FP  KP    + +   +  + ++L+    +++PN R T  +A  HP+  ++R   
Sbjct: 316 IKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  254 bits (651), Expect = 1e-81
 Identities = 89/362 (24%), Positives = 159/362 (43%), Gaps = 44/362 (12%)

Query: 58  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 113
           VG G++G V++AK ++    +  A+K++       +  RE+ +++ L HPN+++L+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 114 STTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           S  D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 169 NCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYYR 219
               + HRD+KP N+LV    P   ++K+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---------GVDQLVEIIKVLG 270
           APEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 271 TPTRE---------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
            P  +         E   +  ++    +       + +  + +   +A  L+ +     P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 322 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
             R T+ +A   P+F E  DP             +  +       P +  ++   +  + 
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQG 380

Query: 382 QN 383
            N
Sbjct: 381 NN 382

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  206 bits (526), Expect = 8e-63
 Identities = 92/338 (27%), Positives = 149/338 (44%), Gaps = 73/338 (21%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 102
           Y    V+G GSFG V +A   +  + VA+K V  +KR+      E++I++ L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 103 PNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLI 151
            N++ +   F         F     E L +NL  +++      N+         Q   L 
Sbjct: 159 MNVIHMLENFTFRNHICMTF-----ELLSMNLYELIKK-----NK--------FQGFSLP 200

Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
            V+ + + I + L  +H    I H D+KP+N LL       +K+ DFGS+      +   
Sbjct: 201 LVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVY 257

Query: 211 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
           +YI SR+YRAPE+I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG
Sbjct: 258 TYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316

Query: 271 TPTREEIK-----------CMNPNYTEFKF---------------PQIKPHPWHKVFQKR 304
            P+++ +               P Y                     +++  P  + +   
Sbjct: 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376

Query: 305 LPPEA----VDLVCRFFQYSPNLRCTALEACVHPFFDE 338
           L        +D + +  ++ P +R T  +A  HP+   
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  198 bits (505), Expect = 3e-60
 Identities = 86/340 (25%), Positives = 137/340 (40%), Gaps = 44/340 (12%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 103
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 104 NIVALKHC-----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 158
           + +   H       F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNVSYI 213
           Q+   L Y+H   GI H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 267
            +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP--------------EAVDLV 313
           +LG      ++        F   +       K+    L                E  D +
Sbjct: 256 LLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 314 CRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 353
               Q  P  R  A     HP+  +           R L 
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  198 bits (504), Expect = 4e-60
 Identities = 96/347 (27%), Positives = 143/347 (41%), Gaps = 78/347 (22%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 102
           Y  + ++G GSFG V +A  R   E VAIK +   K + N    E+++++++        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 103 PNIVALKHCF---------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLI 151
             IV LK  F         F     E L  NL              +  R      + L 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVF-----EMLSYNL-------------YDLLRNTNFRGVSLN 157

Query: 152 YVKLYTYQICRALAYIHNC-IGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPN 209
             + +  Q+C AL ++    + I H D+KP+N LL NP    +K+ DFGS+     G+  
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRI 215

Query: 210 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
             YI SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VL
Sbjct: 216 YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274

Query: 270 GTPTRE--------------------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 309
           G P                        +K       E+K P  +        +   P   
Sbjct: 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334

Query: 310 ---------------VDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
                           DL+ R   Y P  R     A  H FF +  D
Sbjct: 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  194 bits (494), Expect = 2e-59
 Identities = 72/344 (20%), Positives = 123/344 (35%), Gaps = 68/344 (19%)

Query: 27  VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--- 83
           +G E  +    ++ GR         Y     +G+G    VFQ    E  +I AIK V   
Sbjct: 13  LGTENLYFQSMSVKGRI--------YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLE 63

Query: 84  -LQDKRYKN--RELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIA 138
              ++   +   E+  +  L   +  I+ L          + +Y+  V+E     +N   
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWL 118

Query: 139 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 198
           +      + +     K Y   +  A+  IH   GI H D+KP N L+      LKL DFG
Sbjct: 119 KK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFG 171

Query: 199 SAKVLVKGEPNV---SYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAE 245
            A  +     +V   S + +  Y  PE I             ++ +   D+WS GC++  
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231

Query: 246 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL 305
           +  G+  F         +  I             ++PN+ E +FP I             
Sbjct: 232 MTYGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDI------------P 265

Query: 306 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 349
             +  D++    +  P  R +  E   HP+      P  ++  G
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  194 bits (494), Expect = 1e-58
 Identities = 83/387 (21%), Positives = 139/387 (35%), Gaps = 94/387 (24%)

Query: 14  SRSVNGFKNIIDGVGAETGH---VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAK 70
               +G +N+      E  H        +            ++    +G G+FG V   +
Sbjct: 5   HHHSSGRENLYFQGDDEIVHFSWKKGMLLNNA---------FLVIRKMGDGTFGRVLLCQ 55

Query: 71  CRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHPNIVALKHCF---------F 113
             +  +  A+K V   K+Y      E  I++ +     ++ NIV     F         F
Sbjct: 56  HIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF 115

Query: 114 STTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
                E L  +L  ++            NY        +  +KLY  +I +AL Y+    
Sbjct: 116 -----EPLGPSLYEIIT---------RNNY----NGFHIEDIKLYCIEILKALNYLRKM- 156

Query: 172 GICHRDIKPQN-LLVNPHTH-----------------------QLKLCDFGSAKVLVKGE 207
            + H D+KP+N LL +P+                          +KL DFG A    K +
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSD 214

Query: 208 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
            + S I +R YRAPE+I     +  + D+WS GCV+AEL  G  LF     ++ L  +  
Sbjct: 215 YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMES 273

Query: 268 VLGTPTREEI---------KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA--------V 310
           ++    +  +         K +N +  +  +P+           K+  P           
Sbjct: 274 IIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333

Query: 311 DLVCRFFQYSPNLRCTALEACVHPFFD 337
           D +    Q  P LR +  E   H F +
Sbjct: 334 DFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  193 bits (493), Expect = 1e-58
 Identities = 79/354 (22%), Positives = 129/354 (36%), Gaps = 76/354 (21%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 101
           Y     +G G+FG V +      G   VA+K +    +Y+     E+ +++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 102 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 150
               V +   F         F     E L  N    L+           N+    Q  PL
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAF-----ELLGKNTFEFLK---------ENNF----QPYPL 122

Query: 151 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 192
            +V+   YQ+C AL ++H    + H D+KP+N+L                         +
Sbjct: 123 PHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

Query: 193 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 252
           ++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E   G  L
Sbjct: 182 RVADFGSA--TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTL 238

Query: 253 FPGESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKPHPWHKVFQK 303
           F      + LV + K+LG      I               + E            K  + 
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298

Query: 304 RLPPEA------VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 351
            +  ++       DL+ R  ++ P  R T  EA +HPFF  L          R 
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  192 bits (489), Expect = 3e-58
 Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 60/319 (18%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN- 104
           Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 105 -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
            I+ L          + +Y+  V+E     +N   +      + +     K Y   +  A
Sbjct: 70  KIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEA 120

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 220
           +  IH   GI H D+KP N L+      LKL DFG A  +     +V   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 221 PELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
           PE I             ++ +   D+WS GC++  +  G+  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 330
                    ++PN+ E +FP I               +  D++    +  P  R +  E 
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 331 CVHPFFDELRDPNTRLPNG 349
             HP+      P  ++  G
Sbjct: 272 LAHPYVQIQTHPVNQMAKG 290

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  191 bits (487), Expect = 3e-58
 Identities = 58/304 (19%), Positives = 110/304 (36%), Gaps = 27/304 (8%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 106
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
            L      TT +    L  ++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTRH-KVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 165 AYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            ++    GI HR+IKP N++           KL DFG+A+ L   E  VS   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 222 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 272
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 332
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 333 HPFF 336
               
Sbjct: 303 ETSD 306

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  193 bits (492), Expect = 4e-58
 Identities = 69/325 (21%), Positives = 116/325 (35%), Gaps = 60/325 (18%)

Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQM 99
           S +   Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 100 LDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 157
           L   +  I+ L          + +Y+  V+E     +N   +      + +     K Y 
Sbjct: 111 LQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYW 161

Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYIC 214
             +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   S + 
Sbjct: 162 KNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 215 SRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 264
           +  Y  PE I             ++ +   D+WS GC++  +  G+  F         + 
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 324
            I             ++PN+ E +FP I               +  D++    +  P  R
Sbjct: 279 AI-------------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQR 312

Query: 325 CTALEACVHPFFDELRDPNTRLPNG 349
            +  E   HP+      P  ++  G
Sbjct: 313 ISIPELLAHPYVQIQTHPVNQMAKG 337

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  189 bits (483), Expect = 2e-57
 Identities = 78/345 (22%), Positives = 135/345 (39%), Gaps = 76/345 (22%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 101
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q+++ L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 102 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 150
               V +   F         F     E L L+    ++            +        L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVF-----ELLGLSTYDFIK---------ENGF----LPFRL 117

Query: 151 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 192
            +++   YQIC+++ ++H+   + H D+KP+N+L                         +
Sbjct: 118 DHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 193 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 252
           K+ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC++ E  LG  +
Sbjct: 177 KVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTV 233

Query: 253 FPGESGVDQLVEIIKVLGTPTREEIK---------CMNPNYTEFKFPQIKPHPWHKVFQK 303
           FP     + L  + ++LG   +  I+             ++ E            K  ++
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293

Query: 304 RLPPE------AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
            +  +        DL+ +  +Y P  R T  EA  HPFFD L+  
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  186 bits (474), Expect = 2e-56
 Identities = 67/287 (23%), Positives = 106/287 (36%), Gaps = 49/287 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM-QMLDHPNIVALK 109
            +G GS+G VF+ + +E G + A+K+ +      +D+  K  E+    ++  HP  V L+
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             +    +   LY  L  E    +   + ++       +P   V  Y      ALA++H+
Sbjct: 124 QAWE---EGGILY--LQTELCGPS---LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             G+ H D+KP N+ + P     KL DFG    L              Y APEL+     
Sbjct: 176 Q-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGS 231

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           Y TA D++S G  + E+     L  G  G  QL +                         
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--------------------- 270

Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
           P+             L  E   ++    +  P LR TA      P  
Sbjct: 271 PEFTAG---------LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  185 bits (472), Expect = 2e-56
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 42/299 (14%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHCF 112
           V+G G++G+V+  +       +AIK++  +D RY      E+ + + L H NIV      
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83

Query: 113 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
           +  +  E  ++ + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN 141

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGATE 229
             I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I     
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 230 -YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
            Y  A DIWS GC + E+  G+P F       +L E    +                 FK
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------FK 237

Query: 289 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 347
               K HP      + +  EA   + + F+  P+ R  A +  V  F           P
Sbjct: 238 VGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  189 bits (481), Expect = 4e-56
 Identities = 62/302 (20%), Positives = 118/302 (39%), Gaps = 51/302 (16%)

Query: 49  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIV 106
           K+S+  + V+G G+ G +   +       VA+K++L +   + +RE+Q+++  D HPN++
Sbjct: 23  KISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVI 81

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
                      K+  +  + +E         + +         P+  ++    Q    LA
Sbjct: 82  RYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLA 132

Query: 166 YIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNVSY---IC-SRY 217
           ++H+   I HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  
Sbjct: 133 HLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 218 YRAPELIFGATE--YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 274
           + APE++    +   T  +DI+S GCV   ++  G   F                G   +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQ 235

Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
            +   +            + H             A +L+ +     P  R +A     HP
Sbjct: 236 RQANILLGAC-SLDCLHPEKH---------EDVIARELIEKMIAMDPQKRPSAKHVLKHP 285

Query: 335 FF 336
           FF
Sbjct: 286 FF 287

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  185 bits (470), Expect = 3e-55
 Identities = 50/338 (14%), Positives = 90/338 (26%), Gaps = 57/338 (16%)

Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQ 98
           S+ +        +  G   VVF  +  E  E  A+K                +       
Sbjct: 58  SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117

Query: 99  MLDHPNIVALKHCF---------------------FSTTDKEELYLNLVLEYVP---ETV 134
            L   +    +                            D       L++       E +
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177

Query: 135 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 194
                          ++ + + T Q+ R  A + +  G+ H    P NL + P    L L
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LML 235

Query: 195 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLF 253
            D  +   +  G    +      Y   E +      +T A++ W  G  +  +      F
Sbjct: 236 GDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293

Query: 254 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 313
              +   +       L  P  +                             LP     L+
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLI 333

Query: 314 CRFFQYSPNLRCTALEACVHPFFDELRD-PNTRLPNGR 350
            RF  +    R   LEA   P F +L++  ++ L  G+
Sbjct: 334 GRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  185 bits (471), Expect = 5e-55
 Identities = 63/313 (20%), Positives = 115/313 (36%), Gaps = 32/313 (10%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 106
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
            L      TT +      L++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGM 125

Query: 165 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            ++    GI HR+IKP N++           KL DFG+A+ L   E  VS   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 222 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 272
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 332
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQ--- 299

Query: 333 HPFFDELRDPNTR 345
             FF E  D   R
Sbjct: 300 --FFAETSDILHR 310

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  184 bits (468), Expect = 4e-54
 Identities = 75/323 (23%), Positives = 127/323 (39%), Gaps = 60/323 (18%)

Query: 43  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD 101
           N     K   ++E ++G GS G V   +    G  VA+K++L D       E++++   D
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66

Query: 102 -HPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARN--YSRIHQRMPLIYVKLYT 157
            HPN++   +C  +      LY+   LE       + +          +           
Sbjct: 67  DHPNVIRY-YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVK 205
            QI   +A++H+   I HRD+KPQN+LV+  +             ++ + DFG  K L  
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 206 GEPNVSY----IC-SRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL-LGQPLF 253
           G+ +          +  +RAPEL+  +         T +IDI+S GCV   +L  G+  F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 254 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 313
             +    +   II+                   F   ++K      +       EA DL+
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276

Query: 314 CRFFQYSPNLRCTALEACVHPFF 336
            +   + P  R TA++   HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  180 bits (458), Expect = 4e-54
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 61/320 (19%)

Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD 101
           + +    +    V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60

Query: 102 HPNIVALKHCF--------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 151
           H  +V     +          T  K++  L + +EY       + I        +     
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
             +    QI  AL+YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK + +    + 
Sbjct: 121 LFR----QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILK 174

Query: 212 YICSR---------------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
                                Y A E++ G   Y   ID++S G +  E++   P   G 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGM 232

Query: 257 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 316
                 V I+K L +                +FP     P    F          ++   
Sbjct: 233 E----RVNILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLL 267

Query: 317 FQYSPNLRCTALEACVHPFF 336
             + PN R  A       + 
Sbjct: 268 IDHDPNKRPGARTLLNSGWL 287

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  184 bits (469), Expect = 8e-54
 Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 52/318 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 105
           Y     +G+G++G V   + + T    AIK +               E+ ++++LDHPNI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 161
           + L   F     +++    LV+E     E  + I     ++   +        +   Q+ 
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN---EV----DAAVIIKQVL 146

Query: 162 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
             + Y+H    I HRD+KP+N LL +      +K+ DFG + V    +     + + YY 
Sbjct: 147 SGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE++    +Y    D+WS G ++  LL G P F G++  DQ  EI+         +++ 
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
               +            W  V        A DL+ +  Q+    R +A +A  HP+  E+
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

Query: 340 RDPNTRLPNGRPLPPLFN 357
                       L     
Sbjct: 299 CSKKESGIELPSLANAIE 316

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  178 bits (454), Expect = 8e-54
 Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 45/299 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 105
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           V          D+    L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 165 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 219
              H        + HRD+KP N+ ++     +KL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           +PE +     Y    DIWS GC++ EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                 E KF +I               E  +++ R        R +  E   +P   E
Sbjct: 230 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  187 bits (476), Expect = 1e-53
 Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 29/322 (9%)

Query: 40  GGRNGNSKQKV--SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----R 92
           GGR+ +   +    +  +  +GTG FG V +   ++TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 93  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLN-LVLEYVP--ETVNRIARNYSRIHQRMP 149
           E+QIM+ L+HPN+V+ +             L  L +EY    +    + +        + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLK 119

Query: 150 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGE 207
              ++     I  AL Y+H    I HRD+KP+N+++ P   +   K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 208 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
               ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ----YSPNL 323
                + E I   +      KF  + P P        L       + R+ Q    +    
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTP------NHLSGILAGKLERWLQCMLMWHQRQ 288

Query: 324 RCTALEACVHPFFDELRDPNTR 345
           R T  +      F  L    + 
Sbjct: 289 RGTDPQNPNVGCFQALDSILSL 310

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  183 bits (467), Expect = 2e-53
 Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 49/296 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPN 104
           Y  + V+G GSFG V   K + TG+  A+K +    ++ K  K    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           I+ L   F     +++ Y  LV E     E  + I        +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLS 137

Query: 163 ALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRA 220
            + Y+H    I HRD+KP+N LL +      +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE++ G   Y    D+WSTG ++  LL G P F G +  +   +I+        ++++  
Sbjct: 197 PEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEKG 242

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
              +            W KV        A DL+ +   Y P++R +A +A  H + 
Sbjct: 243 KYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  183 bits (466), Expect = 2e-53
 Identities = 76/318 (23%), Positives = 129/318 (40%), Gaps = 52/318 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 105
           Y    ++G GSFG V + K R T +  A+K +       +D     RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 161
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 162 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
             + Y+H    I HRD+KP+N LL +      +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE++ G   Y    D+WS G ++  LL G P F G++  +   +I+        + ++ 
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
               +            W  +       +A DL+ +   + P+LR TA +   HP+  + 
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

Query: 340 RDPNTRLPNGRPLPPLFN 357
                 + +   L     
Sbjct: 284 SSETPTISDLPSLESAMT 301

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  181 bits (462), Expect = 1e-52
 Identities = 81/306 (26%), Positives = 127/306 (41%), Gaps = 59/306 (19%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------------REL 94
           Y     +G+G++G V   K +      AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 95  QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY 152
            +++ LDHPNI+ L   F    DK+  Y  LV E+    E   +I  N  +  +      
Sbjct: 98  SLLKSLDHPNIIKLFDVF---EDKKYFY--LVTEFYEGGELFEQII-NRHKFDEC----D 147

Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNV 210
                 QI   + Y+H    I HRDIKP+N LL N ++   +K+ DFG +    K     
Sbjct: 148 AANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206

Query: 211 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
             + + YY APE++    +Y    D+WS G +M  LL G P F G++  DQ  +II    
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII---- 256

Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 330
               ++++     +          + W  +       EA +L+     Y  N RCTA EA
Sbjct: 257 ----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEA 299

Query: 331 CVHPFF 336
               + 
Sbjct: 300 LNSRWI 305

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  178 bits (454), Expect = 3e-52
 Identities = 84/305 (27%), Positives = 138/305 (45%), Gaps = 54/305 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------RELQIMQM 99
           YI    +G+G+ G V  A  R+T + VAI+ + + K                 E++I++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 100 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 157
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 245

Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 215
           YQ+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   +
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 216 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 360

Query: 274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 361 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 400

Query: 334 PFFDE 338
           P+  +
Sbjct: 401 PWLQD 405

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  174 bits (444), Expect = 3e-52
 Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 56/297 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 110
            +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
            + ST   ++  + LV E +   T+    + Y +  + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 170 C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSRYYRAP 221
               I HRD+K  N+ +   T  +K+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E+     +Y  ++D+++ G  M E+   +  +       Q+   +               
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-------------- 243

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                     +KP      F K   PE  +++    + + + R +  +   H FF E
Sbjct: 244 --------SGVKP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  175 bits (446), Expect = 4e-52
 Identities = 66/328 (20%), Positives = 103/328 (31%), Gaps = 56/328 (17%)

Query: 38  TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRE 93
            I  ++        Y+    +G G F  V   +    G   A+K++L    QD+    RE
Sbjct: 25  IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76

Query: 94  LQIMQMLDHPNIVALKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 151
             + ++ +HPNI+ L          K E +  L+L +    T+             +   
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134

Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG----- 206
            +      ICR L  IH   G  HRD+KP N+L+     Q  L D GS            
Sbjct: 135 QILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSR 192

Query: 207 -----EPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 259
                +   +  C+  YRAPEL             D+WS GCV+  ++ G+  +      
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252

Query: 260 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY 319
              V +  V                 +   PQ            R       L+      
Sbjct: 253 GDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTV 286

Query: 320 SPNLRCTALEACVHPFFDELRDPNTRLP 347
            P+ R             +   P     
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPGQHTT 314

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  174 bits (443), Expect = 6e-52
 Identities = 77/327 (23%), Positives = 121/327 (37%), Gaps = 68/327 (20%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 104
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 17  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           +V     F    D + ++  +VLE       +    R      + +     + Y  QI  
Sbjct: 77  VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 126

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 213
              Y+H    + HRD+K  NL +N    ++K+ DFG + KV   GE        PN    
Sbjct: 127 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 180

Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
               Y APE++     ++  +D+WS GC+M  LL+G+P F      +  + I K      
Sbjct: 181 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 230

Query: 274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                       E+  P              + P A  L+ +  Q  P  R T  E    
Sbjct: 231 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 266

Query: 334 PFFDELRDPNTRLPNGRPLPPLFNFKP 360
            FF     P         +PP F+  P
Sbjct: 267 EFFTSGYIPARLPITCLTIPPRFSIAP 293

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  175 bits (445), Expect = 7e-52
 Identities = 66/292 (22%), Positives = 108/292 (36%), Gaps = 47/292 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKH 110
              +  VG GSFG V + K ++TG   A+KKV L+   ++  EL     L  P IV L  
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYG 117

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                  +E  ++N+ +E +   ++ ++ +        +P      Y  Q    L Y+H 
Sbjct: 118 AV-----REGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHT 168

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPEL 223
              I H D+K  N+L++    +  LCDFG A  L       S +          + APE+
Sbjct: 169 R-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           + G       +DIWS+ C+M  +L G   +         ++I      P           
Sbjct: 228 VMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI---------- 275

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                  +I P            P     +    +  P  R +A+E      
Sbjct: 276 ------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  174 bits (443), Expect = 2e-51
 Identities = 80/341 (23%), Positives = 125/341 (36%), Gaps = 71/341 (20%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 104
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 43  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           +V     F    D + ++  +VLE       +    R      + +     + Y  QI  
Sbjct: 103 VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 152

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 213
              Y+H    + HRD+K  NL +N    ++K+ DFG + KV   GE        PN    
Sbjct: 153 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 206

Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
               Y APE++     ++  +D+WS GC+M  LL+G+P F      +  + I K      
Sbjct: 207 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 256

Query: 274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                       E+  P              + P A  L+ +  Q  P  R T  E    
Sbjct: 257 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 292

Query: 334 PFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRL 374
            FF     P         +PP F+  P   S + P     L
Sbjct: 293 EFFTSGYIPARLPITCLTIPPRFSIAP---SSLDPSNRKPL 330

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  172 bits (438), Expect = 2e-51
 Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 46/317 (14%)

Query: 33  HVIRTTIGGRNGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQ 85
           H    + G  N   +  +   +I +  +G+G+FG V   + R +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 86  DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSR 143
                  E+++++ LDHPNI+ +   F    D   +Y  +V+E     E + RI    +R
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF---EDYHNMY--IVMETCEGGELLERIVSAQAR 117

Query: 144 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK 201
             + +   YV     Q+  ALAY H+   + H+D+KP+N+L    +    +K+ DFG A+
Sbjct: 118 -GKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 261
           +    E + +   +  Y APE+     + T   DIWS G VM  LL G   F G S  + 
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
             +                     E  +               L P+AVDL+ +     P
Sbjct: 234 QQKATYK-----------------EPNYA---VECRP------LTPQAVDLLKQMLTKDP 267

Query: 322 NLRCTALEACVHPFFDE 338
             R +A +   H +F +
Sbjct: 268 ERRPSAAQVLHHEWFKQ 284

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  171 bits (435), Expect = 6e-51
 Identities = 58/305 (19%), Positives = 110/305 (36%), Gaps = 52/305 (17%)

Query: 45  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 104
           + +  + +    ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH N
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVN 65

Query: 105 IVALKHCF-----------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 151
           IV    C+            +++  +   L + +E+         I +   R  +++  +
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKV 122

Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
                  QI + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L        
Sbjct: 123 LALELFEQITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
              +  Y +PE I    +Y   +D+++ G ++AELL                ++      
Sbjct: 181 SKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD---- 233

Query: 272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
                                       +       +   L+ +     P  R    E  
Sbjct: 234 ---------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

Query: 332 VHPFF 336
                
Sbjct: 267 RTLTV 271

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  172 bits (438), Expect = 7e-51
 Identities = 84/303 (27%), Positives = 136/303 (44%), Gaps = 54/303 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN--------RELQIMQM 99
           YI    +G+G+ G V  A  R+T + VAIK    +       +          E++I++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 100 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 157
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 72  LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 120

Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 215
           YQ+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   +
Sbjct: 121 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 216 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 235

Query: 274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 236 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 275

Query: 334 PFF 336
           P+ 
Sbjct: 276 PWL 278

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  174 bits (442), Expect = 7e-51
 Identities = 83/317 (26%), Positives = 126/317 (39%), Gaps = 46/317 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIMQMLDHPNIVA 107
           Y     +G+G+FGVV +   + TG +   K        DK     E+ IM  L HP ++ 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRAL 164
           L   F    DK E+   L+LE++   E  +RI A +Y      M    V  Y  Q C  L
Sbjct: 113 LHDAF---EDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGL 162

Query: 165 AYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
            ++H    I H DIKP+N++        +K+ DFG A  L   E       +  + APE 
Sbjct: 163 KHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE- 220

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           I          D+W+ G +   LL G   F GE  ++ L  + +                
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--------------- 265

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDP 342
             +++F       +  V      PEA D +    Q  P  R T  +A  HP+   +  + 
Sbjct: 266 --DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315

Query: 343 NTRLPNGRPLPPLFNFK 359
            +R+P+ R        K
Sbjct: 316 TSRIPSSRYNKIRQKIK 332

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  171 bits (436), Expect = 8e-51
 Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 44/294 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 104
           +  E  +G G F  V++A C   G  VA+KKV        + +    +E+ +++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           ++     F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C A
Sbjct: 94  VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRAPE 222
           L ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN 281
            I     Y    DIWS GC++ E+   Q  F G+   +  L + I+              
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-------------- 251

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
               +  +P +               E   LV       P  R           
Sbjct: 252 ----QCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  171 bits (436), Expect = 9e-51
 Identities = 79/306 (25%), Positives = 136/306 (44%), Gaps = 52/306 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIVA 107
           +I   V+G+G+F  VF  K R TG++ A+K + +   +++     E+ +++ + H NIV 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRA 163
           L+  +         Y  LV++ V   E  +RI     Y+   ++   + ++    Q+  A
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118

Query: 164 LAYIHNCIGICHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRA 220
           + Y+H   GI HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVA 175

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE +     Y+ A+D WS G +   LL G P F  E+      +I +             
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
                 ++F       W  +        A D +C   +  PN R T  +A  HP+ D   
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269

Query: 341 DPNTRL 346
             +  +
Sbjct: 270 ALHRDI 275

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  170 bits (434), Expect = 9e-51
 Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 66/306 (21%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKHC 111
           G G FG V+ A+ +++  I+A+K     ++ +        RE++I   L HPNI+ L   
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 112 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    D   +Y  L+LEY P       + +       +        Y  ++  AL+Y H+
Sbjct: 78  FH---DATRVY--LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS 127

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRAPE 222
              + HRDIKP+NLL+      LK+ DFG +            G  +        Y  PE
Sbjct: 128 K-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLPPE 177

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           +I G   +   +D+WS G +  E L+G+P F   +  +    I +V              
Sbjct: 178 MIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 222

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
              EF FP      +       +   A DL+ R  +++P+ R    E   HP+       
Sbjct: 223 ---EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267

Query: 343 NTRLPN 348
            +   N
Sbjct: 268 PSNCQN 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  172 bits (438), Expect = 1e-50
 Identities = 78/359 (21%), Positives = 127/359 (35%), Gaps = 68/359 (18%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 105
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           V  +  F     +E   L +V++Y    +   RI     +         +  +  QIC A
Sbjct: 86  VQYRESF-----EENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLA 137

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 222
           L ++H+   I HRDIK QN+ +      ++L DFG A+VL            + YY +PE
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           +      Y    DIW+ GCV+ EL   +  F   S +  LV  I             ++ 
Sbjct: 196 ICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII------SGSFPPVSL 247

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL--- 339
           +Y                       +   LV + F+ +P  R +        F  +    
Sbjct: 248 HY---------------------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286

Query: 340 -----------------RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
                            +  +  +P  RP     +        I        IP   +K
Sbjct: 287 FLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKK 345

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  170 bits (433), Expect = 1e-50
 Identities = 84/307 (27%), Positives = 132/307 (42%), Gaps = 52/307 (16%)

Query: 44  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIM 97
           G++K  ++  Y  E+ +G GS+G V  A  + T    A K      ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 98  QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 153
           + LDHPNI+ L   F    D  ++Y  LV+E     E   R+     +            
Sbjct: 61  KSLDHPNIIRLYETF---EDNTDIY--LVMELCTGGELFERVVHKRVFRE-------SDA 108

Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVS 211
                 +  A+AY H    + HRD+KP+N L    +    LKL DFG A     G+   +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167

Query: 212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
            + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +    
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--- 222

Query: 272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
                          F FP      W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 223 --------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260

Query: 332 VHPFFDE 338
            H +F++
Sbjct: 261 EHEWFEK 267

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  172 bits (437), Expect = 1e-50
 Identities = 82/348 (23%), Positives = 133/348 (38%), Gaps = 84/348 (24%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---------QDKRYKNRELQIMQMLDH 102
           Y  +  +G GS+GVV  A   +T  I AIK +          +D      E+++M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 103 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKL----- 155
           PNI  L   +    D++ + L  V+E       ++++         +  +  VK      
Sbjct: 88  PNIARLYEVY---EDEQYICL--VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 156 ------------------------------YTYQICRALAYIHNCIGICHRDIKPQN-LL 184
                                            QI  AL Y+HN  GICHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201

Query: 185 VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-----SRYYRAPELIFGATE-YTTAIDIWS 238
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 239 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 298
            G ++  LL+G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 299 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 346
            +      P A DL+      + + R  A+ A  HP+  +  D   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  169 bits (431), Expect = 7e-50
 Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 54/295 (18%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVA---IKKVLQDKRYKNRELQIMQMLDHPNIVAL 108
           Y+    +G G FG+V +     + +      +K    D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VKLYTYQIC 161
              F      EEL   ++ E++   +   RI    +               +  Y +Q+C
Sbjct: 67  HESF---ESMEELV--MIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVC 112

Query: 162 RALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 219
            AL ++H+   I H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y 
Sbjct: 113 EALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYY 170

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE +      +TA D+WS G ++  LL G   F  E+  +Q  +II        E I  
Sbjct: 171 APE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMN 217

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
               + E  F +I               EA+D V R        R TA EA  HP
Sbjct: 218 AEYTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  175 bits (444), Expect = 1e-49
 Identities = 76/308 (24%), Positives = 130/308 (42%), Gaps = 45/308 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 107
           Y     +GTG+FGVV +   R TG   A K V      DK    +E+Q M +L HP +V 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           L   F    D  E+   ++ E++   E   ++A  ++++ +   + Y++    Q+C+ L 
Sbjct: 219 LHDAF---EDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 166 YIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           ++H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+ 
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
            G        D+WS G +   LL G   F GE+  +            T   +K  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF--DELRDP 342
            +  F  I               +  D + +     PN R T  +A  HP+         
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

Query: 343 NTRLPNGR 350
           ++++P+ R
Sbjct: 423 DSQIPSSR 430

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  169 bits (431), Expect = 2e-49
 Identities = 85/325 (26%), Positives = 122/325 (37%), Gaps = 56/325 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 102
           Y    V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 103 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLY 156
           P+IV L   +   +    LY  +V E++   +    I +           +Y       Y
Sbjct: 86  PHIVELLETY---SSDGMLY--MVFEFMDGADLCFEIVK-----RADAGFVYSEAVASHY 135

Query: 157 TYQICRALAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC 214
             QI  AL Y H+   I HRD+KP   LL +   +  +KL  FG A  L +         
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 215 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
            + ++ APE +     Y   +D+W  G ++  LL G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                       ++K     P  W  +        A DLV R     P  R T  EA  H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 334 PFFDELRDPNTRLPNGRPLPPLFNF 358
           P+  E      ++     +  L  F
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKF 312

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  167 bits (425), Expect = 2e-49
 Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 52/299 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y    ++G GSFG V + K R T +  A+K + +            RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 161
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 162 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
             + Y+H    I HRD+KP+N+L+        +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APE++ G   Y    D+WS G ++  LL G P F G++  D L  +              
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                 ++ F       W  +       +A DL+ +   + P+LR TA +   HP+  +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  168 bits (428), Expect = 3e-49
 Identities = 62/325 (19%), Positives = 122/325 (37%), Gaps = 52/325 (16%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN----------------RELQIM 97
             G F  +      +  +  A+K      + + + +                   ELQI+
Sbjct: 40  NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 98  QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIY 152
             + +   +  +      T+ +E+Y+  + EY+      +               +P+  
Sbjct: 98  TDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           +K     +  + +YIHN   ICHRD+KP N+L++ +   +KL DFG ++ +V  +   S 
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKKIKGS- 210

Query: 213 IC-SRYYRAPELIFGATEY-TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
              +  +  PE     + Y    +DIWS G  +  +      F  +  + +L   I+   
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR--- 266

Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 330
               + I+   P      F     +         L  E +D +  F + +P  R T+ +A
Sbjct: 267 ---TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

Query: 331 CVHPFF-----DELRDPNTRLPNGR 350
             H +      ++LR+ +  L   R
Sbjct: 321 LKHEWLADTNIEDLREFSKELYKKR 345

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  168 bits (427), Expect = 4e-49
 Identities = 79/319 (24%), Positives = 129/319 (40%), Gaps = 45/319 (14%)

Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHC 111
           +++ V+G G  G V +   R TG+  A+K +L D     +E+         P+IV +   
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD- 89

Query: 112 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 165
            +      +  L +++E +   E        +SRI +R    +           I  A+ 
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGEL-------FSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 166 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 222
           ++H+   I HRD+KP+NLL  +      LKL DFG AK   +    +   C + YY APE
Sbjct: 143 FLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE 199

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
            + G  +Y  + D+WS G +M  LL G P F   +G      + +         I+    
Sbjct: 200 -VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-- 248

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRD 341
              ++ FP      W +V       +A  L+    +  P  R T  +   HP+    +  
Sbjct: 249 ---QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

Query: 342 PNTRLPNGRPLPPLFNFKP 360
           P T L   R L    +   
Sbjct: 298 PQTPLHTARVLQEDKDHWD 316

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  166 bits (422), Expect = 4e-49
 Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 67/305 (21%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 111
           G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L + 
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 112 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
           F    D   +Y  LVLE     E    +        +       + + +QI   + Y+H+
Sbjct: 80  F---EDSNYVY--LVLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS 130

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYICSRYYRA 220
             GI HRD+   NLL+  +   +K+ DFG + ++ +  E        PN        Y +
Sbjct: 131 H-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPN--------YIS 180

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE+    + +    D+WS GC+   LL+G+P F  ++  + L +++              
Sbjct: 181 PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------------ 227

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
                +++ P      +       L  EA DL+ +  + +P  R +      HPF     
Sbjct: 228 -----DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270

Query: 341 DPNTR 345
              ++
Sbjct: 271 STKSK 275

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  169 bits (429), Expect = 5e-49
 Identities = 73/304 (24%), Positives = 124/304 (40%), Gaps = 45/304 (14%)

Query: 39  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNREL 94
           +  + G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 95  QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLI 151
            +M  LDH N++ L   F     K ++   LV+EYV   E  +RI   +Y+     +  +
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYN-----LTEL 187

Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNV 210
              L+  QIC  + ++H    I H D+KP+N+L VN    Q+K+ DFG A+     E   
Sbjct: 188 DTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246

Query: 211 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
               +  + APE +      +   D+WS G +   LL G   F G++  + L  I+    
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303

Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 330
                           +         +  +       EA + + +      + R +A EA
Sbjct: 304 ---------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340

Query: 331 CVHP 334
             HP
Sbjct: 341 LKHP 344

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  166 bits (422), Expect = 6e-49
 Identities = 58/339 (17%), Positives = 101/339 (29%), Gaps = 90/339 (26%)

Query: 40  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQ- 95
           G     S+    +     +G+G FG VF+   R  G I AIK+    L     +   L+ 
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 96  ---IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 151
                 +  H ++V     +      E+ ++ +  EY    ++        RI       
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115

Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH------------------THQLK 193
            +K    Q+ R L YIH+   + H DIKP N+ ++                        K
Sbjct: 116 ELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 194 LCDFGSAKVL-----VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 248
           + D G    +      +G+          + A E++     +    DI++    +     
Sbjct: 175 IGDLGHVTRISSPQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAG 226

Query: 249 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP- 307
            +PL                                            WH++ Q RLP  
Sbjct: 227 AEPLPRNG--------------------------------------DQWHEIRQGRLPRI 248

Query: 308 ------EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
                 E  +L+       P  R +A+    H       
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  167 bits (425), Expect = 6e-49
 Identities = 70/326 (21%), Positives = 119/326 (36%), Gaps = 59/326 (18%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 101
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYT 157
           H N++ L   +    ++ ++   L+LE V   E  + +A+  + S             + 
Sbjct: 74  HHNVITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKESLSE-------EEATSFI 121

Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYIC 214
            QI   + Y+H    I H D+KP+N+++   N     +KL DFG A  +  G      I 
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 215 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
            +  + APE I          D+WS G +   LL G   F G++  + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233

Query: 274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                        + F       +           A D + +        R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 334 PFFDELRDPNTRLPNGRPLPPLFNFK 359
           P+     D    +     +  L NF+
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFR 298

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  166 bits (422), Expect = 7e-49
 Identities = 67/318 (21%), Positives = 117/318 (36%), Gaps = 60/318 (18%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIV 106
           +     +G G FGVVF+AK +      AIK++        +    RE++ +  L+HP IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 107 ALKHCFF-------STTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTY 158
              + +              ++YL + ++    E +         I +R           
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-- 216
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 217 -----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 265
                       Y +PE I G   Y+  +DI+S G ++ ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 266 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 325
           ++                    KFP +              P    +V      SP  R 
Sbjct: 240 VR------------------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERP 272

Query: 326 TALEACVHPFFDELRDPN 343
            A+    +  F++L  P 
Sbjct: 273 EAINIIENAVFEDLDFPG 290

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  165 bits (421), Expect = 8e-49
 Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 66/296 (22%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 109
            +G G FG V+ A+ ++   I+A+K     ++ ++       RE++I   L HPNI+ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F    D++ +Y  L+LE+ P  E    + +     H R        +  ++  AL Y 
Sbjct: 81  NYFH---DRKRIY--LMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYC 130

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRA 220
           H    + HRDIKP+NLL+      LK+ DFG +            G  +        Y  
Sbjct: 131 HER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YLP 180

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE+I G   +   +D+W  G +  E L+G P F   S  +    I+ V            
Sbjct: 181 PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------ 227

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                + KFP     P+       L   + DL+ +  +Y P  R        HP+ 
Sbjct: 228 -----DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  165 bits (420), Expect = 9e-49
 Identities = 73/314 (23%), Positives = 118/314 (37%), Gaps = 62/314 (19%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 101
           Y     +G+G F +V + + + TG+  A K          +    +    RE+ I++ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 155
           HPNI+ L   F    +K ++   L+LE V   E  + +A   S                 
Sbjct: 67  HPNIITLHDIF---ENKTDVV--LILELVSGGELFDFLAEKES---------LTEDEATQ 112

Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           +  QI   + Y+H+   I H D+KP+N+++   N    ++KL DFG A  +  G      
Sbjct: 113 FLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKN 170

Query: 213 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
           I  +  + APE I          D+WS G +   LL G   F GE+  + L  I  V   
Sbjct: 171 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV--- 226

Query: 272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
                          + F       +           A D + R     P  R T  ++ 
Sbjct: 227 --------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSL 264

Query: 332 VHPFFDELRDPNTR 345
            H +   +R  N R
Sbjct: 265 EHSWIKAIRRRNVR 278

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  167 bits (424), Expect = 2e-48
 Identities = 87/291 (29%), Positives = 123/291 (42%), Gaps = 46/291 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 109
           +  E  +G G+  +V++ K + T +  A+K + +    K    E+ ++  L HPNI+ LK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 165
             F       E+   LVLE V   E  +RI     YS   +R     VK    QI  A+A
Sbjct: 115 EIF---ETPTEIS--LVLELVTGGELFDRIVEKGYYS---ERDAADAVK----QILEAVA 162

Query: 166 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
           Y+H   GI HRD+KP+NLL   P     LK+ DFG +K++       +   +  Y APE 
Sbjct: 163 YLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE- 220

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           I     Y   +D+WS G +   LL G   F  E G   +   I            C    
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------NC---- 266

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
             E+ F       W +V        A DLV +     P  R T  +A  HP
Sbjct: 267 --EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  167 bits (424), Expect = 2e-48
 Identities = 80/319 (25%), Positives = 120/319 (37%), Gaps = 51/319 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 161
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 91  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 138

Query: 162 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
            ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y 
Sbjct: 139 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 197

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 198 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 245

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
                  + +P      W  V      PEA  L+      +P  R TA +A   P+    
Sbjct: 246 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291

Query: 340 RDPNTRLPNGRPLPPLFNF 358
               + +     +  L  F
Sbjct: 292 ERVASAIHRQDTVDCLKKF 310

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  165 bits (421), Expect = 2e-48
 Identities = 71/328 (21%), Positives = 121/328 (36%), Gaps = 63/328 (19%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 101
           Y     +G+G F VV + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 155
           HPN++ L   +    +K ++   L+LE V   E  + +A   S                 
Sbjct: 73  HPNVITLHEVY---ENKTDVI--LILELVAGGELFDFLAEKES---------LTEEEATE 118

Query: 156 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           +  QI   + Y+H+   I H D+KP+N+++   N    ++K+ DFG A  +  G      
Sbjct: 119 FLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKN 176

Query: 213 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
           I  +  + APE I          D+WS G +   LL G   F G++  + L  +  V   
Sbjct: 177 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV--- 232

Query: 272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
                          ++F       +           A D + R     P  R T  ++ 
Sbjct: 233 --------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSL 270

Query: 332 VHPFFDELRDPNTRLPNGRPLPPLFNFK 359
            HP+    +D    L        +  FK
Sbjct: 271 QHPWIKP-KDTQQALSRKASAVNMEKFK 297

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  168 bits (428), Expect = 3e-48
 Identities = 77/320 (24%), Positives = 122/320 (38%), Gaps = 52/320 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y     +G G+F VV +      G+  A   +   K          RE +I ++L HPNI
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 161
           V L       +++   Y  L+ + V   E    I     YS   +      ++    QI 
Sbjct: 73  VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAREYYS---EADASHCIQ----QIL 120

Query: 162 RALAYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYY 218
            A+ + H   G+ HR++KP+NLL  +      +KL DFG A  +   +        +  Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
            +PE +     Y   +D+W+ G ++  LL+G P F  E       +I             
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227

Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                   + FP      W  V      PEA DL+ +    +P+ R TA EA  HP+   
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273

Query: 339 LRDPNTRLPNGRPLPPLFNF 358
                + +     +  L  F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  166 bits (422), Expect = 4e-48
 Identities = 71/329 (21%), Positives = 118/329 (35%), Gaps = 65/329 (19%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 101
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VK 154
           HPNI+ L   +    ++ ++   L+LE V   E  + +  +                   
Sbjct: 74  HPNIITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKES----------LSEEEAT 118

Query: 155 LYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVS 211
            +  QI   + Y+H    I H D+KP+N+++   N     +KL DFG A  +  G     
Sbjct: 119 SFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FK 176

Query: 212 YIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
            I  +  + APE I          D+WS G +   LL G   F G++  + L  I  V  
Sbjct: 177 NIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-- 233

Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 330
                           + F       + +         A D + +        R T  EA
Sbjct: 234 ---------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEA 270

Query: 331 CVHPFFDELRDPNTRLPNGRPLPPLFNFK 359
             HP+     D    +     +  L NFK
Sbjct: 271 LRHPWITP-VDTQQAMVRRESVVNLENFK 298

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  166 bits (423), Expect = 5e-48
 Identities = 83/311 (26%), Positives = 124/311 (39%), Gaps = 42/311 (13%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKH 110
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 111 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRAL 164
             +         L +V+E +   E        +SRI  R    +           I  A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 165 AYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 222
            Y+H+   I HRD+KP+NLL  +   +  LKL DFG AK         +   + YY APE
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
            + G  +Y  + D+WS G +M  LL G P F    G+     +           I+    
Sbjct: 234 -VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR---- 280

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 341
              +++FP      W +V       E   L+    +  P  R T  E   HP+  +    
Sbjct: 281 -MGQYEFPN---PEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

Query: 342 PNTRLPNGRPL 352
           P T L   R L
Sbjct: 332 PQTPLHTSRVL 342

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  165 bits (419), Expect = 7e-48
 Identities = 74/319 (23%), Positives = 125/319 (39%), Gaps = 59/319 (18%)

Query: 33  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 92
           H I   +   +        Y  +  +G GS+ V  +   + T    A+K + + KR    
Sbjct: 7   HSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE 64

Query: 93  ELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS----- 142
           E++I+     HPNI+ LK  +    D + +Y  +V E +   E +++I R   +S     
Sbjct: 65  EIEILLRYGQHPNIITLKDVY---DDGKYVY--VVTELMKGGELLDKILRQKFFSEREAS 119

Query: 143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGS 199
            +             + I + + Y+H   G+ HRD+KP N+L    + +   +++CDFG 
Sbjct: 120 AV------------LFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGF 166

Query: 200 AKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 258
           AK L      +   C +  + APE +     Y  A DIWS G ++  +L G   F     
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225

Query: 259 VDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 317
                 + ++  G               +F         W+ V        A DLV +  
Sbjct: 226 DTPEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKML 262

Query: 318 QYSPNLRCTALEACVHPFF 336
              P+ R TA     HP+ 
Sbjct: 263 HVDPHQRLTAALVLRHPWI 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  161 bits (411), Expect = 2e-47
 Identities = 78/297 (26%), Positives = 115/297 (38%), Gaps = 51/297 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 161
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 68  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115

Query: 162 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
            ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y 
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                  + +P      W  V      PEA  L+      +P  R TA +A   P+ 
Sbjct: 223 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  161 bits (409), Expect = 1e-46
 Identities = 68/309 (22%), Positives = 113/309 (36%), Gaps = 52/309 (16%)

Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDH-P 103
           +    +G G F VV Q   + TG+  A K +   KR +          E+ ++++    P
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCP 89

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
            ++ L   +    +  E+   L+LEY    E  +        + + +    V     QI 
Sbjct: 90  RVINLHEVY---ENTSEII--LILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQIL 141

Query: 162 RALAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC-SRYY 218
             + Y+H    I H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y
Sbjct: 142 EGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEY 199

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
            APE I      TTA D+W+ G +   LL     F GE   +  + I +V          
Sbjct: 200 LAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV---------- 248

Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                     +       +  V        A D +      +P  R TA     H +  +
Sbjct: 249 -------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

Query: 339 LRDPNTRLP 347
               N   P
Sbjct: 294 WDFENLFHP 302

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  160 bits (407), Expect = 1e-46
 Identities = 77/317 (24%), Positives = 121/317 (38%), Gaps = 62/317 (19%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYK-NRELQIMQ 98
           Y  + ++G G   VV +   + T +  A+K            + +Q+ R    +E+ I++
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 99  MLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 153
            +  HPNI+ LK  +         +  LV + +   E  + +      S    R      
Sbjct: 79  KVSGHPNIIQLKDTY---ETNTFFF--LVFDLMKKGELFDYLTEKVTLSEKETR------ 127

Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
                 +   +  +H    I HRD+KP+N+L++   + +KL DFG +  L  GE      
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVC 184

Query: 214 CSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 268
            +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I+  
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244

Query: 269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 328
                             ++F       W             DLV RF    P  R TA 
Sbjct: 245 -----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAE 279

Query: 329 EACVHPFFDELRDPNTR 345
           EA  HPFF +      R
Sbjct: 280 EALAHPFFQQYVVEEVR 296

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  160 bits (408), Expect = 2e-46
 Identities = 67/311 (21%), Positives = 132/311 (42%), Gaps = 42/311 (13%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQMLD-HPNIVALK 109
            + +  +G GSF +  +   +++ +  A+K + +       +E+  +++ + HPNIV L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 165
             F    D+   +  LV+E +   E   RI +  ++S   +            ++  A++
Sbjct: 73  EVF---HDQLHTF--LVMELLNGGELFERIKKKKHFS---ETE----ASYIMRKLVSAVS 120

Query: 166 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 222
           ++H+  G+ HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE
Sbjct: 121 HMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
            +     Y  + D+WS G ++  +L GQ  F            ++++     ++IK    
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG-- 231

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 341
              +F F       W  V       EA DL+       PN R        + +  +    
Sbjct: 232 ---DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

Query: 342 PNTRLPNGRPL 352
            +  L     L
Sbjct: 281 SSNPLMTPDIL 291

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  160 bits (406), Expect = 4e-46
 Identities = 81/388 (20%), Positives = 130/388 (33%), Gaps = 76/388 (19%)

Query: 4   ASLGNGGVGSSRSVNGFKNIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSF 63
           A  G+ G  S R  + F           G  +   +G                V+  G F
Sbjct: 2   AGPGSLGGASGRDQSDF----------VGQTV--ELGELR--------LRVRRVLAEGGF 41

Query: 64  GVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQML-DHPNIVALKHCFFSTTD- 117
             V++A+   +G   A+K++L    +  R   +E+  M+ L  HPNIV          + 
Sbjct: 42  AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101

Query: 118 -KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICH 175
                   L+L  + +               +    V    YQ CRA+ ++H     I H
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIH 161

Query: 176 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------------EPNVSYICSRYYRAPE 222
           RD+K +NLL++     +KLCDFGSA  +                E  ++   +  YR PE
Sbjct: 162 RDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220

Query: 223 LI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           +I  +         DIW+ GC++  L   Q  F   +     + I+              
Sbjct: 221 IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRIVNG------------ 264

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF-FDEL 339
                ++  P   PH                L+    Q +P  R +  E           
Sbjct: 265 -----KYSIP---PHD-------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309

Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIP 367
           R+ N + P    L     +    LS  P
Sbjct: 310 RNVNPKSPITELLEQNGGYGSATLSRGP 337

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  158 bits (400), Expect = 6e-45
 Identities = 52/338 (15%), Positives = 108/338 (31%), Gaps = 80/338 (23%)

Query: 46  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 98
            ++  + +   V+G        +A  +ETGE   +      +R  +        E+  ++
Sbjct: 69  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128

Query: 99  ML-------------------------DHPNIVALKHCFFSTTDKEELYLNLVLEYVPET 133
           +L                             ++ ++            +L   ++   +T
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188

Query: 134 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 193
              +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P +++++     + 
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VF 246

Query: 194 LCDFGSAKVLVKGEPNVSYICSRYYRAPELI----------FGATEYTTAIDIWSTGCVM 243
           L  F      V+    V    SR +  PEL              T  T + D W+ G V+
Sbjct: 247 LTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

Query: 244 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 303
             +         ++ +               E I         F+              K
Sbjct: 304 YWIWCADLPITKDAALG------------GSEWI---------FRSC------------K 330

Query: 304 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            +P     L+  F +Y    R   L+A   P +++LR 
Sbjct: 331 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  155 bits (395), Expect = 9e-45
 Identities = 79/307 (25%), Positives = 121/307 (39%), Gaps = 72/307 (23%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 109
           ++G GSF  V  A+   T    AIK      ++++    Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
             F    D E+LY    L Y    E +  I +              + YT +I  AL Y+
Sbjct: 97  FTF---QDDEKLY--FGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYL 146

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS---------YICSRYY 218
           H   GI HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+     
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV----- 199

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
            +PEL+        + D+W+ GC++ +L+ G P F   +    + + I            
Sbjct: 200 -SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII----------- 245

Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP------NLRCTALEACV 332
                  E+ FP            ++  P+A DLV +                       
Sbjct: 246 -----KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288

Query: 333 HPFFDEL 339
           HPFF+ +
Sbjct: 289 HPFFESV 295

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  155 bits (394), Expect = 4e-44
 Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 65/309 (21%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----------KVLQDKRYK-NRELQIMQM 99
           Y  + V+G G   VV +   R TG   A+K           + L++ R    RE  I++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 100 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS-RIHQRMPLIYV 153
           +  HP+I+ L   +        ++  LV + +   E  + +      S +          
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMF--LVFDLMRKGELFDYLTEKVALSEK--------ET 202

Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           +     +  A++++H    I HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +
Sbjct: 203 RSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LREL 259

Query: 214 C-SRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 267
           C +  Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319

Query: 268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 327
                             +++F       W             DL+ R  Q  P  R TA
Sbjct: 320 G-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTA 354

Query: 328 LEACVHPFF 336
            +A  HPFF
Sbjct: 355 EQALQHPFF 363

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  156 bits (395), Expect = 6e-44
 Identities = 56/382 (14%), Positives = 115/382 (30%), Gaps = 90/382 (23%)

Query: 34  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-- 91
            + + +G R        + +   V+G        +A  +ETGE   +      +R  +  
Sbjct: 68  RVESELGER------PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 121

Query: 92  -----RELQIMQML-------------------------DHPNIVALKHCFFSTTDKEEL 121
                 E+  +++L                             ++ ++            
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 181

Query: 122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 181
           +L   ++   +T   +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P 
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPV 240

Query: 182 NLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY----YRAPELIFGA----TEYTTA 233
           +++++     + L  F        G   VS I   +      A  ++       T  T A
Sbjct: 241 DIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297

Query: 234 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 293
            D W+ G  +  +         ++ +                                  
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------------- 326

Query: 294 PHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD---PNTRLPN 348
                 +F+  K +P     L+  F +Y    R   L+A   P +++LR        L  
Sbjct: 327 ----EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQ 382

Query: 349 GRPLPPLFNFKPPELSGIPPET 370
               P      PP  +  P E 
Sbjct: 383 TDGEPTREGGAPPSGTSQPDEA 404

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  155 bits (393), Expect = 9e-44
 Identities = 79/320 (24%), Positives = 135/320 (42%), Gaps = 61/320 (19%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 109
            +G GSFG V   +  +T ++ A+K     K ++    R   +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F    D+E+++  +V++ +   +    + +N            VKL+  ++  AL Y+
Sbjct: 82  YSF---QDEEDMF--MVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYL 131

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF-- 225
            N   I HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+    
Sbjct: 132 QNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNPN 283
               Y+ A+D WS G    ELL G+  +   S     ++V   +                
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---------------- 233

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDP 342
            T   +P                 E V L+ +  + +P+ R + L      P+     D 
Sbjct: 234 TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM---NDI 278

Query: 343 N-TRLPNGRPLPPLFNFKPP 361
           N   +   R +P    F P 
Sbjct: 279 NWDAVFQKRLIPG---FIPN 295

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  154 bits (390), Expect = 1e-43
 Identities = 73/330 (22%), Positives = 133/330 (40%), Gaps = 34/330 (10%)

Query: 38  TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--R 92
           T   + G  K    +     +G G+ GVVF+   + +G ++A K +   ++        R
Sbjct: 22  TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80

Query: 93  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI 151
           ELQ++   + P IV     F+S  +     +++ +E++   +++++ +   RI    P  
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGRI----PEQ 131

Query: 152 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
            +   +  + + L Y+     I HRD+KP N+LVN    ++KLCDFG +  L+    N S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189

Query: 212 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
           ++ +R Y +PE + G   Y+   DIWS G  + E+ +G+   P     +  +     +  
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

Query: 272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ----------KRLP-----PEAVDLVCRF 316
              E                +   P   +F+           +LP      E  D V + 
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308

Query: 317 FQYSPNLRCTALEACVHPFFDELRDPNTRL 346
              +P  R    +  VH F           
Sbjct: 309 LIKNPAERADLKQLMVHAFIKRSDAEEVDF 338

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  152 bits (386), Expect = 2e-43
 Identities = 77/332 (23%), Positives = 126/332 (37%), Gaps = 65/332 (19%)

Query: 53  IAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIMQML-DHPNIVA 107
           + E V+G G+   V       T +  A+K    +    +    RE++++     H N++ 
Sbjct: 16  LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT-------- 157
           L   F    +++  Y  LV E +             S IH+R      + +         
Sbjct: 76  LIEFF---EEEDRFY--LVFEKMRGGSI-------LSHIHKR------RHFNELEASVVV 117

Query: 158 YQICRALAYIHNCIGICHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE-------P 208
             +  AL ++HN  GI HRD+KP+N+L  +P     +K+CDF     +           P
Sbjct: 118 QDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 209 NVSYIC-SRYYRAPELI----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
            +   C S  Y APE++      A+ Y    D+WS G ++  LL G P F G  G D   
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 264 EIIKVLGTPTR---EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 320
           +  +          E I+       +++FP      W  +        A DL+ +     
Sbjct: 237 DRGEACPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRD 283

Query: 321 PNLRCTALEACVHPFFDELRDPNTRLPNGRPL 352
              R +A +   HP+      P   LP    L
Sbjct: 284 AKQRLSAAQVLQHPWVQG-CAPENTLPTPMVL 314

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  154 bits (392), Expect = 2e-43
 Identities = 85/377 (22%), Positives = 130/377 (34%), Gaps = 100/377 (26%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKR--YKNRELQIMQMLDHPNIVALK 109
           V+G G+F  V   K ++TG++ A+K      +L+         E  ++   D   I  L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
             F    D+  LY  LV+EY    + +  +    S+  +R+P    + Y  +I  A+  +
Sbjct: 128 FAF---QDENYLY--LVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSV 178

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 219
           H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+      
Sbjct: 179 HR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL------ 230

Query: 220 APELI------FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
           +PE++       G   Y    D W+ G    E+  GQ  F  +S   +    I       
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------- 282

Query: 274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEA 330
                 ++        P +            +P EA D + R     P  R     A + 
Sbjct: 283 ------VHYK-EHLSLPLVDEG---------VPEEARDFIQRLLC-PPETRLGRGGAGDF 325

Query: 331 CVHPFF-----DELRDPNTRLPNGRPLPPLF-----------NF------KPPELSGIPP 368
             HPFF     D LRD            P F           NF          +SG   
Sbjct: 326 RTHPFFFGLDWDGLRD----------SVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGE 375

Query: 369 ETINRLIPEHARKQNLF 385
              +            F
Sbjct: 376 TLSDIREGAPLGVHLPF 392

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  152 bits (385), Expect = 2e-43
 Identities = 77/318 (24%), Positives = 117/318 (36%), Gaps = 56/318 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKH 110
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 111 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             +         L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 169 NCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           +   I HRD+KP+NLL  +   +  LKL DFG                     A E    
Sbjct: 135 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-- 171

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y  + D+WS G +M  LL G P F    G+     +           I+       +
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MGQ 218

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD-PNTR 345
           ++FP      W +V       E   L+    +  P  R T  E   HP+  +    P T 
Sbjct: 219 YEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

Query: 346 LPNGRPLPPLFNFKPPEL 363
           L   R L      +  ++
Sbjct: 271 LHTSRVL-KEDKERWEDV 287

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  152 bits (386), Expect = 6e-43
 Identities = 87/351 (24%), Positives = 139/351 (39%), Gaps = 56/351 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 106
           Y     +G+G+FGV    + + T E+VA+K       + +     RE+   + L HPNIV
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
             K    + T    L   +++EY    E   RI         R      + +  Q+   +
Sbjct: 80  RFKEVILTPTH---LA--IIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGV 129

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
           +Y H+ + ICHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 224 IFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           +    EY     D+WS G  +  +L+G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
              ++  P              + PE   L+ R F   P  R +  E   H +F  L++ 
Sbjct: 238 ---KYSIP---DDIR-------ISPECCHLISRIFVADPATRISIPEIKTHSWF--LKNL 282

Query: 343 NTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA------RKQNLFMA 387
              L N         F+ PE      +TI ++I E        R  + FM 
Sbjct: 283 PADLMN--ESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMT 331

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  154 bits (390), Expect = 6e-43
 Identities = 76/307 (24%), Positives = 123/307 (40%), Gaps = 57/307 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 109
           V+G G+FG V   K +   ++ A+K     ++L+         E  ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F    D   LY  LV++Y    + +  +    S+   R+P    + Y  ++  A+  +
Sbjct: 141 YAF---QDDNNLY--LVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRAPELI- 224
           H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++ 
Sbjct: 192 HQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 225 ---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
               G   Y    D WS G  M E+L G+  F  ES + +    I             MN
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------MN 295

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN-LRCT-ALEACVHPFF--- 336
                F+FP              +   A DL+ R      + L      +   HPFF   
Sbjct: 296 HK-ERFQFPTQVTD---------VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345

Query: 337 --DELRD 341
             D +R+
Sbjct: 346 DWDNIRN 352

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  150 bits (379), Expect = 5e-42
 Identities = 44/297 (14%), Positives = 92/297 (30%), Gaps = 36/297 (12%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIK----KVLQDKRYKNRELQIMQMLD 101
                H++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQ 159
               +           +    L  V E       +N I    +   + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----------LKLCDFGSAKVLVKGEPN 209
           +   +  +H+C  I H DIKP N ++     +          L L D G +  +      
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 210 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEI 265
               +   +  ++  E++     +   ID +     +  +L G  +    E G  +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 266 IKVL-GTPTREEIKCMNPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQ 318
            + L       E   +  N  +               KVFQ+    +   L  R   
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  148 bits (375), Expect = 7e-42
 Identities = 75/326 (23%), Positives = 130/326 (39%), Gaps = 59/326 (18%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---RELQIMQMLDHP 103
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           N++ L    ++   K+++Y  +V+EY      E ++ +        +R P+     Y  Q
Sbjct: 67  NVIQLVDVLYNEE-KQKMY--MVMEYCVCGMQEMLDSVP------EKRFPVCQAHGYFCQ 117

Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SR 216
           +   L Y+H+  GI H+DIKP NLL+      LK+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLHSQ-GIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 217 YYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            ++ PE+  G   ++   +DIWS G  +  +  G   F G++        I  L     E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223

Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
            I         +  P                P   DL+    +Y P  R +  +   H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 336 FDELRDPNTRLPNGRPLPPLFNFKPP 361
           F +   P        P+PP  + K  
Sbjct: 267 FRKKHPPAEAPV---PIPPSPDTKDR 289

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  149 bits (379), Expect = 3e-41
 Identities = 82/321 (25%), Positives = 133/321 (41%), Gaps = 63/321 (19%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 109
           ++G G+FG V   K + TG   A+K      ++      +   E +++Q   HP + ALK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F  T D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+
Sbjct: 215 YSF-QTHDR--LCF--VMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYL 264

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 226
           H+   + +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++  
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I                   E
Sbjct: 324 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEE 365

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 341
            +FP            + L PEA  L+    +  P  R       A E   H FF     
Sbjct: 366 IRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---AG 410

Query: 342 PN-TRLPNGRPLPPLFNFKPP 361
                +   +  PP   FKP 
Sbjct: 411 IVWQHVYEKKLSPP---FKPQ 428

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  146 bits (371), Expect = 5e-41
 Identities = 84/350 (24%), Positives = 141/350 (40%), Gaps = 60/350 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 103
           Y     +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           NIV L     +        L L++EY    E  + +       H RM     +    QI 
Sbjct: 75  NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIV 124

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
            A+ Y H    I HRD+K +NLL++     +K+ DFG +     G    ++  +  Y AP
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182

Query: 222 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           EL  G  +Y    +D+WS G ++  L+ G   F G++ + +L E +              
Sbjct: 183 ELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------- 227

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
                +++ P      +       +  +  +L+ RF   +P  R T  +     + +   
Sbjct: 228 ---RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272

Query: 341 DPNTRLPNGRPLPPLFNFKPPELS---GIPPETINRLIPEHARKQNLFMA 387
           + +   P   P   + + K  ++    G   E I   +     K +   A
Sbjct: 273 EEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL--SKMKYDEITA 320

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  146 bits (370), Expect = 9e-41
 Identities = 83/320 (25%), Positives = 133/320 (41%), Gaps = 64/320 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 109
           ++G G+FG V   + + TG   A+K      ++      +   E +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           +  F T D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+
Sbjct: 72  YA-FQTHDR--LC--FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYL 121

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIFG 226
           H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++  
Sbjct: 122 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I                   E
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------MEE 221

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 341
            +FP            + L PEA  L+    +  P  R       A E   H FF     
Sbjct: 222 IRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---LS 266

Query: 342 PN-TRLPNGRPLPPLFNFKP 360
            N   +   + LPP   FKP
Sbjct: 267 INWQDVVQKKLLPP---FKP 283

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  150 bits (380), Expect = 1e-40
 Identities = 74/322 (22%), Positives = 121/322 (37%), Gaps = 58/322 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 108
           V+G G FG VF  + + TG++ A  K L  KR K R        E +I+  +    IV+L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            +  F T       L LV+  +   +    I       +          YT QI   L +
Sbjct: 251 AYA-FETKTD----LCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEH 304

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 225
           +H    I +RD+KP+N+L++   + +++ D G A  L  G+        +  + APEL+ 
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
           G  EY  ++D ++ G  + E++  +  F       +  E+         + +      Y 
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAVTYP 413

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 340
           +                    P + D      Q  P  R      +      HP F   R
Sbjct: 414 DK-----------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF---R 453

Query: 341 DPN-TRLPNGRPLPPLFNFKPP 361
           D +  +L  G   PP   F P 
Sbjct: 454 DISWRQLEAGMLTPP---FVPD 472

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  143 bits (364), Expect = 1e-40
 Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 50/296 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
                          Y  L LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SRYYRAP 221
            Y+H  IGI HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 222 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           EL+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                          PW K     +    + L+ +    +P+ R T  +     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  151 bits (382), Expect = 2e-40
 Identities = 73/324 (22%), Positives = 128/324 (39%), Gaps = 65/324 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 105
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           V + + F      ++L    +L+ +   +    +++     H       ++ Y  +I   
Sbjct: 255 VCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILG 304

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 223
           L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ + + +  Y APE+
Sbjct: 305 LEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPEV 361

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           +     Y ++ D +S GC++ +LL G   F      D             + EI      
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI------ 402

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CT---ALEACVHPFFDE 338
                                  PE   L+    Q   N R  C    A E    PFF  
Sbjct: 403 -----DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

Query: 339 LRDPN-TRLPNGRPLPPLFNFKPP 361
           L   +   +   +  PP     PP
Sbjct: 456 L---DWQMVFLQKYPPP---LIPP 473

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  143 bits (364), Expect = 2e-40
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 41/299 (13%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 110
            +G G++GVV + +   +G+I+A+K++   +  +  K    +L I M+ +D P  V    
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
             F   D     + + +E +  ++++  +      Q +P   +      I +AL ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG---A 227
           + + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y+   DIWS G  M EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 346
             PQ+    +          E VD   +  + +   R T  E   HPFF       T +
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  144 bits (366), Expect = 2e-40
 Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 50/313 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
                          Y  L LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--SYIC-SRYYRAP 221
            Y+H  IGI HRDIKP+NLL++     LK+ DFG A V          + +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 222 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           EL+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
                          PW K     +    + L+ +    +P+ R T  +     ++++  
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269

Query: 341 DPNTRLPNGRPLP 353
               + P      
Sbjct: 270 KKGAKRPRVTSGG 282

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  144 bits (366), Expect = 2e-40
 Identities = 87/359 (24%), Positives = 148/359 (41%), Gaps = 86/359 (23%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 109
            +GTGSFG V   + R  G   A+K      V++ K   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
             F    D ++++  ++++Y+   E  + + ++     QR P    K Y  ++C AL Y+
Sbjct: 73  GTF---QDAQQIF--MIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYL 122

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 221
           H+   I +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y AP
Sbjct: 123 HSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIAP 172

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E++     Y  +ID WS G ++ E+L G   F   +   +  E I               
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL-------------- 216

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 336
               E +FP                 +  DL+ R           NL+    +   HP+F
Sbjct: 217 --NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

Query: 337 DELRDPN-TRLPNGRPLPPLFNFKPPELSG---------IPPETINRLIPEHARKQNLF 385
            E+      +L +     P   ++PP   G          P E IN  +       +LF
Sbjct: 263 KEV---VWEKLLSRNIETP---YEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 315

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  148 bits (376), Expect = 5e-40
 Identities = 87/321 (27%), Positives = 135/321 (42%), Gaps = 59/321 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 108
           V+G G FG V   + R TG++ A  K L+ KR K R        E QI++ ++   +V+L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            +  + T D     L LVL  +   +    I   Y       P      Y  +IC  L  
Sbjct: 250 AYA-YETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++  
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
              YT + D W+ GC++ E++ GQ  F                    REE+         
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRK------------KKIKREEV--------- 397

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 341
                +K  P  + + +R  P+A  L  +     P  R      +A E   HP F   + 
Sbjct: 398 --ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF---KK 450

Query: 342 PN-TRLPNGRPLPPLFNFKPP 361
            N  RL  G   PP   FKP 
Sbjct: 451 LNFKRLGAGMLEPP---FKPD 468

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  145 bits (368), Expect = 7e-40
 Identities = 80/306 (26%), Positives = 125/306 (40%), Gaps = 68/306 (22%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 109
           V+G G+FG V   + + T ++ A+K     ++++     +   E  IM   + P +V L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           + F    D   LY  +V+EY+P  + VN ++         +P  + + YT ++  AL  I
Sbjct: 136 YAF---QDDRYLY--MVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAI 184

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 219
           H+ +G  HRD+KP N+L++   H LKL DFG+   + K              YI      
Sbjct: 185 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI------ 236

Query: 220 APELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 276
           +PE++    G   Y    D WS G  + E+L+G   F  +S    LV             
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS--------- 283

Query: 277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVH 333
            K MN       FP              +  EA +L+C F      +R       E   H
Sbjct: 284 -KIMNHK-NSLTFP---DDND-------ISKEAKNLICAFLT-DREVRLGRNGVEEIKRH 330

Query: 334 PFFDEL 339
            FF   
Sbjct: 331 LFFKND 336

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  142 bits (361), Expect = 9e-40
 Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 67/321 (20%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 101
           Y    ++G+G FG V+          VAIK     ++       N      E+ +++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 102 H--PNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 156
                ++ L   +F   D     L  +LE      +  + I          +     + +
Sbjct: 105 SGFSGVIRLLD-WFERPDS--FVL--ILERPEPVQDLFDFITE-----RGALQEELARSF 154

Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 215
            +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS  +L            +
Sbjct: 155 FWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGT 211

Query: 216 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
           R Y  PE I     Y   +  +WS G ++ +++ G   F  +       EII+       
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257

Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
                      +  F             +R+  E   L+       P+ R T  E   HP
Sbjct: 258 ----------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

Query: 335 FFDELRDPNTRLP-NGRPLPP 354
           +  ++  P      +   L P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSP 316

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  140 bits (355), Expect = 3e-39
 Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 40/289 (13%)

Query: 41  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------R 92
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 93  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 150
           E+Q +++  HP+I+ L     + TD    +  +V+EYV   E  + I +     H R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICK-----HGRVEE 110

Query: 151 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
           +  +    QI  A+ Y H    + HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 211 SYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV- 268
              C S  Y APE+I G       +DIWS G ++  LL G   F  E  V  L + I+  
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGG 226

Query: 269 -------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 307
                  L       +  M   +P         I+ H W   F++ LP 
Sbjct: 227 VFYIPEYLNRSVATLLMHMLQVDPL-KRATIKDIREHEW---FKQDLPS 271

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  140 bits (355), Expect = 9e-39
 Identities = 89/324 (27%), Positives = 136/324 (41%), Gaps = 68/324 (20%)

Query: 57  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDHPNI 105
           V+G G +G VFQ +      TG+I A+K      ++++ +       E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           V L + F  T  K  LYL  +LEY+   E   ++ R                Y  +I  A
Sbjct: 84  VDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMA 133

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPE 222
           L ++H   GI +RD+KP+N+++N   H +KL DFG  K  +         C    Y APE
Sbjct: 134 LGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++   + +  A+D WS G +M ++L G P F GE+   + ++ I                
Sbjct: 192 ILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL--------------- 234

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFD 337
              +   P              L  EA DL+ +  + +   R       A E   HPFF 
Sbjct: 235 -KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF- 280

Query: 338 ELRDPN-TRLPNGRPLPPLFNFKP 360
             R  N   L   +  PP   FKP
Sbjct: 281 --RHINWEELLARKVEPP---FKP 299

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  139 bits (354), Expect = 1e-38
 Identities = 86/322 (26%), Positives = 137/322 (42%), Gaps = 66/322 (20%)

Query: 57  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR-ELQIMQMLDHPNIVA 107
           V+G GSFG VF  K     +  ++ A+K      +    R + + E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 108 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           L + F  T  K  LYL  +L+++   +   R+++             VK Y  ++  AL 
Sbjct: 91  LHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALD 140

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 224
           ++H+  GI +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE++
Sbjct: 141 HLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                +T + D WS G +M E+L G   F G+    + + +I                  
Sbjct: 199 NR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL----------------K 240

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDEL 339
            +   PQ             L PEA  L+   F+ +P  R         E   H FF   
Sbjct: 241 AKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF--- 285

Query: 340 RDPN-TRLPNGRPLPPLFNFKP 360
              +  +L      PP   FKP
Sbjct: 286 STIDWNKLYRREIHPP---FKP 304

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  140 bits (354), Expect = 2e-38
 Identities = 86/339 (25%), Positives = 140/339 (41%), Gaps = 63/339 (18%)

Query: 46  SKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIM 97
           SK+ +  YI    +G GSFG V  A   +T + VA+K      + +   +    RE+  +
Sbjct: 4   SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63

Query: 98  QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLY 156
           ++L HP+I+ L     + TD   +   +V+EY   E  + I        +RM     + +
Sbjct: 64  KLLRHPHIIKLYDVITTPTD---IV--MVIEYAGGELFDYIVE-----KKRMTEDEGRRF 113

Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 215
             QI  A+ Y H    I HRD+KP+NLL++ +   +K+ DFG + ++  G   +   C S
Sbjct: 114 FQQIICAIEYCH-RHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGS 170

Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 275
             Y APE+I G       +D+WS G V+  +L+G+  F  E  +  L + +         
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN-------- 221

Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                      +  P      +       L P A  L+ R     P  R T  E    P+
Sbjct: 222 --------SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261

Query: 336 FDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRL 374
           F      N  LP       L   +  + S      +++L
Sbjct: 262 F------NVNLP-----DYLRPMEEVQGSYADSRIVSKL 289

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  138 bits (349), Expect = 4e-38
 Identities = 68/313 (21%), Positives = 114/313 (36%), Gaps = 73/313 (23%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---------------------- 91
           G GS+GVV  A         A+K     K+++   +                        
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 92  ---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQ 146
              +E+ I++ LDHPN+V L        +++ LY+  V E V     +           +
Sbjct: 82  QVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGPVMEVPT------LK 132

Query: 147 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 206
            +     + Y   + + + Y+H    I HRDIKP NLLV      +K+ DFG +      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGS 190

Query: 207 EPNVSYIC-SRYYRAPELIFGAT-EYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 263
           +  +S    +  + APE +      ++  A+D+W+ G  +   + GQ  F  E  +  L 
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLH 249

Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
             IK                    +FP     P        +  +  DL+ R    +P  
Sbjct: 250 SKIK----------------SQALEFPD---QPD-------IAEDLKDLITRMLDKNPES 283

Query: 324 RCTALEACVHPFF 336
           R    E  +HP+ 
Sbjct: 284 RIVVPEIKLHPWV 296

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  138 bits (351), Expect = 6e-38
 Identities = 79/326 (24%), Positives = 130/326 (39%), Gaps = 77/326 (23%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 109
            +GTGSFG V   K +E+G   A+K     KV++ K   +   E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 110 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
             F    D   LY  +V+EYV   E  + +     R   R    + + Y  QI     Y+
Sbjct: 108 FSF---KDNSNLY--MVMEYVAGGEMFSHL-----RRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 221
           H+   + +RD+KP+NLL++   + +++ DFG AK +        G P           AP
Sbjct: 158 HSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALAP 207

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E+I     Y  A+D W+ G ++ E+  G P F  +    Q+ E I          +    
Sbjct: 208 EIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG-- 253

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 336
               + +FP                 +  DL+    Q        NL+    +   H +F
Sbjct: 254 ----KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

Query: 337 DELRDPN-TRLPNGRPLPPLFNFKPP 361
                 +   +   +   P   F P 
Sbjct: 298 ATT---DWIAIYQRKVEAP---FIPK 317

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  137 bits (347), Expect = 9e-38
 Identities = 68/323 (21%), Positives = 115/323 (35%), Gaps = 68/323 (21%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 101
           Y    ++G G FG VF          VAIK     +VL      +      E+ ++  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 102 ----HPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVK 154
               HP ++ L   +F T +     L  VLE      +  + I          +     +
Sbjct: 93  AGGGHPGVIRL-LDWFETQEG--FML--VLERPLPAQDLFDYITE-----KGPLGEGPSR 142

Query: 155 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 214
            +  Q+  A+ + H+  G+ HRDIK +N+L++      KL DFGS  +L           
Sbjct: 143 CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--D 199

Query: 215 -SRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 272
            +R Y  PE I    +Y      +WS G ++ +++ G   F  +       EI++     
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---- 248

Query: 273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 332
                        E  FP              + P+   L+ R     P+ R +  E  +
Sbjct: 249 -------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

Query: 333 HPFFDELRDPNTRLPNGRPLPPL 355
            P+     +     P+     PL
Sbjct: 284 DPWMQTPAEDVPLNPSKGGPAPL 306

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  137 bits (346), Expect = 1e-37
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 28/220 (12%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 112
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 113 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT-----YQICRALAY 166
               +     + LV+EY    ++      Y+ +H   PL Y           Q  + +AY
Sbjct: 70  --CLNP----VCLVMEYAEGGSL------YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 167 IHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           +H+     + HRD+KP NLL+      LK+CDFG+A          +   S  + APE+ 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVF 175

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 264
            G + Y+   D++S G ++ E++  +  F    G    + 
Sbjct: 176 EG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  137 bits (346), Expect = 1e-37
 Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 46/301 (15%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 110
            +G+G+ G V++ + R+TG ++A+K++      +  K    +L + ++  D P IV    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
            F + TD     + + +E +     ++     R+   +P   +   T  I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI----FG 226
            G+ HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 285
             +Y    D+WS G  + EL  GQ  +       + L ++++    P             
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 345
               P +  H            +    V          R    +   H F          
Sbjct: 248 ----PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

Query: 346 L 346
           +
Sbjct: 297 V 297

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  137 bits (348), Expect = 2e-37
 Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLD-HPNIVAL 108
           V+G GSFG V  ++ + T E+ A+K      V+QD   +    E +++ +    P +  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 87  HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 136

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 225
           + +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I 
Sbjct: 137 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                   
Sbjct: 195 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 236

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 340
              +P            K +  EAV +        P  R         +   H FF   R
Sbjct: 237 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 281

Query: 341 DPN-TRLPNGRPLPPLFNFKP 360
             +  +L      PP   +KP
Sbjct: 282 YIDWEKLERKEIQPP---YKP 299

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  137 bits (346), Expect = 2e-37
 Identities = 64/358 (17%), Positives = 115/358 (32%), Gaps = 103/358 (28%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
           +     +G G FGVVF+AK +      AIK++    R        RE++ +  L+HP IV
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 107 ALKHCF----------------------------------------------------FS 114
              + +                                                      
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 115 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 174
                ++YL + ++   +   +   N     +            QI  A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186

Query: 175 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------------VKGEPNVSYICSRYYRAP 221
           HRD+KP N+        +K+ DFG    +                  +   + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E I G   Y+  +DI+S G ++ ELL     F  +    +++  ++              
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
                 KFP        K       P+   +V      SP  R  A +   +  F+ L
Sbjct: 288 ----NLKFP---LLFTQK------YPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  135 bits (343), Expect = 4e-37
 Identities = 69/300 (23%), Positives = 121/300 (40%), Gaps = 39/300 (13%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 110
            +G G++G V +   + +G+I+A+K++   + +K  K    +L + M+  D P IV    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   D       + +E +  + ++  +  YS +   +P   +   T    +AL ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
            + I HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 230 ---YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
              Y    D+WS G  + EL  G+  +P  + V   +  + V G P         P    
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP---------P---- 248

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 346
            +    +   +         P  ++ V        + R    E   HPF     +    +
Sbjct: 249 -QLSNSEEREF--------SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  136 bits (345), Expect = 5e-37
 Identities = 82/318 (25%), Positives = 136/318 (42%), Gaps = 61/318 (19%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 108
           ++G GSFG VF A+ ++T +  AIK      VL D   +    E +++ +  +HP +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
               F T +   L+   V+EY+   + +  I         +  L     Y  +I   L +
Sbjct: 84  FCT-FQTKEN--LF--FVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQF 133

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 225
           +H+  GI +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ 
Sbjct: 134 LHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
           G  +Y  ++D WS G ++ E+L+GQ  F G+   ++L   I+                  
Sbjct: 192 G-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR----------------MD 233

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDPN- 343
              +P            + L  EA DL+ + F   P  R         HP F   R+ N 
Sbjct: 234 NPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF---REINW 278

Query: 344 TRLPNGRPLPPLFNFKPP 361
             L      PP   F+P 
Sbjct: 279 EELERKEIDPP---FRPK 293

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  136 bits (345), Expect = 7e-37
 Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 64/320 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIM-QMLDHPNIVAL 108
           V+G GSFG V  A+ +      A+K      +L+ K  ++   E  ++ + + HP +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
               F T DK  LY   VL+Y+   E    + R      +       + Y  +I  AL Y
Sbjct: 105 HFS-FQTADK--LY--FVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGY 154

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 225
           +H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE++ 
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               Y   +D W  G V+ E+L G P F   +   ++ + I                   
Sbjct: 213 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL----------------NK 254

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----CTALEACVHPFFDELRD 341
             +                +   A  L+    Q     R       +E   H FF     
Sbjct: 255 PLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF---SL 299

Query: 342 PN-TRLPNGRPLPPLFNFKP 360
            N   L N +  PP   F P
Sbjct: 300 INWDDLINKKITPP---FNP 316

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  135 bits (343), Expect = 7e-37
 Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 66/322 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 108
           V+G GSFG V  A+ +ETG++ A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             C F T D+  L+   V+E+V   + +  I +      +R      + Y  +I  AL +
Sbjct: 90  FCC-FQTPDR--LF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMF 139

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 225
           +H+  GI +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE++ 
Sbjct: 140 LHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               Y  A+D W+ G ++ E+L G   F  E+  D L E I                   
Sbjct: 198 E-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------ND 239

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 339
           E  +P              L  +A  ++  F   +P +R              HPFF   
Sbjct: 240 EVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF--- 284

Query: 340 RDPN-TRLPNGRPLPPLFNFKP 360
           ++ +  +L + +  PP   F+P
Sbjct: 285 KEIDWAQLNHRQIEPP---FRP 303

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  135 bits (342), Expect = 1e-36
 Identities = 88/328 (26%), Positives = 143/328 (43%), Gaps = 66/328 (20%)

Query: 57  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDH-PN 104
           V+GTG++G VF  +     +TG++ A+K      ++Q  +       E Q+++ +   P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           +V L + F  T  K  L+L  +L+Y+   E    +++      +R     V++Y  +I  
Sbjct: 121 LVTLHYAF-QTETK--LHL--ILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVL 170

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRA 220
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C +  Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMA 228

Query: 221 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           P+++ G    +  A+D WS G +M ELL G   F  +   +   EI           I  
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL- 279

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHP 334
                +E  +PQ             +   A DL+ R     P  R       A E   H 
Sbjct: 280 ----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323

Query: 335 FFDELRDPN-TRLPNGRPLPPLFNFKPP 361
           FF   +  N   L   +   P   FKP 
Sbjct: 324 FF---QKINWDDLAAKKVPAP---FKPV 345

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  136 bits (343), Expect = 1e-36
 Identities = 79/364 (21%), Positives = 136/364 (37%), Gaps = 84/364 (23%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQML-----DHP 103
           Y     +G G F  V+ +   +  + VA+K V   + Y      E+++++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 104 N---IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 160
           N   +V L   F   +     ++ +V E +   + +     +  +Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 161 CRALAYIHNCIGICHRDIKPQNLLV----------------------------------- 185
            + L Y+H    I H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 186 -------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 232
                        N    ++K+ D G+A  +   +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 233 AIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 279
             DIWST C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLP------PEAVDLVCRFFQYSPNLRCTALEACVH 333
                      ++KP    +V  ++            D +    +  P  R TA E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 334 PFFD 337
           P+ +
Sbjct: 393 PWLN 396

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  136 bits (345), Expect = 3e-36
 Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 40/289 (13%)

Query: 41  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--R 92
            +  + + K+  YI    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 93  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 150
           E+Q +++  HP+I+ L     + +D   ++  +V+EYV   E  + I +     + R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSD---IF--MVMEYVSGGELFDYICK-----NGRLDE 115

Query: 151 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
              +    QI   + Y H    + HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 116 KESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 172

Query: 211 SYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV- 268
              C S  Y APE+I G       +DIWS+G ++  LL G   F  +  V  L + I   
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICDG 231

Query: 269 -------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 307
                  L       +K M   +P         I+ H W   F++ LP 
Sbjct: 232 IFYTPQYLNPSVISLLKHMLQVDPM-KRATIKDIREHEW---FKQDLPK 276

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  133 bits (336), Expect = 7e-36
 Identities = 79/322 (24%), Positives = 138/322 (42%), Gaps = 57/322 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVAL 108
           V+G GS+  V   + ++T  I A+K      V  D+   +   E  + +   +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             C F T  +  L+   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 76  HSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 125

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 225
           +H   GI +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ 
Sbjct: 126 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
           G  +Y  ++D W+ G +M E++ G+  F      D   +        T + +        
Sbjct: 184 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-------- 227

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 339
              F  I          + L  +A  ++  F    P  R          +   HPFF   
Sbjct: 228 ---FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF--- 279

Query: 340 RDPN-TRLPNGRPLPPLFNFKP 360
           R+ +   +   + +PP   FKP
Sbjct: 280 RNVDWDMMEQKQVVPP---FKP 298

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  132 bits (334), Expect = 9e-36
 Identities = 72/328 (21%), Positives = 122/328 (37%), Gaps = 71/328 (21%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-------RELQIMQM 99
           Y     +G+G+FG V+ A  +E  + V +K     KVL+D   ++        E+ I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 100 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 156
           ++H NI+ +   F    ++      LV+E      +    I R     H R+        
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDR-----HPRLDEPLASYI 135

Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 215
             Q+  A+ Y+     I HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRL-KDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 216 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 274
             Y APE++ G   Y    +++WS G  +  L+  +  F       +L E ++       
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238

Query: 275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
                          P              +  E + LV    Q  P  R T  +    P
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

Query: 335 FFDELRDPNTRLPNGRPLPPLFNFKPPE 362
           +  +  +             +F    PE
Sbjct: 277 WVTQPVN-----LADYTWEEVFRVNKPE 299

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  132 bits (333), Expect = 4e-35
 Identities = 79/322 (24%), Positives = 138/322 (42%), Gaps = 57/322 (17%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVAL 108
           V+G GS+  V   + ++T  I A++      V  D+   +   E  + +   +HP +V L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             C F T  +  L+   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 119 HSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 168

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 225
           +H   GI +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ 
Sbjct: 169 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
           G  +Y  ++D W+ G +M E++ G+  F      D   +        T + +        
Sbjct: 227 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-------- 270

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC----VHPFFDEL 339
              F  I          + L  +A  ++  F    P  R  C           HPFF   
Sbjct: 271 ---FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF--- 322

Query: 340 RDPN-TRLPNGRPLPPLFNFKP 360
           R+ +   +   + +PP   FKP
Sbjct: 323 RNVDWDMMEQKQVVPP---FKP 341

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  128 bits (323), Expect = 2e-34
 Identities = 50/224 (22%), Positives = 85/224 (37%), Gaps = 30/224 (13%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHP 103
           E  +G G FG+V + +  +   +VAIK ++                  RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           NIV L        +       +V+E+VP   +     + +     +           I  
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIAL 133

Query: 163 ALAYIHNC-IGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYICSRY 217
            + Y+ N    I HRD++  N+ +           K+ DFG ++           + +  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 218 YRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 260
           + APE I    E YT   D +S   ++  +L G+  F   S   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  127 bits (321), Expect = 2e-34
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIV 106
           E ++G G FG V++A     G+ VA+K    D             +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 107 ALK-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           AL+  C      +  L   LV+E+     +NR+        +R+P   +  +  QI R +
Sbjct: 70  ALRGVC----LKEPNLC--LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGM 118

Query: 165 AYIHNC--IGICHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
            Y+H+   + I HRD+K  N+L+             LK+ DFG A+   +    +S   +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177

Query: 216 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 255
             + APE+I  +  ++   D+WS G ++ ELL G+  F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  131 bits (330), Expect = 1e-33
 Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQM-LDHPNIVAL 108
           V+G GSFG V  ++ + T E+ A+K      V+QD        E +++ +    P +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 408 HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 457

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 225
           + +  GI +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I 
Sbjct: 458 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                   
Sbjct: 516 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 557

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 340
              +P            K +  EAV +        P  R         +   H FF   R
Sbjct: 558 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 602

Query: 341 DPN-TRLPNGRPLPPLFNFKP 360
             +  +L      PP   +KP
Sbjct: 603 YIDWEKLERKEIQPP---YKP 620

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  124 bits (314), Expect = 4e-33
 Identities = 73/311 (23%), Positives = 120/311 (38%), Gaps = 46/311 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 107 ALKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           +    F     K+EL+  LV++      V + +  I          +    +     ++ 
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSR---- 216
             L Y+H   G  HRD+K  N+L+      +++ DFG SA +   G+   +    R    
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187

Query: 217 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
               + APE++     Y    DIWS G    EL  G   +     +  L+  ++      
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241

Query: 274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                  N        P ++     K   K+       ++    Q  P  R TA E   H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

Query: 334 PFFDELRDPNT 344
            FF + ++   
Sbjct: 289 KFFQKAKNKEF 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  126 bits (317), Expect = 6e-33
 Identities = 58/346 (16%), Positives = 119/346 (34%), Gaps = 44/346 (12%)

Query: 59  GTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNIVALKHCF 112
           G      V  A+ + TGE V ++++      ++       EL + ++ +HPNIV  +  F
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 113 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 171
            +  +     L +V  ++   +   +   +      M  + +      + +AL YIH+ +
Sbjct: 96  IADNE-----LWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-M 147

Query: 172 GICHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGEPNVSYICSRYYRAPEL 223
           G  HR +K  ++L++    ++ L    S         +  V  +     +    + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 224 IF-GATEYTTAIDIWSTGCVMAELLLGQP----------LF-------PGESGVDQLVEI 265
           +      Y    DI+S G    EL  G            L        P       +   
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266

Query: 266 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 325
              +          ++ + T               + +   P     V +  Q +P+ R 
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326

Query: 326 TALEACVHPFFDELRDPNTRL--PNGRPLPPLFNFKPPELSGIPPE 369
           +A     H FF +++   +       RP+ P+ NF+  +       
Sbjct: 327 SASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGI 372

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (326), Expect = 6e-33
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 36/231 (15%)

Query: 37  TTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD-------KR 88
             + G+         Y  +  +  G  G ++ A  R   G  V +K  L           
Sbjct: 76  DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125

Query: 89  YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN-LVLEYVP-ETVNRIARNYSRIHQ 146
               E Q +  + HP+IV +   F   TD+    +  +V+EYV  +++ R         Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRS------KGQ 177

Query: 147 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 206
           ++P+     Y  +I  AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +   
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRI--N 232

Query: 207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
                Y  +  ++APE++      T A DI++ G  +A L L  P   G  
Sbjct: 233 SFGYLYG-TPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  124 bits (313), Expect = 7e-33
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 108
           +  +G GSFG V +A+    G  VA+K +++   +        RE+ IM+ L HPNIV  
Sbjct: 42  KEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 109 K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
                   T    L   +V EY+   ++ R+    S   +++         Y + + + Y
Sbjct: 100 MGAV----TQPPNLS--IVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNY 152

Query: 167 IHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELI 224
           +HN    I HR++K  NLLV+   + +K+CDFG +++      +  S   +  + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPG 255
                     D++S G ++ EL   Q  +  
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (308), Expect = 6e-32
 Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 51/303 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 104
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
            +  + C+            LV+EY   + + +   + +    +  + +   T+   + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 225 FGATE--YTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
               E  Y   +D+WS G +   EL   +P     + +  L  I +              
Sbjct: 223 LAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ------------NE 269

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
                   P ++   W + F+        + V    Q  P  R T+     H F    R 
Sbjct: 270 S-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314

Query: 342 PNT 344
           P  
Sbjct: 315 PTV 317

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  121 bits (306), Expect = 7e-32
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKN--RELQIMQMLDHPNIVALKH 110
             V+G G FG   +   RETGE++ +K++++  ++  +   +E+++M+ L+HPN++    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                   + L    + EY+   T+  I ++      + P      +   I   +AY+H+
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS 126

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------------- 216
              I HRD+   N LV      + + DFG A+++V  +     + S              
Sbjct: 127 M-NIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 217 --YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 255
             Y+ APE+I G   Y   +D++S G V+ E++      P 
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (301), Expect = 3e-31
 Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 39/241 (16%)

Query: 33  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------ 86
           H+I   I  R         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 87  ---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYS 142
              KR++ RE+     L H NIV++        + +  YL  V+EY+   T+      Y 
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTL----SEYI 102

Query: 143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
             H  + +     +T QI   + + H+ + I HRDIKPQN+L++     LK+ DFG AK 
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160

Query: 203 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 258
           L   E +++     + +  Y +PE   G        DI+S G V+ E+L+G+P F GE+ 
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217

Query: 259 V 259
           V
Sbjct: 218 V 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (301), Expect = 4e-31
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 37/241 (15%)

Query: 35  IRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRY 89
             + +  R         Y    ++G G    V  A+       VA+K VL     +D  +
Sbjct: 6   TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55

Query: 90  KNR---ELQIMQMLDHPNIVALKHCFF---STTDKEELYLNLVLEYVP-ETVNRIARNYS 142
             R   E Q    L+HP IVA+    +              +V+EYV   T+    R+  
Sbjct: 56  YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107

Query: 143 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 202
                M            C+AL + H   GI HRD+KP N++++  T+ +K+ DFG A+ 
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARA 165

Query: 203 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 258
           +     +V+     I +  Y +PE   G +      D++S GCV+ E+L G+P F G+S 
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSP 224

Query: 259 V 259
           V
Sbjct: 225 V 225

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  120 bits (302), Expect = 4e-31
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 110
              +G G +G V+  K R  GE VA+K     ++    RE +I Q   + H NI+  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 168
               T    +LYL  + +Y    ++    ++ +      + L Y           L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 169 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 216
             I        I HRD+K +N+LV  +     + D G A   +     V    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 217 YYRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 247
            Y  PE++  +      +     D++S G ++ E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  118 bits (299), Expect = 5e-31
 Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 48/302 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
           +     +G GSFG VF+     T ++VAIK +  ++         +E+ ++   D P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
                +   T      L +++EY+   +   +          +    +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 224
           Y+H+     HRDIK  N+L++    ++KL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
             +  Y +  DIWS G    EL  G+P                    P  E    ++P  
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP--------------------PHSE----LHPMK 226

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
             F  P+  P P     +        + V       P+ R TA E   H F        +
Sbjct: 227 VLFLIPKNNP-P---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

Query: 345 RL 346
            L
Sbjct: 283 YL 284

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (298), Expect = 7e-31
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 47/292 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 107
           Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+   +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
               +    +     L +V+EY+   ++  +          M    +     +  +AL +
Sbjct: 82  YLDSYLVGDE-----LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEF 131

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 225
           +H+   + HRDIK  N+L+      +KL DFG    +   +    + + + Y+ APE++ 
Sbjct: 132 LHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 226 GATEYTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
               Y   +DIWS G +MA E++ G+P +  E+ +  L  I    GTP  +         
Sbjct: 190 R-KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN-------- 238

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                    P     +F+        D + R  +     R +A E   H F 
Sbjct: 239 ---------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  118 bits (298), Expect = 7e-31
 Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 34/216 (15%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 110
              VG G +G V++   +  GE VA+K    +D++   RE ++     L H NI+  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 168
              S     +L+L  +  Y    ++    +  +      + ++        I   LA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122

Query: 169 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 216
             I        I HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 217 YYRAPELI-----FGATEYTTAIDIWSTGCVMAELL 247
            Y APE++         +    +DIW+ G V+ E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  118 bits (297), Expect = 9e-31
 Identities = 48/224 (21%), Positives = 95/224 (42%), Gaps = 26/224 (11%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 108
              +G+GSFG V++ K       VA+K +               E+ +++   H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 109 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
              F   +   +L +  V ++    ++            +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYL 136

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 224
           H    I HRD+K  N+ ++   + +K+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 HAK-SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 225 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
                  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  117 bits (295), Expect = 1e-30
 Identities = 24/211 (11%), Positives = 71/211 (33%), Gaps = 22/211 (10%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 108
              +     G +++ + +  G  + +K +          R  N E   +++  HPN++ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 109 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
                        +  L+  ++P  ++  +    +     +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFL 127

Query: 168 HNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           H     I    +  ++++++      ++                +      + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182

Query: 227 --ATEYTTAIDIWSTGCVMAELLLGQPLFPG 255
                   + D+WS   ++ EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  117 bits (296), Expect = 2e-30
 Identities = 77/297 (25%), Positives = 123/297 (41%), Gaps = 41/297 (13%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 109
           +     +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 110 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
             +F  TD     L +V+EY    +V+ I       ++ +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGA 227
             +   HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I   
Sbjct: 143 F-MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
             Y    DIWS G    E+  G+P +     +  +  I      PT  +           
Sbjct: 201 -GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK----------- 247

Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                 P  W   F         D V +    SP  R TA +   HPF    +  + 
Sbjct: 248 ------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (295), Expect = 3e-30
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 47/286 (16%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 113
           +G GS G+V  A+ + +G  VA+K +     Q +     E+ IM+   H N+V +   + 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 114 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 172
                EEL++  ++E++    +  I         R+    +      + +ALAY+H   G
Sbjct: 113 V---GEELWV--LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QG 161

Query: 173 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 231
           + HRDIK  ++L+     ++KL DFG  A++        S + + Y+ APE+I   + Y 
Sbjct: 162 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYA 219

Query: 232 TAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 290
           T +DIWS G +M  E++ G+P +  +S V  +  +      P  +               
Sbjct: 220 TEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN-------------- 263

Query: 291 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
               H    V +        D + R     P  R TA E   HPF 
Sbjct: 264 ---SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  116 bits (292), Expect = 5e-30
 Identities = 73/307 (23%), Positives = 126/307 (41%), Gaps = 54/307 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 107
           +     +G G+FG V++AK +ETG + A K +     ++      E++I+   DHP IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 108 LKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           L   ++         L +++E+     V   +  + R        +    +++   Q+  
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR-------GLTEPQIQVVCRQMLE 128

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAP 221
           AL ++H+   I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ AP
Sbjct: 129 ALNFLHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

Query: 222 ELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
           E++   T     Y    DIWS G  + E+   +P     + +  L++I K    PT    
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT- 244

Query: 278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 337
                           P  W   F+        D +      +P  R +A +   HPF  
Sbjct: 245 ----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVS 280

Query: 338 ELRDPNT 344
            +     
Sbjct: 281 SITSNKA 287

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  115 bits (291), Expect = 1e-29
 Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 28/219 (12%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRYK---NRELQIMQMLDHP 103
           Y    +VG G  G V++A+      IVA+K ++      D  ++    RE +    L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           ++V +           +LY+   +  +             R    +          QI  
Sbjct: 95  HVVPI---HDFGEIDGQLYV--DMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYY 218
           AL   H   G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHA-AGATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 257
            APE    +   T   DI++  CV+ E L G P + G+ 
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  115 bits (291), Expect = 1e-29
 Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 42/307 (13%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQML-DHPNIVA 107
           +    +VG G++G V++ +  +TG++ AIK +     ++    +E+ +++    H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 108 LKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
               F        +  L LV+E+    +V  + +N       +   ++     +I R L+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLS 143

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 224
           ++H    + HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 225 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
                    Y    D+WS G    E+  G P       +  L  I +             
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 248

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
           NP       P++K   W K FQ          +      + + R    +   HPF  +  
Sbjct: 249 NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294

Query: 341 DPNTRLP 347
           +      
Sbjct: 295 NERQVRI 301

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  114 bits (288), Expect = 4e-29
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 110
           +  +G G FG V++ K R  GE VA+K    +++R   RE +I Q   L H NI+  +  
Sbjct: 47  QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 111 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                    +L+L  V +Y    ++      Y+   + M    +KL        LA++H 
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGM----IKL-ALSTASGLAHLHM 157

Query: 170 CI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----RY 217
            I        I HRD+K +N+LV  +     + D G A         +    +     + 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 218 YRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 247
           Y APE++  +      E     DI++ G V  E+ 
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  113 bits (285), Expect = 7e-29
 Identities = 39/223 (17%), Positives = 83/223 (37%), Gaps = 37/223 (16%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 108
             ++G G FG V+  +       VAI+ +  ++  ++      RE+   +   H N+V  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 109 K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
              C         L   ++       T+  + R+       + +   +    +I + + Y
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGY 145

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 220
           +H   GI H+D+K +N+  +     + + DFG   +    +        R       + A
Sbjct: 146 LHAK-GILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 221 PELIFGATE--------YTTAIDIWSTGCVMAELLLGQPLFPG 255
           PE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  113 bits (285), Expect = 7e-29
 Identities = 56/247 (22%), Positives = 98/247 (39%), Gaps = 35/247 (14%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 110
             V   G FG V++A+     E VA+K    QDK+    E ++  +  + H NI+  +  
Sbjct: 29  LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
               T+   +L+L  +  +          ++ + +         +    + R LAY+H  
Sbjct: 87  EKRGTSVDVDLWL--ITAFHE---KGSLSDFLKANVVSWNELCHIA-ETMARGLAYLHED 140

Query: 171 I---------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 217
           I          I HRDIK +N+L+  +     + DFG A      E   S   +      
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAGDTHGQVGT 196

Query: 218 --YRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 271
             Y APE++ GA     +    ID+++ G V+ EL        G      L    ++   
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256

Query: 272 PTREEIK 278
           P+ E+++
Sbjct: 257 PSLEDMQ 263

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  113 bits (283), Expect = 2e-28
 Identities = 56/254 (22%), Positives = 98/254 (38%), Gaps = 39/254 (15%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHC 111
             ++G G +G V++         VA+K     +++    E  I ++  ++H NI      
Sbjct: 18  LELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 112 FFSTTDKEELYLNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
               T    +   LV+EY P       ++ + S       L +       + R LAY+H 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129

Query: 170 CI--------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 217
            +         I HRD+  +N+LV        + DFG +  L                  
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 218 -----YRAPELIFGA------TEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVD-QLVE 264
                Y APE++ GA            +D+++ G +  E+ +    LFPGES  + Q+  
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 265 IIKVLGTPTREEIK 278
             +V   PT E+++
Sbjct: 249 QTEVGNHPTFEDMQ 262

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  106 bits (266), Expect = 4e-26
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 52/238 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 106 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 163
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 164 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 219
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 220 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
                    A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (263), Expect = 6e-26
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 46/218 (21%)

Query: 55  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
              +G G+FG V   +       TGE+VA+KK LQ    ++     RE++I++ L H NI
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 106 VALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 163
           V  K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ 
Sbjct: 74  VKYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 164 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 219
           + Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         +++  
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDKE--------FFKVK 174

Query: 220 ----------APELIFGATEYTTAIDIWSTGCVMAELL 247
                     APE +   ++++ A D+WS G V+ EL 
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (261), Expect = 2e-25
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 44/217 (20%)

Query: 55  EHVVGTGSFGVVFQAKCR----ETGEIVAIK--KVLQDKRYKN--RELQIMQMLDHPNIV 106
              +G G+FG V   +       TGE+VA+K  +   ++  ++  RE++I++ L H NIV
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 107 ALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 164
             K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 165 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         YY+   
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206

Query: 220 ---------APELIFGATEYTTAIDIWSTGCVMAELL 247
                    APE +   ++++ A D+WS G V+ EL 
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  102 bits (256), Expect = 9e-25
 Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 44/235 (18%)

Query: 55  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
              +G G FG V           TGE+VA+K +  D   ++     +E+ I++ L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           +  K C     D     L LV+EYVP       R+Y   H  + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148

Query: 166 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 219
           Y+H  + I   HRD+  +N+L++ +   +K+ DFG AK + +G          YYR    
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196

Query: 220 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 265
                   APE +     +  A D+WS G  + ELL          +   +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  102 bits (255), Expect = 1e-24
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)

Query: 55  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
              +G G+FG V   +       TG +VA+K  LQ           RE+QI++ L    I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 164
           V  +        ++ L   LV+EY+P   +   R++ + H+ R+    + LY+ QIC+ +
Sbjct: 87  VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 165 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+    C+   HRD+  +N+LV      +K+ DFG AK+L   +         YY    
Sbjct: 141 EYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVRE 188

Query: 220 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL 247
                    APE L      ++   D+WS G V+ EL 
Sbjct: 189 PGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELF 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  101 bits (253), Expect = 2e-24
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 55  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
              +G G FG V   +       TGE VA+K +  +    +     +E++I++ L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRAL 164
           V  K      T+     + L++E++P   +   + Y   +  ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 165 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+     +   HRD+  +N+LV    HQ+K+ DFG  K +   +         YY    
Sbjct: 140 DYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKD 187

Query: 220 ---------APELIFGATEYTTAIDIWSTGCVMAELL 247
                    APE +  +  +  A D+WS G  + ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  100 bits (252), Expect = 2e-24
 Identities = 55/238 (23%), Positives = 100/238 (42%), Gaps = 49/238 (20%)

Query: 53  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKV---LQDKRYKN---RELQIMQMLDHPN 104
           + +  +G+G+FG V +   +    +  VA+K +     D   K+    E  +MQ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV +        + E     LV+E            Y + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 165 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+   N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 220 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
                    APE + +   ++++  D+WS G +M E    GQ  + G  G +   ++E
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 33/216 (15%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 111
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 167
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 221
            N I   HRD+  +N LV  + H +K+ DFG ++++        Y      +      AP
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 181

Query: 222 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
           E L +   +++   D+W+ G ++ E+   G   +PG
Sbjct: 182 ESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 98.4 bits (246), Expect = 9e-24
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 37/220 (16%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 112
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 168
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 222
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184

Query: 223 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
            L     +++T  D+WS G ++ E+   G+  +P     D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 49/238 (20%)

Query: 53  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 105
           IA+  +G G+FG V Q   R   +   VAIK + Q     +      E QIM  LD+P I
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 164
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 165 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+   N +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 220 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
                    APE + F   ++++  D+WS G  M E L  GQ  +    G +    +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 50/237 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 106 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 163
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 164 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 219
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 220 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
                    A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  100 bits (250), Expect = 2e-23
 Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 37/215 (17%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 112
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 113 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 168
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 222
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356

Query: 223 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
            L     +++T  D+WS G ++ E+   G+  +P 
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (251), Expect = 2e-23
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 33/226 (14%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 111
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 167
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 221
            N I   HR++  +N LV    H +K+ DFG ++++        Y      +      AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
           E +     ++   D+W+ G ++ E+   G   +PG       +L+E
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 111
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 167
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 221
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 299 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 350

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
           E       +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 53/237 (22%), Positives = 90/237 (37%), Gaps = 50/237 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
             V+G+G FG V +      GE     V IK +      ++       +  +  LDH +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 164
           V L            L   LV +Y+P        ++ R H+  +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 165 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+  H  +   HR++  +N+L+     Q+++ DFG A +L   +               
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---------KQLLYS 175

Query: 220 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
                    A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 176 EAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 44/235 (18%), Positives = 79/235 (33%), Gaps = 50/235 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI-------VAIKKVLQDKRYKN----RELQIMQMLDHP 103
              +G G+F  +F+   RE G+        V +K + +  R  +        +M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 104 NIVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQIC 161
           ++V     C       +E    LV E+V          Y + ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 162 RALAYI--HNCIGICHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVKGEPNVSY 212
            A+ ++  +  I   H ++  +N+L+     +        KL D G +  ++  +     
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175

Query: 213 ICSRYYR------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
                 +       PE I        A D WS G  + E+   G           
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 96.1 bits (240), Expect = 8e-23
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 47/232 (20%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 111
              +G G FG V+        + VA+K + Q     +    E  +M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 167
            ++   +E +Y  ++ EY+    N    ++ +    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 219
            N I   HRD++  N+LV+      K+ DFG A+++   E         Y          
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174

Query: 220 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 264
              APE + +G   +T   D+WS G ++ E++  G+  +PG +   V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.8 bits (246), Expect = 9e-23
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 111
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 167
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 221
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 382 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 433

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
           E       +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 434 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 94.9 bits (237), Expect = 2e-22
 Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 110
              +G+G FGVV   K +   + VA+K + +    ++   +E Q M  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 167
           C    + +  +Y  +V EY+    N    NY R H +       L   Y +C  +A++  
Sbjct: 72  C----SKEYPIY--IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 219
           H  I   HRD+  +N LV+     +K+ DFG  + ++  +         Y          
Sbjct: 123 HQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169

Query: 220 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 264
              APE   +   +Y++  D+W+ G +M E+  LG+  +   +   V   V 
Sbjct: 170 KWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 98.5 bits (245), Expect = 2e-22
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 47/232 (20%)

Query: 53  IAEHVVGTGSFGVVFQAKCR-ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 105
           IA+  +G G+FG V Q   R    +I VAIK + Q     +      E QIM  LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 164
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 165 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+   N +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 220 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
                    APE + F   ++++  D+WS G  M E L  GQ  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 45/226 (19%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 110
              +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 167
           C     ++  +   LV E++    +    +Y R  + +      L     +C  +AY+  
Sbjct: 72  C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 219
              I   HRD+  +N LV  +   +K+ DFG  + ++  +         Y          
Sbjct: 123 ACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPV 169

Query: 220 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
              +PE   F    Y++  D+WS G +M E+   G+  +   S  +
Sbjct: 170 KWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 47/232 (20%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 111
           E  +G G FG V+ A   +  + VA+K +            E  +M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 112 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 167
                 KE +Y  ++ E++         ++ +  +       KL  ++ QI   +A+I  
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 219
            N I   HRD++  N+LV+      K+ DFG A+V+   E         Y          
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349

Query: 220 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
              APE + FG   +T   D+WS G ++ E++  G+  +PG S  +  + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.8 bits (234), Expect = 5e-22
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 48/230 (20%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
             ++G G FG V++            VA+K   +D    N+     E  IM+ LDHP+IV
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 165
            L        ++E  +  +++E  P        +Y   ++  + ++ + LY+ QIC+A+A
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 166 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 219
           Y+   NC+   HRDI  +N+LV      +KL DFG ++ +   +         YY+    
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174

Query: 220 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
                  +PE + F    +TTA D+W     M E+L  G+  F      D
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 51/239 (21%), Positives = 90/239 (37%), Gaps = 52/239 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
             ++G G FG V +A+ ++       VA+K +  D    +      RE   M+  DHP++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 106 VALKH-CFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYT 157
             L      S          ++L ++           +RI  N   +  +  L+    + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT-LVR---FM 143

Query: 158 YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 215
             I   + Y+   N I   HRD+  +N ++      + + DFG ++ +  G+        
Sbjct: 144 VDIACGMEYLSSRNFI---HRDLAARNCMLAED-MTVCVADFGLSRKIYSGD-------- 191

Query: 216 RYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
            YYR            A E L      YT   D+W+ G  M E++  GQ  + G    +
Sbjct: 192 -YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 58/230 (25%), Positives = 89/230 (38%), Gaps = 49/230 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 109
              +G G+FG VF  + R    +VA+K   +      +     E +I++   HPNIV L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 110 H--CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAY 166
              C    T K+ +Y  +V+E V          + R       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 167 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 219
           +    CI   HRD+  +N LV    + LK+ DFG ++    G          Y       
Sbjct: 229 LESKCCI---HRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLR 275

Query: 220 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
                  APE L +G   Y++  D+WS G ++ E   LG   +P  S   
Sbjct: 276 QVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 52/239 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN-------RELQIMQMLDHPN 104
              +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 163
           ++ L    +       +   +V E  P        +  R HQ    L  +  Y  Q+   
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 164 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 219
           + Y+     I   HRD+  +NLL+      +K+ DFG  + L + +         +Y   
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181

Query: 220 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
                     APE L      ++ A D W  G  + E+   GQ  + G +G      ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 51/238 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
             ++G G FG V +   ++       VA+K +  D   +        E   M+   HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 158
           + L       + +      ++L ++           +R+      I  +  L+    +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT-LLK---FMV 154

Query: 159 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
            I   + Y+   N +   HRD+  +N ++      + + DFG +K +  G+         
Sbjct: 155 DIALGMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD--------- 201

Query: 217 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
           YYR            A E L      YT+  D+W+ G  M E+   G   +PG    +
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 45/226 (19%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 110
              +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 167
           C    T +  ++  ++ EY+    N    NY R  +        L     +C A+ Y+  
Sbjct: 88  C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 219
              +   HRD+  +N LVN     +K+ DFG ++ ++  E         Y          
Sbjct: 139 KQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPV 185

Query: 220 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
               PE L++   ++++  DIW+ G +M E+  LG+  +   +  +
Sbjct: 186 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 91.1 bits (227), Expect = 4e-21
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 165
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 166 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 219
           Y+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+    
Sbjct: 131 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 177

Query: 220 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
                  APE + F    +T+A D+W  G  M E+L  G   F G    D    +E
Sbjct: 178 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.2 bits (227), Expect = 6e-21
 Identities = 60/250 (24%), Positives = 94/250 (37%), Gaps = 60/250 (24%)

Query: 59  GTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHPNIVA 107
           G G+FG V +A        +    VA+K +     L ++     EL+++  L +H NIV 
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91

Query: 108 LKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVK 154
           L       T        ++ EY                 +             + L    
Sbjct: 92  LLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 155 LYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
           L +  YQ+ + +A++   NCI   HRD+  +N+L+       K+CDFG A+ +       
Sbjct: 147 LLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHG-RITKICDFGLARDIKNDS--- 199

Query: 211 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 257
                  Y             APE IF    YT   D+WS G  + EL  LG   +PG  
Sbjct: 200 ------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 258 GVDQLVEIIK 267
              +  ++IK
Sbjct: 253 VDSKFYKMIK 262

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 59/238 (24%), Positives = 93/238 (39%), Gaps = 51/238 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           E ++G+G  G V   + R  G+    VAIK +      + R     E  IM   DHPNI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 107 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRAL 164
            L+       T        +V EY+    N     + R H     I   +     +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 165 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+     +   HRD+  +N+LV+ +    K+ DFG ++VL                   
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTT 212

Query: 220 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 264
                    APE + F    +++A D+WS G VM E+L  G+  +   +  D    VE
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 165
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 166 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 219
           Y+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+    
Sbjct: 506 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 552

Query: 220 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 264
                  APE + F    +T+A D+W  G  M E+L  G   F G     V   +E
Sbjct: 553 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 47/231 (20%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 106
           + VVG G FG V   + +   +    VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 107 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 164
            L+       T  + +   +V EY+    N    ++ R H  +  +I +      I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 165 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 219
            Y+     +   HRD+  +N+L+N +    K+ DFG  +VL              Y    
Sbjct: 161 KYLSDMGYV---HRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRG 209

Query: 220 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
                   +PE + +   ++T+A D+WS G V+ E++  G+  +   S  D
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 31/256 (12%), Positives = 54/256 (21%), Gaps = 60/256 (23%)

Query: 25  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 84
           D V    G  I     GR         Y      G       +QA        VA+  V 
Sbjct: 18  DDVQLVPGARI---ANGR---------YRLLIFHGGVPPLQFWQALDTALDRQVALTFVD 65

Query: 85  ----QDKRYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNR 136
                              +  +D P +  +         +    +  V E++   ++  
Sbjct: 66  PQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--VAEWIRGGSLQE 120

Query: 137 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 196
           +A            +        +  A    H   G+      P  + V+     + L  
Sbjct: 121 VAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-DGDVVLAY 172

Query: 197 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 256
                                                 DI   G  +  LL+ +   P  
Sbjct: 173 PA-------------------TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEA 205

Query: 257 SGVDQLVEIIKVLGTP 272
                L    +     
Sbjct: 206 GVRSGLAPAERDTAGQ 221

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 55/236 (23%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE---IVAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 106
           + V+G G FGVV+  +  +  +     AIK    + + +      RE  +M+ L+HPN++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 162
           AL          E L   ++L Y+    +     + R  QR P    LI    +  Q+ R
Sbjct: 86  ALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS---FGLQVAR 135

Query: 163 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 219
            + Y+     +   HRD+  +N +++  +  +K+ DFG A+ ++  E         YY  
Sbjct: 136 GMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE---------YYSV 182

Query: 220 -------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
                        A E L      +TT  D+WS G ++ ELL  G P +      D
Sbjct: 183 QQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 56/248 (22%), Positives = 100/248 (40%), Gaps = 61/248 (24%)

Query: 59  GTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALK 109
           G G+FG VF A+C          +VA+K +    L  ++   RE +++  L H +IV   
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83

Query: 110 HCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKLY-- 156
                  D + L   +V EY+                 I  +      +  L   ++   
Sbjct: 84  GV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 157 TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 214
             QI   + Y+   + +   HRD+  +N LV  +   +K+ DFG ++ +   +       
Sbjct: 139 ASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTD------- 187

Query: 215 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGESGV 259
             YYR             PE +++   ++TT  D+WS G ++ E+   G QP +   S  
Sbjct: 188 --YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP-WFQLS-N 241

Query: 260 DQLVEIIK 267
            +++E I 
Sbjct: 242 TEVIECIT 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 48/237 (20%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 105
           + V+G G FG V++   + +       VAIK +      K R     E  IM    H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 106 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 163
           + L+       +  + +   ++ EY+    N     + R       ++ +      I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 164 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 219
           + Y+   N +   HRD+  +N+LVN +    K+ DFG ++VL             Y    
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAT------YTTSG 209

Query: 220 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 264
                   APE + +    +T+A D+WS G VM E++  G+  +   S   V + + 
Sbjct: 210 GKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)

Query: 56  HVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD-HPN 104
             +G G+FG V +A         T   VA+K +       + R    EL+I+  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLI 151
           +V L      T     L   +++E+               E V             + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 152 YVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
           ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEK-NVVKICDFGLARDIYKDP-- 202

Query: 210 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 256
                   Y             APE IF    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 203 -------DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGV 254

Query: 257 SGVDQLVEIIK 267
              ++    +K
Sbjct: 255 KIDEEFCRRLK 265

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 55/236 (23%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 106
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 162
           +L         +      +VL Y+    +   RN+ R     P    LI    +  Q+ +
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 139

Query: 163 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 219
            + Y+     +   HRD+  +N +++     +K+ DFG A+ +   E         YY  
Sbjct: 140 GMKYLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSV 186

Query: 220 -------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
                        A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 187 HNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 50/245 (20%), Positives = 99/245 (40%), Gaps = 54/245 (22%)

Query: 56  HVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLDHPNI 105
             +G GSFG+V++   +   +      VAIK V     ++++     E  +M+  +  ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 158
           V L       +  +     +++E +            R A   + +     L  +     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 159 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
           +I   +AY+  +  +   HRD+  +N +V      +K+ DFG  + + + +         
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCMVAED-FTVKIGDFGMTRDIYETD--------- 192

Query: 217 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 262
           YYR            +PE L  G   +TT  D+WS G V+ E+  L +  + G S  +Q+
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQV 249

Query: 263 VEIIK 267
           +  + 
Sbjct: 250 LRFVM 254

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 51/233 (21%), Positives = 92/233 (39%), Gaps = 49/233 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 106
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 162
           +L         +      +VL Y+    +   RN+ R     P    LI    +  Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203

Query: 163 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 219
            + ++     +   HRD+  +N +++     +K+ DFG A+ +   E +        +  
Sbjct: 204 GMKFLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNK 253

Query: 220 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
                     A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 254 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 52/260 (20%), Positives = 98/260 (37%), Gaps = 68/260 (26%)

Query: 55  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 104
              +G G FG V +A             VA+K +       + R    E  +++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 145
           ++ L       +    L   L++EY                      +      +     
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 146 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
               L    L  + +QI + + Y+     +   HRD+  +N+LV     ++K+ DFG ++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEG-RKMKISDFGLSR 198

Query: 202 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-L 248
            + + +          Y             A E +F    YTT  D+WS G ++ E++ L
Sbjct: 199 DVYEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTL 248

Query: 249 G-QPLFPGESGVDQLVEIIK 267
           G  P +PG    ++L  ++K
Sbjct: 249 GGNP-YPGIP-PERLFNLLK 266

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 60/251 (23%), Positives = 98/251 (39%), Gaps = 58/251 (23%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLD-HP 103
              +G G+FG V +A     G+      VA+K +       +K     EL+IM  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVP---------ETVNRIARNYSRIHQRMPLIYVK 154
           NIV L       T    +   ++ EY                +  + +            
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 155 L--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 210
           L  ++ Q+ + +A++   NCI   HRD+  +N+L+    H  K+ DFG A+ ++      
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS--- 218

Query: 211 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 256
                  Y             APE IF    YT   D+WS G ++ E+  LG  P +PG 
Sbjct: 219 ------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGI 270

Query: 257 SGVDQLVEIIK 267
               +  +++K
Sbjct: 271 LVNSKFYKLVK 281

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 60/251 (23%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNI 105
           +  +G G+FG VF A+C          +VA+K +       ++   RE +++ ML H +I
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP----------ETVNRIARNYSRIHQRMPLIYVKL 155
           V         T+   L   +V EY+              +             PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 156 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
                Q+   + Y+   + +   HRD+  +N LV      +K+ DFG ++ +   +    
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD---- 212

Query: 212 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 256
                YYR             PE +++   ++TT  D+WS G V+ E+   G QP +   
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQL 264

Query: 257 SGVDQLVEIIK 267
           S   + ++ I 
Sbjct: 265 S-NTEAIDCIT 274

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 59/260 (22%), Positives = 97/260 (37%), Gaps = 67/260 (25%)

Query: 55  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHP 103
             V+G+G+FG V  A             VA+K +       ++     EL++M  L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVP------------------ETVNRIARNYSRIH 145
           NIV L       T    +Y  L+ EY                    E      +      
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 146 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
               L +  L  + YQ+ + + ++   +C+   HRD+  +N+LV      +K+CDFG A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHG-KVVKICDFGLAR 220

Query: 202 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--L 247
            ++             Y             APE +F    YT   D+WS G ++ E+  L
Sbjct: 221 DIMSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 270

Query: 248 LGQPLFPGESGVDQLVEIIK 267
              P +PG        ++I+
Sbjct: 271 GVNP-YPGIPVDANFYKLIQ 289

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 50/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)

Query: 55  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 104
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 160
           IV        +      +  +++E +      +  R  R        + ++ +      I
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 161 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 216
                Y+  ++ I   HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197

Query: 217 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 262
           YYR             PE  + G   +T+  D WS G ++ E+  LG   +P +S   ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254

Query: 263 VEIIK 267
           +E + 
Sbjct: 255 LEFVT 259

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)

Query: 55  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 104
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 160
           IV        +      +  ++LE +      +  R  R        + ++ +      I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 161 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 216
                Y+  ++ I   HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238

Query: 217 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 262
           YYR             PE  + G   +T+  D WS G ++ E+  LG   +P +S   ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295

Query: 263 VEIIK 267
           +E + 
Sbjct: 296 LEFVT 300

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 53/253 (20%), Positives = 93/253 (36%), Gaps = 62/253 (24%)

Query: 55  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 104
              +G   FG V++         E  + VAIK +        +     E  +   L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYV 153
           +V L       T  + L   ++  Y                + +         +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 154 KL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 209
                  QI   + Y+  H+ +   H+D+  +N+LV      +K+ D G  + +   +  
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDK-LNVKISDLGLFREVYAAD-- 182

Query: 210 VSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFP 254
                  YY+            APE +++G  +++   DIWS G V+ E+   G QP + 
Sbjct: 183 -------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YC 232

Query: 255 GESGVDQLVEIIK 267
           G S    +VE+I+
Sbjct: 233 GYS-NQDVVEMIR 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 56/261 (21%), Positives = 99/261 (37%), Gaps = 70/261 (26%)

Query: 55  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 104
              +G G+FG VFQA+       E   +VA+K +        +    RE  +M   D+PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 145
           IV L          + +   L+ EY+                       +   R      
Sbjct: 112 IVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 146 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 201
              PL   +      Q+   +AY+     +   HRD+  +N LV  +   +K+ DFG ++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGEN-MVVKIADFGLSR 222

Query: 202 VLVKGEPNVSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL- 247
            +   +         YY+             PE + +    YTT  D+W+ G V+ E+  
Sbjct: 223 NIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271

Query: 248 LG-QPLFPGESGVDQLVEIIK 267
            G QP + G +  ++++  ++
Sbjct: 272 YGLQP-YYGMA-HEEVIYYVR 290

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 61/254 (24%)

Query: 55  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 101
              +G G FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 150
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 151 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 206
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  + + +K+ DFG A+ +   
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 256

Query: 207 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 253
           +         YY+            APE +F    YT   D+WS G +M E+  LG   +
Sbjct: 257 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 306

Query: 254 PGESGVDQLVEIIK 267
           PG   V++L +++K
Sbjct: 307 PGIP-VEELFKLLK 319

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.6 bits (207), Expect = 6e-18
 Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 61/254 (24%)

Query: 55  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 101
              +G G+FG V  A+              VA+K +      +D      E+++M+M+  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPL 150
           H NI+ L       T    LY  +++EY                          +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 151 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 206
               L    YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG A+ +   
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTED-NVMKIADFGLARDIHHI 244

Query: 207 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 253
           +         YY+            APE +F    YT   D+WS G ++ E+  LG   +
Sbjct: 245 D---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPY 294

Query: 254 PGESGVDQLVEIIK 267
           PG   V++L +++K
Sbjct: 295 PGVP-VEELFKLLK 307

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 61/254 (24%)

Query: 55  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 101
              +G G+FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 150
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 151 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 206
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  + + +K+ DFG A+ +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 210

Query: 207 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 253
           +         YY+            APE +F    YT   D+WS G +M E+  LG   +
Sbjct: 211 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 260

Query: 254 PGESGVDQLVEIIK 267
           PG   V++L +++K
Sbjct: 261 PGIP-VEELFKLLK 273

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 80.3 bits (197), Expect = 5e-17
 Identities = 46/330 (13%), Positives = 91/330 (27%), Gaps = 74/330 (22%)

Query: 58  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----------RELQIMQML----- 100
           +G G FG VF  +       VAIK + ++     N            E+ I + L     
Sbjct: 28  IGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 101 ----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIY-- 152
                    + L            L L     Y     + N     +      + L +  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 153 -----------------VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 195
                             K   +Q+  +LA     +   HRD+   N+L+   + + KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLH 204

Query: 196 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 255
              + K        +                  +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCGL-------------QVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 256 ESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKPHPW--HKVFQKRLP 306
           +   D   +I +++           +P       +Y   K  +        +    K++ 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309

Query: 307 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            +  +       +S     +A +       
Sbjct: 310 RKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 60/238 (25%)

Query: 55  EHVVGTGSFGVVFQAKCRETGE--IVAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 106
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKL 155
            L         +  LY  L +EY P             +               L   +L
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 156 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 211
             +   + R + Y+     I   HRD+  +N+LV  + +  K+ DFG ++          
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191

Query: 212 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 255
                 Y             A E L +    YTT  D+WS G ++ E++ LG   + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 16/157 (10%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 108
           Y     +G GSFGV+F+       + VAIK   +         E +  ++L     I  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            +       +E L+  LV++ +  ++  +     R   +  +  V +   Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123

Query: 169 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 201
               + +RDIKP N L+    + + + + + DFG  K
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 16/157 (10%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQMLDH-PNIVAL 108
           +     +G G+FG +   K   T E VAIK   +       + E +  + L     I  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            +           Y  +VLE +  ++  +     R      L  V +   Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122

Query: 169 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 201
           +   + +RD+KP+N L+    N     + + DF  AK
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 14/155 (9%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 108
           Y     +G+GSFG ++       GE VAIK      ++     E +I +M+     I  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           + C       E  Y  +V+E +  ++  +    SR   +  L  V L   Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122

Query: 169 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 201
           +     HRD+KP N L+      + + + DFG AK
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQML-DHPNIVAL 108
           +     +G+GSFG ++     +T E VAIK      ++     E +I ++L     I  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
           +         E  Y  LV++ +  ++  +   ++   +++ L  V +   Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 169 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 201
           +     HRDIKP N L+      +Q+ + DFG AK
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 45/250 (18%), Positives = 81/250 (32%), Gaps = 49/250 (19%)

Query: 31  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK 90
            G V+    G +         ++    +G+G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 91  N---RELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVPET 133
                EL+  Q +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 134 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQL 192
           + +I    +          V     ++   L YIH      H DIK  NLL+   +  Q+
Sbjct: 138 LQKI-SGQNG---TFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 193 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWSTG 240
            L D+G +        +  Y         +   G  E+ T++            D+   G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 241 CVMAELLLGQ 250
             M   L G+
Sbjct: 248 YCMLRWLCGK 257

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.0 bits (175), Expect = 6e-14
 Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 56/236 (23%)

Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQ 95
            N  ++   +  + +G G FGVV+  K       VA+KK+                 E++
Sbjct: 25  NNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82

Query: 96  IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS------RIHQRMP 149
           +M    H N+V L     S+   +     LV  Y+P        N S       +    P
Sbjct: 83  VMAKCQHENLVELLGF--SSDGDDLC---LVYVYMP--------NGSLLDRLSCLDGTPP 129

Query: 150 LIYVKLYTYQIC----RALAYIH-NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSA 200
           L +      +I       + ++H N   I HRDIK  N+L+           K+ DFG A
Sbjct: 130 LSWHM--RCKIAQGAANGINFLHENHH-I-HRDIKSANILLDEAFTA-----KISDFGLA 180

Query: 201 KVLVKGEPNVSYICSR----Y-YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 251
           +   K     + + SR      Y APE + G  E T   DI+S G V+ E++ G P
Sbjct: 181 RASEKFA--QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 47/220 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVAL-K 109
           + ++G G FG V++   R+ G  VA+K+   +          E++ +    HP++V+L  
Sbjct: 44  KFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQIC----RA 163
            C       E   + L+ +Y+    N   +   Y      M + + +    +IC    R 
Sbjct: 103 FC------DERNEMILIYKYME---NGNLKRHLYGSDLPTMSMSWEQ--RLEICIGAARG 151

Query: 164 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY----- 217
           L Y+H   I I HRD+K  N+L++ +    K+ DFG +K   + +   +++ +       
Sbjct: 152 LHYLHTRAI-I-HRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLSTVVKGTLG 206

Query: 218 YRAPELIFGATEY------TTAIDIWSTGCVMAELLLGQP 251
           Y  P       EY      T   D++S G V+ E+L  + 
Sbjct: 207 YIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 46/252 (18%), Positives = 76/252 (30%), Gaps = 52/252 (20%)

Query: 32  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 91
           G +I                +     +G G FG ++ A    + E V        K   +
Sbjct: 26  GEIITDMAAAA---------WKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPS 75

Query: 92  R------ELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVP 131
                  EL+  Q    P  +                           + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 132 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTH 190
             + +I    ++   R     V   + +I   L YIH      H DIK  NLL+N  +  
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191

Query: 191 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWS 238
           Q+ L D+G A        + +Y             G  E+ T+I            D+  
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246

Query: 239 TGCVMAELLLGQ 250
            G  M + L G 
Sbjct: 247 LGYCMIQWLTGH 258

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 48/221 (21%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 109
           ++++G G FG V++ +    G +VA+K++ +++          E++++ M  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-------RIHQRMPLIYVKLYTYQIC- 161
                 T  E L   LV  Y+         N S       R   + PL + K    +I  
Sbjct: 94  GF--CMTPTERL---LVYPYMA--------NGSVASCLRERPESQPPLDWPK--RQRIAL 138

Query: 162 ---RALAYIHN-C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 216
              R LAY+H+ C   I HRD+K  N+L++    +  + DFG AK++   +   +++ + 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTA 194

Query: 217 Y-----YRAPE-LIFG-ATEYTTAIDIWSTGCVMAELLLGQ 250
                 + APE L  G ++E T   D++  G ++ EL+ GQ
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 37/255 (14%), Positives = 78/255 (30%), Gaps = 56/255 (21%)

Query: 31  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG--------EIVAIK- 81
           TG V+    G +         +  +      + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 82  -----------KVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 128
                         Q   K  +  + + +       I             ++ Y  LVL 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV----HQDKYRFLVLP 138

Query: 129 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP- 187
            +  ++        +    +    V     ++  AL ++H      H ++  +N+ V+P 
Sbjct: 139 SLGRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPE 195

Query: 188 HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------D 235
              Q+ L  +G A        +V+Y             G  E+  ++            D
Sbjct: 196 DQSQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSD 250

Query: 236 IWSTGCVMAELLLGQ 250
           + S G  M + L G 
Sbjct: 251 LQSLGYCMLKWLYGF 265

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 29/127 (22%)

Query: 156 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
           Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K        
Sbjct: 198 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYKDP------ 247

Query: 214 CSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 260
               Y             APE IF    YT   D+WS G ++ E+  LG   +PG    +
Sbjct: 248 ---DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

Query: 261 QLVEIIK 267
           +    +K
Sbjct: 304 EFCRRLK 310

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	390
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.67
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.6
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.31
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.29
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.17
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.16
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.0
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.78
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.75
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.62
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.51
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.42
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.39
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.37
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.33
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.31
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.3
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.25
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.2
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.83
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.71
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.93
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.47

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.1e-64  Score=458.17  Aligned_cols=253  Identities=31%  Similarity=0.520  Sum_probs=218.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|+.++|||||+++++|     .+..
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            35799999999999999999999999999999998542       23456899999999999999999999     3445


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ++|+|||||+| +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus       106 ~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g-~vKl~DFGla  179 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTA  179 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCC-CEEEEEcCCc
Confidence            68999999985 88877764    4679999999999999999999998 9999999999999999988 7999999999


Q ss_pred             cccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          201 KVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       201 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      +......   ...+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.++.+.         
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---------  249 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL---------  249 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Confidence            8764332   23467899999999999654 5899999999999999999999999999888888777652         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHH------HhcCCcccccCCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDP  342 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~------~l~hp~f~~~~~~  342 (390)
                              .+.            +++.+++++++||++||++||++|+|++|      +++||||+++++.
T Consensus       250 --------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          250 --------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             --------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             --------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence                    111            23568999999999999999999999987      5899999998754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-64  Score=477.60  Aligned_cols=288  Identities=37%  Similarity=0.646  Sum_probs=239.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.++|||||++++++..... .+...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999996432      234579999999999999999998754321 23455


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+|||||+|+|..++..    .+.+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+.
T Consensus       134 ~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENC-ELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCC-CEEEeecceeee
Confidence            889999999998776653    5689999999999999999999998 9999999999999999988 799999999986


Q ss_pred             cccC-----CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          203 LVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       203 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ....     ....+.+||+.|+|||++.+...|+.++||||+||++|||++|++||.+.+..+++..|....+.++...+
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            5332     23356789999999999987777899999999999999999999999999999999999999999887654


Q ss_pred             hhcCcCcc---cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCC
Q 016401          278 KCMNPNYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  344 (390)
Q Consensus       278 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~  344 (390)
                      ........   ...++...+.+|...+ +.++++++|||++||++||++|+|+.|+|+||||++..++..
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~  356 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD  356 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence            33221110   1134444455555544 568999999999999999999999999999999999877653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.5e-64  Score=451.02  Aligned_cols=249  Identities=28%  Similarity=0.415  Sum_probs=202.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++|||||++++++.     +...
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCE
Confidence            3799999999999999999999999999999998543       133568999999999999999999983     3445


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+|||||+|+|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus        88 ~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  161 (275)
T 3hyh_A           88 IIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHL-NVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTC-CEEECCSSCC--
T ss_pred             EEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCC-CEEEeecCCCee
Confidence            889999999998877764    4679999999999999999999998 9999999999999999988 799999999987


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ........+.+||+.|||||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+...              
T Consensus       162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--------------  227 (275)
T 3hyh_A          162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--------------  227 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred             cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------
Confidence            666555667889999999999977665678999999999999999999999988877766666541              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                         ...            ++..+++++++||++||++||++|||++|+|+||||+.
T Consensus       228 ---~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          228 ---VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ---CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ---CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence               111            23468999999999999999999999999999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7e-63  Score=455.80  Aligned_cols=252  Identities=27%  Similarity=0.421  Sum_probs=216.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|.+     ...+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3446789999999999999999999943     345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      |||||+| +|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999985 77776653     579999999999999999999998 9999999999999999998 79999999998764


Q ss_pred             cC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+......            
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~------------  288 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------  288 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC------------
T ss_pred             CCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC------------
Confidence            43 33456789999999999954 55999999999999999999999999998888877766542100            


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                    ....+..+++++++||.+||++||++|||+.|+|+||||++..
T Consensus       289 --------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          289 --------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             --------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                          0011246899999999999999999999999999999998753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-61  Score=457.41  Aligned_cols=252  Identities=28%  Similarity=0.431  Sum_probs=216.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..|++.+.||+|+||.||+|+++.+|+.||||++...    ...+.+|+.+|+.++|||||+++++|.+     ...+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3446789999999999999999999944     345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      |||||+| +|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+...
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence            9999985 77776653     579999999999999999999998 9999999999999999998 79999999998764


Q ss_pred             cC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..... +           
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~-----------  365 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-P-----------  365 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----------
T ss_pred             CCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C-----------
Confidence            43 33456789999999999954 4599999999999999999999999999888887776654210 0           


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                    .......+++++++||.+||++||++|+|+.|+|+||||++..
T Consensus       366 --------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          366 --------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             --------------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             --------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                          0011246899999999999999999999999999999998743

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-62  Score=454.93  Aligned_cols=251  Identities=28%  Similarity=0.422  Sum_probs=209.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...      ...+.+|+.+|+.++|||||++++++.     +...+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence            5899999999999999999999999999999998543      234568999999999999999999984     34458


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+|||||+ |+|.+++...  ....+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.
T Consensus        99 yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~  174 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TVQLGDFGIARV  174 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTC-CEEECSTTEESC
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-CEEEccccccee
Confidence            89999998 5888877642  23457899999999999999999998 9999999999999999988 799999999986


Q ss_pred             cccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          203 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       203 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ...... ..+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.++....            
T Consensus       175 ~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------------  241 (350)
T 4b9d_A          175 LNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS------------  241 (350)
T ss_dssp             CCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------------
T ss_pred             ecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------
Confidence            543322 245679999999999965 459999999999999999999999999998888887776521            


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                             ++         .++..+++++++||.+||++||++|||+.|+|+||||++
T Consensus       242 -------~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 -------FP---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -------CC---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                   00         012468999999999999999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.6e-62  Score=445.46  Aligned_cols=252  Identities=29%  Similarity=0.436  Sum_probs=209.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||+||+|++.   .+++.||||++.+.      .....+|+++|+.++|||||++++++.     +
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~   97 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----T   97 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----E
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----E
Confidence            458999999999999999999974   46889999998542      234567999999999999999999984     3


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      +..+|+|||||+| +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFG  171 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFG  171 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTS-CEEEESSE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCC-CEEecccc
Confidence            4458899999984 88777764    4679999999999999999999998 9999999999999999998 79999999


Q ss_pred             CccccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          199 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       199 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      +|+..... ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.++.+.         
T Consensus       172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------  241 (304)
T 3ubd_A          172 LSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA---------  241 (304)
T ss_dssp             EEEC-----CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred             cceeccCCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------
Confidence            99865433 33456789999999999965 45999999999999999999999999999888888777652         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                              ...            +++.+|+++++||++||++||++|||     ++|+++||||+++++
T Consensus       242 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          242 --------KLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             --------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             --------CCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence                    111            23468999999999999999999998     579999999998753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.4e-61  Score=459.33  Aligned_cols=315  Identities=72%  Similarity=1.233  Sum_probs=283.1

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceEE
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  123 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  123 (390)
                      ......+|++.+.||+|+||.||+|++..+++.||||++..+.....+|+++++.++||||+++++++..... .+..++
T Consensus        49 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             CCCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             CCcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            3345568999999999999999999999999999999998777777789999999999999999998865432 456678


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++||||+++++...+..+......+++..++.++.||+.||+|||+ .||+||||||+|||++.++..+||+|||+++..
T Consensus       129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            8999999999888887776667889999999999999999999998 999999999999999977657899999999877


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ..........||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++++.++.+..+.+..+++.
T Consensus       208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~  287 (420)
T 1j1b_A          208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  287 (420)
T ss_dssp             CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred             ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            66666667789999999999977667999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP  360 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  360 (390)
                      +..+.++.....+|...++..+++++++||++||.+||.+|||+.|+|+||||++++++...+++....|..++|..
T Consensus       288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  364 (420)
T 1j1b_A          288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTT  364 (420)
T ss_dssp             CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCH
T ss_pred             hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCH
Confidence            99999999999999999989999999999999999999999999999999999999888777777777777777654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.9e-61  Score=434.93  Aligned_cols=251  Identities=23%  Similarity=0.339  Sum_probs=207.8

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      |++.+.||+|+||+||+|.++.+++.||+|++....      ..+.+|+++|+.++|||||+++++|.+.. ....++|+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            578889999999999999999999999999985432      33568999999999999999999885432 23556889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--cccccCCCCcEEEcC-CCCcEEEeecCCcc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNP-HTHQLKLCDFGSAK  201 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~-~~~~vkl~Dfg~a~  201 (390)
                      |||||+ |+|.+++..    ...+++..++.++.||+.||+|||+ +|  ||||||||+||||+. ++ .+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence            999998 488877764    4679999999999999999999998 88  999999999999985 55 79999999997


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .. ......+.+||+.|||||++.+  .|+.++|||||||++|||+||++||.+.+....+.+.+.....          
T Consensus       181 ~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~----------  247 (290)
T 3fpq_A          181 LK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------  247 (290)
T ss_dssp             GC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------
T ss_pred             eC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC----------
Confidence            53 3344456789999999999853  4999999999999999999999999887665555443321000          


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                      ...++...++++++||.+||+.||++|||+.|+|+||||++
T Consensus       248 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          248 ----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                            01123457899999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-61  Score=445.71  Aligned_cols=256  Identities=26%  Similarity=0.371  Sum_probs=214.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEEec
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      ..|++.++||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+|+.++|||||++++++.     +..++||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEec
Confidence            479999999999999999999999999999999976443 358999999999999999999984     34458899999


Q ss_pred             cc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCC
Q 016401          130 VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  208 (390)
Q Consensus       130 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~  208 (390)
                      |+ |+|.+++..    .+.+++..++.++.||+.||+|||+ +|||||||||+||||+.++..+||+|||+|+.......
T Consensus       132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            98 488888764    3679999999999999999999998 99999999999999998875699999999986643321


Q ss_pred             ------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          209 ------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       209 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                            ....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.++...  .+          
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~----------  273 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PP----------  273 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CC----------
T ss_pred             ccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CC----------
Confidence                  123579999999999965 45999999999999999999999999987776666666541  00          


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHH-------------hcCCcccccCCCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-------------CVHPFFDELRDPN  343 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~-------------l~hp~f~~~~~~~  343 (390)
                                   + ...+++.+++++++||.+||++||++|||+.|+             |+|||+.+.++|.
T Consensus       274 -------------~-~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          274 -------------P-IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             -------------G-GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             -------------C-chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                         0 012345789999999999999999999999997             6799998876553

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-61  Score=455.32  Aligned_cols=332  Identities=51%  Similarity=0.979  Sum_probs=284.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCC----------
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD----------  117 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----------  117 (390)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++..+.....+|+.+++.++||||+++++++....+          
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            3458999999999999999999999999999999998877777799999999999999999999865433          


Q ss_pred             -----------------------CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcc
Q 016401          118 -----------------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC  174 (390)
Q Consensus       118 -----------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~iv  174 (390)
                                             .+..++++||||++++|...+..+......+++..++.++.||+.||+|||+ .||+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~  163 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGIC  163 (383)
T ss_dssp             -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCc
Confidence                                   3456688999999999988888777777889999999999999999999998 9999


Q ss_pred             cccCCCCcEEEcCCCCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 016401          175 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP  254 (390)
Q Consensus       175 H~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  254 (390)
                      ||||||+|||++.+...+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|++||.
T Consensus       164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  243 (383)
T 3eb0_A          164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS  243 (383)
T ss_dssp             CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence            99999999999854338999999999877666666777889999999999776679999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCC
Q 016401          255 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  334 (390)
Q Consensus       255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp  334 (390)
                      +.+..+++.++++.++.|..+.+..+++.+....++......|...++..+++++.+||.+||++||++|||+.|+|+||
T Consensus       244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (383)
T 3eb0_A          244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP  323 (383)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-------CCCCCCCC--CCCCCCCCCCCCCCCCCChHHHhhhCcHHHH
Q 016401          335 FFDELRD-------PNTRLPNG--RPLPPLFNFKPPELSGIPPETINRLIPEHAR  380 (390)
Q Consensus       335 ~f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (390)
                      ||+++++       +....++.  ..+|+++++.+.+++.++++..++++|++..
T Consensus       324 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  378 (383)
T 3eb0_A          324 FFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS  378 (383)
T ss_dssp             GGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC---
T ss_pred             HHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhc
Confidence            9998754       23333444  5677888888777777788889999888753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.5e-60  Score=451.00  Aligned_cols=333  Identities=68%  Similarity=1.176  Sum_probs=294.8

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceEE
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  123 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  123 (390)
                      ......+|++.+.||+|+||.||+|++..+++ ||+|++..+.....+|+.+++.++||||+++++++..... .+..++
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            34455789999999999999999999987665 8999887777777799999999999999999999866544 566778


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc-CCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||+++++...+..+......+++..++.++.||+.||+|||+ .||+||||||+|||++ .++ .+||+|||+++.
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~  191 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKI  191 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTT-EEEECCCTTCEE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCC-cEEEeeCCCccc
Confidence            8999999998888777766667889999999999999999999998 9999999999999999 555 899999999987


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+.+.++.|..+.+..+++
T Consensus       192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            76666667788999999999997766799999999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPE  362 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (390)
                      .+....++.....++...++..+++++.+||.+||++||++|||+.++|+||||++++++....++...+|+++++...+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (394)
T 4e7w_A          272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEE  351 (394)
T ss_dssp             GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHH
T ss_pred             hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHH
Confidence            99888999999999999998899999999999999999999999999999999999998888878888888888887544


Q ss_pred             CCCCChHHHhhhCcHHHHh
Q 016401          363 LSGIPPETINRLIPEHARK  381 (390)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~  381 (390)
                      +. ..++.+.+++|.+.++
T Consensus       352 ~~-~~~~~~~~~~~~~~~~  369 (394)
T 4e7w_A          352 LS-VRPDLISRLVPQHAEA  369 (394)
T ss_dssp             HH-TCGGGHHHHSCGGGCS
T ss_pred             hh-cCHHHHHhhccHhhhh
Confidence            33 3557777888777543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.1e-59  Score=436.92  Aligned_cols=279  Identities=27%  Similarity=0.445  Sum_probs=214.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccch--hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .++|++.+.||+|+||+||+|+++   .+++.||||++....  ....+|+++|+.+ +||||++++++|.     ...+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECCE
Confidence            457999999999999999999875   467899999885433  3456899999998 6999999999984     3445


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+|||||+ ++|.+++       +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+...+||+|||+|+
T Consensus        95 ~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            899999998 4776655       358999999999999999999998 9999999999999999874489999999997


Q ss_pred             ccccCC-----------------------------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 016401          202 VLVKGE-----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  252 (390)
Q Consensus       202 ~~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  252 (390)
                      ......                             ...+.+||+.|+|||++.+...|+.++||||+||++|||++|++|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            543221                             123457999999999998777799999999999999999999999


Q ss_pred             CC-CCChHHHHHHHHHHhCCCCHHHHhhcCcCc--c-------------------cccCCCC----CCCCcccccccCCC
Q 016401          253 FP-GESGVDQLVEIIKVLGTPTREEIKCMNPNY--T-------------------EFKFPQI----KPHPWHKVFQKRLP  306 (390)
Q Consensus       253 f~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~-------------------~~~~~~~----~~~~~~~~~~~~~~  306 (390)
                      |. +.++.+++..|....|.+............  .                   ....|..    ............++
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            85 567788899999888765443322110000  0                   0000000    00001111235689


Q ss_pred             hhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          307 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       307 ~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ++++|||++||++||++|+|++|+|+||||++++
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999998763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-58  Score=420.70  Aligned_cols=260  Identities=23%  Similarity=0.390  Sum_probs=193.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCC-------
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD-------  117 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------  117 (390)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....     ....+|+++|++++|||||++++++.+...       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            36999999999999999999999999999999985322     234589999999999999999999865432       


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      ....++|+|||||++ +|.+++..... .....+..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCC-cEEEcc
Confidence            235568999999984 88777764221 1234556788999999999999998 9999999999999999988 799999


Q ss_pred             cCCccccccCCC-------------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 016401          197 FGSAKVLVKGEP-------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  263 (390)
Q Consensus       197 fg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  263 (390)
                      ||+|+.......             ..+.+||+.|||||++.+ ..|+.++|||||||++|||++   ||.+..  +...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            999986643321             234579999999999965 459999999999999999996   775432  2222


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      .+...........                         ....++.+.+||++||+.||++|||+.|+|+||||+++..|.
T Consensus       236 ~~~~~~~~~~p~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFPPL-------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCCHH-------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCCCC-------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            2222211110000                         123467889999999999999999999999999999876543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.9e-58  Score=450.29  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=210.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHH---HHHHHHhCCCCceeeecceeccCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNR---ELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ..+.|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+   ++.+++.++|||||+++++|     
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----  261 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----  261 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----
Confidence            3468999999999999999999999999999999985422       11223   45666778999999999999     


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      .+..++|+|||||+| +|..++..    .+.+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|
T Consensus       262 ~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G-~vKL~D  335 (689)
T 3v5w_A          262 HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISD  335 (689)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTS-CEEECC
T ss_pred             EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCC-CEEecc
Confidence            344568999999985 88777764    4679999999999999999999998 9999999999999999998 699999


Q ss_pred             cCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCC
Q 016401          197 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVLGTPT  273 (390)
Q Consensus       197 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~  273 (390)
                      ||+|+..... ...+.+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+..+   ....+...     
T Consensus       336 FGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-----  409 (689)
T 3v5w_A          336 LGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----  409 (689)
T ss_dssp             CTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-----
T ss_pred             cceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-----
Confidence            9999876443 34567899999999999655669999999999999999999999998644322   22222220     


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                                  ..            .++..+++++++||.+||++||.+|++     ++|+++||||+++++
T Consensus       410 ------------~~------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW  458 (689)
T 3v5w_A          410 ------------AV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  458 (689)
T ss_dssp             ------------CC------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred             ------------CC------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence                        01            133568999999999999999999998     799999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.9e-56  Score=441.63  Aligned_cols=259  Identities=26%  Similarity=0.423  Sum_probs=220.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|     .+...+|+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence            5899999999999999999999999999999998543    23456899999999999999999999     34456899


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC-CCcEEEeecCCcccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  203 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~Dfg~a~~~  203 (390)
                      |||||+| +|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||+|+..
T Consensus       232 v~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          232 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            9999985 77665532   24579999999999999999999998 999999999999999864 237999999999987


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .........+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+....              
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~--------------  372 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD--------------  372 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--------------
T ss_pred             cCCCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC--------------
Confidence            66666667789999999999965 458999999999999999999999999999888887776521              


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                         +.++        ......+++++++||++||++||++|||+.|+|+||||+...++.
T Consensus       373 ---~~~~--------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          373 ---WNMD--------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             ---CCCC--------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             ---CCCC--------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence               1111        112246899999999999999999999999999999999876543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-55  Score=424.86  Aligned_cols=320  Identities=32%  Similarity=0.532  Sum_probs=236.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||+||+|+++.+++.||||++...      .....+|+.+|+.++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999999999999999998542      233458999999999999999999986554344456


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+||||++++|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+.
T Consensus       132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDC-SVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCC-CEeecccccchh
Confidence            889999999998777753    4679999999999999999999998 9999999999999999988 799999999986


Q ss_pred             cccCC----------------------------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh------
Q 016401          203 LVKGE----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL------  248 (390)
Q Consensus       203 ~~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~------  248 (390)
                      .....                            .....+||++|+|||++.....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            53221                            22445789999999988666679999999999999999998      


Q ss_pred             -----CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcCcCccc---ccCCCCCCCCcccc
Q 016401          249 -----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKV  300 (390)
Q Consensus       249 -----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  300 (390)
                           |.++|.+.+                    ..+++..+.+.++.+..+.+.........   ..++......+...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 788887754                    35788899999999998887654322100   12222233333333


Q ss_pred             cccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCChHHHhhhCcHHH
Q 016401          301 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA  379 (390)
Q Consensus       301 ~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (390)
                      + +..++++.+||++||.+||++|||++|+|+||||++++++........  +..+.+.  +...++.+.++..+.++.
T Consensus       366 ~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~--~~~~~~~--~~~~~~~~~~~~~~~~e~  439 (458)
T 3rp9_A          366 F-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATE--KVRLPFN--DWMNMDEPQLRYAFVKEI  439 (458)
T ss_dssp             S-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSS--CCCCSSC--TTSCCCHHHHHHHHHHHH
T ss_pred             C-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCC--CCCCCcc--ccccCCHHHHHHHHHHHH
Confidence            3 467999999999999999999999999999999999877554322211  1111222  334566667766655554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-55  Score=407.96  Aligned_cols=254  Identities=23%  Similarity=0.371  Sum_probs=200.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ...+|.+.+.||+|+||+||+|+++     .+++.||||+++...    ..+.+|+++|++++|||||++++++.+    
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----  114 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE----  114 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence            3457999999999999999999865     368899999986432    345689999999999999999999843    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh-----------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  186 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~  186 (390)
                       ...+|+|||||+ |+|.+++.....           ...++++..+..++.||+.||+|||+ ++||||||||+||||+
T Consensus       115 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          115 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVG  192 (329)
T ss_dssp             -SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEEC
Confidence             333789999998 588888765321           23468999999999999999999998 9999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 016401          187 PHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  262 (390)
Q Consensus       187 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  262 (390)
                      .++ .+||+|||+|+.......   .....||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+
T Consensus       193 ~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  270 (329)
T 4aoj_A          193 QGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI  270 (329)
T ss_dssp             TTT-EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred             CCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            988 899999999986543322   234578999999999965 459999999999999999998 89999998877776


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      ..+.+.. .               .            ..++.+++++.+|+.+||+.||++|||+.|++++  ++.+
T Consensus       271 ~~i~~g~-~---------------~------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~l  317 (329)
T 4aoj_A          271 DCITQGR-E---------------L------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQAL  317 (329)
T ss_dssp             HHHHHTC-C---------------C------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--HHHH
T ss_pred             HHHHcCC-C---------------C------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHH
Confidence            6655420 0               0            1235689999999999999999999999999753  4443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.5e-56  Score=405.17  Aligned_cols=254  Identities=23%  Similarity=0.354  Sum_probs=207.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|.+.+.||+|+||+||+|++.     .+++.||||+++...    ..+.+|+++|++++|||||++++++.+.    
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC----
Confidence            358999999999999999999875     357899999986432    3456899999999999999999998443    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhh---------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYS---------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  189 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~  189 (390)
                       ..+|+|||||+ |+|.+++....         .....+++..+..++.||+.||+|||+ ++||||||||+|||++.++
T Consensus        88 -~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           88 -DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCC
Confidence             33789999998 59988887542         123469999999999999999999998 9999999999999999988


Q ss_pred             CcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016401          190 HQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  265 (390)
Q Consensus       190 ~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  265 (390)
                       .+||+|||+|+.......   .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus       166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             799999999986543322   2335689999999999654 59999999999999999998 89999998877776666


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          266 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      .+.. .                           ...++.+|+++.+||.+||+.||++|||+.++  |+|++++.
T Consensus       244 ~~~~-~---------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          244 TQGR-V---------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HHTC-C---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             HcCC-C---------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            5420 0                           01235689999999999999999999999999  67887764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-53  Score=411.07  Aligned_cols=319  Identities=31%  Similarity=0.520  Sum_probs=245.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|++.+.||+|+||.||+|+++.+++.||||++...      .....+|+.+|+.++||||+++++++..........+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            4799999999999999999999999999999998642      2334589999999999999999999865433333458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||++++|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+..
T Consensus       106 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~-~~kL~DFGla~~~  179 (432)
T 3n9x_A          106 YIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDC-SVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCC-CEEEccCCCcccc
Confidence            89999999998877753    4569999999999999999999998 9999999999999999988 7999999999865


Q ss_pred             ccCC-----------------------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-----------C
Q 016401          204 VKGE-----------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-----------G  249 (390)
Q Consensus       204 ~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-----------g  249 (390)
                      ....                       .....+||++|+|||++.....++.++|||||||++|||++           |
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            4322                       12566889999999998666779999999999999999998           5


Q ss_pred             CCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcCcCccc---ccCCCCCCCCcccccccCCChhH
Q 016401          250 QPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEA  309 (390)
Q Consensus       250 ~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  309 (390)
                      .++|.+.+                 ..+++..+.+.+|.|..+.+.........   ...+.....++...+ +.+++++
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~  338 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDDG  338 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHHH
Confidence            66666654                 36788999999999999887654322110   012222233333333 4689999


Q ss_pred             HHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCChHHHhhhCcHHH
Q 016401          310 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA  379 (390)
Q Consensus       310 ~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (390)
                      .+||++||++||++|||++|+|+||||++++++..........  .+.+.  +...++.+.++.++.++.
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~e~  404 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKI--ILPFD--DWMVLSETQLRYIFLKEV  404 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCC--CCSSC--TTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCC--CCChh--hcccCCHHHHHHHHHHHH
Confidence            9999999999999999999999999999998765432221111  11222  234566777777666654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.1e-54  Score=417.71  Aligned_cols=285  Identities=31%  Similarity=0.536  Sum_probs=228.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  121 (390)
                      ..+|++.+.||+|+||+||+|++..+++.||||++...      .....+|+.+++.++||||+++++++..... .+..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            35899999999999999999999999999999998643      2334579999999999999999999854432 2345


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+|+||||+++++...+.      ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCCC-
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCC-CEEEEEEEeee
Confidence            678999999998765553      458999999999999999999998 9999999999999999988 79999999998


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ............||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+++.++++.++.|..+.+..+.
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            77655556677899999999999664 59999999999999999999999999999999999999999999988776554


Q ss_pred             cCcccc--cCCCCCCCCcccccccC-----------CChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          282 PNYTEF--KFPQIKPHPWHKVFQKR-----------LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       282 ~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      .....+  ..+......+...++..           .++++++||++||++||++|||++|+|+||||+...++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence            322111  11111222222222221           15679999999999999999999999999999987654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.3e-54  Score=408.70  Aligned_cols=285  Identities=33%  Similarity=0.654  Sum_probs=223.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|.++.+++.||||++...      .....+|+.+++.+. ||||+++++++..   .+...
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~   85 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DNDRD   85 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTSSC
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCCCE
Confidence            4799999999999999999999999999999988432      223447999999997 9999999999853   23344


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+||||++++|..++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|+.
T Consensus        86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAEC-HVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCC-CEEecCCccccc
Confidence            789999999998877764     578999999999999999999998 9999999999999999988 799999999975


Q ss_pred             cccC----------------------CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 016401          203 LVKG----------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  260 (390)
Q Consensus       203 ~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  260 (390)
                      ....                      ......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            4321                      112346789999999999776679999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCccccc------CCCCCCCCccccc------------ccCCChhHHHHHHHhcccCCC
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEFK------FPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPN  322 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~  322 (390)
                      ++..++..++.|..+.+......+...-      ........+...+            ...+++++.+||++||++||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            9999999999999887765433221100      0000011111111            126789999999999999999


Q ss_pred             cCCCHHHHhcCCcccccCCCCC
Q 016401          323 LRCTALEACVHPFFDELRDPNT  344 (390)
Q Consensus       323 ~R~s~~~~l~hp~f~~~~~~~~  344 (390)
                      +|||+.|+|+||||+.+.++..
T Consensus       319 ~R~t~~e~l~Hp~~~~~~~~~~  340 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFHNPNE  340 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTCCGGG
T ss_pred             cCCCHHHHhCCHHHHHhcCCcc
Confidence            9999999999999998876554

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=395.25  Aligned_cols=248  Identities=21%  Similarity=0.295  Sum_probs=196.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..++++.+.||+|+||+||+|+++   ..||||+++..      ...+.+|+.+|++++|||||++++++..    +.  
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~~--  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----DN--  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SS--
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----Ce--
Confidence            357889999999999999999874   35999988532      2345689999999999999999997621    12  


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+|||||+ |+|.+++..   ....+++..+..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGL-TVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTE-EEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCC-cEEEeeccCce
Confidence            679999998 588777753   23579999999999999999999998 9999999999999999988 79999999998


Q ss_pred             ccccCC---CCcceeeccccccchhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          202 VLVKGE---PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       202 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ......   .....+||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+..+.+..++...       
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~-------  253 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG-------  253 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT-------
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC-------
Confidence            653322   23456799999999999642  358999999999999999999999999887766665555421       


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                ...|..      ...+..+++++.+||.+||+.||++|||+.+++++
T Consensus       254 ----------~~~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          254 ----------YASPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             ----------CCCCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ----------CCCCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                      111111      11235689999999999999999999999987654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.1e-54  Score=405.26  Aligned_cols=298  Identities=49%  Similarity=0.903  Sum_probs=243.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhh---HHHHHHHHHhCCCCceeeecceeccCCC--CCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLDHPNIVALKHCFFSTTD--KEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~  123 (390)
                      ..+|++.+.||+|+||.||+|++..+++.||||++..+...   ..+|+..+..++||||+++++++.....  ....++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            35899999999999999999999999999999988654332   3456777788899999999999865432  456678


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH--hcCCcccccCCCCcEEEcC-CCCcEEEeecCCc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--NCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSA  200 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH--~~~~ivH~Dlkp~NIll~~-~~~~vkl~Dfg~a  200 (390)
                      ++||||+++++...+.........+++..++.++.|++.||.|||  + .||+||||||+|||++. ++ .+||+|||++
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADG-TLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTT-EEEECCCTTC
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCC-cEEEeeCCCc
Confidence            899999999988777766666778999999999999999999999  8 89999999999999997 55 8999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+..+
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            87766555566778999999999977666899999999999999999999999999999999999999999999998888


Q ss_pred             CcCcccccCCCCCCCCccccccc---CCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN  348 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~  348 (390)
                      .+.............+|...++.   ..++++.+||.+||++||.+|||+.++|+||||+++.++...+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~  330 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPN  330 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTT
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCC
Confidence            77666655555555555554433   357899999999999999999999999999999998876654443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-54  Score=396.49  Aligned_cols=249  Identities=20%  Similarity=0.267  Sum_probs=203.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ...+++.+.||+|+||+||+|+..     .+++.||||+++..     ...+.+|+.++++++|||||++++++...   
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---  101 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD---  101 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC---
Confidence            347899999999999999999863     46789999998543     23466899999999999999999998432   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  185 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll  185 (390)
                        ..+|+|||||+ |+|.+++....            .....+++..+..++.||+.||+|||+ ++||||||||+||||
T Consensus       102 --~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 --QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLV  178 (308)
T ss_dssp             --SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             --CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEE
Confidence              33779999998 58988886432            123468999999999999999999998 999999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 016401          186 NPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  261 (390)
Q Consensus       186 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  261 (390)
                      +.++ .+||+|||+|+......   ......||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+.
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9988 79999999998654332   23445789999999999654 59999999999999999998 8999999887766


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      +..+....                  ..          ..++.+|+++.+|+.+||+.||++|||+.+++++
T Consensus       257 ~~~i~~~~------------------~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          257 VEMIRNRQ------------------VL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTTC------------------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCC------------------CC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            65554310                  00          1235689999999999999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5e-53  Score=386.47  Aligned_cols=281  Identities=33%  Similarity=0.556  Sum_probs=226.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|++.+.||+|+||+||+|+++.+++.||||++....      ....+|+.+++.++||||+++++++.     ....+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence            37999999999999999999999999999999985332      33457999999999999999999984     33458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||+++++...+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence            89999999988666543   34679999999999999999999998 9999999999999999988 7999999999765


Q ss_pred             ccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+..+.+..+.
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            432 2234457799999999997766689999999999999999987766 67777788888898888888766544332


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ........+............+.+++++++||++||++||++|||++|+|+||||++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            11111111211111122223356899999999999999999999999999999998753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.2e-53  Score=395.72  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=204.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEeccc-----hhhHHHHHHHHHhCCC-CceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQD-----KRYKNRELQIMQMLDH-PNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~-----~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~  117 (390)
                      .++|++.+.||+|+||+||+|.+..+     ++.||||++...     ...+.+|+++|.+++| ||||++++++...  
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~--  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec--
Confidence            35899999999999999999997654     368999998543     2335579999999976 8999999987432  


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhh------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEE
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  184 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~------------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIl  184 (390)
                        ...+|+|||||+ |+|.+++......            ...+++..+..++.||+.||+|||+ ++||||||||+|||
T Consensus       141 --~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  217 (353)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcccee
Confidence              223679999998 5998888764321            2458899999999999999999998 99999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 016401          185 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  260 (390)
Q Consensus       185 l~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  260 (390)
                      ++.++ .+||+|||+|+........   ....||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+
T Consensus       218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99988 7999999999866443322   345789999999999654 59999999999999999998 999999877655


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .+.+++.....+                           ..++.+++++.+||.+||+.||++|||+.++++|
T Consensus       296 ~~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            555554421110                           1234689999999999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2e-52  Score=394.42  Aligned_cols=317  Identities=32%  Similarity=0.609  Sum_probs=249.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+|++.+.||+|+||.||+|++..+++.||||++....     ....+|+++++.++||||+++++++...........|
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            47999999999999999999999999999999986322     3345799999999999999999998655434445678


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||++++|..++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus       107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  179 (364)
T ss_dssp             EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCC-CEEEEeCcceEecC
Confidence            9999999998877753     569999999999999999999998 9999999999999999888 79999999997654


Q ss_pred             cCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          205 KGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       205 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....    .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+..+.+.+.
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            3221    234578999999999877667899999999999999999999999999999999999999999998877654


Q ss_pred             CcCc---ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCC
Q 016401          281 NPNY---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN  357 (390)
Q Consensus       281 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~  357 (390)
                      ....   .....+.....+|...+ +.+++++.+||.+||++||++|||+.++|+||||+...++....    .....+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~~  334 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPFK  334 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCCC
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcCC
Confidence            2110   00122222333333333 56899999999999999999999999999999999875543221    1112222


Q ss_pred             CCCCCCCCCChHHHhhhCcHHH
Q 016401          358 FKPPELSGIPPETINRLIPEHA  379 (390)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~  379 (390)
                      ++ .+...++.+.+++++.++.
T Consensus       335 ~~-~~~~~~~~~~~~~~~~~e~  355 (364)
T 3qyz_A          335 FD-MELDDLPKEKLKELIFEET  355 (364)
T ss_dssp             CC------CCHHHHHHHHHHHT
T ss_pred             cc-cccccCCHHHHHHHHHHHH
Confidence            22 3455677777777665543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-52  Score=394.11  Aligned_cols=285  Identities=33%  Similarity=0.614  Sum_probs=230.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4799999999999999999999999999999998432      1234589999999999999999999854322 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+||||++++|..++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  177 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  177 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence            679999998898877764     579999999999999999999998 9999999999999999988 799999999986


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..  .......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+.+..+.++.+.+..+..
T Consensus       178 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cc--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            53  2345567899999999997756799999999999999999999999999999999999999999999887765432


Q ss_pred             Cccc---ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCC
Q 016401          283 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  344 (390)
Q Consensus       283 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~  344 (390)
                      ....   ..++......+...+ +..++++.+||.+||..||++|||+.++|+||||+.+.++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             HHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence            2110   123333344444444 568999999999999999999999999999999999877653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.5e-53  Score=388.13  Aligned_cols=279  Identities=35%  Similarity=0.665  Sum_probs=225.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|++.+.||+|+||+||+|++. +++.||+|++....      ....+|+++++.++||||+++++++.     ...++
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   94 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERCL   94 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSCE
T ss_pred             hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCEE
Confidence            48999999999999999999995 58999999985332      23458999999999999999999983     33458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||+++++...+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        95 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~  169 (311)
T 3niz_A           95 TLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDG-ALKLADFGLARAF  169 (311)
T ss_dssp             EEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEET
T ss_pred             EEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCC-CEEEccCcCceec
Confidence            89999999988776654   23569999999999999999999998 9999999999999999888 7999999999865


Q ss_pred             ccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred             CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence            433 2234457899999999997766789999999999999999999999999998899999999888876654433211


Q ss_pred             C--cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      .  +....+......++.. +.+.+++++.+||++||++||++|||+.|+|+||||+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             cchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            0  0011111122222322 2356889999999999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.8e-52  Score=386.48  Aligned_cols=253  Identities=28%  Similarity=0.403  Sum_probs=216.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+++++.++||||+++++++.     ....
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCE
Confidence            347999999999999999999999999999999985432      23457999999999999999999983     3445


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||||++ ++|.+.+..    .+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        89 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  162 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADM-NIKIADFGFSN  162 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTCCG
T ss_pred             EEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCC-CEEEeeccCce
Confidence            889999997 587776654    3679999999999999999999998 9999999999999999988 79999999998


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ...........+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+...             
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------  229 (328)
T 3fe3_A          163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-------------  229 (328)
T ss_dssp             GGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred             ecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence            7766655667789999999999977665568999999999999999999999998877666665541             


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                          .+.            ++..+++++.+||++||..||.+|||+.++++||||+...+
T Consensus       230 ----~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          230 ----KYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             ----CCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             ----CCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence                111            12357899999999999999999999999999999987654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.3e-53  Score=390.78  Aligned_cols=288  Identities=33%  Similarity=0.629  Sum_probs=227.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh-----hHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....     ...+|+.+++.++||||+++++++..     ....|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            379999999999999999999999999999999864332     22369999999999999999999843     33478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+++++...+...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            99999999887776642   3568999999999999999999998 9999999999999999888 79999999997553


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  282 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  282 (390)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+....+..... 
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            322 223457799999999997766789999999999999999999999999999999999999988887654432211 


Q ss_pred             -CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCC
Q 016401          283 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN  348 (390)
Q Consensus       283 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~  348 (390)
                       .+..+.++......... ..+.+++++.+||++||++||++|||+.|+|+||||.++.......+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  297 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPD  297 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCT
T ss_pred             hhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCC
Confidence             11112222222222211 224689999999999999999999999999999999998765544333

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.3e-52  Score=390.21  Aligned_cols=282  Identities=31%  Similarity=0.551  Sum_probs=224.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++||||+++++++.     ....
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~  107 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HNHR  107 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ETTE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cCCE
Confidence            348999999999999999999999999999999985432      22347999999999999999999984     3345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC----CcEEEeecC
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDFG  198 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----~~vkl~Dfg  198 (390)
                      +|+||||++++|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++    ..+||+|||
T Consensus       108 ~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          108 LHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            889999999998877764    4569999999999999999999998 9999999999999995332    259999999


Q ss_pred             CccccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          199 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       199 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....+
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            99765432 22344567999999999977666899999999999999999999999999999999999998887766543


Q ss_pred             hhcCcCc-ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          278 KCMNPNY-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       278 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ....... ....++......+...++..+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            3221100 01122333333444445556899999999999999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-52  Score=385.50  Aligned_cols=284  Identities=28%  Similarity=0.522  Sum_probs=229.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHhCC---CCceeeecceeccCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLD---HPNIVALKHCFFSTT  116 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~  116 (390)
                      ..+|++.+.||+|+||+||+|++..+++.||||++....         ....+|+.+++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            348999999999999999999999999999999985321         24457888877764   999999999987665


Q ss_pred             CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          117 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      .....++++||||++++|..++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEEee
Confidence            55566789999999999887776422  2348999999999999999999998 9999999999999999888 799999


Q ss_pred             cCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          197 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       197 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++.+..+.+....
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            9999876655556667889999999999654 489999999999999999999999999999999999999888776654


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      +..... .....++.....++.. ..+.+++++.+||.+||++||++|||+.++|+||||++.
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          243 WPRDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SCSSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             ccchhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            322110 0111122222222222 235689999999999999999999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.7e-52  Score=394.75  Aligned_cols=314  Identities=32%  Similarity=0.540  Sum_probs=232.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4799999999999999999999999999999998542      2234579999999999999999998854321 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+|||+++++|..++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence            679999999888776653     579999999999999999999998 9999999999999999888 799999999976


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+..+..
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            432  344568899999999997756799999999999999999999999999999999999999999999887765432


Q ss_pred             Cccc---ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCC
Q 016401          283 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  359 (390)
Q Consensus       283 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  359 (390)
                      ....   ...+..+...+...+ ...++++.+||++||.+||++|||+.++|+||||+.+.++.....     .+.+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~-----~~~~~~~  333 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV-----ADPYDQS  333 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCC-----CCCCCGG
T ss_pred             HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCC-----CCCCCcc
Confidence            2100   122333333444433 467999999999999999999999999999999999877653211     1122222


Q ss_pred             CCCCCCCChHHHhhhCcHHH
Q 016401          360 PPELSGIPPETINRLIPEHA  379 (390)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~  379 (390)
                       .+......+.+++++.++.
T Consensus       334 -~~~~~~~~~~~~~~~~~e~  352 (367)
T 2fst_X          334 -LESRDLLIDEWKSLTYDEV  352 (367)
T ss_dssp             -GSSCCCCHHHHHHHHHHHH
T ss_pred             -hhhccCCHHHHHHHHHHHH
Confidence             1223455666666655544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.6e-52  Score=379.38  Aligned_cols=278  Identities=35%  Similarity=0.630  Sum_probs=220.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|++.+.||+|+||.||+|++ .+++.||+|++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            3799999999999999999998 678999999985332      334589999999999999999999843     2347


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||++++|..++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus        76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence            89999999988777654   23678999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             ccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            332 2234457899999999997666689999999999999999999999999999899999988887765543322110


Q ss_pred             Cc-ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          283 NY-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       283 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      .. ....+......+|.. +...+++++.+||++||+.||++|||+.++|+||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            00 000111112222322 235689999999999999999999999999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.1e-52  Score=390.67  Aligned_cols=251  Identities=29%  Similarity=0.480  Sum_probs=210.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+|++.+.||+|+||+||+|+++.+++.||||++.+..       ....+|..+++.+ +||||+++++++.     ...
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~~   97 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----TPD   97 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----eCC
Confidence            48999999999999999999999999999999986432       2344799999988 7999999999983     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g-~ikL~DFG~a  171 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGMC  171 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCC-CEEEccccce
Confidence            58899999985 77666654    4679999999999999999999998 9999999999999999988 6999999999


Q ss_pred             ccccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++...           
T Consensus       172 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------  239 (353)
T 3txo_A          172 KEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------  239 (353)
T ss_dssp             BCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             eecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence            75332 2334556799999999999654 4899999999999999999999999999888877777652           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH------HHHhcCCcccccCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  341 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~------~~~l~hp~f~~~~~  341 (390)
                            ...            ++..+++++.+||++||++||++|+++      .++++||||+++.+
T Consensus       240 ------~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          240 ------EVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence                  111            224578999999999999999999998      89999999998754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.8e-52  Score=383.94  Aligned_cols=286  Identities=32%  Similarity=0.553  Sum_probs=216.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+|++.+.||+|+||.||+|.++.+++.||||++....     ....+|+.+++.++||||+++++++.     ....+|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeEE
Confidence            47999999999999999999999999999999985432     34568999999999999999999983     344588


Q ss_pred             EEEecccccHHHHHHHhhhh--cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          125 LVLEYVPETVNRIARNYSRI--HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +||||++++|..++......  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            99999999998887654321  2458999999999999999999998 9999999999999999888 799999999976


Q ss_pred             cccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          203 LVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       203 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            5432 223445789999999999766668999999999999999999999999999999999999888877654433221


Q ss_pred             cCcc-cccCCCCCCCCc----ccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          282 PNYT-EFKFPQIKPHPW----HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       282 ~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      .... ....+......+    .......++.++.+||.+||+.||++|||+.++|+||||++...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            1000 000111111111    111234678999999999999999999999999999999987643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.9e-51  Score=381.68  Aligned_cols=252  Identities=27%  Similarity=0.418  Sum_probs=214.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence            35899999999999999999999999999999998543       223457999999999999999999983     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a  152 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCC-CEEEeeccch
Confidence            58899999985 77666653    4679999999999999999999998 9999999999999999988 7999999999


Q ss_pred             ccccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+...           
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  220 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------  220 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             hhcccCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence            75432 334456789999999999955 45899999999999999999999999988876666665541           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                            ...            ++..+++++++||++||+.||++||     ++.++++||||+.+.+
T Consensus       221 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence                  111            2346899999999999999999999     8999999999998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.9e-52  Score=392.14  Aligned_cols=322  Identities=29%  Similarity=0.482  Sum_probs=234.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            47999999999999999999999999999999986421      234579999999999999999999854331 23346


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+||||+++++...+.      ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~  176 (371)
T 2xrw_A          105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  176 (371)
T ss_dssp             EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred             eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence            88999999998876653      468999999999999999999998 9999999999999999888 799999999986


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+..+.+..+.+
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             -------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             cccccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            654444456788999999999965 4589999999999999999999999999999999999999888888776654432


Q ss_pred             Ccccc--cCCCCCCCCcccccc-----------cCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCC
Q 016401          283 NYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG  349 (390)
Q Consensus       283 ~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~  349 (390)
                      ....+  ..+......+...++           ...++++++||++||++||++|||+.++|+||||+...++.....  
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~--  333 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA--  333 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC--
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC--
Confidence            21110  011111111111111           112578999999999999999999999999999987655322111  


Q ss_pred             CCCCCCCCCCCCCCCCCChHHHhhhCcHHHHhhhh
Q 016401          350 RPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL  384 (390)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (390)
                       ..|..... ........-+.++++++.....-+.
T Consensus       334 -~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  366 (371)
T 2xrw_A          334 -PPPKIPDK-QLDEREHTIEEWKELIYKEVMDLEH  366 (371)
T ss_dssp             -CCCCCCTT-TTCCCCCCHHHHHHHHHHHHHHHCC
T ss_pred             -CCCCCCCh-hhccccCcHHHHHHHHHHHHHHHhh
Confidence             11111111 1223345667788887777666444

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-51  Score=387.44  Aligned_cols=255  Identities=24%  Similarity=0.357  Sum_probs=216.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      .+.|++.+.||+|+||.||+|.++.+|+.||+|++....          ....+|+.+++.++||||+++++++.     
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----   85 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE-----   85 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence            357999999999999999999999999999999986432          34568999999999999999999983     


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC---cEEE
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL  194 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---~vkl  194 (390)
                      ....+|+||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.   .+||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEE
Confidence            3445889999996 587766643    4679999999999999999999998 99999999999999987653   6999


Q ss_pred             eecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          195 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+........ 
T Consensus       161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-  238 (361)
T 2yab_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD-  238 (361)
T ss_dssp             CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-
T ss_pred             EecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence            99999987766555566789999999999954 4589999999999999999999999999888777766654211111 


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                              ..+...+++++++||++||..||++|||+.++|+||||+..
T Consensus       239 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          239 ------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             ------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             ------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence                                    11224679999999999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-51  Score=391.16  Aligned_cols=254  Identities=26%  Similarity=0.468  Sum_probs=208.7

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      ....+|++.+.||+|+||+||+|+++.+++.||||++.+..       ....+|..++.++ +||||+++++++.     
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----  123 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----  123 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----
Confidence            34468999999999999999999999999999999986432       2245789998876 8999999999983     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      ....+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DF  197 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDY  197 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCC-CEEEeec
Confidence            34458899999985 77666654    4679999999999999999999998 9999999999999999998 7999999


Q ss_pred             CCcccc-ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------HHHH-HHHHH
Q 016401          198 GSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQL-VEIIK  267 (390)
Q Consensus       198 g~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~-~~i~~  267 (390)
                      |+|+.. .........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.....        .+.+ ..+..
T Consensus       198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             TTCBCCCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             ceeeecccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence            999853 23344556789999999999965 4589999999999999999999999965321        1112 22221


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH------HHHhcCCcccccCC
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  341 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~------~~~l~hp~f~~~~~  341 (390)
                      .                 ..            .++..+++++++||++||+.||++|+++      .++++||||+.+.+
T Consensus       277 ~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          277 K-----------------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             C-----------------CC------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             c-----------------cc------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence            0                 11            1235689999999999999999999985      79999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=374.24  Aligned_cols=283  Identities=36%  Similarity=0.622  Sum_probs=220.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++.     .....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence            47999999999999999999999999999999885432      23447999999999999999999984     33457


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ++||||+++++...+   ......+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHH---HHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHH---HhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            899999997553322   2234679999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  280 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  280 (390)
                      .... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+..........  
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            4322 2345578999999999977667899999999999999999999999999999998888888777665443221  


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ...+.....+............+++++++.+||++||.+||++|||+.++|+||||+++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence            11122222222211111112224689999999999999999999999999999999988654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-51  Score=383.41  Aligned_cols=283  Identities=34%  Similarity=0.588  Sum_probs=225.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++....         ....+|+.+++.++||||+++++++..     
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-----
Confidence            458999999999999999999999999999999985321         234589999999999999999999843     


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ....++||||+++++...+..   ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence            333779999999988666543   23468899999999999999999998 9999999999999999988 799999999


Q ss_pred             ccccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          200 AKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       200 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ++..... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.+.
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            9865432 233456789999999999766668999999999999999999999999999999999999988887765544


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ..........+...+..++.. +...+++++++||++||..||++|||+.|+|+||||+....+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            332211112222222222222 225678999999999999999999999999999999876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8e-51  Score=391.23  Aligned_cols=280  Identities=30%  Similarity=0.527  Sum_probs=227.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhC------CCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML------DHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++..+.   ....+|+++++.+      +|+||+++++++..     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----
Confidence            347999999999999999999999999999999997653   2345688888877      57799999998843     


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC-cEEEeecC
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-~vkl~Dfg  198 (390)
                      ...+|+||||++++|..++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++. .+||+|||
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            34588999999999888776532  2458999999999999999999998 89999999999999998872 29999999


Q ss_pred             CccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          199 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       199 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ++...  ........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.++...+.
T Consensus       248 ~a~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYE--HQRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEET--TCCCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceec--CCcccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            99654  3334556889999999999765 48999999999999999999999999999999999999999999988765


Q ss_pred             hcCcCcccccC---C---------------------------CCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHH
Q 016401          279 CMNPNYTEFKF---P---------------------------QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  328 (390)
Q Consensus       279 ~~~~~~~~~~~---~---------------------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~  328 (390)
                      ........+..   +                           ......|...+....++++.+||++||++||++|||+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence            43211100000   0                           01122333344455688999999999999999999999


Q ss_pred             HHhcCCccccc
Q 016401          329 EACVHPFFDEL  339 (390)
Q Consensus       329 ~~l~hp~f~~~  339 (390)
                      |+|+||||++.
T Consensus       405 e~L~Hpw~~~~  415 (429)
T 3kvw_A          405 QALRHPWLRRR  415 (429)
T ss_dssp             HHHTSTTTC--
T ss_pred             HHhCChhhccC
Confidence            99999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.5e-51  Score=383.90  Aligned_cols=285  Identities=34%  Similarity=0.625  Sum_probs=229.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCC-CceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~  122 (390)
                      .+|.+.+.||+|+||.||+|.++.+|+.||||++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4899999999999999999999999999999998643      13345799999999999999999998543321 1122


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+||||++++|...+      ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus       122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~  193 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH  193 (371)
T ss_dssp             CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred             EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence            4799999999876554      3469999999999999999999998 9999999999999999888 799999999975


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+..++.
T Consensus       194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            432  334557899999999997756799999999999999999999999999999999999999999998877655432


Q ss_pred             Cccc---ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCC
Q 016401          283 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  345 (390)
Q Consensus       283 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~  345 (390)
                      ....   ...+......+.. ..+.+++++.+||++||++||++|||+.++|+||||+.+.++...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~  336 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE  336 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             hhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccc
Confidence            2110   0112222222222 225679999999999999999999999999999999988765543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.4e-51  Score=387.88  Aligned_cols=260  Identities=28%  Similarity=0.464  Sum_probs=217.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||+||+|+++.+++.||+|++.+.       .....+|+.+++.++||||+++++++.     +.
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----EC
Confidence            446899999999999999999999999999999998542       233568999999999999999999983     44


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .++|+||||++ |+|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCC-CEEEeccce
Confidence            56889999996 588776653     468999999999999999999998 9999999999999999988 799999999


Q ss_pred             ccccccCCC--CcceeeccccccchhhcCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      |+.......  ....+||+.|+|||++.+..   .++.++|||||||++|||++|++||.+.+..+.+.++.....    
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----  290 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----  290 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc----
Confidence            976543321  23567999999999996533   278999999999999999999999999988888877765210    


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc--CCCHHHHhcCCcccccCCCCC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPNT  344 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~s~~~~l~hp~f~~~~~~~~  344 (390)
                                 .+.+|.          ...+++++++||++||+.+|.+  |+++.++++||||+++.+.+.
T Consensus       291 -----------~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~  341 (410)
T 3v8s_A          291 -----------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE  341 (410)
T ss_dssp             -----------HCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred             -----------cccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence                       011111          1357999999999999999988  999999999999999876443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.9e-50  Score=379.37  Aligned_cols=288  Identities=28%  Similarity=0.570  Sum_probs=227.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---------------hhHHHHHHHHHhCCCCceeeecceec
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVALKHCFF  113 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~~~~~~  113 (390)
                      ..+|++.+.||+|+||.||+|.+.. ++.||||++....               ....+|+++++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            3579999999999999999999864 8999999884321               34568999999999999999999987


Q ss_pred             cCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEE
Q 016401          114 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  193 (390)
Q Consensus       114 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  193 (390)
                      ........++|+||||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~-~~k  174 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNN-DIT  174 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEE
T ss_pred             eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCC-CEE
Confidence            766566677899999999988776653   23579999999999999999999998 9999999999999999888 799


Q ss_pred             EeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          194 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       194 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      |+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999998665555556678899999999997656689999999999999999999999999999999999999999988


Q ss_pred             HHHHhhcCcC-c---ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          274 REEIKCMNPN-Y---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       274 ~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      .+........ .   ............|.. ..+..++.+.+||.+||++||++|||+.++|+||||+.+.++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence            7765432111 0   001111222222222 2356789999999999999999999999999999999986543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-51  Score=375.54  Aligned_cols=250  Identities=27%  Similarity=0.478  Sum_probs=214.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|++.+.||+|+||.||+|+++.+|+.||+|++.+.       .....+|+.+++.++||||+++++++.     +..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence            35899999999999999999999999999999998543       233457999999999999999999983     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+||||+++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCC-CEEEeecCcc
Confidence            58899999985 88777754    4679999999999999999999998 9999999999999999988 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      +....  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++...            
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------  218 (318)
T 1fot_A          154 KYVPD--VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------  218 (318)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------------
T ss_pred             eecCC--ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence            76532  3345678999999999955 45899999999999999999999999998877777766652            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                           ...            ++..+++++++||++||..||++|+     +++++++||||+++.+
T Consensus       219 -----~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          219 -----ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             -----CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence                 111            2246799999999999999999999     8999999999998753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-50  Score=379.47  Aligned_cols=318  Identities=31%  Similarity=0.616  Sum_probs=238.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            357999999999999999999999999999999985322     233479999999999999999998754333334557


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||++++|...+..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNC-DLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCC-cEEEEeccccccc
Confidence            89999999998777754     579999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             ccCCC-----------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016401          204 VKGEP-----------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       204 ~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      .....           .....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            33211           1234679999999998766678999999999999999999999999999888888888887776


Q ss_pred             CHHHH-hhcCcC-ccc--ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCC
Q 016401          273 TREEI-KCMNPN-YTE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN  348 (390)
Q Consensus       273 ~~~~~-~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~  348 (390)
                      ..... .+.... ...  ...+.....++.. ..+.+++++.+||++||..||++|||+.++|+||||+...++......
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~  321 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEG  321 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCC
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccccc
Confidence            53211 110000 000  0111111112222 224689999999999999999999999999999999998776544322


Q ss_pred             CCCCC-CCCCCCCCCCCCCChHHHhhhCc
Q 016401          349 GRPLP-PLFNFKPPELSGIPPETINRLIP  376 (390)
Q Consensus       349 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  376 (390)
                       .+.| ..+++.. ....+..+.+++.+.
T Consensus       322 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~  348 (353)
T 2b9h_A          322 -EPIPPSFFEFDH-YKEALTTKDLKKLIW  348 (353)
T ss_dssp             -CCCCGGGGGGGC-CSSCCCHHHHHHHHH
T ss_pred             -CCCCcceeeecc-hhhcCCHHHHHHHHH
Confidence             2222 2232221 223445555555443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-51  Score=382.11  Aligned_cols=253  Identities=27%  Similarity=0.482  Sum_probs=213.2

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|.+.+.||+|+||.||+|+++.+++.||||++.+..       ....+|..+++.+ +||||+++++++.     .
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----T   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----C
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----e
Confidence            3458999999999999999999999999999999986432       2345788888876 9999999999983     3


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ...+|+||||++| +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG  163 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFG  163 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCC-CEEEeECh
Confidence            4458899999974 88777654    3679999999999999999999998 9999999999999999988 79999999


Q ss_pred             Ccccccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          199 SAKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       199 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      +++.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...         
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------  233 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------  233 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC---------
Confidence            9975432 233456688999999999965 45899999999999999999999999998877776666541         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHH-HHhcCCcccccCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  341 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~-~~l~hp~f~~~~~  341 (390)
                              ..            .++..+++++++||++||..||++||++. ++++||||+++.+
T Consensus       234 --------~~------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          234 --------NP------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             --------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             --------CC------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence                    01            12245799999999999999999999998 9999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.7e-51  Score=380.62  Aligned_cols=250  Identities=29%  Similarity=0.420  Sum_probs=209.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||+++++++..     ..
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence            34899999999999999999999999999999998542       2345689999999999999999999843     34


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .+|+||||++|++.+.+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus        83 ~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~DFG~s~  156 (336)
T 3h4j_B           83 DIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNL-NVKIADFGLSN  156 (336)
T ss_dssp             EEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTC-CEEECCSSCTB
T ss_pred             EEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCC-CEEEEEeccce
Confidence            5889999999988777654    3679999999999999999999998 8999999999999999888 79999999998


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ...........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....                 
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----------------  219 (336)
T 3h4j_B          157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----------------  219 (336)
T ss_dssp             TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------------
T ss_pred             eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------------
Confidence            766555556678999999999997655457899999999999999999999976542111000                 


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                           .       ......++..+++++.+||++||..||.+|||+.|+++||||+.
T Consensus       220 -----i-------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          220 -----V-------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             -----C-------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             -----H-------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                 0       00111234568999999999999999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.7e-51  Score=380.70  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=213.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+|++.+.||+|+||+||+|+++.+++.||||++.+..       ....+|..++..+ .||||+++++++.     ..
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----CS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----cC
Confidence            458999999999999999999999999999999986432       2345789999887 8999999999983     34


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+|+||||++| +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~  167 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFGM  167 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCC-cEEEEeCCc
Confidence            458899999975 88777654    3579999999999999999999998 9999999999999999988 799999999


Q ss_pred             cccccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          200 AKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       200 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ++.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+...          
T Consensus       168 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------  236 (353)
T 2i0e_A          168 CKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------  236 (353)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred             ccccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC----------
Confidence            975432 333456678999999999955 45899999999999999999999999998887777776651          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                             ...            ++..+++++++||++||..||.+||+     +.++++||||+.+.+
T Consensus       237 -------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          237 -------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             -------CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             -------CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence                   111            23468999999999999999999994     699999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-50  Score=379.97  Aligned_cols=258  Identities=29%  Similarity=0.373  Sum_probs=210.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||.||+|.++.+++.||||++...         .....+|+.+++.++||||+++++++..     
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence            34799999999999999999999999999999998532         2345689999999999999999999843     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEEEee
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCD  196 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~D  196 (390)
                      ...+|+||||++ ++|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++  ..+||+|
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEec
Confidence            345889999998 58877776555445568999999999999999999998 9999999999999998654  2499999


Q ss_pred             cCCccccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          197 FGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       197 fg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. .+.+..+......... 
T Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~-  253 (351)
T 3c0i_A          177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP-  253 (351)
T ss_dssp             CTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH-
T ss_pred             CcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc-
Confidence            999986644332 345678999999999955 458999999999999999999999998753 3334444331100000 


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                              .....+++++++||++||..||++|||+.++|+||||+..
T Consensus       254 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          254 ------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             ------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             ------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                                    0113578999999999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.4e-50  Score=376.96  Aligned_cols=252  Identities=26%  Similarity=0.468  Sum_probs=206.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+|++.+.||+|+||.||+|+++.+++.||||++.+..       ....+|..+++++ +||||+++++++.     ..
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eC
Confidence            458999999999999999999999999999999986432       2245799999888 8999999999983     34


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFG~  156 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGM  156 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCGGG
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEEeccc
Confidence            458899999975 87766654    3579999999999999999999998 9999999999999999988 799999999


Q ss_pred             ccccc-cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 016401          200 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKVL  269 (390)
Q Consensus       200 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~  269 (390)
                      ++... ........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.....         ......+... 
T Consensus       157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-  234 (345)
T 3a8x_A          157 CKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-  234 (345)
T ss_dssp             CBCSCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-
T ss_pred             cccccCCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-
Confidence            97533 2333456688999999999965 4589999999999999999999999975321         1112222210 


Q ss_pred             CCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH------HHHhcCCcccccCC
Q 016401          270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  341 (390)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~------~~~l~hp~f~~~~~  341 (390)
                                      ..            .++..+++++++||++||+.||++||++      .++++||||+++.+
T Consensus       235 ----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          235 ----------------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             ----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             ----------------CC------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence                            01            1235689999999999999999999995      89999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.6e-50  Score=369.38  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=212.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ...+|++.+.||+|+||+||+|.+..+++.||||++...    .....+|+.+++.++||||+++++++..     ...+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEE
Confidence            345899999999999999999999999999999998532    2345689999999999999999999843     3347


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||++ ++|.+++..     ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~  165 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQ  165 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            89999996 588777653     468999999999999999999998 9999999999999999888 799999999876


Q ss_pred             cccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          203 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       203 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+..... +         
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~---------  234 (297)
T 3fxz_A          166 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-P---------  234 (297)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-C---------
T ss_pred             cCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C---------
Confidence            54432 23456789999999999654 589999999999999999999999998887776665554210 0         


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                      ....+..+++.+.+||.+||+.||++|||+.++|+||||+..
T Consensus       235 ----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          235 ----------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             ----------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ----------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                            001124678999999999999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.9e-50  Score=386.68  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=218.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|++.++||+|+||+||+|+++.+++.||||++.+.       .....+|+.++..++||||+++++++.     +..
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-----DDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCC
Confidence            45899999999999999999999999999999998542       223568999999999999999999983     344


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+||||+. |+|..++..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+|
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence            5889999996 588777754   24679999999999999999999998 9999999999999999988 7999999999


Q ss_pred             cccccCCCC--cceeeccccccchhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          201 KVLVKGEPN--VSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       201 ~~~~~~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +........  ...+||+.|+|||++.    +...++.++|||||||++|||++|++||.+.+..+.+.++.....    
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----  298 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----  298 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc----
Confidence            765443322  3357899999999996    244589999999999999999999999999988888877764210    


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCc--CCCHHHHhcCCcccccCCCCC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPNT  344 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--R~s~~~~l~hp~f~~~~~~~~  344 (390)
                                 .+.+|..         ...+++++++||++||+.+|++  |++++++++||||+++.+...
T Consensus       299 -----------~~~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          299 -----------RFQFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             -----------HCCCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             -----------cccCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence                       0111110         1357999999999999999988  999999999999999876543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.1e-50  Score=376.79  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=215.3

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ....+|++.+.||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.     +
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~  112 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----D  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----c
Confidence            34568999999999999999999999999999999985432       23457999999999999999999883     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ...+|+||||++ ++|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus       113 ~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFg  186 (350)
T 1rdq_E          113 NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFG  186 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCC-CEEEcccc
Confidence            445889999997 588777764    3579999999999999999999998 9999999999999999988 79999999


Q ss_pred             CccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          199 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       199 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      +++....  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...          
T Consensus       187 ~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------  253 (350)
T 1rdq_E          187 FAKRVKG--RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------  253 (350)
T ss_dssp             TCEECSS--CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred             cceeccC--CcccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence            9986533  3345689999999999965 45899999999999999999999999998877777666551          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                             ...            ++..+++++.+||++||+.||++||+     +.++++||||+.+.+
T Consensus       254 -------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          254 -------KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             -------CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             -------CCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                   111            23468999999999999999999998     999999999998653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=373.21  Aligned_cols=256  Identities=23%  Similarity=0.364  Sum_probs=215.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----------hhhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      -..+|++.+.||+|+||.||+|.++.+++.||+|++...          .....+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   84 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----   84 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            345899999999999999999999999999999998542          234568999999999999999999983    


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC---cEE
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLK  193 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---~vk  193 (390)
                       .....|+||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.   .+|
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           85 -NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEE
Confidence             3445889999997 488776643    4679999999999999999999998 99999999999999987652   599


Q ss_pred             EeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          194 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       194 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      |+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence            999999987655555556789999999999954 4589999999999999999999999998887777666654211111


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                               ......+++.+++||++||..||++|||+.++|+||||+..
T Consensus       238 -------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          238 -------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             -------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             -------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                                     11124578999999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-51  Score=376.42  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=214.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|+||.||+|.++.+++.||+|.+....   ....+|+.+++.++||||+++++++.+     ...+|+|
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv   79 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEEE
Confidence            47999999999999999999999999999999986432   334689999999999999999999843     3458899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC--CCCcEEEeecCCcccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVL  203 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~Dfg~a~~~  203 (390)
                      |||+++ +|.+.+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.  ++ .+||+|||++...
T Consensus        80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~  154 (321)
T 1tki_A           80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCC-CEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeEC
Confidence            999985 77665532   23468999999999999999999998 99999999999999986  45 7999999999877


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ..........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+..........        
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------  225 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--------  225 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH--------
T ss_pred             CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh--------
Confidence            655555667789999999999554 47999999999999999999999999988877777766532211111        


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                       ..+.+++++++||.+||..||++|||+.++|+||||++.
T Consensus       226 -----------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          226 -----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -----------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                             114579999999999999999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.4e-51  Score=383.92  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=211.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|++.+.||+|+||.||+|.++.+++.||+|++.+..       ....+|+.+++.++||||+++++++.     ...
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence            458999999999999999999999999999999985432       34457999999999999999999984     334


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+||||+.| +|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~a  162 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHG-HVHITDFNIA  162 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCC-CEEEecccee
Confidence            58899999975 77666653    4679999999999999999999998 9999999999999999988 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHH
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREE  276 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~  276 (390)
                      +...........+||+.|+|||++.+  ...++.++|||||||++|+|++|..||...+..  ..+.......       
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-------  235 (384)
T 4fr4_A          163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-------  235 (384)
T ss_dssp             EECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-------
T ss_pred             eeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-------
Confidence            87766666677889999999999954  234899999999999999999999999754322  2222221110       


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-HHHHhcCCcccccCC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDELRD  341 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-~~~~l~hp~f~~~~~  341 (390)
                               ..            .++..+++++.+||++||..||.+||+ +.++++||||+++.+
T Consensus       236 ---------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          236 ---------VV------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             ---------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             ---------cc------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                     01            123467999999999999999999998 899999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=384.40  Aligned_cols=262  Identities=27%  Similarity=0.445  Sum_probs=216.2

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||+||+|+++.+++.||||++.+.       .....+|..++..++||||+++++++.     +.
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-----DE  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-----CS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eC
Confidence            346899999999999999999999999999999998542       233567999999999999999999983     34


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .++|+||||++ ++|..++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g-~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCG-HIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCC-CEEEeechh
Confidence            56889999996 5887777642   3579999999999999999999998 9999999999999999988 699999999


Q ss_pred             ccccccCCC--CcceeeccccccchhhcC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016401          200 AKVLVKGEP--NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       200 a~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      ++.......  ....+||+.|+|||++..      ...++.++|||||||++|||++|++||.+.+..+.+.++..... 
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-  287 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE-  287 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Confidence            986644332  234578999999999962      34589999999999999999999999999888887777764210 


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcC---CCHHHHhcCCcccccCCCCC
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDELRDPNT  344 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~s~~~~l~hp~f~~~~~~~~  344 (390)
                                    ...+|.         +...+++++++||++||+ ||++|   ++++++++||||+++.+...
T Consensus       288 --------------~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          288 --------------HLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             --------------HCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             --------------CcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                          011111         124689999999999999 99998   58999999999999876443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-50  Score=380.73  Aligned_cols=254  Identities=24%  Similarity=0.414  Sum_probs=209.4

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHHH-HHhCCCCceeeecceeccCCCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ....+|++.+.||+|+||+||+|+++.+++.||||++.+...       ...+|..+ ++.++||||+++++++.     
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----
Confidence            345689999999999999999999999999999999865421       12345555 46689999999999983     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      ....+|+||||++| +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~ikL~DF  183 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDF  183 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEeeC
Confidence            34468899999985 77666654    4678999999999999999999998 9999999999999999988 7999999


Q ss_pred             CCcccccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          198 GSAKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       198 g~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      |+++.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+...        
T Consensus       184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------  254 (373)
T 2r5t_A          184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--------  254 (373)
T ss_dssp             CBCGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--------
T ss_pred             ccccccccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------
Confidence            99986432 334456789999999999965 45899999999999999999999999998887777776651        


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH----HHHhcCCcccccCC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  341 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~----~~~l~hp~f~~~~~  341 (390)
                               ..            .+++.+++++++||++||+.||.+|+++    .++++||||+.+.+
T Consensus       255 ---------~~------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          255 ---------PL------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             ---------CC------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             ---------cc------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence                     01            1235689999999999999999999986    69999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.7e-50  Score=379.20  Aligned_cols=254  Identities=29%  Similarity=0.413  Sum_probs=212.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|++.+.||+|+||.||+|.++.+++.||+|++....      ....+|+.+++.++||||+++++++.     +....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~  103 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESFH  103 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence            47999999999999999999999999999999985432      33457999999999999999999983     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEEEeecCCc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSA  200 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~a  200 (390)
                      |+||||+.+ +|.+.+..    ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++  ..+||+|||++
T Consensus       104 ~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            899999985 77655543    4578999999999999999999998 9999999999999998653  25999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+....           
T Consensus       179 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~-----------  246 (362)
T 2bdw_A          179 IEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-----------  246 (362)
T ss_dssp             BCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred             eEecCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            87665555556789999999999954 458999999999999999999999999888776666665421           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                            +.++.        .....+++++++||.+||..||++|||+.++|+||||...
T Consensus       247 ------~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          247 ------YDYPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ------CCCCT--------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ------CCCCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                  11110        0114579999999999999999999999999999999753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=385.56  Aligned_cols=290  Identities=28%  Similarity=0.476  Sum_probs=211.9

Q ss_pred             cccEEE-eeeeeecCceEEEEEEEc--CCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIA-EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+.|.+ .++||+|+||.||+|+++  .+++.||||++...  .....+|+.+|+.++||||+++++++...   ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeE
Confidence            356887 558999999999999976  56889999998654  23456899999999999999999998542   23458


Q ss_pred             EEEEecccccHHHHHHHhhhh-----cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE----cCCCCcEEE
Q 016401          124 NLVLEYVPETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKL  194 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~~vkl  194 (390)
                      |+||||++++|..++......     ...+++..++.++.||+.||+|||+ .||+||||||+|||+    +.++ .+||
T Consensus        96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kl  173 (405)
T 3rgf_A           96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKI  173 (405)
T ss_dssp             EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTT-CEEE
T ss_pred             EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCC-cEEE
Confidence            899999999988877654322     1248999999999999999999998 999999999999999    5555 7999


Q ss_pred             eecCCccccccC----CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHH
Q 016401          195 CDFGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQ  261 (390)
Q Consensus       195 ~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~  261 (390)
                      +|||+++.....    .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...         .++
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999999765432    2224467899999999997766689999999999999999999999987654         478


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCc---------ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          262 LVEIIKVLGTPTREEIKCMNPNY---------TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      +..++..++.|....+.......         ....+.......+........++.+.+||++||++||++|||+.|+|+
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            88999998888765443321100         000000000000111112234789999999999999999999999999


Q ss_pred             CCcccccCCCC
Q 016401          333 HPFFDELRDPN  343 (390)
Q Consensus       333 hp~f~~~~~~~  343 (390)
                      ||||++...+.
T Consensus       334 hp~f~~~~~~~  344 (405)
T 3rgf_A          334 DPYFLEDPLPT  344 (405)
T ss_dssp             SGGGTSSSCCC
T ss_pred             ChhhccCCCCc
Confidence            99998765443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.9e-50  Score=373.27  Aligned_cols=283  Identities=33%  Similarity=0.590  Sum_probs=226.0

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ....+|++.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++||||+++++++.     ..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   96 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK   96 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence            34468999999999999999999999999999999885432      22347999999999999999999983     34


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ...|+||||+++++...+.   .....+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHH---HSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCC-cEEEEeCCCc
Confidence            4578999999986544332   234679999999999999999999998 9999999999999999888 7999999999


Q ss_pred             cccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ...... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.........
T Consensus       172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            765432 2234457899999999997665689999999999999999999999999999999999888887776554322


Q ss_pred             --cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 --MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                        ..+.+.....+............+.+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence              233334444444433333333345789999999999999999999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4e-51  Score=374.65  Aligned_cols=266  Identities=21%  Similarity=0.203  Sum_probs=187.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh-hH--HHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YK--NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++..... ..  +.|+..+..++|||||++++++.... .....+|+|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            3699999999999999999997  589999999865432 22  34555667789999999999985432 223457899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC--------CcccccCCCCcEEEcCCCCcEEEeec
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~--------~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      ||||+ |+|.+++..     ..+++..+..++.|++.||+|||+ .        +||||||||+||||+.++ .+||+||
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DF  152 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  152 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCC-CEEEEeC
Confidence            99998 588887764     568999999999999999999997 5        899999999999999998 7999999


Q ss_pred             CCccccccCCCC-----cceeeccccccchhhcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016401          198 GSAKVLVKGEPN-----VSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       198 g~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  267 (390)
                      |+|+........     ...+||+.|||||++.+..     .++.++|||||||++|||+||.+||......+...... 
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~-  231 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-  231 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc-
Confidence            999866443322     2357999999999996532     25779999999999999999988764322110000000 


Q ss_pred             HhCCCCHHHHhh-cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          268 VLGTPTREEIKC-MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       268 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ....+..+.+.. ...   ....|.++    ........+..+.+|+.+||+.||++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~---~~~rp~~p----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVCE---QKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCSSCCHHHHHHHHTT---SCCCCCCC----GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHhc---ccCCCCCC----ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            000000000000 000   00000000    000111234578899999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.3e-50  Score=386.10  Aligned_cols=255  Identities=27%  Similarity=0.399  Sum_probs=210.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||.||+|.++.+|+.||+|++....      ....+|+.+++.++||||+++++++     .+...
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence            458999999999999999999999999999999985432      3346899999999999999999998     34455


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC--CCcEEEeecCC
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGS  199 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~Dfg~  199 (390)
                      .|+||||+.+ +|.+.+..    ...+++..+..++.||+.||+|||+ .||+||||||+|||++.+  ...+||+|||+
T Consensus        85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            8899999985 77666654    4679999999999999999999998 999999999999999842  23799999999


Q ss_pred             ccccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          200 AKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       200 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      +........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....         
T Consensus       160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------  229 (444)
T 3soa_A          160 AIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA---------  229 (444)
T ss_dssp             CBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC---------
T ss_pred             eEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---------
Confidence            976544322 345678999999999954 458999999999999999999999999988777777665521         


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                              +.++.   .     ..+.+++++++||.+||+.||++|||+.++|+||||+..
T Consensus       230 --------~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          230 --------YDFPS---P-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             --------CCCCT---T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             --------CCCCc---c-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                    11110   0     114579999999999999999999999999999999763

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=373.84  Aligned_cols=314  Identities=32%  Similarity=0.570  Sum_probs=238.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCC-CceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~  122 (390)
                      .+|.+.+.||+|+||.||+|.++.+|+.||||++....      ....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            47999999999999999999999999999999985431      2345799999999999999999998543221 1123


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+||||++++|...+      ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||++..
T Consensus       104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            5799999998765443      2469999999999999999999998 9999999999999999888 799999999975


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+..+..
T Consensus       176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            432  234567899999999997656789999999999999999999999999999999999999999888776655432


Q ss_pred             Cccc---ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCC
Q 016401          283 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  359 (390)
Q Consensus       283 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  359 (390)
                      ....   ...+......+.. ....+++++.+||.+||..||++|||+.++|+||||+...++......    ...+.. 
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~----~~~~~~-  327 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEA----QQPFDD-  327 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCC----SSCCCC-
T ss_pred             HHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccC----CCCCcc-
Confidence            2100   0112222222222 224679999999999999999999999999999999987765433221    111211 


Q ss_pred             CCCCCCCChHHHhhhCcHHH
Q 016401          360 PPELSGIPPETINRLIPEHA  379 (390)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~  379 (390)
                      ..+...++.+.+++.+.++.
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~  347 (353)
T 3coi_A          328 SLEHEKLTVDEWKQHIYKEI  347 (353)
T ss_dssp             TTTTCCCCHHHHHHHHHHHH
T ss_pred             chhhccCCHHHHHHHHHHHH
Confidence            12234456666666655443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.7e-50  Score=375.33  Aligned_cols=287  Identities=29%  Similarity=0.473  Sum_probs=223.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC---CC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  119 (390)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            458999999999999999999999999999999884332      234589999999999999999998854321   12


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ...+|+||||+++++...+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-CEEEccchh
Confidence            445789999999988766653   23569999999999999999999998 9999999999999999888 799999999


Q ss_pred             ccccccC-----CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +......     .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9765422     22244567999999999977666899999999999999999999999999999999999888777665


Q ss_pred             HHHhhcCcC--cccccCCCCCCCCcccc-cccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          275 EEIKCMNPN--YTEFKFPQIKPHPWHKV-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       275 ~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      +.+......  +................ .....++++.+||.+||++||++|||+.|+|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            443222110  01111110000000000 0011377899999999999999999999999999998643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.8e-50  Score=377.47  Aligned_cols=258  Identities=27%  Similarity=0.441  Sum_probs=197.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+|++.+.||+|+||.||+|+++.+++.||||++....   ....+|+.+++.++||||+++++++.+     ...+|+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEEE
Confidence            458999999999999999999999999999999986532   445689999999999999999999843     345889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC-cEEEeecCCcccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVL  203 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-~vkl~Dfg~a~~~  203 (390)
                      ||||+. ++|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||+++..
T Consensus        94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999997 488776654    3579999999999999999999998 99999999999999986652 4999999999755


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ..........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...+..            
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~------------  236 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS------------  236 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT------------
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc------------
Confidence            44445566789999999999977654445599999999999999999999876543333333322100            


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                       ..+..+.          ...+++++++||++||..||++|||+.++++||||...
T Consensus       237 -~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          237 -VKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -TCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             -CCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence             0011111          12578999999999999999999999999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-49  Score=360.60  Aligned_cols=255  Identities=29%  Similarity=0.436  Sum_probs=206.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....     ....+|+++++.++||||+++++++.     .....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   95 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNM   95 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeE
Confidence            358999999999999999999999999999999986433     34568999999999999999999983     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC---CCCcEEEeecCC
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGS  199 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~Dfg~  199 (390)
                      |+||||+++ +|...+.........+++..++.++.||+.||+|||+ .||+||||||+||+++.   ++ .+||+|||+
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg~  173 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHS-PIKIIDFGL  173 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTC-CEEECCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCC-CEEEEeeec
Confidence            899999985 8888877665556789999999999999999999998 99999999999999953   34 799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.............+|+.|+|||++.  ..++.++|||||||++|+|++|..||.+.+..+....+....  +       
T Consensus       174 a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~-------  242 (285)
T 3is5_A          174 AELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE--P-------  242 (285)
T ss_dssp             CCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C-------
T ss_pred             ceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--c-------
Confidence            98765555556677899999999984  348999999999999999999999998877655544433210  0       


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                              ..         ......+++++.+||++||+.||++|||+.|+|+||||++
T Consensus       243 --------~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          243 --------NY---------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --------CC---------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             --------cc---------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                    00         0011347899999999999999999999999999999975

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.2e-49  Score=365.33  Aligned_cols=291  Identities=31%  Similarity=0.546  Sum_probs=231.5

Q ss_pred             CcccccEEEeeeeeecCceEEEEEEEc-CCCcEEEEEEeccch------hhHHHHHHHHHhC---CCCceeeecceeccC
Q 016401           46 SKQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFST  115 (390)
Q Consensus        46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~  115 (390)
                      .....+|++.+.||+|+||.||+|++. .+++.||||++....      ....+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            344568999999999999999999995 678999999885321      2345788777766   899999999988543


Q ss_pred             CCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEe
Q 016401          116 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  195 (390)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  195 (390)
                      ........++||||++++|..++....  ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~-~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred             ccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCC-CEEEe
Confidence            334566788999999999888776532  2458999999999999999999998 9999999999999999888 79999


Q ss_pred             ecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          196 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       196 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      |||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+...
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            99999765444444556789999999999654 58999999999999999999999999999999999999888877665


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      .+...... ....+......+ ...+...++..+++||.+||..||++|||+.++++||||+++....
T Consensus       242 ~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          242 DWPRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             GSCTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             cCcccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            44321100 000111111111 1223467899999999999999999999999999999999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.6e-50  Score=374.62  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .++|++.+.||+|+||.||+|.++.+++.||||++.+......+|++++.++ +||||+++++++     .+..++|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEEE
Confidence            3579999999999999999999999999999999987776777899999888 799999999998     3445688999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC---CcEEEeecCCcccc
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFGSAKVL  203 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~~vkl~Dfg~a~~~  203 (390)
                      ||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||+..+.   ..+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99975 77666653    4569999999999999999999998 9999999999999985432   14999999999865


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHhh
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      .... .....++|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.   +..+.+..+...           
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-----------  238 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-----------  238 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-----------
T ss_pred             cCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-----------
Confidence            4432 33456789999999999653 4889999999999999999999999863   223333333321           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                            .+.+        ...++..+++++++||++||..||++|||+.++++||||.+.
T Consensus       239 ------~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          239 ------KFSL--------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             ------CCCC--------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ------Cccc--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence                  0111        111224689999999999999999999999999999999764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.1e-49  Score=369.60  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=212.2

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++.     ..
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence            345899999999999999999999999999999998543       233457999999999999999999983     34


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ...|+||||+++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~  187 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGL  187 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCC-CEEEeeccC
Confidence            458899999984 77666543    3679999999999999999999998 9999999999999999888 799999999


Q ss_pred             ccccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          200 AKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       200 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      +...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...          
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------  256 (335)
T 2owb_A          188 ATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------  256 (335)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------
T ss_pred             ceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC----------
Confidence            9765432 223445789999999999654 4899999999999999999999999887766655544431          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                             .+.            ++..+++.+.+||++||+.||++|||+.++++||||.....+
T Consensus       257 -------~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          257 -------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             -------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             -------CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence                   111            124578999999999999999999999999999999875443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=371.58  Aligned_cols=255  Identities=29%  Similarity=0.424  Sum_probs=194.8

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++||||+++++++.     .....++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEE
Confidence            446799999999999999999999999999999998653  334567999999999999999999983     3345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC---CCCcEEEeecCCcc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAK  201 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~Dfg~a~  201 (390)
                      ||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.   ++ .+||+|||+++
T Consensus       126 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDA-PLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTC-CEEECCCC---
T ss_pred             EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCC-CEEEccCcccc
Confidence            9999974 77665543    4568999999999999999999998 99999999999999975   55 79999999998


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~  280 (390)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.. ..+...            
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~------------  266 (349)
T 2w4o_A          200 IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC------------  266 (349)
T ss_dssp             -------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT------------
T ss_pred             ccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC------------
Confidence            66544444566789999999999654 5899999999999999999999999876655433 333221            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                           ....        .......++.++++||++||..||++|||+.++|+||||+..
T Consensus       267 -----~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          267 -----EYYF--------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             -----CCCC--------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             -----CCcc--------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                 0000        001124678999999999999999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.6e-50  Score=367.88  Aligned_cols=253  Identities=26%  Similarity=0.431  Sum_probs=203.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------------------------------hhHHHHHHHHH
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQ   98 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------~~~~~E~~~l~   98 (390)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....                              ....+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            358999999999999999999999999999999985432                              23568999999


Q ss_pred             hCCCCceeeecceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 016401           99 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  177 (390)
Q Consensus        99 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~D  177 (390)
                      .++||||+++++++..   .....+|+||||+++ +|..+.     ....+++..++.++.||+.||+|||+ .||+|||
T Consensus        92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred             hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccC
Confidence            9999999999998843   224568899999985 443321     23579999999999999999999998 9999999


Q ss_pred             CCCCcEEEcCCCCcEEEeecCCccccccCCC-CcceeeccccccchhhcCCCC--CCCchhHHHHHHHHHHHHhCCCCCC
Q 016401          178 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFP  254 (390)
Q Consensus       178 lkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~  254 (390)
                      |||+|||++.++ .+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|+|++|..||.
T Consensus       163 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999888 799999999976543322 234578999999999965432  4778999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCC
Q 016401          255 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  334 (390)
Q Consensus       255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp  334 (390)
                      +.+.......+...                 ...++.          ...+++++.+||.+||..||++|||+.++++||
T Consensus       242 ~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          242 DERIMCLHSKIKSQ-----------------ALEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             CSSHHHHHHHHHHC-----------------CCCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             CccHHHHHHHHhcc-----------------cCCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            87765544444321                 011111          135789999999999999999999999999999


Q ss_pred             cccc
Q 016401          335 FFDE  338 (390)
Q Consensus       335 ~f~~  338 (390)
                      ||++
T Consensus       295 ~~~~  298 (298)
T 2zv2_A          295 WVTR  298 (298)
T ss_dssp             HHHC
T ss_pred             cccC
Confidence            9963

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-49  Score=369.74  Aligned_cols=283  Identities=30%  Similarity=0.529  Sum_probs=219.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ...+|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++ ||||+++++++..   ....+.++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~l  110 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPAL  110 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceEE
Confidence            346899999999999999999999999999999998643 445678999999997 9999999998843   22345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ +|..++       ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++..+||+|||+++...
T Consensus       111 v~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          111 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            9999985 554433       248899999999999999999998 9999999999999999776679999999998766


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHH-hhcCc
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEI-KCMNP  282 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~~~~  282 (390)
                      .........+|+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+....+.+..... .....
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            55555667889999999999765679999999999999999999999985 45566667776666554332221 11110


Q ss_pred             Cccc-c--cCCCCCCCCccc----ccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          283 NYTE-F--KFPQIKPHPWHK----VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       283 ~~~~-~--~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      .... +  .........|..    .....+++++.+||++||++||++|||++++|+||||+.+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            0000 0  000001111111    112347999999999999999999999999999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-49  Score=373.18  Aligned_cols=277  Identities=25%  Similarity=0.421  Sum_probs=220.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCC-----CCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----HPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~~  120 (390)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+.     ||||+++++++..     .
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-----~  108 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-----Y  108 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-----T
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-----C
Confidence            358999999999999999999999999999999986432   33457999999996     9999999998843     3


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC-------------
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-------------  187 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-------------  187 (390)
                      ...|+||||++++|..++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.             
T Consensus       109 ~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          109 DHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             CeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhcc
Confidence            3588999999889988876532  2458999999999999999999998 99999999999999975             


Q ss_pred             ------------CCCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016401          188 ------------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  255 (390)
Q Consensus       188 ------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  255 (390)
                                  ++ .+||+|||++....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus       186 ~~~~~~~~~~~~~~-~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          186 TDGKKIQIYRTKST-GIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCCEEEEEEESCC-CEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCC-CEEEEeccCceecC--CCCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        44 79999999997543  233456789999999999654 589999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCccc--c-------cCCCCCCC--------CcccccccCCChhHHHHHHHhcc
Q 016401          256 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE--F-------KFPQIKPH--------PWHKVFQKRLPPEAVDLVCRFFQ  318 (390)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~  318 (390)
                      .+..+.+..+....+..+...+.........  +       .++.....        .....+....++.+.+||++||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            9998999888888877776655433211100  0       01100000        00001112235788899999999


Q ss_pred             cCCCcCCCHHHHhcCCccc
Q 016401          319 YSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       319 ~dP~~R~s~~~~l~hp~f~  337 (390)
                      +||++|||+.++|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999996

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.8e-50  Score=387.08  Aligned_cols=253  Identities=27%  Similarity=0.413  Sum_probs=206.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|++.+.||+|+||.||+|+++.+++.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence            358999999999999999999999999999999986431       223468899999999999999999843     34


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+..||+||||||+|||++.++ .+||+|||+|
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a  296 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLC  296 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCC
T ss_pred             EEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCc
Confidence            58899999985 77666643    467999999999999999999999536999999999999999988 7999999999


Q ss_pred             ccccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...           
T Consensus       297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  364 (446)
T 4ejn_A          297 KEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------  364 (446)
T ss_dssp             CTTCC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             eeccCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------
Confidence            75332 233345678999999999965 45899999999999999999999999988877666665541           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                            ...            ++..+++++.+||.+||.+||.+||     ++.++++||||+++.+
T Consensus       365 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          365 ------EIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence                  111            2346799999999999999999999     9999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.1e-49  Score=358.28  Aligned_cols=258  Identities=28%  Similarity=0.393  Sum_probs=214.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++....      ....+|+.+++.++||||+++++++.     ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence            358999999999999999999999999999999985432      33457999999999999999999983     3445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEEEeecCC
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS  199 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~  199 (390)
                      .|+||||+.+ +|...+..    ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++  ..+||+|||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            7899999985 77655543    3679999999999999999999998 9999999999999997654  2499999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.............+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------  224 (284)
T 3kk8_A          155 AIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY---------  224 (284)
T ss_dssp             CEECCSSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------
T ss_pred             eEEcccCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc---------
Confidence            987665555556788999999999965 4589999999999999999999999998887766666554211         


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                              ..+.        .....+++++.+||.+||+.||++|||+.++|+||||++.+..
T Consensus       225 --------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          225 --------DYPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             --------CCCT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             --------cCCc--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence                    1110        0113578999999999999999999999999999999886543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-49  Score=368.23  Aligned_cols=252  Identities=29%  Similarity=0.453  Sum_probs=205.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccch--------hhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ..+|++.+.||+|+||.||+|++.   .+++.||+|++.+..        ....+|+.+++.++||||+++++++..   
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT---   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence            458999999999999999999985   689999999986431        234579999999999999999999843   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                        ...+|+||||++ ++|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus        93 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~D  164 (327)
T 3a62_A           93 --GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQG-HVKLTD  164 (327)
T ss_dssp             --SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTS-CEEECC
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCC-cEEEEe
Confidence              334789999998 577766654    3578999999999999999999998 9999999999999999888 799999


Q ss_pred             cCCccccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          197 FGSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       197 fg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...       
T Consensus       165 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-------  236 (327)
T 3a62_A          165 FGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-------  236 (327)
T ss_dssp             CSCC----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-------
T ss_pred             CCcccccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------
Confidence            9998754322 22344578999999999965 45899999999999999999999999998877777666552       


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                                ...            ++..+++++++||.+||..||++||     ++.++++||||+++.+
T Consensus       237 ----------~~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          237 ----------KLN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             ----------CCC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             ----------CCC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                      011            2245789999999999999999999     8999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.1e-49  Score=375.96  Aligned_cols=286  Identities=20%  Similarity=0.341  Sum_probs=209.4

Q ss_pred             cccccEEEeeeeeec--CceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           47 KQKVSYIAEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ....+|++.+.||+|  +||.||+|+++.+++.||||++....      ....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----   97 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----   97 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----
Confidence            355689999999999  99999999999999999999986432      334579999999999999999999843    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                       ...+|+||||++ ++|..++...  ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+||
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~df  172 (389)
T 3gni_B           98 -DNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGL  172 (389)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCG
T ss_pred             -CCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEccc
Confidence             345889999998 5887777642  23569999999999999999999998 9999999999999999888 7999999


Q ss_pred             CCccccccC--------CCCcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016401          198 GSAKVLVKG--------EPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  268 (390)
Q Consensus       198 g~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  268 (390)
                      |.+......        .......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            987644221        112234678999999999653 45899999999999999999999999887766655544331


Q ss_pred             hCCCC-------HHHHh-hcCc-----Cccc-c----cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHH
Q 016401          269 LGTPT-------REEIK-CMNP-----NYTE-F----KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  330 (390)
Q Consensus       269 ~~~~~-------~~~~~-~~~~-----~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~  330 (390)
                      .....       .+.+. ....     .... .    ..+. ........++..+++++++||++||++||++|||+.++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            10000       00000 0000     0000 0    0000 00011112345689999999999999999999999999


Q ss_pred             hcCCcccccCCC
Q 016401          331 CVHPFFDELRDP  342 (390)
Q Consensus       331 l~hp~f~~~~~~  342 (390)
                      |+||||+.+...
T Consensus       332 l~hp~f~~~~~~  343 (389)
T 3gni_B          332 LNHSFFKQIKRR  343 (389)
T ss_dssp             TTSGGGGGC---
T ss_pred             hcCHHHHHHhhc
Confidence            999999987653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9e-49  Score=363.18  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=215.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----------hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      .++|++.+.||+|+||.||+|.++.+++.||||++...          .....+|+.+++.++||||+++++++.     
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence            45799999999999999999999999999999998542          233568999999999999999999983     


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC---cEEE
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL  194 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---~vkl  194 (390)
                      .....|+||||++ ++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++.   .+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEE
Confidence            3445889999996 588777653    4678999999999999999999998 99999999999999987763   5999


Q ss_pred             eecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          195 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......  
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--  237 (321)
T 2a2a_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF--  237 (321)
T ss_dssp             CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC--
T ss_pred             ccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc--
Confidence            99999987665555556678999999999954 458999999999999999999999999888777666554421111  


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                             ...+...+++.+.+||++||..||++|||+.++++||||+...
T Consensus       238 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          238 -----------------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             -----------------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             -----------------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence                                   1112246789999999999999999999999999999998653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-49  Score=388.44  Aligned_cols=257  Identities=23%  Similarity=0.381  Sum_probs=212.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|.+.+.||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.     ..
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~  257 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TK  257 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eC
Confidence            4468999999999999999999999999999999985432       23457999999999999999999883     34


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+|+||||++ ++|...+.........+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g-~vkL~DFGl  335 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDG-NVRISDLGL  335 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCC-CEEEeecce
Confidence            45889999998 48877776544334579999999999999999999998 9999999999999999988 799999999


Q ss_pred             ccccccCCCC-cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~  274 (390)
                      ++........ ...+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.    .+....+...      
T Consensus       336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~------  408 (543)
T 3c4z_A          336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ------  408 (543)
T ss_dssp             CEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC------
T ss_pred             eeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc------
Confidence            9876544333 34589999999999965 4589999999999999999999999987642    2233333221      


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                                 ..            .++..+++++++||++||+.||++||+     +.++++||||+.+.+
T Consensus       409 -----------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          409 -----------AV------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             -----------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             -----------cc------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                       01            123568999999999999999999996     589999999998753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-49  Score=372.22  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=213.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|++.+.||+|+||.||+|.++.+++.||+|++...    .....+|+.+++.++||||+++++++.     +...+|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            35799999999999999999999999999999998643    234568999999999999999999983     344588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC-CCcEEEeecCCccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKV  202 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~Dfg~a~~  202 (390)
                      +||||+.+ +|.+.+..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++.+ ...+||+|||++..
T Consensus       125 lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999975 77655532   23468999999999999999999998 999999999999999753 23699999999987


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....             
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-------------  266 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-------------  266 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-------------
T ss_pred             cCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            655544556678999999999954 458999999999999999999999999988777766655421             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                          +.++        ......+++++++||++||..||++|||+.++|+||||+...
T Consensus       267 ----~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          267 ----WEFD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             ----CCCC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ----CCCC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                1111        011245799999999999999999999999999999998643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.4e-49  Score=366.18  Aligned_cols=254  Identities=28%  Similarity=0.349  Sum_probs=205.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++...     .....+|+.+++.++||||+++++++.     .....|
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~   81 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY   81 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeEE
Confidence            4799999999999999999999999999999998533     234568999999999999999999883     344578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|...+.    ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  155 (323)
T 3tki_A           82 LFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  155 (323)
T ss_dssp             EEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCC-CEEEEEeecccee
Confidence            99999975 6644442    24569999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             ccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....   ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..............         
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------  226 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------  226 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---------
Confidence            3322   2235678999999999976665588999999999999999999999876544332222111000         


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                             .     ..+     ...+++++.+||.+||..||++|||+.|+++||||+...
T Consensus       227 -------~-----~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          227 -------Y-----LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             -------T-----STT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -------c-----CCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence                   0     000     145789999999999999999999999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9e-49  Score=355.42  Aligned_cols=254  Identities=30%  Similarity=0.442  Sum_probs=214.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++...    .....+|+++++.++||||+++++++.     .....|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            35899999999999999999999999999999998542    344568999999999999999999983     344588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE---cCCCCcEEEeecCCc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA  200 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~Dfg~a  200 (390)
                      +||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence            99999975 77666654    3568999999999999999999998 999999999999999   5555 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .............+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......+...    
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  230 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD----  230 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH----
T ss_pred             eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh----
Confidence            87665555566788999999999854  389999999999999999999999999887777766655321111111    


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                           ...+++++.+||.+||+.||++|||+.++|+||||++..
T Consensus       231 ---------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          231 ---------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             ---------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             ---------------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                 135789999999999999999999999999999998753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.6e-49  Score=359.55  Aligned_cols=258  Identities=25%  Similarity=0.373  Sum_probs=199.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh------hHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...+|++.+.||+|+||.||+|++..+++.||||++.....      ...++...++.++||||+++++++...     .
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----G   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----C
Confidence            34689999999999999999999999999999999854321      122345557888999999999998533     2


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..|+||||+++++...+.........+++..++.++.||+.||+|||+ + ||+||||||+||+++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALG-QVKMCDFGIS  157 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence            378999999999988887766667789999999999999999999998 7 999999999999999888 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhh---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHH
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~  276 (390)
                      .............+|+.|+|||++   .....++.++|||||||++|+|++|..||... .....+....... .     
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-----  231 (290)
T 3fme_A          158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-S-----  231 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-C-----
T ss_pred             ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-C-----
Confidence            876555555556789999999997   34456899999999999999999999999864 3333343333310 0     


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                   +        ......+++++.+||.+||+.||++|||+.++++||||+..
T Consensus       232 -------------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          232 -------------P--------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             -------------C--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             -------------C--------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                         0        00113578999999999999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.3e-49  Score=384.78  Aligned_cols=255  Identities=29%  Similarity=0.441  Sum_probs=213.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----------------hhHHHHHHHHHhCCCCceeeecce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------------RYKNRELQIMQMLDHPNIVALKHC  111 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~E~~~l~~l~h~~iv~~~~~  111 (390)
                      ..+|++.+.||+|+||+||+|+++.+++.||||++....                 ....+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            357999999999999999999999999999999985422                 234579999999999999999999


Q ss_pred             eccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC
Q 016401          112 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  190 (390)
Q Consensus       112 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  190 (390)
                      +     ....++|+|||||++ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus       115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          115 F-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             E-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTC
T ss_pred             E-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCC
Confidence            8     344568899999985 77666654    3679999999999999999999998 99999999999999987653


Q ss_pred             --cEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016401          191 --QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  268 (390)
Q Consensus       191 --~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  268 (390)
                        .+||+|||++.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+...
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  262 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG  262 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence              599999999987765555566789999999999853  4899999999999999999999999998887777776652


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      .......                         ....+++++++||++||++||.+|||+.++|+||||+...
T Consensus       263 ~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          263 KYYFDFN-------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             CCCCCHH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CCCCCcc-------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            1111111                         1145799999999999999999999999999999998764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=365.77  Aligned_cols=285  Identities=29%  Similarity=0.506  Sum_probs=219.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCC---------
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTT---------  116 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---------  116 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....    ....+|+.+++.++||||+++++++....         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            47999999999999999999999999999999885432    33457999999999999999998874321         


Q ss_pred             CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          117 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      .......|+||||++++|.+++.     ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++..+||+|
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence            12345678999999998877664     3578999999999999999999998 99999999999999985544899999


Q ss_pred             cCCccccccC----CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016401          197 FGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       197 fg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      ||++......    .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999765322    122334568899999998765678999999999999999999999999999888888888877666


Q ss_pred             CHHHHhhcCcCcccc---cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          273 TREEIKCMNPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ..+....+......+   ... ....++ ..+.+.++.++++||++||+.||++|||+.++|+||||+....|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMT-EPHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTT-SCCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             chhhhhhhhhcCccccccccc-CCCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            655443321111000   000 001111 12235689999999999999999999999999999999986544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.9e-49  Score=388.90  Aligned_cols=256  Identities=26%  Similarity=0.447  Sum_probs=212.1

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||.||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||+++++++.     ..
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~  256 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TK  256 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eC
Confidence            456899999999999999999999999999999998542       223457999999999999999999883     34


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+|+||||++ ++|...+....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g-~vKL~DFGl  332 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHG-HIRISDLGL  332 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCC-CeEEEeccc
Confidence            45889999997 58876665421  2459999999999999999999998 9999999999999999988 799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHH
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~  276 (390)
                      ++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.   .+.+...+...       
T Consensus       333 a~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-------  404 (576)
T 2acx_A          333 AVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------  404 (576)
T ss_dssp             CEECCTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-------
T ss_pred             ceecccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-------
Confidence            987765555556789999999999965 4589999999999999999999999987643   22222222210       


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                                           ...++..+++++++||++||+.||.+||     ++.++++||||+++.+
T Consensus       405 ---------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          405 ---------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             ---------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             ---------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence                                 0112356899999999999999999999     7999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-49  Score=383.99  Aligned_cols=251  Identities=28%  Similarity=0.431  Sum_probs=214.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~   88 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----P   88 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            3458999999999999999999999999999999985432       245689999999999999999999843     3


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+|+||||++ ++|.+++..    .+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~-~vkL~DFG~  162 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGL  162 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCC-CeEEEeccc
Confidence            45889999996 577665542    4679999999999999999999998 9999999999999999888 799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+.++....          
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------  232 (476)
T 2y94_A          163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------  232 (476)
T ss_dssp             CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC----------
T ss_pred             hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------
Confidence            9876655555667899999999999765545789999999999999999999999887766666554310          


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                             +.            .+..+++++.+||++||..||++|||+.++++||||+.
T Consensus       233 -------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          233 -------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             -------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             -------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                   11            12457899999999999999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.7e-49  Score=385.31  Aligned_cols=255  Identities=28%  Similarity=0.460  Sum_probs=211.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||+||+|+++.+++.||||++..      ......+|+++++.++||||+++++++.     ....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~   95 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence            3589999999999999999999999999999999843      2334568999999999999999999983     3455


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEEEeecCC
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS  199 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~  199 (390)
                      +|+||||+.+ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            8899999985 77666544    3679999999999999999999998 9999999999999996432  2699999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+....          
T Consensus       171 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------  238 (486)
T 3mwu_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK----------  238 (486)
T ss_dssp             TTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred             CeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            987655555566789999999999954  48999999999999999999999999988877777665521          


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                             +.++        ......+++++++||++||..||++|||+.++|+||||+...
T Consensus       239 -------~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          239 -------YAFD--------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             -------CCSC--------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             -------CCCC--------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                   0000        001145799999999999999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=373.97  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=205.3

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      |...+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.++++++||||+++++++.     ....+|+||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEE
Confidence            33467899999999999999999999999998653    334568999999999999999999983     334588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE--cCCCCcEEEeecCCccccc
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll--~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||+++ +|.+.+..   ....+++..+..++.||+.||+|||+ .||+||||||+|||+  +.++ .+||+|||++....
T Consensus       166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK  240 (373)
T ss_dssp             ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCC-cEEEEeCCCceecC
Confidence            99974 77665543   23468999999999999999999998 999999999999999  4444 79999999998776


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......             
T Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------  306 (373)
T 2x4f_A          241 PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-------------  306 (373)
T ss_dssp             TTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------------
T ss_pred             CccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------------
Confidence            5555556679999999999954 45899999999999999999999999999888877777653111             


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                          .+        ......+++++++||.+||+.||.+|||+.++|+||||++..
T Consensus       307 ----~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          307 ----LE--------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             ----SC--------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ----CC--------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                10        011145799999999999999999999999999999998753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.9e-49  Score=398.60  Aligned_cols=253  Identities=25%  Similarity=0.418  Sum_probs=214.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC-CCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|++.+.||+|+||+||+|+++.+++.||||++.+..       ....+|..++..+ .||+|+.+++++     ..
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence            3458999999999999999999999999999999986431       2344688889887 799999999988     33


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ...+|+||||+++ +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g-~ikL~DFG  487 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFG  487 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCC-cEEEeecc
Confidence            4458899999985 87776654    3579999999999999999999998 9999999999999999998 79999999


Q ss_pred             Cccccc-cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          199 SAKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       199 ~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      +|+... ........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...         
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---------  557 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH---------  557 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS---------
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence            998533 2334456789999999999954 45899999999999999999999999998888777777541         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH-----HHHhcCCcccccCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  341 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~-----~~~l~hp~f~~~~~  341 (390)
                              ..            .++..+++++++||++||++||++|+++     .++++||||+.+.+
T Consensus       558 --------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          558 --------NV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             --------CC------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             --------CC------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence                    11            1235689999999999999999999997     99999999998764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-49  Score=362.91  Aligned_cols=247  Identities=28%  Similarity=0.386  Sum_probs=197.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh------hHHHHHHHHHh-CCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+|++.+.||+|+||+||+|++..+++.||||++.....      ...+|+..+.. .+||||+++++++.     +...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            689999999999999999999999999999998754221      12234444444 49999999999983     3445


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+||||++++|...+...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence            8899999999987776543   4579999999999999999999998 8999999999999999888 799999999987


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.   +..  +.           
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~-----------  268 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GY-----------  268 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TC-----------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cC-----------
Confidence            655555555678999999999864  589999999999999999999877755432221   111  00           


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                    ....++..+++++.+||.+||++||++|||+.++|+||||++
T Consensus       269 --------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 --------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             --------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                          011123467999999999999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3e-49  Score=386.58  Aligned_cols=255  Identities=31%  Similarity=0.504  Sum_probs=215.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|++.+.||+|+||.||+|+++.+++.||||++...       .....+|+.+++.++||||+++++++     ....
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            35899999999999999999999999999999998432       23456899999999999999999998     3345


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc---CCCCcEEEeec
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDF  197 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~---~~~~~vkl~Df  197 (390)
                      ++|+||||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++   .++ .+||+||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Df  173 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDA-NIRIIDF  173 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCT
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCC-cEEEEee
Confidence            68899999974 77665543    4679999999999999999999998 9999999999999994   444 7999999


Q ss_pred             CCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          198 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       198 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      |++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+....        
T Consensus       174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------  243 (484)
T 3nyv_A          174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK--------  243 (484)
T ss_dssp             THHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             eeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--------
Confidence            99987765555566789999999999965  48999999999999999999999999988877777665521        


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                               +.++        ......+++++++||++||++||++|||+.++|+||||+....
T Consensus       244 ---------~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          244 ---------YTFE--------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             ---------CCCC--------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             ---------CCCC--------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                     0000        0011457999999999999999999999999999999998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.8e-48  Score=363.54  Aligned_cols=251  Identities=27%  Similarity=0.410  Sum_probs=210.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...|.+.+.||+|+||.||+|++..+++.||||++....       ....+|+++++.++||||+++++++..     ..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence            357999999999999999999999999999999985321       234579999999999999999999843     33


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ..|+||||+.|++.+.+...   ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++.
T Consensus       128 ~~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  202 (348)
T 1u5q_A          128 TAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSAS  202 (348)
T ss_dssp             EEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCB
T ss_pred             eEEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEeeccCce
Confidence            57899999999887766532   4679999999999999999999998 9999999999999999888 89999999997


Q ss_pred             ccccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ....   .....||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+.+..+.+..+.... .        
T Consensus       203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-~--------  270 (348)
T 1u5q_A          203 IMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S--------  270 (348)
T ss_dssp             SSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C--------
T ss_pred             ecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C--------
Confidence            6532   234678999999999853  4458999999999999999999999999888776666554410 0        


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                +        ......+++.+.+||.+||+.||++|||+.++++||||...
T Consensus       271 ----------~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          271 ----------P--------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             ----------C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ----------C--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                      0        00123578999999999999999999999999999999763

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.5e-48  Score=365.40  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=211.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHhC-CCCceeeecceeccCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQML-DHPNIVALKHCFFSTT  116 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  116 (390)
                      .+|.+.+.||+|+||.||+|.++.+|+.||||++....            ....+|+.+++.+ +||||+++++++.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            47999999999999999999999899999999885432            2345799999999 8999999999883   


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEe
Q 016401          117 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  195 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  195 (390)
                        .....|+||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+
T Consensus       171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEEC
T ss_pred             --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEE
Confidence              34458899999986 78777654    3579999999999999999999998 9999999999999999888 79999


Q ss_pred             ecCCccccccCCCCcceeeccccccchhhcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016401          196 DFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  270 (390)
Q Consensus       196 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  270 (390)
                      |||++.............||+.|+|||++.+     ...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999987765555566789999999999853     23478999999999999999999999998877666665554211


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      .....                         ....+++.+.+||.+||..||++|||+.++|+||||++
T Consensus       323 ~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSP-------------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHH-------------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCc-------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            11111                         11357899999999999999999999999999999973

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-48  Score=383.24  Aligned_cols=253  Identities=27%  Similarity=0.440  Sum_probs=210.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|++.+.||+|+||+||+|+++.+++.||||++...      .....+|+.+++.++||||+++++++.     ....+
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  111 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNY  111 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence            4799999999999999999999999999999998543      234568999999999999999999983     34458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEEEeecCCc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSA  200 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~a  200 (390)
                      |+|||||.+ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++..+  ..+||+|||++
T Consensus       112 ~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            899999985 77665543    3679999999999999999999998 9999999999999997643  25999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .............||+.|+|||++.  ..++.++||||+||++|+|++|.+||.+.+..+.+..+......         
T Consensus       187 ~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------  255 (494)
T 3lij_A          187 AVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT---------  255 (494)
T ss_dssp             EECBTTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred             eECCCCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            8776555556678999999999984  34899999999999999999999999998887777666552111         


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                              ++        ......+++++++||++||+.||.+|||+.++|+||||+..
T Consensus       256 --------~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          256 --------FD--------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             --------CC--------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             --------CC--------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                    00        01114679999999999999999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-49  Score=366.89  Aligned_cols=263  Identities=30%  Similarity=0.471  Sum_probs=209.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++....         ....+|+.+++.++||||+++++++.     +
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence            358999999999999999999999999999999985431         34557999999999999999999983     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhh------------------------------------cCCCcHHHHHHHHHHHHH
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRI------------------------------------HQRMPLIYVKLYTYQICR  162 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~ql~~  162 (390)
                      ....|+||||++ ++|.+.+..+...                                    ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            455889999997 5776665321100                                    112467788999999999


Q ss_pred             HHHHHHhcCCcccccCCCCcEEEcCCCC-cEEEeecCCccccccCC-----CCcceeeccccccchhhcC-CCCCCCchh
Q 016401          163 ALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGE-----PNVSYICSRYYRAPELIFG-ATEYTTAID  235 (390)
Q Consensus       163 al~~LH~~~~ivH~Dlkp~NIll~~~~~-~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~~~D  235 (390)
                      ||+|||+ .||+||||||+|||++.++. .+||+|||++.......     ......||+.|+|||++.+ ...++.++|
T Consensus       180 ~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999998 99999999999999986542 69999999997653322     1245578999999999964 256899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHH
Q 016401          236 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR  315 (390)
Q Consensus       236 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  315 (390)
                      ||||||++|+|++|..||.+.+..+....+......                 .+        ......+++++.+||.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------------~~--------~~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-----------------FE--------NPNYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------TT--------SGGGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-----------------cC--------CcccccCCHHHHHHHHH
Confidence            999999999999999999998887777766652110                 00        00113478999999999


Q ss_pred             hcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          316 FFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       316 ~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ||..||.+|||+.++|+||||+++.+.
T Consensus       314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999987643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-48  Score=369.58  Aligned_cols=281  Identities=33%  Similarity=0.576  Sum_probs=217.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHhCC-CC-----ceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLD-HP-----NIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++.....   ...+|+.+++.++ |+     +|+++++++..     
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  127 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-----  127 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----
Confidence            3589999999999999999999999999999999975432   3346888888885 44     48888888743     


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh-cCCcccccCCCCcEEEcC--CCCcEEEee
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CIGICHRDIKPQNLLVNP--HTHQLKLCD  196 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~-~~~ivH~Dlkp~NIll~~--~~~~vkl~D  196 (390)
                      ....|+||||++++|.+++....  ...+++..++.++.||+.||.|||+ ..||+||||||+|||++.  ++ .+||+|
T Consensus       128 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred             CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence            34588999999999988876532  2468999999999999999999993 169999999999999953  44 799999


Q ss_pred             cCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          197 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       197 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ||++....  .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++...
T Consensus       205 FG~a~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLG--QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETT--CCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceecc--cccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99997653  334456789999999999654 589999999999999999999999999999999999999999888766


Q ss_pred             HhhcCcCcccc-cCCC--------------CCC---CCccccccc-----------------CCChhHHHHHHHhcccCC
Q 016401          277 IKCMNPNYTEF-KFPQ--------------IKP---HPWHKVFQK-----------------RLPPEAVDLVCRFFQYSP  321 (390)
Q Consensus       277 ~~~~~~~~~~~-~~~~--------------~~~---~~~~~~~~~-----------------~~~~~~~~li~~~L~~dP  321 (390)
                      +.........+ ..+.              ...   ..+...+..                 ..++++++||++||++||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence            54321100000 0000              000   000000000                 001478999999999999


Q ss_pred             CcCCCHHHHhcCCcccccC
Q 016401          322 NLRCTALEACVHPFFDELR  340 (390)
Q Consensus       322 ~~R~s~~~~l~hp~f~~~~  340 (390)
                      ++|||+.|+|+||||++..
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-49  Score=369.89  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=204.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccc--------hhhHHHHHHHHHhC-CCCceeeecceeccC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD--------KRYKNRELQIMQML-DHPNIVALKHCFFST  115 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  115 (390)
                      ...+|++.+.||+|+||.||+|++.   .+++.||||++...        .....+|+.+++.+ .||||+++++++.. 
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence            3468999999999999999999984   58999999998532        13345799999999 69999999998833 


Q ss_pred             CCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          116 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       116 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                          ...+|+||||+++ +|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||
T Consensus       131 ----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl  200 (355)
T 1vzo_A          131 ----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVL  200 (355)
T ss_dssp             ----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEE
T ss_pred             ----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-cEEE
Confidence                3457899999985 88777654    3579999999999999999999998 9999999999999999888 7999


Q ss_pred             eecCCccccccCC--CCcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016401          195 CDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       195 ~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      +|||+++......  ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+.......+...+  
T Consensus       201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--  278 (355)
T 1vzo_A          201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--  278 (355)
T ss_dssp             SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--
T ss_pred             eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--
Confidence            9999997553222  22345789999999999652 347899999999999999999999997644322222222210  


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                            ...                 ...++..++..+.+||.+||..||++||     ++.++++||||+.+.+
T Consensus       279 ------~~~-----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          279 ------LKS-----------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             ------HHC-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             ------hcc-----------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                  000                 0012346789999999999999999999     9999999999998753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.6e-48  Score=351.92  Aligned_cols=251  Identities=29%  Similarity=0.481  Sum_probs=208.1

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||+++++++.     ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence            345899999999999999999999999999999998542       233557999999999999999999983     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ...++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .++|+|||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~l~Dfg~  155 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGW  155 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTS-CEEECSCCE
T ss_pred             CEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCC-CEEEEeccc
Confidence            458899999984 77666654    3568999999999999999999998 9999999999999999888 799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +..... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+...           
T Consensus       156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------  222 (279)
T 3fdn_A          156 SVHAPS-SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------  222 (279)
T ss_dssp             ESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-----------
T ss_pred             cccCCc-ccccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-----------
Confidence            864432 23345678999999999954 45899999999999999999999999988776666555441           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                            ..            .++..+++++.+||.+||..||++|||+.++++||||+...
T Consensus       223 ------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          223 ------EF------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             ------CC------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             ------CC------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                  01            12245789999999999999999999999999999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.3e-48  Score=353.44  Aligned_cols=253  Identities=26%  Similarity=0.428  Sum_probs=210.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++.     ...
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence            35899999999999999999999999999999998543       223457999999999999999999983     344


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..++||||++ ++|..++..    ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~  162 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLA  162 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCC-CEEEEeccCc
Confidence            5889999998 477665543    3578999999999999999999998 9999999999999999888 7999999999


Q ss_pred             cccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ...... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+...           
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------  230 (294)
T 2rku_A          163 TKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-----------  230 (294)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred             eecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------
Confidence            765432 22344568999999999954 45899999999999999999999999887766555444321           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                            ...            ++..+++.+.+||.+||+.||++|||+.++++||||.....+
T Consensus       231 ------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          231 ------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ------cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence                  011            224578999999999999999999999999999999875443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.2e-48  Score=352.84  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=210.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----------hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...          .....+|+.+++.++||||+++++++..     
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-----   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence            5799999999999999999999999999999988543          2345689999999999999999999843     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC---cEEEe
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLC  195 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---~vkl~  195 (390)
                      ....++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.   .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEE
Confidence            345789999997 588777754    3578999999999999999999998 99999999999999987652   69999


Q ss_pred             ecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          196 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       196 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      |||++.............+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+.......   
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---  230 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF---  230 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC---
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC---
Confidence            9999987655544455678999999999954 458999999999999999999999999887766665554321111   


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                                            .......+++.+.+||.+||..||++|||+.++++||||+.++..
T Consensus       231 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          231 ----------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             ----------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             ----------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                                  111124578999999999999999999999999999999987543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.7e-48  Score=369.18  Aligned_cols=282  Identities=27%  Similarity=0.395  Sum_probs=220.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCC--------CCceeeecceeccCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD--------HPNIVALKHCFFSTTDK  118 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~--------h~~iv~~~~~~~~~~~~  118 (390)
                      .+|++.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++        |+||+++++++.... .
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-V  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-T
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-C
Confidence            47999999999999999999999999999999996543   33457999999985        788999999874321 2


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CcccccCCCCcEEEcCCC--------
Q 016401          119 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT--------  189 (390)
Q Consensus       119 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~--------  189 (390)
                      ...++|+||||+++++...+...  ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.++        
T Consensus       116 ~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          116 NGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            45568999999998887766542  23569999999999999999999998 8 999999999999998664        


Q ss_pred             ----------------------------------------CcEEEeecCCccccccCCCCcceeeccccccchhhcCCCC
Q 016401          190 ----------------------------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE  229 (390)
Q Consensus       190 ----------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  229 (390)
                                                              ..+||+|||++.....  ......||+.|+|||++.+. .
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGS-G  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTS-C
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCC-C
Confidence                                                    2699999999976533  23456789999999999765 4


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcCcCcccccC----CCCC-CCCcc
Q 016401          230 YTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF----PQIK-PHPWH  298 (390)
Q Consensus       230 ~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~  298 (390)
                      ++.++|||||||++|+|++|+.||.+.+      ..+.+..+.+..+.++...+.........+..    .... ..+|.
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            8999999999999999999999998655      45677888888888887665433221111100    0000 00000


Q ss_pred             --c------ccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          299 --K------VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       299 --~------~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                        .      .++...++++.+||.+||++||++|||+.++|+||||+.
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence              0      012234567899999999999999999999999999963

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.8e-48  Score=370.17  Aligned_cols=259  Identities=27%  Similarity=0.372  Sum_probs=199.2

Q ss_pred             cccEEEe-eeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHH-HhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           49 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        49 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ...|.+. +.||+|+||+||+|.++.+++.||||++... ....+|+.++ +..+||||+++++++.... .+..++|+|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv  137 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV  137 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEE
Confidence            3578877 7999999999999999999999999998643 4456888887 4558999999999874321 235668899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC---CCCcEEEeecCCccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  202 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~Dfg~a~~  202 (390)
                      |||+++ +|.+++...  ....+++..++.++.||+.||+|||+ .||+||||||+|||++.   ++ .+||+|||+++.
T Consensus       138 ~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~  213 (400)
T 1nxk_A          138 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKE  213 (400)
T ss_dssp             EECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEE
T ss_pred             EEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCc-cEEEEecccccc
Confidence            999985 887777542  12469999999999999999999998 99999999999999987   45 799999999987


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHh
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~  278 (390)
                      ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...    ....+...          
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~----------  282 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----------  282 (400)
T ss_dssp             CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT----------
T ss_pred             cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC----------
Confidence            655444566788999999999854 558999999999999999999999998765322    12222110          


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                             .+.++.        .....+++++++||++||..||++|||+.++++||||...
T Consensus       283 -------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          283 -------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             -------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                   111111        0114579999999999999999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-48  Score=362.36  Aligned_cols=254  Identities=24%  Similarity=0.429  Sum_probs=186.5

Q ss_pred             ccEEEe---eeeeecCceEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAE---HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+|.+.   +.||+|+||.||+|.++.+++.||||++... .....+|+.+++.+. ||||+++++++.     +....|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEE
Confidence            367775   7899999999999999999999999998654 345568999999997 999999999983     345588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC--cEEEeecCCcc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK  201 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~Dfg~a~  201 (390)
                      +||||+++ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+||+|||+++
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999985 88776654    4679999999999999999999998 99999999999999976542  69999999997


Q ss_pred             ccccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCCCC
Q 016401          202 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-------DQLVEIIKVLGTPT  273 (390)
Q Consensus       202 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~~~  273 (390)
                      ...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..       +.+..+...     
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-----  231 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-----  231 (325)
T ss_dssp             ECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-----
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-----
Confidence            554332 2345577999999999954 45899999999999999999999999875432       122221110     


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                  .+.        +.......+++++++||++||..||++|||+.++++||||++.
T Consensus       232 ------------~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          232 ------------DFS--------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             ------------CCC--------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             ------------CCC--------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                        000        0111114579999999999999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=364.29  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=206.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHhCCCCceeeecceeccCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      ..+|++.+.||+|+||.||+|+++.+++.||||++....            ....+|+.+++.++||||+++++++    
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            358999999999999999999999999999999986532            2344799999999999999999998    


Q ss_pred             CCCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          117 DKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                       .....+++||||+.+  +|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||
T Consensus        99 -~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL  171 (335)
T 3dls_A           99 -ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDF-TIKL  171 (335)
T ss_dssp             -ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEE
T ss_pred             -eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCC-cEEE
Confidence             334558899999864  67665543    4579999999999999999999998 9999999999999999887 7999


Q ss_pred             eecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          195 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||......      ..       
T Consensus       172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-------  238 (335)
T 3dls_A          172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-------  238 (335)
T ss_dssp             CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred             eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence            99999987766655566789999999999976654588999999999999999999999652210      00       


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                .            ....+..+++++.+||.+||..||++|||+.++++||||+..
T Consensus       239 ----------~------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 ----------A------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             ----------T------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ----------h------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                      0            001123578999999999999999999999999999999763

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.5e-48  Score=374.50  Aligned_cols=256  Identities=30%  Similarity=0.447  Sum_probs=198.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHhCCCCceeeecceeccCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+|++++||||+++++++.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            468999999999999999999999999999999986432            13568999999999999999999872   


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEE
Q 016401          117 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLK  193 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vk  193 (390)
                        ... .|+||||+++ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++  ..+|
T Consensus       211 --~~~-~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 --AED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             --SSE-EEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             --cCc-eEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence              222 6799999975 6544332    34679999999999999999999998 9999999999999997543  2599


Q ss_pred             EeecCCccccccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016401          194 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       194 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      |+|||+++............||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+......+...+.....
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999987655555556789999999999853  345788999999999999999999999876544333333321110


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      .                        +.......+++.+.+||++||+.||++|||+.++|+||||++.
T Consensus       363 ~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 N------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             C------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             C------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            0                        0011124579999999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.2e-48  Score=356.31  Aligned_cols=253  Identities=27%  Similarity=0.434  Sum_probs=209.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...|...+.||+|+||.||+|+++.+|+.||||++...    .....+|+.+++.++||||+++++++..     ....|
T Consensus        44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~  118 (321)
T 2c30_A           44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELW  118 (321)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEE
Confidence            34699999999999999999999999999999998533    2335689999999999999999998844     23478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|.+++.     ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus       119 lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~  191 (321)
T 2c30_A          119 VLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQI  191 (321)
T ss_dssp             EEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-cEEEeeeeeeeec
Confidence            99999975 7766553     3569999999999999999999998 9999999999999999888 7999999998765


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... .+          
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~----------  259 (321)
T 2c30_A          192 SKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PP----------  259 (321)
T ss_dssp             CSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CC----------
T ss_pred             ccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC----------
Confidence            4332 2345678999999999954 458999999999999999999999998887766655544310 00          


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                              ..       .....+++++.+||.+||+.||++|||+.++++||||....
T Consensus       260 --------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          260 --------KL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             --------CC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             --------Cc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                    00       01135789999999999999999999999999999998643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.3e-48  Score=352.38  Aligned_cols=257  Identities=27%  Similarity=0.414  Sum_probs=213.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------------hhHHHHHHHHHhCC-CCceeeecceecc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFS  114 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~  114 (390)
                      ..+|++.+.||+|+||.||+|.++.+++.||||++....             ....+|+.+++++. ||||+++++++  
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--   93 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   93 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee--
Confidence            358999999999999999999999999999999985331             23347999999995 99999999988  


Q ss_pred             CCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEE
Q 016401          115 TTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  193 (390)
Q Consensus       115 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  193 (390)
                         ......++||||++ ++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+|
T Consensus        94 ---~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~k  164 (298)
T 1phk_A           94 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIK  164 (298)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEE
T ss_pred             ---ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCC-cEE
Confidence               33456889999998 588777754    3578999999999999999999998 9999999999999999888 799


Q ss_pred             EeecCCccccccCCCCcceeeccccccchhhc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016401          194 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  268 (390)
Q Consensus       194 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  268 (390)
                      |+|||++.............+|+.|+|||++.     ....++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99999998765555555667899999999985     2345789999999999999999999999888776666555442


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      .                 ...+        ......++..+.+||.+||..||++|||+.++|+||||++...
T Consensus       245 ~-----------------~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          245 N-----------------YQFG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             C-----------------CCCC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             C-----------------cccC--------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            1                 0000        0011357899999999999999999999999999999987643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.7e-48  Score=359.48  Aligned_cols=257  Identities=24%  Similarity=0.377  Sum_probs=199.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCC------
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD------  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------  117 (390)
                      ..+|++.+.||+|+||.||+|+++.+++.||||++...     .....+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            35899999999999999999999999999999998632     2345689999999999999999998754322      


Q ss_pred             ----------------------------------------------CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcH
Q 016401          118 ----------------------------------------------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPL  150 (390)
Q Consensus       118 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~  150 (390)
                                                                    ....++++||||+++ +|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                          223458899999986 88777764322 233556


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCC-------------CCcceeeccc
Q 016401          151 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------PNVSYICSRY  217 (390)
Q Consensus       151 ~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~t~~  217 (390)
                      ..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            6789999999999999998 9999999999999999888 79999999998664432             2234568999


Q ss_pred             cccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCc
Q 016401          218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW  297 (390)
Q Consensus       218 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (390)
                      |+|||++.+. .++.++|||||||++|+|++|..|+.     +....+..........                      
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPL----------------------  293 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCH----------------------
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCc----------------------
Confidence            9999999654 58999999999999999999876642     1111111111000000                      


Q ss_pred             ccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          298 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       298 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                         .....++++.+||.+||+.||++|||+.++|+||||+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               012357888999999999999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.2e-47  Score=348.69  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=208.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ....|++.+.||+|+||.||+|.+..++..||+|++....      ....+|+.+++.++||||+++++++.... .+..
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~  102 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK  102 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCc
Confidence            3457999999999999999999999999999999985432      23457999999999999999999875432 3456


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--cccccCCCCcEEEc-CCCCcEEEeec
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVN-PHTHQLKLCDF  197 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~-~~~~~vkl~Df  197 (390)
                      ++|+||||+++ +|..++..    ...+++..++.++.||+.||.|||+ .|  |+||||||+||+++ .++ .+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~-~~kl~Df  176 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDL  176 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCT
T ss_pred             eEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCC-CEEEeeC
Confidence            68899999975 88777754    3678999999999999999999998 88  99999999999998 455 7999999


Q ss_pred             CCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          198 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       198 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      |++.... ........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+................      
T Consensus       177 g~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  247 (290)
T 1t4h_A          177 GLATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------  247 (290)
T ss_dssp             TGGGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------
T ss_pred             CCccccc-ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC------
Confidence            9996443 233345678999999998853  4899999999999999999999999886655554433321000      


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                          ...++...++++.+||.+||..||++|||+.++++||||++
T Consensus       248 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 --------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             --------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             --------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                11123456889999999999999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.1e-48  Score=349.67  Aligned_cols=251  Identities=28%  Similarity=0.423  Sum_probs=201.8

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----P   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence            3458999999999999999999999999999999985432       234589999999999999999998833     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ...|+||||+++ +|.+++..    ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~  157 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGL  157 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred             CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCC-CEEEeeccc
Confidence            457899999974 88777754    3568999999999999999999998 8999999999999999888 799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +.............+|+.|+|||++.+....+.++||||||+++|+|++|..||.+.+..+....+...           
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------  226 (276)
T 2h6d_A          158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG-----------  226 (276)
T ss_dssp             GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-----------
Confidence            987655444455678999999999966554578999999999999999999999887765555444331           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                            ..            .++..++..+.+||.+||+.||++|||+.++++||||++
T Consensus       227 ------~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          227 ------VF------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             ------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ------cc------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence                  00            112457899999999999999999999999999999976

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.7e-48  Score=365.38  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=199.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCC--CCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...|++.+.||+|+||.||+|.+.. ++.||||++....      ....+|+.+++.+.  ||||+++++++..     .
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~  128 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D  128 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----C
Confidence            3469999999999999999999865 8999999985432      33458999999996  5999999998843     3


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .++|+|||+.+++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++. + .+||+|||++
T Consensus       129 ~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~-~~kl~DFG~a  201 (390)
T 2zmd_A          129 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGIA  201 (390)
T ss_dssp             SEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEESS-S-CEEECCCSSS
T ss_pred             CEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEEC-C-eEEEEecCcc
Confidence            45889999887888887764    3578889999999999999999998 99999999999999964 4 6999999999


Q ss_pred             cccccCCC---CcceeeccccccchhhcC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 016401          201 KVLVKGEP---NVSYICSRYYRAPELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEII  266 (390)
Q Consensus       201 ~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~  266 (390)
                      +.......   .....||+.|+|||++.+          ...++.++|||||||++|+|++|.+||.+.... ..+..+.
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence            86543322   234578999999999954          135889999999999999999999999875432 2333222


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      ..   .            ...            .++...+.++.+||.+||..||.+|||+.++|+||||+....
T Consensus       282 ~~---~------------~~~------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          282 DP---N------------HEI------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CT---T------------SCC------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             Cc---c------------ccC------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            10   0            000            122345789999999999999999999999999999986543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.9e-48  Score=356.28  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=197.8

Q ss_pred             cccEEEe-eeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ...|++. +.||+|+||.||+|.+..+++.||||++...    .....+|+.+++++ +||||+++++++..     ...
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence            3479995 7899999999999999999999999998543    23456899999885 79999999999843     345


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC--cEEEeecCC
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGS  199 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~Dfg~  199 (390)
                      +|+||||++ ++|..++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.  .+||+|||+
T Consensus        86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            889999998 588777754    3578999999999999999999998 89999999999999987652  399999999


Q ss_pred             ccccccCC--------CCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--------
Q 016401          200 AKVLVKGE--------PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--------  259 (390)
Q Consensus       200 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------  259 (390)
                      +.......        ......||+.|+|||++.+    ...++.++|||||||++|+|++|..||.+....        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            87543211        1223458999999999853    134789999999999999999999999875421        


Q ss_pred             ------H-HHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          260 ------D-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       260 ------~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                            . ....+...                 ...++        ......+++++++||++||..||++|||+.++|+
T Consensus       241 ~~~~~~~~~~~~i~~~-----------------~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          241 ACPACQNMLFESIQEG-----------------KYEFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCHHHHHHHHHHHHHC-----------------CCCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhHHHHHHHHHhcc-----------------CcccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                  1 11222110                 00010        0011357899999999999999999999999999


Q ss_pred             CCcccccC
Q 016401          333 HPFFDELR  340 (390)
Q Consensus       333 hp~f~~~~  340 (390)
                      ||||++..
T Consensus       296 hp~~~~~~  303 (316)
T 2ac3_A          296 HPWVQGCA  303 (316)
T ss_dssp             STTCC---
T ss_pred             ChhhcCCC
Confidence            99998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.4e-48  Score=358.87  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=207.2

Q ss_pred             ccEEEe-eeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCce
Q 016401           50 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ++|.+. +.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.+ .||||+++++++     ....
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~~  102 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS  102 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeCC
Confidence            478888 8999999999999999999999999998542      23456899999999 469999999998     3344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC---CCCcEEEeec
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDF  197 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~Df  197 (390)
                      ..|+||||+.+ +|..++..  .....+++..++.++.||+.||+|||+ .||+||||||+|||++.   ++ .+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~-~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLG-DIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence            58899999986 66444321  123668999999999999999999998 99999999999999987   45 7999999


Q ss_pred             CCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          198 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       198 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      |++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........    
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----  253 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS----  253 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----
T ss_pred             ccccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC----
Confidence            99987655555556678999999999954 4589999999999999999999999999887777666655311110    


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                                           ......+++.+.+||.+||+.||++|||++++|+||||+.+...
T Consensus       254 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          254 ---------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             ---------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             ---------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence                                 11114578999999999999999999999999999999987643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.3e-47  Score=347.51  Aligned_cols=251  Identities=27%  Similarity=0.462  Sum_probs=210.8

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++...       .....+|+++++.++||||+++++++.     ..
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   86 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DR   86 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cC
Confidence            345899999999999999999999999999999998532       234568999999999999999999983     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ...|+||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~  160 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKG-ELKIADFGW  160 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCC-CEEEecccc
Confidence            457899999975 88777654    3568999999999999999999998 9999999999999999888 799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +...... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+...           
T Consensus       161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------  227 (284)
T 2vgo_A          161 SVHAPSL-RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------  227 (284)
T ss_dssp             CEECSSS-CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred             cccCccc-ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-----------
Confidence            8654332 2345678999999999965 45899999999999999999999999887766655544321           


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                            ..            .++..++.++++||.+||..||.+|||+.++++||||+...
T Consensus       228 ------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          228 ------DL------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ------cc------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                  01            12245789999999999999999999999999999998753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.8e-47  Score=359.38  Aligned_cols=287  Identities=30%  Similarity=0.475  Sum_probs=220.2

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCC-----------CCceeeecceec
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFF  113 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~~  113 (390)
                      ...+|++.+.||+|+||.||+|++..+++.||||++..+.   ....+|+.++++++           |+||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            3458999999999999999999999999999999986543   33457999998886           899999999885


Q ss_pred             cCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CcccccCCCCcEEEcCCC---
Q 016401          114 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT---  189 (390)
Q Consensus       114 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~---  189 (390)
                      ... ....++++||||++++|..++....  ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.++   
T Consensus        97 ~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCCc
Confidence            432 2345688999999889988876532  3568999999999999999999998 8 999999999999995322   


Q ss_pred             --CcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHH
Q 016401          190 --HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQ  261 (390)
Q Consensus       190 --~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~  261 (390)
                        ..+||+|||++.....  ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+      ..+.
T Consensus       173 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             CcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence              2699999999976533  23445789999999999664 48999999999999999999999998654      4567


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccc-------cCCCCCCCCcc------cccccCCChhHHHHHHHhcccCCCcCCCHH
Q 016401          262 LVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWH------KVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  328 (390)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~  328 (390)
                      +..+.+.++.++...+.........+       ........+..      ..++...++++.+||.+||+.||++|||+.
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            78888888888776554322110000       00000000000      012234567899999999999999999999


Q ss_pred             HHhcCCcccccCC
Q 016401          329 EACVHPFFDELRD  341 (390)
Q Consensus       329 ~~l~hp~f~~~~~  341 (390)
                      ++|+||||++...
T Consensus       330 ell~hp~f~~~~~  342 (373)
T 1q8y_A          330 GLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHTCGGGTTCTT
T ss_pred             HHhhChhhhcccC
Confidence            9999999998543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=352.55  Aligned_cols=256  Identities=25%  Similarity=0.401  Sum_probs=210.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++...        .....+|+.+++.++||||+++++++..   .+..
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEKQ   81 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C---
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCCC
Confidence            4799999999999999999999999999999998543        2345689999999999999999998743   2233


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      ..|+||||+++++..++....  ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||++.
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGG-TLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCC-cEEeecccccc
Confidence            478999999988776665432  4579999999999999999999998 9999999999999999888 79999999997


Q ss_pred             ccccCC---CCcceeeccccccchhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          202 VLVKGE---PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       202 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ......   ......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+...         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---------  228 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG---------  228 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC---------
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC---------
Confidence            653221   123456799999999996532 2477999999999999999999999987766655554431         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                              ..            .++..+++.+.+||.+||..||++|||+.++++||||++...
T Consensus       229 --------~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          229 --------SY------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             --------CC------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             --------CC------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence                    01            122467899999999999999999999999999999988654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.5e-47  Score=355.45  Aligned_cols=280  Identities=26%  Similarity=0.478  Sum_probs=218.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEE-cCCCcEEEEEEeccch---hhHHHHHHHHHhCCCC------ceeeecceeccCCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKC-RETGEIVAIKKVLQDK---RYKNRELQIMQMLDHP------NIVALKHCFFSTTDKE  119 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~  119 (390)
                      .+|++.+.||+|+||.||+|.+ ..+++.||||++....   ....+|+.+++.++|+      +++++++++.     .
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-----~   88 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-----H   88 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----E
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----c
Confidence            4899999999999999999998 5678999999986543   3345799999888665      4899988873     3


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC------------
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP------------  187 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~------------  187 (390)
                      ..+.|+||||++++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.            
T Consensus        89 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           89 HGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccc
Confidence            34588999999989988776532  2368899999999999999999998 99999999999999986            


Q ss_pred             -------CCCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 016401          188 -------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  260 (390)
Q Consensus       188 -------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  260 (390)
                             ++ .+||+|||++....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+
T Consensus       166 ~~~~~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINP-DIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCC-CEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCC-CceEeeCcccccCc--cccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   34 69999999997543  23345678999999999965 458999999999999999999999999999888


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcc----cccCCCCC---------CCCcc--cccccCCChhHHHHHHHhcccCCCcCC
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYT----EFKFPQIK---------PHPWH--KVFQKRLPPEAVDLVCRFFQYSPNLRC  325 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~  325 (390)
                      .+..+....+..+...+........    ...+....         ..++.  .......++++.+||.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            8888888888777665544321100    00000000         00000  001123357899999999999999999


Q ss_pred             CHHHHhcCCcccccCC
Q 016401          326 TALEACVHPFFDELRD  341 (390)
Q Consensus       326 s~~~~l~hp~f~~~~~  341 (390)
                      |+.|+++||||+.++.
T Consensus       322 t~~ell~hp~f~~~~~  337 (339)
T 1z57_A          322 TLREALKHPFFDLLKK  337 (339)
T ss_dssp             CHHHHTTSGGGGGGGC
T ss_pred             CHHHHhcCHHHHHHhc
Confidence            9999999999998753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.3e-47  Score=350.93  Aligned_cols=253  Identities=28%  Similarity=0.452  Sum_probs=209.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|.+.+.||+|+||.||+|++..+|+.||+|++....    ....+|+.+++.++||||+++++++.     .....|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            358999999999999999999999999999999986432    33568999999999999999999883     344578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE---cCCCCcEEEeecCCc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA  200 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~Dfg~a  200 (390)
                      +||||+++ +|.+.+..    ...+++..+..++.|++.||+|||+ .||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~  156 (304)
T 2jam_A           83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENS-KIMITDFGLS  156 (304)
T ss_dssp             EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred             EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence            99999974 87766654    3578999999999999999999998 999999999999999   5555 7999999998


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....           
T Consensus       157 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-----------  223 (304)
T 2jam_A          157 KMEQN-GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY-----------  223 (304)
T ss_dssp             CCCCC-BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC-----------
T ss_pred             eecCC-CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            75432 23344568999999999854 458999999999999999999999999887766665554421           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                            +.        +...+...+++++.+||.+||..||++|||+.++|+||||+..
T Consensus       224 ------~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          224 ------YE--------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ------CC--------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ------CC--------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                  00        0111224679999999999999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.4e-48  Score=365.67  Aligned_cols=266  Identities=16%  Similarity=0.145  Sum_probs=189.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhC--CCCceeeecceec------
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML--DHPNIVALKHCFF------  113 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l--~h~~iv~~~~~~~------  113 (390)
                      ...|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.+  +||||++++..+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999999999999999986532       2234575444444  6999888654332      


Q ss_pred             -cCCC--------C----CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHH------HHHHHHHHHHHHHHHhcCCcc
Q 016401          114 -STTD--------K----EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV------KLYTYQICRALAYIHNCIGIC  174 (390)
Q Consensus       114 -~~~~--------~----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~------~~~~~ql~~al~~LH~~~~iv  174 (390)
                       ....        .    ....+|+||||++++|.+++.....   .+.+...      ..++.||+.||+|||+ +||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence             1100        0    1145789999999999988876532   3344444      5666999999999998 9999


Q ss_pred             cccCCCCcEEEcCCCCcEEEeecCCccccccCCCCcceeeccccccchhhcC-CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 016401          175 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLF  253 (390)
Q Consensus       175 H~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf  253 (390)
                      ||||||+|||++.++ .+||+|||+++...  .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||
T Consensus       217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999988 79999999998552  22224567799999999954 145899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          254 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .+......                    ..+............+.......+++++.+||.+||+.||++|||+.++|+|
T Consensus       294 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGIK--------------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTCT--------------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCcccc--------------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            87642100                    0000000011111111111224789999999999999999999999999999


Q ss_pred             CcccccCC
Q 016401          334 PFFDELRD  341 (390)
Q Consensus       334 p~f~~~~~  341 (390)
                      |||+++.+
T Consensus       354 p~f~~~~~  361 (371)
T 3q60_A          354 PEFLQLQN  361 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-49  Score=376.76  Aligned_cols=254  Identities=18%  Similarity=0.238  Sum_probs=194.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHH---HHHhCCCCceeeecceeccCC--
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQ---IMQMLDHPNIVALKHCFFSTT--  116 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~---~l~~l~h~~iv~~~~~~~~~~--  116 (390)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...       .....+|+.   +++.++||||+++++.+....  
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46899999999999999999999999999999998532       134457984   455558999999985442111  


Q ss_pred             --------------CCCce---EEEEEEecccccHHHHHHHhhhhcC---CCcHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 016401          117 --------------DKEEL---YLNLVLEYVPETVNRIARNYSRIHQ---RMPLIYVKLYTYQICRALAYIHNCIGICHR  176 (390)
Q Consensus       117 --------------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~~---~~~~~~~~~~~~ql~~al~~LH~~~~ivH~  176 (390)
                                    +....   ..|+||||++|+|.+++........   .+++..+..++.||+.||+|||+ .||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence                          11111   2679999999999988876433221   23457788899999999999998 999999


Q ss_pred             cCCCCcEEEcCCCCcEEEeecCCccccccCCCCcceeeccccccchhhcCC----------CCCCCchhHHHHHHHHHHH
Q 016401          177 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAEL  246 (390)
Q Consensus       177 Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el  246 (390)
                      ||||+|||++.++ .+||+|||+++..  ........| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999888 7999999999753  223344566 999999999654          2589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC
Q 016401          247 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  326 (390)
Q Consensus       247 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s  326 (390)
                      ++|+.||.+.+..+....+.                                 .....+++++.+||.+||..||++|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            99999997654211111000                                 011467999999999999999999999


Q ss_pred             HHHHhcCCcccccC
Q 016401          327 ALEACVHPFFDELR  340 (390)
Q Consensus       327 ~~~~l~hp~f~~~~  340 (390)
                      +.++++||||+.++
T Consensus       354 ~~e~l~hp~f~~~~  367 (377)
T 3byv_A          354 PLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHTSHHHHHHH
T ss_pred             HHHHhhChHHHHHH
Confidence            99999999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.2e-48  Score=350.23  Aligned_cols=252  Identities=21%  Similarity=0.265  Sum_probs=203.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++...      .....+|+..+..+ +||||+++++++..     .
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----D   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----T
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----C
Confidence            346899999999999999999999999999999998642      23344788888888 99999999998843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC----------
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----------  189 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----------  189 (390)
                      ...++||||+++ +|.+++.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++          
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence            458899999975 9998888766556789999999999999999999998 9999999999999998432          


Q ss_pred             --------CcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 016401          190 --------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  261 (390)
Q Consensus       190 --------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  261 (390)
                              ..+||+|||.+......   ....+|+.|+|||++.+...++.++|||||||++|+|++|.+++.....   
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             cccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                    26999999999765432   2345899999999997665677899999999999999999988755432   


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      ...+...                   ..         ..++..+++++.+||.+||..||++|||+.++++||||+..
T Consensus       237 ~~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 WHEIRQG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHTT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHcC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            2222110                   00         11234689999999999999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1e-47  Score=356.26  Aligned_cols=256  Identities=30%  Similarity=0.458  Sum_probs=204.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHhCCCCceeeecceeccCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            358999999999999999999999999999999985432            235689999999999999999998732  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC--cEE
Q 016401          117 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLK  193 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--~vk  193 (390)
                         .. .|+||||+++ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+|
T Consensus        87 ---~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           87 ---ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ---SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred             ---Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence               12 6799999975 77655532    4679999999999999999999998 99999999999999986542  499


Q ss_pred             EeecCCccccccCCCCcceeeccccccchhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016401          194 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       194 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      |+|||++.............||+.|+|||++.  +...++.++|||||||++|+|++|..||........+...+.....
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            99999998654433334456899999999974  3455899999999999999999999999876543333333222111


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      ..                        .......+++++.+||.+||..||++|||+.++|+||||++.
T Consensus       238 ~~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             cc------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            00                        001124578999999999999999999999999999999763

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=357.32  Aligned_cols=253  Identities=25%  Similarity=0.346  Sum_probs=199.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCC--CceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+|++.+.||+|+||.||+|.+ .+++.||||++....      ....+|+.+++.++|  +||+++++++.     ..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence            34899999999999999999998 468999999985432      334579999999987  99999999883     34


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          121 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       121 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .++|+|||+.+++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++ ++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~-~~kl~DFG~a  154 (343)
T 3dbq_A           82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIA  154 (343)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TT-EEEECCCSSS
T ss_pred             CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CC-cEEEeecccc
Confidence            46889999888898887764    4678999999999999999999998 9999999999999998 44 6999999999


Q ss_pred             cccccCCC---CcceeeccccccchhhcC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 016401          201 KVLVKGEP---NVSYICSRYYRAPELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEII  266 (390)
Q Consensus       201 ~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~  266 (390)
                      +.......   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||.+.... ..+..+.
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  234 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  234 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence            76543322   234578999999999853          245889999999999999999999999765432 2222221


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      .   .                        .....++...+.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       235 ~---~------------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          235 D---P------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             C---T------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             c---C------------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            1   0                        0011122456789999999999999999999999999999986433

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=348.03  Aligned_cols=250  Identities=28%  Similarity=0.465  Sum_probs=184.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++.     ....
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   85 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSNY   85 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSSE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCCe
Confidence            47999999999999999999999999999999985432       34568999999999999999999983     3445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .|+||||+++ +|..++..   ....+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus        86 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~  160 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNM-NIKIADFGLAT  160 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEEeeccee
Confidence            8899999975 77666653   23568999999999999999999998 9999999999999999888 79999999997


Q ss_pred             ccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+..             
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------  226 (278)
T 3cok_A          161 QLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-------------  226 (278)
T ss_dssp             ECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-------------
T ss_pred             eccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-------------
Confidence            65432 22334578999999999854 4589999999999999999999999987654332221100             


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                          ..+            ..+..++.++.+||.+||..||++|||+.++++||||...
T Consensus       227 ----~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          227 ----ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             ----SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             ----ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence                000            1224578999999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-47  Score=354.20  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=207.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .++|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            358999999999999999999999999999999986432       23457999999999999999999875433 2234


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      +.|+||||++ ++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence            5689999997 588777754    3579999999999999999999998 9999999999999999888 7999999999


Q ss_pred             cccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          201 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       201 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ........    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+.   
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---  239 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---  239 (311)
T ss_dssp             ------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---
Confidence            76543321    2335689999999999654 589999999999999999999999998887776665554211110   


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                                            ......+++++.+||.+||..||++||++.+++.|+|++....
T Consensus       240 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          240 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ----------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ----------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                                  1112458999999999999999999999999999999987543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-48  Score=359.31  Aligned_cols=277  Identities=20%  Similarity=0.295  Sum_probs=208.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+++++.++||||+++++++...   .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            358999999999999999999999999999999986422     3345899999999999999999987432   23347


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE----cCCCCcEEEeecC
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFG  198 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~~vkl~Dfg  198 (390)
                      |+||||++ ++|..++..... ...+++..++.++.||+.||+|||+ .||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence            89999997 588777765322 2348999999999999999999998 999999999999998    6555 69999999


Q ss_pred             CccccccCCCCcceeeccccccchhhcC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH
Q 016401          199 SAKVLVKGEPNVSYICSRYYRAPELIFG-------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIK  267 (390)
Q Consensus       199 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~  267 (390)
                      +++............||+.|+|||++..       ...++.++|||||||++|+|++|..||.....    .+.+.++..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            9987766655566779999999999852       35589999999999999999999999975432    333444433


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCc
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  335 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~  335 (390)
                      .........+.......  +.+..  ..+....+...++..+.+||++||++||++|||++|+|+||-
T Consensus       242 ~~p~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGP--IDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCC--EEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCc--cccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            21110000000000000  00000  000111222345678999999999999999999999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6.7e-47  Score=344.99  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=210.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++...      .....+|++++++++||||+++++++.     .....
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   96 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSSF   96 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCeE
Confidence            4899999999999999999999999999999998532      234568999999999999999999883     33457


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEEEeecCCc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSA  200 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~a  200 (390)
                      |+||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++  ..+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            899999974 77666543    3578999999999999999999998 9999999999999997643  26999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .............+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+....           
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  238 (287)
T 2wei_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK-----------  238 (287)
T ss_dssp             GTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             eeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            87655544455678999999999854  38999999999999999999999999887766655544310           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                            +..+        ......+++++.+||++||..||++|||+.++|+||||++..+
T Consensus       239 ------~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          239 ------YAFD--------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             ------CCCC--------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             ------CCCC--------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                  0000        0011357899999999999999999999999999999998653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4e-47  Score=344.21  Aligned_cols=254  Identities=27%  Similarity=0.337  Sum_probs=204.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++.     .....|
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   81 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY   81 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEEE
Confidence            47999999999999999999999999999999985432     34568999999999999999999884     334578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|.+.+.    ....+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~  155 (276)
T 2yex_A           82 LFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  155 (276)
T ss_dssp             EEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCC-CEEEeeCCCcccc
Confidence            99999985 6654442    24568999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             ccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....   ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.............          
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  225 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------  225 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC----------
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc----------
Confidence            3322   223456899999999996655457899999999999999999999987654322221111000          


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                            ...     .     ....+++.+.+||.+||..||++|||+.++++||||++..
T Consensus       226 ------~~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          226 ------TYL-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             ------TTS-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             ------ccc-----C-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                  000     0     0135789999999999999999999999999999998753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.6e-47  Score=354.98  Aligned_cols=280  Identities=26%  Similarity=0.444  Sum_probs=217.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCC-cEEEEEEeccch---hhHHHHHHHHHhCCCCc------eeeecceeccCCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK---RYKNRELQIMQMLDHPN------IVALKHCFFSTTDKE  119 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~~  119 (390)
                      .+|++.+.||+|+||+||+|.+..++ +.||||++....   ....+|+.+++.++|++      ++.+++++.     .
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-----~   93 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-----F   93 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-----E
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-----e
Confidence            48999999999999999999998776 689999986532   33457999999987665      788877773     3


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE--------------
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV--------------  185 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll--------------  185 (390)
                      ....|+||||+++++...+....  ...+++..++.++.||+.||+|||+ +||+||||||+|||+              
T Consensus        94 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           94 HGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence            34588999999988877665421  2468999999999999999999998 999999999999999              


Q ss_pred             -----cCCCCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 016401          186 -----NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  260 (390)
Q Consensus       186 -----~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  260 (390)
                           +.++ .+||+|||++....  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus       171 ~~~~~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNT-SIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCC-CEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCC-cEEEeecCcccccc--ccccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 4455 79999999997543  233456789999999999654 58999999999999999999999999999888


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccc----cCCCCC---------CCCcc--cccccCCChhHHHHHHHhcccCCCcCC
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQIK---------PHPWH--KVFQKRLPPEAVDLVCRFFQYSPNLRC  325 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~  325 (390)
                      .+..+.+..+..+...+.........+    ..+...         ..++.  .......+.++.+||++||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            888888888887776654432110000    000000         00000  000112346899999999999999999


Q ss_pred             CHHHHhcCCcccccCC
Q 016401          326 TALEACVHPFFDELRD  341 (390)
Q Consensus       326 s~~~~l~hp~f~~~~~  341 (390)
                      |+.++|+||||+++..
T Consensus       327 t~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CHHHHTTSGGGGGCCH
T ss_pred             CHHHHhcChhhcCCCh
Confidence            9999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.9e-47  Score=359.86  Aligned_cols=282  Identities=24%  Similarity=0.398  Sum_probs=208.3

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++..+     .....+|+.+++.++||||+++++++..     ..
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~  104 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG  104 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TT
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CC
Confidence            3456899999999999999999999999999999998643     2334589999999999999999998843     34


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..|+||||+++ +|..++..    ...+++..+..++.|++.||.|||+ . ||+||||||+|||++.++ .+||+|||+
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  178 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG-EIKLCDFGV  178 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTC-CEEECCCCC
T ss_pred             EEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCC-CEEEEECCC
Confidence            48899999975 88777764    3578999999999999999999997 6 999999999999999888 799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh-
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-  278 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-  278 (390)
                      +...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+............. 
T Consensus       179 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          179 SGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             CHHHHHH-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             Ccccccc-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            8754332 2344578999999999965 458999999999999999999999998877554432221111000000000 


Q ss_pred             --hcCcCcccccCCCC------------CCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          279 --CMNPNYTEFKFPQI------------KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       279 --~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                        ........+.....            ............++.++.+||++||.+||++|||+.++|+||||+....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence              00000000000000            0000011112347889999999999999999999999999999987643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.8e-47  Score=342.29  Aligned_cols=258  Identities=25%  Similarity=0.397  Sum_probs=211.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...+|++.+.||+|+||.||+|.++.+++.||+|++...      .....+|+.+++.++||||+++++++..   ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCc
Confidence            345899999999999999999999999999999998542      2334579999999999999999997743   2234


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-----cccccCCCCcEEEcCCCCcEEEe
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLC  195 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~-----ivH~Dlkp~NIll~~~~~~vkl~  195 (390)
                      ..|+||||+++ +|.+++.........+++..++.++.|++.||+|||+ .|     |+||||||+||+++.++ .+||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~  158 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLG  158 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSS-CEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCC-CEEEe
Confidence            57899999975 8988887765555669999999999999999999998 88     99999999999999888 79999


Q ss_pred             ecCCccccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          196 DFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       196 Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      |||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....     
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-----  232 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-----  232 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----
T ss_pred             cCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-----
Confidence            9999976533221 1234679999999999654 48999999999999999999999998887655555444310     


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                    .         ..++..+++++.+||.+||..||++|||+.++++|+|+.+-
T Consensus       233 --------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          233 --------------F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             --------------C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             --------------c---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                          0         01224578999999999999999999999999999999764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=347.22  Aligned_cols=261  Identities=23%  Similarity=0.366  Sum_probs=206.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhC-CCCceeeecceeccCCC-CCceE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      ...+|++.+.||+|+||.||+|++..+++.||||++...   .....+|+.+++.+ .||||+++++++..... .....
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            345899999999999999999999999999999998543   34556899999998 89999999999865332 12456


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||||+++ +|.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~  177 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCTTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCC-CEEEeeCcCce
Confidence            7899999985 8888776532  3578999999999999999999998 9999999999999999888 79999999987


Q ss_pred             ccccCC-CCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          202 VLVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       202 ~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ...... ......+|+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+..+.+..+....       
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------  250 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-------  250 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------
Confidence            653322 2344578999999999852    3458899999999999999999999998877666554443310       


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                  .        .......+++.+.+||.+||..||++|||+.++++||||++.
T Consensus       251 ------------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          251 ------------A--------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ------------C--------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ------------c--------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                        0        001124578999999999999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-46  Score=344.58  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=206.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++...    .....+|+.+++.++||||+++++++...     ...
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeE
Confidence            345899999999999999999999999999999988543    23455799999999999999999988432     347


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ++||||+++ +|..++..   ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus        92 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  166 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEG-DIRLADFGVSAK  166 (302)
T ss_dssp             EEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTS-CEEECCCHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCC-CEEEEECCCCcc
Confidence            899999985 66665543   24679999999999999999999998 9999999999999999888 799999998754


Q ss_pred             cccC-CCCcceeeccccccchhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          203 LVKG-EPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       203 ~~~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      .... .......+|+.|+|||++.    ....++.++|||||||++|+|++|..||...+..+.+..+....  +     
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-----  239 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--P-----  239 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C-----
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--C-----
Confidence            3211 1223457899999999984    34558999999999999999999999999887766655554310  0     


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                  +       ....+..++.++.+||.+||..||++|||+.++++||||+.+.
T Consensus       240 ------------~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          240 ------------P-------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             ------------C-------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             ------------c-------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                        0       0011245789999999999999999999999999999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.4e-46  Score=343.96  Aligned_cols=249  Identities=25%  Similarity=0.384  Sum_probs=208.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..|++.+.||+|+||.||+|.+..+++.||||++...     .....+|+.+++.++||||+++++++..     ....|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence            4799999999999999999999999999999998543     2445689999999999999999998843     33578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|..++.     ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQL  169 (303)
T ss_dssp             EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCC-CEEEeecccceec
Confidence            99999985 7766654     3579999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             ccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+...  .           
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-----------  235 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--N-----------  235 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--C-----------
T ss_pred             CccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--C-----------
Confidence            4332 2344578999999999955 45899999999999999999999999887765555443321  0           


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                     ...++..++..+.+||.+||..||++|||+.++++||||...
T Consensus       236 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          236 ---------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ---------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ---------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                           001224678999999999999999999999999999999764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=343.76  Aligned_cols=256  Identities=29%  Similarity=0.429  Sum_probs=205.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++....  ....+|+.+++.++||||+++++++..     ....|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEE
Confidence            4458999999999999999999999999999999986543  445689999999999999999998843     334789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+++ +|.+++..   ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus       102 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~  176 (314)
T 3com_A          102 VMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLT  176 (314)
T ss_dssp             EEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECB
T ss_pred             EeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCC-CEEEeecccchhhh
Confidence            9999986 88777653   24679999999999999999999998 9999999999999999888 79999999997654


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....  +           
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-----------  242 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--P-----------  242 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C-----------
T ss_pred             hhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--C-----------
Confidence            332 2344578999999999955 458999999999999999999999998877655544332210  0           


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                            +       ....+..+++.+.+||.+||..||++|||+.++++||||+...
T Consensus       243 ------~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          243 ------P-------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             ------C-------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             ------c-------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                  0       0011245789999999999999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-46  Score=343.53  Aligned_cols=256  Identities=27%  Similarity=0.393  Sum_probs=203.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++     ....
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            34799999999999999999999999999999988432       13345799999999999999999988     3445


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..|+||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  158 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIA  158 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCSSS
T ss_pred             eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEEeCCCc
Confidence            58899999985 88777754    3579999999999999999999998 9999999999999999888 7999999999


Q ss_pred             cccccCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          201 KVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       201 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      .......  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...+.... ..+      
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~------  230 (294)
T 4eqm_A          159 KALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD-SVP------  230 (294)
T ss_dssp             TTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS-CCC------
T ss_pred             cccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-cCC------
Confidence            7654332  22345689999999999654 4899999999999999999999999988766555443321 000      


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                       .....++..+++.+.++|.+||..||++||+..+.+.+.|..-+.
T Consensus       231 -----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          231 -----------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             -----------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             -----------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                             011112356899999999999999999999777777777765443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.7e-47  Score=349.00  Aligned_cols=267  Identities=25%  Similarity=0.382  Sum_probs=191.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...     .....+|+.+++.++||||+++++++....     ..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   88 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----EL   88 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----CE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----Cc
Confidence            34899999999999999999999889999999988543     223457999999999999999999885432     37


Q ss_pred             EEEEeccc-ccHHHHHHHhhhh----cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          124 NLVLEYVP-ETVNRIARNYSRI----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ++||||++ ++|.+++......    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg  166 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDG-SVQIADFG  166 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCC-CEEEEecc
Confidence            89999996 5888877654322    3458999999999999999999998 9999999999999999888 79999999


Q ss_pred             CccccccCC------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016401          199 SAKVLVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       199 ~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      ++.......      ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+........  .+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~  244 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--DP  244 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--SC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--CC
Confidence            987553321      1234568999999999865445899999999999999999999999887765544333221  00


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      .                 ..............+++++.+||.+||..||.+|||+.++++||||+..+.
T Consensus       245 ~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          245 P-----------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             C-----------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             C-----------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            0                 000000011122467899999999999999999999999999999988653

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=344.53  Aligned_cols=256  Identities=23%  Similarity=0.369  Sum_probs=189.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh------hHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||.||+|.++.+++.||||++.....      ...++..+++.++||||+++++++..     ...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CCc
Confidence            3589999999999999999999999999999999864321      12234557888899999999999843     345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .|+||||+++.+..+...   ....+++..++.++.||+.||.|||+ . ||+||||||+||+++.++ .+||+|||++.
T Consensus        99 ~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~  173 (318)
T 2dyl_A           99 VFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERG-QIKLCDFGISG  173 (318)
T ss_dssp             EEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTS-CEEECCCTTC-
T ss_pred             EEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCC-CEEEEECCCch
Confidence            889999997666554432   24679999999999999999999997 6 999999999999999888 79999999997


Q ss_pred             ccccCCCCcceeeccccccchhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHH
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~  276 (390)
                      ............+|+.|+|||++.    ....++.++|||||||++|+|++|..||.... ..+.+..+....  +.   
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~---  248 (318)
T 2dyl_A          174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PP---  248 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CC---
T ss_pred             hccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CC---
Confidence            665554455567899999999995    23458899999999999999999999998743 334444443310  00   


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                 ..+          ....+++++.+||.+||..||.+|||+.++++||||+...
T Consensus       249 -----------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 -----------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             -----------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             -----------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                       000          0135789999999999999999999999999999998754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.3e-46  Score=339.42  Aligned_cols=258  Identities=23%  Similarity=0.340  Sum_probs=198.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCC--------
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTD--------  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--------  117 (390)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            357999999999999999999999999999999986543   334579999999999999999998754321        


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      ......|+||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCC-CEEEee
Confidence            235668899999975 888877642   3457788899999999999999998 9999999999999999888 799999


Q ss_pred             cCCccccccC---------------CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 016401          197 FGSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  261 (390)
Q Consensus       197 fg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  261 (390)
                      ||++......               .......+|+.|+|||++.+...++.++|||||||++|+|++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765321               122345689999999999765568999999999999999998   5543222222


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      ....+...                ...        +...++...++.+++||++||+.||.+|||+.++++||||+.
T Consensus       237 ~~~~~~~~----------------~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          237 ILKKLRSV----------------SIE--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHST----------------TCC--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHhcccc----------------ccc--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            21111100                000        111133456788999999999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-46  Score=350.31  Aligned_cols=264  Identities=24%  Similarity=0.357  Sum_probs=184.7

Q ss_pred             cccEEEee-eeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           49 KVSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        49 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ..+|.+.+ .||+|+||.||+|.++.+++.||||++........+....++.++||||+++++++.... ....++++||
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~  105 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLIIM  105 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEEE
Confidence            35799965 699999999999999999999999999776555555556678889999999999884422 3356688999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEEEeecCCccccc
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLV  204 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~a~~~~  204 (390)
                      ||+++ +|..++...  ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++  ..+||+|||++....
T Consensus       106 e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~  182 (336)
T 3fhr_A          106 ECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT  182 (336)
T ss_dssp             ECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred             eccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence            99986 887777642  22469999999999999999999998 9999999999999997542  259999999997553


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      . .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.............+..             
T Consensus       183 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  247 (336)
T 3fhr_A          183 Q-NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-------------  247 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred             c-cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-------------
Confidence            3 23345677999999999854 45889999999999999999999999776543322111111000             


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                      .....+        ......+++++++||++||..||++|||+.++|+||||+..
T Consensus       248 ~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ---CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            000000        01114579999999999999999999999999999999863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.4e-46  Score=350.99  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=200.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc-------CCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceecc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS  114 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~  114 (390)
                      ...+|++.+.||+|+||.||+|++.       .++..||||++....     ....+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4468999999999999999999974       345679999986432     2345799999999 89999999999843


Q ss_pred             CCCCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCC
Q 016401          115 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  181 (390)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~  181 (390)
                           ...+|+||||+++ +|.+++.....            ....+++..+..++.||+.||+|||+ +||+||||||+
T Consensus       159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~  232 (370)
T 2psq_A          159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR  232 (370)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred             -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence                 3337899999985 88888775321            12458899999999999999999998 99999999999


Q ss_pred             cEEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 016401          182 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  257 (390)
Q Consensus       182 NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  257 (390)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+
T Consensus       233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999888 799999999986543321   2334567889999999654 58999999999999999999 999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          258 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ..+....+....                            ....+..+++++.+||.+||..||++|||+.+++++
T Consensus       311 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          311 VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGGHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            655544333210                            001224678999999999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.9e-46  Score=345.61  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=186.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHH-HHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||.||+|.++.+++.||||++....     ....+|.. +++.++||||+++++++..     ...
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence            358999999999999999999999999999999986432     12223444 6777899999999999843     345


Q ss_pred             EEEEEecccccHHHHHHHhhh-hcCCCcHHHHHHHHHHHHHHHHHHHhcC-CcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          123 LNLVLEYVPETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .++||||+++++..++..... ....+++..+..++.|++.||.|||+ . ||+||||||+||+++.++ .+||+|||++
T Consensus        96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  173 (327)
T 3aln_A           96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSG-NIKLCDFGIS  173 (327)
T ss_dssp             EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred             eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence            789999999988777764332 35678999999999999999999998 8 999999999999999888 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhhc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHH
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  276 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~  276 (390)
                      .............||+.|+|||++.   ....++.++|||||||++|+|++|..||.+.+.. +.+..+.          
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----------  243 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV----------  243 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC----------
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh----------
Confidence            8765544444557899999999983   2345899999999999999999999999764321 1110000          


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                               ...     ...+.......+++++.+||.+||..||++|||+.++++||||....
T Consensus       244 ---------~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          244 ---------KGD-----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             ---------CSC-----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ---------cCC-----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                     000     00111112246799999999999999999999999999999998754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.2e-47  Score=350.65  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=204.6

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHhCC--CCceeeeccee
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCF  112 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~  112 (390)
                      ......+|++.+.||+|+||.||+|.+..+++.||||++....          ....+|+.++++++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            3344568999999999999999999999999999999985432          23457999999996  59999999998


Q ss_pred             ccCCCCCceEEEEEEeccc--ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC
Q 016401          113 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  190 (390)
Q Consensus       113 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  190 (390)
                      .     .....++|||++.  ++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.+..
T Consensus       118 ~-----~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~  187 (320)
T 3a99_A          118 E-----RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRG  187 (320)
T ss_dssp             E-----CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTT
T ss_pred             e-----cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCC
Confidence            3     3345789999997  678777654    3678999999999999999999998 99999999999999994333


Q ss_pred             cEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016401          191 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  270 (390)
Q Consensus       191 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  270 (390)
                      .+||+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+      .+...  
T Consensus       188 ~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~--  258 (320)
T 3a99_A          188 ELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--  258 (320)
T ss_dssp             EEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--
T ss_pred             CEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc--
Confidence            8999999999765432 33456789999999999765545789999999999999999999996532      11110  


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                                     .            ..++..+++++.+||.+||..||++|||+.++++||||++...
T Consensus       259 ---------------~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          259 ---------------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             ---------------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             ---------------c------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                           0            0122468999999999999999999999999999999987643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-46  Score=350.62  Aligned_cols=273  Identities=20%  Similarity=0.323  Sum_probs=205.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---------------------hhHHHHHHHHHhCCCCceee
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------------RYKNRELQIMQMLDHPNIVA  107 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~E~~~l~~l~h~~iv~  107 (390)
                      ..+|++.+.||+|+||.||+|.+  +++.||||++....                     ....+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            35899999999999999999998  89999999985321                     45678999999999999999


Q ss_pred             ecceeccCCCCCceEEEEEEecccc-cHHHHHHH----hhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          108 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARN----YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       108 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                      +++++..     ....|+||||+++ +|.+++..    .......+++..++.++.||+.||+|||+..||+||||||+|
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999843     3458899999986 66544111    011146789999999999999999999952699999999999


Q ss_pred             EEEcCCCCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 016401          183 LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESG-VD  260 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~-~~  260 (390)
                      |+++.++ .+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|..||.+.+. .+
T Consensus       183 il~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          183 ILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9999888 7999999999765333 3345678999999999976534666 99999999999999999999988776 44


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ....+.......+        .....+..+ .. ..........+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       261 ~~~~i~~~~~~~~--------~~~~~~~~~-~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          261 LFNNIRTKNIEYP--------LDRNHFLYP-LT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHTSCCCCCC--------CSSSSSTTT-TC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHhccCcCCc--------cchhhhhcc-cc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            4333322100000        000000000 00 0001112256899999999999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1e-45  Score=343.98  Aligned_cols=247  Identities=19%  Similarity=0.208  Sum_probs=199.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.+ +||||+++++++..     ..+.|+|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEE
Confidence            4799999999999999999999999999999988543  34567899999999 99999999998843     3457899


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCc-----EEEeecCCcc
Q 016401          127 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSAK  201 (390)
Q Consensus       127 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~-----vkl~Dfg~a~  201 (390)
                      |||++++|.+++...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .     +||+|||+++
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           84 LELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCE
T ss_pred             EEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCC-CCCCceEEEEEcccce
Confidence            999988998887653   4679999999999999999999998 9999999999999998776 4     9999999998


Q ss_pred             ccccCCC--------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 016401          202 VLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG  270 (390)
Q Consensus       202 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~  270 (390)
                      .......        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.   .+.+..+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            6544322        245678999999999965 4589999999999999999999999987543   233333332211


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ..+.+                        .....++ ++.+||.+||..||.+||++.++++
T Consensus       238 ~~~~~------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ATPIE------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HSCHH------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCHH------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11111                        0112344 9999999999999999999988765

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.5e-45  Score=338.09  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=195.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...+|++.+.||+|+||.||+|++  +++.||||++....      ....+|++++++++||||+++++++..     ..
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PP  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TT
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence            345899999999999999999987  58899999985432      234579999999999999999999843     23


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--cccccCCCCcEEEcCCCCcEEEeecC
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      .+++||||+++ +|..++..... ...+++..+..++.||+.||+|||+ .|  |+||||||+|||++.++ .+||+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg  184 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKY-TVKVCDFG  184 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTC-CEEECCCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCC-cEEECCCC
Confidence            37799999985 88777764221 2248999999999999999999998 89  99999999999999888 79999999


Q ss_pred             CccccccCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          199 SAKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       199 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      +++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....       
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------  256 (309)
T 3p86_A          185 LSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-------  256 (309)
T ss_dssp             -----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-------
T ss_pred             CCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Confidence            997543322 2345678999999999965 4589999999999999999999999998876665554432110       


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc--CCcccc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  338 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~--hp~f~~  338 (390)
                                          ...++..+++++.+||++||..||++|||+.++++  +++++.
T Consensus       257 --------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 --------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             --------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                01123568999999999999999999999999986  555543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-46  Score=350.84  Aligned_cols=257  Identities=19%  Similarity=0.220  Sum_probs=205.1

Q ss_pred             cccccEEEeeeeeecCceEEEEEE-----EcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      ....+|++.+.||+|+||.||+|.     +..+++.||||++...     .....+|+.+++.++||||+++++++..  
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--  145 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--  145 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence            345689999999999999999999     4557889999998532     2234579999999999999999999843  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhh---cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--C
Q 016401          117 DKEELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--H  190 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~  190 (390)
                         ....|+||||+. ++|..++......   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++  .
T Consensus       146 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          146 ---SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTC
T ss_pred             ---CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCc
Confidence               223679999996 4888888764321   2458899999999999999999998 9999999999999998543  2


Q ss_pred             cEEEeecCCccccccC---CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 016401          191 QLKLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  266 (390)
Q Consensus       191 ~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~  266 (390)
                      .+||+|||+++.....   .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+.
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            5999999999754322   223345678899999999654 48999999999999999998 999999887766655544


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      ....                            ...+..+++.+.+||.+||+.||++|||+.++++|.++..
T Consensus       301 ~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 SGGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCC----------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            3110                            0112467899999999999999999999999999988754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=344.18  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=185.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCC-CCceeeecceeccCC---CCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLD-HPNIVALKHCFFSTT---DKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~---~~~~~  121 (390)
                      .+|++.+.||+|+||.||+|++..+++.||||++....    ....+|+.+++++. ||||+++++++....   .....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            38999999999999999999999999999999884432    33457999999995 999999999874322   24556


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--cccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          122 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       122 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      .++++|||++|+|.+++..... ...+++..++.++.||+.||+|||+ .|  |+||||||+|||++.++ .+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            6889999999999887765432 4569999999999999999999998 89  99999999999999888 799999999


Q ss_pred             ccccccCCCC-------------cceeeccccccchhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 016401          200 AKVLVKGEPN-------------VSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  264 (390)
Q Consensus       200 a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  264 (390)
                      +.........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|..||.+.........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            9765432211             1445899999999983  334578999999999999999999999976543221110


Q ss_pred             HHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCc
Q 016401          265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  335 (390)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~  335 (390)
                      .                     ...          ......+..+.+||++||+.||++|||+.++++|-+
T Consensus       265 ~---------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          265 K---------------------YSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ----------------------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             c---------------------ccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            0                     000          011346788999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=338.31  Aligned_cols=248  Identities=25%  Similarity=0.484  Sum_probs=201.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|++...    .....+|+++++.++||||+++++++..     ....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence            45899999999999999999999999999999988542    2344589999999999999999999843     34478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|.+++...   ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  158 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENK-NVVVADFGLARLM  158 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence            99999975 887777642   4679999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             ccCCCC---------------cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-----HH
Q 016401          204 VKGEPN---------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-----LV  263 (390)
Q Consensus       204 ~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~  263 (390)
                      ......               ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........     ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~  237 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR  237 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence            332221               14578999999999955 5589999999999999999999999875332110     00


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ...                               ....+..+++.+.+||.+||+.||++|||+.++++  |++.++
T Consensus       238 ~~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          238 GFL-------------------------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             HHH-------------------------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             ccc-------------------------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence            000                               11123568899999999999999999999999986  776654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.6e-45  Score=332.90  Aligned_cols=249  Identities=19%  Similarity=0.193  Sum_probs=202.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|+||.||+|.+..+++.||||++...  .....+|+.+++.+ .|+|++++++++     ......++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~lv   84 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV   84 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeEEE
Confidence            4799999999999999999999999999999988543  34567899999999 799999999887     334457899


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC----cEEEeecCCccc
Q 016401          127 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH----QLKLCDFGSAKV  202 (390)
Q Consensus       127 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~----~vkl~Dfg~a~~  202 (390)
                      |||++++|.+++...   ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.    .+||+|||++..
T Consensus        85 ~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999988998887653   3469999999999999999999998 99999999999999986652    399999999986


Q ss_pred             cccCCC--------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCC
Q 016401          203 LVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGT  271 (390)
Q Consensus       203 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~  271 (390)
                      ......        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+   ..+.+..+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            544322        244568999999999955 458999999999999999999999998743   33333333332111


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      +...                        .+...+++++.+||.+||..||++|||+.++++
T Consensus       240 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1111                        112467999999999999999999999998875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=335.36  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=199.1

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      |....+||+|+||.||+|.+..+++.||||.+....    ....+|+.+++.++||||+++++++..     ....++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEE
Confidence            333449999999999999999999999999985432    335689999999999999999998833     34578999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC-CCCcEEEeecCCcccccc
Q 016401          128 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       128 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~Dfg~a~~~~~  205 (390)
                      ||++ ++|..++.... ....+++..++.++.||+.||+|||+ .||+|+||||+||+++. ++ .+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~-~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           99 EQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSG-VLKISDFGTSKRLAG  175 (295)
T ss_dssp             ECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTC-CEEECCTTTCEESCC
T ss_pred             EeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCC-CEEEeecccccccCC
Confidence            9996 58877776421 12356788899999999999999998 99999999999999987 55 799999999976543


Q ss_pred             CC-CCcceeeccccccchhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          206 GE-PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       206 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||..................            
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  243 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------  243 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC------------
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc------------
Confidence            22 22345689999999999543 23789999999999999999999999765433322111111000            


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                    ...++..+++++.+||.+||..||++|||+.++|+||||+...
T Consensus       244 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          244 --------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             --------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             --------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                          0112346799999999999999999999999999999998754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.8e-45  Score=335.83  Aligned_cols=253  Identities=25%  Similarity=0.343  Sum_probs=197.1

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCC--CCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|++.+.||+|+||.||+|.+. +++.||||++....      ....+|+.+++.++  |+||+++++++.     .
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~   99 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T   99 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----C
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----c
Confidence            3458999999999999999999985 58899999985432      33457999999997  599999999883     3


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+.|+|||+.+++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++. + .+||+|||+
T Consensus       100 ~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~  172 (313)
T 3cek_A          100 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGI  172 (313)
T ss_dssp             SSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-T-EEEECCCSS
T ss_pred             CCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEEC-C-eEEEeeccc
Confidence            345889999888898887764    4578999999999999999999998 99999999999999974 4 799999999


Q ss_pred             ccccccCCC---CcceeeccccccchhhcCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 016401          200 AKVLVKGEP---NVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEI  265 (390)
Q Consensus       200 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i  265 (390)
                      +........   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|..||...... ..+..+
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            976543322   2345689999999998541          35788999999999999999999999765432 222222


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          266 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ...              .             ....++...+.++.+||.+||..||++|||+.++++||||+...
T Consensus       253 ~~~--------------~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          253 IDP--------------N-------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             HCT--------------T-------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             Hhc--------------c-------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            110              0             00112244688999999999999999999999999999998643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=339.76  Aligned_cols=246  Identities=23%  Similarity=0.335  Sum_probs=198.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCc---EEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|++.+.||+|+||.||+|.+..+++   .||||++...     ...+.+|+.+++.++||||+++++++.     .
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  121 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----R  121 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----G
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            45689999999999999999999986554   5999998643     233457999999999999999999983     3


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ....|+||||+++ +|..++..   ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  196 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFG  196 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred             CCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCC-CEEECCCC
Confidence            3447899999975 88777653   23579999999999999999999998 9999999999999999888 79999999


Q ss_pred             CccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          199 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       199 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      ++.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....    
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----  271 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY----  271 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----
Confidence            99865433221    122346789999999654 48999999999999999999 999998887766665554311    


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                    .          ...+..+++++.+||.+||..||++|||+.++++
T Consensus       272 --------------~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          272 --------------R----------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             --------------C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------C----------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                          0          0122467999999999999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.1e-45  Score=339.59  Aligned_cols=261  Identities=19%  Similarity=0.261  Sum_probs=189.4

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCc---EEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ...+|++.+.||+|+||.||+|.+..++.   .||||++...      .....+|+.+++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34589999999999999999999877765   8999988543      23355899999999999999999988543322


Q ss_pred             C-ceEEEEEEecccc-cHHHHHHHhhhh--cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          119 E-ELYLNLVLEYVPE-TVNRIARNYSRI--HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       119 ~-~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                      . ....++||||+.+ +|..++......  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~-~~kl  178 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDM-TVCV  178 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCC-CEEE
Confidence            1 1124799999985 887777654321  2258999999999999999999998 9999999999999999887 7999


Q ss_pred             eecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016401          195 CDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  270 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  270 (390)
                      +|||++........   .....+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.... 
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-  256 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-  256 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-
Confidence            99999976543322   2234457789999999654 58999999999999999999 999999887766655554310 


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-------HHHHhcCCccccc
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-------ALEACVHPFFDEL  339 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-------~~~~l~hp~f~~~  339 (390)
                                                 ....+..+++++.+||.+||..||++|||       +++++.|||+...
T Consensus       257 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          257 ---------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             ---------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             ---------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                                       00112467899999999999999999999       7788899999764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4e-45  Score=332.31  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=208.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCC-----------C
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT-----------D  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----------~  117 (390)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++........+|+++++.++||||+++++++....           .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            35899999999999999999999999999999999877777889999999999999999999874311           1


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      .....+++||||+++ +|.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~D  165 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTK-QVKIGD  165 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCC-CEEECc
Confidence            234568899999996 8888776532  3678999999999999999999998 9999999999999999887 799999


Q ss_pred             cCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          197 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       197 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....  .....+..         
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred             chhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence            999987665555556678999999999965 458999999999999999999998874211  11111100         


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                            ..++..++..+.+||.+||..||++|||+.++++|.+.-.
T Consensus       234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                  0112457899999999999999999999999999988654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.3e-45  Score=328.73  Aligned_cols=246  Identities=19%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|++...   .....+|++++++++||||+++++++.+     ....|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceE
Confidence            3458999999999999999999986 5778999998653   3445689999999999999999999843     33378


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|..++..   ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCC-CEEeccccccccc
Confidence            99999975 77776653   23568999999999999999999998 9999999999999999887 7999999999754


Q ss_pred             ccCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....  ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....           
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-----------  224 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-----------  224 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----------
T ss_pred             cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-----------
Confidence            3221  12334457789999999544 48999999999999999999 999999887766655554310           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                       ....+...++.+.+||.+||+.||++|||+.++++|
T Consensus       225 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          225 -----------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                             011124578999999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1e-45  Score=342.75  Aligned_cols=269  Identities=21%  Similarity=0.239  Sum_probs=198.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|++.  ++.||||++.....   ...+|+.+++.++||||+++++++.... .....+|
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            3458999999999999999999875  78999999864332   2345888899999999999999985433 2244578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC----------CcccccCCCCcEEEcCCCCcEE
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------GICHRDIKPQNLLVNPHTHQLK  193 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~----------~ivH~Dlkp~NIll~~~~~~vk  193 (390)
                      +||||+++ +|.+++..     ..+++..++.++.|++.||+|||+ .          ||+||||||+|||++.++ .+|
T Consensus        99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEE
T ss_pred             EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEE
Confidence            99999975 88887754     569999999999999999999998 8          999999999999999887 799


Q ss_pred             EeecCCccccccCCC---CcceeeccccccchhhcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016401          194 LCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  266 (390)
Q Consensus       194 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  266 (390)
                      |+|||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+...........
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999976543322   2345789999999999653    235668899999999999999999998754422221112


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .....+....+......  ....+..    ...+-....++++.+||.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVH--KKKRPVL----RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTT--SCCCCCC----CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhc--ccCCCCc----cccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            22223333322211000  0000000    000011123456999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=353.82  Aligned_cols=254  Identities=23%  Similarity=0.351  Sum_probs=190.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .+|.+.+.||+|+||+|+. ....+++.||||++..+ .....+|+.+|+.+ +||||+++++++     .+..+.|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence            3799999999999999764 34467899999998543 24457899999999 899999999887     3344588999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC---C-CcEEEeecCCcccc
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH---T-HQLKLCDFGSAKVL  203 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~---~-~~vkl~Dfg~a~~~  203 (390)
                      ||++++|.+++...   .....+..+..++.||+.||+|||+ .||+||||||+|||++.+   + ..+||+|||+++..
T Consensus        98 E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            99999988777642   2334555677899999999999998 999999999999999532   1 25889999999866


Q ss_pred             ccCC----CCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          204 VKGE----PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       204 ~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ....    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||....... ...+..   ..    
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~~---~~----  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILLG---AC----  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHTT---CC----
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHhc---cC----
Confidence            4332    2344578999999999964  3457889999999999999999 999996544322 111111   00    


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                 ......       .....+..+++||.+||+.||++|||+.++++||||..+
T Consensus       246 -----------~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          246 -----------SLDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             -----------CCTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             -----------CccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence                       000000       002245678999999999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.8e-45  Score=342.65  Aligned_cols=252  Identities=23%  Similarity=0.345  Sum_probs=202.2

Q ss_pred             ccccEEEeeeeeecCceEEEEEE-----EcCCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  116 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  116 (390)
                      ...+|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+++++.+ .||||+++++++... 
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence            34689999999999999999999     55677999999986532     2356899999999 789999999988432 


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhh---------------------------------------------------
Q 016401          117 DKEELYLNLVLEYVPE-TVNRIARNYSRI---------------------------------------------------  144 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~---------------------------------------------------  144 (390)
                         ...+++||||+.+ +|.+++......                                                   
T Consensus        99 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           99 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             ---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence               2336799999985 888887654221                                                   


Q ss_pred             -----------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCC---Cc
Q 016401          145 -----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NV  210 (390)
Q Consensus       145 -----------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~  210 (390)
                                 ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||++........   ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC-
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhcc
Confidence                       1228899999999999999999998 9999999999999999887 799999999976533322   23


Q ss_pred             ceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 016401          211 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  289 (390)
Q Consensus       211 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  289 (390)
                      ...+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+.........                  
T Consensus       254 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------  314 (359)
T 3vhe_A          254 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------  314 (359)
T ss_dssp             -CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC------------------
T ss_pred             ccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC------------------
Confidence            4567889999999965 458999999999999999998 99999887765555554442111                  


Q ss_pred             CCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                               ...+..+++++.+||.+||..||++|||+.++++|
T Consensus       315 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          315 ---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                     01124578999999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.4e-45  Score=352.71  Aligned_cols=259  Identities=28%  Similarity=0.405  Sum_probs=190.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-hhHHHHHHHHHhC-CCCceeeecceeccCCCCCceEEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++     ....++|+|
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv   87 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA   87 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence            3468889999999999998754 4679999999986543 3446899999876 899999999887     334568899


Q ss_pred             EecccccHHHHHHHhhhhcCC---CcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC------------Cc
Q 016401          127 LEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT------------HQ  191 (390)
Q Consensus       127 ~e~~~~~l~~~~~~~~~~~~~---~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~------------~~  191 (390)
                      |||++++|.+++.........   .++..+..++.||+.||+|||+ .||+||||||+|||++.++            ..
T Consensus        88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceE
Confidence            999999998888653322111   1233457799999999999998 9999999999999997532            26


Q ss_pred             EEEeecCCccccccCCC-----CcceeeccccccchhhcC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 016401          192 LKLCDFGSAKVLVKGEP-----NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  259 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  259 (390)
                      +||+|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|+|++ |..||.+....
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            99999999986644322     224578999999999954      2458999999999999999999 99999765433


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          260 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      +  ..+...                 .+..+..     .......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       247 ~--~~i~~~-----------------~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 E--SNIIRG-----------------IFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             H--HHHHHT-----------------CCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             H--HHHhcC-----------------CCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            2  222221                 0111111     00111235688999999999999999999999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-44  Score=325.55  Aligned_cols=246  Identities=20%  Similarity=0.299  Sum_probs=200.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+.+++.++||||+++++++.     .....+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceE
Confidence            4568999999999999999999885 5778999998653   334568999999999999999999883     333478


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||++ ++|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred             EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCC-CEEEccCccceec
Confidence            9999997 4787777553   3468999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             ccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .....  .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+....           
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------  222 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-----------  222 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred             chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-----------
Confidence            33321  1223456789999999654 48999999999999999999 999998887666555443310           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                       ....+...++.+.+||.+||+.||++|||+.++++|
T Consensus       223 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          223 -----------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             001123468899999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-45  Score=339.64  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=201.2

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ...+|++.+.||+|+||.||+|++.     .+++.||||++....     ....+|+.+++.++||||+++++++..   
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence            4568999999999999999999987     355899999986432     335679999999999999999999843   


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhh--------------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRI--------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHR  176 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------------------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~  176 (390)
                        ....|+||||+++ +|.+++......                    ...+++..++.++.||+.||.|||+ +||+||
T Consensus       122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~  198 (343)
T 1luf_A          122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR  198 (343)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence              2337799999985 888888753211                    2568999999999999999999998 999999


Q ss_pred             cCCCCcEEEcCCCCcEEEeecCCccccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 016401          177 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPL  252 (390)
Q Consensus       177 Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~p  252 (390)
                      ||||+|||++.++ .+||+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus       199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999888 79999999997553321   22344678899999999654 48999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          253 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       253 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      |.+.+..+....+....                   .         ...+..+++++.+||++||..||++|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGN-------------------I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCC-------------------c---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            98887666555443210                   0         0122467899999999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=337.80  Aligned_cols=245  Identities=25%  Similarity=0.406  Sum_probs=196.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHhC----CCCceeeecceecc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQML----DHPNIVALKHCFFS  114 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l----~h~~iv~~~~~~~~  114 (390)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++++    +||||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            457999999999999999999999999999999985432          2234699999998    89999999998833


Q ss_pred             CCCCCceEEEEEEec-cc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc-CCCCc
Q 016401          115 TTDKEELYLNLVLEY-VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQ  191 (390)
Q Consensus       115 ~~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~~  191 (390)
                           ....++|||+ +. ++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+||+++ .++ .
T Consensus       110 -----~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~  178 (312)
T 2iwi_A          110 -----QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG-C  178 (312)
T ss_dssp             --------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT-E
T ss_pred             -----CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC-e
Confidence                 3346789998 54 588777764    3568999999999999999999998 8999999999999999 555 8


Q ss_pred             EEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016401          192 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      +||+|||++...... ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||....      .+...   
T Consensus       179 ~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~---  248 (312)
T 2iwi_A          179 AKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---  248 (312)
T ss_dssp             EEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT---
T ss_pred             EEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh---
Confidence            999999999765433 33456789999999999665544568999999999999999999996532      11110   


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                    ..            .++..+++++.+||.+||..||++|||+.++++||||+...
T Consensus       249 --------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          249 --------------EL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             --------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             --------------cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                          00            12246789999999999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=340.47  Aligned_cols=251  Identities=21%  Similarity=0.307  Sum_probs=202.8

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCC-------CcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceec
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFF  113 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~  113 (390)
                      ....+|.+.+.||+|+||.||+|++..+       +..||||++....     ....+|+++++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            3456999999999999999999997533       3579999986432     3345799999999 9999999999984


Q ss_pred             cCCCCCceEEEEEEecccc-cHHHHHHHhhhh------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCC
Q 016401          114 STTDKEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  180 (390)
Q Consensus       114 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp  180 (390)
                      .     ....|+||||+++ +|.+++......            ...+++..++.++.||+.||+|||+ .||+||||||
T Consensus       146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp  219 (382)
T 3tt0_A          146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA  219 (382)
T ss_dssp             S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred             c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence            3     2337799999975 888888764311            2458999999999999999999998 9999999999


Q ss_pred             CcEEEcCCCCcEEEeecCCccccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 016401          181 QNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  256 (390)
Q Consensus       181 ~NIll~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~  256 (390)
                      +|||++.++ .+||+|||+++......   ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus       220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999888 79999999997654322   2234456889999999965 458999999999999999999 99999888


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          257 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      +..+....+....                            ....+..+++++.+||++||..||++|||+.+++++
T Consensus       298 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 PVEELFKLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CHHHHHHHHHTTC----------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCC----------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7665554443210                            001124679999999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.5e-45  Score=341.96  Aligned_cols=257  Identities=16%  Similarity=0.124  Sum_probs=196.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC-----CcEEEEEEeccchhhHHHH---------------HHHHHhCCCCceeeec
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKRYKNRE---------------LQIMQMLDHPNIVALK  109 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~E---------------~~~l~~l~h~~iv~~~  109 (390)
                      .+|++.+.||+|+||.||+|.+..+     ++.||||++........+|               +..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4799999999999999999998764     5889999986654433333               4455566799999999


Q ss_pred             ceeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc--C
Q 016401          110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--P  187 (390)
Q Consensus       110 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~--~  187 (390)
                      +++.... ....+.|+||||++++|..++..   ....+++..++.++.||+.||+|||+ .||+||||||+|||++  .
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred             eeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence            9885432 23466889999998898887764   23679999999999999999999998 8999999999999998  6


Q ss_pred             CCCcEEEeecCCccccccCCC--------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 016401          188 HTHQLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV  259 (390)
Q Consensus       188 ~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  259 (390)
                      ++ .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus       190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            66 799999999976533211        1334589999999999654 4899999999999999999999999864433


Q ss_pred             HHHHHHHHHhCCCCH-HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          260 DQLVEIIKVLGTPTR-EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       260 ~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ............+.. ..+...        +           ....+++++.+||..||..||++||++.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~--------~-----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKC--------F-----------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHH--------S-----------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHh--------c-----------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            333222221111111 111100        0           01457999999999999999999999998875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-44  Score=324.65  Aligned_cols=242  Identities=28%  Similarity=0.446  Sum_probs=188.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+|++.+.||+|+||.||+|.+.  ++.||||++...        .....+|+++++.++||||+++++++.     ..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence            358999999999999999999985  889999988532        133557999999999999999999983     33


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC---cccccCCCCcEEEcC--------C
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG---ICHRDIKPQNLLVNP--------H  188 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~---ivH~Dlkp~NIll~~--------~  188 (390)
                      ...|+||||+++ +|..++.     ...+++..++.++.|++.||+|||+ .|   |+||||||+||+++.        +
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccC
Confidence            447899999974 6665553     4679999999999999999999998 88   999999999999986        3


Q ss_pred             CCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016401          189 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  268 (390)
Q Consensus       189 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  268 (390)
                      + .+||+|||++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus       153 ~-~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  229 (271)
T 3dtc_A          153 K-ILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN  229 (271)
T ss_dssp             C-CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred             c-ceEEccCCcccccccc-cccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence            4 6999999999755433 23356789999999999654 5899999999999999999999999987765554443321


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          269 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                                 ......+..+++.+.+||.+||..||++|||+.++++|
T Consensus       230 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 ---------------------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ---------------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                       00111235678999999999999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-44  Score=333.87  Aligned_cols=250  Identities=20%  Similarity=0.339  Sum_probs=200.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ...+|.+.+.||+|+||.||+|.+.     .+++.||||++....     ....+|+++++.++||||+++++++..   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence            4468999999999999999999983     456889999986432     334579999999999999999998843   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh--------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHR  176 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~  176 (390)
                        ....|+||||++ ++|.+++.....                    ....+++..++.++.||+.||+|||+ +||+||
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~  174 (314)
T 2ivs_A           98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR  174 (314)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred             --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence              233779999998 588888876432                    12348899999999999999999998 999999


Q ss_pred             cCCCCcEEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 016401          177 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPL  252 (390)
Q Consensus       177 Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~p  252 (390)
                      ||||+||+++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus       175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999887 799999999976543322   1233457889999999654 48999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          253 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       253 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      |.+.+..+....+....                            ....+..+++++.+||.+||..||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            98877655443332210                            00122468999999999999999999999999986


Q ss_pred             C
Q 016401          333 H  333 (390)
Q Consensus       333 h  333 (390)
                      +
T Consensus       305 ~  305 (314)
T 2ivs_A          305 D  305 (314)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.7e-44  Score=328.03  Aligned_cols=249  Identities=22%  Similarity=0.229  Sum_probs=199.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .+|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++|++++..+..+..    ...+.++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv~   84 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM   84 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEEE
Confidence            4799999999999999999999999999999987543  3456789999999999987776665532    334578999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc---CCCCcEEEeecCCccccc
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~---~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||++++|.+++...   ...+++..+..++.||+.||+|||+ +||+||||||+|||++   .++ .+||+|||++....
T Consensus        85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           85 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred             EecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccc
Confidence            99988998877642   3579999999999999999999998 9999999999999994   555 79999999998654


Q ss_pred             cCCC--------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCC
Q 016401          205 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPT  273 (390)
Q Consensus       205 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~  273 (390)
                      ....        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.   .+.+..+.......+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            4322        2455789999999999654 489999999999999999999999987432   233333332211111


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .                        ..+...+++++.+||.+||+.||++|||+.++++
T Consensus       239 ~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 I------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             H------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             h------------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1                        1112457899999999999999999999998875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.4e-44  Score=325.61  Aligned_cols=244  Identities=23%  Similarity=0.310  Sum_probs=196.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----------hhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....           ....+|+.+++.++||||+++++++..   
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   94 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN---   94 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence            358999999999999999999999999999999984321           345689999999999999999998832   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--cccccCCCCcEEEcCCCC----
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTH----  190 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~----  190 (390)
                        ..  ++||||++ ++|...+..   ....+++..+..++.|++.||+|||+ .|  |+||||||+|||++.++.    
T Consensus        95 --~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           95 --PP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             --TT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             --CC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCce
Confidence              22  48999998 577665543   24579999999999999999999998 89  999999999999987662    


Q ss_pred             cEEEeecCCccccccCCCCcceeeccccccchhhcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH
Q 016401          191 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ--LVEIIK  267 (390)
Q Consensus       191 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~  267 (390)
                      .+||+|||+++...  .......+|+.|+|||++.. ...++.++|||||||++|+|++|..||...+..+.  ...+..
T Consensus       167 ~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  244 (287)
T 4f0f_A          167 CAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE  244 (287)
T ss_dssp             CEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred             eEEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence            29999999997442  23345678999999999843 33478899999999999999999999987654332  222211


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                       .                          .+...++..+++++.+||.+||+.||++|||+.++++
T Consensus       245 -~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          245 -E--------------------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             -S--------------------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -c--------------------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             0                          0111223568999999999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.8e-44  Score=330.54  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=202.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  117 (390)
                      ..+|++.+.||+|+||.||+|.+     ..+++.||||++....     ....+|+.+++++ +||||+++++++...  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC--
Confidence            45899999999999999999985     4567899999986432     3345899999999 999999999998432  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhh--------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                         ...++||||+++ +|.+++.....              ....+++..++.++.||+.||+|||+ .||+||||||+|
T Consensus       100 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N  175 (313)
T 1t46_A          100 ---GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN  175 (313)
T ss_dssp             ---SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             ---CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence               336799999975 88888765321              12358999999999999999999998 999999999999


Q ss_pred             EEEcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016401          183 LLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  258 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  258 (390)
                      |+++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus       176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999887 7999999999766443321   234567889999998654 58999999999999999998 9999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          259 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ...+.........                           ...+..+++++.+||.+||..||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            6655555442110                           11124578999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.7e-44  Score=326.01  Aligned_cols=246  Identities=21%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|.+. ++..||||++...   .....+|+++++.++||||+++++++..     ....|
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   95 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIF   95 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCCeE
Confidence            3458999999999999999999886 6778999998653   3445689999999999999999999833     33478


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||++ ++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~  170 (283)
T 3gen_A           96 IITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYV  170 (283)
T ss_dssp             EEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTS-CEEECSTTGGGGB
T ss_pred             EEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCC-CEEEccccccccc
Confidence            9999996 5787776542   3569999999999999999999998 9999999999999999888 7999999999754


Q ss_pred             ccCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....  ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...+..+....+.....          
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------  239 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----------  239 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred             cccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC----------
Confidence            3221  12233457789999999654 48999999999999999998 9999998887666655543110          


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                        ...+...++.+.+||.+||..||++|||+.++++|
T Consensus       240 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          240 ------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                              01124568999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-44  Score=341.74  Aligned_cols=246  Identities=22%  Similarity=0.303  Sum_probs=199.2

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ...+|.+.+.||+|+||.||+|.++.+++.||||++....     ..+.+|+++++.++||||+++++++..     ...
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence            4568999999999999999999999899999999986432     234579999999999999999999843     233


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||||++ ++|.+++...   ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~  261 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKN-VLKISDFGMSR  261 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCC-cEEECcCCCce
Confidence            779999997 5887777642   3468999999999999999999998 9999999999999999888 79999999997


Q ss_pred             ccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          202 VLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       202 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      .......   .....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+...         
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~---------  331 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---------  331 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT---------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------
Confidence            5432211   1122357789999999644 48999999999999999998 99999887765544333221         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                               ..          ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       332 ---------~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          332 ---------GR----------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ---------CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CC----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                     00          0122457899999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3e-44  Score=327.43  Aligned_cols=248  Identities=21%  Similarity=0.343  Sum_probs=203.5

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++..+.   ....+|+.+++.++||||+++++++..     ....
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCE
Confidence            34568999999999999999999999999999999986543   335589999999999999999999833     3337


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      |+||||++ ++|.+++....  ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence            89999998 58877776422  3568999999999999999999998 8999999999999999887 799999999976


Q ss_pred             cccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          203 LVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       203 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      ......  .....+|+.|+|||++.+. .++.++||||||+++|+|++ |.+||.+.+..+....+....          
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~----------  229 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------  229 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred             ccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------
Confidence            543321  2334567889999999654 48999999999999999999 999998877655444333210          


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                        ....+..+++++.+||++||..||.+|||+.++++
T Consensus       230 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          230 ------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                              01122467899999999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-44  Score=331.28  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=193.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEE----EcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|++.+.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++||||+++++++...   +
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---H
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence            44689999999999999999998    56789999999986433    3346899999999999999999987432   1


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ...+++||||++ ++|.+++...   ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCC-eEEEccCc
Confidence            223679999996 5888877653   2458999999999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          199 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       199 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      ++........    .....++..|+|||++.+. .++.++|||||||++|+|++|..||.....  ..   ....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~---~~~~~~~~~  233 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDKQ  233 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HH---HHHHCTTCC
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChH--HH---HhhhcCccc
Confidence            9976543321    1223457789999999654 489999999999999999999999865321  11   111111110


Q ss_pred             HH------HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EE------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ..      ......   .          .....+..+++++.+||.+||..||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~---~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          234 GQMIVFHLIELLKN---N----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             THHHHHHHHHHHHT---T----------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cchhHHHHHHHHhc---c----------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00      000000   0          001123568999999999999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.5e-44  Score=327.32  Aligned_cols=249  Identities=22%  Similarity=0.232  Sum_probs=197.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc--chhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ++|++.+.||+|+||.||+|++..+++.||||++..  ......+|+.+++.++|++++..+..+..    ...+.++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv~   84 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM   84 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEEE
Confidence            579999999999999999999999999999998643  23456789999999999988877666532    334578999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE---cCCCCcEEEeecCCccccc
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||++++|.+++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||+   +.++ .+||+|||++....
T Consensus        85 e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred             EccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCC-eEEEecCccceecc
Confidence            99988998877642   4579999999999999999999998 999999999999999   6666 79999999998654


Q ss_pred             cCCC--------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC
Q 016401          205 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPT  273 (390)
Q Consensus       205 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~  273 (390)
                      ....        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..   ..+..+.......+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            4322        2345789999999999654 4899999999999999999999999875432   22222222110011


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .                        ......+++++.+||.+||+.||++|||+.++++
T Consensus       239 ~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 I------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             H------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             h------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            0                        1112457899999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-44  Score=330.69  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=193.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-hhHHHHHHHHHh--CCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+|++.+.||+|+||+||+|++  +++.||||++.... ....+|.+++..  ++||||+++++++.... .....+|+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence            35899999999999999999987  58999999986543 334467777776  79999999999865432 33456789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH--------hcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH--------~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      ||||+++ +|.+++.     ...+++..+..++.||+.||+|||        + .||+||||||+|||++.++ .+||+|
T Consensus        84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~-~~kl~D  156 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNG-QCCIAD  156 (301)
T ss_dssp             EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTS-CEEECC
T ss_pred             ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCC-CEEEee
Confidence            9999985 8877774     357999999999999999999999        8 8999999999999999888 799999


Q ss_pred             cCCccccccCCCC-----cceeeccccccchhhcCCC-----CCCCchhHHHHHHHHHHHHhC----------CCCCCCC
Q 016401          197 FGSAKVLVKGEPN-----VSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLG----------QPLFPGE  256 (390)
Q Consensus       197 fg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g----------~~pf~~~  256 (390)
                      ||++.........     ....||+.|+|||++.+..     .++.++|||||||++|+|++|          ..||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            9999765443322     2347899999999996543     234799999999999999999          8888653


Q ss_pred             Ch----HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          257 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       257 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ..    ...+.......                 ...    .......+....++++.+||.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------------~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          237 VPNDPSFEDMRKVVCVD-----------------QQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SCSSCCHHHHHHHHTTS-----------------CCC----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCcchhhhhHHHhcc-----------------CCC----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            22    22222221100                 000    011111223345678999999999999999999999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=335.29  Aligned_cols=253  Identities=22%  Similarity=0.306  Sum_probs=202.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccc-----hhhHHHHHHHHHhC-CCCceeeecceeccCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTT  116 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  116 (390)
                      ...+|++.+.||+|+||.||+|.+.     .+++.||||++...     .....+|+.+++++ +||||+++++++..  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence            3468999999999999999999973     45678999998543     23456899999999 99999999999843  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhh-------------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 016401          117 DKEELYLNLVLEYVPE-TVNRIARNYSRI-------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHR  176 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~  176 (390)
                         ....|+||||+++ +|.+++......                   ...+++..+..++.||+.||+|||+ .||+||
T Consensus       121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~  196 (344)
T 1rjb_A          121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHR  196 (344)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred             ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence               2337799999974 888887653211                   1347899999999999999999998 999999


Q ss_pred             cCCCCcEEEcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 016401          177 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPL  252 (390)
Q Consensus       177 Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~p  252 (390)
                      ||||+|||++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus       197 Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          197 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence            9999999999888 7999999999766443322   334568889999999654 58999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          253 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       253 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      |.+....+.+..+....                 ..          ...+..+++++.+||.+||..||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~-----------------~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNG-----------------FK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             STTCCCSHHHHHHHHTT-----------------CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCcHHHHHHHHhcC-----------------CC----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            98877655555544421                 00          0112457899999999999999999999999997


Q ss_pred             CCc
Q 016401          333 HPF  335 (390)
Q Consensus       333 hp~  335 (390)
                      |-.
T Consensus       328 ~l~  330 (344)
T 1rjb_A          328 FLG  330 (344)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            643

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.8e-46  Score=352.84  Aligned_cols=273  Identities=21%  Similarity=0.331  Sum_probs=201.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....     ....+|+++++.++||||+++++++...   .....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence            358999999999999999999999999999999986422     3345899999999999999999987432   23347


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE----cCCCCcEEEeecC
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFG  198 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~~vkl~Dfg  198 (390)
                      |+||||++ ++|..++..... ...+++..++.++.||+.||+|||+ .||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence            89999997 588777654322 2348999999999999999999998 999999999999998    5555 69999999


Q ss_pred             CccccccCCCCcceeeccccccchhhcCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 016401          199 SAKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIK  267 (390)
Q Consensus       199 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~  267 (390)
                      +++............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||....    ..+.+.++..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            99876555445566789999999998531       347889999999999999999999997532    2344444433


Q ss_pred             HhCCCCHHHHhhcCc-CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          268 VLGTPTREEIKCMNP-NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                        +.|.. .+..... ....+.+..  ..+....+...++..+.+||++||++||++||++.++++
T Consensus       242 --~~p~~-~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 --GKPSG-AISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             --SCCTT-CCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             --CCCcc-cchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence              22211 1100000 000000000  000111122345678899999999999999999998854

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.8e-44  Score=327.87  Aligned_cols=246  Identities=24%  Similarity=0.309  Sum_probs=189.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      -.+|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence            358999999999999999999999999999999986432       334579999999999999999998843     34


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      ..|+||||+++ +|.+++..    ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~  181 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADD-FAYLVDFGIA  181 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSCCC-
T ss_pred             eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCC-CEEEecCccC
Confidence            57899999985 88777764    3579999999999999999999998 9999999999999999887 7999999998


Q ss_pred             cccccCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          201 KVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       201 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      .......  ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.. .+....... .       
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~-------  251 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA-I-------  251 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC-C-------
T ss_pred             ccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC-C-------
Confidence            7654322  2234568999999999955 45899999999999999999999999876543 222222210 0       


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-CHHHHhc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACV  332 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-s~~~~l~  332 (390)
                                       +.....++.+++++.+||.+||..||++|| ++.++++
T Consensus       252 -----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 -----------------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -----------------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -----------------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                             001122356899999999999999999999 7777663

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-44  Score=335.34  Aligned_cols=250  Identities=23%  Similarity=0.318  Sum_probs=200.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEE--EEEEeccc-----hhhHHHHHHHHHhC-CCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|++.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+++++++ +||||+++++++.     .
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~   97 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H   97 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----E
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----e
Confidence            3358999999999999999999998888865  99988542     23456899999999 9999999999983     3


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  186 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~  186 (390)
                      ....|+||||+++ +|.+++....            .....+++..++.++.||+.||+|||+ .||+||||||+||+++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG  176 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEc
Confidence            3458899999974 8888776532            123468999999999999999999998 9999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016401          187 PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  265 (390)
Q Consensus       187 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i  265 (390)
                      .++ .+||+|||++.............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       177 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          177 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CCC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            887 7999999999754333333445568889999999543 48999999999999999998 99999888765544433


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          266 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ...                  .          ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus       255 ~~~------------------~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          255 PQG------------------Y----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGT------------------C----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcC------------------C----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            221                  0          001124578999999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.2e-44  Score=331.76  Aligned_cols=258  Identities=21%  Similarity=0.286  Sum_probs=206.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ...+|++.+.||+|+||.||+|.+.     .+++.||||++....     ....+|+.+++.++||||+++++++..   
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   99 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---   99 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence            3458999999999999999999876     357889999986432     234579999999999999999999833   


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhh------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  190 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  190 (390)
                        ....++||||+++ +|.+++......      ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++ 
T Consensus       100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~-  175 (322)
T 1p4o_A          100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-  175 (322)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-
T ss_pred             --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCC-
Confidence              2336799999984 888887654322      1457889999999999999999998 9999999999999999887 


Q ss_pred             cEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 016401          191 QLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  266 (390)
Q Consensus       191 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~  266 (390)
                      .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            799999999975533221   2234568899999999654 48999999999999999999 899998877665554443


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC------CcccccC
Q 016401          267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH------PFFDELR  340 (390)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h------p~f~~~~  340 (390)
                      ...                   .         ...+..+++.+.+||.+||..||++|||+.++++|      ++|+++.
T Consensus       255 ~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          255 EGG-------------------L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             TTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             cCC-------------------c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            210                   0         00124678999999999999999999999999975      7777664


Q ss_pred             C
Q 016401          341 D  341 (390)
Q Consensus       341 ~  341 (390)
                      .
T Consensus       307 ~  307 (322)
T 1p4o_A          307 F  307 (322)
T ss_dssp             S
T ss_pred             c
Confidence            3

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.8e-44  Score=327.78  Aligned_cols=244  Identities=18%  Similarity=0.250  Sum_probs=194.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCC-------cEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      ...+|.+.+.||+|+||.||+|.+..++       ..||+|++....    ....+|+.+++.++||||+++++++... 
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   84 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-   84 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-
Confidence            3468999999999999999999998777       479999985432    3345799999999999999999998432 


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCc----
Q 016401          117 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----  191 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~----  191 (390)
                          ...++||||++ ++|.+++...   ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++..    
T Consensus        85 ----~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           85 ----DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             ----TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred             ----CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCcccccc
Confidence                23679999998 5888877652   2348999999999999999999998 999999999999999887621    


Q ss_pred             ---EEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 016401          192 ---LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIK  267 (390)
Q Consensus       192 ---vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~i~~  267 (390)
                         +||+|||++....   ......+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+. ........
T Consensus       157 ~~~~kl~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~~  232 (289)
T 4fvq_A          157 PPFIKLSDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYE  232 (289)
T ss_dssp             CCEEEECCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHH
T ss_pred             cceeeeccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHHhh
Confidence               9999999986442   2234567889999999976466899999999999999999955 55544443 33222222


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .                             ...++...++++.+||++||+.||++|||+.++++|
T Consensus       233 ~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          233 D-----------------------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             T-----------------------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             c-----------------------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            1                             001123467889999999999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.9e-44  Score=329.05  Aligned_cols=256  Identities=19%  Similarity=0.266  Sum_probs=194.7

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcC---CCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ....+|.+.+.||+|+||.||+|.+..   +++.||+|++....      ....+|+.+++.++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345689999999999999999998765   45689999985431      234579999999999999999999865443


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhh--hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                      ......++||||+.+ +|..++....  .....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kl  188 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDM-TVCV  188 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTS-CEEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEE
Confidence            333356899999985 8877775432  223569999999999999999999998 9999999999999999888 7999


Q ss_pred             eecCCccccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016401          195 CDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  270 (390)
Q Consensus       195 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  270 (390)
                      +|||++.......   ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... 
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-  266 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-  266 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-
Confidence            9999997654332   1223456788999999965 458999999999999999999 999998877666555443310 


Q ss_pred             CCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                                 ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus       267 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 ---------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ---------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       001224678999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.5e-44  Score=323.81  Aligned_cols=246  Identities=26%  Similarity=0.356  Sum_probs=189.0

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCC---CcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|++.+.||+|+||.||+|.+..+   +..||+|++...     .....+|+.+++.++||||+++++++..     
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   87 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence            445899999999999999999998654   457999987542     2234579999999999999999998721     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      . ..|+||||+++ +|.+++...   ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        88 ~-~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg  161 (281)
T 1mp8_A           88 N-PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFG  161 (281)
T ss_dssp             S-SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC--
T ss_pred             C-ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCC-CEEECccc
Confidence            1 25699999985 887777542   3468999999999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          199 SAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       199 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ++........  .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~------  234 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------  234 (281)
T ss_dssp             -----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------
T ss_pred             cccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC------
Confidence            9976543322  123345778999999954 458999999999999999996 999999877666555443210      


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                            ...++..+++++.+||.+||..||++|||+.+++++
T Consensus       235 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          235 ----------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                  001225689999999999999999999999999753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.3e-44  Score=332.28  Aligned_cols=246  Identities=22%  Similarity=0.302  Sum_probs=195.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcE----EEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ...+|++.+.||+|+||.||+|.+..+++.    ||+|.+....     ....+|+.+++.++||||+++++++.     
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence            445899999999999999999999888876    6777664321     33457999999999999999999872     


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      +. ..++||||+. ++|...+...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+||
T Consensus        86 ~~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Df  159 (325)
T 3kex_A           86 GS-SLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPS-QVQVADF  159 (325)
T ss_dssp             BS-SEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSS-CEEECSC
T ss_pred             CC-ccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCC-eEEECCC
Confidence            12 2679999998 5776666532   3468899999999999999999998 9999999999999999888 7999999


Q ss_pred             CCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          198 GSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       198 g~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      |+++.......   .....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....    
T Consensus       160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----  234 (325)
T 3kex_A          160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----  234 (325)
T ss_dssp             SGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----
T ss_pred             CcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----
Confidence            99986644322   2334567789999999654 48999999999999999999 999998876555444333210    


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                              ....+..++.++.+||.+||..||++|||+.++++|
T Consensus       235 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          235 ------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    001123468889999999999999999999999876

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-45  Score=351.28  Aligned_cols=254  Identities=20%  Similarity=0.218  Sum_probs=192.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCC-Cceeeecce---------
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDH-PNIVALKHC---------  111 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h-~~iv~~~~~---------  111 (390)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.+++.+.| +|...+...         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34699999999999999999999999999999988622       2335589999999987 322111111         


Q ss_pred             ------------eccCCCCCceEEEEEEecccccHHHHHHHhhh---hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 016401          112 ------------FFSTTDKEELYLNLVLEYVPETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHR  176 (390)
Q Consensus       112 ------------~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~  176 (390)
                                  +..........++++|+++.++|.+++.....   ....+++..+..++.||+.||+|||+ +||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence                        10000011223678999999999888764422   23447778889999999999999998 999999


Q ss_pred             cCCCCcEEEcCCCCcEEEeecCCccccccCCCCcceeeccccccchhhc---------CCCCCCCchhHHHHHHHHHHHH
Q 016401          177 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF---------GATEYTTAIDIWSTGCVMAELL  247 (390)
Q Consensus       177 Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~ell  247 (390)
                      ||||+|||++.++ .+||+|||+++.....  .....| +.|+|||++.         ....++.++|||||||++|+|+
T Consensus       236 DiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999998 6999999998754332  344566 9999999993         3344788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCH
Q 016401          248 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA  327 (390)
Q Consensus       248 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~  327 (390)
                      +|+.||.+.+..+....+                       +.          ....+++++.+||.+||..||++|||+
T Consensus       312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999775432211100                       00          013578999999999999999999999


Q ss_pred             HHHhcCCcccccC
Q 016401          328 LEACVHPFFDELR  340 (390)
Q Consensus       328 ~~~l~hp~f~~~~  340 (390)
                      .++++||||+.+.
T Consensus       359 ~~~l~~~~~~~~~  371 (413)
T 3dzo_A          359 LQAMETPEYEQLR  371 (413)
T ss_dssp             HHHTTSHHHHHHH
T ss_pred             HHHHhCHHHHHHH
Confidence            9999999998763

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3e-43  Score=324.29  Aligned_cols=251  Identities=27%  Similarity=0.452  Sum_probs=190.6

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||+++++++..     .
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence            345899999999999999999999999999999998531       1234579999999999999999998843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ...++||||+++ +|.+++.........+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCC-CEEEEeccc
Confidence            347899999986 8888887766666779999999999999999999998 9999999999999999888 799999999


Q ss_pred             ccccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHH
Q 016401          200 AKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       200 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  277 (390)
                      +........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+.......        
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  253 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--------  253 (310)
T ss_dssp             ----------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--------
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--------
Confidence            876543322 234568999999999955 4589999999999999999999999976432 12222221110        


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                ..+.        .....+++++.+||.+||..||++|||+.++++
T Consensus       254 ----------~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          254 ----------DYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             ----------CSCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------cCCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                      0110        111457899999999999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=334.63  Aligned_cols=257  Identities=16%  Similarity=0.143  Sum_probs=191.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC---CCcEEEEEEeccchhh---------------HHHHHHHHHhCCCCceeeecc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRY---------------KNRELQIMQMLDHPNIVALKH  110 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~---------------~~~E~~~l~~l~h~~iv~~~~  110 (390)
                      ..+|++.+.||+|+||.||+|.+..   ++..||||++......               ..+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3589999999999999999999987   7889999998654321               235777788889999999999


Q ss_pred             eeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC-
Q 016401          111 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-  189 (390)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-  189 (390)
                      ++.... .+..+.|+||||++++|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ 
T Consensus       116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSST
T ss_pred             cccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCC
Confidence            885432 33567899999997788776653    2378999999999999999999998 8999999999999998664 


Q ss_pred             CcEEEeecCCccccccCC--------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHH
Q 016401          190 HQLKLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVD  260 (390)
Q Consensus       190 ~~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~  260 (390)
                      ..+||+|||+++......        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ...
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence            269999999997653221        11345789999999999654 58999999999999999999999996532 222


Q ss_pred             HHHHHH-HHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          261 QLVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       261 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ...... ......+.....+.                    -...+++++.+||.+||..||++|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            222222 21111111111110                    01257899999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1e-43  Score=330.85  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=202.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCc-----EEEEEEeccc-----hhhHHHHHHHHHhC-CCCceeeecceeccCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTT  116 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  116 (390)
                      ...+|++.+.||+|+||.||+|.+..+++     .||+|++...     .....+|+.+++.+ +||||+++++++..  
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH--  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence            34589999999999999999999976654     7999998643     23355899999999 89999999999843  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhh----------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE
Q 016401          117 DKEELYLNLVLEYVPE-TVNRIARNYSRI----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  185 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll  185 (390)
                         ....|+||||+++ +|.+++......          ...+++..+..++.||+.||+|||+ .||+||||||+|||+
T Consensus       122 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          122 ---GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL  197 (333)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred             ---CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence               2337799999975 888888754332          3468999999999999999999998 999999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 016401          186 NPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  261 (390)
Q Consensus       186 ~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  261 (390)
                      +.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+......
T Consensus       198 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          198 TNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             CCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            9887 7999999999765443321   234567889999999654 48999999999999999998 9999988776665


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      +..+......                           ...+...++.+.+||.+||..||.+|||+.++++
T Consensus       276 ~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 FYKLVKDGYQ---------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            5555442100                           0112456899999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.2e-45  Score=336.89  Aligned_cols=268  Identities=19%  Similarity=0.209  Sum_probs=199.4

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ....+|++.+.||+|+||.||+|.+. +++.||||++....    ....+|+.+++.++||||+++++++..     ...
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  109 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNE  109 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TTC
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCe
Confidence            34568999999999999999999974 68999999875432    345689999999999999999998843     233


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++||||+++ +|.+++.........+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~  187 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENF-VPKITDFGISK  187 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCC-CEEEeeccccc
Confidence            7799999984 7765554322223458999999999999999999998 9999999999999999888 79999999997


Q ss_pred             ccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          202 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       202 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      ......   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+........     .... 
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~-  260 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESH-  260 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHH-
T ss_pred             ccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcc-
Confidence            543221   22345689999999999654 4899999999999999999999999765432211110000     0000 


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCc
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  335 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~  335 (390)
                       ..     ..+...........+....+..+.+++.+||..||++|||+.++++|..
T Consensus       261 -~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          261 -NN-----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             -TT-----TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -cc-----ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence             00     0011111111112223445678999999999999999999999997643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.6e-44  Score=335.20  Aligned_cols=269  Identities=21%  Similarity=0.300  Sum_probs=202.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ...+|.+.+.||+|+||.||+|++ .+++.||||++....     ....+|+++++.++||||+++++++...     ..
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~  101 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE  101 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----SC
T ss_pred             HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC-----Cc
Confidence            345899999999999999999986 468999999985432     2456899999999999999999998432     23


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC---CcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---GICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~---~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      .++||||+.+ +|..++.........+++..+..++.|++.||+|||+ .   ||+||||||+|||++.++ .+||+|||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg  179 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEF-EAVVGDFG  179 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTC-CEEECCCS
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCC-CEEeccCc
Confidence            6799999985 8888887655445569999999999999999999998 8   999999999999999887 79999999


Q ss_pred             CccccccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCC
Q 016401          199 SAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE----SGVDQLVEIIKVLGTP  272 (390)
Q Consensus       199 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~  272 (390)
                      ++........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...    ...........     
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----  253 (326)
T 3uim_A          180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-----  253 (326)
T ss_dssp             SCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-----
T ss_pred             cccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-----
Confidence            9986543322  2334589999999999654 4899999999999999999999999521    10001111111     


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                            ..   .................+....+..+.+|+.+||+.||.+|||+.++++|-.-..+
T Consensus       254 ------~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          254 ------GL---LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             ------TT---TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             ------HH---hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence                  00   00011111111111122223445789999999999999999999999988764443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=331.77  Aligned_cols=254  Identities=23%  Similarity=0.346  Sum_probs=198.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      .+|++.+.||+|+||.||+|++..+++.||||++...    .....+|+.+++.++||||+++++++.... ......|+
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            4899999999999999999999999999999988432    234458999999999999999999885322 23456789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+.+ +|..++.........+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            9999986 8888887765556789999999999999999999998 8999999999999999888 79999999986542


Q ss_pred             cCCCC----------cceeeccccccchhhcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Q 016401          205 KGEPN----------VSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGT  271 (390)
Q Consensus       205 ~~~~~----------~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~  271 (390)
                      .....          ....||+.|+|||++.+..  .++.++|||||||++|+|++|..||...... +.......    
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----  261 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----  261 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH----
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh----
Confidence            21111          2234689999999985432  2689999999999999999999999531100 00111110    


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                             .      ....+          ....+++++.+||.+||..||.+|||+.+++++
T Consensus       262 -------~------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          262 -------N------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -------C------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------c------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                   0      00111          114578999999999999999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-43  Score=318.56  Aligned_cols=245  Identities=19%  Similarity=0.313  Sum_probs=199.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++....   ....+|+.+++.++||||+++++++..     ....|+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEE
Confidence            358999999999999999999986 67889999986542   445689999999999999999998843     233779


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||++ ++|.+++...   ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  155 (267)
T ss_dssp             EECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             EEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCC-CEEEcccccccccc
Confidence            999997 4887777542   3568999999999999999999998 9999999999999999887 79999999987543


Q ss_pred             cC--CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KG--EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ..  .......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+....            
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~------------  222 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------  222 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------
T ss_pred             cccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC------------
Confidence            21  111234567789999999544 48999999999999999999 899998877666555443310            


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                      ....+...++.+.+||.+||..||++|||+.+++++
T Consensus       223 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          223 ----------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            001124578999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-43  Score=328.07  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEE-----cCCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  117 (390)
                      ..+|++.+.||+|+||.||+|++     ..+++.||||++....     ....+|+.+++.+ .||||+++++++...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            45899999999999999999985     4567899999986532     2345799999999 789999999987432  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhh------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEE
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  184 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIl  184 (390)
                        ...+++||||+++ +|..++......            ...+++..+..++.||+.||.|||+ .||+||||||+||+
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence              2346799999985 888877653221            1228899999999999999999998 99999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 016401          185 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  260 (390)
Q Consensus       185 l~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  260 (390)
                      ++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99887 7999999999765433222   345678899999999654 48999999999999999998 999998876555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .+.........                           ...+..+++++.++|.+||..||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTR---------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCcc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            54444432110                           01124578999999999999999999999999876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-43  Score=329.57  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=200.9

Q ss_pred             CCcccccEEEeeeeeecCceEEEEEE----EcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCC
Q 016401           45 NSKQKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTT  116 (390)
Q Consensus        45 ~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  116 (390)
                      .-....+|++.+.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++||||+++++++..  
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   95 (327)
T 3lxl_A           18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG--   95 (327)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec--
Confidence            33455699999999999999999999    56789999999986442    235689999999999999999998753  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEe
Q 016401          117 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  195 (390)
Q Consensus       117 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  195 (390)
                       .+...+|+||||++ ++|.+++...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+
T Consensus        96 -~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~-~~kl~  169 (327)
T 3lxl_A           96 -PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEA-HVKIA  169 (327)
T ss_dssp             -SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEEC
T ss_pred             -CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCC-CEEEc
Confidence             34456889999996 5887777653   2468999999999999999999998 9999999999999999888 79999


Q ss_pred             ecCCccccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016401          196 DFGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       196 Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      |||++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||......... ........
T Consensus       170 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~  247 (327)
T 3lxl_A          170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDV  247 (327)
T ss_dssp             CGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----C
T ss_pred             ccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hccccccc
Confidence            9999986543322    1234568889999999654 4799999999999999999999998654321110 00000000


Q ss_pred             CCHHHHh-hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          272 PTREEIK-CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       272 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      +....+. .....             .....+..+++++.+||.+||..||++|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          248 PALSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             CHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0000000 00000             0011235689999999999999999999999999753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.1e-44  Score=330.38  Aligned_cols=246  Identities=22%  Similarity=0.337  Sum_probs=191.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcE----EEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ...+|++.+.||+|+||+||+|++..+++.    ||+|.+...     ...+.+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence            445899999999999999999999877765    477776422     23456899999999999999999998431   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                        . .++|+||+. ++|...+...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+||
T Consensus        90 --~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Df  161 (327)
T 3poz_A           90 --T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDF  161 (327)
T ss_dssp             --S-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred             --C-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCC-CEEEccC
Confidence              2 557888887 5777766542   3568999999999999999999998 9999999999999999888 7999999


Q ss_pred             CCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          198 GSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       198 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      |+++........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....    
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----  236 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----  236 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC----
Confidence            999865443322   223457789999999654 58999999999999999999 999998876554433332210    


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                    .          ...+..++.++.+|+.+||+.||++|||+.+++++
T Consensus       237 --------------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          237 --------------R----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             --------------C----------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             --------------C----------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                          0          01124578899999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=337.41  Aligned_cols=259  Identities=14%  Similarity=0.112  Sum_probs=196.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC--------CcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccC------
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET--------GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST------  115 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------  115 (390)
                      .+|++.+.||+|+||.||+|++..+        ++.||||++... ....+|++++++++||||++++..+...      
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            4899999999999999999999874        889999998654 4567999999999999999854332110      


Q ss_pred             -----CCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC-
Q 016401          116 -----TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-  189 (390)
Q Consensus       116 -----~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-  189 (390)
                           ......+.|+||||++++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ 
T Consensus       121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             CCCEEEEETTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEETTEE
T ss_pred             chhhccccCCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEcCCCC
Confidence                 001245678999999889988887532  3679999999999999999999998 9999999999999999775 


Q ss_pred             CcEEEeecCCccccccCC--------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHH
Q 016401          190 HQLKLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVD  260 (390)
Q Consensus       190 ~~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~  260 (390)
                      ..+||+|||+++......        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ..+
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  276 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE  276 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH
Confidence            269999999997653321        1133478999999999965 458999999999999999999999998764 333


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          261 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+..........        ...+.        .   .......+++++.+||.+||..||++|||+.++++
T Consensus       277 ~~~~~~~~~~~~--------~~~~~--------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          277 DIMKQKQKFVDK--------PGPFV--------G---PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHS--------CCCEE--------C---TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhccCC--------hhhhh--------h---hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            333332211000        00000        0   00011357899999999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-43  Score=329.40  Aligned_cols=250  Identities=23%  Similarity=0.331  Sum_probs=198.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEc-------CCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceecc
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS  114 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~  114 (390)
                      ...+|++.+.||+|+||.||+|++.       .+++.||||++....     ....+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4468999999999999999999985       456789999986432     2345799999999 89999999998833


Q ss_pred             CCCCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCC
Q 016401          115 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  181 (390)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~  181 (390)
                           ...+|+||||+++ +|.+++.....            ....+++..++.++.||+.||+|||+ .||+||||||+
T Consensus       113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~  186 (334)
T 2pvf_A          113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR  186 (334)
T ss_dssp             -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGG
T ss_pred             -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccc
Confidence                 3347899999975 88888765321            12348899999999999999999998 99999999999


Q ss_pred             cEEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 016401          182 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  257 (390)
Q Consensus       182 NIll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  257 (390)
                      ||+++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       187 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          187 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            99999888 799999999976543321   2233457889999999654 48999999999999999999 999998887


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          258 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      ..+....+....                            ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus       265 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          265 VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHHTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCC----------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            665554443310                            001124678999999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.4e-43  Score=319.39  Aligned_cols=246  Identities=27%  Similarity=0.371  Sum_probs=195.2

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcC---CCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|++.+.||+|+||.||+|.+..   ++..||+|++...     .....+|+.+++.++||||+++++++..     
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence            34589999999999999999998653   3456999998653     2344579999999999999999998732     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      .. .|+||||+. ++|.+++...   ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        85 ~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg  158 (281)
T 3cc6_A           85 EP-TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPE-CVKLGDFG  158 (281)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETT-EEEECCCC
T ss_pred             CC-CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCC-cEEeCccC
Confidence            11 468999998 5887777542   3568999999999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          199 SAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       199 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ++........  .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.... .    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~----  232 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-R----  232 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-C----
T ss_pred             CCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-C----
Confidence            9976543321  223455788999999954 458999999999999999998 999998776655554443310 0    


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                             ...+..+++.+.+||.+||..||++|||+.+++++
T Consensus       233 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          233 -----------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                   00124578999999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.4e-43  Score=320.79  Aligned_cols=249  Identities=20%  Similarity=0.279  Sum_probs=187.9

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ....+|++.+.||+|+||.||+|++.   ..||+|++....      ....+|+.+++.++||||++++++..     ..
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   92 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----AP   92 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-----CC
Confidence            34458999999999999999999864   359999885322      33457999999999999999988651     11


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                       ..++||||++ ++|...+..   ....+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||+
T Consensus        93 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~  166 (289)
T 3og7_A           93 -QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDN-TVKIGDFGL  166 (289)
T ss_dssp             -SCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTT-EEEECCCC-
T ss_pred             -ccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCC-CEEEcccee
Confidence             2579999998 477665532   24568999999999999999999998 9999999999999999888 899999999


Q ss_pred             ccccccC---CCCcceeeccccccchhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKG---EPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~---~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +......   .......||+.|+|||++.  ....++.++|||||||++|+|++|+.||.+.+..+.+.........+. 
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-  245 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-  245 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-
Confidence            8754321   2223456899999999985  234578899999999999999999999998777766666554321110 


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                            ....+...+++++.+||.+||..||++|||+.++++
T Consensus       246 ----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 ----------------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ----------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                  001122467899999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.4e-44  Score=331.39  Aligned_cols=256  Identities=18%  Similarity=0.222  Sum_probs=198.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEE-----EcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD  117 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  117 (390)
                      ...+|++.+.||+|+||.||+|+     +..+++.||||++...     .....+|+.+++.++||||+++++++..   
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC---
Confidence            34589999999999999999999     5567889999998532     2334579999999999999999999843   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhh---cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--Cc
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQ  191 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~  191 (390)
                        ....|+||||++ ++|.+++......   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++  ..
T Consensus       105 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 --SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred             --CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence              223679999996 5888887754321   1348899999999999999999998 9999999999999998432  26


Q ss_pred             EEEeecCCccccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016401          192 LKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~  267 (390)
                      +||+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            9999999987543322   12334568899999999654 48999999999999999998 9999988776555444432


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      .. .                           ...+..+++.+.+||.+||..||.+|||+.++++|.|+..
T Consensus       261 ~~-~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          261 GG-R---------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TC-C---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-C---------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            10 0                           0112467899999999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4e-43  Score=316.84  Aligned_cols=245  Identities=12%  Similarity=0.181  Sum_probs=197.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ...+|++.+.||+|+||.||+|++.  ++.||||++....      ....+|+.+++.++||||+++++++...   ...
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence            3458999999999999999999985  8899999986432      2355799999999999999999988442   223


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--cccccCCCCcEEEcCCCCcEEEeecC
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ..++||||+++ +|.+++...  ....+++..+..++.||+.||+|||+ .|  |+||||||+||+++.++ .++|+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~-~~~l~~~~  158 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM-TARISMAD  158 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred             CeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCc-ceeEEecc
Confidence            46799999985 888877642  12258999999999999999999998 89  99999999999999887 69999988


Q ss_pred             CccccccCCCCcceeeccccccchhhcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          199 SAKVLVKGEPNVSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       199 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ++...    ......+|+.|+|||++.+..  .++.++|||||||++|+|++|..||.+.+..+....+.....      
T Consensus       159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------  228 (271)
T 3kmu_A          159 VKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL------  228 (271)
T ss_dssp             SCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC------
T ss_pred             ceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC------
Confidence            87542    223456799999999996543  123389999999999999999999998877666555543110      


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                           ...++..+++++.+||.+||..||++|||+.++++
T Consensus       229 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          229 ---------------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 01123568999999999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.6e-43  Score=319.67  Aligned_cols=244  Identities=24%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             ccccEEEee-eeeecCceEEEEEE--EcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           48 QKVSYIAEH-VVGTGSFGVVFQAK--CRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        48 ~~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ...+|.+.+ .||+|+||.||+|.  +..+++.||||++...      .....+|+.+++.++||||+++++++ ..   
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~---   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA---   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES---
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC---
Confidence            345899998 99999999999995  4567889999998643      23455799999999999999999987 21   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                       . ..++||||++ ++|.+++..    ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+||
T Consensus        90 -~-~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~-~~kl~Df  161 (291)
T 1xbb_A           90 -E-SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDF  161 (291)
T ss_dssp             -S-SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCC
T ss_pred             -C-CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCC-cEEEccC
Confidence             1 2679999998 588777754    4568999999999999999999998 9999999999999999887 7999999


Q ss_pred             CCccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016401          198 GSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       198 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      |++.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+... .  
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~--  237 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-E--  237 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C--
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C--
Confidence            999765433221    122346889999999654 47899999999999999999 99999887765544433221 0  


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                               ...++..+++++.+||.+||..||++|||+.++++
T Consensus       238 -------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 -------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     00122467999999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.3e-44  Score=348.03  Aligned_cols=247  Identities=20%  Similarity=0.353  Sum_probs=201.8

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|.++.++..||||++..+.   ..+.+|+.+|++++||||+++++++..     ...+|
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence            4568999999999999999999999889999999986543   345689999999999999999999843     23377


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+. ++|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENH-LVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG-CEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCC-cEEEeecccceec
Confidence            9999998 58888776432  3468899999999999999999998 9999999999999999887 7999999999865


Q ss_pred             ccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .....  .....++..|+|||++... .++.++|||||||++|||++ |..||.+.+..+....+...            
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------  435 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------------  435 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT------------
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence            33221  1223456789999999654 48999999999999999999 99999887765544333221            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                            ..          ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       436 ------~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          436 ------YR----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ------CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CC----------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                  00          0122468999999999999999999999999974

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.4e-43  Score=322.65  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=195.0

Q ss_pred             cccEEEeeeeeecCceEEEEEE----EcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||.||+|+    +..+++.||||++....     ....+|+.+++.++||||+++++++...   .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence            4579999999999999999999    56789999999986432     3456899999999999999999988542   2


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ...+++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg  171 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFG  171 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCC-CEEECccc
Confidence            2347799999975 887777542   3569999999999999999999998 9999999999999999888 79999999


Q ss_pred             CccccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          199 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       199 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      ++........    .....+|..|+|||++.+. .++.++|||||||++|+|++|..|+....  .   ......+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~--~---~~~~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM--A---LFLKMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH--H---HHHHHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh--h---HHhhccCCccc
Confidence            9986644332    2234567889999999654 47899999999999999999998864321  1   11111111110


Q ss_pred             HH-HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EE-IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .. ..........         ......+..+++++.+||.+||..||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 QMTVTRLVNTLKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGHHHHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            00 0000000000         0001123568999999999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7e-43  Score=338.06  Aligned_cols=245  Identities=23%  Similarity=0.334  Sum_probs=198.1

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ....+|++.+.||+|+||.||+|.+.  ++.||||+++.+.  ..+.+|+.++++++||||+++++++....    ..+|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceE
Confidence            34568999999999999999999985  7899999996543  34568999999999999999999874322    2378


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+++ +|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  339 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCC-CEEEeeCCCcccc
Confidence            99999985 8888876532  2347899999999999999999998 9999999999999999888 7999999999754


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.+.              
T Consensus       340 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------------  402 (450)
T 1k9a_A          340 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------  402 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT--------------
T ss_pred             ccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------
Confidence            322  2233568889999999654 58999999999999999998 99999887665555444321              


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                          ..          ...+..+++++.+||.+||..||++|||+.++++
T Consensus       403 ----~~----------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          403 ----YK----------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CC----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                00          0123568999999999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1e-43  Score=335.61  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=188.6

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEc---CCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ....+|.+.+.||+|+||.||+|+++   .++..||||++...     ...+.+|+.++++++||||+++++++..    
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----  117 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----  117 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----
Confidence            34568999999999999999999986   45778999998643     2335579999999999999999999843    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                       ....++||||++ ++|.+++...   ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+||
T Consensus       118 -~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Df  191 (373)
T 2qol_A          118 -SKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDF  191 (373)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             -CCceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCC-CEEECcC
Confidence             233779999996 5887777542   3468999999999999999999998 9999999999999999888 7999999


Q ss_pred             CCccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016401          198 GSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       198 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      |+++........    ....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+....   
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~---  267 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---  267 (373)
T ss_dssp             ----------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE---
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence            999765433211    11234678999999965 458999999999999999998 999998887665554443210   


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                     ..+          .+..++..+.+||.+||+.||++||++.++++
T Consensus       268 ---------------~~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          268 ---------------RLP----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---------------ECC----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCC----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                           000          12357899999999999999999999998875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-43  Score=319.19  Aligned_cols=248  Identities=26%  Similarity=0.319  Sum_probs=198.4

Q ss_pred             ccccEEEee-eeeecCceEEEEEEEc--CCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|.+.+ .||+|+||.||+|.+.  .+++.||||++...     .....+|+++++.++||||+++++++. .    
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~----   81 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A----   81 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S----
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C----
Confidence            345788877 9999999999999864  46788999998653     233457999999999999999999872 1    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      . ..++||||+++ +|..++..   ....+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        82 ~-~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg  155 (287)
T 1u59_A           82 E-ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFG  155 (287)
T ss_dssp             S-SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCT
T ss_pred             C-CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCC-CEEECccc
Confidence            1 16799999985 77666642   23569999999999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          199 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       199 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      ++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~----  230 (287)
T 1u59_A          156 LSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----  230 (287)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----
T ss_pred             ceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC----
Confidence            9976543322    1223457889999999544 48999999999999999998 999998877666554443210    


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  335 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~  335 (390)
                                              ...++..+++++.+||.+||..||++||++.++++|.+
T Consensus       231 ------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          231 ------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                                    00123568999999999999999999999999998643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.4e-45  Score=363.57  Aligned_cols=283  Identities=25%  Similarity=0.339  Sum_probs=206.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  123 (390)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...     .....+|+++++.++||||+++++++..... ......
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            3799999999999999999999999999999988543     2334579999999999999999988743221 123446


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC--cEEEeecCCc
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSA  200 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~Dfg~a  200 (390)
                      |+||||++ ++|..++..... ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++.  .+||+|||++
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            79999996 588777764321 2358899999999999999999998 99999999999999986652  4899999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............   ..........
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~---~~~~~~~~~~  247 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSNEHIVVY  247 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---------CCSC
T ss_pred             cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh---cccchhhhhh
Confidence            87766555566788999999999954 4589999999999999999999999987654332111100   0000000000


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ........+..  ..+....+...+++.+.+||.+||.+||++|||+.++++||||+.+.
T Consensus       248 ~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          248 DDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            00001111111  11112223345678999999999999999999999999999998763

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-43  Score=325.19  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=192.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCC----cEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ...+|.+.+.||+|+||.||+|.+..++    ..||||++....     ....+|+.+++.++||||+++++++..    
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  117 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----  117 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec----
Confidence            4458999999999999999999986553    459999986432     234579999999999999999999833    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                       ....++||||+++ +|..++..   ....+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+||
T Consensus       118 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Df  191 (333)
T 1mqb_A          118 -YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDF  191 (333)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             -CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCC-cEEECCC
Confidence             3347899999986 88777654   23579999999999999999999998 9999999999999999888 7999999


Q ss_pred             CCccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016401          198 GSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       198 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      |++.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....   
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~---  267 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---  267 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC---
Confidence            999765432211    122347789999999654 58999999999999999998 999998877665554443210   


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                     ..          ..+..+++.+.+||.+||..||++||++.+++++
T Consensus       268 ---------------~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          268 ---------------RL----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------CC----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------cC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           00          0124578999999999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.4e-43  Score=339.54  Aligned_cols=249  Identities=20%  Similarity=0.224  Sum_probs=197.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+++++.+.|++++..+..+.    ....+.++||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~lvm   82 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNVLVM   82 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEEEEE
Confidence            5799999999999999999999999999999987532  345678999999998866555444442    2334578999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE---cCCCCcEEEeecCCccccc
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||++++|.+++...   ...+++..++.++.||+.||+|||+ +||+||||||+||||   +.++ .+||+|||+++...
T Consensus        83 e~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~  157 (483)
T 3sv0_A           83 DLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYR  157 (483)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred             ECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCC-eEEEEeCCcceecc
Confidence            99988998887642   4579999999999999999999998 999999999999999   4555 79999999998664


Q ss_pred             cCCCC--------cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCC
Q 016401          205 KGEPN--------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPT  273 (390)
Q Consensus       205 ~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~  273 (390)
                      .....        ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...   .+.+..+........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            43321        256789999999999654 589999999999999999999999987543   233333332211111


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+                        .+...+++++.+||.+||..||++||++.++++
T Consensus       237 ~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            11                        112467899999999999999999999887654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=325.48  Aligned_cols=244  Identities=22%  Similarity=0.334  Sum_probs=189.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEE----EEEEecc-----chhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ..+|++.+.||+|+||.||+|.+..+++.+    |+|.+..     ......+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            458999999999999999999998888765    6665532     224456899999999999999999988432    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                       . .++|++|+. ++|.+++...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus        90 -~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kL~DfG  162 (327)
T 3lzb_A           90 -T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             -S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             -C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence             2 557888887 5777766542   4569999999999999999999998 9999999999999999888 79999999


Q ss_pred             CccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          199 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       199 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +++........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....     
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-----  236 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----  236 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            99765433222   233457789999999654 58999999999999999999 999998877655443332210     


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                   .          ...+..++.++.+||++||..||.+|||+.++++
T Consensus       237 -------------~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          237 -------------R----------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -------------C----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------C----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                         0          0112457899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=328.24  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=188.5

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-hhHHHHHHHHHhC--CCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML--DHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|+||.||+|++.  ++.||||++.... ....+|.+++..+  +||||+++++++..... ....+|+|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEEE
Confidence            58999999999999999999985  8999999985443 2334566666554  99999999998854322 22457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC--------CcccccCCCCcEEEcCCCCcEEEeec
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~--------~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      |||+++ +|.+++..     ..+++..+..++.|++.||+|||+ .        ||+||||||+|||++.++ .+||+||
T Consensus       114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            999975 88887753     579999999999999999999997 8        999999999999999888 7999999


Q ss_pred             CCccccccCCCC-----cceeeccccccchhhcCCCCCCC------chhHHHHHHHHHHHHhC----------CCCCCCC
Q 016401          198 GSAKVLVKGEPN-----VSYICSRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLG----------QPLFPGE  256 (390)
Q Consensus       198 g~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~------~~DiwslG~il~ell~g----------~~pf~~~  256 (390)
                      |++.........     ....||+.|+|||++.+.. +..      ++|||||||++|||++|          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999765433222     2457899999999996543 444      39999999999999999          6677543


Q ss_pred             Ch----HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          257 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       257 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ..    ..........                     ...............+++++.+||.+||+.||++|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCI---------------------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             SCSSCCHHHHHHHHTT---------------------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCchhhhHHHHhh---------------------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            21    1222221110                     0000000011112346678999999999999999999999987


Q ss_pred             C
Q 016401          333 H  333 (390)
Q Consensus       333 h  333 (390)
                      |
T Consensus       325 ~  325 (337)
T 3mdy_A          325 T  325 (337)
T ss_dssp             H
T ss_pred             H
Confidence            5

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.1e-43  Score=339.53  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=199.3

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|.+. ++..||||++...   ...+.+|+.+++.++||||+++++++.    .  ..+|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----~--~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT----K--EPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC----S--SSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe----C--CccE
Confidence            4568999999999999999999985 4678999998653   334568999999999999999999873    1  1267


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+. ++|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTC-CEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCC-cEEEeeCCCceEc
Confidence            9999997 58888776432  2367888999999999999999998 9999999999999999887 7999999999765


Q ss_pred             ccCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....  ......+|..|+|||++... .++.++|||||||++|||++ |+.||.+.+..+....+....           
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-----------  402 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-----------  402 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-----------
T ss_pred             CCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            3221  11223457789999999544 58999999999999999999 999999888776665554321           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                             ..+          .+..+++++.+||.+||..||++|||+.++++
T Consensus       403 -------~~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          403 -------RMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             -------CCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CCC----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                   111          12467999999999999999999999999874

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-42  Score=318.57  Aligned_cols=242  Identities=26%  Similarity=0.349  Sum_probs=187.1

Q ss_pred             ccEEEe-eeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHH-HhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .+|.+. +.||+|+||.||+|.+..+++.||||++... ....+|+.++ +.++||||+++++++.... ....++|+||
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~   94 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVM   94 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEEE
Confidence            468887 7899999999999999999999999998653 4456888887 6679999999999874321 2356688999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC---CCCcEEEeecCCcccc
Q 016401          128 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  203 (390)
Q Consensus       128 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~Dfg~a~~~  203 (390)
                      ||+++ +|.+++...  ....+++..++.++.||+.||+|||+ .||+||||||+||+++.   ++ .+||+|||++...
T Consensus        95 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~  170 (299)
T 3m2w_A           95 ECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKET  170 (299)
T ss_dssp             CCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEEC
T ss_pred             eecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCC-cEEEecccccccc
Confidence            99985 888777652  23469999999999999999999998 99999999999999987   45 7999999998643


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      .                      ...++.++|||||||++|+|++|..||.+.+..+.......                
T Consensus       171 ~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~----------------  212 (299)
T 3m2w_A          171 T----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------------  212 (299)
T ss_dssp             T----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC----------------
T ss_pred             c----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH----------------
Confidence            1                      12378899999999999999999999977543221100000                


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                        ....   ....+.......+++++.+||.+||..||++|||+.++++||||+...
T Consensus       213 --~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          213 --RIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             --SSCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             --HHhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence              0000   000111111246799999999999999999999999999999998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.1e-43  Score=316.43  Aligned_cols=243  Identities=22%  Similarity=0.339  Sum_probs=191.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ..+|++.+.||+|+||.||+|.+.  ++.||||++..+.  ....+|+.+++.++||||+++++++...    ....|+|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceEEE
Confidence            458999999999999999999874  8899999986543  3456899999999999999999986432    2236799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||+++ +|.+++....  ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS  169 (278)
T ss_dssp             ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC------
T ss_pred             EecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCC-cEEEeeccccccccc
Confidence            999986 8888776532  2237888999999999999999998 9999999999999999887 799999999875432


Q ss_pred             CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          206 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       206 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      .  .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+..+....+...                
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~----------------  230 (278)
T 1byg_A          170 T--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------------  230 (278)
T ss_dssp             --------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT----------------
T ss_pred             c--ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----------------
Confidence            2  233456888999999954 458999999999999999998 99999887655444333210                


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                        .          ....+..+++.+.++|.+||..||++|||+.++++
T Consensus       231 --~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 --Y----------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             --C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --C----------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence              0          01122467999999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-42  Score=318.01  Aligned_cols=247  Identities=21%  Similarity=0.313  Sum_probs=193.9

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCC---CcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...+|++.+.||+|+||.||+|.+..+   ...||+|.+....     ....+|+.++++++||||+++++++..    .
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~   98 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----S   98 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----S
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----C
Confidence            345899999999999999999997543   3468999885422     334579999999999999999998643    2


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ....++||||+++ +|.+++..   ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg  173 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKF-TVKVADFG  173 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSCG
T ss_pred             CCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCC-CEEECccc
Confidence            2336799999986 88777753   23568899999999999999999998 9999999999999999888 79999999


Q ss_pred             CccccccCC-----CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016401          199 SAKVLVKGE-----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       199 ~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      ++.......     ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+....   
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~---  249 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---  249 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC---
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC---
Confidence            997553321     12344567889999999554 58999999999999999999 677887766555544443210   


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                               ....+..+++.+.+||.+||..||++|||+.++++
T Consensus       250 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          250 -------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     00112457899999999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-42  Score=314.71  Aligned_cols=251  Identities=23%  Similarity=0.324  Sum_probs=200.4

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|.+. +++.||||++...   .....+|+++++.++||||+++++++..     . ..+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~-~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----C-CcE
Confidence            3458999999999999999999985 5678999998653   3445689999999999999999998731     1 167


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+. ++|.+++....  ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLI  159 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence            9999996 58877665321  2368999999999999999999998 9999999999999999887 7999999999765


Q ss_pred             ccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .....  .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....           
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----------  227 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-----------  227 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred             cCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-----------
Confidence            43221  1233457789999999543 48999999999999999999 999998887666554443210           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc--CCcccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  338 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~--hp~f~~  338 (390)
                                       ....+..+++++.+||.+||..||++|||+.++++  ..+|..
T Consensus       228 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          228 -----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                             01122467899999999999999999999999875  344443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=328.22  Aligned_cols=276  Identities=21%  Similarity=0.289  Sum_probs=193.1

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-hhHHHHHHH--HHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQI--MQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~--l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|++  +++.||||++.... .....|.++  +..++||||+++++.+..........+|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            345899999999999999999986  58999999986433 222334444  4458999999998866544445666788


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC---------CcccccCCCCcEEEcCCCCcEEE
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------GICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~---------~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                      +||||++ ++|.+++..     ...++..+..++.||+.||+|||+ .         ||+||||||+|||++.++ .+||
T Consensus        89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL  161 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVI  161 (336)
T ss_dssp             EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTS-CEEE
T ss_pred             EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCC-cEEE
Confidence            9999996 588887754     456888999999999999999998 8         999999999999999888 7999


Q ss_pred             eecCCccccccCC---------CCcceeeccccccchhhcCC------CCCCCchhHHHHHHHHHHHHhCCCCCCC-CCh
Q 016401          195 CDFGSAKVLVKGE---------PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLLGQPLFPG-ESG  258 (390)
Q Consensus       195 ~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~-~~~  258 (390)
                      +|||+++......         ......||+.|+|||++.+.      ..++.++|||||||++|||++|..||.. ...
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            9999997653321         11234689999999999652      2356789999999999999999766543 221


Q ss_pred             HHHHHHHH-HHhCCCCHHHHhhcC-cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc----
Q 016401          259 VDQLVEII-KVLGTPTREEIKCMN-PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV----  332 (390)
Q Consensus       259 ~~~~~~i~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~----  332 (390)
                      .+....+. .....+....+.... .......++.    .+..  ...+++++.+||.+||..||++|||+.++++    
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----cccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            11111111 111222222222110 0000001110    0000  0124568999999999999999999999954    


Q ss_pred             --CCcccc
Q 016401          333 --HPFFDE  338 (390)
Q Consensus       333 --hp~f~~  338 (390)
                        ++|-++
T Consensus       316 ll~~~~~~  323 (336)
T 3g2f_A          316 LMMIWERN  323 (336)
T ss_dssp             HHHCCCC-
T ss_pred             HHHHHHhc
Confidence              566554

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-42  Score=337.02  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=195.4

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++....   ..+.+|+.++++++||||+++++++..      ...|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            44689999999999999999999864 4679999986532   345689999999999999999998732      1267


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+. ++|.+++...  ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCC-CEEECCCccceec
Confidence            9999997 4888777542  23568999999999999999999998 9999999999999999887 7999999999765


Q ss_pred             ccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .....  .....++..|+|||++... .++.++|||||||++|||++ |..||.+.+..+.+..+...            
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~------------  397 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------  397 (452)
T ss_dssp             ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred             CCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence            43221  1233457789999999654 58999999999999999999 99999988776655544321            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                            ...          ..+..+++.+.+||.+||..||++|||+.++++
T Consensus       398 ------~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          398 ------YRM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             ------CCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                  000          112467899999999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.3e-42  Score=314.74  Aligned_cols=244  Identities=28%  Similarity=0.409  Sum_probs=186.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ..+|++.+.||+|+||.||+|++.  ++.||||++....  ....+|+.++++++||||+++++++.     +.  .|+|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence            358999999999999999999974  7889999986543  34568999999999999999999873     22  5699


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc--CCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~--~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |||+++ +|.+++.... ....+++..+..++.|++.||+|||+.  +||+||||||+||+++.++..+||+|||++...
T Consensus        78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999975 8877776422 123478889999999999999999962  489999999999999988745899999999754


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ....... +.           
T Consensus       157 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-----------  221 (307)
T 2eva_A          157 QT--HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GT-----------  221 (307)
T ss_dssp             ----------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TC-----------
T ss_pred             cc--ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CC-----------
Confidence            32  2234568999999999955 4589999999999999999999999976433221 1111110 00           


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                     .......+++.+.+||.+||..||++|||+.++++
T Consensus       222 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          222 ---------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ---------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                           00112467899999999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-42  Score=314.65  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=194.0

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCCCc---EEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      .....|.+.+.||+|+||.||+|.+..+++   .||+|++....     ....+|+.+++.++||||+++++++....  
T Consensus        18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   95 (298)
T 3pls_A           18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE--   95 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS--
T ss_pred             ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC--
Confidence            345579999999999999999999765544   79999986432     23457999999999999999999884322  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                        ...++||||+. ++|.+++..   ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .+||+||
T Consensus        96 --~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~-~~kl~Df  168 (298)
T 3pls_A           96 --GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESF-TVKVADF  168 (298)
T ss_dssp             --SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECCT
T ss_pred             --CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEeCcC
Confidence              22468999986 588776653   24568999999999999999999998 9999999999999999888 7999999


Q ss_pred             CCccccccC-----CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCC
Q 016401          198 GSAKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGT  271 (390)
Q Consensus       198 g~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~  271 (390)
                      |++......     .......+|+.|+|||.+.+ ..++.++|||||||++|+|++| .+||...+..+....+....  
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--  245 (298)
T 3pls_A          169 GLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR--  245 (298)
T ss_dssp             TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC--
T ss_pred             CCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC--
Confidence            999754321     12233456889999999954 4589999999999999999995 55565555444433332210  


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                                ....+..+++.+.+||.+||..||.+|||+.++++
T Consensus       246 --------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          246 --------------------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                      00112457899999999999999999999999885

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-43  Score=329.36  Aligned_cols=248  Identities=20%  Similarity=0.307  Sum_probs=187.7

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCC---CcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ....|++.+.||+|+||.||+|.+..+   +..||+|.+...     ...+.+|+.+++.++||||+++++++...    
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----  162 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----  162 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----
Confidence            445799999999999999999997543   246899988542     23345799999999999999999986432    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ....|+||||+++ +|.+++..   ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DFG  237 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFG  237 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             CCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCC-CEEEeecc
Confidence            2236799999985 88777753   23568889999999999999999998 9999999999999999888 79999999


Q ss_pred             CccccccCCC-----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016401          199 SAKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       199 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      +++.......     .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...  . 
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~-  313 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R-  313 (373)
T ss_dssp             --------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--C-
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--C-
Confidence            9975533221     123456788999999965 458999999999999999999 78888876655444433221  0 


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                               ....+..+++.+.++|.+||..||++|||+.+++++
T Consensus       314 -------------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 -------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     001124578999999999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.6e-43  Score=328.40  Aligned_cols=246  Identities=16%  Similarity=0.170  Sum_probs=191.0

Q ss_pred             ccccEEEeeeeeecCceEEEEE-----EEcCCCcEEEEEEeccch-hhHHHHHHHHHhCC---CCceeeecceeccCCCC
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQA-----KCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD---HPNIVALKHCFFSTTDK  118 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~  118 (390)
                      ...+|.+.+.||+|+||.||+|     .+..+++.||||++.... ....+|+.+++.+.   |+||+.+++++....  
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~--  140 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN--  140 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS--
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC--
Confidence            3468999999999999999999     467789999999986543 34567888888887   899999999885433  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh-hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC---------
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---------  187 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---------  187 (390)
                         ..|+||||++ ++|.+++..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.         
T Consensus       141 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          141 ---GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             ---CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC----
T ss_pred             ---CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccccc
Confidence               3779999998 588888876543 24569999999999999999999998 99999999999999987         


Q ss_pred             --CCCcEEEeecCCcccccc---CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 016401          188 --HTHQLKLCDFGSAKVLVK---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL  262 (390)
Q Consensus       188 --~~~~vkl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  262 (390)
                        ++ .+||+|||+|+....   ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......   
T Consensus       217 ~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~---  291 (365)
T 3e7e_A          217 DLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGG---  291 (365)
T ss_dssp             --CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred             cccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence              56 799999999975432   2223445789999999999654 4899999999999999999999999653210   


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCC
Q 016401          263 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  334 (390)
Q Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp  334 (390)
                                             .+.......     .  ...++.+.+++.+||..+|.+|++..+.+.+.
T Consensus       292 -----------------------~~~~~~~~~-----~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          292 -----------------------ECKPEGLFR-----R--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             -----------------------EEEECSCCT-----T--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             -----------------------ceeechhcc-----c--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence                                   000000000     0  12367789999999999999997765555543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.3e-42  Score=315.36  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=191.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcC-CCc--EEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRE-TGE--IVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      .+|++.+.||+|+||.||+|.+.. +++  .||||++...       .....+|+.+++.++||||+++++++...    
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   93 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   93 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence            489999999999999999998643 333  6899987532       13345799999999999999999988432    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                       . .++||||+. ++|.+.+...   ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||
T Consensus        94 -~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg  166 (291)
T 1u46_A           94 -P-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG  166 (291)
T ss_dssp             -S-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             -C-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCC-CEEEcccc
Confidence             1 569999998 5887776643   3568999999999999999999998 9999999999999999887 79999999


Q ss_pred             CccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          199 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       199 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      ++.........    ....+|..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+.+..+....    
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----  241 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG----  241 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC----
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC----
Confidence            99765433221    233457789999999654 47899999999999999999 999999887766555443310    


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                                   ...          ..+..+++++.++|.+||..||++|||+.++++  +++++
T Consensus       242 -------------~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~  282 (291)
T 1u46_A          242 -------------ERL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA  282 (291)
T ss_dssp             -------------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             -------------CCC----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence                         000          112467899999999999999999999999986  45544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.8e-43  Score=320.69  Aligned_cols=257  Identities=21%  Similarity=0.272  Sum_probs=194.3

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .|...+.||+|+||.||+|.+  +++.||||++...        .....+|+.+++.++||||+++++++...     ..
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-----DD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----Cc
Confidence            466679999999999999986  5789999988532        23456899999999999999999988432     23


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++||||++ ++|.+++.... ....+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~  181 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAF-TAKISDFGLAR  181 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCC-cEEEeeccccc
Confidence            779999996 58877776432 24568999999999999999999998 9999999999999999887 79999999987


Q ss_pred             ccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          202 VLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       202 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      .......   .....||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+......+..+.+...........
T Consensus       182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (307)
T 2nru_A          182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED  259 (307)
T ss_dssp             ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred             ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence            6543222   223468999999999854  37999999999999999999999998765443333333221111000000


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .....     .         ...+...+..+.++|.+||..||.+|||+.+++++
T Consensus       260 ~~~~~-----~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          260 YIDKK-----M---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HSCSS-----C---------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hcccc-----c---------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00000     0         00112346789999999999999999999999853

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-42  Score=320.14  Aligned_cols=254  Identities=25%  Similarity=0.355  Sum_probs=191.5

Q ss_pred             cEEEeeeeeecCceEEEEEE----EcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           51 SYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .|++.+.||+|+||.||+|.    +..+++.||||++....     ....+|+++++.++||||+++++++...   +..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~  108 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAA  108 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCc
Confidence            45999999999999998875    34578999999986542     3346899999999999999999988542   234


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+++||||+++ +|..++..     ..+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a  181 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDR-LVKIGDFGLA  181 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGC
T ss_pred             eEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCC-CEEECCcccc
Confidence            57899999975 87766643     459999999999999999999998 9999999999999999887 7999999999


Q ss_pred             cccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-
Q 016401          201 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-  275 (390)
Q Consensus       201 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  275 (390)
                      ........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......     ....+..... 
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~  255 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQM  255 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccch
Confidence            86644322    2234568889999999654 47899999999999999999999996532110     0000111000 


Q ss_pred             ---HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          276 ---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       276 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                         .+......            ......+..+++++.+||++||..||++|||+.++++
T Consensus       256 ~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          256 TVLRLTELLER------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhc------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               00000000            0001122568899999999999999999999999984

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.9e-42  Score=321.99  Aligned_cols=253  Identities=22%  Similarity=0.228  Sum_probs=193.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHh--CCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|+||.||+|++  +++.||||++... .....+|.++++.  ++||||+++++++..... .....|+|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeEEE
Confidence            4799999999999999999998  4899999998643 3344578888888  799999999998854331 12257899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH--------hcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH--------~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      |||+++ +|.+++..     ..+++..++.++.|++.||+|||        + .||+||||||+|||++.++ .+||+||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~-~~kL~Df  191 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNG-TCCIADL  191 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTS-CEEECCC
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCC-CEEEEEC
Confidence            999986 88887754     46899999999999999999999        7 8999999999999999888 7999999


Q ss_pred             CCccccccCCC-----CcceeeccccccchhhcCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 016401          198 GSAKVLVKGEP-----NVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLG----------QPLFPGES  257 (390)
Q Consensus       198 g~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~ell~g----------~~pf~~~~  257 (390)
                      |++........     .....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99976644432     234568999999999965422     23689999999999999999          77886643


Q ss_pred             h----HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          258 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       258 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .    .+.+.......                 ...+..    .........++.+.+||.+||..||++|||+.++++|
T Consensus       272 ~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQ-----------------KLRPNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTS-----------------CCCCCC----CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHH-----------------HhCCCC----cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            2    12222211100                 000000    0011112345689999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.9e-42  Score=343.00  Aligned_cols=241  Identities=23%  Similarity=0.300  Sum_probs=191.7

Q ss_pred             cEEE-eeeeeecCceEEEEEEE--cCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           51 SYIA-EHVVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        51 ~y~~-~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+.+ .+.||+|+||.||+|.+  +.+++.||||+++...      ..+.+|+.+++.++||||+++++++..     ..
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~  443 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ES  443 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SS
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CC
Confidence            3444 34899999999999954  4567899999986432      345689999999999999999998721     12


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                       .++||||+.+ +|..++..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       444 -~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~-~~kL~DFGla  516 (635)
T 4fl3_A          444 -WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLS  516 (635)
T ss_dssp             -EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCTTHH
T ss_pred             -EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCC-CEEEEEcCCc
Confidence             6799999984 78777753    4678999999999999999999998 9999999999999999888 7999999999


Q ss_pred             cccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          201 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       201 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      +.......    .....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+....      
T Consensus       517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------  589 (635)
T 4fl3_A          517 KALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------  589 (635)
T ss_dssp             HHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------
T ss_pred             cccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            86543322    122345788999999954 458999999999999999998 999999888766555444310      


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                            ....+..+++++.+||.+||..||++|||+.++++
T Consensus       590 ----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          590 ----------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                  00122468999999999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.9e-42  Score=339.49  Aligned_cols=245  Identities=24%  Similarity=0.362  Sum_probs=198.8

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++....   ..+.+|+.+|+.++||||+++++++..      ..+|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            44689999999999999999999864 4679999986532   345689999999999999999998732      1267


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +||||+.+ +|.+++...  ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence            99999985 888777542  23568999999999999999999998 9999999999999999887 7999999999755


Q ss_pred             ccCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....  ......++..|+|||++... .++.++|||||||++|||++ |..||.+....+.+..+...            
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~------------  480 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------  480 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred             CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence            3211  11223456789999999654 58999999999999999999 99999988776655544321            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                            ...          ..+..++.++.+||.+||..||++|||+.++++
T Consensus       481 ------~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          481 ------YRM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             ------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                  000          112467899999999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=315.89  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=195.7

Q ss_pred             cccccEEEeeeeeecCceEEEEEE----EcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ....+|++.+.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++||||+++++++...   
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  114 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---  114 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---
Confidence            345689999999999999999998    46689999999986432    3456899999999999999999987432   


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      +...+++||||+++ +|.+++...   ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+||
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kL~Df  189 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDF  189 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCC-cEEEecC
Confidence            22346799999975 888777642   3468999999999999999999998 9999999999999999887 7999999


Q ss_pred             CCccccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          198 GSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       198 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      |++........    .....++..|+|||++.+. .++.++|||||||++|+|++|..||....  ..+   .+..+...
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~---~~~~~~~~  263 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPP--AEF---MRMIGNDK  263 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHH---HHHHCTTC
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHH---HHhhcccc
Confidence            99986544322    1223457789999999654 47899999999999999999999885421  111   11111111


Q ss_pred             HHH-----H-hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          274 REE-----I-KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       274 ~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ...     + ..+..   ...          ...+..+++++.+||++||..||++|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~---~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          264 QGQMIVFHLIELLKN---NGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CTHHHHHHHHHHHHT---TCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhhHHHHHHHhhc---CCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            100     0 00000   000          0112468899999999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=339.53  Aligned_cols=248  Identities=26%  Similarity=0.324  Sum_probs=194.8

Q ss_pred             ccEEEee-eeeecCceEEEEEEEc--CCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .+|.+.+ .||+|+||.||+|.++  .++..||||+++..     ...+.+|+++|+.++||||+++++++..     + 
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~-  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E-  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----S-
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----C-
Confidence            4566666 8999999999999875  35667999998643     2345689999999999999999998842     1 


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+||||+.+ +|..++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~-~vkL~DFGla  483 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRH-YAKISDFGLS  483 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCSTT
T ss_pred             CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCC-cEEEeeccCc
Confidence            27799999985 77666643   24568999999999999999999998 9999999999999999887 7999999999


Q ss_pred             cccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          201 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       201 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      +........    ....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+....      
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------  556 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------  556 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC------
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------
Confidence            865433221    12234678999999964 458999999999999999998 999999888776655543310      


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh---cCCccc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC---VHPFFD  337 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l---~hp~f~  337 (390)
                                            ...++..+++++.+||.+||..||++||++.+++   ++.|+.
T Consensus       557 ----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          557 ----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                                  0012346899999999999999999999999875   455543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.7e-43  Score=329.83  Aligned_cols=247  Identities=18%  Similarity=0.180  Sum_probs=181.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHhCC---------CCceee-
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLD---------HPNIVA-  107 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~---------h~~iv~-  107 (390)
                      .+|++.+.||+|+||+||+|++  +|+.||||++....            ....+|+.+++.++         ||||++ 
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5899999999999999999998  68999999986542            44568999999886         555554 


Q ss_pred             ----------------ecceeccCCC--------CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHH
Q 016401          108 ----------------LKHCFFSTTD--------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR  162 (390)
Q Consensus       108 ----------------~~~~~~~~~~--------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~  162 (390)
                                      +++++.+...        .....+|+||||+.+ ++...+.     ...+++..++.++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence                            4444432100        013458899999974 3333221     256899999999999999


Q ss_pred             HHHHHH-hcCCcccccCCCCcEEEcCCC-------------------CcEEEeecCCccccccCCCCcceeeccccccch
Q 016401          163 ALAYIH-NCIGICHRDIKPQNLLVNPHT-------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE  222 (390)
Q Consensus       163 al~~LH-~~~~ivH~Dlkp~NIll~~~~-------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE  222 (390)
                      ||+||| + .||+||||||+|||++.++                   ..+||+|||+|+....    ....||+.|+|||
T Consensus       173 aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE  247 (336)
T 2vuw_A          173 SLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSG
T ss_pred             HHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChh
Confidence            999999 8 8999999999999998775                   2699999999986543    2458899999999


Q ss_pred             hhcCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccc
Q 016401          223 LIFGATEYTTAIDIWSTGCV-MAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV  300 (390)
Q Consensus       223 ~~~~~~~~~~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (390)
                      ++.+..  +.++||||+|++ .+++++|..||.+....... ..+....                  ....   . ....
T Consensus       248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------~~~~---~-~~~~  303 (336)
T 2vuw_A          248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM------------------TFKT---K-CNTP  303 (336)
T ss_dssp             GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC------------------CCSS---C-CCSH
T ss_pred             hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh------------------ccCc---c-cchh
Confidence            996543  889999998777 77888999998542111111 1221110                  0000   0 0011


Q ss_pred             cccCCChhHHHHHHHhcccCCCcCCCHHHHh-cCCccc
Q 016401          301 FQKRLPPEAVDLVCRFFQYSPNLRCTALEAC-VHPFFD  337 (390)
Q Consensus       301 ~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l-~hp~f~  337 (390)
                      ..+.+++++++||++||++|     |+.|+| +||||+
T Consensus       304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            22457889999999999987     999999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.9e-41  Score=337.36  Aligned_cols=246  Identities=26%  Similarity=0.346  Sum_probs=197.2

Q ss_pred             cccccEEEeeeeeecCceEEEEEEEcCC---CcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           47 KQKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        47 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      ....+|++.+.||+|+||.||+|.+..+   +..||||++....     ....+|+.+++.++||||+++++++..    
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----  462 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----  462 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            3456899999999999999999998643   4679999875432     334579999999999999999998721    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeec
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  197 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  197 (390)
                      +  ..|+||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+||
T Consensus       463 ~--~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~-~vkL~DF  535 (656)
T 2j0j_A          463 N--PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDF  535 (656)
T ss_dssp             S--SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred             C--ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCC-CEEEEec
Confidence            1  2679999998 5887777542   3468999999999999999999998 9999999999999999888 7999999


Q ss_pred             CCccccccCCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          198 GSAKVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       198 g~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      |+++........  ....+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+.+..+.....    
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~----  610 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----  610 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC----
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----
Confidence            999865433221  223457889999999644 58999999999999999997 9999998887776665544100    


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                              ..++..+++.+.+||.+||..||++|||+.++++
T Consensus       611 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          611 ------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                    0122468999999999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=313.80  Aligned_cols=249  Identities=18%  Similarity=0.255  Sum_probs=193.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||.||+|.+..   .+|+|++...      .....+|+.+++.++||||+++++++...     ..
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~  103 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----PH  103 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----SC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----Cc
Confidence            3589999999999999999999853   4999988532      13345799999999999999999998433     33


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +++||||+. ++|.+++..   ....+++..++.++.||+.||+|||+ .||+||||||+||+++ ++ .+||+|||++.
T Consensus       104 ~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~  177 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NG-KVVITDFGLFS  177 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCCC
T ss_pred             eEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CC-CEEEeecCCcc
Confidence            789999997 577666543   23468999999999999999999998 9999999999999998 45 79999999976


Q ss_pred             cccc------CCCCcceeeccccccchhhcC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016401          202 VLVK------GEPNVSYICSRYYRAPELIFG--------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       202 ~~~~------~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  267 (390)
                      ....      ........||+.|+|||++.+        ...++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  257 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT  257 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence            5421      122233457899999999954        23478899999999999999999999988776655544432


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ..                   .+        ......++.++.+||.+||..||++|||+.++++  .++.+.
T Consensus       258 ~~-------------------~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~  301 (319)
T 2y4i_B          258 GM-------------------KP--------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLP  301 (319)
T ss_dssp             TC-------------------CC--------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-
T ss_pred             CC-------------------CC--------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence            10                   00        0011357889999999999999999999999985  444443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-41  Score=345.80  Aligned_cols=242  Identities=25%  Similarity=0.346  Sum_probs=195.0

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC-CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||.||+|.+.. +++.||||++....     ....+|+.+++.++||||+++++++.........+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3589999999999999999999976 78999999885322     23457999999999999999999986655445555


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .|+||||++| +|...+.      ..+++..+..++.||+.||.|||+ +||+||||||+|||++.+  .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC--cEEEEecccch
Confidence            7899999985 5544332      379999999999999999999998 999999999999999975  69999999998


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+....                      
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------------  282 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------------  282 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------------
T ss_pred             hcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------------------
Confidence            65332   456789999999999543  489999999999999999999988652110                      


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                            ..+.       .......++.+.+||.+||..||++||+..+++.|+|+.-+
T Consensus       283 ------~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          283 ------GLPE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ------SCCT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------cccc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                  0000       00001246789999999999999999999999999998654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-39  Score=296.25  Aligned_cols=220  Identities=14%  Similarity=0.051  Sum_probs=173.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.++..++||||+++++++..     ...
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence            47999999999999999999999999999999986432       345679999999999999999999843     345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .|+||||++| +|.+++..      ......+..++.||+.||+|||+ +||+||||||+|||++.++ .+||++++   
T Consensus       106 ~~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g-~~kl~~~~---  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDG-DVVLAYPA---  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTS-CEEECSCC---
T ss_pred             EEEEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCC-CEEEEecc---
Confidence            8899999984 77776632      24556788899999999999998 9999999999999999888 79998543   


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                                      |++        .++.++|||||||++|+|++|+.||.+.+..+.+...                
T Consensus       175 ----------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----------------  214 (286)
T 3uqc_A          175 ----------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------------  214 (286)
T ss_dssp             ----------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------------
T ss_pred             ----------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------------
Confidence                            232        2789999999999999999999999876532211000                


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                           ..... ........+...+++++.+||.+||..||++| |+.++++
T Consensus       215 -----~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          215 -----ERDTA-GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             -----CBCTT-SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             -----HHHhc-cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                 00000 00011112335689999999999999999999 9999986

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2e-33  Score=278.18  Aligned_cols=178  Identities=17%  Similarity=0.077  Sum_probs=123.3

Q ss_pred             eeeecCceEEEEEEEcCCCcEEEEEEeccc--------------hhhHHHHHHHHHhC-CCCceeeecceeccCCCCCce
Q 016401           57 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        57 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ..+.|+.|.+..++..-.|+.||+|++.++              ...+.+|+++|+++ .|+||+++++++     +++.
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            356677777777777778999999998543              12345799999999 799999999998     4555


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+||||||++| +|.+++..    .+++++.   .|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCC-CEEEeecccC
Confidence            68999999996 88777764    3556654   578999999999998 9999999999999999998 7999999999


Q ss_pred             cccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCC
Q 016401          201 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  250 (390)
Q Consensus       201 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  250 (390)
                      +..... ....+.+||+.|+|||++.+  .+..++|+||+|++++++.++.
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence            865433 33456789999999999954  3678899999999988876654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=8.9e-28  Score=236.46  Aligned_cols=179  Identities=16%  Similarity=0.237  Sum_probs=132.0

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           53 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ...+.||+|+||.||+|.  ..++.+++|+.....            ....+|++++++++||||+++..++....   .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---N  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT---T
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC---c
Confidence            456799999999999994  457889999763211            12468999999999999995444433222   2


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                        .|+||||++ ++|.+++..            +..++.|++.||+|||+ +||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence              479999997 587665542            56789999999999998 99999999999999997   699999999


Q ss_pred             ccccccCCC--------CcceeeccccccchhhcC-CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 016401          200 AKVLVKGEP--------NVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFP  254 (390)
Q Consensus       200 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~  254 (390)
                      ++.......        .....||+.|+|||++.. ...|+..+|+|+..+-..+.+.++.+|.
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            987643221        135678999999999954 1337888999999998888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.8e-24  Score=195.78  Aligned_cols=138  Identities=18%  Similarity=0.159  Sum_probs=108.5

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----------------------hhhHHHHHHHHHhCCCCceeeec
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------------------KRYKNRELQIMQMLDHPNIVALK  109 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------------------~~~~~~E~~~l~~l~h~~iv~~~  109 (390)
                      |.+.+.||+|+||.||+|.+ .+|+.||||++...                      .....+|+.++++++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            44559999999999999999 88999999998532                      123458999999999  5 6666


Q ss_pred             ceeccCCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC
Q 016401          110 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  188 (390)
Q Consensus       110 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  188 (390)
                      .++..      ...|+||||++| +|.+ +          .......++.|++.||.|||+ .||+||||||+|||++ +
T Consensus       168 ~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          168 KVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-T
T ss_pred             eEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-C
Confidence            65411      225799999986 6643 1          112355789999999999998 9999999999999999 7


Q ss_pred             CCcEEEeecCCccccccCCCCcceeeccccccchhhc
Q 016401          189 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF  225 (390)
Q Consensus       189 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~  225 (390)
                      + .+||+|||+|..            +..+.|||.+.
T Consensus       229 ~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 E-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             T-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             C-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            6 799999999863            33478999873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=2.3e-21  Score=173.23  Aligned_cols=133  Identities=17%  Similarity=0.236  Sum_probs=102.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcE--EEEEEeccch----------------------------hhHHHHHHHHHhC
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDK----------------------------RYKNRELQIMQML  100 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~----------------------------~~~~~E~~~l~~l  100 (390)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+|+.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            588999999999999999999778999  9999864321                            1346799999999


Q ss_pred             CCCcee--eecceeccCCCCCceEEEEEEecccc------cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH-hcC
Q 016401          101 DHPNIV--ALKHCFFSTTDKEELYLNLVLEYVPE------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-NCI  171 (390)
Q Consensus       101 ~h~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH-~~~  171 (390)
                      .|+++.  .++..         ...++||||+++      .|.....       ..++..+..++.|++.||.||| + .
T Consensus       128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~  190 (258)
T 1zth_A          128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-A  190 (258)
T ss_dssp             HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-S
T ss_pred             HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-C
Confidence            887642  22221         114699999953      4433321       1234467889999999999999 8 8


Q ss_pred             CcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          172 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       172 ~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      ||+||||||+|||++.   .++|+|||+|...
T Consensus       191 givHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ELVHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             CEECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             CEEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            9999999999999997   5999999999643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=1.3e-18  Score=161.71  Aligned_cols=141  Identities=12%  Similarity=0.089  Sum_probs=91.4

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh------------------hHHHHHHHHHhCCCCceeeeccee
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------YKNRELQIMQMLDHPNIVALKHCF  112 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~E~~~l~~l~h~~iv~~~~~~  112 (390)
                      -|.+.+.||+|++|.||+|.+. +|+.||||+++....                  ....+.++.....|+|+.+++...
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            4999999999999999999984 699999998742110                  011122222222344444333322


Q ss_pred             ccCCCC-CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC-
Q 016401          113 FSTTDK-EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-  190 (390)
Q Consensus       113 ~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-  190 (390)
                      ...... .....++||||++|...   ..      -........++.||+.+|.+||+ .|||||||||.|||++.++. 
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L---~~------l~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPM---RQ------VSSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEG---GG------CCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEEEECS
T ss_pred             CCCCeeeeccCceEEEEecCCccH---hh------hcccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeCCCCc
Confidence            111100 00002599999987321   11      11222346778999999999998 89999999999999987652 


Q ss_pred             --------cEEEeecCCccc
Q 016401          191 --------QLKLCDFGSAKV  202 (390)
Q Consensus       191 --------~vkl~Dfg~a~~  202 (390)
                              .+.|+||+.+..
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEE
T ss_pred             ccccccccceEEEEeCCccc
Confidence                    288999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=1.2e-11  Score=110.28  Aligned_cols=134  Identities=14%  Similarity=0.095  Sum_probs=99.1

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEecc----chhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      .|++...++.|+.+.||++...  ++.+++|+...    ......+|+.+++.+. +..+.+++++..     .....|+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence            5889999999999999999753  68899998853    3345778999999984 566667776652     2344779


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------  170 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~----------------------------------  170 (390)
                      |||+++| .+....         .+......++.++..+|..||+.                                  
T Consensus        88 v~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999998 443221         01122346678899999999960                                  


Q ss_pred             ------------------------CCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          171 ------------------------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       171 ------------------------~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                                              ..++|+|++|.|||++.+. .+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                    3489999999999998643 46799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.17  E-value=6.7e-11  Score=104.96  Aligned_cols=132  Identities=16%  Similarity=0.098  Sum_probs=88.4

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHhCCCCc--eeeecceeccCCCCCceEEEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .|.+..+.+.|..+.||++.. .+|..+++|+.... .....+|+.+++.+.+.+  +.+++.+...     ....++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEE
Confidence            466655545667799999965 46778999987543 234578999999986544  3456655422     12367999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----------------------------------  172 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~-----------------------------------  172 (390)
                      ||++|.... .       ....   ...++.+++..|..||+ ..                                   
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            999973211 0       0111   12445566666777765 32                                   


Q ss_pred             -----------------------cccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          173 -----------------------ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       173 -----------------------ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                                             ++|+|++|.||+++.+. .+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                   99999999999998654 46799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.06  E-value=7.5e-10  Score=103.24  Aligned_cols=141  Identities=16%  Similarity=0.190  Sum_probs=98.6

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEec--cc-----hhhHHHHHHHHHhCCC--CceeeecceeccCCCCCceEE
Q 016401           53 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--QD-----KRYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~-----~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ...+.|+.|.++.||++...  +..+++|+..  ..     .....+|+.+++.+..  ..+++++..+.+..  .....
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSC
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCe
Confidence            34677899999999999864  4678999775  22     2356789999999974  44666666553221  11234


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc---------------------------------
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC---------------------------------  170 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~---------------------------------  170 (390)
                      |+||||++|...   ..  .....++......++.+++.+|..||+.                                 
T Consensus       117 ~~vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          117 FYIMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             EEEEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EEEEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            689999997321   00  1123466777788889999999999961                                 


Q ss_pred             ------------------------CCcccccCCCCcEEEcCCCC-cEEEeecCCccc
Q 016401          171 ------------------------IGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  202 (390)
Q Consensus       171 ------------------------~~ivH~Dlkp~NIll~~~~~-~vkl~Dfg~a~~  202 (390)
                                              ..++|+|++|.|||++.++. .+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    36899999999999987652 368999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=2.6e-10  Score=103.81  Aligned_cols=183  Identities=13%  Similarity=0.151  Sum_probs=108.9

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCC-CCce--eeecceeccCCCCCceEEEEEEec
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLD-HPNI--VALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      .+.++.|....||++.     ..+++|+....  .....+|.++|+.+. +..+  .+++...  .........|+||++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceEEEcc
Confidence            3458999999999864     45899986543  244568999998884 3322  2222221  111111234689999


Q ss_pred             ccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 016401          130 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--------------------------------------  170 (390)
Q Consensus       130 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~--------------------------------------  170 (390)
                      ++| .+.....      ..++......++.+++..|..||+.                                      
T Consensus        98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            997 3221111      2345555566666666666666630                                      


Q ss_pred             -------------------CCcccccCCCCcEEEcCC-CCcEEEeecCCccccccCCCCcceeecccc---ccchhhc--
Q 016401          171 -------------------IGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYY---RAPELIF--  225 (390)
Q Consensus       171 -------------------~~ivH~Dlkp~NIll~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y---~aPE~~~--  225 (390)
                                         ..++|+|++|.||+++.+ +..+.|+||+.+....   +.........+   ..|+...  
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~---~~~Dl~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD---PDNDFISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC---TTHHHHTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC---hHHHHHHHHhhccccCHHHHHHH
Confidence                               147999999999999974 3367899999886431   11111111111   2222210  


Q ss_pred             -C-CC---------CCCCchhHHHHHHHHHHHHhCCCCC
Q 016401          226 -G-AT---------EYTTAIDIWSTGCVMAELLLGQPLF  253 (390)
Q Consensus       226 -~-~~---------~~~~~~DiwslG~il~ell~g~~pf  253 (390)
                       . ..         ......+.|+++.++|.+.+|..+|
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             0 00         0122358999999999999998766

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.60  E-value=4.6e-07  Score=82.30  Aligned_cols=69  Identities=12%  Similarity=-0.055  Sum_probs=45.3

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCc---eeeecceeccCCCCCceEEEEEEec
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN---IVALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      .+.++.|....||+.     +..+++|+-...  .....+|.++|+.+.+..   +.+++.+..  .  .....++|||+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEec
Confidence            455788999999988     467899975432  234568999999997532   333333321  1  12234699999


Q ss_pred             ccc
Q 016401          130 VPE  132 (390)
Q Consensus       130 ~~~  132 (390)
                      ++|
T Consensus        95 i~G   97 (306)
T 3tdw_A           95 VQG   97 (306)
T ss_dssp             CCS
T ss_pred             cCC
Confidence            997

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.31  E-value=6.9e-06  Score=72.90  Aligned_cols=130  Identities=15%  Similarity=0.143  Sum_probs=78.8

Q ss_pred             eeecCce-EEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHhCCC-CceeeecceeccCCCCCceEEEEEEecccc-c
Q 016401           58 VGTGSFG-VVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-T  133 (390)
Q Consensus        58 lg~G~~g-~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~  133 (390)
                      +..|..+ .||+......+..+++|+-... .....+|...|+.+.. -.+.+++.+..+     ....++|||+++| .
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCcc
Confidence            4445444 7999888777788999986543 2345689999988842 223444444421     2236799999987 3


Q ss_pred             HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 016401          134 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--------------------------------------------  169 (390)
Q Consensus       134 l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~--------------------------------------------  169 (390)
                      +.......        ......+..++...|.-||+                                            
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            33322110        00112223333444444432                                            


Q ss_pred             -------c------CCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          170 -------C------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       170 -------~------~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                             .      ..++|+|+.+.|||++.++ .+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence                   0      1279999999999999765 56799999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=5.1e-06  Score=76.31  Aligned_cols=75  Identities=12%  Similarity=0.216  Sum_probs=40.7

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCC--ceeeecceeccCC--CCCceEEEEEEecc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP--NIVALKHCFFSTT--DKEELYLNLVLEYV  130 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~--~~~~~~~~lv~e~~  130 (390)
                      .+.|+.|..+.||++...  +..+++|+..........|..+++.|...  .+.+++... +..  .......+++|+|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~-~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNK-KGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCT-TSCSCEEETTEEEEEEECC
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecC-CCCEEEEECCEEEEEEEee
Confidence            345667778899999863  34599999876544445677777766321  223332210 000  01123467899999


Q ss_pred             cc
Q 016401          131 PE  132 (390)
Q Consensus       131 ~~  132 (390)
                      +|
T Consensus       114 ~G  115 (346)
T 2q83_A          114 EG  115 (346)
T ss_dssp             CC
T ss_pred             cC
Confidence            86

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.16  E-value=1.2e-05  Score=75.68  Aligned_cols=72  Identities=17%  Similarity=0.161  Sum_probs=45.1

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----------hhhHHHHHHHHHhCCC--Cc-eeeecceeccCCCCC
Q 016401           54 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLDH--PN-IVALKHCFFSTTDKE  119 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~E~~~l~~l~h--~~-iv~~~~~~~~~~~~~  119 (390)
                      ..+.||.|..+.||++....+++.|+||.....           ......|.++++.+..  +. +.+++.+.     .+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-----~~  108 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----TE  108 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----TT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-----CC
Confidence            456789999999999986656788999975321           1223579999888742  33 33444321     12


Q ss_pred             ceEEEEEEecccc
Q 016401          120 ELYLNLVLEYVPE  132 (390)
Q Consensus       120 ~~~~~lv~e~~~~  132 (390)
                      .  .++|||++++
T Consensus       109 ~--~~lvmE~l~g  119 (397)
T 2olc_A          109 M--AVTVMEDLSH  119 (397)
T ss_dssp             T--TEEEECCCTT
T ss_pred             c--cEEEEEeCCC
Confidence            2  3589999975

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.00  E-value=2.6e-05  Score=72.16  Aligned_cols=79  Identities=9%  Similarity=0.093  Sum_probs=50.0

Q ss_pred             EEEeeee-eecCceEEEEEEEc---C---CCcEEEEEEeccch-------hhHHHHHHHHHhCCC---Cceeeecceecc
Q 016401           52 YIAEHVV-GTGSFGVVFQAKCR---E---TGEIVAIKKVLQDK-------RYKNRELQIMQMLDH---PNIVALKHCFFS  114 (390)
Q Consensus        52 y~~~~~l-g~G~~g~V~~~~~~---~---~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h---~~iv~~~~~~~~  114 (390)
                      ....+.| +.|....+|++...   .   ++..+++|+.....       ....+|+.+++.+..   -.+.+++.+...
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            4455678 88888999988753   0   25679999765432       346789999988842   245555554422


Q ss_pred             CCCCCceEEEEEEecccc
Q 016401          115 TTDKEELYLNLVLEYVPE  132 (390)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~  132 (390)
                      ...  ....++|||+++|
T Consensus       102 ~~~--~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 GDV--LGTPFFLMDYVEG  117 (357)
T ss_dssp             STT--TSSCEEEEECCCC
T ss_pred             CCc--cCCceEEEEecCC
Confidence            110  1224589999986

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.78  E-value=0.00013  Score=65.84  Aligned_cols=65  Identities=12%  Similarity=0.059  Sum_probs=41.0

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCce-eeecceeccCCCCCceEEEEEEecc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLNLVLEYV  130 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~~  130 (390)
                      .+.|+.|....+|++      ..+++|+.....   ....+|+.+++.+....+ .+++...     .+..  ++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~~--~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PATG--VMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTTC--CEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCCC--EEEEeec
Confidence            677899999999999      458899875432   223578888887743222 2333322     1112  3799999


Q ss_pred             -cc
Q 016401          131 -PE  132 (390)
Q Consensus       131 -~~  132 (390)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             64

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.75  E-value=0.00068  Score=57.09  Aligned_cols=100  Identities=18%  Similarity=0.094  Sum_probs=65.9

Q ss_pred             cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCCcce
Q 016401          133 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY  212 (390)
Q Consensus       133 ~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~  212 (390)
                      +|..++..+   +.++++.++|.++.|.+.+|.-+-..+.-..+=+.|..|++..+| .|.+.+ ..+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            677777764   589999999999999999988763112222344567999999998 577654 1110           


Q ss_pred             eeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCC
Q 016401          213 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  250 (390)
Q Consensus       213 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  250 (390)
                      .....+.|||...  ...+.+.-|+|||+++|.-+--.
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            1122367888763  23578899999999999988643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.62  E-value=0.00025  Score=67.14  Aligned_cols=77  Identities=13%  Similarity=-0.037  Sum_probs=45.8

Q ss_pred             CCcccccCCCCcEEEcCCCCcEEEeecCCccccccCCCCcceee--ccccccchhhcCCC--CCCCchhHHHHHHHHHHH
Q 016401          171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGAT--EYTTAIDIWSTGCVMAEL  246 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~~DiwslG~il~el  246 (390)
                      ..++|+|++|.|||++.++  +.|+||+.+..............  ...|.+|+......  ......++..+...+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            6799999999999998764  99999998864321111111111  23466666552111  011234455777777777


Q ss_pred             HhC
Q 016401          247 LLG  249 (390)
Q Consensus       247 l~g  249 (390)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.51  E-value=0.00044  Score=62.76  Aligned_cols=145  Identities=12%  Similarity=0.050  Sum_probs=75.8

Q ss_pred             EEeeeeeecCceEEEEEEEcCCCcEEEEEEecc--chhhHHHHHHHHHhCCCCce--eeecceeccCCC--CCceEEEEE
Q 016401           53 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNI--VALKHCFFSTTD--KEELYLNLV  126 (390)
Q Consensus        53 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~--~~~~~~~lv  126 (390)
                      .-.+.|+.|....+|++... ++ .+++|+...  .......|..+++.+....+  .+++... +...  ......+++
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEEE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEEE
Confidence            34567788888999999763 33 688998865  33455678888887743222  2222110 0000  001235689


Q ss_pred             EecccccH------------HHHHHHhhhhcCCC--------cHH-HHHH--------------HHHHHHHHHHHHHh--
Q 016401          127 LEYVPETV------------NRIARNYSRIHQRM--------PLI-YVKL--------------YTYQICRALAYIHN--  169 (390)
Q Consensus       127 ~e~~~~~l------------~~~~~~~~~~~~~~--------~~~-~~~~--------------~~~ql~~al~~LH~--  169 (390)
                      |++++|..            ...+...-.....+        ... +...              +...+...++.+..  
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            99998621            11111110000000        100 0000              00113344555542  


Q ss_pred             ----cCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          170 ----CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       170 ----~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                          ..+++|+|+++.|||++.+. .+.|+||+.+.
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~  216 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  216 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             cccCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence                13699999999999998764 45799999874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.42  E-value=0.002  Score=57.43  Aligned_cols=71  Identities=14%  Similarity=0.129  Sum_probs=49.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCC---ceeeecceeccCCCCCceEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHP---NIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ...-++.+|.|..+.||++.. .+|+.|++|+....    ...+.+|+..|+.|...   .+.+++...       .  -
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------~--~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------D--R   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-------T--T
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-------C--c
Confidence            466778899999999999987 57899999986432    23467899999988432   223333221       1  2


Q ss_pred             EEEEeccc
Q 016401          124 NLVLEYVP  131 (390)
Q Consensus       124 ~lv~e~~~  131 (390)
                      ++||||+.
T Consensus        86 ~lv~e~l~   93 (288)
T 3f7w_A           86 TLAMEWVD   93 (288)
T ss_dssp             EEEEECCC
T ss_pred             eEEEEeec
Confidence            47899986

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.39  E-value=0.0015  Score=61.85  Aligned_cols=70  Identities=17%  Similarity=0.248  Sum_probs=46.9

Q ss_pred             EeeeeeecCceEEEEEEEcC-------CCcEEEEEEecc-ch-hhHHHHHHHHHhCCCCce-eeecceeccCCCCCceEE
Q 016401           54 AEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ-DK-RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYL  123 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~-~~-~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~  123 (390)
                      -.+.|+.|....||++....       .+..|++|+... .. ....+|..+++.+...++ .++++.+     .+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            45678889899999998642       257899998844 22 344579999988853333 3454443     11    


Q ss_pred             EEEEecccc
Q 016401          124 NLVLEYVPE  132 (390)
Q Consensus       124 ~lv~e~~~~  132 (390)
                      .+|+||++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            178999875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.37  E-value=0.0019  Score=61.69  Aligned_cols=70  Identities=16%  Similarity=0.173  Sum_probs=45.9

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHhCCCCcee-eecceeccCCCCCceEEEEEEec
Q 016401           54 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      -.+.|+.|-...+|++.....+..|++|+......   ...+|..+++.|...++. +++..+     . +.   +||||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~-~G---~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----T-NG---RIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----T-TE---EEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----C-Ce---EEEEe
Confidence            45678888899999998754457899998743221   235899999999755543 555544     1 11   49999


Q ss_pred             ccc
Q 016401          130 VPE  132 (390)
Q Consensus       130 ~~~  132 (390)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.33  E-value=0.0021  Score=58.35  Aligned_cols=73  Identities=14%  Similarity=0.008  Sum_probs=43.7

Q ss_pred             eeeeecCceEEEEEEEcCCCcEEEEEEecc---chhhHHHHHHHHHhCCCCc--eeeecceeccCCC--CCceEEEEEEe
Q 016401           56 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD--KEELYLNLVLE  128 (390)
Q Consensus        56 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e  128 (390)
                      ..|+ |....||++.. .+|+.+++|+...   .......|..+++.+....  +++++..  +...  ......+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence            3455 77788998865 3466799998853   2344567888888874222  3333322  1100  01234568999


Q ss_pred             cccc
Q 016401          129 YVPE  132 (390)
Q Consensus       129 ~~~~  132 (390)
                      +++|
T Consensus       108 ~i~G  111 (328)
T 1zyl_A          108 SVGG  111 (328)
T ss_dssp             CCCC
T ss_pred             ecCC
Confidence            9986

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.31  E-value=0.0019  Score=60.02  Aligned_cols=138  Identities=20%  Similarity=0.253  Sum_probs=77.3

Q ss_pred             eeeeeecCceEEEEEEEcC-------CCcEEEEEEecc---chhhHHHHHHHHHhCCCCce-eeecceeccCCCCCceEE
Q 016401           55 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYL  123 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~---~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~  123 (390)
                      .+.|..|....+|++....       +++.|++|+.-.   ......+|..+++.+....+ .+++..+     .+ .  
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~-g--  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE-G--  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT-E--
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC-c--
Confidence            3567778888999998642       357899998633   22334589999988843222 3444444     22 1  


Q ss_pred             EEEEeccccc------------HHHHHHHhhhhcC-------CC--cHHHHHHHHHHHHH-------------------H
Q 016401          124 NLVLEYVPET------------VNRIARNYSRIHQ-------RM--PLIYVKLYTYQICR-------------------A  163 (390)
Q Consensus       124 ~lv~e~~~~~------------l~~~~~~~~~~~~-------~~--~~~~~~~~~~ql~~-------------------a  163 (390)
                       +||||++|.            ...+.....+.+.       ..  -...+..+..++..                   .
T Consensus       127 -~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          127 -RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             -EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             -cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence             799999851            1122222221111       11  13445555544322                   2


Q ss_pred             HHHHHh-------cCCcccccCCCCcEEEcCC---CCcEEEeecCCcc
Q 016401          164 LAYIHN-------CIGICHRDIKPQNLLVNPH---THQLKLCDFGSAK  201 (390)
Q Consensus       164 l~~LH~-------~~~ivH~Dlkp~NIll~~~---~~~vkl~Dfg~a~  201 (390)
                      +..|..       ...++|+|+.+.||+++.+   ...+.|+||..|.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            333331       1258999999999999876   2269999999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.30  E-value=0.0018  Score=59.00  Aligned_cols=32  Identities=38%  Similarity=0.561  Sum_probs=26.5

Q ss_pred             CCcccccCCCCcEEEcCC---CCcEEEeecCCccc
Q 016401          171 IGICHRDIKPQNLLVNPH---THQLKLCDFGSAKV  202 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~---~~~vkl~Dfg~a~~  202 (390)
                      ..++|+|+.+.|||++.+   ...+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999864   12689999998863

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.25  E-value=0.0015  Score=59.06  Aligned_cols=72  Identities=14%  Similarity=0.057  Sum_probs=50.7

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHhCC---CCceeeecceeccCCCCCceEEEEEEec
Q 016401           54 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYLNLVLEY  129 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~  129 (390)
                      -.+.|+.|....+|+...  ++..+++|+.... .....+|...|+.|.   ...+++++.....     ....++|||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEe
Confidence            456789999999999985  4678999987543 344668999988883   2445566554421     2346799999


Q ss_pred             ccc
Q 016401          130 VPE  132 (390)
Q Consensus       130 ~~~  132 (390)
                      ++|
T Consensus       113 l~G  115 (312)
T 3jr1_A          113 LNK  115 (312)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            985

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.20  E-value=0.00098  Score=61.79  Aligned_cols=69  Identities=13%  Similarity=0.135  Sum_probs=41.1

Q ss_pred             eeeeeecCceEEEEEEEcC--------CCcEEEEEEeccchh---hHHHHHHHHHhCCCCce-eeecceeccCCCCCceE
Q 016401           55 EHVVGTGSFGVVFQAKCRE--------TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELY  122 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~  122 (390)
                      .+.|+.|....+|++....        .+..+++|+......   ....|..+++.+....+ .+++..+     .    
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~----  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N----  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence            4567888888999998643        136799998754322   23578888888853333 3444332     1    


Q ss_pred             EEEEEecccc
Q 016401          123 LNLVLEYVPE  132 (390)
Q Consensus       123 ~~lv~e~~~~  132 (390)
                      -++||||++|
T Consensus       109 ~~~v~e~i~G  118 (369)
T 3c5i_A          109 GGRIEEWLYG  118 (369)
T ss_dssp             TEEEEECCCS
T ss_pred             CcEEEEEecC
Confidence            1378999876

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.83  E-value=0.0059  Score=55.85  Aligned_cols=31  Identities=26%  Similarity=0.532  Sum_probs=26.5

Q ss_pred             CCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      ..++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            4699999999999998766 699999987753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.93  E-value=0.054  Score=50.93  Aligned_cols=70  Identities=13%  Similarity=0.115  Sum_probs=45.0

Q ss_pred             EeeeeeecCceEEEEEEEcCC-------CcEEEEEEeccch---hhHHHHHHHHHhCCCCce-eeecceeccCCCCCceE
Q 016401           54 AEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK---RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELY  122 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~  122 (390)
                      -.+.|..|....+|++.....       ++.|++|+.....   ....+|..+++.+....+ .++++.+     .    
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence            445677788889999987521       5789999874322   123589999988853233 3444332     1    


Q ss_pred             EEEEEecccc
Q 016401          123 LNLVLEYVPE  132 (390)
Q Consensus       123 ~~lv~e~~~~  132 (390)
                      -++||+|++|
T Consensus       145 ~~~I~efI~G  154 (424)
T 3mes_A          145 EGRIEEFIDG  154 (424)
T ss_dssp             TEEEEECCCS
T ss_pred             CCEEEEEeCC
Confidence            1478999986

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.47  E-value=0.39  Score=44.68  Aligned_cols=31  Identities=29%  Similarity=0.493  Sum_probs=24.6

Q ss_pred             CcccccCCCCcEEEcC-----CCCcEEEeecCCccc
Q 016401          172 GICHRDIKPQNLLVNP-----HTHQLKLCDFGSAKV  202 (390)
Q Consensus       172 ~ivH~Dlkp~NIll~~-----~~~~vkl~Dfg~a~~  202 (390)
                      .++|+|+.+.|||+..     +...+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            3689999999999932     233699999998853

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	390
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-126
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-75
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-71
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-70
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-67
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-67
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-67
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-66
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-66
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-66
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-64
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-64
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-62
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-61
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-60
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-59
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-59
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-58
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-57
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-57
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-54
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-52
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-52
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-52
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-49
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-49
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-44
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-44
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-42
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-42
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-40
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-38
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  366 bits (940), Expect = e-126
 Identities = 238/341 (69%), Positives = 279/341 (81%), Gaps = 3/341 (0%)

Query: 41  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 100
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70

Query: 101 DHPNIVALKHCFFST-TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 159
           DH NIV L++ F+S+   K+E+YLNLVL+YVPETV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHAR 380
           RDPN +LPNGR  P LFNF   ELS  PP     LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLA-TILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 8e-75
 Identities = 102/342 (29%), Positives = 175/342 (51%), Gaps = 25/342 (7%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKN---RELQIMQMLDHPNIV 106
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            +     + T ++   + LV   +   + ++ +      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKY 124

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 222
           IH+   + HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 280
           ++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 281 -NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
                     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 381
            DP+       P+         EL  +P E +  LI E   +
Sbjct: 302 YDPSD-----EPIAEAPFKFDMELDDLPKEKLKELIFEETAR 338

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 8e-71
 Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 31/305 (10%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
           +     +G G+ GVVF+   + +G ++A K +  + +        RELQ++   + P IV
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
                F       E+ +   +E++            +   R+P   +   +  + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           +     I HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 285
            T Y+   DIWS G  + E+ +G+   P       +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 286 EFKF--------------PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
              +                I   P  K+       E  D V +    +P  R    +  
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 332 VHPFF 336
           VH F 
Sbjct: 297 VHAFI 301

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (565), Expect = 1e-70
 Identities = 99/303 (32%), Positives = 149/303 (49%), Gaps = 23/303 (7%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 107
            +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L   F     K  + L  V +++      +          +   ++K Y     + L Y+
Sbjct: 65  LLDAF---GHKSNISL--VFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 226
           H    I HRD+KP NLL++ +   LKL DFG AK         ++   +R+YRAPEL+FG
Sbjct: 117 HQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
           A  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+   M      
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 344
             F      P H +F      + +DL+   F ++P  R TA +A    +F     P    
Sbjct: 235 VTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293

Query: 345 RLP 347
           +LP
Sbjct: 294 QLP 296

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-67
 Identities = 102/307 (33%), Positives = 165/307 (53%), Gaps = 21/307 (6%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           +     +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L         + +LYL  V E++ + + +     +     +PL  +K Y +Q+ + LA
Sbjct: 64  VKLLDVI---HTENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLA 116

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 224
           + H+   + HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 283
            G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
             +  FP+     + KV    L  +   L+ +   Y PN R +A  A  HPFF ++  P 
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292

Query: 344 TRLPNGR 350
             +P+ R
Sbjct: 293 --VPHLR 297

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  213 bits (543), Expect = 4e-67
 Identities = 89/300 (29%), Positives = 147/300 (49%), Gaps = 21/300 (7%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALK 109
           Y     +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
                  D       LV E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H+
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             GI HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 230 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 288
           Y  ++D+WS GC++A ++  + P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 289 FPQIKPHPWHKVFQKRLP--------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
           F  I      K +++ +         PEA+D + +  +Y    R TA EA  HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 5e-67
 Identities = 100/335 (29%), Positives = 159/335 (47%), Gaps = 24/335 (7%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 105
           Y     VG+G++G V  A   +TG  VA+KK+      +   +   REL++++ + H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           + L   F      EE     ++ ++         N     Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           YIH+   I HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
               Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 286 EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
                   Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP
Sbjct: 252 RNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 343 NTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPE 377
           +       P+   ++    E   +  +    L  +
Sbjct: 311 DD-----EPVADPYDQ-SFESRDLLIDEWKSLTYD 339

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 1e-66
 Identities = 86/309 (27%), Positives = 144/309 (46%), Gaps = 22/309 (7%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y     +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 106 VALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           V L     +     ++ +  + LV ++     + +A   S +  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-----SYICSRY 217
            L YIH    I HRD+K  N+L+      LKL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHRN-KILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
           YR PEL+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 278 KCMNPNYTEFKFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 334
             ++      K   +K        ++      P A+DL+ +     P  R  + +A  H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 335 FFDELRDPN 343
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-66
 Identities = 97/316 (30%), Positives = 158/316 (50%), Gaps = 21/316 (6%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y     VG+G++G V  A    TG  VAIKK+ +  + +       REL++++ + H N+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 106 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           + L   F      ++     LV+ ++   + ++ +     H+++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGL 134

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            YIH   GI HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 285 TEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 341
            +      P+++   +  +      P AV+L+ +        R TA EA  HP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 342 PNTRLPNGRPLPPLFN 357
                P  +     F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  212 bits (541), Expect = 2e-66
 Identities = 73/309 (23%), Positives = 120/309 (38%), Gaps = 41/309 (13%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 107
           Y     +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V 
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L   F    D  E+ +  + E++      +    +  H +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF---EDDNEMVM--IYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 168 HNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
                   D+WS G +   LL G   F GE+  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 344
                             +  +  D + +     PN R T  +A  HP+      P  ++
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 345 RLPNGRPLP 353
           ++P+ R   
Sbjct: 294 QIPSSRYTK 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 1e-64
 Identities = 96/299 (32%), Positives = 150/299 (50%), Gaps = 18/299 (6%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y     +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L           +  L LV E+       + + +   +  +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 224
           + H+   + HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 225 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           FGA  Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
                +P             +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-64
 Identities = 90/299 (30%), Positives = 147/299 (49%), Gaps = 17/299 (5%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDKRYKN------RELQIMQML---D 101
           Y     +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           HPN+V L      +    E  L LV E+V +  +            +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ--DLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
           R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E++   + Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
                  F      P  K     +     DL+ +   ++P  R +A  A  HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  202 bits (514), Expect = 3e-63
 Identities = 96/295 (32%), Positives = 151/295 (51%), Gaps = 20/295 (6%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y     +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NI
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L           +  L LV E++      + +        +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 224
           Y H+   + HRD+KPQNLL+N    +LK+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 283
            G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
             +  F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-62
 Identities = 79/309 (25%), Positives = 122/309 (39%), Gaps = 34/309 (11%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKH 110
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++  +    P+IV +  
Sbjct: 14  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 72

Query: 111 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            + +     +  L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 73  VYENLYAGRK-CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 169 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 226
           +   I HRD+KP+NLL         LKL DFG AK         +   + YY APE++  
Sbjct: 129 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +Y  + D+WS G +M  LL G P F    G+     +   +                +
Sbjct: 188 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------Q 233

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTR 345
           ++FP  +           +  E   L+    +  P  R T  E   HP+     + P T 
Sbjct: 234 YEFPNPEW--------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

Query: 346 LPNGRPLPP 354
           L   R L  
Sbjct: 286 LHTSRVLKE 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  202 bits (515), Expect = 2e-62
 Identities = 80/335 (23%), Positives = 127/335 (37%), Gaps = 44/335 (13%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 112
            +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 113 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 170
               DK E+ L  +LE++   E  +RIA        +M    V  Y  Q C  L ++H  
Sbjct: 96  ---EDKYEMVL--ILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 171 IGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
             I H DIKP+N++        +K+ DFG A  L   E       +  + APE++     
Sbjct: 147 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EP 204

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
                D+W+ G +   LL G   F GE  ++ L  + +       +              
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------ 252

Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPN 348
                          + PEA D +    Q  P  R T  +A  HP+   +  +  +R+P+
Sbjct: 253 -------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299

Query: 349 GRPLPPLFNFKPPELSGIPPETINRLIPEHARKQN 383
            R        K        P+     I   +  + 
Sbjct: 300 SRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRK 334

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 2e-61
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 44/295 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
                             L LEY          +       MP    + + +Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCS---GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 223
           +H   GI HRDIKP+NLL++   + LK+ DFG A V               +  Y APEL
Sbjct: 119 LHGI-GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 224 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
           +     +   +D+WS G V+  +L G+  +   S   Q                      
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----------------- 219

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
               K  +   +PW K+         + L+ +    +P+ R T  +     ++++
Sbjct: 220 ----KEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 1e-60
 Identities = 99/344 (28%), Positives = 156/344 (45%), Gaps = 33/344 (9%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 105
           Y     +G+G+ G+V  A        VAIKK+ +  + +       REL +M+ ++H NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 106 VALKHCFFSTTDKEEL-YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           ++L + F      EE   + LV+E +       A     I   +    +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMD------ANLCQVIQMELDHERMSYLLYQMLCGI 132

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            ++H+  GI HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 280
            G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K +    
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 281 ------NPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 331
                  P Y    FP++ P    P      K    +A DL+ +     P  R +  +A 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 332 VHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI 375
            HP+ +   DP        P P +++ +  E      E    LI
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQLDERE-HTIEEWKELI 349

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (498), Expect = 1e-60
 Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 49/305 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 104
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
            +  + C+     +   +  LV+EY        +       + +  + +   T+   + L
Sbjct: 77  TIQYRGCY---LREHTAW--LVMEYCL---GSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 225 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
               E  Y   +D+WS G    EL   +P     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 342
                + P ++   W             + V    Q  P  R T+     H F    R P
Sbjct: 229 ----NESPALQSGHW--------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 343 NTRLP 347
              + 
Sbjct: 277 TVIMD 281

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-60
 Identities = 60/289 (20%), Positives = 117/289 (40%), Gaps = 40/289 (13%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 108
           +  +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
            +  + +T K +  + LV E +    +   + Y +  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 169 -NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 227
                I HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 228 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 287
            +Y  ++D+++ G  M E+   +  +       Q+   +     P               
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233

Query: 288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                        F K   PE  +++    + + + R +  +   H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-59
 Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 48/292 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 104
           +     +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I+ L   F    D   +YL  +LEY P           +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF---HDATRVYL--ILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           +Y H+   + HRDIKP+NLL+      LK+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
            G   +   +D+WS G +  E L+G+P F   +  +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
            EF FP              +   A DL+ R  +++P+ R    E   HP+ 
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-59
 Identities = 67/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 105
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           V         T+     L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 165 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 219
              H        + HRD+KP N+ ++   + +KL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           +PE +     Y    DIWS GC++ EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                 E KF +I               E  +++ R        R +  E   +P 
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 1e-59
 Identities = 64/294 (21%), Positives = 117/294 (39%), Gaps = 44/294 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 107
           +     +G G+FG V++A+ +ET  + A K +     ++      E+ I+   DHPNIV 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L   F     +  L++  ++E+       +      + + +    +++   Q   AL Y+
Sbjct: 74  LLDAF---YYENNLWI--LIEFCAG--GAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFG 226
           H+   I HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 227 AT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
            T     Y    D+WS G  + E+   +P     + +  L++I K               
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-------------- 230

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 336
                  P             R      D + +  + + + R T  +   HPF 
Sbjct: 231 EPPTLAQP------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  194 bits (494), Expect = 2e-59
 Identities = 95/349 (27%), Positives = 150/349 (42%), Gaps = 49/349 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 108
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 109 KH----------CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 158
                         F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNVSYI 213
           Q+   L Y+H   GI H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 267
            +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 268 VLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHKV------FQKRLPPEAVDLVC 314
           +LG      ++      T F          ++K  P   V      F K    E  D + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 315 RFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 356
              Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-59
 Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 42/293 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVAL 108
           Y+    +G G FG+V +     + +    K V     D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 109 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
              F      EEL +  + E++   +   RI  +   +++R     +  Y +Q+C AL +
Sbjct: 67  HESF---ESMEELVM--IFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117

Query: 167 IHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 225
           +H+   I H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+  
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 226 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
                +TA D+WS G ++  LL G   F  E+    +  I+    T   E          
Sbjct: 177 H-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                            K +  EA+D V R        R TA EA  HP+  +
Sbjct: 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 9e-58
 Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 45/309 (14%)

Query: 44  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQM 99
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 100 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 159
             +PNIV     +      +EL++  V+EY+                 M    +     +
Sbjct: 74  NKNPNIVNYLDSY---LVGDELWV--VMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYY 218
             +AL ++H+   + HRDIK  N+L+      +KL DFG    +   +   S +  + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
            APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP      
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234

Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                  E + P            ++L     D + R        R +A E   H F   
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Query: 339 LRDPNTRLP 347
            +  ++  P
Sbjct: 276 AKPLSSLTP 284

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (476), Expect = 3e-57
 Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 42/303 (13%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
           Y    V+GTG+F  V  A+ + T ++VAIK + +            E+ ++  + HPNIV
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           AL   +        LYL  +++ V         +                 +Q+  A+ Y
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 167 IHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
           +H+   I HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 344
                           +   +   A D +    +  P  R T  +A  HP+       + 
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 345 RLP 347
            + 
Sbjct: 276 NIH 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 3e-57
 Identities = 89/329 (27%), Positives = 132/329 (40%), Gaps = 67/329 (20%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPN 104
           +    ++G GSF  V  A+   T    AIK + +    K        RE  +M  LDHP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
            V L   F    D E+LY    L Y     N     Y R          + YT +I  AL
Sbjct: 70  FVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAP 221
            Y+H    I HRD+KP+N+L+N   H +++ DFG+AKVL          S++ +  Y +P
Sbjct: 122 EYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           EL+        + D+W+ GC++ +L+ G P F   +      +IIK+             
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPF 335
               E+ FP+            +  P+A DLV +        R    E         HPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

Query: 336 FDELRDPNTRLPNGRPLPPLFNFKPPELS 364
           F+ +   N           L    PP+L+
Sbjct: 270 FESVTWEN-----------LHQQTPPKLT 287

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  186 bits (472), Expect = 4e-57
 Identities = 75/306 (24%), Positives = 121/306 (39%), Gaps = 54/306 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------------LQDKRYKNRELQIMQ 98
           Y  + ++G G   VV +   + T +  A+K +              + +    +E+ I++
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 99  ML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 157
            +  HPNI+ LK  +     +   +  LV + +         +Y      +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116

Query: 158 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 217
             +   +  +H    I HRD+KP+N+L++   + +KL DFG +  L  GE       +  
Sbjct: 117 RALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174

Query: 218 YRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 272
           Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I       
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227

Query: 273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 332
                  M+ NY +F  P+                   DLV RF    P  R TA EA  
Sbjct: 228 -------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

Query: 333 HPFFDE 338
           HPFF +
Sbjct: 270 HPFFQQ 275

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 6e-54
 Identities = 84/354 (23%), Positives = 142/354 (40%), Gaps = 62/354 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ--------IMQMLDHP 103
           +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++        +    +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
            +  +   F     KE L+  +  EY+          + +   +  L     Y  +I   
Sbjct: 64  FLTHMFCTF---QTKENLFFVM--EYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 222
           L ++H+  GI +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 223 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
           ++ G  +Y  ++D WS G ++ E+L+GQ  F G+   +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFFDELRD 341
            Y  +                 L  EA DL+ + F   P  R         HP F E+  
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN- 262

Query: 342 PNTRLPNGRPLPP----------LFNFKPPELSGIPPETINRLIPEHARKQNLF 385
               L      PP            NF    L+  P  +       ++  QN+F
Sbjct: 263 -WEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-52
 Identities = 65/317 (20%), Positives = 120/317 (37%), Gaps = 49/317 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 101
           Y     +G+G F VV + + + TG   A K + + +   +          RE+ I++ + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           HPN++ L   +    +K ++ L  +LE V         ++    + +       +  QI 
Sbjct: 72  HPNVITLHEVY---ENKTDVIL--ILELVA---GGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 162 RALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 218
             + Y+H+   I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  +
Sbjct: 124 NGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
            APE++          D+WS G +   LL G   F G++  + L  +  V      E   
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--- 238

Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 338
                                 +       A D + R     P  R T  ++  HP+   
Sbjct: 239 ----------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

Query: 339 LRDPNTRLPNGRPLPPL 355
            +D    L +    P  
Sbjct: 277 -KDTQQALSSAWSHPQF 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  175 bits (445), Expect = 1e-52
 Identities = 81/355 (22%), Positives = 143/355 (40%), Gaps = 68/355 (19%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 104
           +     +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I+ +   F     ++   + ++++Y+         +  R  QR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 224
            Y+H+   I +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 225 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
                Y  +ID WS G ++ E+L G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDEL 339
            E +FP                 +  DL+ R      + R         +   HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

Query: 340 RDPNTRLPNGRPLPPLFNFKPPELSGI---------PPETINRLIPEHARKQNLF 385
                +L +     P   ++PP   G          P E IN  +       +LF
Sbjct: 264 --VWEKLLSRNIETP---YEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 313

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 8e-52
 Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 56/303 (18%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 101
           Y    ++G+G FG V+          VAIK V +D+               E+ +++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 102 --HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 159
                ++ L   F            L+LE       +   ++      +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 160 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 219
           +  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 220 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
            PE I     +  +  +WS G ++ +++ G   F  +       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
                                F++R+  E   L+       P+ R T  E   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 340 RDP 342
             P
Sbjct: 262 LLP 264

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  174 bits (443), Expect = 1e-51
 Identities = 69/325 (21%), Positives = 122/325 (37%), Gaps = 57/325 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 101
           +    ++G G FG V+  +  +TG++ A+K + + +            +   L ++   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
            P IV + + F      ++L    +L+ +          +   H       ++ Y  +I 
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMN---GGDLHYHLSQHGVFSEADMRFYAAEII 117

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S   +  Y AP
Sbjct: 118 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 281
           E++     Y ++ D +S GC++ +LL G   F      D+  EI +              
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-------------- 219

Query: 282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFF 336
                                    PE   L+    Q   N R       A E    PFF
Sbjct: 220 -----------MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

Query: 337 DELRDPNTRLPNGRPLPPLFNFKPP 361
             L      +   +  PP     PP
Sbjct: 269 RSL--DWQMVFLQKYPPP---LIPP 288

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (418), Expect = 4e-49
 Identities = 65/295 (22%), Positives = 106/295 (35%), Gaps = 43/295 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 104
           Y    ++G G    V  A+       VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IVA+ +              +V+EYV        R+       M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRA 220
            + H   GI HRD+KP N++++   + +K+ DFG A+ +     +V    + I +  Y +
Sbjct: 125 NFSHQN-GIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           PE   G        D++S GCV+ E+L G+P F G+S V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
                                 + L  +   +V +    +P  R           
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 6e-49
 Identities = 71/328 (21%), Positives = 120/328 (36%), Gaps = 59/328 (17%)

Query: 49  KVS---YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 98
           KV+   +    ++G G+FG V   + + TG   A+K + ++             E +++Q
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 99  MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 158
              HP + ALK+ F      + L        +          +    +       + Y  
Sbjct: 61  NTRHPFLTALKYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGA 112

Query: 159 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 218
           +I  AL Y+H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C    
Sbjct: 113 EIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPE 170

Query: 219 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 278
                +    +Y  A+D W  G VM E++ G+  F  +        I+            
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------- 219

Query: 279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVH 333
                  E +FP            + L PEA  L+    +  P  R       A E   H
Sbjct: 220 ------EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261

Query: 334 PFFDELRDPNTRLPNGRPLPPLFNFKPP 361
            FF  +      +   + LPP   FKP 
Sbjct: 262 RFFLSIN--WQDVVQKKLLPP---FKPQ 284

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 52/294 (17%), Positives = 106/294 (36%), Gaps = 47/294 (15%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 104
                  +G+GSFG V++ K       VA+K +               E+ +++   H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           I+                L +V ++   +   +  +   I  +  +I +     Q  + +
Sbjct: 66  ILLFMGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 221
            Y+H    I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + AP
Sbjct: 118 DYLH-AKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 222 ELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           E+I       Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++             
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------- 224

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
               Y      +++ +          P     L+    +   + R    +    
Sbjct: 225 ---GYLSPDLSKVRSN---------CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (402), Expect = 2e-46
 Identities = 56/315 (17%), Positives = 103/315 (32%), Gaps = 54/315 (17%)

Query: 39  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 96
           +G R         Y     +G+GSFG ++       GE VAIK      ++     E +I
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 97  MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 156
            +M+     +       +  D    Y  +V+E +  ++  +   ++   ++  L  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLL 108

Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNV---- 210
             Q+   + YIH+     HRD+KP N L+        +   DFG AK       +     
Sbjct: 109 ADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 211 ----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 266
               +   +  Y +     G  E +   D+ S G V+    LG   + G     +  +  
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY- 225

Query: 267 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 326
                                +  + K     +V  K  P E    +        + +  
Sbjct: 226 --------------------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265

Query: 327 A---LEACVHPFFDE 338
                +   + F  +
Sbjct: 266 YSYLRQLFRNLFHRQ 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  154 bits (391), Expect = 5e-45
 Identities = 48/280 (17%), Positives = 96/280 (34%), Gaps = 33/280 (11%)

Query: 39  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 96
           +G           Y     +G GSFGV+F+       + VAIK   +         E + 
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 97  MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 156
            ++L     +   + F      E L+  LV++ +  ++  +     R   +  +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMA 106

Query: 157 TYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNV-- 210
             Q+   +  IH    + +RDIKP N L+      + + + + DFG  K           
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 211 ------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 264
                 +   +  Y +     G  E +   D+ + G V    L G   + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 265 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 304
             ++        ++ +   + E +F +   +  +  F   
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-44
 Identities = 54/281 (19%), Positives = 99/281 (35%), Gaps = 43/281 (15%)

Query: 56  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 113
             +G G FG V        G  VA+K +  D   +    E  +M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 114 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 173
                    L +V EY+ +  + +    SR    +    +  ++  +C A+ Y+      
Sbjct: 71  EEKG----GLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124

Query: 174 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 233
            HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++T 
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTK 180

Query: 234 IDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 292
            D+WS G ++ E+   G+  +P     D +  + K                         
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------------- 215

Query: 293 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
               +        PP   +++   +     +R + L+    
Sbjct: 216 ---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  154 bits (389), Expect = 4e-44
 Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 57/312 (18%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 109
            +GTGSFG V   K +E+G   A+K + + K  K         E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 169
             F   ++   +   +    +   + R          R    + + Y  QI     Y+H+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 170 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 229
              + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I     
Sbjct: 160 L-DLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KG 214

Query: 230 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 289
           Y  A+D W+ G ++ E+  G P F  +  +    +I                        
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------------ 250

Query: 290 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFFDELRDPNT 344
                      F      +  DL+    Q        NL+    +   H +F      + 
Sbjct: 251 -----VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTDW 302

Query: 345 RLPNGRPLPPLF 356
                R +   F
Sbjct: 303 IAIYQRKVEAPF 314

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-42
 Identities = 76/337 (22%), Positives = 132/337 (39%), Gaps = 61/337 (18%)

Query: 47  KQKVS---YIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKV--------LQDKRYKNR 92
            +KV    +    V+GTG++G VF  +     +TG++ A+K +         +   +   
Sbjct: 18  AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77

Query: 93  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 152
           E Q+++ +     +   H  F    + +L+L L      E    +++      +R     
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQ-----RERFTEHE 130

Query: 153 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 212
           V++Y  +I  AL ++H   GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y
Sbjct: 131 VQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAY 188

Query: 213 IC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 269
                  Y     +  G + +  A+D WS G +M ELL G   F  +   +   EI +  
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-- 246

Query: 270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----- 324
                                  +       + + +   A DL+ R     P  R     
Sbjct: 247 -----------------------RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283

Query: 325 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 361
             A E   H FF ++   +  L   +   P   FKP 
Sbjct: 284 RDADEIKEHLFFQKINWDD--LAAKKVPAP---FKPV 315

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 8e-42
 Identities = 58/299 (19%), Positives = 110/299 (36%), Gaps = 35/299 (11%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVA 107
           + + +  +G G FG V+  + +  GE VA+K     +    ++  E+    ML H NI+ 
Sbjct: 4   TIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
                 +  +     L LV +Y     +    +Y      + +  +          LA++
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHE---HGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116

Query: 168 HNCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICS 215
           H  I        I HRD+K +N+LV        + D G A         +       + +
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 216 RYYRAPELIFGA-----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 270
           + Y APE++  +      E     DI++ G V  E+     +  G     QL     V  
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPS 234

Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 329
            P+ EE++ +          +++P+  ++            ++   +  +   R TAL 
Sbjct: 235 DPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 9e-41
 Identities = 67/300 (22%), Positives = 110/300 (36%), Gaps = 47/300 (15%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVA 107
           S   E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L         +E +Y+  V EY+ +             + + L  +     QI   +AY+
Sbjct: 77  LYAVV----SEEPIYI--VTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYICSRYYRAPELIF 225
                  HRD++  N+LV  +    K+ DFG A+++   E            + APE   
Sbjct: 130 ERM-NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 226 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 284
               +T   D+WS G ++ EL   G+  +PG    + L ++ +    P   E        
Sbjct: 188 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------- 239

Query: 285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFFDELRDP 342
                                P    DL+C+ ++  P  R T   L+A +  +F      
Sbjct: 240 ---------------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-40
 Identities = 57/293 (19%), Positives = 107/293 (36%), Gaps = 47/293 (16%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 108
                 +G G FG V+          VA+K + Q     +    E  +M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
                    +E +Y+  + EY+    + +    +    ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 226
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 227 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
              +T   D+WS G ++ E++  G+  +PG +  + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE--ACVHPFF 336
                      +  V     P E   L+   ++  P  R T     + +  FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (355), Expect = 8e-40
 Identities = 53/293 (18%), Positives = 114/293 (38%), Gaps = 43/293 (14%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 108
              +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 78

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
                  T +   Y+    E++               Q +  + +     QI  A+ Y+ 
Sbjct: 79  LGVC---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE 132

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--YYRAPELIFG 226
                 HRD+  +N LV  + H +K+ DFG ++++                + APE +  
Sbjct: 133 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 227 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 286
             +++   D+W+ G ++ E+            + Q+ E+++                   
Sbjct: 191 -NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDYR 234

Query: 287 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 339
            + P            +  P +  +L+   +Q++P+ R +  E  +H  F+ +
Sbjct: 235 MERP------------EGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (355), Expect = 1e-39
 Identities = 65/309 (21%), Positives = 117/309 (37%), Gaps = 54/309 (17%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVL-----QDKRYKNRELQIMQMLDH 102
               E V+G G FG V     +  G+    VAIK +      + +R    E  IM   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 103 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 162
           PN++ L+      T    +   ++ E++      +     +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMEN--GSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 163 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------ 216
            + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLA-DMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 217 YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 275
            + APE I    ++T+A D+WS G VM E++  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 335
           +                             P     L+   +Q   N R    +  V+  
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQ-IVNTL 287

Query: 336 FDELRDPNT 344
              +R+PN+
Sbjct: 288 DKMIRNPNS 296

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 4e-39
 Identities = 57/298 (19%), Positives = 103/298 (34%), Gaps = 53/298 (17%)

Query: 57  VVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIV 106
            +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
            L              + +V E  P     +     +      L  +  Y  Q+   + Y
Sbjct: 75  RLYGVV------LTPPMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 223
           + +     HRD+  +NLL+      +K+ DFG  + L + + +     +    +      
Sbjct: 127 LESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 224 IFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 282
                 ++ A D W  G  + E+   GQ  + G +G   L +I K      R E      
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE------ 238

Query: 283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 340
                                  P +  +++ + + + P  R T +   +  F  E +
Sbjct: 239 ---------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 7e-39
 Identities = 47/282 (16%), Positives = 96/282 (34%), Gaps = 43/282 (15%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 113
            +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L     
Sbjct: 12  EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 69

Query: 114 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 173
              ++  +   LV E++      ++              +      +C  +AY+     +
Sbjct: 70  --LEQAPIC--LVFEFMEH--GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CV 122

Query: 174 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGATEYT 231
            HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y+
Sbjct: 123 IHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYS 180

Query: 232 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 291
           +  D+WS G +M E+     +        ++VE I                         
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------------------------ 216

Query: 292 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                +     +        ++   ++  P  R         
Sbjct: 217 ---TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-38
 Identities = 58/301 (19%), Positives = 106/301 (35%), Gaps = 56/301 (18%)

Query: 53  IAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 104
           + +  +G+G+FG V +   +  +  + VA+K +  +            E  +MQ LD+P 
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 105 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 164
           IV +        + E   L  V+E            Y + ++ +    +    +Q+   +
Sbjct: 70  IVRMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 165 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NVSYICSRYYRA 220
            Y+       HRD+  +N+L+    H  K+ DFG +K L   E              + A
Sbjct: 121 KYLEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 221 PELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 279
           PE I    ++++  D+WS G +M E    GQ  + G  G +    + K            
Sbjct: 179 PECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-- 235

Query: 280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFF 336
                                     P E  DL+   + Y    R       +   + ++
Sbjct: 236 --------------------------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269

Query: 337 D 337
           D
Sbjct: 270 D 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-38
 Identities = 68/300 (22%), Positives = 111/300 (37%), Gaps = 54/300 (18%)

Query: 53  IAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 105
           IA+  +G G+FG V Q   R   +   VAIK + Q     +     RE QIM  LD+P I
Sbjct: 12  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 71

Query: 106 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 165
           V L          +   L LV+E        + +      + +P+  V    +Q+   + 
Sbjct: 72  VRLIGVC------QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMK 123

Query: 166 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAP 221
           Y+       HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + AP
Sbjct: 124 YLE-EKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           E I    ++++  D+WS G  M E L  GQ  +    G + +  I +             
Sbjct: 182 ECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------------ 228

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFFD 337
                  K  +  P           PPE   L+   + Y    R   L         ++ 
Sbjct: 229 -------KRMECPPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 3e-38
 Identities = 62/317 (19%), Positives = 107/317 (33%), Gaps = 70/317 (22%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDKRYKN-----RELQIMQML- 100
                V+G+G+FG V  A      +      VA+K + +            EL++M  L 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 101 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------------ETVNRIARN 140
            H NIV L       T    +Y  L+ EY                      E  N+    
Sbjct: 99  SHENIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 141 YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 200
                  +    +  + YQ+ + + ++       HRD+  +N+LV      +K+CDFG A
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLA 211

Query: 201 KVLVKGEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 256
           + ++     V    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 257 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 316
                  ++I+               N  +   P                 E   ++   
Sbjct: 271 PVDANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSC 303

Query: 317 FQYSPNLRCTALEACVH 333
           + +    R +       
Sbjct: 304 WAFDSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 4e-38
 Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 45/288 (15%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 108
                 +GTG FGVV   K R     VAIK + +    ++    E ++M  L H  +V L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 109 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 168
                  T +  ++  ++ EY+      +      +  R     +      +C A+ Y+ 
Sbjct: 65  YGVC---TKQRPIF--IITEYMAN--GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 169 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAPELIFG 226
                 HRD+  +N LVN     +K+ DFG ++ ++  E   S        +  PE++  
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 227 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 285
            +++++  DIW+ G +M E+  LG+  +   +  +    I + L                
Sbjct: 176 -SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------------- 218

Query: 286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
               P +               +   ++   +    + R T      +
Sbjct: 219 RLYRPHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 5e-38
 Identities = 64/329 (19%), Positives = 119/329 (36%), Gaps = 55/329 (16%)

Query: 57  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 107
           V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 108 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 167
           L     ++T      + L+ + +P     +          +   Y+  +  QI + + Y+
Sbjct: 76  LLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 168 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR---YYRAPELI 224
            +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E I
Sbjct: 128 EDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 225 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 283
                YT   D+WS G  + EL+  G   + G     ++  I++      +  I      
Sbjct: 186 LH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPI------ 237

Query: 284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 343
                                   +   ++ + +    + R    E  +  F    RDP 
Sbjct: 238 ---------------------CTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQ 275

Query: 344 TRLPNGRPLPPLFNFKPPELSGIPPETIN 372
             L          +   P  S      ++
Sbjct: 276 RYLV--IQGDERMHLPSPTDSNFYRALMD 302

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-36
 Identities = 62/308 (20%), Positives = 106/308 (34%), Gaps = 65/308 (21%)

Query: 52  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQML- 100
                 +G G+FG V +A        +    VA+K +              EL+++  L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 101 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP---------------ETVNRIARNYSRIH 145
           +H NIV L       T        ++ EY                               
Sbjct: 85  NHMNIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
             + L  +  ++YQ+ + +A++ +     HRD+  +N+L+       K+CDFG A+ +  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197

Query: 206 GEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
               V    +R    + APE IF    YT   D+WS G  + EL  LG   +PG     +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
             ++IK                             +  +  +  P E  D++   +   P
Sbjct: 257 FYKMIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 322 NLRCTALE 329
             R T  +
Sbjct: 290 LKRPTFKQ 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (323), Expect = 5e-35
 Identities = 61/318 (19%), Positives = 108/318 (33%), Gaps = 73/318 (22%)

Query: 57  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
            +G G+FG VFQA+       E   +VA+K + ++          RE  +M   D+PNIV
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP---------------------ETVNRIARNYSRIH 145
                       + + L  + EY+                        ++  AR  S   
Sbjct: 80  ---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134

Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
             +          Q+   +AY+       HRD+  +N LV  +   +K+ DFG ++ +  
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMV-VKIADFGLSRNIYS 192

Query: 206 GEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
            +      +      +  PE IF    YTT  D+W+ G V+ E+   G   + G +  + 
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           +  +                          I   P      +  P E  +L+   +   P
Sbjct: 252 IYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKLP 283

Query: 322 NLRCTALEACVHPFFDEL 339
             R +     +H     +
Sbjct: 284 ADRPSFCS--IHRILQRM 299

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 5e-35
 Identities = 66/293 (22%), Positives = 100/293 (34%), Gaps = 50/293 (17%)

Query: 52  YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHP 103
                 +G G FG V Q            VAIK               +E   M+  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 104 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 163
           +IV L           E  + +++E        +          + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTL--GELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 164 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAP 221
           LAY+ +     HRDI  +N+LV+ +   +KL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           E I     +T+A D+W  G  M E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                                    PP    L+ + + Y P+ R    E    
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 8e-35
 Identities = 52/304 (17%), Positives = 106/304 (34%), Gaps = 57/304 (18%)

Query: 55  EHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 106
             V+G G FG V+     +        A+K + +            E  IM+   HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 166
           +L      +    E    +VL Y+     R             +  +  +  Q+ + + +
Sbjct: 92  SLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 145

Query: 167 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAP 221
           +       HRD+  +N +++     +K+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 222 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 280
           E +    ++TT  D+WS G ++ EL+  G P +P  +  D  V +++       E     
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--- 259

Query: 281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHP 334
                                    P    +++ + +     +R +       + A    
Sbjct: 260 -------------------------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

Query: 335 FFDE 338
           F  E
Sbjct: 295 FIGE 298

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-34
 Identities = 55/292 (18%), Positives = 98/292 (33%), Gaps = 50/292 (17%)

Query: 51  SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLD 101
               + V+G G FG V++   + +       VAIK +      K       E  IM    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
           H NI+ L+         +   + ++ EY+        +          ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC----SRY 217
             + Y+ N     HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLANM-NYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 218 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 277
           + APE I    ++T+A D+WS G VM E++        E    ++++ I           
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 329
                              +        P     L+ + +Q     R    +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 3e-34
 Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 56/300 (18%)

Query: 55  EHVVGTGSFGVVFQAKCRETGEI--VAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 106
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 107 ALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQRMPLIYV 153
            L             YL L +EY P                +      +     +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 154 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 213
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 214 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 273
               + A E +   + YTT  D+WS G ++ E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 333
                         + P                 E  DL+ + ++  P  R +  +  V 
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-33
 Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 66/309 (21%)

Query: 52  YIAEHVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDKRYKN-----RELQIMQM 99
            +    +G G+FG V  A+     +        VA+K +  D   K+      E+++M+M
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 100 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIH 145
           +  H NI+   +   + T    LY+  ++EY              P  +           
Sbjct: 75  IGKHKNII---NLLGACTQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 146 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 205
           +++    +    YQ+ R + Y+ +     HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 206 GEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 261
            +             + APE +F    YT   D+WS G ++ E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 321
           L +++K                  E        +            E   ++   +   P
Sbjct: 246 LFKLLK------------------EGHRMDKPSN---------CTNELYMMMRDCWHAVP 278

Query: 322 NLRCTALEA 330
           + R T  + 
Sbjct: 279 SQRPTFKQL 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-33
 Identities = 58/310 (18%), Positives = 107/310 (34%), Gaps = 62/310 (20%)

Query: 52  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQML 100
                 +G G+FG V +A         T   VA+K + +       +   +    ++ + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 101 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQR 147
            H N+V L              L +++E+               E V             
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 148 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 207
           + L ++  Y++Q+ + + ++ +     HRD+  +N+L++     +K+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 208 PNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLV 263
             V          + APE IF    YT   D+WS G ++ E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 264 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 323
             +K                 T  + P                PE    +   +   P+ 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 324 RCTALEACVH 333
           R T  E   H
Sbjct: 281 RPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-31
 Identities = 55/315 (17%), Positives = 114/315 (36%), Gaps = 63/315 (20%)

Query: 52  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD 101
                 +G GSFG+V++   +     E    VAIK V     ++++     E  +M+  +
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 102 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVK 154
             ++V         +  +     +++E +            R A   + +     L  + 
Sbjct: 82  CHHVV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 155 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 214
               +I   +AY++      HRD+  +N +V      +K+ DFG  + + + +       
Sbjct: 137 QMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGK 194

Query: 215 ---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLG 270
                 + +PE +     +TT  D+WS G V+ E+  L +  + G S    L  +++   
Sbjct: 195 GLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--- 250

Query: 271 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--- 327
                                +   P         P    +L+   +QY+P +R +    
Sbjct: 251 -------------------GGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEI 285

Query: 328 ---LEACVHPFFDEL 339
              ++  + P F E+
Sbjct: 286 ISSIKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.4 bits (213), Expect = 2e-20
 Identities = 31/204 (15%), Positives = 57/204 (27%), Gaps = 34/204 (16%)

Query: 57  VVGTGSFGVVFQAKCRETGEIVAIKKV--------------LQDKRYKNRELQIMQMLDH 102
           ++G G    VF     E      +K                     + +         + 
Sbjct: 7   LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 103 PNIVALKHCFFSTT-DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 161
             +  L+          E   +  ++E             ++   R+ +         I 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAV--LMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 162 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 221
             +A  ++   I H D+   N+LV      + + DF  +  +  GE     I  R  R  
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168

Query: 222 ELIFGATEYTTAIDIWSTGCVMAE 245
              F    Y T  DI S    + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	390
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.27
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.94
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.83
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.16
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.97
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.3

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-65  Score=474.30  Aligned_cols=329  Identities=71%  Similarity=1.210  Sum_probs=284.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHhCCCCceeeecceeccCCC-CCceEEEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNLVL  127 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv~  127 (390)
                      ..+|+..++||+|+||+||+|+++.+|+.||||++..+.....+|+.+|++++||||++++++|..... .+..++|+||
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            447999999999999999999999999999999998877777899999999999999999999865433 4567889999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccCC
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  207 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~~  207 (390)
                      |||++++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++......
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            999998877777666667789999999999999999999998 9999999999999999887679999999998776666


Q ss_pred             CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 016401          208 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  287 (390)
Q Consensus       208 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  287 (390)
                      ...+..||+.|+|||++.+...++.++||||+||++|||++|++||.+.+..+++.++.+.++.+..+.+....+.+...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            67778899999999999777779999999999999999999999999999999999999999999999999888888888


Q ss_pred             cCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 016401          288 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIP  367 (390)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (390)
                      .++.....++.....+..++++.+||++||++||++|||+.|+|+||||++++++...+++.+..+..+++...++. ..
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~  336 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS-SN  336 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHT-TC
T ss_pred             cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhcc-CC
Confidence            88888888888888888999999999999999999999999999999999999888777777766666665533333 23


Q ss_pred             hHHHhhhCcHHH
Q 016401          368 PETINRLIPEHA  379 (390)
Q Consensus       368 ~~~~~~~~~~~~  379 (390)
                      +.....++|+++
T Consensus       337 ~~~~~~~~p~~~  348 (350)
T d1q5ka_         337 PPLATILIPPHA  348 (350)
T ss_dssp             GGGHHHHSCTTT
T ss_pred             ccccccCCCccc
Confidence            333444555543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-60  Score=426.10  Aligned_cols=247  Identities=30%  Similarity=0.497  Sum_probs=212.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+.       .....+|+.+++.++|||||++++++.     +...
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence            4799999999999999999999999999999998532       233458999999999999999999984     3445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+|||||++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        81 ~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~  154 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWSV  154 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCSCS
T ss_pred             EEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCC-CEeecccceee
Confidence            8899999984 88777654    4679999999999999999999998 9999999999999999888 79999999997


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      .... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.++.+.             
T Consensus       155 ~~~~-~~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------------  219 (263)
T d2j4za1         155 HAPS-SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------  219 (263)
T ss_dssp             CCCC-CCCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred             ecCC-CcccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence            6543 33455679999999999965 45899999999999999999999999988877766665431             


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                          ...            +++.+++++++||.+||+.||++|||++|+|+||||++
T Consensus       220 ----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         220 ----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ----CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                111            23468999999999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-60  Score=433.95  Aligned_cols=276  Identities=35%  Similarity=0.602  Sum_probs=225.8

Q ss_pred             EeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           54 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+|+.++|||||++++++..     ..++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence            4688999999999999999999999999985322         234589999999999999999999943     33478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      +||||+.+++...+.   .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCC-ccccccCccccccC
Confidence            999999987644332   335679999999999999999999998 9999999999999999888 79999999997654


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ... .....+||+.|+|||++.....|+.++||||+||++|||++|.+||.+.++.+++.++.+.++.+..+.+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            432 3345678999999999977777899999999999999999999999999999999999999998887655433222


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ............++...+ +.+++++++||++||++||++|||+.|+|+||||++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            222223333333333333 46899999999999999999999999999999998643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-60  Score=429.06  Aligned_cols=252  Identities=31%  Similarity=0.518  Sum_probs=212.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|++++||||+++++++.     +..
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDE   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSS
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECC
Confidence            45799999999999999999999999999999998532       133568999999999999999999983     345


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+|||||++ +|.+++..    .+.+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+|
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~-~vkl~DFG~a  155 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTA  155 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCc-eEEecccccc
Confidence            58899999985 77666554    4679999999999999999999998 9999999999999999988 7999999999


Q ss_pred             cccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          201 KVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       201 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      +......   .....+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.++.+.         
T Consensus       156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~---------  225 (288)
T d1uu3a_         156 KVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------  225 (288)
T ss_dssp             EECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT---------
T ss_pred             eecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC---------
Confidence            8664332   23456799999999999654 5899999999999999999999999998887777766541         


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHH------HhcCCcccccCC
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRD  341 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~------~l~hp~f~~~~~  341 (390)
                              .+.            ++..+++++++||++||+.||++|||++|      +++||||+++.+
T Consensus       226 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w  275 (288)
T d1uu3a_         226 --------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  275 (288)
T ss_dssp             --------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             --------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence                    111            23468999999999999999999999987      588999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-60  Score=429.36  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=213.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+++.++|||||++++++.+     ..++|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            4799999999999999999999999999999998532    2345689999999999999999999843     345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      |||||+| +|..++.     ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        95 vmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCC-cEeeccchhheeec
Confidence            9999985 7766543     2579999999999999999999998 9999999999999999888 79999999998764


Q ss_pred             cCC-CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          205 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       205 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.... .+           
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~-----------  234 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP-----------  234 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC-----------
T ss_pred             cccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CC-----------
Confidence            433 3455679999999999965 458999999999999999999999999988877777666531 00           


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                    ....++.+++++++||++||+.||++|||+.|+|+||||+.
T Consensus       235 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         235 --------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             --------------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             --------------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                          00122568999999999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-60  Score=427.21  Aligned_cols=252  Identities=27%  Similarity=0.338  Sum_probs=207.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...     .....+|+++|++++|||||++++++.+     ...+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~~   79 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY   79 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----CceeE
Confidence            4799999999999999999999999999999998543     2345689999999999999999999843     34588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +|||||++ +|.+++.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..
T Consensus        80 ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~  153 (271)
T d1nvra_          80 LFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  153 (271)
T ss_dssp             EEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCC-CEEEccchhheee
Confidence            99999985 7755543    34679999999999999999999998 9999999999999999888 7999999999866


Q ss_pred             ccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          204 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       204 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ....   .....+||+.|+|||++.+...++.++|||||||++|+|++|++||...+..............         
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---------  224 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------  224 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT---------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------
Confidence            4332   2345679999999999977665678899999999999999999999876554433333221000         


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                  ...     ....+++++++||.+||+.||++|||++|+|+||||++
T Consensus       225 ------------~~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         225 ------------YLN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ------------TST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ------------CCC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                        000     11457999999999999999999999999999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-60  Score=423.27  Aligned_cols=254  Identities=25%  Similarity=0.395  Sum_probs=205.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++....      ....+|++++++++|||||++++++.+   ..+..
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence            468999999999999999999999999999999985432      234579999999999999999998854   22334


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-----cccccCCCCcEEEcCCCCcEEEee
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~-----ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      +|+|||||+ |+|.+++.........+++..++.++.||+.||+|||+ +|     |+||||||+|||++.++ .+||+|
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~-~vkl~D  157 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  157 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTS-CEEECC
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence            789999998 59988888776667889999999999999999999998 66     99999999999999988 799999


Q ss_pred             cCCccccccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          197 FGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       197 fg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      ||+|+....... .....||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+...++...-      
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~------  230 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK------  230 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC------
Confidence            999987654332 345678999999999954 458999999999999999999999999888777666655410      


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcc
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  336 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f  336 (390)
                                   .+         .++..+++++++||++||+.||++|||+.|+|+|||+
T Consensus       231 -------------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 -------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -------------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                         00         1234689999999999999999999999999999995

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-59  Score=424.53  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=217.8

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----------hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.          ...+.+|+.+|++++|||||++++++.     
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence            35799999999999999999999999999999998532          233568999999999999999999983     


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC---cEEE
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL  194 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---~vkl  194 (390)
                      +...+|+|||||+ |+|.+++..    .+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.   .+||
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEe
Confidence            4455889999998 488777764    3679999999999999999999998 99999999999999987653   4999


Q ss_pred             eecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          195 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      +|||+|.............+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+......   
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---  234 (293)
T d1jksa_         159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE---  234 (293)
T ss_dssp             CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---
T ss_pred             cchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---
Confidence            99999987766666667789999999999954 45899999999999999999999999998888877766542111   


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                            +...+++++|+++++||++||+.||++|||++|+|+||||+...
T Consensus       235 ----------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         235 ----------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             ----------------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             ----------------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                  11122356899999999999999999999999999999998754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=424.67  Aligned_cols=289  Identities=31%  Similarity=0.547  Sum_probs=234.3

Q ss_pred             CcccccEEEeeeeeecCceEEEEEEEcCC-CcEEEEEEeccc------hhhHHHHHHHHHhC---CCCceeeecceeccC
Q 016401           46 SKQKVSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQD------KRYKNRELQIMQML---DHPNIVALKHCFFST  115 (390)
Q Consensus        46 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~------~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~  115 (390)
                      .+..++|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+|+.+   +||||++++++|...
T Consensus         3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            34456899999999999999999999765 677999998532      22345788887766   799999999998665


Q ss_pred             CCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEe
Q 016401          116 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  195 (390)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  195 (390)
                      ......++|++|||+++++......  .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~-~~kl~  158 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLA  158 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred             ccccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCC-Ceeec
Confidence            5556678899999999876554433  234678999999999999999999998 9999999999999999888 79999


Q ss_pred             ecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          196 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       196 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      |||+++............||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+..+.+.++.+..+.+...
T Consensus       159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             chhhhhhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            9999987655555667789999999999965 459999999999999999999999999999999999999999888776


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      .+....... ...+......+. ..+...+++.+++||++||++||++|||+.|+|+||||++++.
T Consensus       238 ~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         238 DWPRDVALP-RQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             GSCTTCSSC-GGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccch-hhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            543321111 111111111122 2234678999999999999999999999999999999998854

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-59  Score=416.86  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=206.6

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      -|++.+.||+|+||+||+|+++.+++.||+|++....      ..+.+|+++|++++|||||++++++.+.. .+...+|
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~   88 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV   88 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEE
Confidence            3578889999999999999999999999999885432      23458999999999999999999885433 3345688


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--cccccCCCCcEEEcC-CCCcEEEeecCCc
Q 016401          125 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNP-HTHQLKLCDFGSA  200 (390)
Q Consensus       125 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~-~~~~vkl~Dfg~a  200 (390)
                      +|||||++ +|..++..    ...+++..++.++.||+.||+|||+ ++  |+||||||+|||++. ++ .+||+|||+|
T Consensus        89 ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~-~~Kl~DFGla  162 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLA  162 (270)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTGG
T ss_pred             EEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCC-CEEEeecCcc
Confidence            99999985 88777654    4679999999999999999999998 88  999999999999975 55 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      +.. .........||+.|+|||++.+  .++.++|||||||++|||++|+.||.+......+.+.+... ..        
T Consensus       163 ~~~-~~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~~--------  230 (270)
T d1t4ha_         163 TLK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VK--------  230 (270)
T ss_dssp             GGC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CC--------
T ss_pred             eec-cCCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-CC--------
Confidence            753 3333456789999999999854  48999999999999999999999998766555544433210 00        


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                                       ...++...++++++||.+||+.||++|||++|+|+||||+
T Consensus       231 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                             0112345789999999999999999999999999999996

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-59  Score=424.04  Aligned_cols=283  Identities=35%  Similarity=0.647  Sum_probs=230.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ++|++++.||+|+||+||+|++..+|+.||||++..+      .....+|+++|++++|||||++++++.+     ...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            4799999999999999999999999999999998533      2344589999999999999999999944     3458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |+||||+++++...+...  ....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||.|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccC-cceeccCCcceec
Confidence            899999998876655432  24679999999999999999999998 9999999999999999888 7999999999866


Q ss_pred             ccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ... .......||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            443 3344567899999999987777678999999999999999999999999999999999998888776554432211


Q ss_pred             Ccc-cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          283 NYT-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       283 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ... ....+......+... ...+++++++||++||++||++|||+.|+|+||||+++.+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKV-VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHH-STTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhhh-ccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            100 011122222222222 24678999999999999999999999999999999988654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-58  Score=426.25  Aligned_cols=250  Identities=27%  Similarity=0.433  Sum_probs=215.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||+++++++     .+..+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence            4799999999999999999999999999999998642       23345799999999999999999999     44556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+|||||+| +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        80 ~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~  153 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK  153 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred             cccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCC-CEEEeeccccc
Confidence            8999999995 77665554    4679999999999999999999998 9999999999999999998 79999999998


Q ss_pred             cccc-CCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      .... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+...            
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------------  220 (337)
T d1o6la_         154 EGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------  220 (337)
T ss_dssp             CSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             ccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------------
Confidence            6543 3344567899999999999654 5899999999999999999999999998887776666541            


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~  340 (390)
                           ...            ++..+++++++||++||++||.+|++     +.++++||||+++.
T Consensus       221 -----~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         221 -----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence                 111            23568999999999999999999994     89999999998864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-59  Score=426.53  Aligned_cols=253  Identities=28%  Similarity=0.457  Sum_probs=199.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      .+.|++.+.||+|+||+||+|+++.+++.||||++....     ....+|+.+|+.++|||||++++++     .++.++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            357999999999999999999999999999999986432     2344799999999999999999998     344558


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcC---CCCcEEEeecCC
Q 016401          124 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGS  199 (390)
Q Consensus       124 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~Dfg~  199 (390)
                      |+|||||+ |+|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||+..   ++ .+||+|||+
T Consensus        83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~  156 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDS-KIMISDFGL  156 (307)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCC--
T ss_pred             EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCc-eEEEeccce
Confidence            89999998 588777753    4679999999999999999999998 99999999999999953   45 799999999


Q ss_pred             ccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          200 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       200 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      |+.........+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+.+..          
T Consensus       157 a~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~----------  225 (307)
T d1a06a_         157 SKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE----------  225 (307)
T ss_dssp             ----------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC----------
T ss_pred             eEEccCCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC----------
Confidence            987665655667789999999999965 458999999999999999999999999988777776665421          


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                             ...        .....+.+|+++++||.+||++||++|||+.|+|+||||+.
T Consensus       226 -------~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         226 -------YEF--------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             -------CCC--------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             -------CCC--------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                   000        11122568999999999999999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-59  Score=422.28  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=212.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +.|++.+.||+|+||+||+|+++.+++.||||++...    .....+|+++|+.++|||||++++++.+     ...+|+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence            4699999999999999999999999999999998542    2345689999999999999999999843     345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      |||||++ +|..++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        87 vmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCC-CEEEEechhhhccC
Confidence            9999985 77666543   24679999999999999999999998 9999999999999999988 79999999997543


Q ss_pred             cC-CCCcceeeccccccchhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          205 KG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       205 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      .. .......||+.|+|||++..    ...|+.++|||||||++|+|++|++||.+.+..+.+.++....  +       
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~-------  232 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--P-------  232 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--C-------
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C-------
Confidence            32 12235678999999999842    3458999999999999999999999999988888777766520  0       


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                +       ....+..+++++++||++||+.||++|||+.|+|+||||+.
T Consensus       233 ----------~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         233 ----------P-------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ----------C-------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ----------C-------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                      0       00112468999999999999999999999999999999974

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-58  Score=421.59  Aligned_cols=249  Identities=27%  Similarity=0.410  Sum_probs=209.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..|++.+.||+|+||+||+|+++.+++.||||++....       ....+|+.+|+.++|||||++++++.+     ...
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence            36999999999999999999999999999999985432       234579999999999999999999843     345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+|||||.+++.....   .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|..
T Consensus        90 ~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCC-CEEEeecccccc
Confidence            88999999976543322   234679999999999999999999998 9999999999999999888 799999999976


Q ss_pred             cccCCCCcceeeccccccchhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...   .....||+.|+|||++.+  ...|+.++|||||||++|||++|..||.+.+..+.+..+....           
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~-----------  230 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-----------  230 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            433   345679999999999964  2458999999999999999999999999988877777665521           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                              .+        ...+..+++++++||.+||+.||++|||++++|+||||+.
T Consensus       231 --------~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         231 --------SP--------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             --------CC--------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             --------CC--------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                    00        0112457899999999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.1e-59  Score=430.59  Aligned_cols=258  Identities=26%  Similarity=0.400  Sum_probs=218.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....    ....+|+.+|++++|||||++++++.+     ...+|+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            47999999999999999999999999999999985432    334589999999999999999999843     445889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC-CCcEEEeecCCcccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  203 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~Dfg~a~~~  203 (390)
                      |||||+| +|.+.+..   ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||+|+..
T Consensus       101 vmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999985 77666532   24579999999999999999999998 999999999999999643 237999999999877


Q ss_pred             ccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 016401          204 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  283 (390)
Q Consensus       204 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (390)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......            
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------------  243 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN------------  243 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------------
T ss_pred             ccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence            666666678899999999999654 5899999999999999999999999999888888777653111            


Q ss_pred             cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          284 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                           .+        ......+++++++||++||.+||++|||++|+|+||||+....+
T Consensus       244 -----~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         244 -----MD--------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             -----SC--------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             -----CC--------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                 10        11224689999999999999999999999999999999987554

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-58  Score=428.70  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=215.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++....    ....+|+.+|++++|||||+++++|.     +...+|+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            46999999999999999999999999999999986432    34457999999999999999999983     4455889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEc--CCCCcEEEeecCCccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--PHTHQLKLCDFGSAKV  202 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~--~~~~~vkl~Dfg~a~~  202 (390)
                      |||||+| +|.+.+.   ....++++..++.++.||+.||+|||+ +||+||||||+|||++  .++ .+||+|||+|+.
T Consensus       104 vmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~  178 (352)
T d1koba_         104 ILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKAS-SVKIIDFGLATK  178 (352)
T ss_dssp             EEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCC-CEEECCCTTCEE
T ss_pred             EEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCC-eEEEeeccccee
Confidence            9999985 7644332   234569999999999999999999998 9999999999999997  344 799999999988


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....             
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------------  244 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-------------  244 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-------------
T ss_pred             cCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            766666667789999999999955 458999999999999999999999999998888877776521             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                          +.+        ......++++++++||.+||++||.+|||+.|+|+||||+..
T Consensus       245 ----~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         245 ----WEF--------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             ----CCC--------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ----CCC--------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                111        111224689999999999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-59  Score=428.90  Aligned_cols=281  Identities=25%  Similarity=0.436  Sum_probs=208.1

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++..+     .....+|+.+|+.++|||||+++++|.+     ...
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~   78 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE   78 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence            456899999999999999999999999999999998543     2334589999999999999999999943     345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+||||+.+ +|..++..    .+.+++..++.++.||+.||+|||+.+||+||||||+|||++.++ .+||+|||+|+
T Consensus        79 ~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~  153 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG  153 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred             EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCcc
Confidence            8899999995 88777764    367999999999999999999999624999999999999999988 79999999998


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhc
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~  280 (390)
                      ..... ...+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ...+....+.+........
T Consensus       154 ~~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         154 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HHHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             ccCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            65432 33467899999999999764 599999999999999999999999987664432 2222222121111000000


Q ss_pred             CcC--cccc---cCCC---------CCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          281 NPN--YTEF---KFPQ---------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       281 ~~~--~~~~---~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                      ...  ....   ..+.         .............++.+++|||.+||++||++|||++|+|+||||++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            000  0000   0000         0000001111134688999999999999999999999999999998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-58  Score=423.73  Aligned_cols=249  Identities=27%  Similarity=0.477  Sum_probs=213.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++|||||++++++.     +..+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence            4799999999999999999999999999999998532       233458999999999999999999983     3456


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +|+|||||.| ++..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        79 ~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             eeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCC-CEEEecCccce
Confidence            8899999986 55444443    5678999999999999999999998 9999999999999999988 79999999998


Q ss_pred             ccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          202 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       202 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ....  ...+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+.++...             
T Consensus       153 ~~~~--~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------  216 (316)
T d1fota_         153 YVPD--VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------  216 (316)
T ss_dssp             ECSS--CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred             Eecc--ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-------------
Confidence            6533  3456789999999999954 45899999999999999999999999998888877777652             


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                          ..            .+++.++++++++|++||.+||.+|+     |++++|+||||+++.+
T Consensus       217 ----~~------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         217 ----EL------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             ----CC------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ----CC------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence                11            12356899999999999999999996     8999999999998753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-58  Score=424.87  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=214.3

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+|+.++|||||++++++.     ...
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----ccc
Confidence            468999999999999999999999999999999985321       23458999999999999999999983     344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+++||||+.+ ++...+..    .+.+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g-~ikL~DFG~a  188 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFA  188 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCC-CEEeeeceee
Confidence            58899999985 66665543    4679999999999999999999998 9999999999999999988 7999999999


Q ss_pred             cccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          201 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       201 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      +....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+.++....           
T Consensus       189 ~~~~~--~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----------  254 (350)
T d1rdqe_         189 KRVKG--RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----------  254 (350)
T ss_dssp             EECSS--CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             eeccc--ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-----------
Confidence            87633  3456789999999999965 458999999999999999999999999988877777766520           


Q ss_pred             CcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccCC
Q 016401          281 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  341 (390)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~~  341 (390)
                            .            .++..+++++.+||++||.+||.+|+     |++++++||||+++.+
T Consensus       255 ------~------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         255 ------V------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ------C------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ------C------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                  1            12246899999999999999999995     8999999999998753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=422.92  Aligned_cols=284  Identities=33%  Similarity=0.609  Sum_probs=229.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      .+|++++.||+|+||+||+|.++.+|+.||||++....      ....+|+.+|+.++|||||+++++|..... .....
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            48999999999999999999999999999999986432      234579999999999999999999855432 23345


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+||||++.++..+...     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus        98 ~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~  170 (346)
T d1cm8a_          98 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  170 (346)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccccc-ccccccccceec
Confidence            789999998887766543     679999999999999999999998 9999999999999999988 799999999976


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..  .......||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+.....
T Consensus       171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         171 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            53  3445678899999999998777789999999999999999999999999999999999999999998877654432


Q ss_pred             Ccc---cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          283 NYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       283 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      ...   ....+......+...+ .++++++++||++||++||++|||+.|+|+||||+.+.++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             hhhhhhhccCCcccccchHHhc-cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence            211   0122333333443333 57899999999999999999999999999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-57  Score=409.83  Aligned_cols=253  Identities=28%  Similarity=0.427  Sum_probs=216.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------------hhHHHHHHHHHhCC-CCceeeecceeccC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFST  115 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  115 (390)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+..             ....+|+.++++++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            47999999999999999999999999999999985431             12457999999997 99999999999   


Q ss_pred             CCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEE
Q 016401          116 TDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  194 (390)
Q Consensus       116 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  194 (390)
                        .++..+|+|||||+ |+|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEE
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCC-CeEE
Confidence              34556899999998 488887764    4679999999999999999999998 9999999999999999888 7999


Q ss_pred             eecCCccccccCCCCcceeeccccccchhhcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016401          195 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  269 (390)
Q Consensus       195 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  269 (390)
                      +|||+++............||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+...-
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999987766666667789999999999852     3347889999999999999999999999998877777766521


Q ss_pred             CCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                       ...        ......++|+++++||.+||+.||++|||++|+|+||||++
T Consensus       232 -----------------~~~--------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         232 -----------------YQF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             -----------------CCC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             -----------------CCC--------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                             110        01112468999999999999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.1e-57  Score=411.99  Aligned_cols=277  Identities=35%  Similarity=0.629  Sum_probs=223.3

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...      .....+|+.+|++++||||+++++++...     ...
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence            48999999999999999999985 7899999998543      23456899999999999999999999543     337


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      |++|||+.+++...+.   ...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||.|...
T Consensus        76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            8999999987755543   235779999999999999999999998 9999999999999999988 7999999999765


Q ss_pred             ccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          204 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       204 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ..... .....+++.|+|||.+.+...++.++||||+||++|||++|++||.+.+..+++.++....+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            43322 34456899999999998777789999999999999999999999999999999999999888877654433211


Q ss_pred             Ccc-cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          283 NYT-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       283 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      ... ..........++ ..+.+.++++++|||++||++||++|||+.|+|+||||++
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            110 111111122222 2334678999999999999999999999999999999974

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.7e-57  Score=424.50  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=208.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHH---HHHHHHhCCCCceeeecceeccCCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+   |+.+++.++|||||++++++.     .
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence            47999999999999999999999999999999985321       11223   466777788999999999983     3


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      ...+|+|||||+ |+|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g-~iKl~DFG  152 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLG  152 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCC-cEEEeeec
Confidence            445889999998 588777754    4678999999999999999999998 9999999999999999988 79999999


Q ss_pred             CccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016401          199 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  278 (390)
Q Consensus       199 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (390)
                      +|+..... ......||+.|+|||++.....|+.++|||||||++|+|++|+.||.+.+..+... +.+....       
T Consensus       153 la~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~-------  223 (364)
T d1omwa3         153 LACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT-------  223 (364)
T ss_dssp             TCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSS-------
T ss_pred             eeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccc-------
Confidence            99866443 34556899999999999766678999999999999999999999998765433322 2211100       


Q ss_pred             hcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCC-----HHHHhcCCcccccCC
Q 016401          279 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  341 (390)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~~~l~hp~f~~~~~  341 (390)
                                        ....++..+++++++||.+||++||++|||     ++++++||||+++.+
T Consensus       224 ------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         224 ------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             ------------------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             ------------------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                              011123568999999999999999999999     799999999998753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=416.50  Aligned_cols=316  Identities=32%  Similarity=0.607  Sum_probs=241.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  124 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  124 (390)
                      .+|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++||||+++++++.........++|
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            47999999999999999999999999999999986432     2345799999999999999999998665444455577


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          125 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       125 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ++|++++++|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+...
T Consensus        88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCC-CEEEcccCceeecc
Confidence            8888888899888764     579999999999999999999998 9999999999999999888 79999999997653


Q ss_pred             cCC----CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016401          205 KGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  280 (390)
Q Consensus       205 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (390)
                      ...    .....+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..++..........+........
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            322    2344578999999999866667899999999999999999999999999999999888888888876654322


Q ss_pred             CcC---cccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCC
Q 016401          281 NPN---YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN  357 (390)
Q Consensus       281 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~  357 (390)
                      ...   ......+.....++...+ +.+++++++||.+||++||.+|||+.|+|+||||+...++....    ..+..+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~----~~~~~~~  315 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPFK  315 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC-
T ss_pred             hhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc----cccCccC
Confidence            110   001123333344444433 56899999999999999999999999999999999776543221    1122222


Q ss_pred             CCCCCCCCCChHHHhhhCcHH
Q 016401          358 FKPPELSGIPPETINRLIPEH  378 (390)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~  378 (390)
                      ++ .+...++.+.+++++.++
T Consensus       316 ~~-~~~~~~~~~~l~~l~~~e  335 (345)
T d1pmea_         316 FD-MELDDLPKEKLKELIFEE  335 (345)
T ss_dssp             --------CCHHHHHHHHHHH
T ss_pred             CC-hhhhhCCHHHHHHHHHHH
Confidence            32 334456666666655443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=416.75  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=216.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ++|++.+.||+|+||+||+|.++.+++.||||++....   ....+|+++|+.++|||||+++++|.     +...+|+|
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~lv   79 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEE
Confidence            47999999999999999999999999999999996543   33558999999999999999999984     34458999


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC-CcEEEeecCCccccc
Q 016401          127 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-HQLKLCDFGSAKVLV  204 (390)
Q Consensus       127 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~~vkl~Dfg~a~~~~  204 (390)
                      ||||+| +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||+++...
T Consensus        80 mE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            999985 77666643   23469999999999999999999998 9999999999999997542 379999999998776


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      .........+|+.|+|||.+.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.....+.          
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------  224 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----------  224 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH----------
T ss_pred             cCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh----------
Confidence            5555667788999999999955 45899999999999999999999999999988888887763211111          


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                                     ...+.+++++++||++||..||++|||++|+|+||||+.
T Consensus       225 ---------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         225 ---------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                           112458999999999999999999999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-57  Score=415.23  Aligned_cols=250  Identities=28%  Similarity=0.496  Sum_probs=210.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHH-HhCCCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.++.       ....+|..++ +.++|||||++++++.     +..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence            47999999999999999999999999999999985432       1233566655 4689999999999983     345


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+|||||++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCC-ceeccccchh
Confidence            58999999985 88777654    4678999999999999999999998 9999999999999999888 7999999999


Q ss_pred             cccccC-CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016401          201 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  279 (390)
Q Consensus       201 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (390)
                      +..... .......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++...  .        
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~--------  219 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N--------  219 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C--------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------
Confidence            865443 333456789999999999654 5899999999999999999999999998877777666541  1        


Q ss_pred             cCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHH-HHhcCCcccccC
Q 016401          280 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELR  340 (390)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~-~~l~hp~f~~~~  340 (390)
                             .            .+++.+|+++++||++||++||++|||+. ++++||||++++
T Consensus       220 -------~------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         220 -------P------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             -------C------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                   1            12346899999999999999999999995 899999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-57  Score=406.12  Aligned_cols=245  Identities=25%  Similarity=0.390  Sum_probs=203.8

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHhCC--CCceeeecceeccCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTTD  117 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~  117 (390)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++.++.          ....+|+.+|++++  |||||++++++.    
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~----   79 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE----   79 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence            47999999999999999999999999999999985431          22358999999996  899999999983    


Q ss_pred             CCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEe
Q 016401          118 KEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  195 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  195 (390)
                       +....|+||||+.+  ++..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+...+||+
T Consensus        80 -~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          80 -RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             -CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             -eCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence             34457899999974  55555543    4679999999999999999999998 9999999999999998765589999


Q ss_pred             ecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          196 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       196 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      |||+|+... .....+..||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+      .+.+.       
T Consensus       154 DFG~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-------  219 (273)
T d1xwsa_         154 DFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-------  219 (273)
T ss_dssp             CCTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred             ccccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence            999997543 3334567899999999999766656788999999999999999999997532      12210       


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  340 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~  340 (390)
                                .            ..+++++|+++++||++||++||++|||++|+|+||||+++.
T Consensus       220 ----------~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 ----------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ----------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ----------c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                      0            112356899999999999999999999999999999998753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=400.07  Aligned_cols=282  Identities=33%  Similarity=0.546  Sum_probs=224.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  123 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  123 (390)
                      ++|++++.||+|+||+||+|+++.+++.||||+++.+.      ....+|+.+|+.++||||+++++++.     +....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence            47999999999999999999999999999999985432      33458999999999999999999983     34457


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccc
Q 016401          124 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  203 (390)
Q Consensus       124 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~  203 (390)
                      +++++++.+.....+.   ...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||.|+..
T Consensus        77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            8999999976543332   235788999999999999999999998 9999999999999999887 7999999999876


Q ss_pred             ccCCC-CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          204 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       204 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ..... .....+++.|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+.+.++....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            54332 334456888999999977666899999999999999999999875 5666677788888877776654433222


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                      ........+..............+++.+++||++||++||.+|||++|+|+||||+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence            111111122222222222334578899999999999999999999999999999998654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.7e-56  Score=408.78  Aligned_cols=282  Identities=30%  Similarity=0.523  Sum_probs=223.5

Q ss_pred             ccccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEE
Q 016401           48 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        48 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..++|++++.||+|+||+||+|+++.+|+.||||+++.. .....+|+.+|+.++ ||||++++++|..   ....++|+
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~  109 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPAL  109 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeE
Confidence            346899999999999999999999999999999998654 345568999999995 9999999998843   23345789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      |||||++ +|..       ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|+...
T Consensus       110 v~e~~~~~~L~~-------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         110 VFEHVNNTDFKQ-------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEECCCSCBGGG-------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EEeecCCCcHHH-------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceecc
Confidence            9999996 4422       23579999999999999999999998 9999999999999999776579999999998776


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcC--
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMN--  281 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~--  281 (390)
                      .........+|+.|+|||++.+...++.++||||+||++|+|++|+.||... +..++...+.+.++.+.........  
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            6666677789999999999987777899999999999999999999999764 4556667777776655443332211  


Q ss_pred             ---cCcccccCCCCCCCCcc----cccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCC
Q 016401          282 ---PNYTEFKFPQIKPHPWH----KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  341 (390)
Q Consensus       282 ---~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~  341 (390)
                         ..+... ........+.    ......++++++|||++||++||++|||++|+|+||||+.+.+
T Consensus       262 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         262 ELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCGGGGGT-CCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             ccCcccchh-cccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence               111110 0000111111    1122457899999999999999999999999999999998754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=410.08  Aligned_cols=284  Identities=35%  Similarity=0.596  Sum_probs=228.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+..      ....+|+.+|+.++|||||++++++..... .+..+
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            47999999999999999999999999999999986432      234589999999999999999999855433 23334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +++++++++++|.+++.     .+++++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||++..
T Consensus        98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~  170 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  170 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred             EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccc-cccccccchhcc
Confidence            55666666678877664     3579999999999999999999998 9999999999999999988 799999999865


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .  ........||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+..+.......
T Consensus       171 ~--~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         171 T--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             C--TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             c--CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            4  33345567899999999987777789999999999999999999999999999999999999888887765543221


Q ss_pred             Cccc---ccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCCC
Q 016401          283 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  343 (390)
Q Consensus       283 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~~  343 (390)
                      ....   ...+......+...+ .+++++++|||++||++||++|||+.|+|+||||+++.++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence            1100   112222223333322 46899999999999999999999999999999999887654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=410.60  Aligned_cols=284  Identities=31%  Similarity=0.524  Sum_probs=219.9

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCC-CCceE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  122 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  122 (390)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....      ....+|+.+|+.++||||++++++|..... ....+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            47999999999999999999999999999999986431      234589999999999999999999854322 34567


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccc
Q 016401          123 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  202 (390)
Q Consensus       123 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~  202 (390)
                      +|+|||||.+++...+      ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred             eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccccc-ceeeechhhhhc
Confidence            8999999999875544      3578999999999999999999998 9999999999999999988 699999999987


Q ss_pred             cccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          203 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       203 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...........+|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+......++....+.+..+.+.....
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             cccccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            766666677789999999999966 4589999999999999999999999999999999999999999888876655433


Q ss_pred             Ccccc--cCCCCCCCCc-----------ccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccccCCC
Q 016401          283 NYTEF--KFPQIKPHPW-----------HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  342 (390)
Q Consensus       283 ~~~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~~~~  342 (390)
                      ....+  ..+......+           ........++++++||++||.+||++|||++|+|+||||+...++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence            22111  0000001111           111122346789999999999999999999999999999986543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=403.23  Aligned_cols=285  Identities=29%  Similarity=0.467  Sum_probs=220.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCC---CC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~  119 (390)
                      ..+|++++.||+|+||+||+|+++.+|+.||||++..+      .....+|+.+|++++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            45899999999999999999999999999999998433      2234589999999999999999998854322   12


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          120 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       120 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ...+|+||||+.+++....   ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~---~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH---TCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCccchh---hhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCC-cEEeeecce
Confidence            3457899999998764433   2335679999999999999999999998 9999999999999999998 799999999


Q ss_pred             ccccccC-----CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      ++.....     ......+||+.|+|||++.+...++.++||||+||++|||++|++||.+.++.+.+..+.+..+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9755322     22344578999999999987777999999999999999999999999999999999999998887765


Q ss_pred             HHHhhcCcCccc--ccCCCCCCCCccccc-ccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          275 EEIKCMNPNYTE--FKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       275 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      +...........  +.............+ ....+++++|||.+||++||++|||+.|+|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            543322111100  111111111111100 1124778999999999999999999999999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=409.46  Aligned_cols=262  Identities=26%  Similarity=0.360  Sum_probs=208.5

Q ss_pred             ccEEEee-eeeecCceEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHh-CCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ++|.+.+ .||+|+||+||+|+++.+++.||||++.. .....+|+.++.+ .+|||||+++++|.+.. ....++|+||
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ivm   88 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVM   88 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEEE
Confidence            4798875 69999999999999999999999999865 4456689998655 58999999999884322 3356689999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC--CcEEEeecCCccccc
Q 016401          128 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLV  204 (390)
Q Consensus       128 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~Dfg~a~~~~  204 (390)
                      |||+ |+|.+++...  ....+++..++.++.||+.||+|||+ .||+||||||+|||++.+.  ..+||+|||+|+...
T Consensus        89 Ey~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          89 ECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             ECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             ECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeecc
Confidence            9998 5888877642  23569999999999999999999998 9999999999999998532  269999999998776


Q ss_pred             cCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 016401          205 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  284 (390)
Q Consensus       205 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (390)
                      .........||+.|+|||++.+ ..|+.++|||||||++|+|+||++||.+.+..+....+...+..             
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-------------  231 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-------------  231 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-------------
T ss_pred             CCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-------------
Confidence            6666677889999999999954 45899999999999999999999999887655544433321100             


Q ss_pred             ccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCcccc
Q 016401          285 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  338 (390)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~  338 (390)
                      ..+.++        ......+++++++||++||++||++|||+.|+|+||||++
T Consensus       232 ~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 GQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             CSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            011111        1112357999999999999999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.7e-54  Score=385.75  Aligned_cols=256  Identities=26%  Similarity=0.361  Sum_probs=202.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHhCCCCceeeecceeccCCCCCce
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      .++|++.+.||+|+||+||+|++..+|+.||||++..+.       ..+.+|+.+++.++||||+++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            357999999999999999999999999999999985431       23457999999999999999999885433 3445


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCc
Q 016401          122 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  200 (390)
Q Consensus       122 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a  200 (390)
                      .+|+||||++| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~-~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTS-CEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccc-cceeehhhhh
Confidence            68899999995 66555543    4679999999999999999999998 9999999999999999888 7999999998


Q ss_pred             cccccCC----CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          201 KVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       201 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      .......    .....+||+.|+|||++.+ ..++.++|||||||++|+|+||++||.+.+..+.+.+++.....+    
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~----  233 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----  233 (277)
T ss_dssp             EECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC----
T ss_pred             hhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC----
Confidence            6543322    2345678999999999965 458999999999999999999999999988887777666521110    


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  337 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~  337 (390)
                                           .....+.+|+++++||.+||++||++||+..+.+.|+|.+
T Consensus       234 ---------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 ---------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ---------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                 1112356899999999999999999999555555577764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-53  Score=384.73  Aligned_cols=252  Identities=19%  Similarity=0.320  Sum_probs=203.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+|++.+.||+|+||+||+|.++.+++.||||+++.+.   ..+.+|+.+|++++|||||++++++.+.     ..+|+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeEE
Confidence            358999999999999999999999999999999986543   3456899999999999999999998432     23679


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      |||||+ |++..++...  ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCC-cEEEccccceeecC
Confidence            999998 5777766542  23578999999999999999999998 9999999999999999988 79999999998654


Q ss_pred             cCCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          205 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       205 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      .....  ....||+.|+|||++.+. .|+.++|||||||++|||++|..||........+.+++...             
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-------------  232 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------------  232 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-------------
T ss_pred             CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-------------
Confidence            33222  334578999999999654 58999999999999999999766655544444444444310             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCCccccc
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  339 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp~f~~~  339 (390)
                          +          ...++..+++++++||.+||+.||++|||+.++++  +|+.+
T Consensus       233 ----~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         233 ----Y----------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             ----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ----C----------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                0          01123568999999999999999999999999964  56544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=380.14  Aligned_cols=248  Identities=21%  Similarity=0.270  Sum_probs=197.4

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      ..+|++.+.||+|+||+||+|+.+   ..||||++...      ...+.+|+.+|++++|||||++++++..     . .
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-----~-~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----P-Q   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S-S
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-----c-E
Confidence            357999999999999999999864   35999998532      2345589999999999999999987621     1 2


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      +++|||||+ |+|.+++..   ....+++..+..++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDL-TVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCC-CEEEcccccee
Confidence            679999998 588776653   23569999999999999999999998 9999999999999999988 79999999997


Q ss_pred             ccccCC---CCcceeeccccccchhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          202 VLVKGE---PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       202 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ......   ......||+.|+|||++.+.  ..|+.++|||||||++|||+||+.||.+.+..+.+..+......++   
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p---  229 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP---  229 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence            654322   22345789999999999542  3479999999999999999999999998877776665554321110   


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                          .....+.++++++.+||.+||..||++|||+.+++++
T Consensus       230 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 --------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                0111235689999999999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=375.00  Aligned_cols=244  Identities=19%  Similarity=0.318  Sum_probs=191.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|+||+||+|+++ +++.||||++...   ...+.+|++++++++|||||++++++....     .+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEE
Confidence            47999999999999999999985 5778999998643   244568999999999999999999984432     37799


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||++ |+|.+++..   ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus        79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred             EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCC-CeEecccchheeccC
Confidence            99998 577766553   23568899999999999999999998 9999999999999999988 799999999986544


Q ss_pred             CCCC--cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ....  ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+....             
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-------------  219 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------------  219 (263)
T ss_dssp             -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-------------
T ss_pred             CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-------------
Confidence            3222  335679999999999654 59999999999999999999 567777666655555554310             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                     ....+..+++++.+||.+||+.||++|||++++++|
T Consensus       220 ---------------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         220 ---------------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                           001224578999999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-53  Score=387.62  Aligned_cols=250  Identities=22%  Similarity=0.331  Sum_probs=202.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCc-----EEEEEEeccc-----hhhHHHHHHHHHhC-CCCceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  117 (390)
                      .++|++.+.||+|+||+||+|++..+++     .||+|.+...     .....+|+.++.++ +|||||++++++.+.  
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS--  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence            3589999999999999999999876543     6999988432     23345799999988 899999999998433  


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh-------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSR-------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  177 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~D  177 (390)
                         ..+|+|||||+ |+|.+++.....                   ....+++..++.++.||+.||+|||+ +||+|||
T Consensus       114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD  189 (325)
T d1rjba_         114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  189 (325)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence               33789999998 588888764321                   12358899999999999999999998 9999999


Q ss_pred             CCCCcEEEcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 016401          178 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLF  253 (390)
Q Consensus       178 lkp~NIll~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf  253 (390)
                      |||+|||++.++ .+||+|||+|+........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||
T Consensus       190 lKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         190 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCC
Confidence            999999999888 8999999999866554432   345679999999999654 58999999999999999997 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          254 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .+.+..+.+.+++...                 ...          ..+..+++++++||.+||+.||++|||++|+++|
T Consensus       268 ~~~~~~~~~~~~~~~~-----------------~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVDANFYKLIQNG-----------------FKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCSHHHHHHHHTT-----------------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcC-----------------CCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9877767776665521                 100          1234689999999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-53  Score=378.22  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=201.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+|++.+.||+|+||+||+|+++ +++.||||++....   ..+.+|++++++++|||||++++++..    +.  +|+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~--~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----EP--IYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----CC--eEE
Confidence            358999999999999999999985 57889999986432   345689999999999999999997632    11  569


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||++ |+|...+...  ....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+...
T Consensus        85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~  160 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLIE  160 (272)
T ss_dssp             EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeeccc-ceeeccccceEEcc
Confidence            999998 4776654332  23468999999999999999999998 9999999999999999988 79999999998764


Q ss_pred             cCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+....            
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~------------  227 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------  227 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------
Confidence            432  22345678999999999654 489999999999999999995 56666666555554443210            


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc--CCcccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  338 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~--hp~f~~  338 (390)
                                      ....+..+++++.+||.+||+.||++|||++++++  |+||..
T Consensus       228 ----------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         228 ----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                            01123568999999999999999999999999998  888864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-52  Score=380.98  Aligned_cols=246  Identities=24%  Similarity=0.355  Sum_probs=189.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCc---EEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+|++.+.||+|+||+||+|+++.+++   .||||.+...     ...+.+|+++|++++|||||++++++...     
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence            3579999999999999999999987665   5889987532     23456899999999999999999998433     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+|+|||||++ +|..++..   ....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGl  174 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGL  174 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCC-cEEECCccc
Confidence            237799999985 67665543   23568999999999999999999998 9999999999999999988 799999999


Q ss_pred             ccccccCCCC------cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016401          200 AKVLVKGEPN------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  272 (390)
Q Consensus       200 a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (390)
                      |+........      ....+|+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+..+....   
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~---  250 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY---  250 (299)
T ss_dssp             ---------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence            9865433221      22356889999999965 458999999999999999998 899999888766665554310   


Q ss_pred             CHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          273 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                     ..          ..+..+++++.+||.+||+.||++|||+.+++++
T Consensus       251 ---------------~~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         251 ---------------RL----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ---------------CC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------CC----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                           00          0124689999999999999999999999998864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=388.83  Aligned_cols=255  Identities=28%  Similarity=0.462  Sum_probs=206.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEE---cCCCcEEEEEEeccc--------hhhHHHHHHHHHhCCC-CceeeecceeccCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKVLQD--------KRYKNRELQIMQMLDH-PNIVALKHCFFSTTD  117 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~  117 (390)
                      ++|++++.||+|+||+||+|++   +.+|+.||||++.+.        .....+|++++++++| |||+++++++     
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-----   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence            5799999999999999999987   457899999988532        2334579999999987 7999999988     


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEee
Q 016401          118 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  196 (390)
Q Consensus       118 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  196 (390)
                      .+...++++|||+.+ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~vkL~D  172 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTD  172 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEESC
T ss_pred             ccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCC-CEEEee
Confidence            334458899999985 77666654    4678899999999999999999998 9999999999999999988 799999


Q ss_pred             cCCccccccC--CCCcceeeccccccchhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          197 FGSAKVLVKG--EPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       197 fg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      ||+|+.....  .......|++.|+|||.+.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+....  
T Consensus       173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--  250 (322)
T d1vzoa_         173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--  250 (322)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred             ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--
Confidence            9999765332  2234567899999999996543 4788999999999999999999999887655555444432100  


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCC-----CHHHHhcCCcccccC
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  340 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~~~l~hp~f~~~~  340 (390)
                                   .          ...++..+++++++||++||++||++||     |++|+|+||||++++
T Consensus       251 -------------~----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         251 -------------S----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             -------------C----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             -------------C----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence                         0          0112346899999999999999999999     589999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=370.44  Aligned_cols=244  Identities=21%  Similarity=0.295  Sum_probs=202.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      ++|++.+.||+|+||+||+|+++ +++.||||+++..   ...+.+|+.++++++||||+++++++.+.     ..+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEE
Confidence            47999999999999999999984 7889999998653   34456899999999999999999998432     237899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcccccc
Q 016401          127 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  205 (390)
Q Consensus       127 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~  205 (390)
                      |||++ |++..++..   ....+++..+.+++.|++.||+|||+ .||+||||||+|||++.++ .+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence            99998 566655443   24578899999999999999999998 9999999999999999888 799999999976543


Q ss_pred             CCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 016401          206 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  282 (390)
Q Consensus       206 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (390)
                      ...  .....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+..             
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-------------  218 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------------  218 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-------------
T ss_pred             CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            322  2345679999999999654 48999999999999999998 899999988777665554310             


Q ss_pred             CcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          283 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                     ....+..+++++.+||++||+.||++|||+.++++|
T Consensus       219 ---------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         219 ---------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                           001224678999999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=376.21  Aligned_cols=246  Identities=24%  Similarity=0.308  Sum_probs=195.5

Q ss_pred             EEEe-eeeeecCceEEEEEEEc--CCCcEEEEEEeccch------hhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           52 YIAE-HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        52 y~~~-~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      +.+. +.||+|+||+||+|.++  .+++.||||+++.+.      ..+.+|+++|++++|||||++++++..     +. 
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~-   81 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ES-   81 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SS-
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CC-
Confidence            4444 57999999999999864  456789999985421      235689999999999999999998732     12 


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .|+|||||++ +|..++..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        82 ~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~-~~kl~DFGla~  155 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSK  155 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccC-cccccchhhhh
Confidence            5699999984 77776654    4679999999999999999999998 9999999999999999888 79999999998


Q ss_pred             ccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          202 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       202 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      ........    ....||+.|+|||++.+. .++.++|||||||++|||++ |++||.+.+..+....+.+.  .     
T Consensus       156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~-----  227 (277)
T d1xbba_         156 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--E-----  227 (277)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--C-----
T ss_pred             hccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence            65433222    234678999999999654 48999999999999999998 89999988766555444321  0     


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHH---hcCCcccc
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFDE  338 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~---l~hp~f~~  338 (390)
                                           ...++..+|+++.+||.+||..||++|||++++   |+|+|++-
T Consensus       228 ---------------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 ---------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ---------------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                                 001235689999999999999999999999988   56776643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=376.70  Aligned_cols=250  Identities=26%  Similarity=0.336  Sum_probs=201.6

Q ss_pred             cccEEEeee-eeecCceEEEEEEEcC--CCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHV-VGTGSFGVVFQAKCRE--TGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+|.+.+. ||+|+||+||+|.++.  ++..||||+++..     ...+.+|+++|++++|||||++++++.+     +
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----C
Confidence            457899885 9999999999998754  4557999998543     2334579999999999999999998732     1


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      . +|+|||||++ +|..++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        82 ~-~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGl  155 (285)
T d1u59a_          82 A-LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGL  155 (285)
T ss_dssp             S-EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             e-EEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCC-ceeeccchh
Confidence            1 6799999995 77665532   23579999999999999999999998 9999999999999999888 799999999


Q ss_pred             ccccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016401          200 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  274 (390)
Q Consensus       200 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (390)
                      |+.......    .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+.  .   
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--~---  229 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--K---  229 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--C---
T ss_pred             hhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C---
Confidence            986644322    2234578999999999654 58999999999999999998 99999988776665554331  0   


Q ss_pred             HHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHH---hcCCcccc
Q 016401          275 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFDE  338 (390)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~---l~hp~f~~  338 (390)
                                             ...+++.+|+++.+||.+||..||++|||+.++   |+|+|+.-
T Consensus       230 -----------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         230 -----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             -----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                                   001235689999999999999999999999877   67888854

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=368.90  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=196.6

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEE
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      ..+|++.+.||+|+||+||+|+++.+ +.||||++....   ..+.+|+.++++++|||||++++++.+    +.  +++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~----~~--~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EP--IYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec----CC--eEE
Confidence            35899999999999999999999654 679999986433   446689999999999999999998732    12  569


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccc
Q 016401          126 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  204 (390)
Q Consensus       126 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~  204 (390)
                      ||||+.+ ++..++...  ..+.+++..+..++.||+.||+|||+ .||+||||||+||||+.++ .+||+|||+|+...
T Consensus        89 v~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~  164 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIE  164 (285)
T ss_dssp             EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC---
T ss_pred             EEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCC-cEEEcccchhhhcc
Confidence            9999995 565554432  24569999999999999999999998 9999999999999999888 79999999998654


Q ss_pred             cCC--CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016401          205 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  281 (390)
Q Consensus       205 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (390)
                      ...  ......||+.|+|||++.. ..++.++|||||||++|||++| .+||.+....+.+..+....            
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~------------  231 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------  231 (285)
T ss_dssp             -----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------
Confidence            332  2234567999999999965 4589999999999999999995 45556666555555443311            


Q ss_pred             cCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc--CCccccc
Q 016401          282 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDEL  339 (390)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~--hp~f~~~  339 (390)
                            .          ...+..+++++++||.+||+.||++|||++++++  |+||...
T Consensus       232 ------~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         232 ------R----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ------C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ------C----------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                  0          0122568999999999999999999999999987  8888654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=363.54  Aligned_cols=245  Identities=23%  Similarity=0.307  Sum_probs=186.7

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCC----cEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      ...|++.++||+|+||.||+|.++.++    ..||||++....     ..+.+|++++++++|||||++++++...    
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~----   81 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY----   81 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC----
Confidence            347999999999999999999987654    479999985421     2345899999999999999999998433    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                       ...++||||+.+ ++...+..   ....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++ .+||+|||
T Consensus        82 -~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG  155 (283)
T d1mqba_          82 -KPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFG  155 (283)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCC
T ss_pred             -CceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCC-eEEEcccc
Confidence             237799999986 45444332   34679999999999999999999998 9999999999999999988 79999999


Q ss_pred             CccccccCCC----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCC
Q 016401          199 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       199 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      +|+.......    .....||+.|+|||++.+ ..++.++|||||||++|||++|. +||.+.+..+.+..+...     
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-----  229 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-----  229 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-----
Confidence            9986544322    123457899999999965 45999999999999999999965 555555544444333221     


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                                   ..          ...+..+++++.+||.+||..||++|||+.++++
T Consensus       230 -------------~~----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         230 -------------FR----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             -------------CC----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------CC----------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                         00          0122457899999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-51  Score=366.64  Aligned_cols=245  Identities=26%  Similarity=0.348  Sum_probs=190.2

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCC---CcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      ..+|++.+.||+|+||.||+|++..+   +..||||.+...     ...+.+|+.++++++|||||++++++..      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            35899999999999999999998654   356899987532     1234579999999999999999998731      


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ..+|+||||+++ ++..++..   ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~-~~Kl~DfG~  154 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGL  154 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred             CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCC-cEEEccchh
Confidence            126799999985 66555433   24578999999999999999999998 9999999999999999988 799999999


Q ss_pred             ccccccCCC--CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016401          200 AKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  276 (390)
Q Consensus       200 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (390)
                      |+.......  .....||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+....       
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-------  226 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------  226 (273)
T ss_dssp             ----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred             heeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Confidence            986543322  234457899999999965 458999999999999999998 899999888777666554310       


Q ss_pred             HhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          277 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                           ...+++++|+++.+||.+||..||++|||+.++++|
T Consensus       227 ---------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         227 ---------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                 001235789999999999999999999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=371.62  Aligned_cols=245  Identities=22%  Similarity=0.328  Sum_probs=193.6

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCc----EEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCc
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  120 (390)
                      .+|++.++||+|+||+||+|.+..+|+    .||+|.+...     ...+.+|++++++++|||||++++++.+.     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            469999999999999999999988876    5888877432     23456899999999999999999998432     


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          121 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       121 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      . .+++|||+. ++|...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~-~~kl~DFGl  157 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGL  157 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred             C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCC-CeEeecccc
Confidence            2 346666665 677665543   35679999999999999999999998 9999999999999999988 799999999


Q ss_pred             ccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016401          200 AKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  275 (390)
Q Consensus       200 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (390)
                      |+........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+. ..+   
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-~~~---  232 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERL---  232 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-CCC---
T ss_pred             ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC---
Confidence            9876443322   234579999999999654 58999999999999999998 89999887765554444331 000   


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcCC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  334 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~hp  334 (390)
                                              ..++.+++++.+||.+||..||++|||+.++++|.
T Consensus       233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence                                    11246789999999999999999999999999883

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=366.48  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=191.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  118 (390)
                      ++|++.+.||+|+||.||+|.+..     +++.||||++....     ....+|..++.++ .|+||+.+++++...   
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~---   89 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---   89 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC---
Confidence            589999999999999999999754     45789999985432     2233566666665 688999998877432   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEE
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  185 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll  185 (390)
                       +..+++|||||+ |+|..++.....            ....+++..+..++.||+.||+|||+ +||+||||||+|||+
T Consensus        90 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl  167 (299)
T d1ywna1          90 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL  167 (299)
T ss_dssp             -TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             -CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeE
Confidence             233679999998 588888865432            13458899999999999999999998 999999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 016401          186 NPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQ  261 (390)
Q Consensus       186 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~  261 (390)
                      +.++ .+||+|||+|+.......   .....||+.|+|||++.+ ..++.++||||+||++|||++| .+||.+.+..+.
T Consensus       168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9888 799999999976543322   234578999999999965 4589999999999999999986 578888776666


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          262 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      +..++.....+                           ..+..+++++++||.+||+.||++|||+.++++|
T Consensus       246 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            65555431111                           1224679999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=359.67  Aligned_cols=243  Identities=22%  Similarity=0.338  Sum_probs=194.1

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      .+|++.+.||+|+||.||+|+++  |+.||||+++.+.  ..+.+|++++++++||||+++++++....    ..+|+||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEEE
Confidence            47999999999999999999984  7889999996543  44568999999999999999999874322    2267999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCccccccC
Q 016401          128 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  206 (390)
Q Consensus       128 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~~~~~~  206 (390)
                      ||++ |+|.+++....  ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.... 
T Consensus        81 ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~-  155 (262)
T d1byga_          81 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS-  155 (262)
T ss_dssp             CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC-------
T ss_pred             eccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCC-CEeecccccceecCC-
Confidence            9998 58888776432  2358899999999999999999998 9999999999999999998 799999999986533 


Q ss_pred             CCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 016401          207 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  285 (390)
Q Consensus       207 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (390)
                       ......+|+.|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+....+.+.                 
T Consensus       156 -~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-----------------  216 (262)
T d1byga_         156 -TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----------------  216 (262)
T ss_dssp             -------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------------
T ss_pred             -CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             23345678999999999654 58999999999999999998 78999887766655554321                 


Q ss_pred             cccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          286 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                 ....++..+++++++||++||..||.+|||+.+++++
T Consensus       217 -----------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         217 -----------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                       0111235688999999999999999999999999873

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=357.78  Aligned_cols=243  Identities=24%  Similarity=0.337  Sum_probs=189.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCC-C--cEEEEEEeccc-------hhhHHHHHHHHHhCCCCceeeecceeccCCCCC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  119 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  119 (390)
                      .+|++.+.||+|+||.||+|++..+ +  ..||||++..+       ...+.+|+++|++++||||+++++++.+     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            4799999999999999999986433 3  36899987532       1234689999999999999999998842     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecC
Q 016401          120 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  198 (390)
Q Consensus       120 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg  198 (390)
                      . .+++||||++ +++.+.+..   ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             c-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccccc-ceeeccch
Confidence            1 2569999998 466555443   23569999999999999999999998 9999999999999999988 89999999


Q ss_pred             CccccccCCCC----cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016401          199 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  273 (390)
Q Consensus       199 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (390)
                      +++........    ....++..|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+..+.+..    
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~----  231 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG----  231 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC----
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC----
Confidence            99876443322    23346788999999965 458999999999999999998 899999998888776665421    


Q ss_pred             HHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHh
Q 016401          274 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  331 (390)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l  331 (390)
                                   ...          ..++.+|+++++||.+||..||++|||+.+++
T Consensus       232 -------------~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         232 -------------ERL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             -------------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             -------------CCC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                         000          12256899999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-49  Score=361.29  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=199.1

Q ss_pred             cccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      .++|++.+.||+|+||+||+|+.+     .+++.||||++...     ...+.+|+.+|+.++||||+++++++....  
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC--
Confidence            457999999999999999999975     35678999998543     234568999999999999999999984432  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhh--------------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYS--------------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  177 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~D  177 (390)
                         ..+++|||+. |+|.+++....                    .....+++..+..++.||+.||+|||+ .+|||||
T Consensus        90 ---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD  165 (301)
T d1lufa_          90 ---PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  165 (301)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             ---ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence               3779999998 58888775421                    112348889999999999999999998 9999999


Q ss_pred             CCCCcEEEcCCCCcEEEeecCCccccccCC---CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCC
Q 016401          178 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLF  253 (390)
Q Consensus       178 lkp~NIll~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf  253 (390)
                      |||+|||++.++ .+||+|||+|+......   ......+|+.|+|||.+.+ ..|+.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCC
Confidence            999999999988 79999999997653332   2234567899999999965 45999999999999999999985 788


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          254 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+.+..+.+..+.+..                   .+         ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~e~~~~v~~~~-------------------~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGN-------------------IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTSCHHHHHHHHHTTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCC-------------------CC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8888777666554310                   00         122568999999999999999999999999953

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=366.48  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=200.4

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcE--EEEEEecc-----chhhHHHHHHHHHhC-CCCceeeecceeccCCCCCce
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  121 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  121 (390)
                      ++|++.+.||+|+||.||+|+++.++..  ||||++..     ....+.+|+++|+++ +|||||++++++.+     ..
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence            5899999999999999999999888774  67777642     223456899999998 79999999999853     33


Q ss_pred             EEEEEEeccc-ccHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC
Q 016401          122 YLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  188 (390)
Q Consensus       122 ~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  188 (390)
                      .+|+||||++ |+|.+++....            .....+++..+..++.||+.||.|||+ .+|+||||||+|||++.+
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCC
Confidence            4889999999 58888775431            224578999999999999999999998 999999999999999998


Q ss_pred             CCcEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 016401          189 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIK  267 (390)
Q Consensus       189 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~i~~  267 (390)
                      + .+||+|||+|+............||..|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+.+..+.+
T Consensus       164 ~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         164 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             G-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             C-ceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            8 7999999999866555555556789999999999654 5899999999999999999965 67877776665544432


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                      .                  .          ....+..+++++++||.+||+.||++|||+.++++|
T Consensus       242 ~------------------~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 G------------------Y----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             T------------------C----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c------------------C----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            1                  0          001224679999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=359.69  Aligned_cols=248  Identities=21%  Similarity=0.311  Sum_probs=193.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcCCC-------cEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  115 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  115 (390)
                      .++|++.+.||+|+||.||+|++..++       ..||||++..+.     ....+|...+.++ +|||||++++++.+ 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            358999999999999999999976554       479999985543     2234688888777 89999999999943 


Q ss_pred             CCCCceEEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          116 TDKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       116 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                          +..+++||||+. |++..++.....            ....+++..+..++.||+.||+|||+ .+||||||||+|
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N  165 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  165 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence                334789999998 588887764321            13468999999999999999999998 999999999999


Q ss_pred             EEEcCCCCcEEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016401          183 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  258 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  258 (390)
                      ||++.++ .+||+|||+++.......   .....+|+.|+|||.+.+ ..|+.++|||||||++|||++ |.+||.+.+.
T Consensus       166 iLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         166 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             EEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            9999998 799999999986644332   234578999999999965 459999999999999999998 7899988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          259 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+....+... ..                           ..++..+++++++||.+||++||++|||+.|+++
T Consensus       244 ~~~~~~i~~~-~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 EELFKLLKEG-HR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTT-CC---------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcC-CC---------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            5544433221 00                           0123568999999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-49  Score=359.49  Aligned_cols=259  Identities=21%  Similarity=0.234  Sum_probs=198.0

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      ++|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+++++.++|+|++..+..+..    .....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEEEE
Confidence            4799999999999999999999999999999987543  3456789999999998876665554432    233477999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC--CCcEEEeecCCcccccc
Q 016401          128 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVK  205 (390)
Q Consensus       128 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~Dfg~a~~~~~  205 (390)
                      ||+++++...+..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++..  ...+||+|||+|+....
T Consensus        83 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9999988665543   34679999999999999999999998 999999999999998542  23699999999987644


Q ss_pred             CCC--------CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016401          206 GEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  277 (390)
Q Consensus       206 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (390)
                      ...        .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+....+......    ..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----~~  233 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KM  233 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH----HH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc----cC
Confidence            321        2345789999999999654 5899999999999999999999999876654443333221000    00


Q ss_pred             hhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHH---HHhcCCcccc
Q 016401          278 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL---EACVHPFFDE  338 (390)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~---~~l~hp~f~~  338 (390)
                                .       .......+++|+++.+||.+||..||++||++.   ++|+|+|.+.
T Consensus       234 ----------~-------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         234 ----------S-------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ----------H-------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------C-------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                      0       000112246899999999999999999999986   5577887654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-48  Score=366.27  Aligned_cols=283  Identities=30%  Similarity=0.464  Sum_probs=208.7

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHhCC-----------CCceeeecceeccC
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFST  115 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~~  115 (390)
                      .+|++++.||+|+||+||+|+++.+|+.||||+++++.   ....+|+.+++.+.           |+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            36999999999999999999999999999999997653   33457999888875           57888888877432


Q ss_pred             CCCCceEEEEEEecc--cccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCC---
Q 016401          116 TDKEELYLNLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---  190 (390)
Q Consensus       116 ~~~~~~~~~lv~e~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---  190 (390)
                         ...+.+++|+++  .++......  ......+++..++.++.||+.||+|||+..||+||||||+|||++.++.   
T Consensus        93 ---~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          93 ---GPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             ---ETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             ---cccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence               122233444444  344333332  2335678999999999999999999996478999999999999986542   


Q ss_pred             --cEEEeecCCccccccCCCCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHH
Q 016401          191 --QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQL  262 (390)
Q Consensus       191 --~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~  262 (390)
                        .++|+|||.+....  ......+||+.|+|||++... .++.++|+||+||++++|++|+.||...+      ..+.+
T Consensus       168 ~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         168 LIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             cceeeEeecccccccc--cccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence              49999999987543  334556789999999999754 48999999999999999999999997543      34567


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccc-------cCCCCCCCCccc------ccccCCChhHHHHHHHhcccCCCcCCCHHH
Q 016401          263 VEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHK------VFQKRLPPEAVDLVCRFFQYSPNLRCTALE  329 (390)
Q Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~R~s~~~  329 (390)
                      ......++.++.+...........+       ........++..      .+....+++++|||.+||++||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            7778888888776654322111111       111111111111      112345678999999999999999999999


Q ss_pred             HhcCCcccccC
Q 016401          330 ACVHPFFDELR  340 (390)
Q Consensus       330 ~l~hp~f~~~~  340 (390)
                      +|+||||++..
T Consensus       325 ~L~Hp~f~~~~  335 (362)
T d1q8ya_         325 LVNHPWLKDTL  335 (362)
T ss_dssp             HHTCGGGTTCT
T ss_pred             HhcCcccCCCC
Confidence            99999999653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-49  Score=358.33  Aligned_cols=255  Identities=21%  Similarity=0.287  Sum_probs=204.9

Q ss_pred             cccEEEeeeeeecCceEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHhCCCCceeeecceeccCCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  118 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  118 (390)
                      .++|++.+.||+|+||+||+|.++.     +++.||||++....     ..+.+|+.++++++||||+++++++...   
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~---   95 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG---   95 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS---
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC---
Confidence            4689999999999999999998752     35789999986432     2245899999999999999999998432   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCc
Q 016401          119 EELYLNLVLEYVP-ETVNRIARNYSR------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  191 (390)
Q Consensus       119 ~~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~  191 (390)
                        ...++||||+. |+|..++.....      ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ +
T Consensus        96 --~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~-~  171 (308)
T d1p4oa_          96 --QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T  171 (308)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-C
T ss_pred             --CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCc-e
Confidence              23679999998 578777654321      11346888999999999999999998 9999999999999999988 7


Q ss_pred             EEEeecCCccccccCCC---CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 016401          192 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIK  267 (390)
Q Consensus       192 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~  267 (390)
                      +||+|||+|+.......   .....+|+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999976544322   2334689999999999654 589999999999999999998 588888877776665543


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc------CCccccc
Q 016401          268 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDEL  339 (390)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~------hp~f~~~  339 (390)
                      ..                   .+         ..++.+++.+.+||.+||+.||++|||+.++++      +|+|+++
T Consensus       251 ~~-------------------~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         251 GG-------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             TC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             CC-------------------CC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            10                   00         112468899999999999999999999999987      7777654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=355.41  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=201.5

Q ss_pred             cccEEEeeeeeecCceEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHhC-CCCceeeecceeccCCC
Q 016401           49 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  117 (390)
Q Consensus        49 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  117 (390)
                      .++|++.+.||+|+||.||+|++.     .+++.||||++....     ..+.+|+.+++++ +|||||++++++.+.  
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~--   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--
Confidence            358999999999999999999863     467789999986432     2345799999998 699999999998432  


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh--------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCc
Q 016401          118 KEELYLNLVLEYVP-ETVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  182 (390)
Q Consensus       118 ~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~N  182 (390)
                         ..+|+|||||+ |++..++.....              ....+++..+..++.||+.||+|||+ +||+||||||+|
T Consensus       100 ---~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N  175 (311)
T d1t46a_         100 ---GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN  175 (311)
T ss_dssp             ---SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence               33789999998 477777764321              23368899999999999999999998 999999999999


Q ss_pred             EEEcCCCCcEEEeecCCccccccCCCC---cceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016401          183 LLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  258 (390)
Q Consensus       183 Ill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  258 (390)
                      |+++.++ .+||+|||.++........   ....||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+.
T Consensus       176 Il~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999887 7999999999876543322   33577999999999965 458999999999999999998 6777877777


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          259 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      .+.+.+++.....+                           ..+..+++++.+||.+||+.||++|||++++++
T Consensus       254 ~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            67776666531111                           122457899999999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-47  Score=345.03  Aligned_cols=249  Identities=19%  Similarity=0.196  Sum_probs=198.2

Q ss_pred             ccEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHhCCC-CceeeecceeccCCCCCceEEEEE
Q 016401           50 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLV  126 (390)
Q Consensus        50 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv  126 (390)
                      .+|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++| +|++.+++++     ......|+|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEEE
Confidence            3799999999999999999999999999999987543  3446789999999976 8999988887     334457899


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCC----CCcEEEeecCCccc
Q 016401          127 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKV  202 (390)
Q Consensus       127 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~----~~~vkl~Dfg~a~~  202 (390)
                      |||++++|..++...   ...+++..+..++.|++.||+|||+ +||+||||||+|||++.+    ...+||+|||+|+.
T Consensus        80 me~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999999987776542   3579999999999999999999998 999999999999999742    23699999999986


Q ss_pred             cccCC--------CCcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Q 016401          203 LVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGT  271 (390)
Q Consensus       203 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~  271 (390)
                      .....        ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....   +....+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            54321        2234579999999999965 45899999999999999999999999865432   223333322111


Q ss_pred             CCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          272 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ++..                        .+.+++|+++.+++..|+..+|++||+...+.+
T Consensus       235 ~~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CChH------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            1111                        112468999999999999999999999876643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=350.32  Aligned_cols=245  Identities=19%  Similarity=0.256  Sum_probs=188.5

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCC---cEEEEEEeccc-----hhhHHHHHHHHHhCCCCceeeecceeccCCCCCceE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  122 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  122 (390)
                      .+...++||+|+||+||+|++..++   ..||||+++..     ...+.+|+++|++++||||+++++++...    +..
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~  103 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS  103 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCc
Confidence            4455789999999999999986543   36899998532     23356899999999999999999987432    234


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          123 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       123 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .++|||||++ ++.+++..   .....++..+..++.|++.||.|||+ .+|+||||||+|||+++++ .+||+|||+++
T Consensus       104 ~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~  178 (311)
T d1r0pa_         104 PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLAR  178 (311)
T ss_dssp             EEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSSGGGC
T ss_pred             eEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCC-CEEEecccchh
Confidence            7899999995 66555543   24567788899999999999999998 9999999999999999887 79999999998


Q ss_pred             ccccCCC-----CcceeeccccccchhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHH
Q 016401          202 VLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTRE  275 (390)
Q Consensus       202 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~  275 (390)
                      .......     .....||+.|+|||.+.+. .++.++|||||||++|||++|..||........ ...+...  .    
T Consensus       179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~----  251 (311)
T d1r0pa_         179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R----  251 (311)
T ss_dssp             CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--C----
T ss_pred             hccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--C----
Confidence            6543322     2235679999999999654 589999999999999999998777765433222 2222210  0    


Q ss_pred             HHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhcC
Q 016401          276 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  333 (390)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~h  333 (390)
                                            ....++.+++++.+||.+||..||++|||+.|+++|
T Consensus       252 ----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 ----------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                  001224678999999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=346.20  Aligned_cols=266  Identities=21%  Similarity=0.201  Sum_probs=187.2

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccchhh-HHH--HHHHHHhCCCCceeeecceeccCCCCCceEEEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNR--ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  127 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~--E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  127 (390)
                      +|.+.+.||+|+||.||+|++  +|+.||||++..+... ..+  |+..+..++||||+++++++.+.. .....+|+||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence            699999999999999999986  5899999998654322 223  444556789999999999986543 3344678999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh-------cCCcccccCCCCcEEEcCCCCcEEEeecCC
Q 016401          128 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-------CIGICHRDIKPQNLLVNPHTHQLKLCDFGS  199 (390)
Q Consensus       128 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~-------~~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~  199 (390)
                      ||++ |+|..++..     ..+++..+..++.|++.||+|||+       .+||+||||||+||||+.++ .+||+|||+
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl  154 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL  154 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTT
T ss_pred             ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCc
Confidence            9997 588888764     468999999999999999999995       15999999999999999988 799999999


Q ss_pred             ccccccCCC-----CcceeeccccccchhhcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016401          200 AKVLVKGEP-----NVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  269 (390)
Q Consensus       200 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  269 (390)
                      ++.......     .....||+.|+|||++.+..     .++.++|||||||++|||+||.+||......+...... ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-~~  233 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-VP  233 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-SC
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-cc
Confidence            987654332     23457899999999985432     25678999999999999999998875322110000000 00


Q ss_pred             CCCCHHHHhhcCcCcccccCCCCCCCCcccccccCCChhHHHHHHHhcccCCCcCCCHHHHhc
Q 016401          270 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  332 (390)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~~~l~  332 (390)
                      ..+....+...      .......+..............+.+|+.+||..||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~------~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SSCCHHHHHHH------HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHH------HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            00111111000      0000000000011111223456899999999999999999999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=4.7e-26  Score=192.24  Aligned_cols=160  Identities=17%  Similarity=0.113  Sum_probs=117.2

Q ss_pred             EEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccch----------------------hhHHHHHHHHHhCCCCceeeec
Q 016401           52 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------RYKNRELQIMQMLDHPNIVALK  109 (390)
Q Consensus        52 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~~  109 (390)
                      |.+.++||+|+||+||+|++. +|+.||||++....                      ....+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568899999999999999984 78999999864210                      1123578889999999998876


Q ss_pred             ceeccCCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccccCCCCcEEEcCCC
Q 016401          110 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  189 (390)
Q Consensus       110 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~  189 (390)
                      ++.     .    .+++|||+++..          ...++...+..++.|++.+|+|||+ +||+||||||+|||++++ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~----------~~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKE----------LYRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEE----------GGGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeecccc----------ccchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-
Confidence            543     1    258999999732          1224555577889999999999998 999999999999999965 


Q ss_pred             CcEEEeecCCccccccCCCCcceeecccccc------chhhcCCCCCCCchhHHHHHHHH
Q 016401          190 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA------PELIFGATEYTTAIDIWSTGCVM  243 (390)
Q Consensus       190 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~a------PE~~~~~~~~~~~~DiwslG~il  243 (390)
                       .++|+|||.|.........       .|..      .+.+ . ..|+.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH-c-CCCCCcccHHHHHHHH
Confidence             4999999999754322111       1111      1222 2 3478999999985443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.27  E-value=2.5e-06  Score=73.20  Aligned_cols=75  Identities=16%  Similarity=0.113  Sum_probs=48.9

Q ss_pred             cEEEeeeeeecCceEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHhCC-CCceeeecceeccCCCCCceEEEE
Q 016401           51 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  125 (390)
Q Consensus        51 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  125 (390)
                      .|++.+..+.++.+.||+..  ..++.++||+....    .....+|..+++.+. +-.+.+++.+.     ..+...++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            57777776666678999886  35667889987533    234568998888774 32234444433     22234679


Q ss_pred             EEecccc
Q 016401          126 VLEYVPE  132 (390)
Q Consensus       126 v~e~~~~  132 (390)
                      ||++++|
T Consensus        88 v~~~l~G   94 (263)
T d1j7la_          88 LMSEADG   94 (263)
T ss_dssp             EEECCSS
T ss_pred             EEEeccc
Confidence            9999987

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.94  E-value=3.5e-05  Score=70.09  Aligned_cols=71  Identities=17%  Similarity=0.139  Sum_probs=43.3

Q ss_pred             eeeeeecCceEEEEEEEcCCCcEEEEEEecc-----------chhhHHHHHHHHHhCC-C--CceeeecceeccCCCCCc
Q 016401           55 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD-H--PNIVALKHCFFSTTDKEE  120 (390)
Q Consensus        55 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~~  120 (390)
                      .+.||.|....||++.+..+++.++||.-..           .......|.+.|+.+. +  ..+++++.+.     .+.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-----~~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----TEM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-----CCC
Confidence            4568999999999999877788999995421           1122346888888773 2  2344444332     222


Q ss_pred             eEEEEEEecccc
Q 016401          121 LYLNLVLEYVPE  132 (390)
Q Consensus       121 ~~~~lv~e~~~~  132 (390)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              2479999974

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.83  E-value=3.3e-05  Score=65.53  Aligned_cols=69  Identities=19%  Similarity=0.134  Sum_probs=43.1

Q ss_pred             eeecC-ceEEEEEEEcCCCcEEEEEEeccch-hhHHHHHHHHHhCCCCc--eeeecceeccCCCCCceEEEEEEecccc
Q 016401           58 VGTGS-FGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPE  132 (390)
Q Consensus        58 lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~~  132 (390)
                      +..|. .+.||+... ..+..+++|...... ....+|...++.+....  +.+++.+..     +....++||++++|
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence            34444 468899876 456678899775433 34668999988874333  334444431     12235689999975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.16  E-value=0.0011  Score=59.90  Aligned_cols=70  Identities=17%  Similarity=0.230  Sum_probs=45.8

Q ss_pred             EeeeeeecCceEEEEEEEcC-------CCcEEEEEEeccc--hhhHHHHHHHHHhCCCCcee-eecceeccCCCCCceEE
Q 016401           54 AEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYL  123 (390)
Q Consensus        54 ~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~  123 (390)
                      -++.|+.|-.-.+|++....       ..+.|.+++.-..  .....+|..+++.+.-.++. +++.++     .+    
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----
Confidence            34578888899999998753       3456778876432  22345799999888533443 555554     21    


Q ss_pred             EEEEecccc
Q 016401          124 NLVLEYVPE  132 (390)
Q Consensus       124 ~lv~e~~~~  132 (390)
                      .+|+||++|
T Consensus       117 g~I~efi~g  125 (395)
T d1nw1a_         117 GRLEEYIPS  125 (395)
T ss_dssp             EEEECCCCE
T ss_pred             ceEEEEecc
Confidence            368999874

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.97  E-value=0.0023  Score=56.01  Aligned_cols=68  Identities=16%  Similarity=-0.005  Sum_probs=39.8

Q ss_pred             eEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHhCCCCce--eeecceeccCCCCCceEEEEEEecccc
Q 016401           64 GVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVPE  132 (390)
Q Consensus        64 g~V~~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~~  132 (390)
                      -.||++.. .+|+.|++|+....   ...+..|...+..|....+  +.....--........+.+.++++++|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            58999987 56889999988543   3445678888888743222  111111000000123446678888864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.30  E-value=0.016  Score=49.99  Aligned_cols=30  Identities=27%  Similarity=0.269  Sum_probs=26.0

Q ss_pred             CCcccccCCCCcEEEcCCCCcEEEeecCCcc
Q 016401          171 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  201 (390)
Q Consensus       171 ~~ivH~Dlkp~NIll~~~~~~vkl~Dfg~a~  201 (390)
                      .|+||+|+.++||+++.+. ..-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCcchhhhhccccc-ceeEecccccc
Confidence            4799999999999999775 46899999874